0001387467-22-000066.txt : 20220920 0001387467-22-000066.hdr.sgml : 20220920 20220919213750 ACCESSION NUMBER: 0001387467-22-000066 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 118 CONFORMED PERIOD OF REPORT: 20220630 FILED AS OF DATE: 20220920 DATE AS OF CHANGE: 20220919 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALPHA & OMEGA SEMICONDUCTOR Ltd CENTRAL INDEX KEY: 0001387467 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 000000000 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34717 FILM NUMBER: 221251986 BUSINESS ADDRESS: STREET 1: 475 OAKMEAD PARKWAY CITY: SUNNYVALE STATE: CA ZIP: 94085 BUSINESS PHONE: 408-830-9742 MAIL ADDRESS: STREET 1: 475 OAKMEAD PARKWAY CITY: SUNNYVALE STATE: CA ZIP: 94085 FORMER COMPANY: FORMER CONFORMED NAME: ALPHA & OMEGA SEMICONDUCTOR LTD DATE OF NAME CHANGE: 20070123 10-K 1 aosl-20220630.htm 10-K FY 2022 aosl-20220630
00013874672022FYfalseP3Yhttp://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNethttp://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet00013874672021-07-012022-06-3000013874672021-12-31iso4217:USD00013874672022-07-31xbrli:shares00013874672022-06-3000013874672021-06-30iso4217:USDxbrli:shares00013874672020-07-012021-06-3000013874672019-07-012020-06-300001387467us-gaap:PreferredStockMember2019-06-300001387467us-gaap:CommonStockMember2019-06-300001387467us-gaap:TreasuryStockMember2019-06-300001387467us-gaap:AdditionalPaidInCapitalMember2019-06-300001387467us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-06-300001387467us-gaap:RetainedEarningsMember2019-06-300001387467us-gaap:ParentMember2019-06-300001387467us-gaap:NoncontrollingInterestMember2019-06-3000013874672019-06-300001387467us-gaap:CommonStockMember2019-07-012020-06-300001387467us-gaap:AdditionalPaidInCapitalMember2019-07-012020-06-300001387467us-gaap:ParentMember2019-07-012020-06-300001387467us-gaap:TreasuryStockMember2019-07-012020-06-300001387467us-gaap:RetainedEarningsMember2019-07-012020-06-300001387467us-gaap:NoncontrollingInterestMember2019-07-012020-06-300001387467us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-07-012020-06-300001387467us-gaap:PreferredStockMember2020-06-300001387467us-gaap:CommonStockMember2020-06-300001387467us-gaap:TreasuryStockMember2020-06-300001387467us-gaap:AdditionalPaidInCapitalMember2020-06-300001387467us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-300001387467us-gaap:RetainedEarningsMember2020-06-300001387467us-gaap:ParentMember2020-06-300001387467us-gaap:NoncontrollingInterestMember2020-06-3000013874672020-06-300001387467us-gaap:CommonStockMember2020-07-012021-06-300001387467us-gaap:AdditionalPaidInCapitalMember2020-07-012021-06-300001387467us-gaap:ParentMember2020-07-012021-06-300001387467us-gaap:TreasuryStockMember2020-07-012021-06-300001387467us-gaap:RetainedEarningsMember2020-07-012021-06-300001387467us-gaap:NoncontrollingInterestMember2020-07-012021-06-300001387467us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-07-012021-06-300001387467us-gaap:PreferredStockMember2021-06-300001387467us-gaap:CommonStockMember2021-06-300001387467us-gaap:TreasuryStockMember2021-06-300001387467us-gaap:AdditionalPaidInCapitalMember2021-06-300001387467us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-300001387467us-gaap:RetainedEarningsMember2021-06-300001387467us-gaap:ParentMember2021-06-300001387467us-gaap:NoncontrollingInterestMember2021-06-300001387467us-gaap:CommonStockMember2021-07-012022-06-300001387467us-gaap:AdditionalPaidInCapitalMember2021-07-012022-06-300001387467us-gaap:ParentMember2021-07-012022-06-300001387467us-gaap:TreasuryStockMember2021-07-012022-06-300001387467us-gaap:RetainedEarningsMember2021-07-012022-06-300001387467us-gaap:NoncontrollingInterestMember2021-07-012022-06-300001387467us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-07-012022-06-300001387467us-gaap:PreferredStockMember2022-06-300001387467us-gaap:CommonStockMember2022-06-300001387467us-gaap:TreasuryStockMember2022-06-300001387467us-gaap:AdditionalPaidInCapitalMember2022-06-300001387467us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300001387467us-gaap:RetainedEarningsMember2022-06-300001387467us-gaap:ParentMember2022-06-300001387467us-gaap:NoncontrollingInterestMember2022-06-300001387467aosl:FacilityinLiangjiangNewAreaofChongqingtheJointVentureMembersrt:ParentCompanyMember2021-12-012021-12-01xbrli:pure0001387467aosl:ChongqingFundsMemberaosl:FacilityinLiangjiangNewAreaofChongqingtheJointVentureMember2021-12-012021-12-010001387467aosl:FacilityinLiangjiangNewAreaofChongqingtheJointVentureMember2022-06-302022-06-300001387467aosl:ThirdPartyInvestorsMemberaosl:ThirdPartyInvestorsMemberus-gaap:CorporateJointVentureMember2021-12-010001387467aosl:ThirdPartyInvestorsMemberus-gaap:CorporateJointVentureMember2021-12-012021-12-31iso4217:CNY0001387467us-gaap:CorporateJointVentureMember2021-11-302021-11-300001387467us-gaap:CorporateJointVentureMember2021-12-022021-12-0200013874672021-12-02aosl:director00013874672021-11-300001387467aosl:ThirdPartyInvestorsMemberaosl:ThirdPartyInvestorsMemberus-gaap:CorporateJointVentureMember2021-12-240001387467aosl:ThirdPartyInvestorsMemberus-gaap:CorporateJointVentureMember2021-12-242021-12-240001387467aosl:ThirdPartyInvestorsMemberaosl:EmployeeIncentivePlanMemberus-gaap:CorporateJointVentureMemberaosl:EmployeeIncentivePlanMember2021-12-240001387467us-gaap:CorporateJointVentureMember2021-12-312021-12-310001387467aosl:ThirdPartyInvestorsMemberus-gaap:CorporateJointVentureMember2022-01-262022-01-2600013874672022-01-262022-01-260001387467aosl:HHGraceMemberus-gaap:SupplierConcentrationRiskMemberus-gaap:CostOfGoodsProductLineMember2021-07-012022-06-300001387467aosl:HHGraceMemberus-gaap:SupplierConcentrationRiskMemberus-gaap:CostOfGoodsProductLineMember2020-07-012021-06-300001387467aosl:HHGraceMemberus-gaap:SupplierConcentrationRiskMemberus-gaap:CostOfGoodsProductLineMember2019-07-012020-06-300001387467srt:MinimumMemberus-gaap:BuildingMember2021-07-012022-06-300001387467us-gaap:MachineryAndEquipmentMembersrt:MinimumMember2021-07-012022-06-300001387467us-gaap:MachineryAndEquipmentMembersrt:MaximumMember2021-07-012022-06-300001387467srt:MinimumMemberus-gaap:EquipmentMember2021-07-012022-06-300001387467srt:MaximumMemberus-gaap:EquipmentMember2021-07-012022-06-300001387467srt:MinimumMemberus-gaap:ComputerEquipmentMember2021-07-012022-06-300001387467us-gaap:ComputerEquipmentMembersrt:MaximumMember2021-07-012022-06-300001387467us-gaap:OfficeEquipmentMember2021-07-012022-06-300001387467us-gaap:LeaseholdImprovementsMembersrt:MinimumMember2021-07-012022-06-300001387467us-gaap:LeaseholdImprovementsMembersrt:MaximumMember2021-07-012022-06-300001387467us-gaap:VehiclesMember2021-07-012022-06-300001387467srt:MinimumMemberus-gaap:SoftwareDevelopmentMember2021-07-012022-06-300001387467us-gaap:SoftwareDevelopmentMembersrt:MaximumMember2021-07-012022-06-300001387467us-gaap:CorporateJointVentureMember2021-07-012022-06-300001387467us-gaap:CorporateJointVentureMember2021-12-012021-12-310001387467us-gaap:CorporateJointVentureMember2021-12-010001387467aosl:ChongqingFundsMemberaosl:FacilityinLiangjiangNewAreaofChongqingtheJointVentureMember2021-12-312021-12-310001387467aosl:ThirdPartyInvestorsMemberaosl:ThirdPartyInvestorsMemberus-gaap:CorporateJointVentureMember2022-01-260001387467aosl:ThirdPartyInvestorsMemberaosl:ThirdPartyInvestorsMemberus-gaap:CorporateJointVentureMember2022-01-262022-01-260001387467aosl:ThirdPartyInvestorsMember2022-01-262022-01-260001387467aosl:ThirdPartyInvestorsTransaction1Memberus-gaap:CorporateJointVentureMember2021-07-012022-06-300001387467aosl:ThirdPartyInvestorsTransaction2Memberus-gaap:CorporateJointVentureMember2021-07-012022-06-300001387467aosl:FacilityinLiangjiangNewAreaofChongqingtheJointVentureMember2022-03-310001387467aosl:FacilityinLiangjiangNewAreaofChongqingtheJointVentureMember2022-01-012022-03-310001387467us-gaap:CorporateJointVentureMember2022-06-302022-06-300001387467us-gaap:CorporateJointVentureMember2021-12-022022-06-300001387467aosl:StockOptionsAndRestrictedStockUnitsRsusMember2021-07-012022-06-300001387467aosl:StockOptionsAndRestrictedStockUnitsRsusMember2020-07-012021-06-300001387467aosl:StockOptionsAndRestrictedStockUnitsRsusMember2019-07-012020-06-300001387467us-gaap:EmployeeStockMember2021-07-012022-06-300001387467us-gaap:EmployeeStockMember2020-07-012021-06-300001387467us-gaap:EmployeeStockMember2019-07-012020-06-300001387467srt:MinimumMember2021-07-012022-06-300001387467srt:MaximumMember2021-07-012022-06-300001387467us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMemberaosl:CustomerMember2021-07-012022-06-300001387467us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMemberaosl:CustomerMember2020-07-012021-06-300001387467us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMemberaosl:CustomerMember2019-07-012020-06-300001387467us-gaap:CustomerConcentrationRiskMemberaosl:CustomerBMemberus-gaap:SalesRevenueNetMember2021-07-012022-06-300001387467us-gaap:CustomerConcentrationRiskMemberaosl:CustomerBMemberus-gaap:SalesRevenueNetMember2020-07-012021-06-300001387467us-gaap:CustomerConcentrationRiskMemberaosl:CustomerBMemberus-gaap:SalesRevenueNetMember2019-07-012020-06-300001387467us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMemberaosl:CustomerMember2021-07-012022-06-300001387467us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMemberaosl:CustomerMember2020-07-012021-06-300001387467us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMemberaosl:CustomerBMember2021-07-012022-06-300001387467us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMemberaosl:CustomerBMember2020-07-012021-06-300001387467us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMemberaosl:CustomerCMember2020-07-012021-06-300001387467us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMemberaosl:CustomerDMember2021-07-012022-06-300001387467us-gaap:LandMember2022-06-300001387467us-gaap:LandMember2021-06-300001387467us-gaap:BuildingMember2022-06-300001387467us-gaap:BuildingMember2021-06-300001387467us-gaap:MachineryAndEquipmentMember2022-06-300001387467us-gaap:MachineryAndEquipmentMember2021-06-300001387467aosl:EquipmentAndToolingMember2022-06-300001387467aosl:EquipmentAndToolingMember2021-06-300001387467us-gaap:ComputerEquipmentMember2022-06-300001387467us-gaap:ComputerEquipmentMember2021-06-300001387467us-gaap:FurnitureAndFixturesMember2022-06-300001387467us-gaap:FurnitureAndFixturesMember2021-06-300001387467us-gaap:LeaseholdImprovementsMember2022-06-300001387467us-gaap:LeaseholdImprovementsMember2021-06-300001387467aosl:LandUseRightsMember2022-06-300001387467aosl:LandUseRightsMember2021-06-300001387467aosl:ComputerSoftwareDevelopmentMember2022-06-300001387467aosl:ComputerSoftwareDevelopmentMember2021-06-300001387467aosl:ComputerSoftwareDevelopmentMember2020-06-300001387467aosl:PatentsAndPatentedTechnologyMember2022-06-300001387467aosl:PatentsAndPatentedTechnologyMember2021-06-300001387467us-gaap:TradeNamesMember2022-06-300001387467us-gaap:TradeNamesMember2021-06-300001387467us-gaap:CustomerRelationshipsMember2022-06-300001387467us-gaap:CustomerRelationshipsMember2021-06-300001387467aosl:PatentsAndPatentedTechnologyMember2021-07-012022-06-300001387467us-gaap:TradeNamesMember2021-07-012022-06-300001387467aosl:CustomerMember2022-06-300001387467aosl:CustomerBMember2022-06-300001387467aosl:OtherCustomersMember2022-06-300001387467aosl:CustomerMember2021-06-300001387467aosl:CustomerBMember2021-06-300001387467country:CNus-gaap:BaseRateMemberaosl:BankOfCommunicationsLimitedMember2019-10-310001387467country:CNus-gaap:BaseRateMemberaosl:BankOfCommunicationsLimitedMember2019-10-012019-10-310001387467aosl:BankOfCommunicationsLimitedMember2019-10-310001387467aosl:BankOfCommunicationsLimitedMember2021-09-300001387467aosl:BankOfCommunicationsLimitedMemberaosl:CreditFacility3Point85PercentDueNovember182022Member2021-10-012021-12-310001387467aosl:BankOfCommunicationsLimitedMemberaosl:CreditFacility3Point85PercentDueNovember182022Member2021-12-310001387467aosl:BankOfCommunicationsLimitedMember2022-06-300001387467aosl:IndustrialAndCommercialBankofChinaMemberus-gaap:ForeignLineOfCreditMember2018-11-160001387467aosl:IndustrialAndCommercialBankofChinaMemberaosl:LineOfCreditFacilityTradeBorrowingsMemberus-gaap:ForeignLineOfCreditMember2018-11-160001387467aosl:IndustrialAndCommercialBankofChinaMemberaosl:LineOfCreditFacilityWorkingCapitalBorrowingsMemberus-gaap:ForeignLineOfCreditMember2018-11-160001387467aosl:IndustrialAndCommercialBankofChinaMemberus-gaap:ForeignLineOfCreditMember2021-10-012021-12-310001387467aosl:IndustrialAndCommercialBankofChinaMemberus-gaap:ForeignLineOfCreditMember2021-12-310001387467aosl:IndustrialAndCommercialBankofChinaMemberus-gaap:ForeignLineOfCreditMember2022-06-300001387467us-gaap:SecuredDebtMemberaosl:AccountsReceivableFactoringAgreementAugustNinthTwoThousandNineteenMember2019-08-090001387467us-gaap:SecuredDebtMemberaosl:AccountsReceivableFactoringAgreementAugustNinthTwoThousandNineteenMember2019-08-092019-08-090001387467us-gaap:SecuredDebtMemberaosl:AccountsReceivableFactoringAgreementAugustNinthTwoThousandNineteenMember2021-08-110001387467us-gaap:SecuredDebtMemberaosl:AccountsReceivableFactoringAgreementAugustNinthTwoThousandNineteenMember2022-06-300001387467aosl:JirehSemiconductorIncorporatedMemberaosl:SalesLeaseBackTransactionWithJirehSemiconductorIncorporatedMember2021-09-30iso4217:EUR0001387467aosl:JirehSemiconductorIncorporatedMemberaosl:SalesLeaseBackTransactionWithJirehSemiconductorIncorporatedMember2021-04-300001387467aosl:JirehSemiconductorIncorporatedMemberaosl:SalesLeaseBackTransactionWithJirehSemiconductorIncorporatedMember2022-06-300001387467aosl:JirehSemiconductorIncorporatedMemberaosl:SalesLeaseBackTransactionWithJirehSemiconductorIncorporatedMember2021-07-012022-06-300001387467us-gaap:MachineryAndEquipmentMemberaosl:JirehSemiconductorIncorporatedMemberaosl:SalesLeaseBackTransactionWithJirehSemiconductorIncorporatedMember2022-06-300001387467aosl:JirehMemberus-gaap:SecuredDebtMember2021-08-180001387467aosl:JirehMemberus-gaap:SecuredDebtMember2021-08-182021-08-180001387467aosl:JirehMemberus-gaap:SecuredDebtMember2022-02-162022-02-160001387467aosl:JirehMemberus-gaap:SecuredDebtMember2022-06-300001387467us-gaap:SecuredDebtMember2018-05-010001387467us-gaap:SecuredDebtMember2018-05-012018-05-010001387467us-gaap:SecuredDebtMember2022-06-300001387467aosl:VariableInterestRateTermLoanMaturingAugust2022Memberaosl:TermLoanMemberus-gaap:SecuredDebtMember2017-08-150001387467aosl:VariableInterestRateTermLoanMaturingAugust2022Memberaosl:TermLoanMemberus-gaap:SecuredDebtMember2017-08-152017-08-150001387467aosl:VariableInterestRateTermLoanMaturingAugust2022Memberaosl:TermLoanMemberus-gaap:SecuredDebtMember2018-01-120001387467aosl:VariableInterestRateTermLoanMaturingAugust2022Memberaosl:TermLoanMemberus-gaap:SecuredDebtMember2018-07-310001387467aosl:VariableInterestRateTermLoanMaturingAugust2022Memberaosl:TermLoanMembersrt:MinimumMemberus-gaap:SecuredDebtMemberus-gaap:LondonInterbankOfferedRateLIBORMember2017-08-152017-08-150001387467aosl:VariableInterestRateTermLoanMaturingAugust2022Memberaosl:TermLoanMemberus-gaap:SecuredDebtMemberus-gaap:LondonInterbankOfferedRateLIBORMembersrt:MaximumMember2017-08-152017-08-150001387467aosl:VariableInterestRateTermLoanMaturingAugust2022Memberaosl:TermLoanMemberus-gaap:SecuredDebtMember2022-06-300001387467aosl:YinHaiLeasingCompanyandChinaImportExportBankMemberaosl:YinHaiLeasingCompanyandChinaImportExportBankMemberaosl:LeaseFinancingMember2018-05-09aosl:votes00013874672010-10-222022-06-300001387467aosl:TreasuryStockReissuedMember2010-10-222022-06-300001387467aosl:TwoThousandEighteenPlanMembersrt:MaximumMemberaosl:StockOptionsAndRestrictedStockUnitsRsusMember2018-11-300001387467aosl:TwoThousandEighteenPlanMembersrt:MaximumMemberaosl:StockOptionsAndRestrictedStockUnitsRsusMember2021-11-012021-11-300001387467aosl:TwoThousandEighteenPlanMembersrt:MaximumMemberaosl:StockOptionsAndRestrictedStockUnitsRsusMember2021-11-300001387467aosl:TwoThousandEighteenPlanMemberaosl:StockOptionsAndRestrictedStockUnitsRsusMember2022-06-300001387467aosl:TwoThousandEighteenPlanMemberus-gaap:RestrictedStockUnitsRSUMemberaosl:ExternalBoardMembersMember2021-07-012022-06-300001387467aosl:TwoThousandEighteenPlanMembersrt:MaximumMemberus-gaap:RestrictedStockUnitsRSUMemberaosl:ExternalBoardMembersMember2021-07-012022-06-300001387467srt:MinimumMemberaosl:TwoThousandEighteenPlanMemberus-gaap:RestrictedStockUnitsRSUMember2021-07-012022-06-300001387467srt:MinimumMemberus-gaap:EmployeeStockOptionMemberaosl:TwoThousandEighteenPlanMember2021-07-012022-06-300001387467aosl:NonstatutoryStockOptionsMembersrt:MinimumMemberaosl:TwoThousandEighteenPlanMember2021-07-012022-06-300001387467srt:MinimumMemberaosl:TwoThousandEighteenPlanMemberaosl:StockOptionsAndRestrictedStockUnitsRsusMember2021-07-012022-06-300001387467aosl:TwoThousandEighteenPlanMembersrt:MaximumMemberaosl:StockOptionsAndRestrictedStockUnitsRsusMember2021-07-012022-06-300001387467aosl:TwoThousandEighteenPlanMemberaosl:StockOptionsAndRestrictedStockUnitsRsusMember2021-07-012022-06-300001387467us-gaap:RestrictedStockMember2019-06-300001387467us-gaap:RestrictedStockMember2018-07-012019-06-300001387467us-gaap:RestrictedStockMember2019-07-012020-06-300001387467us-gaap:RestrictedStockMember2020-06-300001387467us-gaap:RestrictedStockMember2020-07-012021-06-300001387467us-gaap:RestrictedStockMember2021-06-300001387467us-gaap:RestrictedStockMember2021-07-012022-06-300001387467us-gaap:RestrictedStockMember2022-06-300001387467aosl:PerformanceBasedRestrictedStockUnitsPRSUsMemberMember2021-07-012022-06-300001387467aosl:PerformanceBasedRestrictedStockUnitsPRSUsMemberMember2020-07-012021-06-300001387467aosl:PerformanceBasedRestrictedStockUnitsPRSUsMemberMember2019-07-012020-06-300001387467aosl:PerformanceBasedRestrictedStockUnitsPRSUsMemberMember2019-06-300001387467aosl:PerformanceBasedRestrictedStockUnitsPRSUsMemberMember2018-07-012019-06-300001387467aosl:PerformanceBasedRestrictedStockUnitsPRSUsMemberMember2020-06-300001387467aosl:PerformanceBasedRestrictedStockUnitsPRSUsMemberMember2021-06-300001387467aosl:PerformanceBasedRestrictedStockUnitsPRSUsMemberMember2022-06-300001387467aosl:MarketbasedRestrictedStockUnitsMSUMember2021-12-012021-12-310001387467aosl:MarketbasedRestrictedStockUnitsMSUMembersrt:MinimumMember2021-12-012021-12-310001387467aosl:MarketbasedRestrictedStockUnitsMSUMembersrt:MaximumMember2021-12-012021-12-310001387467aosl:MarketbasedRestrictedStockUnitsMSUMember2021-07-012022-06-300001387467aosl:MarketbasedRestrictedStockUnitsMSUMember2018-07-012018-09-300001387467aosl:MarketBasedRestrictedStockUnitsMSUPreModificationMember2020-08-302020-08-300001387467aosl:MarketBasedRestrictedStockUnitsMSUPostModificationMember2020-08-312020-08-310001387467aosl:MarketBasedRestrictedStockUnitsMSUPostModificationMember2021-07-012022-06-300001387467aosl:MarketBasedRestrictedStockUnitsMSUPostModificationMember2020-07-012021-06-300001387467aosl:MarketBasedRestrictedStockUnitsMSUPostModificationMember2019-07-012020-06-3000013874672018-07-012019-06-300001387467us-gaap:EmployeeStockMember2018-11-300001387467us-gaap:EmployeeStockMember2021-11-300001387467us-gaap:EmployeeStockMember2021-07-012022-06-300001387467us-gaap:EmployeeStockMember2022-06-300001387467us-gaap:EmployeeStockMembersrt:MaximumMember2021-07-012022-06-300001387467us-gaap:EmployeeStockMember2020-07-012021-06-300001387467us-gaap:EmployeeStockMember2019-07-012020-06-300001387467us-gaap:CostOfSalesMember2021-07-012022-06-300001387467us-gaap:CostOfSalesMember2020-07-012021-06-300001387467us-gaap:CostOfSalesMember2019-07-012020-06-300001387467us-gaap:ResearchAndDevelopmentExpenseMember2021-07-012022-06-300001387467us-gaap:ResearchAndDevelopmentExpenseMember2020-07-012021-06-300001387467us-gaap:ResearchAndDevelopmentExpenseMember2019-07-012020-06-300001387467us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-07-012022-06-300001387467us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-07-012021-06-300001387467us-gaap:SellingGeneralAndAdministrativeExpensesMember2019-07-012020-06-300001387467country:USaosl:RetirementPlan401KMember2021-07-012022-06-300001387467country:US2021-07-012022-06-300001387467srt:MinimumMembercountry:CN2021-07-012022-06-300001387467srt:MaximumMembercountry:CN2021-07-012022-06-300001387467country:TW2021-07-012022-06-300001387467aosl:StateResearchAndDevelopmentCreditCarryforwardMember2022-06-300001387467aosl:StateResearchAndDevelopmentCreditCarryforwardMember2021-06-300001387467aosl:NetOperatingLossFixedAssetAndIntangibleAssetMemberus-gaap:CorporateJointVentureMember2021-06-300001387467aosl:NetOperatingLossFixedAssetAndIntangibleAssetMemberus-gaap:CorporateJointVentureMember2022-06-300001387467us-gaap:DomesticCountryMemberus-gaap:ResearchMember2022-06-300001387467us-gaap:StateAndLocalJurisdictionMember2022-06-300001387467us-gaap:CorporateJointVentureMember2022-06-300001387467aosl:LongTermIncomeTaxPayableMember2022-06-3000013874672020-01-012020-03-31aosl:Segment0001387467country:HK2021-07-012022-06-300001387467country:HK2020-07-012021-06-300001387467country:HK2019-07-012020-06-300001387467country:CN2021-07-012022-06-300001387467country:CN2020-07-012021-06-300001387467country:CN2019-07-012020-06-300001387467country:KR2021-07-012022-06-300001387467country:KR2020-07-012021-06-300001387467country:KR2019-07-012020-06-300001387467country:US2021-07-012022-06-300001387467country:US2020-07-012021-06-300001387467country:US2019-07-012020-06-300001387467aosl:OtherCountriesMember2021-07-012022-06-300001387467aosl:OtherCountriesMember2020-07-012021-06-300001387467aosl:OtherCountriesMember2019-07-012020-06-300001387467aosl:PowerDiscreteMember2021-07-012022-06-300001387467aosl:PowerDiscreteMember2020-07-012021-06-300001387467aosl:PowerDiscreteMember2019-07-012020-06-300001387467aosl:PowerIcMember2021-07-012022-06-300001387467aosl:PowerIcMember2020-07-012021-06-300001387467aosl:PowerIcMember2019-07-012020-06-300001387467aosl:PackagingAndTestingServicesMember2021-07-012022-06-300001387467aosl:PackagingAndTestingServicesMember2020-07-012021-06-300001387467aosl:PackagingAndTestingServicesMember2019-07-012020-06-300001387467country:CN2022-06-300001387467country:CN2021-06-300001387467country:US2022-06-300001387467country:US2021-06-300001387467aosl:OtherCountriesMember2022-06-300001387467aosl:OtherCountriesMember2021-06-300001387467srt:SubsidiariesMembercountry:CNsrt:MinimumMember2021-07-012022-06-300001387467srt:SubsidiariesMembercountry:CNsrt:MaximumMember2021-07-012022-06-300001387467srt:SubsidiariesMembercountry:CN2022-06-300001387467srt:SubsidiariesMembercountry:CN2021-06-300001387467aosl:InventoriesAndServicesMember2022-06-300001387467aosl:InventoriesAndServicesMember2021-06-300001387467us-gaap:CapitalAdditionsMember2022-06-300001387467us-gaap:CapitalAdditionsMember2021-06-300001387467us-gaap:IndemnificationGuaranteeMember2022-06-300001387467us-gaap:IndemnificationGuaranteeMember2021-06-300001387467aosl:LossFromCyberSecurityIncidentMember2022-01-012022-03-310001387467us-gaap:AllowanceForCreditLossMember2019-06-300001387467aosl:AllowanceForPriceAdjustmentsMember2019-06-300001387467us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2019-06-300001387467us-gaap:AllowanceForCreditLossMember2019-07-012020-06-300001387467aosl:AllowanceForPriceAdjustmentsMember2019-07-012020-06-300001387467us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2019-07-012020-06-300001387467us-gaap:AllowanceForCreditLossMember2020-06-300001387467aosl:AllowanceForPriceAdjustmentsMember2020-06-300001387467us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2020-06-300001387467us-gaap:AllowanceForCreditLossMember2020-07-012021-06-300001387467aosl:AllowanceForPriceAdjustmentsMember2020-07-012021-06-300001387467us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2020-07-012021-06-300001387467us-gaap:AllowanceForCreditLossMember2021-06-300001387467aosl:AllowanceForPriceAdjustmentsMember2021-06-300001387467us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2021-06-300001387467us-gaap:AllowanceForCreditLossMember2021-07-012022-06-300001387467aosl:AllowanceForPriceAdjustmentsMember2021-07-012022-06-300001387467us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2021-07-012022-06-300001387467us-gaap:AllowanceForCreditLossMember2022-06-300001387467aosl:AllowanceForPriceAdjustmentsMember2022-06-300001387467us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2022-06-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________________
FORM 10-K
_________________________________
(MARK ONE)
    ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended June 30, 2022
OR
    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM              TO             
Commission file number 001-34717
__________________________
Alpha and Omega Semiconductor Limited
(Exact name of Registrant as Specified in its Charter)
aosl-20220630_g1.jpg

Bermuda77-0553536
(State or Other Jurisdiction of Incorporation or Organization)(I.R.S. Employer Identification Number)
Clarendon House, 2 Church Street
Hamilton HM 11, Bermuda
(Address of Principal Registered
Offices including Zip Code)
(408830-9742
(Registrant's Telephone Number, Including Area Code)
__________________________________________
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Shares, $0.002 par value per share
AOSL
The NASDAQ Global Select Market
Securities registered pursuant to Section 12(g) of the Act:
None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes      No  
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes      No  
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months, (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes      No  
Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes     No  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):
 
Large accelerated filerAccelerated filerNon-accelerated filer
  (Do not check if a smaller reporting company)
Smaller reporting companyEmerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes      No  
The aggregate market value of the voting shares held by non-affiliates of the registrant as of December 31, 2021 was approximately $1,327 million based on the closing price of the registrant's common share as reported on the NASDAQ Global Select Market on December 31, 2021 (the last business day of the registrant's most recently completed second fiscal quarter). The common shares of the registrant held by each executive officer and director and certain affiliated shareholders who beneficially owned 10% or more of the outstanding common stock of the registrant have been excluded in such calculation as such persons and entities may be deemed to be affiliates of the registrant. This determination of affiliate status is not necessarily a conclusive determination for other purposes.

There were 27,397,273 shares of the registrant's common shares outstanding as of August 31, 2022.
 

DOCUMENTS INCORPORATED BY REFERENCE

    Portions of the registrant's Proxy Statement for the registrant's 2022 Annual General Meeting of Shareholders are incorporated by reference into Part III of this Form 10-K to the extent stated herein. The Definitive Proxy Statement is expected to be filed within 120 days of the registrant's fiscal year ended June 30, 2022.








Alpha and Omega Semiconductor Limited
Form 10-K
For the Year Ended June 30, 2022
TABLE OF CONTENTS
 
  Page
Part I. 
    Item 1.
    Item 1A.
    Item 1B.
    Item 2.
    Item 3.
    Item 4.
Part II. 
    Item 5.
    Item 6.
    Item 7.
    Item 7A.
    Item 8.
    Item 9.
    Item 9A.
    Item 9B.
    Item 9C.
Part III. 
    Item 10.
    Item 11.
    Item 12.
    Item 13.
    Item 14.
Part IV. 
    Item 15.



























(This page intentionally left blank.)



PART I

Item 1.Business
Forward Looking Statements
This Annual Report on Form 10-K and the documents incorporated herein by reference contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the “safe harbor” created by those sections. Forward-looking statements are based on our management's beliefs and assumptions and on information currently available to our management. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “could,” “intend,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “project,” “predict,” “potential” and similar expressions intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors, which may cause our actual results, performance, time frames or achievements to be materially different from any future results, performance, time frames or achievements expressed or implied by the forward-looking statements. We discuss many of these risks, uncertainties and other factors in this Annual Report on Form 10-K in greater detail in Item 1A.“Risk Factors.” Given these risks, uncertainties and other factors, you should not place undue reliance on these forward-looking statements. Also, these forward-looking statements represent our estimates and assumptions only as of the date of this filing. You should read this Annual Report on Form 10-K in its entirety and with the understanding that our actual future results may be materially different from what we expect. We hereby qualify our forward-looking statements by these cautionary statements. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
Overview    

We are a designer, developer and global supplier of a broad portfolio of power semiconductors. Our portfolio of power semiconductors includes approximately 2,500 products, and has grown significantly with the introduction of over 130 new products in the fiscal year ended June 30, 2022, and over 160 new products in each of the fiscal years ended June 30, 2021 and 2020, respectively. Our teams of scientists and engineers have developed extensive intellectual properties and technical knowledge that encompass major aspects of power semiconductors, which we believe enables us to introduce and develop innovative products to address the increasingly complex power requirements of advanced electronics. We have an extensive patent portfolio that consists of 888 patents and 62 patent applications in the United States as of June 30, 2022. We also have a total of 936 foreign patents, which were based primarily on our research and development efforts through June 30, 2022. We differentiate ourselves by integrating our expertise in technology, design, and advanced packaging to optimize product performance and cost. Our portfolio of products targets high-volume applications, including portable computers, graphics cards, flat panel TVs, home appliances, power tools, smart phones, battery packs, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment.

During the fiscal year ended June 30, 2022, we continued our diversification strategy by developing new silicon and packaging platforms to expand our serviceable available market, or SAM, and offer higher performance products. Our metal-oxide-semiconductor field-effect transistors, or MOSFET, portfolio expanded significantly across a full range of voltage applications. We also developed new technologies and products designed to penetrate into markets beyond our MOSFET computing base, including the consumer, communications and industrial markets, Insulated Gate Bipolar Transistors, or IGBTs for the home appliance market, as well as power ICs for next generation computing and gaming applications.

Our business model leverages global resources, including research and development and manufacturing in the United States and Asia. Our sales and technical support teams are localized in several growing markets around the world. We operate an 8-inch wafer fabrication facility located in Hillsboro, Oregon (the "Oregon fab"), which is critical for us to accelerate proprietary technology development, new product introduction and improve our financial performance. Recently we expanded and upgraded our manufacturing capabilities at the Oregon Fab. The expansion is expected to be completed in the fiscal quarter ending March 31, 2023. To meet the market demand for more mature high-volume products, we also utilize the wafer manufacturing capacity of selected third party foundries. For assembly and test, we primarily rely upon our in-house facilities in China. In addition, we utilize subcontracting partners for industry standard packages. We believe our in-house packaging and testing capability provides us with a competitive advantage in proprietary packaging technology, product quality, costs and sales cycle time.

On March 29, 2016, the Company entered into a joint venture contract (the “JV Agreement”) with two investment funds owned by the Municipality of Chongqing (the “Chongqing Funds”), pursuant to which the Company and the Chongqing Funds formed a joint venture, (the “JV Company”), for the purpose of constructing and operating a power semiconductor packaging, testing and 12-inch wafer fabrication facility (the “Chongqing Fab”) in the LiangJiang New Area of Chongqing, China (the “JV
1


Transaction”). The Chongqing Fab is being built in phases. As of December 1, 2021, the Company owned 50.9%, and the Chongqing Funds owned 49.1% of the equity interest in the JV Company. The JV Company was accounted under the provisions of the consolidation guidance since the Company had controlling financial interest until December 1, 2021.

Effective December 1, 2021, the Company entered into a share transfer agreement (the “STA”) with a third-party investor (the “Investor”), pursuant to which the Company sold to the Investor approximately 2.1% of outstanding equity interest held by the Company in the JV Company for an aggregate purchase price of RMB 108 million or approximately $16.9 million (the “Transaction”). The Transaction was closed on December 2, 2021 (the “Closing Date”). As a result of the Transaction, as of the Closing Date, the Company’s equity interest in the JV Company decreased from 50.9% to 48.8%. Also, the Company’s right to designate directors on the board of JV Company was reduced to three (3) out of seven (7) directors from four (4) directors prior to the Transaction. As a result of the Transaction, AOS no longer had a controlling financial interest in the JV Company under generally accepted accounting principles. Loss of control is deemed to have occurred when, among other things, a parent company owns less than a majority of the outstanding equity interest in the subsidiary, lacks a controlling financial interest in the subsidiary and, is unable to unilaterally control the subsidiary through other means such as having, or the ability to obtain or represent, a majority of the subsidiary’s board of directors. Because of these factors, as of December 2, 2021, the Company ceased having control over the JV Company. Therefore, the Company deconsolidated the financial statements of the JV Company as of that date. Subsequently, the Company has accounted for its investment in the JV Company using the equity method of accounting.

On December 24, 2021, the Company entered into a share transfer agreement with another third-party investor, pursuant to which the Company sold to this investor 1.1% of outstanding equity interest held by the Company in the JV Company for an aggregate purchase price of RMB 60 million, or approximately $9.4 million. In addition, on December 30, 2021, the JV Company adopted an employee equity incentive plan and issued an equity interest equivalent to 3.99% of the JV Company in exchange for cash. As a result, the Company owned 45.8% of the equity interest in the JV Company as of December 31, 2021.

On January 26, 2022, the JV Company completed a financing transaction pursuant to a corporate financing agreement (the “Financing Agreement”) between the JV Company and certain third-party investors (the “New Investors”). Under the Financing Agreement, the New Investors purchased newly issued equity interest of the JV Company for a total purchase price of RMB 509 million (or approximately $80 million based on the currency exchange rate as of January 26, 2022) (the “Investment”). Immediately following the closing of the Investment, the percentage of outstanding JV Company equity interest beneficially owned by the Company was further reduced to 42.2%.

We were incorporated in Bermuda on September 27, 2000 as an exempted limited liability company. The address of our registered office is Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda. The address of our U.S. office is Alpha and Omega Semiconductor Incorporated, 475 Oakmead Parkway, Sunnyvale, CA 94085. Telephone number of our U.S. office is (408) 830-9742. We have incorporated various wholly-owned subsidiaries in different jurisdictions, and a subsidiary (the JV Company) in which we have a minority interest. Please refer to Exhibit 21.1 to this Form 10-K for a complete list of our subsidiaries.
Our industry

Semiconductors are electronic devices that perform a variety of functions, such as converting or controlling signals, processing data and delivering or managing power. With advances in semiconductor technology, the functionality and performance of semiconductors have generally increased over time, while size and cost have generally decreased. These advances have led to a proliferation of more complex semiconductors being used in a wide variety of consumer, computing, communications and industrial markets and have contributed to the growth of the semiconductor industry. This has been accelerated by more regulations governing energy efficiency in many end applications.
Analog semiconductors

The semiconductor industry is segmented into analog and digital. Analog semiconductors process light, sound, motion, radio waves and electrical currents and voltages. In contrast, digital semiconductors process binary signals represented by a sequence of ones and zeros.

As a result of these fundamental differences, the analog semiconductor industry is distinct from the digital semiconductor industry in terms of the complexity of design and the length of product cycle. Improper interactions between analog circuit elements can potentially render an electronic system inoperable. Experienced engineers engaged in the design process are necessary because computer-aided design cannot fully model the behavior of analog circuitry. Therefore, experienced analog engineers with requisite knowledge are in great demand but short supply worldwide. In addition, analog semiconductors tend to have a longer product life cycle because original design manufacturers, or ODMs and original equipment manufacturers, or OEMs typically design the analog portions of a system to span multiple generations of their products. Once designed into an
2


application, the analog portion is rarely modified because even a slight change to the analog portion can cause unexpected interactions with other components, resulting in system instability.
Power semiconductors

Power semiconductors are a subset of the analog semiconductor sector with their own set of characteristics unique to system power architecture and function. Power semiconductors transfer, manage and switch electricity to deliver the appropriate amount of voltage or current to a broad range of electronic systems and also protect electronic systems from damage resulting from excessive or inadvertent electrical charges.

Power semiconductors can be either discrete devices, which typically comprise only a few transistors or diodes, or ICs, which incorporate a greater number of transistors.  The function of power discrete devices is power delivery by switching, transferring or converting electricity.  Power transistors comprise the largest portion of the power discrete device market. Power ICs, sometimes referred to as power management ICs, perform power delivery and power management functions, such as controlling and regulating voltage and current and controlling power discrete devices.

The growth of the power semiconductor market in recent years has several key drivers. The proliferation of computer and consumer electronics, such as notebooks, tablets, smart phones, flat panel displays and portable media players created the need for sophisticated power management to improve power efficiency and extend battery life. The evolution of these products is characterized by increased functionality, thinner or smaller form factors and decreasing prices. Our Power IC and low voltage (5V-40V) MOSFET products address this market. In the area of AC-DC power supplies for electronic equipment, data centers and servers, the market is characterized by a continuous demand for energy conservation through higher efficiency, which is driving the need for our medium voltage (40V-400V) and high voltage (500V-1000V) MOSFET products. The increased application of power semiconductors to control motors in white goods and industrial applications, is driving demand for Insulated Gate Bipolar Transistors, or IGBTs. IGBTs are also being used in renewable energy and automotive applications.

The evolution toward smaller form factors and complex power requirements in the low voltage areas has driven further integration in power semiconductors, resulting in power ICs that incorporate the functionalities of both power management and power delivery in a single device. Power ICs can be implemented by incorporating all necessary power functions either on one piece of silicon or multiple silicon chips encapsulated into a single device. Additionally, the advancement in semiconductor packaging technology enables increased power density and shrinking form factors.

Power semiconductor suppliers develop and manufacture their products using various approaches which tend to fall across a wide spectrum of balancing cost savings with proprietary technology advantages. At one end of the spectrum are integrated design manufacturers, or IDMs, which own and operate the equipment used in the manufacturing process and design and manufacture products at their in-house facilities. IDMs exercise full control over the implementation of process technologies and have maximum flexibility in setting priorities for their production and delivery schedules. At the other end of the spectrum are completely-outsourced fabless semiconductor companies, which rely entirely on off-the-shelf technologies and processes provided by their manufacturing partners. These companies seek to reduce or eliminate fixed costs by outsourcing both product manufacturing and development of process technologies to third parties. Our model seeks to achieve the best balance between technological advancement and cost effectiveness by using a dedicated in-house technology research and development team to drive rapid new product developments, while utilizing both in-house and third-party foundry capacity for our products. This is particularly important in the development of power semiconductor products due to the unique nature of their technology. While digital technologies are highly standardized in leading foundries, power semiconductor technologies tend to be more unique as they seek to accommodate a wider range of voltage applications. Accordingly, third-party foundries, which are primarily designed and established for digital technologies, may have limited capabilities when it comes to the development of new power semiconductor technologies.
Our strategies

Our strategy is to advance our position as a leading designer, developer and global supplier of a broad portfolio of power semiconductors. To accomplish this, we have adopted a strategy that allows us to accelerate the development of our proprietary technology at our in-house fabrication facilities, bring new products to market faster, and improve our financial performance in the long run. This model also provides quicker response to our customer demands, enhances relationships with strategic customers, and provides flexibility in capacity management and geographic diversification of our wafer supply chain. Our in-house manufacturing capability allows us to retain a higher level of control over the development and application of our proprietary process technology, thereby reducing certain operational risks and costs associated with utilizing third-party foundries. We recently commenced a plan to enhance the manufacturing capability and capacity of our Oregon Fab by investing in new equipment and expanding our factory facilities, which we expect will have a positive impact on our future new
3


product development and revenue, particularly during the period of global shortage of capacity. The expansion is expected to be completed in the fiscal quarter ending March 31, 2023.

Although our largest end-market is the personal computing (“PC”) market, we have successfully diversified our business by expanding into other markets, including the consumer, communications, power supply and industrial markets. While we have made progress in our diversification and expansion into additional applications, we continue to support and grow our PC business by expanding bill-of-material content, gaining market share, and acquiring new customers.

We plan to further expand the breadth of our product portfolio to increase our total bill-of-materials within an electronic system and to address the power requirements of additional electronic systems. Our product portfolio currently consists of approximately 2,500 products and we have introduced over 130 new products in this past fiscal year. We will continue to leverage our expertise to further increase our product lines, including higher performance power ICs, IGBTs and high, medium and low voltage MOSFETs, in order to broaden our addressable market and improve our margin profile. We are also in the process of developing a digital power controller and smart power stage product lines based on the technology that we licensed from STMicro. We believe that our increased product offerings will allow us to penetrate new end-market applications and provide us with an important competitive advantage. OEMs and ODMs generally prefer to limit their supplier base to a smaller set of vendors capable of providing a comprehensive menu of products across multiple electronic platforms.
Leverage our power semiconductor expertise to drive new technology platforms

We believe that the ever-increasing demand for power efficiency in power semiconductors requires expertise in and a deep understanding of the interrelationship among device physics, process technologies, design and packaging. We also believe that engineers with experience and understanding of these multiple disciplines are in great demand but short supply. Within this context, we believe that we are well positioned to be a leader in providing total power management solutions because of our extensive pool of experienced scientists and engineers and our strong IP portfolio. Accordingly, we intend to leverage our expertise to increase the number of power discrete technology platforms and power IC designs, including future digital power controller products that are currently under development, to expand our product offerings and deliver complete power solutions for our targeted applications. In addition, our ability to develop new technology is enhanced by the operation of our own manufacturing facilities in Oregon and Chongqing.

Increase direct relationships and product penetration with OEM and ODM customers

We have developed direct relationships with key OEMs who are responsible for branding, designing and marketing a broad array of electronic products, as well as ODMs who have traditionally been responsible for manufacturing these products. While OEMs typically focus their design efforts on their flagship products, as the industry has evolved, ODMs are increasingly responsible for designing portions, or entire systems, of the products they manufacture for the OEMs. In addition, several ODMs are beginning to design, manufacture and brand their own proprietary products which they sell directly to consumers. We intend to strengthen our existing relationships and form new ones with both OEMs and ODMs by aligning our product development efforts with their product requirements, increasing the number of our products used within their systems, and leveraging our relationships to penetrate their other products. In addition, we are refocusing our research and development efforts to respond more directly to market demand by designing and developing new products based on feedback from our customers, which also allows us to reduce time-to-market and sales cycles.
Leverage global business model for cost-effective growth

We intend to continue to leverage our global resources and regional strengths. We will continue to deploy marketing, sales and technical support teams in close proximity to our end customers. We plan to further expand and align our technical marketing and application support teams along with our sales team to better understand and address the needs of our end customers and their end-market applications, in particular for those with the new technology platforms developed in this past year and in the future. This will assist us in identifying and defining new technology trends and products and to help us gain additional design wins. While we no longer retain a controlling interest in the JV Company, we expect to continue our strong relationship with the JV Company to support our manufacturing capacity, and we recently entered into a new agreement with the JV Company pursuant to which the JV Company agrees to provide us with a guaranteed supply of a fixed number of wafers until December 2023. In addition, we intend to continue to seek potential partners and collaborators to develop new technologies and products, as well as to explore other strategic transactions that will enable us to expand our manufacturing capacity and establish our global footprint.

4


Our products    

To serve the large and diverse analog market for power semiconductors, we have created a broad product portfolio consisting of two major categories: power discretes and power ICs.

Our power discretes products consist primarily of low, medium and high voltage power MOSFETs. Our low voltage MOSFET series is based on our proprietary silicon and package technologies, with deep application know-how in various markets. We have precisely defined technology platforms to address different requirements from various applications. Our medium voltage MOSFETs provide optimized performance with high efficiency, high robustness and high reliability, and are widely used in applications such as TV backlighting, telecom power supplies, and industrial applications. We expanded our high voltage 600V and 700V MOSFET portfolio based on our aMOS5 technology platform to address robust consumer and industrial applications. Our high-voltage portfolio includes our proprietary insulated-gate bipolar transistor ("IGBT") technology, which we provide highly robust and easy-to-use solutions for industrial motor control and white goods applications. We have also released our first 1200V SiC (Silicon carbide) product based on our new AlphaSiC platform, designed to address high efficiency, high density industrial applications such as solar inverters, UPS, and battery management systems.

Our power ICs deliver power as well as control and regulate the power management variables, such as the flow of current and level of voltage. Our DrMOS family of products continued to grow as we paired our latest high performance MOSFET silicon with our latest Driver IC technologies. We continued to expand our EZBuck power IC family with products that feature lower on-resistance, less power consumption, smaller footprint and thermally enhanced packages. While we derive the majority of our revenue from the sales of power discretes products, sales of power ICs continued to gain traction during the past years. Our Type C smart load switch product line has also expanded as it offers reverse blocking capability, designed to protect applications against high voltage exposure.

5


The following table lists our product families and the principal end uses of our products:
 
Product FamilyDescriptionProduct Categories
within Product Type
Typical Application
Power DiscretesLow on-resistance switch used for routing current and switching voltages in power control circuits
High power switches used for power circuits
DC-DC for CPU/GPU
DC-AC conversion
AC-DC conversion
Load switching
Motor control
Battery protection
Power factor correction
Smart phone chargers, battery packs, notebooks, desktop and servers, data centers, base stations, graphics card, game boxes, TVs, AC adapters, power supplies, motor control, power tools, E-vehicles, white goods and industrial motor drives, UPS systems, solar inverters and industrial welding
Power ICsIntegrated devices used for power management and power delivery
DC-DC Buck conversion
DC-DC Boost conversion
Smart load switching DrMOS power stage
Flat panel displays, TVs, Notebooks, graphic cards, servers, DVD/Blu-Ray players, set-top boxes, and networking equipment
Analog power devices used for circuit protection and signal switching
Transient voltage protection
Analog switch
Electromagnetic interference filter
Notebooks, desktop PCs, tablets, flat panel displays, TVs, smart phones, and portable electronic devices
Power discrete products

Power discretes are used across a wide voltage and current spectrum, requiring them to operate efficiently and reliably under harsh conditions. Due to this wide applicability across diverse end-market applications, we market general purpose MOSFETs that are used in multiple applications as well as MOSFETs targeted for specific applications.

Our current power discrete product line includes industry standard trench MOSFETs, SRFETs, XSFET, electrostatic discharge, protected MOSFETs, high and mid-voltage MOSFETs and IGBTs.
Power IC products

In addition to the traditional monolithic or single chip design, we employ a multi-chip approach for the majority of our power ICs. This multi-chip technique leverages our proprietary MOSFET and advanced packaging technologies to offer integrated solutions to our customers. This allows us to update product portfolios by interchanging only the MOSFETs without changing the power management IC, thereby reducing the time required for new product introduction and providing optimal solutions to our customers. We believe that our power IC products improve our competitive position by enabling us to provide higher power density solutions to our end customers than some of our competitors.

The incorporation of both power delivery and power management functions tends to make power ICs more application specific because these two functions have to be properly matched to a particular end product. We have local technical marketing and applications engineers who closely collaborate with our end customers to help ensure that power IC specifications are properly defined at the beginning of the design stage.
New Product Introduction

We introduced several new products based on our proprietary technology platform and continue to expand our product families.

During the fourth quarter of fiscal year of 2022, we introduced compact, 30V, 3A Buck Regulator Module. This device offers a simple, compact solution suited to a wide variety of applications such as industrial, factory automation, networking, and general-purpose point of load. We also introduced 2-in-1 super low capacitance TVS for USB4.0 & thunderbolt 4.0 & HDMI2.1 protection. This device provides the best solution for an ideal pin-out for differential signal, space saving of super high-speed interface application, and reduces the part counts on circuit board. We believe this new approach benefits customers to accomplish the best design and logistics management.

6


During the third quarter of fiscal year of 2022, we introduced the AOZ71026QI, a 2 rail, 6 phase controller for notebook Vcore power delivery. This new device features the world’s lowest quiescent power for a multiphase controller designed to meet Intel IMVP 8, 9, 9.1, and 9.2 specifications. We released the 600V 110mOhm and 140mOhm αMOS5™ Super Junction MOSFETs in DFN8x8 Package. αMOS5 is AOS’s latest generation of high voltage MOSFET, designed to meet the high efficiency and high-density needs for Quick Charger, Adapter, PC Power, Server, Industrial Power, Telecom, and Hyperscale Datacenter applications. We also released AOZ32034AQV, a new product in the family of coil drivers for wireless charging transmitter circuits of up to 50W. Packaged in a thermally enhanced QFN 4 x 4 package, the device is designed for wireless charging applications in charging stations, cordless power tools, vacuum cleaners, drones, and other consumer electronic equipment. In addition, we released our initial eFuse product for sub-power rails in server applications. The new devices offer low RDS(ON) (20mohm) back-to-back MOSFETs to isolate the load from the input bus when the eFuse is off.

During the second quarter of fiscal year of 2022, we released 600V Low Ohmic and Fast Body Diode αMOS5™ Super Junction MOSFETs Family. αMOS5 is our latest generation of high voltage MOSFET, designed to meet the high efficiency and high-density needs for Quick Charger, Adapter, PC Power, Server, Industrial Power, Telecom, and Hyperscale Datacenter applications. We also released our latest 80V Power MOSFET using patented Shield Gate Technology which is optimized for higher switching frequencies used in telecom and server power supply to achieve higher efficiency. The 80V MOSFET family of devices offers the highest levels of power density and energy efficiency, which are essential in solar, power supplies, and battery power applications such as in eScooters.

During the first quarter of fiscal year of 2022, we announced a new family of Coil Drivers. The device is ideally suited to the design of Wireless Charging TX circuits used in cordless power tools, vacuum cleaners, drones, and other consumers’ electronic equipment composed of full-bridge topology with a resonant tank circuit to get the best power conversion efficiency. We also announced a new Type-C Power Delivery high voltage sink protection switch using ideal diode methodology for reverse current protection. The new devices offer low RDS(ON) (20mohm) back-to-back MOSFETs to block any reverse current under fault conditions and are capable of up to 28V absolute maximum voltage. In addition, we introduced the first product of the AOS Digital Controller product portfolio. The AOZ97774QE is offered in a QFN 5mm x 5mm package and provides the industry’s most flexible DC/DC controller supporting 5G Wireless, Networking, Optical Communication, and General-Purpose DC/DC applications.

Distributors and customers     
We have established direct relationships with key OEMs, including Dell Inc., Hewlett-Packard Company, LG Electronics, Inc. and Samsung Group, most of whom we serve through our distributors and ODMs. In addition, based on our historical design win activities, our power semiconductors are also incorporated into products sold to many other leading OEMs.
Through our distributors, we provide products to ODMs who traditionally are contract manufacturers for OEMs. As the industry has evolved, ODMs are increasingly responsible for designing portions, or entire systems, of the products they manufacture for the OEMs. In addition, several ODMs are beginning to design, manufacture and brand their own proprietary products, which they sell directly to consumers. Our ODM customers include Compal Electronics, Inc., Foxconn, Quanta Computer Incorporated, Pegatron, Wistron Corporation and AOC International.
In order to take advantage of the expertise of end-customer fulfillment logistics and shorter payment cycles, we sell most of our products through distributors. In general, under our agreements with distributors, they have limited rights to return unsold merchandise, subject to time and volume limitations. As of June 30, 2022, 2021 and 2020, our two largest distributors were WPG Holdings Limited, or WPG, and Promate Electronic Co. Ltd., or Promate. Sales to WPG and Promate accounted for 39.7% and 24.6% of our revenue, respectively, for the fiscal year ended June 30, 2022, 35.4% and 28.7% of our revenue, respectively, for the fiscal year ended June 30, 2021, and 35.5% and 29.3% of our revenue, respectively, for fiscal year ended June 30, 2020, respectively.
Sales and marketing    

Our marketing division is responsible for identifying high growth markets and applications where we believe our technology can be effectively deployed. We believe that the technical background of our marketing team, including application engineers, helps us better define new products and identify potential end customers and geographic and product market opportunities. For example, as part of our market diversification strategy, we have deployed and plan to recruit more, field application engineers, or FAEs, for our new product offerings, who provide real-time and local response to our end customers' needs. FAEs work with our end customers to understand their requirements and resolve technical problems. FAEs also strive to anticipate future customer needs and facilitate the design-in of our products into the end products of our customers. We believe this strategy increases our share of revenue opportunities within the applications we currently serve, as well as in new end-market applications.

7


Our sales team consists of sales personnel, field application engineers, customer service representatives and customer quality engineers who are responsible for key accounts. We strategically position our team near our end customers through our offices in Taipei, Hong Kong, Shenzhen, Shanghai, Qingdao, Tokyo, Seoul, Heilbronn, and Sunnyvale, California, complemented by our applications centers in Sunnyvale and Shanghai. In addition, our distributors and sales representatives assist us in our sales and marketing efforts by identifying potential customers, creating additional demand and promoting our products, in which case we may pay a sales commission.

Our sales cycle varies depending on the types of products and can range from six to eighteen months.  In general, our traditional power discrete products in PC and TV applications progress more rapidly through the customer's design and marketing processes, and therefore they generally have a shorter sales cycle.  In contrast, our newer Power IC and IGBT products, used mostly in the power supply, home appliance and industrial applications, require a more extended design and marketing timeline and thus have a longer sales cycle.  Typically, our sales cycle for all products comprises of the following steps:
identification of a customer design opportunity;
qualification of the design opportunity by our FAEs through comparison of the power requirements against our product portfolio;
provision of a product sample to the end customer to be included in the customer's pre-production model with the goal of being included in the final bill of materials; and
placement by the customer, or through its distributor, of a full production order as the end customer increases to full volume production.
Competition    

The power semiconductor industry is characterized by fragmentation with many competitors. We compete with different power semiconductor suppliers, depending on the type of product lines and geographical area. Our key competitors in power discretes and power ICs are primarily headquartered in the United States, Japan, Europe, China and Taiwan. Our major competitors in power discretes include Infineon Technologies AG, MagnaChip Semiconductor Corporation, ON Semiconductor Corp., STMicroelectronics N.V., Toshiba Corporation, Diodes Incorporated and Vishay Intertechnology, Inc. Our major competitors for our power ICs include Global Mixed-mode Technology Inc., Monolithic Power Systems, Inc., ON Semiconductor Corp., Richtek Technology Corp., Semtech Corporation, Texas Instruments Inc. and Vishay Intertechnology, Inc.

Our ability to compete depends on a number of factors, including:
our success in expanding and diversifying our serviceable markets, and our ability to develop technologies and product solutions for these markets;
our capability to quickly develop and introduce proprietary technology and best-in-class products;
the performance and cost-effectiveness of our products relative to that of our competitors;
our ability and capacity to manufacture, package and deliver products in large volume on a timely basis at a competitive price;
our success in utilizing new and proprietary technologies to offer products and features previously not available in the marketplace;
our ability to recruit and retain analog semiconductor designers and application engineers; and
our ability to protect our intellectual property.

Some of our competitors have longer operating histories, more brand recognition, and significantly greater financial, technical, research and development, sales and marketing, manufacturing and other resources. However, we believe that we can compete effectively through our integrated and innovative technology platform and design capabilities, including our strong and extensive patent portfolio, strategic global business model, expanding suites of new products, diversified and broad customer base, and excellent on-the-ground support and quick time to market for our products.

8


 Seasonality
As we provide power semiconductors used in consumer electronic products, our business is subject to seasonality. Our sales seasonality is affected by a number of factors, including global and regional economic conditions as well as the PC market conditions, revenue generated from new products, changes in distributor ordering patterns in response to channel inventory adjustments and end customer demand for our products and fluctuations in consumer purchase patterns prior to major holiday seasons. Our normal seasonality has been affected significantly by the COVID-19 pandemic, which has resulted in changes in consumer behavior and industry trends. Given the uncertainty of the global economic conditions resulting from the pandemic, it is difficult for us to predict to what extent our sales seasonality may change in the future.
Backlog
Our sales are made primarily pursuant to standard purchase orders from distributors and direct customers. The amount of backlog to be shipped during any period depends on various factors, and all orders are subject to cancellation or modification, usually with no penalty to customers. The quantities actually purchased by customers, as well as shipment schedules, are frequently revised to reflect changes in both the customers’ requirements and in manufacturing availability. Therefore, our backlog at any point in time is not a reliable indicator of our future revenue.
Research and development    

Because we view technology as a competitive advantage, we invest significant time and capital in research and development to address the technology intensive needs of our end customers. Our research and development expenditures for the fiscal years of 2022, 2021 and 2020 were $71.3 million, $63.0 million and $51.3 million, respectively. Our research and development expenditures primarily consist of salaries, bonuses, benefits, share-based compensation expense, expenses associated with new product prototypes, travel expenses, fees for engineering services provided by outside contractors and consultants, amortization of software and design tools, depreciation of equipment and overhead costs. We continue to invest in developing new technologies and products utilizing our own fabrication and packaging facilities as it is critical to our long-term success. We also evaluate appropriate investment levels and stay focused on new product introductions to improve our competitiveness. We have research and development teams in Silicon Valley (Sunnyvale, California), Oregon, Taiwan, and China. We believe that these diverse research and development teams enable us to develop leading edge technology platforms and new products. Our areas of research and development focus include:

Packaging technologies: Consumer demand for smaller and more compact electronic devices with higher power density is driving the need for advanced packaging technology. Our group of dedicated packaging engineers focuses on smaller form factors, and higher power output with efficient heat dissipation and cost-effectiveness. We have invested resources to develop and enhance our proprietary packaging technologies, including the establishment of our in-house packaging and testing facilities. We believe that our efforts to develop innovative packaging technologies will continue to provide new and cost-effective solutions with higher power density to our customers. During the fiscal year ended June 30, 2022, we continued our diversification strategies by developing new silicon and packaging platforms to expand our SAM and offer higher performance products.

Process technology and device physics: We focus on specialized process technology in the manufacturing of our products, including vertical DMOS, Shielded Gate Trench, Trench field stop IGBTs, charge-balance high voltage MOSFETs, Schottky Diode and BCDMOS processes. Our process engineers work closely with our design team to deploy and implement our proprietary manufacturing processes at our Oregon Fab, and more recently, at the Chongqing Fab as well as the third-party foundries that fabricate our wafers. To improve our process technology, we continue to develop and enhance our expertise in device physics in order to better understand the physical characteristics of materials and the interactions among these materials during the manufacturing process.

New products and new technology platforms: We also invest significantly in the development of new technology platforms and introduction of new products. Because power management affects all electronic systems, we believe that developing a wide portfolio of products enables us to target new applications in addition to expanding our share of power management needs served within existing applications.
As a technology company, we will continue our significant investment in research and development in our low voltage, medium voltage, and high voltage power discretes, IGBT and power modules and power ICs by developing new technology platforms and new products that allow for better product performance, more efficient packages and higher levels of integration.

9


Operations    

The manufacture of our products is divided into two major steps: wafer fabrication and packaging and testing.
Wafer fabrication
    
Our Oregon Fab allows us to accelerate the development of our technology and products, as well as to provide better service to our customers. We allocate our wafer production between our in-house facility and third-party foundries. During the past three years, we have gradually reduced our reliance on third-party foundries and increased allocation of capacity to our Oregon Fab and Chongqing Fab. We recently entered into a new agreement with the JV Company pursuant to which the JV Company agrees to provide us with a guaranteed supply of a fixed number of wafers until December 2023. Currently our main third-party foundry is Shanghai Hua Hong Grace Electronic Company Limited, ("HHGrace"), or formerly HHNEC, located in Shanghai. HHGrace has been manufacturing wafers for us since 2002. HHGrace manufactured 10.3%, 11.5% and 12.7% of the wafers used in our products for the fiscal years ended June 30, 2022, 2021 and 2020, respectively.
Packaging and testing

Completed wafers from the foundries are sent to our in-house packaging and testing facilities or to our subcontractors, where the wafers are cut into individual die, soldered to lead frames, wired to terminals and then encapsulated in protective packaging. After packaging, all devices are tested in accordance with our specifications and substandard or defective devices are rejected. We have established quality assurance procedures that are intended to control quality throughout the manufacturing process, including qualifying new parts for production at each packaging facility, conducting root cause analysis, testing for lots with process defects and implementing containment and preventive actions. The final tested products are then shipped to our distributors or customers.

Our in-house and wholly-owned packaging and testing facilities are located in Shanghai, China which handle most of our packaging and testing requirements for our products. In addition, the JV Company handles a portion of our packaging and testing requirement. We continuously increase the outsourcing portion of our packaging and testing requirements to other contract manufacturers to improve our ability to respond to changes in market demand. Our facilities have the combined capacity to package and test over 600 million parts per month and have available floor space for new package introductions. We believe our ability to package and test our products internally represents a strategic advantage as it protects our proprietary packaging technology, increases the rate of new package introductions, reduces operating expenses and ultimately improves our profit margins.
Quality assurance    

Our quality assurance practices aim to consistently provide our end customers with products that are reliable, durable and free of defects. We strive to do so through design for manufacturing, and continuous improvement in our product design and manufacturing and close collaboration with our manufacturing partners. Our manufacturing operations in China and our manufacturing facility in Oregon are certified to the ISO9001 and IATF16949:2016. These Quality Management System certifications are in recognition of our quality assurance standards. Both ISO9001 and IATF16949:2016 are sets of criteria and procedures established by International Organization of Standardization for developing a fundamental quality management system and focusing on continuous improvement, defect prevention and the reduction of variation and waste. Our products are also in compliance with Restrictions on the use of Hazardous Substances, or RoHS 3.0.

We maintain a supplier management and process engineering team in Shanghai that works with our third-party foundries and packaging and testing subcontractors to monitor the quality of our products, which is designed to ensure that manufacturing of our products is in strict compliance with our process controls, monitoring procedures and product requirements. We also conduct periodic reviews and annual audits to ensure supplier performance. For example, we examine the results of statistical process control systems, implement preventive maintenance, verify the status of quality improvement projects and review delivery time metrics. In addition, we rate and rank each of our suppliers every quarter based on factors such as their quality and performance. Our facility in Oregon integrates manufacturing process controls through our manufacturing execution system, coupled with wafer process controls that include monitoring procedures, preventative maintenance, statistical process control, and testing to ensure that finished wafers delivered will meet and exceed quality and reliability requirements. All materials used to manufacture wafers are controlled through a strict qualification process.

Our manufacturing processes use many raw materials, including silicon wafers, gold, copper, molding compound, petroleum and plastic materials and various chemicals and gases. We obtain our raw materials and supplies from a large number of sources. Although supplies for raw materials used by us are currently adequate, shortages could occur in various essential materials due to interruption of supply or increased demand in the industry.
10


Intellectual property rights     

Intellectual property is a critical component of our business strategy, and we intend to continue to invest in the growth, maintenance and protection of our intellectual property portfolio. We own significant intellectual property in many aspects of power semiconductor technology, including device physics and structure, wafer processes, circuit designs, packaging, modules and subassemblies. We have also entered into intellectual property licensing agreements with other companies, including On Semiconductor Corp. and Giant Semiconductor Corporation, to use selected third-party technology for the development of our products, although we do not believe our business is dependent to any significant degree on any individual third-party license agreement. We have a license agreement with STMicroelectronics International N.V. (“STMicro”), pursuant to which STMicro granted us a world-wide, royalty-free and fully-paid license to use its technologies to develop, market and distribute certain digital multi-phase controller products, which have been offered previously by STMicro. This license agreement allows us to develop a new digital power business that will design and offer a full suite of advance digital power controller products. 

While we focus our patent efforts in the United States, we file corresponding foreign patent applications in other jurisdictions, such as China and Taiwan, when filing is justified by cost and strategic importance. The patents are increasingly important to remain competitive in our industry, and a strong patent portfolio will facilitate the entry of our products into new markets. As of June 30, 2022, we had 888 patents issued in the United States, of which 881 were based on our research and development efforts and 7 were acquired, and these patents are set to expire between 2022 and 2041. We also had a total of 936 foreign patents, including 433 Chinese patents, 460 Taiwanese patents, 24 Korean patents, 4 Hong Kong patents, 5 Philippine patents, 8 Japanese patents, 1 Europe patent and 1 India patent as of June 30, 2022. Substantially all of our foreign patents were based on our research and development efforts. These foreign patents will expire in the years between 2023 and 2041. In addition, as of June 30, 2022, we had a total of 185 patent applications, of which 62 patents were pending in the United States, 76 patents were pending in China, 36 patents were pending in Taiwan and 11 patents were pending in other countries.

As our technologies are deployed in new applications and as we diversify our product portfolio based on new technology platforms, we may be subject to new potential infringement claims. Patent litigation, if and when instituted against us, could result in substantial costs and a diversion of our management's attention and resources. However, we are committed to vigorously defending and protecting our investment in our intellectual property. Therefore, the strength of our intellectual property program, including the breadth and depth of our portfolio, will be critical to our success in the new markets we intend to pursue.
In addition to patent protection, we also rely on a combination of trademark, copyright (including mask work protection), trade secret laws, contractual provisions and similar laws in other jurisdictions. We also enter into confidentiality and invention assignment agreements with our employees, consultants, suppliers, distributors and customers and seek to control access to, and distribution of, our proprietary information.
Human Capital Resources

As of June 30, 2022, we had 2,451 employees, of whom 753 were located in the United States, 1,527 were located in China, and 171 were located in other parts of the world. None of our employees is represented by a collective bargaining agreement. Notwithstanding our global footprint and various geographical locations, we have created an integrated workforce where employees worldwide work and collaborate as a team to advance our common business objectives, while retaining local and regional practices and cultures.

We are committed to providing a work environment in which our employees can realize fully their talents and develop successful careers. As our strength is in our people, we invest significantly in our employees by providing a wide range of training and development opportunities, including mentoring, coaching, attendance at external seminars and professional conferences, and regular in-house training sessions on specific topics. We train our managers to become good stewards for our employees, balancing the need of quality of life and performance results. We believe that these efforts contribute to the growth of our employees, as more than 50% of our managerial positions are filled through promotions of existing employees.

We also keep our employees engaged and informed by providing periodic all-staff communications, and semi-annual performance reviews to ensure that efforts and results are aligned with our business and strategic corporate objectives. We value feedback from our employees and have an open-door policy in our engagement with employees, and we encourage employees to have regular conversations with their managers to share feedback and express concerns. We also solicit employee feedback informally through regular employee interactions. In addition, we conduct employee satisfaction surveys at certain locations to help management identify areas that may require improvement. As part of the AOS tradition, we also organize social events, including annual appreciation picnics (when possible given COVID-19 conditions), and holiday parties, inviting both employees and their families to join. We believe these efforts enable us to build a strong and solid group of loyal employees who form the core of our human capital resource.

11


We are committed to providing an environment where employees from all walks of life are treated with respect, care and dignity. To recruit new talent, we reach out to a broad range of sources, including employee referrals, on-line advertising, recruitment agencies, and other social media platforms to seek out the best qualified candidates regardless of their backgrounds. We are also focused on ensuring a diverse workforce, including our management team. Our Nominating and Corporate Governance Committee leads the effort in recruiting qualified directors to serve on our Board, and we are in compliance with applicable diversity laws. Our employees appreciate and value the strength of our people-oriented culture and the benefits the workplace diversity brings.

We commit to a fair and living wage for all employees. We offer competitive compensation and benefits packages for our employees that include a combination of base salary, annual bonus, discretionary bonus for outstanding achievements, an employee share purchase plan, time-based and performance-based long-term equity compensation. Our equity related compensation programs are designed to motivate and incentivize our employees and align their rewards to financial and other business performance goals, while increasing our shareholder value. We adhere strictly to the Company’s Code of Business Conduct and Ethics and other policies, and ensure that our employment practices respect human rights and comply with national, state and local regulatory requirements at all locations where we conduct business. In addition, we have engaged nationally-recognized outside compensation consulting firms to independently evaluate the appropriateness and effectiveness of compensation for our executives and other officers and to provide benchmarks for executive compensation as compared to peer companies.

The health and safety of our employees are paramount to our company. At each of our major locations, we have formed site safety committees that conduct regular meetings to assess and improve effectiveness of our safety policies and guidelines, to monitor safety incidents and to oversee the implementation of corrective actions. At our U.S. facilities, the COVID-19 prevention committees met regularly to update and enhance prevention measures in accordance to federal, state and county health orders, which allowed us to continue our operations without significant disruptions. In addition, to support remote-working arrangements, we provided office workers with technology resources and in some cases a monthly stipend to set up home offices. To protect our employees and their families against the COVID-19 virus, we also implemented and sponsored bi-weekly on-site COVID-19 testing beginning in January 2021 for essential employees who were authorized to work in our Sunnyvale lab facilities. Our COVID-19 prevention committees at factory sites in China took swift and decisive actions to prevent work-place contagion and to ensure the health and safety of our employees. These actions included providing employees with Personal Protective Equipments, strict visitor controls, frequent sanitization of shuttle buses, temperature checking prior to boarding the shuttles and at the factory entrances, and regular self-audits. As a result of these actions, we had zero COVID-19 cases at our facilities in China. From March 28, 2022 to June 1, 2022, our Songjiang factory was locked down in compliance with the local government’s COVID-19 prevention order. The site was locked down with 885 employees who were not allowed to leave the factory. No one from outside of the factory was permitted to enter, including cleaning crews. A steering committee chaired by the General Manager of the factory and with certain management members from production, facilities and administration was formed on-site immediately to direct the logistics and measures necessary to ensure the safety and wellbeing of our employees onsite, and to provide adequate electricity, water supplies, food, bedding and sanitary supplies. In addition, the committee also ensured that needs were met regarding government contacts, COVID-19 testing, isolation and transfer of sick employees, cleaning and disinfection of public places and restrooms, and trash disposal. All of these requirements were facilitated internally by volunteers within the facilities due to the lock-down. Many of our employees devoted themselves to meet these challenges. The quick actions of the steering committee and our dedicated volunteers with their selfless and heroic acts were indispensable for our on-site employees’ survival during the lock-down. The Company endeavored to provide all support necessary, ranging from material, monetary to psychological assistance. All personnel on-site received special allowances in addition to their regular compensation to compensate for their hardship. Employees who volunteered also received special appreciation bonuses to recognize their self-less and critical contributions. Thanks to our on-site employees and the Company’s combined efforts, when our Songjiang factory received a green light to resume production, despite the on-going city-wide lock-down in Shanghai where most citizens were still restricted in their residences, we were able to resume partial production to deliver products critical to our customers.
Environmental matters    

The semiconductor production process, including the semiconductor wafer manufacturing and packaging process, generates air emissions, liquid wastes, waste water and other industrial wastes. We have installed various types of pollution control equipment for the treatment of air emissions and liquid waste and equipment for recycling and treatment of water in our packaging and testing facilities in China and wafer manufacturing facility in Oregon, USA. Waste generated at our manufacturing facilities, including but not limited to acid waste, alkaline waste, flammable waste, toxic waste, oxide waste and self-igniting waste, is collected and sorted for proper disposal. Our operations in China are subject to regulation and periodic monitoring by China’s State Environmental Protection Bureau, as well as local environmental protection authorities, including those under the Shanghai Municipal Government, which may in some cases establish stricter standards than those imposed by the State Environmental Protection Bureau. Our operation in Oregon is subject to Oregon Department of Environmental Regulations, Federal Environmental Protection Agency laws and regulations, and local jurisdictional regulations. We believe that we have been in material compliance with applicable environmental regulations and standards and have not had a material or adverse effect on our results of operations from complying with these regulations.

12


We have implemented an ISO 14001 environmental management system in our manufacturing facilities in China and Oregon. We also require our subcontractors, including foundries and assembly houses, to meet ISO 14001 standards. We believe that we have adopted pollution control measures for the effective maintenance of environmental protection standards consistent with the requirements applicable to the semiconductor industry in China and the U.S.

Our products sold in worldwide are subject to RoHS in Electrical and Electronic Equipment, which requires that the products do not contain more than agreed levels of lead, cadmium, mercury, hexavalent chromium, polybrominated biphenyl and polybrominated diphenyl ether flame retardants. Our manufacturing facilities in China also obtained QC080000 certification, which is an IECQ Certificate of Conformity Hazardous Substance Process Management for European Directive 2002/95/EC requirements and a Certificate of Green Partner for Sony Green Partner Program. We avoid using these restricted materials to the extent possible when we design our products.

We are also subject to SEC rules that require diligence, disclosure and reporting on whether certain minerals and metals, known as conflict minerals, used in our products originate from the Democratic Republic of Congo and adjoining countries. As of June 30, 2022, 2021 and 2020, we were in compliance with the related conflict minerals rule.

Export Control

We are subject to export and import control laws, trade regulations and other trade requirements that limit which products we sell and where and to whom we sell our products. Because we are committed to complying with all applicable export control laws, regulations, and requirements, we have reviewed and revised our processes and procedures to ensure that our shipments to our customers remain compliant with applicable export laws. As part of the enhanced process, we have also conducted extensive risk assessment on export control compliance and implemented training programs for our employees.
Executive Officers     

The following table lists the names, ages and positions of our executive officers as of August 15, 2022. There are no family relationships between any executive officer, except that Mr. Stephen C. Chang is a son of Dr. Mike F. Chang.
 
NameAge  Position 
Mike F. Chang, Ph.D.77Chairman of the Board and Chief Executive Officer
Stephen C. Chang45President
Yifan Liang58Chief Financial Officer and Corporate Secretary
Wenjun Li, Ph.D.53Chief Operating Officer
Bing Xue, Ph.D.58Executive Vice President of Worldwide Sales and Business Development

Mike F. Chang, Ph.D., is the founder of our company and has served as our Chairman of the Board and Chief Executive Officer since the incorporation of our company. Dr. Chang has extensive experience in both technology development and business operations in the power semiconductor industry. Prior to establishing our company, Dr. Chang served as the Executive Vice President at Siliconix Incorporated, a subsidiary of Vishay Intertechnology Inc., a global manufacturer and supplier of discrete and other power semiconductors, or Siliconix, from 1998 to 2000. Dr. Chang also held various management positions at Siliconix from 1987 to 1998. Earlier in his career, Dr. Chang focused on product research and development in various management positions at General Electric Company from 1974 to 1987. Dr. Chang received his B.S. in electrical engineering from National Cheng Kung University, Taiwan, and M.S. and Ph.D. in electrical engineering from the University of Missouri.

Stephen C. Chang has been serving as our President since January 2021. Prior to that, Mr. Chang served in various management positions including Executive Vice President of Product Line Management, Senior VP of Marketing, VP of the MOSFET Product Line, and Senior Director of Product Marketing. Mr. Chang has over 20 years of industry experience and leads our Product Line Marketing with various managerial responsibilities, including new product development, product lifecycle management, business development, and business strategy. Mr. Chang received his B.A. in Electrical Engineering from University of California, Berkeley and M.B.A. from Santa Clara University.

Yifan Liang has been serving as our Chief Financial Officer since August 2014 and Corporate Secretary since November 2013. Mr. Liang served as our Interim Chief Financial Officer from November 2013 to August 2014, our Chief Accounting Officer since October 2006, and our Assistant Corporate Secretary from November 2009 to November 2013. Mr. Liang joined our company in August 2004 as our Corporate Controller. Prior to joining us, Mr. Liang held various positions at
13


PricewaterhouseCoopers LLP, or PwC, from 1995 to 2004, including Audit Manager in PwC’s San Jose office. Mr. Liang received his B.S. in management information system from the People's University of China and M.A. in finance and accounting from the University of Alabama.

Wenjun. Li, Ph.D., has been serving as our Chief Operating Officer since August 2021. Prior to that, Dr. Li served in various management positions in our Company since 2012, including Executive Vice President of World-Wide Manufacturing, Senior Vice President of World-Wide Manufacturing, Vice President of Front-End Operation, the director of Process Integration and Senior Manager of Process Integration. Dr. Li holds a B.S. in Chemistry and a M.S. in Chemical Engineering from Taiyuan University of Technology, and a Ph.D. in Microelectronics & Solid-State Electronics from the Research Institute of Micro-Nanometer Technology at Shanghai Jiao Tong University.

Bing Xue, Ph.D., has been serving as our Executive Vice President of Worldwide Sales and Business Development since January 2021. Prior to that, Dr. Xue held various managerial positions in our company since 2003, including Senior Vice President of Global Sales, Vice President of Global Sales, Vice President of Worldwide Manufacturing, and General Manager of China Operation. Prior to joining us, Dr. Xue served as the Director of Engineering in Dowslake Microsystem from 2001 to 2003. Dr. Xue received his B.S. in Physics from Xiamen University, and Ph.D. in Physical Chemistry from University of Pennsylvania.
Available Information
Our filing documents and information with the Securities and Exchange Commission (the “SEC”) are available free of charge electronically through our Internet website, www.aosmd.com. as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. In addition, the SEC maintains a website (www.sec.gov) that contains reports, proxy statements, and other information that we file electronically.

14


Item 1A.Risk Factors

Our operations and financial results are subject to various risks and uncertainties, including those described below, that could adversely affect our business, financial condition, results of operations, cash flows, and the trading price of our common stock. Any of the following risks and uncertainties may be exacerbated by the impacts of the COVID-19 pandemic and related events.

Risk Factor Summary

Risks Related to Our Business
Our business operations and financial performance may be adversely affected by the COVID-19 pandemic and related events.
The decline of personal computing (“PC”) markets may have a material adverse effect on our results of operations.
Our strategy of diversification into different market segments may not succeed according to our expectations.
Our operating results may fluctuate from period to period due to many factors, which may make it difficult to predict our future performance.
Geopolitical and economic conflicts between United States and China may adversely affect our business.
Our revenue may fluctuate significantly from period to period due to ordering patterns from our distributors and seasonality.
We may not be able to introduce or develop new and enhanced products that meet or are compatible with our customer’s product requirements in a timely manner.
We may not win sufficient designs, or our design wins may not generate sufficient revenue for us to maintain or expand our business.
Our success depends upon the ability of our OEM end customers to successfully sell products incorporating our products.
The operation of our Oregon Fab subjects us to additional risks and the need for additional capital expenditures which may negatively impact our results of operations.
We may not be able to successfully develop our digital power business.
Defects and poor performance in our products could result in loss of customers, decreased revenue, unexpected expenses and loss of market share.
If we do not forecast demand for our products accurately, we may experience product shortages, delays in product shipment, excess product inventory, or difficulties in planning expenses, which will adversely affect our business and financial condition.
We face intense competition and may not be able to compete effectively which could reduce our revenue and market share.
Our reliance on third-party semiconductor foundries to manufacture our products subjects us to risks.
Our operation of two wholly-owned packaging and testing facilities are subject to risks that could adversely affect our business and financial results.
Our reliance on distributors to sell a substantial portion of our products subjects us to a number of risks.
We have made and may continue to make strategic acquisitions of other companies, assets or businesses and these acquisitions introduce significant risks and uncertainties.
If we are unable to obtain raw materials in a timely manner or if the price of raw materials increases significantly, production time and product costs could increase, which may adversely affect our business.
We may not be able to accurately estimate provisions at fiscal period end for price adjustment and stock rotation rights under our agreements with distributors, and our failure to do so may impact our operating results.
15


We depend on the continuing services of our senior management team and other key personnel, and if we lose a member of our senior management or are unable to successfully retain, recruit and train key personnel, our ability to develop and market our products could be harmed.
Failure to protect our patents and our other proprietary information could harm our business and competitive position.
Intellectual property disputes could result in lengthy and costly arbitration, litigation or licensing expenses or prevent us from selling our products.
The DOJ government investigation and evolving export control regulations may adversely affect our financial performance and business operations.
We may be adversely affected by any disruption in our information technology systems.
Global or regional economic, political and social conditions could adversely affect our business and operating results.
Our business operations could be significantly harmed by natural disasters or global epidemics.
Our insurance may not cover all losses, including losses resulting from business disruption or product liability claims.
Our international operations subject our company to risks not faced by companies without international operations.
If we fail to maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results or prevent fraud.
We are subject to the risk of increased income taxes and changes in existing tax rules.
Our debt agreements include financial covenants that may limit our ability to pursue business and financial opportunities and subject us to risk of default.
The imposition of U.S. corporate income tax on our Bermuda parent and non-U.S. subsidiaries could adversely affect our results of operations.
We may be classified as a passive foreign investment company (“PFIC”), which could result in adverse U.S. federal income tax consequences for U.S. holders.
The average selling prices of products in our markets have historically decreased rapidly and will likely do so in the future, which could harm our revenue and gross margins.
We may be adversely affected by the cyclicality of the semiconductor industry.

Risks Related to Doing Business in China

China’s economic, political and social conditions, as well as government policies, could affect our business and growth.
Changes in China’s laws, legal protections or government policies on foreign investment in China may harm our business.
The continuing potential for new or additional tariffs on imported goods from China could adversely affect our business operations.
Substantial uncertainties exist with respect to the interpretation and implementation of PRC Foreign Investment Law and how it may impact us.
Limitations on our ability to transfer funds to our China subsidiaries could adversely affect our ability to expand our operations, make investments that could benefit our businesses and otherwise fund and conduct our business.
China's currency exchange control and government restrictions on investment repatriation may impact our ability to transfer funds outside of China.
The M&A Rules and certain other PRC regulations establish complex procedures for some acquisitions of Chinese companies by foreign investors, which could make it more difficult for us to pursue growth through acquisitions in China.
Our results of operations may be negatively impacted by fluctuations in foreign currency exchange rates between U.S. dollar and Chinese Yuan, or RMB.
PRC labor laws may adversely affect our results of operations.
Relations between Taiwan and China could negatively affect our business, financial condition and operating results and, therefore, the market value of our common shares.
Risks Related to Our Corporate Structure and Our Common Shares.
16


Our share price may be volatile and you may be unable to sell your shares at or above the purchase price, if at all.
If securities or industry analysts do not publish research or reports about our business, or if they adversely change their recommendations regarding our common shares or if our operating results do not meet their expectations, the trading price of our common shares could decline.
Anti-takeover provisions in our bye-laws could make an acquisition of us more difficult and may prevent attempts by our shareholders to replace or remove our current management.
We are a Bermuda company and the rights of shareholders under Bermuda law may be different from U.S. laws.
Risks Related to Our Business

Our business operations and financial performance may be adversely affected by the COVID-19 pandemic and related events.

Our business operations have been impacted by the global COVID-19 pandemic and the resulting economic downturn. Numerous governmental jurisdictions, including the States of California, Oregon and Texas in the U.S. and countries throughout the Asia Pacific region have imposed various restrictions on commercial activities, resulting in business closures, work stoppages, labor shortage, disruptions to ports, vaccine mandates and other shipping infrastructure, border closures, thereby negatively impacting our customers, suppliers, distributors, employees, offices, and the entire semiconductor ecosystem.

As a result of the COVID-19 pandemic and changing consumer behaviors due to various government restrictions and the growing trend to provide remote-working options by employers, we have experienced shifting market trends, including an increasing demand in markets for notebooks, PCs, gaming devices and other products. While we have benefited from the increasing demand for PC related products, there is no guarantee that this trend will continue, and such increasing demand may discontinue or decline if government authorities relax or terminate COVID-19 related restrictions and consumer behaviors change in response to the reopening of certain economic activities.

Since the start of the second quarter of calendar year 2021, there have been increasing availability and administration of vaccines against COVID-19, as well as an easing of restrictions on social, business, travel, and government activities and functions, and a gradual resumption of economic activities and consumer spending in our industries. However, infection rates continued to fluctuate in various regions and new strains of the virus remain a risk, including a surge of COVID-19 cases and hospitalization due to the spread of Omicron variants in late 2021 and early 2022. During the first half of calendar year of 2022, COVID-19 cases and hospitalization rate continued to decline and governments in various jurisdictions, including the U.S. and Europe, have lifted various restrictions and limitations on economic activities. At the same time, however, new variants of COVID-19, including the BA.5 variant, continued to emerge and contributed to recent rise of infection rates in various jurisdictions in which we operate, including China and U.S. Furthermore, we may be subject to the ongoing global impacts resulting from the pandemic, including disruption of the product supply chains, shortages of semiconductor components and raw materials, and delays in shipments, product development, and product launches and rising inflation rates, any of which may adversely affect our operations. In addition, actions by United States federal, state and local governments, as well as by foreign governments, to address the COVID-19 pandemic, including travel bans, stay-at-home orders and school, business and entertainment venue closures, also had a significant adverse effect on the markets in which we conduct our businesses. COVID-19 poses the risk that our workforce, suppliers, and other partners may be prevented from conducting normal business activities for an extended period of time, including due to shutdowns or stay-at-home orders that may be requested or mandated by governmental authorities.

In April 2022, the city of Shanghai, China entered into a strict lockdown due to surging COVID-19 cases and the local government’s imposition of the “Zero Covid” policy. Our packaging and assembly facilities in Shanghai were shut down and production was halted since early April. Transportation suspension in and out of Shanghai also interrupted the shipping of raw materials and finished parts to and from our Songjiang factory. We received permission to reopen our facilities partially in early May. We gradually ramped up production at these facilities in May 2022 and returned to normal operation in June 2022. The suspension of our Shanghai facilities, and factors limiting the resumption of production, reduced our ability to complete orders from our customers in a timely manner, which adversely affected our revenue and results of operation for the three months ended June 30, 2022. There is no guarantee that additional restrictions and lockdown will not be reimposed by the government, which is outside of our control, and any extension of the lockdown will continue to have a negative impact on our results of operations and financial conditions.

17


We also expect to incur additional incremental costs to comply with various public health and safety requirements imposed by the Shanghai government, which may continue for an extended period of time even after city-wide lockdown is lifted. Furthermore, while we intend to secure alternative sources of packaging capacity from third-party providers to mitigate the impact of the shutdown, there is no guarantee that such source will be available or on terms that are reasonable to us. Even if alternative sources are available, it will be difficult to complete the transition to such sources efficiently and timely, and we currently do not expect that we will be able to secure sufficient third-party packaging sources to substitute or replace fully our in-house capacity. The suspension of our Shanghai facilities, and factors limiting the resumption of production reduced our ability to complete orders from our customers in a timely manner or at all, which adversely affected our revenue and results of operation for the fiscal year ended June 30, 2022. We can not guarantee that the Shanghai government will not impose similar restrictions and lockdown in the future, and any such restrictions and lockdown will adversely affect our operations and financial performance.

The full extent of the future impact of the COVID-19 pandemic on our operational and financial performance is uncertain and will depend on many factors beyond our control, including, without limitation, the timing, extent, trajectory and duration of the pandemic; the availability, distribution and effectiveness of vaccines; the spread of new variants of COVID-19; the continued and renewed imposition of protective public safety measures such as lockdowns and quarantines; the continuing global disruption in supply chains in our industries and the impact of the pandemic on the global economy, inflation and demand for consumer products. Even after the pandemic has subsided and economic activities gradually increase, we may continue to experience material and adverse impacts to our business, operating results, and financial condition as a result of the pandemic’s lasting global economic impact, including any recession that may occur in the future in our industries, as well as possible continuing inflationary impacts resulting from these factors.

Our operation of two wholly-owned packaging and testing facilities are subject to risks that could adversely affect our business and financial results.

We have two wholly-owned packaging and testing facilities located in Shanghai, China that handle most of our packaging and testing requirements. The operation of high-volume packaging and testing facilities and implementation of our advanced packaging technology are complex and demand a high degree of precision and may require modification to improve yields and product performance. We have committed substantial resources to ensure that our packaging and testing facilities operate efficiently and successfully, including the acquisition of equipment and raw materials, and training and management of a large number of technical personnel and employees. Due to the fixed costs associated with operating our own packaging and testing facilities, if we are unable to utilize our in-house facilities at a desirable level of production, our gross margin and results of operations may be adversely affected. For example, a significant decline in our market share or sales orders may negatively impact our factory utilization and reduce our ability to achieve profitability.

In April 2022, the operations of our packaging and testing facilities in Shanghai, China were suspended due to a strict lockdown of the city imposed by the local government in response to surging COVID cases. The facilities were required to be shut down and production was halted since early April. Transportation suspension in and out of Shanghai also interrupted the shipping of raw materials and finished parts to and from our facilities. We received permission to reopen our facilities partially in early May. We gradually ramped up production at these facilities in May and returned to normal operation in June 2022. The suspension of our Shanghai facilities, and factors limiting the resumption of production, reduced our ability to complete orders from our customers in a timely manner, which adversely affected our revenue and results of operation for the three months ended June 30, 2022. There is no guarantee that additional restrictions and lockdown will not be reimposed by the government, which is outside of our control, and any extension of the lockdown will continue to have a negative impact on our results of operation and financial condition. Furthermore, while we intend to secure alternative sources of packaging capacity from third-party providers, there is no guarantee that such sources are available, and even if available, it will be difficult to complete the transition efficiently and timely, and such alternative source of capacity is not expected to be sufficient to substitute or replace fully our in-house capacity. The suspension of our Shanghai facilities had a negative impact on our production and adversely affected our revenue and results of operation for the fiscal year ended June 30, 2022. We can not guarantee that the Shanghai government will not impose similar restrictions and lockdown in the future, and any such restrictions and lockdown will adversely affect our operations and financial performance.

In addition, the operation of our packaging and testing facilities is subject to a number of risks, including the following:

unavailability of equipment, whether new or previously owned, at acceptable terms and prices;
facility equipment failure, power outages or other disruptions;
shortage of raw materials, including packaging substrates, copper, gold and molding compound;
failure to maintain quality assurance and remedy defects and impurities;
18


changes in the packaging requirements of customers;
our limited experience in operating a high-volume packaging and testing facility; and
operation stoppage due to the city-wide COVID-19 lockdown.

Any of the foregoing risks could adversely affect our capacity to package and test our products, which could delay shipment of our products, result in higher expenses, reduce revenue, damage our relationships with customers and otherwise adversely affect our business, results of operations, financial condition and prospects.

Our business operations and financial conditions may be adversely affected by any disruption in our information technology systems, including any cyberattacks and breaches.

Our operations are dependent upon our information technology systems, which encompass all of our major business functions across offices internationally. We rely upon such information technology systems to manage and replenish inventory, complete and track customer orders, coordinate sales activities across all of our products and services, maintain vital data and information, perform financial and accounting tasks and manage and perform various administrative and human resources functions. A substantial disruption in our information technology systems for any extended time period (arising from, for example, system capacity limits from unexpected increases in our volume of business, outages or delays in our service) could result in delays in receiving inventory and supplies or filling customer orders and adversely affect our customer service and relationships. Our systems might be damaged or interrupted by natural or man−made events or by computer viruses, physical or electronic break−ins, cyber-attacks and similar disruptions affecting the global Internet.

In addition, recent widespread ransomware attacks and cybersecurity breaches in the U.S. and elsewhere have affected many companies, including the cybersecurity incident involving SolarWinds Orion in December 2020. In the past, we also experienced ransomware attacks on our information technology system. In April, 2022, we became aware of a cybersecurity incident involving unauthorized access to one of the Company's email account, resulting in unauthorized payments. We recorded a loss of $1.5 million due to the incident for the three months ended March 31, 2022. Immediately following the discovery, we commenced an investigation, contained the incident and implemented additional protective measures and internal control policies and procedures. We also alerted law enforcement authorities and banking institutions in an effort to recover the lost amount. This incident appears to be isolated and its financial impact identified was not material. The Company believes that it has not incurred other damages and losses based on the conclusion of the full investigation. There is no guarantee that we will be able to recover the lost amount.

While these attacks did not have a material adverse effect on our business operation or results of operations, they caused temporary disruptions and interfered with our operations. Any cybersecurity breach and financial loss may also have a negative impact on our internal control over financial reporting. While we have implemented additional measures to enhance our security protocol to protect our system and intend to do so in response to any threats, there is no guarantee that future attacks would be thwarted or prevented. We also expect to incur additional costs and expenses to upgrade our information technology system and establish additional protective measures to prevent future breaches. Furthermore, despite our efforts to investigate, improve and remediate the capability and performance of our information technology system, we may not be able to discover all weaknesses, breaches and vulnerabilities, and failure to do so may expose us to higher risk of data loss and adversely affect our business operations and results of operations.

The decline of personal computing (“PC”) markets may have a material adverse effect on our results of operations.

A significant amount of our revenue is derived from sales of products in the PC markets such as notebooks, motherboards and notebook battery packs.  Our revenue from the PC markets accounted for approximately 44.5%, 42.5% and 41.1% of our total revenue for the years ended June 30, 2022, 2021 and 2020, respectively. The increasing popularity of smaller, mobile computing devices such as tablets and smart phones with touch interfaces is rapidly changing the PC markets both in the United States and abroad.  In the past, we experienced a significant reduction in the demand for our products due to the declining PC markets, which had negatively impacted our revenue, profitability and gross margin. While we recently experienced resurgence of demand in the PC market as a result of the COVID-19 pandemic and related events, there is no assurance that such trend will continue or that the decline of PC market will not occur again, and if it does, we may not be able to implement measures successfully to mitigate or reduce the negative impact on our financial conditions and results of operations.

Our strategy of diversification into different market segments may not succeed according to our expectations and may expose us to new risks and place significant strains on our management, operational, financial and other resources.

19


As part of the growth strategy to diversify our product portfolio and in response to the decline of the PC markets, we have been developing new technologies and products designed to penetrate into other markets and applications, including merchant power supplies, flat panel TVs, smart phones, tablets, gaming consoles, lighting, datacom, telecommunications, home appliances and industrial motor controls. However, there is no guarantee that these diversification efforts will be successful. As a new entrant to some of these markets, we may face intense competition from existing and more established providers and encounter other unexpected difficulties, any of which may hinder or delay our efforts to achieve success. In addition, our new products may have long design and sales cycles. Therefore, if our diversification efforts fail to keep pace with the declining PC markets, we may not be able to alleviate its negative impact on our results of operations.

Our diversification into different market segments may place a significant strain on our management, operational, financial and other resources. To manage this diversification effectively, we will need to take various actions, including:
enhancing management information systems, including forecasting procedures;
further developing our operating, administrative, financial and accounting systems and controls;
managing our working capital and sources of financing;
maintaining close coordination among our engineering, accounting, finance, marketing, sales and operations organizations;
retaining, training and managing our employee base;
enhancing human resource operations and improving employee hiring and training programs;
realigning our business structure to more effectively allocate and utilize our internal resources;
improving and sustaining our supply chain capability; and
managing both our direct and distribution sales channels in a cost-efficient and competitive manner.

Our failure to execute any of the above actions successfully or timely may have an adverse effect on our business and financial results.
Our operating results may fluctuate from period to period due to many factors, which may make it difficult to predict our future performance.
Our periodic operating results may fluctuate as a result of a number of factors, many of which are beyond our control. These factors include, among others:

a deterioration in general demand for electronic products, particularly the PC market, as a result of global or regional financial crises and associated macro-economic slowdowns, and/or the cyclicality of the semiconductor industry;
a deterioration in business conditions at our distributors and /or end customers;
adverse general economic conditions in the countries where our products are sold or used;
the emergence and growth of markets for products we are currently developing;
our ability to successfully develop, introduce and sell new or enhanced products in a timely manner and the rate at which our new products replace declining orders for our older products;
the anticipation, announcement or introduction of new or enhanced products by us or our competitors;
changes in the selling prices of our products and in the relative mix in the unit shipments of our products, which have different average selling prices and profit margins;
the amount and timing of operating costs and capital expenditures, including expenses related to the maintenance and expansion of our business operations and infrastructure;
the announcement of significant acquisitions, disposition or partnership arrangements;
the ramp-up progress and operation of the JV Company, and announcement of significant transactions involving the JV Company;
changes in the utilization of our in-house manufacturing capacity;
supply and demand dynamics and the resulting price pressure on the products we sell;
20


the unpredictable volume and timing of orders, deferrals, cancellations and reductions for our products, which may depend on factors such as our end customers' sales outlook, purchasing patterns and inventory adjustments based on general economic conditions or other factors;
changes in laws and regulations affecting our business operations;
changes in costs associated with manufacturing of our products, including pricing of wafer, raw materials and assembly services;
announcement of significant share repurchase programs;
our concentration of sales in consumer applications and changes in consumer purchasing patterns and confidence; and
the adoption of new industry standards or changes in our regulatory environment.
Any one or a combination of the above factors and other risk factors described in this section may cause our operating results to fluctuate from period to period, making it difficult to predict our future performance. Therefore, comparing our operating results on a period-to-period basis may not be meaningful, and you should not rely on our past results as an indication of our future performance.
Geopolitical and economic conflicts between United States and China may adversely affect our business
Geopolitical conflicts and tensions between the United States and China have threatened and destabilized trading relationships and economic activities between the two countries. Because we have significant operations in both countries, such conflicts and tensions may negatively impact our business. At various times during recent years, the United States and China have had disagreements over political and economic issues, including but not limited to, the recent imposition of tariffs by the U.S. on goods imported from China and to the U.S. government's efforts to restrict transfer and sharing of technologies, including semiconductor technologies, between the two countries. In addition, the U.S. government may enact new and more restrictive export control regulations that may reduce our ability to ship and sell products to certain customers in China and Asia and increase our cost to implement additional measures to comply with such new regulations. In addition, disagreements between the United States and China with respect to their political, military or economic policies toward Taiwan may contribute to further controversies. These controversies and trade frictions could have a material adverse effect on our business by, among other things, making it more difficult for us to coordinate our operations between the United States and China causing a reduction in the demand for our products by customers in the United States or China and reducing our profitability due to increasing cost of compliance.

The continuing political and economic conflicts between U.S. and China have resulted in and may continue to cause retaliatory policies from both countries, including a 2020 executive order issued by the then U.S. President eliminating the preferential trade status of Hong Kong in response to China’s action to impose new security measures and regulation on Hong Kong. The order has made it more costly and difficult for U.S. companies to export goods or conduct businesses in Hong Kong. While we historically have not relied on the preferential trade status to operate in Hong Kong, there is no guarantee that additional policies, rules or regulations will not be implemented by either the U.S. or China that will negatively impact our ability to maintain our sales and other functions and operations in Hong Kong. We also cannot predict what new and additional retaliatory policies and regulations may be implemented by the Chinese government in response to U.S. actions, and such policies and regulations may adversely affect our business operations in China and other Asian countries, including our manufacturing and sales and marketing activities.

Our lack of control over the JV Company may adversely affect our operations.

We formed the JV Company in 2016 which consists of a power semiconductor packaging, testing and 12-inch wafer fabrication facility in Chongqing. The JV Company is our subcontractor, and we rely and expect to continue to rely substantially on the JV Company to provide us with foundry capacity to develop and manufacture our products and to enhance our market position in China. Since the formation of the JV Company, we have retained control over the business operation of the JV Company through our majority equity ownership and board representation. In December 2021, we relinquished control over the JV Company through a series of transactions, including the sale of a portion of our equity interests in the JV Company and issuance of additional equity interests by the JV Company to raise capital. As a result of these transactions, we currently own approximately 42.2% of outstanding equity interest in the JV Company and have the right to designate three (3) out of seven (7) directors, instead of four (4) directors prior to such transaction. The reduction of our equity ownership of the JV Company is part of a plan to enable the JV Company to raise capital more easily and to facilitate a future public listing on the Science and Technology Innovation Board, or STAR Market, of
21


the Shanghai Stock Exchange (the “China IPO”). Such reduction also caused the deconsolidation of the JV Company’s financial statements from our Consolidated Financial Statements.

Because we no longer have a controlling interest in the JV Company, the JV Company is operating and will continue to operate more independently, and our influence on all aspects of the JV Company’s business operations will be diminished. Accordingly, we might not be able to prevent the JV Company from taking actions adverse to our interests. For example, while we remain a major customer of the JV Company, the JV Company may decide to enter into business relationships with other customers and allocate foundry capacities to such customers, which may prevent us from securing a desirable or sufficient level of manufacturing capacity for our products. Even if the JV Company agrees to continue allocating sufficient manufacturing capacity to us, we may not be able to negotiate or obtain favorable pricing or service terms, which may increase our expenses and adversely affect our results of operations.

Our lack of control over the JV Company may also make it more difficult for us to execute our broader business strategies in China, including our R&D, sales and marketing, product innovation efforts and protection of intellectual property rights, because the JV Company may decide not to cooperate with us in these matters. In addition, while we expect to achieve a financial return for our investment in the JV Company as a result of the China IPO, the China IPO process is complex, time-consuming and subject to a number of risks and there is no guarantee that the China IPO will be completed in a timely manner, or at all, and the JV Company’s failure to close the China IPO will negatively affect our investment in the JV Company.

In order to fund its capital expenditures and cost of operation, the JV Company has incurred a significant amount of indebtedness from third-party lenders under several loan and lease financing agreements, some of which are secured by substantially all of the assets of the JV Company. If the JV Company is not able to generate sufficient cash flow to make payments under these loans, the JV Company may be in default, which will adversely affect its ability to continue operations and provide foundry services to us. In addition, the JV Company requires additional funding to continue its operations and to refinance its existing indebtedness. There is no guarantee that the JV Company will be able to obtain financing on favorable terms, or at all, and any such failure may negatively impact our ability to access its wafer manufacturing capacity.

Any of the foregoing risks could materially reduce the expected return of our investment in the JV Transaction and adversely affect our business operations, our financial performance and the trading price of our shares.
Our revenue may fluctuate significantly from period to period due to ordering patterns from our distributors and seasonality.

Demand for our products from our end customers fluctuates depending on their sales outlooks and market and economic conditions. Accordingly, our distributors place purchase orders with us based on their forecasts of end customer demand. Because these forecasts may not be accurate, channel inventory held at our distributors may fluctuate significantly due to the difference between the forecasts and actual demand. As a result, distributors adjust their purchase orders placed with us in response to changing channel inventory levels, as well as their assessment of the latest market demand trends. A significant decrease in our distributors’ channel inventory in one period may lead to a significant rebuilding of channel inventory in subsequent periods, or vice versa, which may cause our quarterly revenue and operating results to fluctuate significantly.
In addition, because our power semiconductors are used in consumer electronics products, our revenue is subject to seasonality. Our sales seasonality is affected by a number of factors, including global and regional economic conditions as well as the PC market conditions, revenue generated from new products, changes in distributor ordering patterns in response to channel inventory adjustments and end customer demand for our products and fluctuations in consumer purchase patterns prior to major holiday seasons. In recent year, broad fluctuations in the semiconductor markets and the global economic conditions, in particular the decline of the PC market conditions, have had a more significant impact on our results of operations, than seasonality, and have made it difficult to assess the impact of seasonal factors on our business. Our normal seasonality cycle has also been impacted by the COVID-19 pandemic and related events, making it more difficult to predict and determine a more consistent seasonality trend. See “Risk Factors- Our business operation and financial performance may be adversely affected by the COVID-19 pandemic and related events.”

If we are unable to introduce or develop new and enhanced products that meet or are compatible with our customer’s product requirements in a timely manner, it may harm our business, financial position and operating results.

Our success depends upon our ability to develop and introduce new and enhanced products that meet or are compatible with our customer’s specifications, performance standards and other product requirements in a timely
22


manner. The development of new and enhanced products involves highly complex processes, and at times we have experienced delays in the introduction of new products. Successful product development and introduction of new products depends on a number of factors, including the accurate product specification; timely completion of design; achievement of manufacturing yields; timely response to changes in customer’s product requirements; quality and cost-effective production; and effective marketing. Since many of our products are designed for specific applications, we must frequently develop new and enhanced products jointly with our customers. In the past, we have encountered product compatibility issues with a major OEM that has negatively impacted our financial results, and although we have resolved fully such issues with the OEM, there is no guarantee that the same compatibility issues will not occur in the future with other OEMs. If we are unable to develop or acquire new products that meet or are compatible with our customer’s specification and other product requirements in a timely manner, we may lose revenue or market share with our customers, which could have a material adverse effect on our business, financial position and operating results.
We may not win sufficient designs, or our design wins may not generate sufficient revenue for us to maintain or expand our business.
We invest significant resources to compete with other power semiconductor companies to win competitive bids for our products in selection processes, known as “design wins.” Our effort to obtain design wins may detract from or delay the completion of other important development projects, impair our relationships with existing end customers and negatively impact sales of products under development. In addition, we cannot be assured that these efforts would result in a design win, that our product would be incorporated into an end customer's initial product design, or that any such design win would lead to production orders and generate sufficient revenue. Furthermore, even after we have qualified our products with a customer and made sales, subsequent changes to our products, manufacturing processes or suppliers may require a new qualification process, which may result in delay and excess inventory. If we cannot achieve sufficient design wins in the future, or if we fail to generate production orders following design wins, our ability to grow our business and improve our financial results will be harmed.
Our success depends upon the ability of our OEM end customers to successfully sell products incorporating our products.
The consumer end markets, in particular the PC market, in which our products are used are highly competitive. Our OEM end customers may not successfully sell their products for a variety of reasons, including:
general global and regional economic conditions;
late introduction or lack of market acceptance of their products;
lack of competitive pricing;
shortage of component supplies;
excess inventory in the sales channels into which our end customers sell their products;
changes in the supply chain; and
changes as a result of regulatory restrictions applicable to China-exported products.

Our success depends on the ability of our OEM end customers to sell their products incorporating our products. In addition, we have expanded our business model to include more OEMs in our direct customer base. The failure of our OEM end customers to achieve or maintain commercial success for any reason could harm our business, results of operations, and financial condition and prospects.

The operation of our Oregon Fab subjects us to additional risks and the need for additional capital expenditures which may negatively impact our results of operations.
The operation of the Oregon Fab requires significant fixed manufacturing cost. In order to manage the capacity of the wafer fabrication facility efficiently, we must perform a forecast of long-term market demand and general economic conditions for our products. Because market conditions may vary significantly and unexpectedly, our forecast may change significantly at any time, and we may not be able to make timely adjustments to our fabrication capacity in response to these changes. During periods of continued decline in market demand, in particular the decline of the PC market, we may not be able to absorb the excess inventory and additional costs associated with operating the facility at higher capacity, which may adversely affect our operating results. Similarly, during periods of unexpected increase in customer demand, we may not be able to ramp up production quickly to meet these demands, which may lead to the loss of significant revenue opportunities. The manufacturing processes of a fabrication facility are complex and subject to
23


interruptions. We may experience production difficulties, including lower manufacturing yields or products that do not meet our or our customers’ specifications, and problems in ramping production and installing new equipment. These difficulties could result in delivery delays, quality problems and lost revenue opportunities. Any significant quality problems could also damage our reputation with our customers and distract us from the development of new and enhanced product which may have a significant negative impact on our financial results.

In addition, semiconductor manufacturing has historically required an upgrading of process technology from time to time to remain competitive, as new and enhanced semiconductor processes are developed which permit smaller, more efficient and more powerful semiconductor devices. Accordingly, we may have to incur substantial capital expenditures and install significant production capacity at our in-house fabrication facility to support new technologies and increased production volume, which may cause delay in our ability to deliver new products or negatively impact our results of operations. For example, we recently commenced a plan to enhance the manufacturing capability and capacity of our Oregon fab by investing in new equipment and expanding our factory facilities, which we expect will have a positive impact on our future new product development and revenue, particularly during the period of global shortage of capacity. The equipment installation contractors have experienced a shortage of skilled labor and certain materials. As a result, the expansion is expected to be now completed in the fiscal quarter ending March 31, 2023, although further delays are possible. While we expect such investment will enable us to accommodate increasing customer demand and generate additional revenue, there is no guarantee that we will be able to do so, and our investment may not produce the return that we expected, which may adversely affect our business and results of operations.

We may not be able to successfully develop our digital power business.

In September 2017, we entered into a license agreement with STMicro, which allows us to develop and market certain digital power multi-phase controller products and enter into a new market, primarily in the computer server market. We are in the process of developing this new digital power business and expect to incur significant costs to develop this business, including costs relating to the hiring and compensation of qualified engineers and technical staff; development of marketing and sales infrastructure, particularly in the computer server market; and other research and development and management activities. We do not expect this new business to generate sufficient revenue to offset our costs in the short term, and there is no guarantee that our attempt to develop a profitable digital business will ultimately succeed. The success of our digital power business depends on a number of factors, including the following:
competition from other companies with greater resources and experiences and more established reputations in the digital power market;
the availability of and our ability to recruit and attract qualified personnel;
our lack of experience and reputation in the digital power market;
difficulties in designing products acceptable to customers;
legal and regulatory restrictions; and
inadequate sales and marketing capability.

Any one of these factors may negatively impact our ability to create a successful digital power business, which would adversely affect our financial condition and results of operations.

Defects and poor performance in our products could result in loss of customers, decreased revenue, unexpected expenses and loss of market share, and we may face warranty and product liability claims arising from defective products.
Our products are complex and must meet stringent quality requirements. Products as complex as ours may contain undetected errors or defects, especially when first introduced or when new versions are released. Errors, defects or poor performance can arise due to design flaws, defects in raw materials or components or manufacturing anomalies, which can affect both the quality and the yield of the product. It can also be potentially dangerous as defective power components, or improper use of our products by customers, may lead to power overloads, which could result in explosion or fire. Any actual or perceived errors, defects or poor performance in our products could result in the replacement or recall of our products, shipment delays, rejection of our products, damage to our reputation, lost revenue, diversion of our engineering personnel from our product development efforts in order to address or remedy any defects and increases in customer service and support costs, all of which could have a material adverse effect on our business and operations.
Furthermore, as our products are typically sold at prices much lower than the cost of the equipment or other devices incorporating our products, any defective, inefficient or poorly performing products, or improper use by customers of power components, may give rise to warranty and product liability claims against us that exceed any revenue or profit we
24


receive from the affected products. We could incur significant costs and liabilities if we are sued and if damages are awarded against us. There is no guarantee that our insurance policies will be available or adequate to protect against such claims. Costs or payments we may make in connection with warranty and product liability claims or product recalls may adversely affect our financial condition and results of operations.
If we do not forecast demand for our products accurately, we may experience product shortages, delays in product shipment, excess product inventory, or difficulties in planning expenses, which will adversely affect our business and financial condition.
We manufacture our products according to our estimates of customer demand. This process requires us to make numerous forecasts and assumptions relating to the demand of our end customers, channel inventory, and general market conditions. Because we sell most of our products to distributors, who in turn sell to our end customers, we have limited visibility as to end customer demand. Furthermore, we do not have long-term purchase commitments from our distributors or end customers, and our sales are generally made by purchase orders that may be cancelled, changed or deferred without notice to us or penalty. As a result, it is difficult to forecast future customer demand to plan our operations.

The utilization of our manufacturing facilities and the provisions for inventory write-downs are important factors in our profitability. If we overestimate demand for our products, or if purchase orders are canceled or shipments delayed, we may have excess inventory, which may result in adjustments to our production plans. These adjustments to our productions may affect the utilization of our own wafer fabrication and packaging facilities. If we cannot sell certain portions of the excess inventory, it will affect our provisions for inventory write-downs. Our inventory write-down provisions are subject to adjustment based on events that may not be known at the time the provisions are made, and such adjustments could be material and impact our financial results negatively.

If we underestimate demand, we may not have sufficient inventory to meet end-customer demand, and we may lose market share and damage relationships with our distributors and end customers and we may have to forego potential revenue opportunities. Obtaining additional supply in the face of product shortages may be costly or impossible, particularly in the short term, which could prevent us from fulfilling orders in a timely manner or at all.
In addition, we plan our operating expenses, including research and development expenses, hiring needs and inventory investments, based in part on our estimates of customer demand and future revenue. If customer demand or revenue for a particular period is lower than we expect, we may not be able to proportionately reduce our fixed operating expenses for that period, which would harm our operating results.
We face intense competition and may not be able to compete effectively which could reduce our revenue and market share.
The power semiconductor industry is highly competitive and fragmented. If we do not compete successfully against current or potential competitors, our market share and revenue may decline. Our main competitors are primarily headquartered in the United States, Japan, Taiwan and Europe. Our major competitors for our power discretes include Infineon Technologies AG, MagnaChip Semiconductor Corporation, ON Semiconductor Corp., STMicroelectronics N.V., Toshiba Corporation, Diodes Incorporated and Vishay Intertechnology, Inc. Our major competitors for our power ICs include Global Mixed-mode Technology Inc., Monolithic Power Systems, Inc., ON Semiconductor Corp., Richtek Technology Corp., Semtech Corporation, Texas Instruments Inc. and Vishay Intertechnology, Inc.
We expect to face competition in the future from our competitors, other manufacturers, designers of semiconductors and start-up semiconductor design companies. Many of our competitors have competitive advantages over us, including:
significantly greater financial, technical, research and development, sales and marketing and other resources, enabling them to invest substantially more resources than us to respond to the adoption of new or emerging technologies or changes in customer requirements;
greater brand recognition and longer operating histories;
larger customer bases and longer, more established relationships with distributors or existing or potential end customers, which may provide them with greater reliability and information regarding future trends and requirements that may not be available to us;
the ability to provide greater incentives to end customers through rebates, and marketing development funds or similar programs;
25


more product lines, enabling them to bundle their products to offer a broader product portfolio or to integrate power management functionality into other products that we do not sell;
greater ability and more resources to influence and participate in the regulatory and legislative process for more favorable laws and regulations; and
captive manufacturing facilities, providing them with guaranteed access to manufacturing facilities in times of global semiconductor shortages.

In addition, the semiconductor industry has experienced increased consolidation over the past several years that may adversely affect our competitive position. Consolidation among our competitors could lead to a less favorable competitive landscape, capabilities and market share, which could harm our business and results of operations.
If we are unable to compete effectively for any of the foregoing or other reasons, our business, results of operations, and financial condition and prospects will be harmed.

Our reliance on third-party semiconductor foundries to manufacture our products subject us to risks.

The allocation of our wafer production between in-house facility and third-party foundries may fluctuate from time to time. We expect to continue to rely in part on third party foundries to meet our wafer requirements. Although we use several independent foundries, our primary third-party foundry is HHGrace, which manufactured 10.3%, 11.5% and 12.7% of the wafers used in our products for the fiscal years ended June 30, 2022, 2021 and 2020, respectively.

If any third-party foundry does not provide competitive pricing or is not able to meet our required capacity for any reason, we may not be able to obtain the required capacity to manufacture our products timely or efficiently. From time to time, third party suppliers may extend lead-times, limit supplies or increase prices due to capacity constraints or other factors, and we may experience a shortage of capacity on an industry-wide basis that may last for an extended period of time. There are no assurances that we will be able to maintain sufficient capacity to meet the full demand from our customers, and failure to do so will adversely affect our results of operations. If we cannot maintain sufficient capacity or control pricing with our existing third-party foundries, we may need to increase our own manufacturing capacity, and there is no assurance that we can ramp up the production of the Oregon Fab timely to meet the increased demand. If not, we may need to seek alternative foundries, which may not be available on commercially reasonable terms, or at all. In addition, the process for qualifying a new foundry is time consuming, difficult and may not be successful, particularly if we cannot integrate our proprietary process technology with the process used by the new foundry. Using a foundry with which we have no established relationship could expose us to potentially unfavorable pricing, unsatisfactory quality or insufficient capacity allocation.

In addition, even though we have been transferring more new product developments to our Oregon Fab and we expect to increase gradually the utilization of capacity at our JV Company as it ramps up production, we still rely on third-party foundries to effectively implement certain of our proprietary technology and processes and also require their cooperation in developing new fabrication processes. Any failure to do so may impair our ability to introduce new products and on time delivery of wafers for our existing products. In order to maintain our profit margins and to meet our customer demand, we need to achieve acceptable production yields and timely delivery of silicon wafers. As is common in the semiconductor industry, we have experienced, and may experience from time to time, difficulties in achieving acceptable production yields and timely delivery from third-party foundry vendors. Minute impurities in a silicon wafer can cause a substantial number of wafers to be rejected or cause numerous die on a wafer to be defective. Low yields often occur during the production of new products, the migration of processes to smaller geometries or the installation and start up of new process technologies.
 
We face a number of other significant risks associated with outsourcing fabrication, including:

limited control over delivery schedules, quality assurance and control and production costs;
discretion of foundries to reduce deliveries to us on short notice, allocate capacity to other customers that may be larger or have long-term customer or preferential arrangements with foundries that we use;
unavailability of, or potential delays in obtaining access to, key process technologies;
limited warranties on wafers or products supplied to us;
damage to equipment and facilities, power outages, equipment or materials shortages that could limit manufacturing yields and capacity at the foundries;
potential unauthorized disclosure or misappropriation of intellectual property, including use of our technology by the foundries to make products for our competitors;
26


financial difficulties and insolvency of foundries; and
acquisition of foundries by third parties.

 Any of the foregoing risks could delay shipment of our products, result in higher expenses and reduced revenue, damage our relationships with customers and otherwise adversely affect our business and operating results.
Our reliance on distributors to sell a substantial portion of our products subjects us to a number of risks.
We sell a substantial portion of our products to distributors, who in turn sell to our end customers. Our distributors typically offer power semiconductor products from several different companies, including our direct competitors. The distributors assume collection risk and provide logistical services to end customers, including stocking our products. Two distributors, WPG and Promate, collectively accounted for 64.3%, 64.1% and 64.8% of our revenue for the fiscal years ended June 30, 2022, 2021 and 2020, respectively. Our agreements with Promate and WPG were renewed in July 2017 and are automatically renewed for each one-year period continuously unless terminated earlier pursuant to the provisions in the agreements. We believe that our success will continue to depend upon these distributors. Our reliance on distributors subjects us to a number of risks, including:
write-downs in inventories associated with stock rotation rights and increases in provisions for price adjustments granted to certain distributors;
potential reduction or discontinuation of sales of our products by distributors;
failure to devote resources necessary to sell our products at the prices, in the volumes and within the time frames that we expect;
focusing their sales efforts on products of our competitors;
dependence upon the continued viability and financial resources of these distributors, some of which are small organizations with limited working capital and all of which depend on general economic conditions and conditions within the semiconductor industry;
dependence on the timeliness and accuracy of shipment forecasts and resale reports from our distributors;
management of relationships with distributors, which can deteriorate as a result of conflicts with efforts to sell directly to our end customers; and
our agreements with distributors which are generally terminable by either party on short notice.
    If any significant distributor becomes unable or unwilling to promote and sell our products, or if we are not able to renew our contracts with the distributors on acceptable terms, we may not be able to find a replacement distributor on reasonable terms or at all and our business could be harmed.

We have made and may continue to make strategic acquisitions of other companies, assets or businesses and these acquisitions introduce significant risks and uncertainties.

In order to position ourselves to take advantage of growth opportunities, we have made, and may continue to make, strategic acquisitions, mergers, partnership and alliances that involve significant risks and uncertainties. Successful acquisitions and alliances in the semiconductor industry are difficult to accomplish because they require, among other things, efficient integration and aligning of product offerings and manufacturing operations and coordination of sales and marketing and research and development efforts. The difficulties of integration and alignment may be increased by the necessity of coordinating geographically separated organizations, the complexity of the technologies being integrated and aligned and the necessity of integrating personnel with disparate business backgrounds and combining different corporate cultures. Furthermore, there is no guarantee that we will be able to identify a viable target for strategic acquisition, and we may incur significant costs and resources in such effort that may not result in a successful acquisition.

In addition, we may also issue equity securities to pay for future acquisitions or alliances, which could be dilutive to existing shareholders. We may also incur debt or assume contingent liabilities in connection with acquisitions and alliances, which could impose restrictions on our business operations and harm our operating results.
If we are unable to obtain raw materials in a timely manner or if the price of raw materials increases significantly, production time and product costs could increase, which may adversely affect our business.

27


Our fabrication and packaging processes depend on raw materials such as silicon wafers, gold, copper, molding compound, petroleum and plastic materials and various chemicals and gases. From time to time, suppliers may extend lead times, limit supplies or increase prices due to capacity constraints or other factors. If the prices of these raw materials rise significantly, we may be unable to pass on the increased cost to our customers. Our results of operations could be adversely affected if we are unable to obtain adequate supplies of raw materials in a timely manner or at reasonable price. In addition, from time to time, we may need to reject raw materials because they do not meet our specifications or the sourcing of such materials do not comply with our conflict mineral policies, resulting in potential delays or declines in output. Furthermore, problems with our raw materials may give rise to compatibility or performance issues in our products, which could lead to an increase in customer returns or product warranty claims. Errors or defects may arise from raw materials supplied by third parties that are beyond our detection or control, which could lead to additional customer returns or product warranty claims that may adversely affect our business and results of operations.
We may not be able to accurately estimate provisions at fiscal period end for price adjustment and stock rotation rights under our agreements with distributors, and our failure to do so may impact our operating results.
We sell a majority of our products to distributors under arrangements allowing price adjustments and returns under stock rotation programs, subject to certain limitations. As a result, we are required to estimate allowances for price adjustments and stock rotation for our products as inventory at distributors at each reporting period end. Our ability to reliably estimate these allowances enables us to recognize revenue upon delivery of goods to distributors instead of upon resale of goods by distributors to end customers.
We estimate the allowance for price adjustment based on factors such as distributor inventory levels, pre-approved future distributor selling prices, distributor margins and demand for our products. Our estimated allowances for price adjustments, which we offset against accounts receivable from distributors, were $18.7 million and $12.4 million at June 30, 2022 and 2021, respectively.
Our accruals for stock rotation are estimated based on historical returns and individual distributor agreement, and stock rotation rights, which are recorded as accrued liabilities on our consolidated balance sheets, are contractually capped based on the terms of each individual distributor agreement. Our estimated liabilities for stock rotation at June 30, 2022 and 2021 were $4.8 million and $3.9 million, respectively.
Our estimates for these allowances and accruals may be inaccurate. If we subsequently determine that any allowance and accrual based on our estimates is insufficient, we may be required to increase the size of our allowances and accrual in future periods, which would adversely affect our results of operations and financial condition.
We depend on the continuing services of our senior management team and other key personnel, and if we lose a member of our senior management or are unable to successfully retain, recruit and train key personnel, our ability to develop and market our products could be harmed.
Our success depends upon the continuing services of members of our senior management team and various engineering and other technical personnel. In particular, our engineers and other sales and technical personnel are critical to our future technological and product innovations. Our industry is characterized by high demand and intense competition for talent and the pool of qualified candidates is limited. We have entered into employment agreements with certain senior executives, but we do not have employment agreements with most of our employees. Many of these employees could leave our company with little or no prior notice and would be free to work for a competitor. If one or more of our senior executives or other key personnel are unable or unwilling to continue in their present positions, we may not be able to replace them easily or at all and other senior management may be required to divert attention from other aspects of our business. In addition, we do not have “key person” life insurance policies covering any member of our management team or other key personnel. The loss of any of these individuals or our inability to attract or retain qualified personnel, including engineers and others, could adversely affect our product introductions, overall business growth prospects, results of operations and financial condition.
Failure to protect our patents and our other proprietary information could harm our business and competitive position.
Our success depends, in part, on our ability to protect our intellectual property. We rely on a combination of patent, copyright (including mask work protection), trademark and trade secret laws, as well as nondisclosure agreements, license agreements and other methods to protect our intellectual property rights, which may not be sufficient to protect our intellectual property. As of June 30, 2022, we owned 888 issued U.S. patents expiring between 2022 and
28


2041 and had 62 pending patent applications with the United States Patent and Trademark Office. In addition, we own patents and have filed patent applications in several jurisdictions outside of the U.S, including China, Taiwan, Japan and Korea.
 Our patents and patent applications may not provide meaningful protection from our competitors, and there is no guarantee that patents will be issued from our patent applications. The status of any patent or patent application involves complex legal and factual determinations and the breadth of a claim is uncertain. In addition, our efforts to protect our intellectual property may not succeed due to difficulties and risks associated with:
policing any unauthorized use of or misappropriation of our intellectual property, which is often difficult and costly and could enable third parties to benefit from our technologies without paying us;
others independently developing similar proprietary information and techniques, gaining authorized or unauthorized access to our intellectual property rights, disclosing such technology or designing around our patents;
the possibility that any patent or registered trademark owned by us may not be enforceable or may be invalidated, circumvented or otherwise challenged in one or more countries may limit our competitive advantages;
uncertainty as to whether patents will be issued from any of our pending or future patent applications with the scope of the claims sought by us, if at all; and
intellectual property laws and confidentiality laws may not adequately protect our intellectual property rights, including, for example, in China where enforcement of China intellectual property-related laws have historically been less effective, primarily because of difficulties in enforcement and low damage awards.
 We also rely on customary contractual protection with our customers, suppliers, distributors, employees and consultants, and we implement security measures to protect our trade secrets. We cannot assure you that these contractual protections and security measures will not be breached, that we will have adequate remedies for any such breach or that our suppliers, employees, distributors or consultants will not assert rights to intellectual property arising out of such contracts.
In addition, we have a number of third-party patent and intellectual property license agreements, one of which requires us to make ongoing royalty payments. In the future, we may need to obtain additional licenses, renew existing license agreements or otherwise replace existing technology. We are unable to predict whether these license agreements can be obtained or renewed or the technology can be replaced on acceptable terms, or at all.
Intellectual property disputes could result in lengthy and costly arbitration, litigation or licensing expenses or prevent us from selling our products.
As is typical in the semiconductor industry, we or our customers may receive claims of infringement from time to time or otherwise become aware of potentially relevant patents or other intellectual property rights held by other parties that may cover some of our technology, products and services or those of our end customers. The semiconductor industry is characterized by vigorous protection and pursuit of intellectual property rights which has resulted in protracted and expensive arbitration and litigation for many companies. Patent litigation has increased in recent years due to increased assertions made by intellectual property licensing entities or non-practicing entities and increasing competition and overlap of product functionality in our markets.

Any litigation or arbitration regarding patents or other intellectual property could be costly and time consuming and could divert our management and key personnel from our business operations. We have in the past and may from time to time in the future become involved in litigation that requires our management to commit significant resources and time. In addition, as part of our strategy to diversify our serviceable markets, we launched several key product families and technologies to enable high efficiency power conversion solutions and we plan to develop and commercialize new products in other power semiconductor markets. Our entry into the commercial markets for high-voltage power semiconductors and other markets as a result of our diversification strategy may subject us to additional and increased risk of disputes or litigation relating to these products.
Because of the complexity of the technology involved and the uncertainty of litigation generally, any intellectual property arbitration or litigation involves significant risks. Any claim of intellectual property infringement against us may require us to:
incur substantial legal and personnel expenses to defend the claims or to negotiate for a settlement of claims;
29


pay substantial damages or settlement to the party claiming infringement;
refrain from further development or sale of our products;
attempt to develop non-infringing technology, which may be expensive and time consuming, if possible at all;
enter into costly royalty or license agreements that might not be available on commercially reasonable terms or at all;
cross-license our technology with a competitor to resolve an infringement claim, which could weaken our ability to compete with that competitor; and
indemnify our distributors, end customers, licensees and others from the costs of and damages of infringement claims by our distributors, end customers, licensees and others, which could result in substantial expenses for us and damage our business relationships with them.
Any intellectual property claim or litigation against us harm our business, results of operations, financial condition and prospects.

The current government investigation and evolving export control regulations may adversely affect our financial performance and business operations.

The U.S. Department of Justice commenced an investigation into the Company’s compliance with export control regulations relating to its business transactions with Huawei and its affiliates (“Huawei”), which were added to the “Entity List” by the Department of Commerce (“DOC”) in May 2019.  In connection with this investigation, DOC requested the Company to suspend shipments of its products to Huawei, and the Company complied with such request. The Company has not shipped any product to Huawei since December 31, 2019. The Company is currently working with DOC to resolve this issue and requested DOC to grant permission to reinstate shipments to Huawei.  To date DOC has not provided us with any timeline or schedule under which DOC will respond to our request. There is no guarantee that DOC will agree to permit us to resume shipment to Huawei on a timely basis, or at all. The DOC’s decision may be influenced by factors beyond our control, such as shifting political dynamics and the macro-economic relationship between the U.S. and China and changes in export control regulations. Our inability to continue such shipment may negatively impact our revenue and financial performance, particularly if we are not able to acquire new customers to offset the loss of shipments to Huawei.

The ongoing government investigations into our export control compliance also subject us to a number of financial and business risks. We expect to incur significant costs and expenses, including legal fees, in connection with our effort to respond to the government investigation, as well as additional legal fees for defending securities class actions resulting from public disclosure of the government investigation. Such additional costs will adversely affect our profitability. While the Company has purchased a D&O insurance policy which may reimburse a portion of such fees and expenses, there is no guarantee that such policy will be sufficient to reduce our costs or that reimbursement can be obtained on a timely basis or at all. Furthermore, the management has diverted its resources and time in response to the investigation, and might not be able to fully engage with the core operation and objectives of our business activities. Finally, while we are fully cooperating with the government in the investigation, we are not able to predict its timing and outcome. In the event that the government decides to bring enforcement action against us, it will result in a material adverse effect on our business operations, our financial conditions and our reputation.

We also expect that the U.S. export control regulations to evolve and change in response to the political and economic tension between the U.S. and China, including potential new export control regulations that may impose additional restrictions on our ability to continue to do business with certain customers in China and Asia. If such changes occur, we may be required to reduce shipments to certain Asian customers, adjust our business practices and incur additional costs to implement new export control compliance procedures, policies and programs, each of which will adversely affect our financial conditions and results of operations.
Global or regional economic, political and social conditions could adversely affect our business and operating results.
External factors such as potential terrorist attacks, acts of war, financial crises, such as the global or regional economic recession, or geopolitical and social turmoil in those parts of the world that serve as markets for our products could have significant adverse effect on our business and operating results in ways that cannot presently be predicted. Any future economic downturn or recession in the global economy in general and, in particular, on the economies in China, Taiwan and other countries where we market and sell our products, will have an adverse effect on our results of operations.
30


Our business operations could be significantly harmed by natural disasters or global epidemics.
We have research and development facilities located in Taiwan and the Silicon Valley in Northern California. Historically, these regions have been vulnerable to natural disasters and other risks, such as earthquakes, fires and floods, which may disrupt the local economy and pose physical risks to our property. We also have sales offices located in Taiwan and Japan where similar natural disasters and other risks may disrupt the local economy and pose physical risks to our operations. We are not currently covered by insurance against business disruption caused by earthquakes. In addition, we currently do not have redundant, multiple site capacity in the event of a natural disaster or other catastrophic event. In the event of such an occurrence, our business would suffer.

Our business could be adversely affected by natural disasters such as epidemics, outbreaks or other health crisis. An outbreak of avian flu or H1N1 flu in the human population, or another similar health crisis, such as the recent COVID-19 pandemic, could adversely affect the economies and financial markets of many countries, particularly in Asia. Moreover, any related disruptions to transportation or the free movement of persons could hamper our operations and force us to close our offices temporarily.
The occurrence of any of the foregoing or other natural or man-made disasters could cause damage or disruption to us, our employees, operations, distribution channels, markets and customers, which could result in significant delays in deliveries or substantial shortages of our products and adversely affect our business results of operations, financial condition or prospects.
Our insurance may not cover all losses, including losses resulting from business disruption or product liability claims.
We have limited product liability, business disruption or other business insurance coverage for our operations. In addition, we do not have any business insurance coverage for our operations to cover losses that may be caused by litigation or natural disasters. Any occurrence of uncovered loss could harm our business, results of operations, financial condition and prospects.
Our international operations subject our company to risks not faced by companies without international operations.
We have adopted a global business model under which we maintain significant operations and facilities through our subsidiaries located in the U.S., China, Taiwan and Hong Kong. Our main research and development center is located in Silicon Valley, and our manufacturing and supply chain is located in China. We also have sales offices and customers throughout Asia, the U.S. and elsewhere in the world. Our international operations may subject us to the following risks:
economic and political instability, including trade tension between the U.S. and China;
costs and delays associated with transportations and communications;
coordination of operations through multiple jurisdictions and time zones;
fluctuations in foreign currency exchange rates;
trade restrictions, changes in laws and regulations relating to, amongst other things, import and export tariffs, taxation, environmental regulations, land use rights and property; and
the laws of, including tax laws, and the policies of the U.S. toward, countries in which we operate.
If we fail to maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results or prevent fraud.
Our management may conclude that our internal control over financial reporting is not effective. Moreover, even if our management concludes that our internal control over financial reporting is effective, our independent registered public accounting firm may decline to issue an opinion as to the effectiveness of our internal control over financial reporting, or may issue a report that is qualified or adverse. Our failure to achieve and maintain effective internal control over financial reporting could result in the loss of investor confidence in the reliability of our financial statements or prevent fraud, which in turn could harm our business and negatively impact the trading price of our shares.

We are subject to the risk of increased income taxes and changes in existing tax rules.

    We conduct our business in multiple jurisdictions, including Hong Kong, Macau, the U.S., China, Taiwan, South Korea, Japan and Germany. The calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax laws and regulations in various taxing jurisdictions. Any of these jurisdictions may assert that we have
31


unpaid taxes. Our effective tax rate was 7.9%, 6.5% and (1.9)% for the fiscal years ended June 30, 2022, 2021 and 2020, respectively.

Any tax rate changes in the tax jurisdictions in which we operate could result in adjustments to our deferred tax assets, if applicable, which would affect our effective tax rate and results of operations. We base our tax position upon the anticipated nature and conduct of our business and upon our understanding of the tax laws of the various countries in which we have assets or conduct activities. However, our tax position is subject to review and possible challenge by tax authorities and to possible changes in law, which may have a retroactive effect. In particular, various proposals over the years have been made to change certain U.S. tax laws relating to foreign entities with U.S. connections. In addition, the U.S. government has proposed various other changes to the U.S. international tax system, certain of which could adversely impact foreign-based multinational corporate groups, and increased enforcement of U.S. international tax laws.

In August 2022 the U.S. enacted the Chip and Science Act of 2022 (the Chips Act). The Chips Act provides incentives to semiconductor chip manufacturers in the United States, including providing a 25% manufacturing investment credits for investments in semiconductor manufacturing property placed in service after December 31, 2022, for which construction begins before January 1, 2027. Property investments qualify for the 25% credit if, among other requirements, the property is integral to the operation of an advanced manufacturing facility, defined as having a primary purpose of manufacturing semiconductors or semiconductor manufacturing equipment. Currently, we are evaluating the impact of the Chips Act to us.

It is possible that these or other changes in the U.S. tax laws, foreign tax laws, or proposed actions by international bodies such as the Organization of Economic Cooperation and Development (OECD) could significantly increase our U.S. or foreign income tax liability in the future, including as described further below in this risk factor.

In December 2017, the European Union (“EU”) identified certain jurisdictions (including Bermuda and Cayman Islands) which it considered had a tax system that facilitated offshore structuring by attracting profits without commensurate economic activity. In order to avoid EU “blacklisting”, both Bermuda and Cayman Islands introduced new legislation in December 2018, which came into force on January 1, 2019. These new laws require Bermuda and Cayman companies carrying on one or more “relevant activity” (including: banking, insurance, fund management, financing, leasing, headquarters, shipping, distribution and service center, intellectual property or holding company) to maintain a substantial economic presence in Bermuda and Cayman Islands in order to comply with the economic substance requirements. Effective from December 31, 2019, we have structured our activities to comply with the new law. However, there is no experience yet as to how the Bermuda and Cayman Islands authorities will interpret and enforce these new rules. The legislation remains subject to further clarification and, accordingly, there is no guarantee that we will be deemed to be compliant. Furthermore, this legislation may require us to make additional changes to the activities we carry on in Bermuda or Cayman Islands, which could increase our costs either directly in those locations or indirectly as a result of increased costs related to moving our operations to other jurisdictions. As a result, we are not able to determine the impact on our operations and net income as of the current period.

In addition, our subsidiaries provide products and services to, and may from time to time undertake certain significant transactions with, us and other subsidiaries in different jurisdictions. We have adopted transfer pricing arrangements for transactions among our subsidiaries. Related party transactions are generally subject to close review by tax authorities, including requirements that transactions be priced at arm's length and be adequately documented. If any tax authorities were successful in challenging our transfer pricing policies or other tax judgments, our income tax expense may be adversely affected and we could also be subject to interest and penalty charges which may harm our business, financial condition and operating results.

Further, the U.S. Congress, the EU, the OECD, and other government agencies in jurisdictions where we and our affiliates do business have had an extended focus on issues related to the taxation of multinational corporations. One example is the OECD’s initiative in the area of “base erosion and profit shifting,” or “BEPS”. Many countries have implemented or begun to implement legislation and other guidance to align their international tax rules with the OECD’s BEPS recommendations. In addition, the OECD has been working on an extension of the BEPS project, being referred to as “BEPS 2.0”, which focuses on two “pillars” of reform. Pillar 1 is focused on global profit allocation and changing where large multinational corporations pay taxes, and pillar 2 includes a global minimum tax rate. The OECD published detailed blueprints of its proposals for pillar 1 and pillar 2 on October 14, 2020. In June 2021, Finance Ministers from the Group of Seven (G7) nations reached an accord on the principles of pillar 2, backing the creation of a global minimum corporate tax rate of at least 15%. Following the G7 announcement, the OECD/G20 Inclusive Framework announced on July 1, 2021 broad agreement on the two pillars, and released a proposal, which has been endorsed by over
32


130 jurisdictions, for a global minimum tax rate of at least 15% for large multinational corporations on a jurisdiction-by-jurisdiction basis. The OECD/G20 Inclusive Framework will work towards an agreement and the release of an implementation plan, which will contemplate bringing pillar 2 into law in 2022 with an effective date in 2023. As a result of the focus on the taxation of multinational corporations, the tax laws in the countries in which we and our affiliates do business could change on a prospective or retroactive basis, and any such changes could adversely affect us.
    
Our debt agreements include financial covenants that may limit our ability to pursue business and financial opportunities and subject us to risk of default.

We have entered into various debt agreements with certain financial institutions, which generally require us to maintain certain financial covenants that have the effect of limiting our ability to take certain actions, including actions to incur debt, repurchase stock, make certain investments and capital expenditures. As we continue to grow our business and expand our operations, we expect to incur additional indebtedness, including loan agreement or equipment leases, in order to fund such capital expenditures. These restrictions may limit our ability to pursue business and financial opportunities that are available or beneficial to us in response to changing and competitive economic environment, which may have an adverse effect on our financial conditions. In addition, a breach of any of these financial covenants, if not waived by the lenders, could trigger an event of default under the debt agreements, which may result in the acceleration of our indebtedness or the loss of our collateral used to secure such indebtedness.

The imposition of U.S. corporate income tax on our Bermuda parent and non-U.S. subsidiaries could adversely affect our results of operations.

We believe that our Bermuda parent and non-U.S. subsidiaries each operate in a manner that they would not be subject to U.S. corporate income tax because they are not engaged in a trade or business in the United States. Nevertheless, there is a risk that the U.S. Internal Revenue Service may assert that our Bermuda parent and non-U.S. subsidiaries are engaged in a trade or business in the United States. If our Bermuda parent and non-U.S. subsidiaries were characterized as being so engaged, we would be subject to U.S. tax at the regular corporate rates on our income that is effectively connected with U.S. trade or business, plus an additional 30% “branch profits” tax on the dividend equivalent amount, which is generally effectively connected income with certain adjustments, deemed withdrawn from the United States. Any such tax could materially and adversely affect our results of operations.

We may be classified as a passive foreign investment company (“PFIC”), which could result in adverse U.S. federal income tax consequences for U.S. holders.

Based on the current and anticipated valuation of our assets and the composition of our income and assets, we do not expect to be considered a PFIC, for U.S. federal income tax purposes for the foreseeable future. However, we must make a separate determination for each taxable year as to whether we are a PFIC after the close of each taxable year and we cannot assure you that we will not be a PFIC for our 2022 taxable year or any future taxable year. Under current law, a non-U.S. corporation will be considered a PFIC for any taxable year if either (1) at least 75% of its gross income is passive income or (2) at least 50% of the value of its assets, generally based on an average of the quarterly values of the assets during a taxable year, is attributable to assets that produce or are held for the production of passive income. PFIC status depends on the composition of our assets and income and the value of our assets, including, among others, a pro rata portion of the income and assets of each subsidiary in which we own, directly or indirectly, at least 25% by value of the subsidiary's equity interests, from time to time. Because we currently hold and expect to continue to hold a substantial amount of cash or cash equivalents, and because the calculation of the value of our assets may be based in part on the value of our common shares, which may fluctuate considerably given that market prices of technology companies historically often have been volatile, we may be a PFIC for any taxable year. If we were treated as a PFIC for any taxable year during which a U.S. holder held common shares, certain adverse U.S. federal income tax consequences could apply for such U.S. holder.
The average selling prices of products in our markets have historically decreased rapidly and will likely do so in the future, which could harm our revenue and gross margins.
As is typical in the semiconductor industry, the average selling price of a particular product has historically declined significantly over the life of the product. In the past, we have reduced the average selling prices of our products in anticipation of future competitive pricing pressures, new product introductions by us or our competitors and other factors. We expect that we will have to similarly reduce prices in the future for older generations of products. Reductions in our average selling prices to one customer could also impact our average selling prices to all customers. A decline in average selling prices would harm our gross margins for a particular product. If not offset by sales of other
33


products with higher gross margins, our overall gross margins may be adversely affected. Our business, results of operations, financial condition and prospects will suffer if we are unable to offset any reductions in our average selling prices by increasing our sales volumes, reducing our costs and developing new or enhanced products on a timely basis, with higher selling prices or gross margins.
We may be adversely affected by the cyclicality of the semiconductor industry.
Our industry is highly cyclical and is characterized by constant and rapid technological change such as the introduction of smart phones and tablets that contributed to the decline in the PC market, product obsolescence and price erosion, evolving standards, uncertain product life cycles and wide fluctuations in product supply and demand. The industry has, from time to time, experienced significant and sometimes prolonged, downturns, which were often connected with or in anticipation of, maturing product cycles and declines in general economic conditions. These downturns have been characterized by diminished product demand, production overcapacity, high inventory levels and accelerated erosion of average selling prices. Any future downturns, in particular the PC markets or in any other markets in which we sell our products, may reduce our revenue and result in us having excess inventory. By contrast, any upturn in the semiconductor industry could result in increased competition for access to limited third-party foundry and packaging and testing capacity, which could prevent us from benefiting from such an upturn or reduce our profit margins.
Risks Related to Doing Business in China
China's economic, political and social conditions, as well as government policies, could affect our business and growth.

Our financial results have been, and are expected to continue to be, affected by the economy in China. If China’s economy is slowing down, it may negatively affect our business operation and financial results. The China economy differs from the economies of most developed countries in many respects, including:
higher level of government involvement;
early stage of development of a market-oriented economy;
rapid growth rate;
higher level of control over foreign currency exchange; and
less efficient allocation of resources.
 The Chinese economy has been transitioning from a planned economy to a more market-oriented economy. Although in recent years the China government has implemented measures emphasizing the utilization of market forces for economic reform, the reduction of state ownership of productive assets and the establishment of corporate governance in business enterprises, the China government continues to retain significant control over the business and productive assets in China. Any changes in China's government policy or China's political, economic and social conditions, or in relevant laws and regulations, may adversely affect our current or future business, results of operations or financial condition. These changes in government policy may be implemented through various means, including changes in laws and regulations, implementation of anti-inflationary measures, change of basic interest rate, changes in the tax rate or taxation system and the imposition of additional restrictions on currency conversion and imports. Furthermore, given China's largely export-driven economy, any changes in the economies of China's principal trading partners and other export-oriented nations may adversely affect our business, results of operations, financial condition and prospects.
Our ability to successfully expand our business operations in China depends on a number of factors, including macroeconomic and other market conditions, and credit availability from lending institutions. In response to the recent global and Chinese economic recession, the China government has promulgated several measures aimed at expanding credit and stimulating economic growth. We cannot assure you that the various macroeconomic measures, monetary policies and economic stimulus package adopted by the China government to guide economic growth will be effective in maintaining or sustaining the growth rate of the Chinese economy. If measures adopted by the China government fail to achieve further growth in the Chinese economy, it may adversely affect our growth, business strategies and operating results. In addition, changes in political and social conditions of China may adversely affect our ability to conduct our business in the region. For example, geopolitical disputes and increased tensions between China and its neighboring countries in which we conduct business could make it more difficult for us to coordinate and manage our international operations in such countries.
34


Changes in China's laws, legal protections or government policies on foreign investment in China may harm our business.
Our business and corporate transactions, including our operations through the JV Company, are subject to laws and regulations applicable to foreign investment in China as well as laws and regulations applicable to foreign-invested enterprises. These laws and regulations frequently change, and their interpretation and enforcement involves uncertainties that could limit the legal protections available to us. Regulations and rules on foreign investments in China impose restrictions on the means that a foreign investor like us may apply to facilitate corporate transactions we may undertake. In addition, the Chinese legal system is based in part on government policies and internal rules, some of which are not published on a timely basis or at all, that may have a retroactive effect. As a result, we may not be aware of our violation of these policies and rules until sometime after the violation. If any of our past operations are deemed to be non-compliant with Chinese law, we may be subject to penalties and our business and operations may be adversely affected. For instance, under Special Administrative Measures (Negative List) for Foreign Investment Access, some industries are categorized as sectors which are restricted or prohibited for foreign investment. As the Negative List is updated every year, there can be no assurance that the China government will not change its policies in a manner that would render part or all of our business to fall within the restricted or prohibited categories. If we cannot obtain approval from relevant authorities to engage in businesses which become prohibited or restricted for foreign investors, we may be forced to sell or restructure a business which has become restricted or prohibited for foreign investment. Furthermore, the China government has broad discretion in dealing with violations of laws and regulations, including levying fines, revoking business and other licenses and requiring actions necessary for compliance. In particular, licenses and permits issued or granted to us by relevant governmental bodies may be revoked at a later time by higher regulatory bodies. If we are forced to adjust our corporate structure or business as a result of changes in government policy on foreign investment or changes in the interpretation and application of existing or new laws, our business, financial condition, results of operations and prospects may be harmed. Moreover, uncertainties in the Chinese legal system may impede our ability to enforce contracts with our business partners, customers and suppliers, or otherwise pursue claims in litigation to recover damages or loss of property, which could adversely affect our business and operations.

The continuing trade tensions between the U.S. and China may result in increased tariffs on imported goods from China that could adversely affect our business operations.

Since 2018, U.S. and China trade tensions led to higher and increasing tariffs imposed by both countries on the import of goods from the other country. The U.S. government used various authorities to implement tariffs on a variety of Chinese goods and materials, which, absent exemptions, include products and applications, including consumer electronics, that incorporate our power discrete and power IC products. In response, China has imposed tariffs on certain American products, and warned of additional actions if the U.S. imposes new or increased tariffs. The continuing trade tensions could have significant adverse effects on world trade and the world economy. While the two countries have negotiated and entered into agreements to gradually reduce certain tariffs, it’s unclear whether those agreements will significantly reduce the tariffs affecting our business operations. The ultimate level of tariffs, the ultimate scope of them, and whether or how any proposed additional tariffs will impact our business is uncertain. We believe that the imposition of additional tariffs by the U.S. government on products incorporating our power semiconductors could deter our customers from purchasing our products originating from China. If so, this would reduce demand for our power semiconductor products or result in pricing adjustments that would lower our gross margin, which could have a material adverse effect on our business and results of operations.

Substantial uncertainties exist with respect to the interpretation and implementation of PRC Foreign Investment Law and how it may impact the viability of our current corporate structure, corporate governance and business operations.
 
On March 15, 2019, the National People’s Congress of the PRC promulgated the Foreign Investment Law, which took effect on January 1, 2020, and replaced the existing laws regulating foreign investment in China, namely, the Sino-foreign Equity Joint Venture Enterprise Law, the Sino-foreign Cooperative Joint Venture Enterprise Law and the Wholly Foreign-invested Enterprise Law, together with their implementation rules and ancillary regulations. The Foreign Investment Law embodies a PRC regulatory trend to rationalize its foreign investment regulatory regime in line with prevailing international practice and the legislative efforts to unify the corporate legal requirements for both foreign and domestic investments. The Foreign Investment Law establishes the basic framework for the access, promotion, protection and administration of foreign investments in China in view of investment protection and fair competition. For example, treatment of foreign investors on a national level will be no less favorable than the treatment received by domestic investors unless such investments fall within a “negative list”. On June 30, 2019, the National Development and Reform Commission (the “NDRC”) and the Ministry of Commerce of the PRC (the “MOC”) published the Special Administrative Measures for Market Access of Foreign Investment (Negative List), which identifies specific sectors where foreign investors will be subject to special administrative measures. The Negative List has been updated twice in
35


June 2020 for year 2021 and December 2021 for year 2022. The current effective Negative List took effect on January 1, 2022.

Since the Foreign Investment Law was newly enacted, uncertainties still exist in relation to its interpretation and implementation. For example, the Foreign Investment Law provides that foreign invested enterprises established according to the existing laws regulating foreign investment may maintain their structure and corporate governance within a five-year transition period, which means that we may be required to adjust the structure and corporate governance of certain of our China subsidiaries in such transition period. Failure to take timely and appropriate measures to cope with any of these or similar regulatory compliance challenges could materially and adversely affect our current corporate structure, corporate governance and business operations.

In addition, under the newly enacted Foreign Investment Law, foreign investors or the foreign invested enterprise should report investment information on the principle of necessity. Any company found to be non-complaint with such investment information reporting obligation might be potentially subject to fines or administrative liabilities.
Limitations on our ability to transfer funds to our China subsidiaries could adversely affect our ability to expand our operations, make investments that could benefit our businesses and otherwise fund and conduct our business.
The transfer of funds from us to our China subsidiaries, either as a shareholder loan or as an increase in registered capital, is subject to registration with or approval by the China's governmental authorities, including the State Administration of Foreign Exchange, or SAFE's, or the relevant examination and approval authority. Our subsidiaries may also experience difficulties in converting our capital contributions made in foreign currencies into RMB due to changes in the China's foreign exchange control policies. Therefore, it may be difficult to change capital expenditure plans once the relevant funds have been remitted from us to our China subsidiaries. These limitations and the difficulties our China subsidiaries may experience on the free flow of funds between us and our China subsidiaries could restrict our ability to act in response to changing market situations in a timely manner.
China's currency exchange control and government restrictions on investment repatriation may impact our ability to transfer funds outside of China.
A significant portion of our business is conducted in China where the currency is the Renminbi. Regulations in China permit foreign owned entities to freely convert the Renminbi into foreign currency for transactions that fall under the “current account,” which includes trade related receipts and payments, interest and dividends. Accordingly, our Chinese subsidiaries may use Renminbi to purchase foreign exchange for settlement of such “current account” transactions without pre-approval. However, pursuant to applicable regulations, foreign‑invested enterprises in China may pay dividends only out of their accumulated profits, if any, determined in accordance with Chinese accounting standards and regulations. In calculating accumulated profits, foreign investment enterprises in China are required to allocate at least 10% of their accumulated profits each year, if any, to fund certain reserve funds unless these reserves have reached 50% of the registered capital of the enterprises.
Other transactions that involve conversion of Renminbi into foreign currency are classified as “capital account” transactions; examples of “capital account” transactions include repatriations of investment by or loans to foreign owners, or direct equity investments in a foreign entity by a China domiciled entity. “Capital account” transactions require prior approval from, or registration with China's State Administration of Foreign Exchange (SAFE) or its provincial branch or its authorized banks to convert a remittance into a foreign currency, such as U.S. dollars, and transmit the foreign currency outside of China.
As a result of these and other restrictions under PRC laws and regulations, our China subsidiaries are restricted in their ability to transfer a portion of their net assets to the parent. Such restricted portion amounted to approximately $92.4 million, or 10.8% of our total consolidated net assets attributed to the Company as of June 30, 2022. We have no assurance that the relevant Chinese governmental authorities in the future will not limit further or eliminate the ability of our China subsidiaries to purchase foreign currencies and transfer such funds to us to meet our liquidity or other business needs. Any inability to access funds in China, if and when needed for use by the Company outside of China, could have a material and adverse effect on our liquidity and our business.

The M&A Rules and certain other PRC regulations establish complex procedures for some acquisitions of Chinese companies by foreign investors, which could make it more difficult for us to pursue growth through acquisitions in China.

36


The Regulations on Mergers and Acquisitions of Domestic Companies by Foreign Investors, or the M&A Rules, adopted by six PRC regulatory agencies in August 2006 and amended in 2009, and some other regulations and rules concerning mergers and acquisitions established additional procedures and requirements that could make merger and acquisition activities by foreign investors more time consuming and complex, including requirements in some instances that the Ministry of Commerce ("MOC") be notified in advance of any change-of-control transaction in which a foreign investor takes control of a PRC domestic enterprise. Moreover, the Anti-Monopoly Law requires that the MOC shall be notified in advance of any concentration of undertaking if certain thresholds are triggered. In addition, the security review rules issued by the MOC that became effective in September 2011 specify that mergers and acquisitions by foreign investors that raise “national defense and security” concerns and mergers and acquisitions through which foreign investors may acquire de facto control over domestic enterprises that raise “national security” concerns are subject to strict review by the MOC, and the rules prohibit any activities attempting to bypass a security review, including by structuring the transaction through a proxy or contractual control arrangement. On July 1, 2015, the National Security Law of China took effect, which provided that China would establish rules and mechanisms to conduct national security review of foreign investments in China that may impact national security. China’s Foreign Investment Law, which became effective in January 2020, reiterates that China will establish a security review system for foreign investments. On December 19, 2020, the NDRC and the MOC jointly issued the Measures for the Security Review of Foreign Investments (the “New FISR Measures”), which was made according to the National Security Law and the Foreign Investment Law of China and became effective on January 18, 2021. The New FISR Measures further expand the scope of national security review on foreign investment compared to the existing rules, while leaving substantial room for interpretation and speculation. In the future, we may grow our business by acquiring complementary businesses. Complying with the requirements of the above-mentioned regulations and other relevant rules to complete such transactions could be time consuming, and any required approval processes, including obtaining approval from the MOC or its local counterparts may delay or inhibit our ability to complete such transactions, which could affect our ability to expand our business or maintain our market share.

Our results of operations may be negatively impacted by fluctuations in foreign currency exchange rates between U.S. dollar and Chinese Yuan, or RMB.
    
While U.S. dollars is our main functional currency and our revenue and a significant portion of our operating expenses are denominated in U.S. dollars, we are required to maintain local currencies, primarily the RMB, in our cash balances in connection with the funding of our overseas operations.  As a result, our costs and operating expenses may be exposed to adverse movements in foreign currency exchange rates between the U.S. dollar and RMB.  We also do not utilize any financial instruments to hedge or reduce potential losses due to the fluctuation of foreign currency exchange rates.  In general, any appreciation of U.S. dollars against a weaker RMB could reduce the value of our cash and cash equivalent balance, which could increase our operating expenses and negatively affect our cash flow, income and profitability.  The value of RMB against the U.S. dollars may fluctuate and is affected by many factors outside of our control, including changes in political and economic conditions, implementation of new monetary policies by the Chinese government and changes in banking regulations, and there is no guarantee that we will be able to mitigate or recoup any losses due to a significant fluctuation in the U.S. dollar/RMB exchange rates.

PRC labor laws may adversely affect our results of operations.

The PRC government promulgated the Labor Contract Law of the PRC, effective on January 1, 2008, as amended, to govern the establishment of employment relationships between employers and employees, and the conclusion, performance, termination of and the amendment to employment contracts. The Labor Contract Law imposes greater liabilities on employers and significantly affects the cost of an employer’s decision to reduce its workforce. Further, it requires that certain termination decisions be based upon seniority and not merit. In the event our subsidiaries decide to significantly change or decrease their workforce in China, the Labor Contract Law could adversely affect their ability to effect such changes in a manner that is most advantageous to our business or in a timely and cost-effective manner, thus materially and adversely affecting our financial condition and results of operations.

In recent years, compensation in various industries in China has increased and may continue to increase in the future. In order to attract and retain skilled personnel, we may need to increase the compensation of our employees. Compensation may, also, increase as inflationary pressure increases in China. In addition, under the Regulations on Paid Annual Leave for Employees, which became effective on January 1, 2008, employees who have served more than one year for a specific employer are entitled to a paid vacation ranging from 5 to 15 days, depending on length of service. Employees who waive such vacation time at the request of employers must be compensated for three times their normal salaries for each waived vacation day. This mandated paid-vacation regulation, coupled with the trend of increasing compensation, may result in increase in our employee-related costs and expenses and decrease in our profit margins.
37


Relations between Taiwan and China could negatively affect our business, financial condition and operating results and, therefore, the market value of our common shares.
Taiwan has a unique international political status. China does not recognize the sovereignty of Taiwan. Although significant economic and cultural relations have been established during recent years between Taiwan and China, relations have often been strained. A substantial number of our key customers and some of our essential sales and engineering personnel are located in Taiwan, and we have a large number of operational personnel and employees located in China. Therefore, factors affecting military, political or economic relationship between China and Taiwan could have an adverse effect on our business, financial condition and operating results.
Risks Related to Our Corporate Structure and Our Common Shares
Our share price may be volatile and you may be unable to sell your shares at or above the purchase price, if at all.

Limited trading volumes and liquidity of our common shares on the NASDAQ Global Select Market may limit the ability of shareholders to purchase or sell our common shares in the amounts and at the times they wish.  In addition, the financial markets in the United States and other countries have experienced significant price and volume fluctuations, and market prices of technology companies have been and continue to be extremely volatile. The trading price of our common shares on The NASDAQ Global Select Market ranged from a low of $24.40 to high of $65.72 from July 1, 2021 to June 30, 2022. At July 31, 2022, the trading price of our common shares was $42.01. Volatility in the price of our shares may be caused by factors outside our control and may be unrelated or disproportionate to our operating results.
The market price for our common shares may be volatile and subject to wide fluctuations in response to factors, including:
actual or anticipated fluctuations in our operating results;
general economic, industry, regional and global market conditions, including the economic conditions of specific market segments for our products, including the PC markets;
our failure to meet analysts' expectations, including expectation regarding our revenue, gross margin and operating expenses;
changes in financial estimates and outlook by securities research analysts;
our ability to increase our gross margin;
announcements by us or our competitors of new products, acquisitions, strategic partnerships, joint ventures or capital commitments;
announcements of technological or competitive developments;
announcement of acquisition, partnership and major corporate transactions;
regulatory developments in our target markets affecting us, our customers or our competitors;
our ability to enter into new market segments, gain market share, diversify our customer base and successfully secure manufacturing capacity;
announcements regarding intellectual property disputes or litigation involving us or our competitors;
changes in the estimation of the future size and growth rate of our markets;
announcement of significant legal proceedings, litigation or government investigation;
additions or departures of key personnel;
repurchase of shares under our repurchase program;
announcement of sales of our securities by us or by our major shareholders;
general economic or political conditions in China and other countries in Asia; and
other factors.
  In the past, securities class action litigation has often been brought against a company following periods of volatility in such company's share price.  This type of litigation could result in substantial costs and divert our management's attention and resources which could negatively impact our business and financial conditions. See Item 3. Legal Proceeding.
38


If securities or industry analysts do not publish research or reports about our business, or if they adversely change their recommendations regarding our common shares or if our operating results do not meet their expectations, the trading price of our common shares could decline.

The market price of our common shares is influenced by the research and reports that industry or securities analysts publish about us or our business. There is no guarantee that these analysts will understand our business and results, or that their reports will be accurate or correctly predict our operating results or prospects. If one or more of these analysts cease coverage of our company or fail to publish reports on us regularly, we could lose visibility in the financial markets, which in turn could cause the market price of our common shares or its trading volume to decline. Moreover, if one or more of the analysts who cover our company downgrade our common shares or if our operating results or prospects do not meet their expectations, the market price of our common shares could decline significantly.
Anti-takeover provisions in our bye-laws could make an acquisition of us more difficult and may prevent attempts by our shareholders to replace or remove our current management.
Certain provisions in our bye-laws may delay or prevent an acquisition of us or a change in our management. In addition, by making it more difficult for shareholders to replace members of our board of directors, these provisions also may frustrate or prevent any attempts by our shareholders to replace or remove our current management because our board of directors is responsible for appointing the members of our management team. These provisions include:
the ability of our board of directors to determine the rights, preferences and privileges of our preferred shares and to issue the preferred shares without shareholder approval;
advance notice requirements for election to our board of directors and for proposing matters that can be acted upon at shareholder meetings; and
the requirement to remove directors by a resolution passed by at least two-thirds of the votes cast by the shareholders having a right to attend and vote at the shareholder meeting.
These provisions could make it more difficult for a third-party to acquire us, even if the third-party's offer may be considered beneficial by many shareholders. As a result, shareholders may be limited in their ability to obtain a premium for their shares.
We are a Bermuda company and the rights of shareholders under Bermuda law may be different from U.S. laws.

We are a Bermuda limited liability exempted company. As a result, the rights of holders of our common shares will be governed by Bermuda law and our memorandum of association and bye-laws.  The rights of shareholders under Bermuda law may differ from the rights of shareholders of companies incorporated in other jurisdictions, including the U.S.  For example, some of our directors are not residents of the United States, and a substantial portion of our assets are located outside the United States.  As a result, it may be difficult for investors to effect service of process on those persons in the U.S. or to enforce in the U.S. judgments obtained in U.S. courts against us or those persons based on civil liability provisions of the U.S. securities laws.  It is doubtful whether courts in Bermuda will enforce judgments obtained in other jurisdictions, including the U.S., against us or our directors or officers under the securities laws of those jurisdictions or entertain actions in Bermuda against us or our directors or officers under the securities laws of other jurisdictions.


39


Item 1B.     Unresolved Staff Comments
None.

40

Item 2.    Properties
As of July 31, 2022, our primary U.S. facility, which houses our research and design function, as well as elements of marketing and administration, is located in Sunnyvale, California. We conduct our manufacturing, research and development, sales and marketing and administration in Asia and North America. We lease all properties used in our business except the wafer fabrication facility in Oregon acquired in January 2012. The following table sets forth the location, size and primary use of our principal properties that are material to our business operations:
Location  Square Footage  Primary Use
475 Oakmead Parkway
Sunnyvale, California, USA 94085
  57,000   Research and development, marketing, sales and administration
3131 Northeast Brookwood Parkway
Hillsboro, Oregon, USA 97124
252,950 Wafer fabrication facility
Building 8/9, No. 91, Lane 109, Rongkang
Road, Songjiang District, Shanghai,
China 201614
  206,179   Packaging and testing, manufacturing support
Building B1, Dongkai Industrial Park,
Songjiang Export Process Zone, Area B, Songjiang, Shanghai, China 201614
250,198 Packaging and testing, manufacturing support
We believe that our current facilities are adequate and that additional space will be available on commercially reasonable terms for the foreseeable future.
41


Item 3.Legal Proceedings 

As previously disclosed, the DOJ commenced an investigation into the Company’s compliance with export control regulations relating to its business transactions with Huawei and its affiliates (“Huawei”), which were added to the “Entity List” by the DOC in May 2019. The Company is cooperating fully with federal authorities in the investigation. The Company has continued to respond to inquiries and requests from DOJ for documents and information relating to the investigation, and the matter is currently pending at DOJ, and DOJ has not provided the Company with any specific timeline or indication as to when the investigation will be concluded or resolved. In connection with this investigation, DOC previously requested the Company to suspend shipments of its products to Huawei. The Company complied with such request, and the Company has not shipped any product to Huawei after December 31, 2019. The Company continues to work with DOC to resolve this issue and requested DOC to grant permission to reinstate the Company’s shipments to Huawei. As part of this process and in response to DOC’s request, the Company provided certain documents and materials relating to the Company’s supply chain and shipment process to DOC, and DOC is currently reviewing this matter. DOC has not informed the Company of any specific timeline or schedule under which DOC will provide a response to the Company’s request.

We have in the past, and may from time to time in the future, become involved in legal proceedings arising from the normal course of business activities. The semiconductor industry is characterized by frequent claims and litigation, including claims regarding patent and other intellectual property rights as well as improper hiring practices. Irrespective of the validity of such claims, we could incur significant costs in the defense thereof or could suffer adverse effects on its operations.


Item 4.         Mine Safety Disclosures

Not Applicable.

42


PART II

Item 5.Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Our common shares have traded on the NASDAQ Global Select Market since April 29, 2010 under the symbol AOSL. As of July 31, 2022, there were approximately 160 holders of record of our common shares, not including those shares held in a street or nominee name.
Dividend Policy
We have never declared or paid cash dividends on our common shares. We currently intend to retain all available funds and any future earnings for use in the operation of our business and do not anticipate paying any dividends on our common share in the foreseeable future. Any future determination to declare dividends will be made at the discretion of our board of directors and will depend on our financial condition, operating results, capital requirements, general business conditions and other factors that our board of directors may deem relevant.

Securities Authorized for Issuance Under Equity Compensation Plans
See Item 12 of Part III of this report regarding information about securities authorized for issuance under our equity compensation plans.

Share Performance Graph
The following graph compares the total cumulative shareholder return on our common shares with the total cumulative return of the NASDAQ Composite Index and the Philadelphia Semiconductor Index for the last five fiscal years ended June 30, 2022, assuming an investment of $100 at the beginning of such period and the reinvestment of any dividends.
The comparisons in the graph below are required by the SEC and are not intended to forecast or be indicative of possible future performance of our common shares.
aosl-20220630_g2.jpg
    
    The above Share Performance Graph and related information shall not be deemed “soliciting material” or to be “filed” with the Securities and Exchange Commission, nor shall such information be incorporated by reference into any future filing under the Securities Act of 1933 or Securities Exchange Act of 1934, each as amended, except to the extent that the Company specifically incorporates it by reference into such filing.

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

In September 2017, the board of directors approved a repurchase program (the “Repurchase Program”) that allowed the Company to repurchase its common shares from the open market pursuant to a pre-established Rule 10b5-1 trading plan or
43


through privately negotiated transactions up to an aggregate of $30.0 million. The amount and timing of any repurchases under the Repurchase Program depend on a number of factors, including but not limited to, the trading price, volume and availability of the Company’s common shares. There is no guarantee that such repurchases under the Repurchase Program will enhance the value of our shares. Shares repurchased under this program are accounted for as treasury shares and the total cost of shares repurchased is recorded as a reduction of shareholders' equity. During the fourth quarter of fiscal year 2022, the Company did not repurchase any shares under the Repurchase Program. As of June 30, 2022, we had $13.4 million available under this repurchase program.






44


Item 6.    [Reserved]

 




45


Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations

You should read the following discussion of the financial condition and results of our operations in conjunction with our consolidated financial statements and the notes to those statements included elsewhere in this annual report. Our consolidated financial statements contained in this annual report are prepared in accordance with U.S. GAAP.
Overview

We are a designer, developer and global supplier of a broad portfolio of power semiconductors. Our portfolio of power semiconductors includes approximately 2,500 products, and has grown significantly with the introduction of over 130 new products in the fiscal year ended June 30, 2022, and over 160 new products in each of the fiscal year ended June 30, 2020 and 2019, respectively. Our teams of scientists and engineers have developed extensive intellectual properties and technical knowledge that encompass major aspects of power semiconductors, which we believe enables us to introduce and develop innovative products to address the increasingly complex power requirements of advanced electronics. We have an extensive patent portfolio that consists of 888 patents and 62 patent applications in the United States as of June 30, 2022. We also have a total of 936 foreign patents, which primarily were based on our research and development efforts through June 30, 2022. We differentiate ourselves by integrating our expertise in technology, design and advanced manufacturing and packaging to optimize product performance and cost. Our portfolio of products targets high-volume applications, including personal computers, graphic cards, game consoles, flat panel TVs, home appliances, power tools, smart phones, battery packs, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment.
Our business model leverages global resources, including research and development and manufacturing in the United States and Asia. Our sales and technical support teams are localized in several growing markets. We operate an 8-inch wafer fabrication facility located in Hillsboro, Oregon, or the Oregon Fab, which is critical for us to accelerate proprietary technology development, new product introduction and improve our financial performance. To meet the market demand for the more mature high volume products, we also utilize the wafer manufacturing capacity of selected third party foundries. For assembly and test, we primarily rely upon our in-house facilities in China. In addition, we utilize subcontracting partners for industry standard packages. We believe our in-house packaging and testing capability provides us with a competitive advantage in proprietary packaging technology, product quality, cost and sales cycle time.

On March 29, 2016, we formed the JV Company with the Chongqing Funds, for the purpose of constructing and operating the Chongqing Fab in the LiangJiang New Area of Chongqing, China. The Chongqing Fab is being built in phases. As of December 1, 2021, we owned 50.9%, and the Chongqing Funds owned 49.1% of the equity interest in the JV Company. The JV Company was accounted under the provisions of the consolidation guidance since we had controlling financial interest until December 1, 2021.

Effective December 1, 2021, we entered into a share transfer agreement ("STA") with a third-party investor (the "Investor"), pursuant to which we sold to the Investor approximately 2.1% of outstanding equity interest held by us in the JV Company for an aggregate purchase price of RMB 108 million or approximately $16.9 million. The STA contained customary representations, warranties and covenants. The Transaction was closed on December 2, 2021. As a result of the Transaction, as of the Closing Date, our equity interest in the JV Company decreased from 50.9% to 48.8%. Also, our right to designate directors on the board of JV Company was reduced to three (3) out of seven (7) directors, from four (4) directors prior to the Transaction. As of December 2, 2021, we no longer have a controlling financial interest in the JV Company under generally accepted accounting principles. Loss of control is deemed to have occurred when, among other things, a parent company owns less than a majority of the outstanding common stock in the subsidiary, lacks a controlling financial interest in the subsidiary and, is unable to unilaterally control the subsidiary through other means such as having, or the ability to obtain or represent, a majority of the subsidiary’s board of directors. All of these loss of control factors were present for us as of December 2, 2021. Accordingly, since December 2, 2021, we have deconsolidated the JV Company in our Consolidated Financial Statements and accounted for our investment in the JV Company using the equity method of accounting.
On December 24, 2021, we entered into a share transfer agreement with another third-party investor, pursuant to which we sold to this investor 1.1% of outstanding equity interest held by us in the JV Company for an aggregate purchase price of RMB 60 million or approximately $9.4 million based on the currency exchange rate as of December 24, 2021. In addition, on December 30, 2021, the JV Company adopted an employee equity incentive plan and issued an equity interest equivalent to 3.99% of the JV Company to exchange in cash. As a result, we owned 45.8% of the equity interest in the JV Company as of December 31, 2021.

On January 26, 2022, the JV Company completed a financing transaction pursuant to the Financing Agreement between the JV Company and certain New Investors. Under the Financing Agreement, the New Investors purchased newly issued equity interest of the JV Company for a total purchase price of RMB 509 million (or approximately $80 million based on the currency
46


exchange rate as of January 26, 2022) (the "Investment"). Following the closing of the Investment, the percentage of outstanding JV Company equity interest beneficially owned by the Company was reduced to 42.2%.

We reduced our ownership of the JV Company to below 50% to increase the flexibility of the JV Company to raise capital to fund its future expansion. Following the Transaction and the successful ramp up to its Phase I target run rate in the September quarter of 2021, as planned, the JV Company commenced an effort to raise up to $200 million of additional capital, including an $80 million round that was completed on January 26, 2022 through private funding for its Phase II expansion. In addition to immediate private funding rounds, the JV Company is also contemplating an eventual listing on the Science and Technology Innovation Board, or STAR Market, of the Shanghai Stock Exchange. The Transaction assists the JV Company in meeting certain regulatory listing requirements. A potential STAR Market listing may take several years to consummate and there is no guarantee that such listing by the JV Company will be successful or will be completed in a timely manner, or at all. In addition, the JV Company will continue to provide us with significant level of foundry capacity to enable us to develop and manufacture our products. On July 12, 2022, the current shareholders of the JV Company entered into a shareholders contract, pursuant to which the JV Company provided us a monthly wafer production capacity guarantee, subject to future increase when the JV Company’s production capacity reaches certain goal.

During the fiscal year ended June 30, 2022, we continued our diversification program by developing new silicon and packaging platforms to expand our serviceable available market, or SAM and offer higher performance products. Our metal-oxide-semiconductor field-effect transistors, or MOSFET, and power IC product portfolio expanded significantly. Our high performance products and deepened customer relationships with our OEM and ODM customers have contributed to the achievement of our record high revenue of $777.6 million for the fiscal year 2022, a 18.4% growth compared to the last fiscal year.

Impact of COVID-19 Pandemic to our Business
Our business operations have been impacted by the global COVID-19 pandemic and the resulting economic downturn. Numerous governmental jurisdictions, including the States of California, Oregon and Texas in the U.S. and countries throughout the Asia Pacific region have imposed various restrictions on commercial activities, resulting in business closures, work stoppages, labor shortage, disruptions to ports, vaccine mandates and other shipping infrastructure, border closures, thereby negatively impacting our customers, suppliers, distributors, employees, offices, and the entire semiconductor ecosystem.

As a result of the COVID-19 pandemic and changing consumer behaviors due to various government restrictions and the growing trend to provide remote-working options by employers, we have experienced shifting market trends, including an increasing demand in markets for notebooks, personal computing ("PC"), gaming devices and other products. While we have benefited from the increasing demand for PC related products, there is no guarantee that this trend will continue, and such increasing demand may discontinue or decline if government authorities relax or terminate COVID-19 related restrictions and consumer behaviors change in response to the reopening of certain economic activities. In an effort to protect the health and safety of our employees and to comply with various government and regulatory guidelines, we also took proactive actions to adopt policies and protocols at our locations around the world, including social distancing guidelines, vaccine and testing protocols.

Since the start of the second quarter of calendar year 2021, there have been increasing availability and administration of vaccines against COVID-19, as well as an easing of restrictions on social, business, travel, and government activities and functions, and a gradual resumption of economic activities and consumer spending in our industries. However, infection rates continued to fluctuate in various regions and new strains of the virus remain a risk, including a surge of COVID-19 cases and hospitalization due to the spread of Omicron variants in late 2021 and early 2022. During the first half of calendar year 2022, COVID-19 cases and hospitalization rate continued to decline and governments in various jurisdictions, including the U.S. and Europe, have lifted various restrictions and limitations on economic activities. At the same time, however, new variants of COVID-19 continued to emerge and contributed to recent rise of infection rates in various jurisdictions in which we operate, including China and U.S. Furthermore, we may be subject to the ongoing global impacts resulting from the pandemic, including disruption of the product supply chains, shortages of semiconductor components, and delays in shipments, product development, and product launches and rising inflation rates.

In April 2022, the operations of our two packaging and testing facilities in Shanghai, China were suspended due to a strict lockdown of the city imposed by the local government in response to surging COVID cases. Our facilities in Shanghai were required to shut down and production was halted beginning in early April. Transportation suspension in and out of Shanghai also interrupted the shipping of raw materials and finished parts to and from our facilities. We received permission to reopen our facilities partially in early May. We gradually ramped up production at these facilities in May and returned to normal operation in June 2022. The suspension of our Shanghai facilities, and the subsequent partial resumption of production,
47


reduced our ability to complete orders from our customers in a timely manner, which adversely affected our revenue and results of operation for the three months ended June 30, 2022. We cannot guarantee that the Shanghai government will not impose similar restrictions and lockdown in the future, and any such restrictions and lockdown will adversely affect our operations and financial performance.

The full extent of the longer-term impact of the COVID-19 pandemic on our operational and financial performance is uncertain and will depend on many factors outside our control, including, without limitation, the timing, extent, trajectory and duration of the pandemic; the availability, distribution and effectiveness of vaccines; the spread of new variants of COVID-19; the continued and renewed imposition of protective public safety measures, including local and regional lockdown and quarantines; the disruption of global supply chain; and the impact of the pandemic on the global economy and demand for consumer products. Although we are unable to predict the full impact and duration of the COVID-19 pandemic on our business, we are actively managing our business operations and financial expenditures in response to continued uncertainty.
Other Factors affecting our performance
In addition to the COVID-19 pandemic and related events as described above, our performance is affected by several key factors, including the following:
The global, regional economic and PC market conditions: Because our products primarily serve consumer electronic applications, any significant change in global and regional economic conditions could materially affect our revenue and results of operations. A significant amount of our revenue is derived from sales of products in the PC markets, such as notebooks, motherboards and notebook battery packs, therefore a substantial decline or downturn in the PC market could have a material adverse effect on our revenue and results of operations. The PC markets have experienced a modest global decline in recent years due to continued growth of demand in tablets and smart phones, worldwide economic conditions and the industry inventory correction which had and may continue to have a material impact on the demand for our products. However, we recently have experienced a significant increase of demand in PC market due to the impact of the COVID-19 pandemic and resulting shift in market trend and consumer behaviors. We cannot predict whether and how long this trend will continue due to the uncertainty and unpredictability of COVID-19 pandemic. A decline of the PC market may have a negative impact on our revenue, factory utilization, gross margin, our ability to resell excess inventory, and other performance measures. We have executed and continue to execute strategies to diversify our product portfolio, penetrate other market segments, including the consumer, communications and industrial markets, and improve gross margins and profit by implementing cost control measures. While making efforts to reduce our reliance on the computing market, we continue to support our computing business and capitalize on the opportunities in this market with a more focused and competitive PC product strategy to gain market share.
Manufacturing costs and capacity availability: Our gross margin is affected by a number of factors including our manufacturing costs, utilization of our manufacturing facilities, the product mixes of our sales, pricing of wafers from third party foundries and pricing of semiconductor raw materials. Capacity utilization affects our gross margin because we have certain fixed costs at our Shanghai facilities and our Oregon Fab. If we are unable to utilize our manufacturing facilities at a desired level, our gross margin may be adversely affected. For example, in April 2022, the operations of our packaging and testing facilities in Shanghai, China were suspended due to a strict lockdown of the city imposed by the local government in response to surging COVID cases. The facilities were required to be shut down and production was halted since early April. Transportation suspension in and out of Shanghai also interrupted the shipping of raw materials and finished parts to and from our facilities. We received permission to reopen our facilities partially in early May. We gradually ramped up production at these facilities in May and returned to normal operation in June 2022. However, there is no guarantee that additional restrictions and lockdown will not be reimposed by the government, which is outside of our control, and any extension of the lockdown will continue to have a negative impact on our results of operation and financial condition. In addition, from time to time, we may experience wafer capacity constraints, particularly at third party foundries, that may prevent us from meeting fully the demand of our customers. For example, the recent global shortage of semiconductor manufacturing capacity has provided us with both challenges and opportunities in the market, and highlighted the importance of maintaining sufficient and independent in-house manufacturing capabilities to meet increasing customer demands. While we can mitigate these constraints by increasing and re-allocating capacity at our own fab, we may not be able to do so quickly or at sufficient level, which could adversely affect our financial conditions and results of operations. In addition, we recently commenced a plan to enhance the manufacturing capability and capacity of our Oregon Fab by investing in new equipment and expanding our factory facilities, which we expect will have a positive impact on our future new product development and revenue, particularly during the period of global shortage of capacity. The expansion is expected to be completed in the fiscal quarter ending March 31, 2023. We also rely substantially on the JV Company to provide foundry capacity to manufacture our products, therefore it is critical that we maintain continuous access to such capacity, which may not be available at sufficient level or at a pricing terms favorable to us because of lack of control over the JV Company’s operation. As a result of sales of our JV Company equity interests and issuance of additional equity interests by the JV Company to third-party investors in financing transactions, our
48


equity interest in the JV Company was reduced to 42.2%, which reduced our control and influence over the JV Company. While we continue to maintain a business relationship with the JV Company to ensure uninterrupted supply of manufacturing capacity, and we are currently negotiating a foundry agreement for the JV Company to provide guarantee level of capacity, the JV Company may take actions or make decisions that adversely impact our ability to access required capacity, and our lack of control and influence may prevent us from eliminating or mitigating such risk.
Erosion and fluctuation of average selling price: Erosion of average selling prices of established products is typical in our industry. Consistent with this historical trend, we expect our average selling prices of existing products to decline in the future. However, in the normal course of business, we seek to offset the effect of declining average selling price by introducing new and higher value products, expanding existing products for new applications and new customers and reducing the manufacturing cost of existing products. These strategies may cause the average selling price of our products to fluctuate significantly from time to time, thereby affecting our financial performance and profitability.
Product introductions and customers’ product requirements: Our success depends on our ability to introduce products on a timely basis that meet or are compatible with our customers' specifications and performance requirements. Both factors, timeliness of product introductions and conformance to customers' requirements, are equally important in securing design wins with our customers. As we accelerate the development of new technology platforms, we expect to increase the pace at which we introduce new products and seek and acquire design wins. If we were to fail to introduce new products on a timely basis that meet customers’ specifications and performance requirements, particularly those products with major OEM customers, and continue to expand our serviceable markets, then we would lose market share and our financial performance would be adversely affected.
Distributor ordering patterns, customer demand and seasonality: Our distributors place purchase orders with us based on their forecasts of end customer demand, and this demand may vary significantly depending on the sales outlook and market and economic conditions of end customers. Because these forecasts may not be accurate, channel inventory held at our distributors may fluctuate significantly, which in turn may prompt distributors to make significant adjustments to their purchase orders placed with us. As a result, our revenue and operating results may fluctuate significantly from quarter to quarter. In addition, because our products are used in consumer electronics products, our revenue is subject to seasonality. Our sales seasonality is affected by numerous factors, including global and regional economic conditions as well as the PC market conditions, revenue generated from new products, changes in distributor ordering patterns in response to channel inventory adjustments and end customer demand for our products and fluctuations in consumer purchase patterns prior to major holiday seasons. In recent periods, broad fluctuations in the semiconductor markets and the global and regional economic conditions, in particular the decline of the PC market conditions, have had a more significant impact on our results of operations than seasonality. Furthermore, our revenue may be impacted by the level of demand from our major customers due to factors outside of our control. If these major customers experience significant decline in the demand of their products, encounter difficulties or defects in their products, or otherwise fail to execute their sales and marketing strategies successfully, it may adversely affect our revenue and results of operations.
Principal line items of statements of operations
The following describes the principal line items set forth in our consolidated statements of operations:
Revenue
We generate revenue primarily from the sale of power semiconductors, consisting of power discretes and power ICs. Historically, a majority of our revenue has been derived from power discrete products. Because our products typically have three-year to five-year life cycles, the rate of new product introduction is an important driver of revenue growth over time. We believe that expanding the breadth of our product portfolio is important to our business prospects, because it provides us with an opportunity to increase our total bill-of-materials within an electronic system and to address the power requirements of additional electronic systems. In addition, a small percentage of our total revenue is generated by providing packaging and testing services to third parties through one of our subsidiaries.
Our product revenue is reported net of the effect of the estimated stock rotation returns and price adjustments that we expect to provide to our distributors. Stock rotation returns are governed by contract and are limited to a specified percentage of the monetary value of products purchased by the distributor during a specified period. At our discretion or upon our direct negotiations with the original design manufacturers (“ODMs”) or original equipment manufacturers (“OEMs”), we may elect to grant special pricing that is below the prices at which we sold our products to the distributors. In these situations, we will grant price adjustments to the distributors reflecting such special pricing. We estimate the price adjustments for inventory at the distributors based on factors such as distributor inventory levels, pre-approved future distributor selling prices, distributor margins and demand for our products.
49



Cost of goods sold
Our cost of goods sold primarily consists of costs associated with semiconductor wafers, packaging and testing, personnel, including share-based compensation expense, overhead attributable to manufacturing, operations and procurement, and costs associated with yield improvements, capacity utilization, warranty and valuation of inventories. As the volume of sales increases, we expect cost of goods sold to increase. While our utilization rates cannot be immune to the market conditions, our goal is to make them less vulnerable to market fluctuations. We believe our market diversification strategy and product growth will drive higher volume of manufacturing which will improve our factory utilization rates and gross margin in the long run.
Operating expenses
Our operating expenses consist of research and development, and selling, general and administrative expenses. We expect our operating expenses as a percentage of revenue to fluctuate from period to period as we continue to exercise cost control measures in response to the declining PC market as well as align our operating expenses to the revenue level.
Research and development expenses. Our research and development expenses consist primarily of salaries, bonuses, benefits, share-based compensation expense, expenses associated with new product prototypes, travel expenses, fees for engineering services provided by outside contractors and consultants, amortization of software and design tools, depreciation of equipment and overhead costs. We continue to invest in developing new technologies and products utilizing our own fabrication and packaging facilities as it is critical to our long-term success. We also evaluate appropriate investment levels and stay focused on new product introductions to improve our competitiveness. We expect that our research and development expenses will fluctuate from time to time.
Selling, general and administrative expenses. Our selling, general and administrative expenses consist primarily of salaries, bonuses, benefits, share-based compensation expense, product promotion costs, occupancy costs, travel expenses, expenses related to sales and marketing activities, amortization of software, depreciation of equipment, maintenance costs and other expenses for general and administrative functions as well as costs for outside professional services, including legal, audit and accounting services. We expect our selling, general and administrative expenses to fluctuate in the near future as we continue to exercise cost control measures.
Income tax expense

We are subject to income taxes in various jurisdictions. Significant judgment and estimates are required in determining our worldwide income tax expense. The calculation of tax liabilities involves dealing with uncertainties in the application of complex tax regulations of different jurisdictions globally. We establish accruals for potential liabilities and contingencies based on a more likely than not threshold to the recognition and de-recognition of uncertain tax positions. If the recognition threshold is met, the applicable accounting guidance permits us to recognize a tax benefit measured at the largest amount of tax benefit that is more likely than not to be realized upon settlement with a taxing authority. If the actual tax outcome of such exposures is different from the amounts that were initially recorded, the differences will impact the income tax and deferred tax provisions in the period in which such determination is made. Changes in the location of taxable income (loss) could result in significant changes in our income tax expense.

We record a valuation allowance against deferred tax assets if it is more likely than not that a portion of the deferred tax assets will not be realized, based on historical profitability and our estimate of future taxable income in a particular jurisdiction. Our judgments regarding future taxable income may change due to changes in market conditions, changes in tax laws, tax planning strategies or other factors. If our assumptions and consequently our estimates change in the future, the deferred tax assets may increase or decrease, resulting in corresponding changes in income tax expense. Our effective tax rate is highly dependent upon the geographic distribution of our worldwide profits or losses, the tax laws and regulations in each geographical region where we have operations, the availability of tax credits and carry-forwards and the effectiveness of our tax planning strategies.

U.S. Tax Cuts and Jobs Act, Enacted December 22, 2017

On December 22, 2017, the United States enacted tax reform legislation through the Tax Cuts and Jobs Act (“the Tax Act”), which significantly changes the existing U.S. tax laws, including, but not limited to, (1) a reduction in the corporate tax rate from 35% to 21%, (2) a shift from a worldwide tax system to a territorial system, (3) eliminating the corporate alternative minimum tax (AMT) and changing how existing AMT credits can be realized, (4) bonus depreciation that will allow for full
50


expensing of qualified property, (5) creating a new limitation on deductible interest expense and (6) changing rules related to uses and limitations of net operating loss carryforwards created in tax years beginning after December 31, 2017.

The Company is not currently subject to the Base Erosion and Anti-Abuse (BEAT) tax, which is a tax imposed on certain entities who make payments to their non U.S. affiliates, where such payments reduce the U.S. tax base . The BEAT tax is imposed at a rate of 10% on Adjusted Taxable Income, excluding certain payments to foreign related entities. It is an incremental tax over and above the corporate income tax and is recorded as a period cost. It is possible that this tax could be applicable in future periods, which would cause an increase to the effective tax rate and cash taxes.

U.S. Coronavirus Aid, Relief and Economic Security Act” (“CARES Act”), Enacted March 27, 2020

On March 27, 2020, the United States enacted the CARES Act, which made the changes to existing U.S. tax laws, including, but not limited to, (1) allowing U.S. federal net operating losses originated in the 2018, 2019 or 2020 tax years to be carried back five years to recover taxes paid based upon taxable income in the prior five years, (2) eliminated the 80% of taxable income limitation on net operating losses for the 2018, 2019 and 2020 tax years (the 80% limitation will be reinstated for tax years after 2020), (3) accelerating the refund of prior year alternative minimum tax credits, (4) modifying the bonus depreciation for qualified improvement property and (5) modifying the limitation on deductible interest expense.

As a result of the ability to carryback net operating losses from the June 2018 and June 2019 years to the June 2015 to June 2017 tax years, net operating losses which were previously tax-effected using the current 21% U.S. federal tax rate were revalued to the U.S. tax rates in effect for the June 2015 to June 2017 tax years due to the ability of receiving tax refunds for the taxes paid in these years. Accordingly, we reported a discrete tax benefit of $1.1 million in the third quarter of fiscal year 2020 related to the re-measurement of the net operating losses that could be realized via the new net operating loss carryback provisions.

“U.S. Consolidated Appropriations Act, 2021” (“CAA 2021”), Enacted December 27, 2020

On December 27, 2020, the United States enacted the Consolidated Appropriations Act, 2021, which made changes to existing U.S. tax laws. There was no material impact of the tax law changes included in the Consolidated Appropriations Act, 2021 to the Company.

“The American Rescue Plan Act of, 2021”, Enacted March 11, 2021

On March 11, 2021, the United States enacted the American Rescue Plan Act of 2021, which made changes to existing U.S. tax laws. There was no material impact of the tax law changes included in the American Rescue Plan Act of 2021 to the Company.

“The Chip and Science Act of 2022”, Enacted August 2, 2022
In August 2022 the U.S. enacted the Chip and Science Act of 2022 (the Chips Act). The Chips Act provides incentives to semiconductor chip manufacturers in the United States, including providing manufacturing investment credits of 25% for investments in semiconductor manufacturing property placed in service after December 31, 2022, for which construction begins before January 1, 2027. Property investments qualify for the 25% credit if, among other requirements, the property is integral to the operation of an advanced manufacturing facility, defined as having a primary purpose of manufacturing semiconductors or semiconductor manufacturing equipment. Currently, we are evaluating the impact of the Chips Act to us.


51


Operating results

The following tables set forth our results of operations and as a percentage of revenue for the fiscal years ended June 30, 2022, 2021 and 2020. Our historical results of operations are not necessarily indicative of the results for any future period.
 
Year Ended June 30,
 202220212020202220212020
(in thousands)(% of revenue)
Revenue$777,552 $656,902 $464,909 100.0 %100.0 %100.0 %
Cost of goods sold (1)508,996 452,359 362,178 65.5 %68.9 %77.9 %
Gross profit268,556 204,543 102,731 34.5 %31.1 %22.1 %
Operating expenses:
Research and development (1)71,259 62,953 51,252 9.2 %9.6 %11.0 %
Selling, general and administrative (1)95,259 77,514 64,816 12.3 %11.8 %13.9 %
Impairment of privately-held investment— — 600 — %— %0.1 %
Total operating expenses166,518 140,467 116,668 21.5 %21.4 %25.0 %
Operating income (loss)102,038 64,076 (13,937)13.0 %9.7 %(2.9)%
Other income (loss), net999 2,456 (1,229)0.1 %0.4 %(0.3)%
Interest expenses, net(3,920)(6,308)(2,743)(0.5)%(1.0)%(0.6)%
Gain on deconsolidation of the JV Company399,093 — — 51.3 %— %— %
Loss on changes of equity interest in the JV Company, net(3,140)— — (0.4)%— %— %
Net income (loss) before income taxes495,070 60,224 (17,909)63.5 %9.1 %(3.8)%
Income tax expense 39,258 3,935 348 5.0 %0.6 %0.1 %
Net income (loss) before loss from equity method investment455,812 56,289 (18,257)58.5 %8.5 %(3.9)%
Equity method investment loss from equity investee2,629 — — 0.3 %— %— %
Net income (loss)453,183 56,289 (18,257)58.2 %8.5 %(3.9)%
Net income (loss) attributable to noncontrolling interest20 (1,827)(11,661)0.0 %(0.3)%(2.5)%
Net income (loss) attributable to Alpha and Omega Semiconductor Limited$453,163 $58,116 $(6,596)58.2 %8.8 %(1.4)%
(1) Includes share-based compensation expense as follows:
 
Year Ended June 30,
 202220212020202220212020
(in thousands)(% of revenue)
Cost of goods sold$5,125 $1,756 $1,530 0.7 %0.3 %0.3 %
Research and development7,049 5,352 2,895 0.9 %0.8 %0.6 %
Selling, general and administrative19,150 8,216 6,029 2.5 %1.3 %1.3 %
$31,324 $15,324 $10,454 4.1 %2.4 %2.2 %

52


Revenue
    The following is a summary of revenue by product type:
Year Ended June 30, Change
20222021202020222021
(in thousands)(in thousands)(in percentage)(in thousands)(in percentage)
Power discrete$545,135 $482,718 $391,941 $62,417 12.9 %$90,777 23.2 %
Power IC220,882 161,726 66,360 59,156 36.6 %95,366 143.7 %
Packaging and testing services11,535 12,458 6,608 (923)(7.4)%5,850 88.5 %
$777,552 $656,902 $464,909 $120,650 18.4 %$191,993 41.3 %
Fiscal 2022 vs 2021

Total revenue was $777.6 million for fiscal year 2022, an increase of $120.7 million, or 18.4%, as compared to $656.9 million for fiscal year 2021. The increase was primarily due to an increase of $62.4 million in sales of power discrete products and an increase of $59.2 million in sales of power IC products. The increase in power discrete and power IC product sales was primarily due to a 21.0% increase in average selling price as compared to last fiscal year due to a shift in product mix, partially offset by a 2.1% decrease in unit shipments. The decrease in revenue of packaging and testing services for the fiscal year 2022 as compared to last fiscal year was primarily due to decreased demand. During fiscal year 2022, we accelerated the development of new technology platforms which allowed us to introduce 49 medium and high voltage MOSFET products, targeting primarily the industrial markets and communication marketing, and 7 module products primarily for the consumer markets, as well as 14 low voltage MOSFET products primarily for the computing and communication markets. In addition, we introduced 69 Power IC new products for computing applications, communication and consumer markets.

Fiscal 2021 vs 2020

Total revenue was $656.9 million for fiscal year 2021, an increase of $192.0 million, or 41.3%, as compared to $464.9 million for fiscal year 2020. The increase was primarily due to an increase of $90.8 million in sales of power discrete products and an increase of $95.4 million in sales of power IC products. The increase in power discrete and power IC product sales was primarily due to a 23.0% increase in unit shipments and a 14.5% increase in average selling price due to a shift in product mix as compared to last fiscal year. The increase in revenue of packaging and testing services for the fiscal year 2021 as compared to last fiscal year was primarily due to increased demand.
Cost of goods sold and gross profit
 Year Ended June 30, Change
 20222021202020222021
 (in thousands)(in thousands)(in percentage)(in thousands)(in percentage)
Cost of goods sold$508,996 $452,359 $362,178 $56,637 12.5 %$90,181 24.9 %
  Percentage of revenue65.5 %68.9 %77.9 %
Gross profit$268,556 $204,543 $102,731 $64,013 31.3 %$101,812 99.1 %
  Percentage of revenue34.5 %31.1 %22.1 %

Fiscal 2022 vs 2021

Cost of goods sold was $509.0 million for fiscal year 2022, an increase of $56.6 million, or 12.5%, as compared to $452.4 million for fiscal year 2021. The increase was primarily due to 18.4% increase in revenue. Gross margin increased by 3.4 percentage points to 34.5% for the fiscal year 2022, as compared to 31.1% for the fiscal year 2021. The increase in gross margin was primarily due to better product mix during the fiscal year ended June 30, 2022. We expect our gross margin to continue to fluctuate in the future as a result of variations in our product mix, semiconductor wafer and raw material pricing, manufacturing labor cost and general economic and PC market conditions.

53


Fiscal 2021 vs 2020

Cost of goods sold was $452.4 million for fiscal year 2021, an increase of $90.2 million, or 24.9%, as compared to $362.2 million for fiscal year 2020. The increase was primarily due to 41.3% increase in revenue. Gross margin increased by 9.0 percentage points to 31.1% for the fiscal year 2021, as compared to 22.1% for the fiscal year 2020. Our JV Company continued its ramp during the fiscal year 2021, which resulted in an increase in the capacity utilization and contributed to the increase in gross margin.
Research and development expenses
 Year Ended June 30, Change
 20222021202020222021
 (in thousands)(in thousands)(in percentage)(in thousands)(in percentage)
Research and development$71,259 $62,953 $51,252 $8,306 13.2 %$11,701 22.8 %

Fiscal 2022 vs 2021

Research and development expenses were $71.3 million for fiscal year 2022, an increase of $8.3 million, or 13.2%, as compared to $63.0 million for fiscal year 2021. The increase was primarily attributable to a $6.8 million increase in employee compensation and benefit expense mainly due to higher bonus accrual, increased headcount and annual merit increase, a $1.7 million increase in share-based compensation expense due to an increase in stock awards granted, a $0.2 million increase in depreciation expenses, and a $0.2 million increase in professional fees, partially offset by a $0.8 million decrease in product prototyping engineering expense as a result of decreased engineering activities. We continue to evaluate and invest resources in developing new technologies and products utilizing our own fabrication and packaging facilities. We believe the investment in research and development are important to meet our strategic objectives.

Fiscal 2021 vs 2020

Research and development expenses were $63.0 million for fiscal year 2021, an increase of $11.7 million, or 22.8%, as compared to $51.3 million for fiscal year 2020. The increase was primarily attributable to a $4.0 million increase in employee compensation and benefit expense mainly due to higher bonus accrual, a $4.2 million increase in product prototyping engineering expense as a result of increased engineering activities, a $2.5 million increase in share-based compensation expense due to higher stock awards price, and a $0.5 million increase in facility expenses as a result of higher office rental expenses and higher utility costs.
Selling, general and administrative expenses
 Year Ended June 30, Change
 20222021202020222021
 (in thousands)(in thousands)(in percentage)(in thousands)(in percentage)
Selling, general and administrative$95,259 $77,514 $64,816 $17,745 22.9 %$12,698 19.6 %

Fiscal 2022 vs 2021

Selling, general and administrative expenses were $95.3 million for fiscal year 2022, an increase of $17.7 million, or 22.9%, as compared to $77.5 million for fiscal year 2021. The increase was primarily attributable to a $8.6 million increase in employee compensation and benefits expenses mainly due to increased headcount, annual merit increase, higher bonus expenses and increased employee and business insurance expenses, as well as $10.9 million increase in share-based compensation expense due to increase in stock award granted, partially offset by a $2.2 million decrease in legal expense related to the government investigation.

Fiscal 2021 vs 2020

Selling, general and administrative expenses were $77.5 million for fiscal year 2021, an increase of $12.7 million, or 19.6%, as compared to $64.8 million for fiscal year 2020. The increase was primarily attributable to a $13.2 million increase in
54


employee compensation and benefits expenses, mainly due to increased headcount, higher bonus expenses and increased employee insurance expenses, as well as $2.2 million increase in share-based compensation expense due to higher stock rewards price. The increase was partially offset by a $1.9 million decrease in legal expense related to the government investigation, and a $0.9 million decrease in business travel expenses as a result of the COVID-19 pandemic.
Impairment of privately-held investment
 Year Ended June 30, Change
 20222021202020222021
 (in thousands)(in thousands)(in percentage)(in thousands)(in percentage)
Impairment of privately-held investment$— $— $600 $— — %$(600)100.0 %
During the fiscal year 2020, we recorded an other-than-temporary impairment charge for our investment of $0.6 million in a privately-held start-up company. As of June 30, 2022 and 2021, we have remaining a privately-held investment of $0.1 million.
Other income (loss), net
 Year Ended June 30, Change
 20222021202020222021
 (in thousands)(in thousands)(in percentage)(in thousands)(in percentage)
Other income (loss), net$999 $2,456 $(1,229)$(1,457)(59.3)%$3,685 (299.8)%
Other income (loss), net decreased by $1.5 million in fiscal year 2022 as compared to the last fiscal year primarily due to increase in foreign currency exchange loss as a result of the depreciation of RMB against USD.
Other income (loss), net increased by $3.7 million in the fiscal year 2021 as compared to the fiscal year 2020 was primarily due to a decrease in foreign currency exchange loss as a result of the appreciation of RMB against USD.
Interest expense, net
 Year Ended June 30, Change
 20222021202020222021
 (in thousands)(in thousands)(in percentage)(in thousands)(in percentage)
Interest expense, net$(3,920)$(6,308)$(2,743)$2,388 (37.9)%$(3,565)130.0 %
Interest expense was primarily related to bank borrowings. Interest expense decreased by $2.4 million in fiscal year 2022 as compared to the prior fiscal year primarily because of deconsolidation of the JV Company in December 2021. Interest expense increased by $3.6 million in fiscal year 2021 as compared to the fiscal year 2020 primarily due to an increase in bank borrowings as well as to a reduction in the interest refund from the Chinese government to the JV Company.
Gain on deconsolidation of the JV Company and Gain/loss on changes of equity interest in the JV Company
Effective December 1, 2021, we entered into the STA with the Investor, pursuant to which we sold to the Investor approximately 2.1% of outstanding equity interest held by us in the JV Company for an aggregate purchase price of RMB 108 million or approximately $16.9 million. The STA contained customary representations, warranties and covenants. The Transaction was closed on December 2, 2021. As a result of the Transaction, as of the Closing Date, our equity interest in the JV Company decreased from 50.9% to 48.8%. Also, our right to designate directors on the board of JV Company was reduced to three (3) out of seven (7) directors, from four (4) directors prior to the Transaction. We no longer have a controlling financial interest in the JV Company under generally accepted accounting principles. Loss of control is deemed to have occurred when, among other things, a parent company owns less than a majority of the outstanding common stock in the subsidiary, lacks a controlling financial interest in the subsidiary and, is unable to unilaterally control the subsidiary through
55


other means such as having, or the ability to obtain, a majority of the subsidiary’s board of directors. All of these loss of control factors were present for us as of December 2, 2021. Accordingly, since December 2, 2021, AOS has accounted for its investment in the JV Company using the equity method of accounting. On December 24, 2021, we entered into a share transfer agreement with another third-party investor, pursuant to which we sold to this investor 1.1% of outstanding equity interest held by us in the JV Company for an aggregate purchase price of RMB 60 million or approximately $9.4 million. In addition, the JV Company adopted an employee equity incentive plan and issued an equity interest equivalent to 3.99% of the JV Company to exchange in cash. As a result, the Company owned 45.8% of the equity interest in the JV Company as of December 31, 2021. On January 26, 2022, the JV Company completed a financing transaction pursuant to the Financing Agreement between the JV Company and certain New Investors. Under the Financing Agreement, the New Investors purchased newly issued equity interest of the JV Company for a total purchase price of RMB 509 million (or approximately $80 million based on the currency exchange rate as of January 26, 2022). Following the closing of the Investment, the percentage of outstanding JV Company equity interest beneficially owned by us was reduced to 42.2%.

During the fiscal year ended June 30, 2022, we recorded a gain of $399.1 million on deconsolidation of the JV Company, and a $3.1 million of loss on changes of equity interest in the JV Company.

We account for our investment in the JV Company as an equity method investment and report our equity in earnings or loss of the JV Company on a three-month lag due to an inability to timely obtain financial information of the JV Company. For the fiscal year ended June 30, 2022 using lag reporting, we recorded $2.6 million of its equity in loss of the JV Company.


Income tax expense
 Year Ended June 30, Change
 20222021202020222021
 (in thousands)(in thousands)(in percentage)(in thousands)(in percentage)
Income tax expense$39,258 $3,935 $348 $35,323 897.7 %$3,587 1,030.7 %

Fiscal 2022 vs 2021

Income tax expense for fiscal years 2022 and 2021 was $39.3 million and $3.9 million, respectively. Income tax expense increased by $35.3 million, or 897.7% in fiscal year 2022 as compared to fiscal year 2021. The income tax expense of $39.3 million for the year ended June 30, 2022 included a $33.5 million discrete tax expense related to the Company’s $396.0 million of income from the sale of equity interest in a joint venture and the related deconsolidation gain as the Company changed from the consolidation method of accounting to the equity method of accounting. In addition, we recorded a tax benefit of $0.4 million from other discrete income tax items. The income tax expense of $3.9 million for the year ended June 30, 2021 included a $0.3 million discrete tax benefit. Excluding the discrete income tax items ($396.0 million of income from the sale of equity interest in a joint venture and the related deconsolidation gain as well as other discrete items), the effective tax rate for the years ended June 30, 2022 and 2021 was 6.3% and 7.1%, respectively. The changes in the tax expense and effective tax rate between the periods resulted primarily from the Company reporting pretax book income of $495.0 million ($99.0 million of pretax book income plus the $396.0 million of income from the sale of equity interest in a joint venture and the related deconsolidation gain) for the year ended June 30, 2022 as compared to a pretax book income of $60.2 million for the year ended June 30, 2021 as well as changes in the mix of earnings in various geographic jurisdictions between the current year and the same period of last year.

Fiscal 2021 vs 2020

Income tax expense for fiscal years 2021 and 2020 was $3.9 million and $0.3 million, respectively. Income tax expense increased by $3.6 million in fiscal year 2021 as compared to fiscal year 2020, primarily due to an approximate $80 million increase in pretax book income in fiscal 2021 (in which we reported a pretax book income of $60.2 million) vs. fiscal 2020 (in which we reported pretax book loss of $17.9 million). Excluding discrete income tax items, the effective tax rate for the current fiscal year was 7.1%, compared to (9.6%) for the prior fiscal year. The changes in the effective tax rate and tax expense between the fiscal years resulted primarily from changes in the mix of earnings in various geographic jurisdictions between the current fiscal year and prior fiscal year.


56


Liquidity and Capital Resources

Our principal need for liquidity and capital resources is to maintain sufficient working capital to support our operations and to invest adequate capital expenditures to grow our business. To date, we finance our operations and capital expenditures primarily through funds generated from operations and borrowings under our term loans, financing lease and other debt agreements.

On August 18, 2021, Jireh Semiconductor Incorporated (“Jireh”) entered into a term loan agreement with a financial institution (the “Bank”) in an amount up to $45.0 million for the purpose of expanding and upgrading the Company’s fabrication facility located in Oregon. The obligation under the loan agreement is secured by substantially all assets of Jireh and guaranteed by the Company. The agreement has a 5.5 year term and matures on February 16, 2027. Jireh is required to make consecutive quarterly payments of principal and interest. The loan accrues interest based on adjusted London Interbank Offered Rate (“LIBOR”) plus the applicable margin based on the outstanding balance of the loan. This agreement contains customary restrictive covenants and includes certain financial covenants that the Company is required to maintain. Jireh drew down $45.0 million on February 16, 2022. As of June 30, 2022, Jireh was in compliance with these covenants and the outstanding balance of this loan was $45.0 million.

In October 2019, the Company’ subsidiary in China entered into a line of credit facility with Bank of Communications Limited in China. This line of credit matured on February 14, 2021 and was based on the China Base Rate multiplied by 1.05, or 4.99% on October 31, 2019. The purpose of the credit facility is to provide short-term borrowings. The Company could borrow up to approximately RMB 60.0 million or $8.5 million based on the currency exchange rate between the RMB and the U.S. Dollar on October 31, 2019. In September 2021, this line of credit was renewed with maximum borrowings up to RMB 140.0 million with the same terms and a maturity date of September 18, 2022. During the three months ended December 31, 2021, the Company borrowed RMB 11.0 million, or $1.6 million, at an interest rate of 3.85% per annum, with principal due on November 18, 2022. As of June 30, 2022, there was $1.6 million outstanding balance under the loan.

On November 16, 2018, the Company’ subsidiary in China entered into a line of credit facility with Industrial and Commercial Bank of China. The purpose of the credit facility was to provide short-term borrowings. The Company could borrow up to approximately RMB 72.0 million or $10.3 million based on currency exchange rate between RMB and U.S. Dollar on November 16, 2018. The RMB 72.0 million consisted of RMB 27.0 million for trade borrowings with a maturity date of December 31, 2021, and RMB 45.0 million for working capital borrowings or trade borrowings with a maturity date of September 13, 2022. During the three months ended December 31, 2021, the Company borrowed RMB 5.0 million, or $0.8 million, at an interest rate of 3.7% per annum, with principal due on September 12, 2022. As of June 30, 2022, the total outstanding balance of this loan was $0.5 million.

In September 2021, Jireh Semiconductor Incorporated (“Jireh”) entered into a financing arrangement agreement with a company (“Lender”) for the lease and purchase of a machinery equipment manufactured by a supplier. The total purchase price of this machinery equipment was euro 12.0 million, or $12.8 million based on the currency exchange rate between the euro and U.S. Dollar on June 30, 2022. In April 2021, Jireh made a down payment of euro 6.0 million, representing 50% of the total purchase price of the equipment, to the supplier. In June 2022, the equipment was delivered to Jireh after Lender paid 40% of the total purchase price, for euro 4.8 million, to the supplier on behalf of Jireh. Based on the terms of the agreement between Jireh and Lender, after the installation and configuration of the equipment for its intended use, Lender will make the remaining 10% payment for the total purchase price and reimburse Jireh for the down payment made to the supplier. By that time, the title of the equipment will be transferred to Lender. This agreement has a 5 years term, after which Jireh has the option to purchase the equipment for $1. Jireh is required to make a monthly payment of interest at an implied interest rate of 4.75% per annum to Lessor. Principal payment is required to be paid monthly after the completion of the title transfer. The financing arrangement is secured by this machinery equipment which had the carrying amount of $12.8 million as of June 30, 2022. As of June 30, 2022, the outstanding balance of this debt financing was $5.0 million.

On August 9, 2019, one of the Company’ wholly-owned subsidiaries (the “Borrower”) entered into a factoring agreement with the Hongkong and Shanghai Banking Corporation Limited (“HSBC”), whereby the Borrower assigns certain of its accounts receivable with recourse. This factoring agreement allowed the Borrower to borrow up to 70% of the net amount of its eligible accounts receivable of the Borrower with a maximum amount of $30.0 million. The interest rate was based on one month London Interbank Offered Rate (“LIBOR”) plus 1.75% per annum. The Company was the guarantor for this agreement. The Company is accounting for this transaction as a secured borrowing under the Transfers and Servicing of Financial Assets guidance. In addition, any cash held in the restricted bank account controlled by HSBC had a legal right of offset against the borrowing. This agreement, with certain financial covenants required, had no expiration date. On August 11, 2021, the Borrower signed an agreement with HSBC to decrease the borrowing maximum amount to $8.0 million with certain financial covenants required. Other terms remain the same. The Borrower was in compliance with these covenants as of June 30, 2022. As of June 30, 2022, there was no outstanding balance and the Company had unused credit of approximately $8.0 million.

57


On May 1, 2018, Jireh entered into a loan agreement with the Bank that provided a term loan in an amount of $17.8 million. The obligation under the loan agreement is secured by certain real estate assets of Jireh and guaranteed by the Company. The loan has a five-year term and matures on June 1, 2023. Beginning June 1, 2018, Jireh made consecutive monthly payments of principal and interest to the Bank. The outstanding principal shall accrue interest at a fixed rate of 5.04% per annum on the basis of a 360-day year. The loan agreement contains customary restrictive covenants and includes certain financial covenants that require the Company to maintain, on a consolidated basis, specified financial ratios. In August 2021, Jireh signed an amendment of this loan with the Bank to modify the financial covenants requirement to align with the new term loan agreement entered into on August 18, 2021 discussed above. The amendment was accounted for as a debt modification and no gain or loss was recognized. The Company was in compliance with these covenants as of June 30, 2022. As of June 30, 2022, the outstanding balance of the term loan was $14.2 million.

On August 15, 2017, Jireh entered into a credit agreement with the Bank that provided a term loan in an amount up to $30.0 million for the purpose of purchasing certain equipment for the fabrication facility located in Oregon. The obligation under the credit agreement is secured by substantially all assets of Jireh and guaranteed by the Company. The credit agreement has a five-year term and matures on August 15, 2022. In January 2018 and July 2018, Jireh drew down on the loan in the amount of $13.2 million and $16.7 million, respectively. Beginning in October 2018, Jireh is required to pay to the Bank on each payment date, the outstanding principal amount of the loan in monthly installments. The loan accrues interest based on an adjusted LIBOR as defined in the credit agreement, plus specified applicable margin in the range of 1.75% to 2.25%, based on the outstanding balance of the loan. The credit agreement contains customary restrictive covenants and includes certain financial covenants that require the Company to maintain, on a consolidated basis, specified financial ratios and fixed charge coverage ratio. In August 2021, Jireh signed an amendment of this loan with the Bank to modify the financial covenants requirement to align with the new term loan agreement entered into on August 18, 2021, discussed above. The amendment was accounted for as a debt modification and no gain or loss was recognized. The Company was in compliance with these covenants as of June 30, 2022. As of June 30, 2022, the outstanding balance of the term loan was $1.9 million.

In September 2017, the board of directors approved a repurchase program (the “Repurchase Program”) that allowed us to repurchase our common shares from the open market pursuant to a pre-established Rule 10b5-1 trading plan or through privately negotiated transactions up to an aggregate of $30.0 million. The amount and timing of any repurchases under the Repurchase Program depend on a number of factors, including but not limited to, the trading price, volume, availability of our common shares and the amount of available cash reserve. Shares repurchased under this program are accounted for as treasury shares and the total cost of shares repurchased is recorded as a reduction of shareholders' equity. During fiscal year 2022, 2021 and 2020, we did not repurchase any shares pursuant to the repurchase program. As of June 30, 2022, the Company had repurchased an aggregate of 6,784,648 shares for a total cost of $67.3 million, at an average price of $9.92 per share, excluding fees and related expenses, since inception of the program. No repurchased shares have been retired. Of the 6,784,648 repurchased shares, 167,395 shares with a weighted average repurchase price of $10.06 per share, were reissued at an average price of $5.00 per share for option exercises and vested restricted stock units (“RSU”). As of June 30, 2022, $13.4 million remain available under the share repurchase program.

The Chinese government imposes certain currency exchange controls on cash transfers out of China. Regulations in China permit foreign owned entities to freely convert the Renminbi into foreign currency for transactions that fall under the “current account,” which includes trade related receipts and payments, interests, and dividend payments. Accordingly, subject to the review and verification of the underlying transaction documents and supporting documents by the account banks in China, our Chinese subsidiaries may use Renminbi to purchase foreign exchange currency for settlement of such “current account” transactions without the pre-approval from China's State Administration of Foreign Exchange (SAFE) or its provincial branch. Pursuant to applicable regulations, foreign-invested enterprises in China may pay dividends only out of their accumulated profits, if any, determined in accordance with Chinese accounting standards and regulations. In calculating accumulated profits, foreign-invested enterprises in China are required to allocate at least 10% of their profits each year, if any, to fund the equity reserve account unless the reserve has reached 50% of the registered capital of the enterprises. While SAFE approval is not statutorily required for eligible dividend payments to the foreign parent, in practice, before making the dividend payment, the account bank may seek SAFE’s opinion with respect to a dividend payment if the payment involves a relatively large amount, which may delay the dividend payment depending on the then overall status of cross-border payments and receipts of China.

Transactions that involve conversion of Renminbi into foreign currency in relation to foreign direct investments and provision of debt financings in China are classified as “capital account” transactions. Examples of “capital account” transactions include repatriations of investments by foreign owners and repayments of loan principal to foreign lenders. "Capital account" transactions require prior approval from SAFE or its provincial branch or an account bank delegated by SAFE to convert a remittance into a foreign currency, such as U.S. dollars, and transmit the foreign currency outside of China. As a result of this and other restrictions under PRC laws and regulations, our China subsidiaries are restricted in their ability to transfer a portion of their net assets to us, and such restriction may adversely affect our ability to generate sufficient liquidity to fund our operations or other expenditures. As of June 30, 2022 and 2021, such restricted portion amounted to approximately
58


$92.4 million and $209.9 million, or 10.8% and 50.4%, of our total consolidated net assets attributable to the Company, respectively. The decrease of restricted net assets was primarily from deconsolidation of the JV Company in China.
    
We believe that our current cash and cash equivalents and cash flows from operations will be sufficient to meet our anticipated cash needs, including working capital and capital expenditures, for at least the next twelve months. In addition, we recently commenced an investment plan to expand the manufacturing capacity and upgrade the operational capabilities of our Oregon Fab. We intend to fund the costs by a combination of cash reserve, bank loans and equipment leases. In the long-term, we may require additional capital due to changing business conditions or other future developments, including any investments or acquisitions we may decide to pursue. If our cash is insufficient to meet our needs, we may seek to raise capital through equity or debt financing. The sale of additional equity securities could result in dilution to our shareholders. The incurrence of indebtedness would result in increased debt service obligations and may include operating and financial covenants that would restrict our operations. We cannot be certain that any financing will be available in the amounts we need or on terms acceptable to us, if at all.
Cash, cash equivalents and restricted cash
As of June 30, 2022 and 2021, we had $314.7 million and $204.8 million of cash, cash equivalents and restricted cash, respectively. Our cash, cash equivalents and restricted cash primarily consisted of cash on hand, restricted cash and short-term bank deposits with original maturities of three months or less. Of the $314.7 million and $204.8 million cash and cash equivalents, $212.6 million and $134.6 million, respectively, were deposited with financial institutions outside the United States.
The following table shows our cash flows from operating, investing and financing activities for the periods indicated:
 
 
Year Ended June 30,
 202220212020
 (in thousands)
Net cash provided by operating activities$218,865 $128,744 $62,315 
Net cash used in investing activities(130,822)(72,539)(60,849)
Net cash provided by (used in) financing activities21,854 (18,991)37,651 
Effect of exchange rate changes on cash, cash equivalents and restricted cash(59)4,895 (708)
Net increase in cash, cash equivalents and restricted cash$109,838 $42,109 $38,409 
Cash flows from operating activities

Net cash provided by operating activities of $218.9 million for fiscal year 2022 resulted primarily from net income of $453.2 million, non-cash charges of $287.6 million and net change in assets and liabilities providing net cash of $53.3 million. The non-cash charges of $287.6 million included depreciation and amortization expenses of $42.9 million, share-based compensation expense of $31.3 million, gain on deconsoidation of the JV Company of $399.1 million, loss on changes of equity interest in the JV Company, net of $3.1 million, deferred income tax on deconsolidation and changes of equity interest in the JV Company of $30.0 million, loss on equity investment of $2.6 million, and net deferred income taxes of $1.6 million. The net change in assets and liabilities providing net cash of $53.3 million was primarily due to $76.4 million increase in accrued and other liabilities, income taxes payable on deconsolidation and changes of equity interest in the JV company of $3.5 million, other payable on equity investee of $48.2 million, and $23.8 million increase in accounts payable primarily due to timing of payment, partially offset by $30.1 million increase in accounts receivable due to timing of billings and collection of payments, $57.4 million increase in inventories, $9.4 million increase in other current and long-term assets primarily due to decrease in advance payments to suppliers, and $1.7 million decrease in income taxes payable.

Net cash provided by operating activities of $128.7 million for fiscal year 2021 resulted primarily from net income of $56.3 million, non-cash charges of $70.0 million and net change in assets and liabilities providing net cash of $2.5 million. The non-cash charges of $70.0 million included depreciation and amortization expenses of $52.7 million, share-based compensation expense of $15.3 million, loss on disposal of property and equipment of $0.4 million, and net deferred income taxes of $1.6 million. The net change in assets and liabilities providing net cash of $2.5 million was primarily due to $48.5 million increase in accrued and other liabilities and $1.7 million increase in income taxes payable, partially offset by $22.5 million increase in accounts receivable due to timing of billings and collection of payments, $18.8 million increase in inventories, $5.8 million increase in other current and long-term assets primarily due to decrease in advance payments to suppliers, and $0.5 million decrease in accounts payable primarily due to timing of payments.
59



Net cash provided by operating activities of $62.3 million for fiscal year 2020 resulted primarily from net loss of $18.3 million, non-cash charges of $56.1 million and net change in assets and liabilities providing net cash of $24.4 million. The non-cash charges of $56.1 million included depreciation and amortization expenses of $45.1 million, share-based compensation expense of $10.5 million, impairment of our investment in a privately-held start-up company of $0.6 million, gain on disposal of property and equipment of $0.1 million, and net deferred income taxes of $0.1 million. The net change in assets and liabilities providing net cash of $24.4 million was primarily due to $27.3 million decrease in other current and long-term assets primarily due to increase in advance payments to suppliers, $11.0 million decrease in accounts receivable due to timing of billings and collection of payments, and $11.0 million increase in accrued and other liabilities, partially offset by $22.8 million increase in inventories, $1.8 million decrease in accounts payable primarily due to timing of payments, and $0.3 million decrease in income taxes payable.

Cash flows from investing activities

Net cash used in investing activities of $130.8 million for the fiscal year 2022 was primarily attributable to $138.0 million purchases of property and equipment, and $20.7 million deconsolidation of cash and cash equivalents of the JV Company, partially offset by $1.4 million government grant related to equipment in the JV Company, $26.3 million proceeds from sale of equity interest in the JV Company and $0.1 million proceeds from sale of property and equipment.

Net cash used in investing activities of $72.5 million for the fiscal year 2021 was primarily attributable to $72.7 million purchases of property and equipment, which was partially offset by $0.1 million government grant related to equipment in the JV Company.

Net cash used in investing activities of $60.8 million for the fiscal year 2020 was primarily attributable to $62.4 million purchases of property and equipment, which was partially offset by $1.3 million government grant related to equipment in the JV Company and $0.3 million of proceeds from sale of property and equipment.
Cash flows from financing activities

Net cash used in financing activities of $21.9 million for the fiscal year 2022 was primarily attributable to $64.3 million of proceeds from borrowings and $6.1 million of proceeds from exercises of share options and issuance of shares under the ESPP, partially offset by $8.6 million in common shares acquired to settle withholding tax related to vesting of restricted stock units, $4.2 million in payments of capital lease obligations, and $35.7 million in repayments of borrowings.

Net cash used in financing activities of $19.0 million for the fiscal year 2021 was primarily attributable to $6.9 million in common shares acquired to settle withholding tax related to vesting of restricted stock units, $16.5 million in payments of capital lease obligations, and $66.6 million in repayments of borrowings, partially offset by $65.9 million of proceeds from borrowings and $5.1 million of proceeds from exercises of share options and issuance of shares under the ESPP.

Net cash provided by financing activities of $37.7 million for the fiscal year 2020 was primarily attributable to $96.2 million of proceeds from borrowings, and $3.4 million of proceeds from exercises of share options and issuance of shares under the ESPP, partially offset by $1.5 million in common shares acquired to settle withholding tax related to vesting of restricted stock units, $11.0 million in payments of capital lease obligations, and $49.4 million in repayments of borrowings.

60


Contractual Obligations
Our contractual obligations as of June 30, 2022 are as follows:
 Payments Due by Period
 Less than  More than
 Total1 year1-3 years3-5years5 years
 (in thousands)
Bank borrowings$68,218 $25,638 $19,951 $22,395 $234 
Finance leases5,318 993 2,166 2,159 — 
Operating leases29,141 5,206 7,275 6,323 10,337 
Capital commitments with respect to property and equipment63,438 63,438 — — — 
Purchase commitments with respect to inventories and others89,863 89,863 — — — 
Total contractual obligations$255,978 $185,138 $29,392 $30,877 $10,571 
As of June 30, 2022, we had recorded liabilities of $2.0 million for uncertain tax positions and $0.2 million for potential interest and penalties, which are not included in the above table because we are unable to reliably estimate the amount of payments in individual years that would be made in connection with these uncertain tax positions.

Commitments

See Note 15 of the Notes to the Consolidated Financial Statements contained in this Annual Report on Form 10-K for a description of commitments.
Off-Balance Sheet Arrangements
As of June 30, 2022, we had no material off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.

61


Critical Accounting Policies and Estimates

The preparation of our consolidated financial statements requires us to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses. To the extent there are material differences between these estimates and actual results, our consolidated financial statements will be affected. On an ongoing basis, we evaluate the estimates, judgments and assumptions including those related to stock rotation returns, price adjustments, allowance for doubtful accounts, valuation of inventories, warranty accrual, income taxes, leases, equity method investment, share-based compensation, recoverability of and useful lives for property, plant and equipment and intangible assets, as well as economic implications of the COVID-19 pandemic.
Revenue recognition

We determine revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract; and (5) recognition of revenue when, or as, a performance obligation is satisfied. We recognize revenue at a point in time when product is shipped to the customer, net of estimated stock rotation returns and price adjustments to certain distributors. We present revenue net of sales taxes and any similar assessments. Our standard payment terms range from 30 to 60 days.

We sell our products primarily to distributors, who in turn sell our products globally to various end customers. Our revenue is net of the effect of the variable consideration relating to estimated stock rotation returns and price adjustments that we expect to provide to certain distributors. Stock rotation returns are governed by contract and are limited to a specified percentage of the monetary value of the products purchased by distributors during a specified period. We estimate provision for stock rotation returns based on historical returns and individual distributor agreements. We also provide special pricing to certain distributors primarily based on volume, to encourage resale of our products. We estimate the expected price adjustments at the time the revenue is recognized based on distributor inventory levels, pre-approved future distributor selling prices, distributor margins and demand for our products. If actual stock rotation returns or price adjustments differ from our estimates, adjustments may be recorded in the period when such actual information is known. Allowance for price adjustments is recorded against accounts receivable and provision for stock rotation is recorded in accrued liabilities on the consolidated balance sheets.

Our performance obligations relate to contracts with a duration of less than one year. We elected to apply the practical expedient provided in ASC 606, “Revenue from Contracts with Customers”. Therefore, we are not required to disclose the aggregate amount of transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period.

We recognize the incremental direct costs of obtaining a contract, which consist of sales commissions, when control over the products they relate to transfers to the customer. Applying the practical expedient, we recognize commissions as expense when incurred, as the amortization period of the commission asset we would have otherwise recognized is less than one year.

Packaging and testing services revenue is recognized at a point in time upon shipment of serviced products to the customer.

Equity method investment

We use the equity method of accounting when we have the ability to exercise significant influence, but not control, as determined in accordance with general accepted accounting principles, over the operating and financial policies of the investee. Effective December 2, 2021, we reduced our equity interest in the JV Company, which resulted in deconsolidation of our investment in the JV Company. As a result, beginning December 2, 2021, we record our investment under equity method of accounting. Due to difficulties in obtaining accurate financial information from the JV Company in a timely manner, we record our share of earnings or losses of such affiliate on a one quarter lag. Therefore, our share of losses of the JV Company for the period from December 2, 2021 to March 31, 2022 was recorded in our Consolidated Statement of Operations for the fiscal year ended June 30, 2022. We recognize and disclose intervening events at the JV Company in the lag period that could materially affect our consolidated financial statements.

We record our interest in the net earnings of our equity method investees, along with adjustments for unrealized profits or losses on intra-entity transactions and amortization of basis differences, within earnings or loss from equity interests in the Consolidated Statements of Income. Profits or losses related to intra-entity sales with its equity method investees are eliminated until realized by the investor and investee. Basis differences represent differences between the cost of the investment and the underlying equity in net assets of the investment and are generally amortized over the lives of the related assets that gave rise to them. Equity method goodwill is not amortized or tested for impairment; instead the equity method investment is tested for impairment. We review for impairment whenever factors indicate that the carrying amount of the
62


investment might not be recoverable. In such a case, the decrease in value is recognized in the period the impairment occurs in the Condensed Consolidated Statements of Income.

Valuation of inventories

We carry inventories at the lower of cost (determined on a first-in, first-out basis) or net realizable value. Cost primarily consists of semiconductor wafers and raw materials, labor, depreciation expenses and other manufacturing expenses and overhead, and packaging and testing fees paid to third parties if subcontractors are used. Valuation of inventories is based on our periodic review of inventory quantities on hand as compared with our sales forecasts, historical usage, aging of inventories, production yield levels and current product selling prices. If actual market conditions are less favorable than those forecasted by us, additional future inventory write-downs may be required that could adversely affect our operating results. Adjustments to inventory, once established are not reversed until the related inventory has been sold or scrapped. If actual market conditions are more favorable than expected and the products that have previously been written down are sold, our gross margin would be favorably impacted.
Accounting for income taxes

We are subject to income taxes in a number of jurisdictions. We must make certain estimates and judgments in determining income tax expense for financial statement purposes. These estimates and judgments occur in the calculation of tax credits, benefits and deductions, and in the calculation of certain tax assets and liabilities which arise from differences in the timing of recognition of revenue and expense for tax and financial statement purposes, as well as interest and penalties related to uncertain tax positions. There are many transactions and calculations for which the ultimate tax determination is uncertain during the ordinary course of business. We establish accruals for certain tax contingencies based on estimates of whether additional taxes may be due. While the final tax outcome of these matters may differ from the amounts that were initially recorded, such differences will impact the income tax and deferred tax provisions in the period in which such determination is made. As a result, significant changes to these estimates may result in an increase or decrease to our tax provision in a subsequent period.

Significant management judgment is also required in determining whether deferred tax assets will be realized in full or in part. When it is more likely than not that all or some portion of specific deferred tax assets such as net operating losses or foreign tax credit carryforwards will not be realized, a valuation allowance must be established for the amount of the deferred tax assets that cannot be realized. We consider all available positive and negative evidence on a jurisdiction-by-jurisdiction basis when assessing whether it is more likely than not that deferred tax assets are recoverable. We consider evidence such as our past operating results, the existence of cumulative losses in recent years and our forecast of future taxable income. We will maintain a partial valuation allowance equal to the state research and development credit carryforwards until sufficient positive evidence exists to support reversal of the valuation allowance.

We have not provided for withholding taxes on the undistributed earnings of our foreign subsidiaries because we intend to reinvest such earnings indefinitely. However, we have recorded a deferred tax liability of $29.6 million at June 30, 2022 related to our investment in the JV Company. As of June 30, 2022, the cumulative amount of undistributed earnings of our foreign subsidiaries considered permanently reinvested was $314.7 million. The determination of the unrecognized deferred tax liability on these earnings is not practicable. Should we decide to remit this income to the Bermuda parent company in a future period, our provision for income taxes may increase materially in that period.

The Financial Accounting Standards Board ("FASB") has issued guidance which clarifies the accounting for income taxes by prescribing a minimum probability threshold that a tax position must meet before a financial statement benefit is recognized. The minimum threshold is defined as a tax position that is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. The tax benefit to be recognized is measured as the largest amount of benefit that is greater than fifty percent likely to be realized upon ultimate settlement. The calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax law and regulations in a multitude of jurisdictions. Although the guidance on the accounting for uncertainty in income taxes prescribes the use of a recognition and measurement model, the determination of whether an uncertain tax position has met those thresholds will continue to require significant judgment by management. If the ultimate resolution of tax uncertainties is different from what is currently estimated, a material impact on income tax expense could result.

Our provision for income taxes is subject to volatility and could be adversely impacted by changes in earnings or tax laws and regulations in various jurisdictions. We are subject to the continuous examination of our income tax returns by the
63


Internal Revenue Service and other tax authorities. We regularly assess the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of our provision for income taxes. There can be no assurance that the outcomes from these continuous examinations will not have an adverse effect on our operating results and financial condition. To the extent that the final tax outcome of these matters is different than the amounts recorded, such differences will impact the provision for income taxes in the period in which such determination is made. The provision for income taxes includes the impact of changes to reserves, as well as the related net interest and penalties.
Share-based compensation expense
We maintain an equity-settled, share-based compensation plan to grant restricted share units and stock options. We recognize share-based compensation expense based on the estimated fair value of the awards, using the accelerated attribution method. The fair value of restricted share units is based on the fair value of the Company's common share on the date of grant. For restricted stock awards subject to market conditions, the fair value of each restricted stock award is estimated at the date of grant using the Monte-Carlo pricing model. Share-based compensation expense is significant to the consolidated financial statements and is calculated using our best estimates, which involve inherent uncertainties and the application of management's judgment. The Black-Scholes option valuation model requires the input of subjective assumptions, including the expected term and stock price volatility. In addition, judgment is also required in estimating the number of stock-based awards that are expected to be forfeited. Forfeitures are estimated based on historical experience at the time of grant. Changes in estimated forfeitures are recognized in the period of change and impact the amount of stock compensation expenses to be recognized in future periods, which could be material if actual results differ significantly from estimates.
Recently Issued Accounting Pronouncements
    See Note 1 of the Notes to the consolidated financial statements under Item 15 in this Annual Report on Form 10-K for a full description of recent accounting pronouncements, including the expected dates of adoption and estimated effects on results of operations and financial condition.

64


Item 7A.Quantitative and Qualitative Disclosures About Market Risk

Foreign currency risk
    
    We and our principal subsidiaries use U.S. dollars as our functional currency because most of the transactions are conducted and settled in U.S. dollars. All of our revenue and a significant portion of our operating expenses are denominated in U.S. dollars. The functional currency for our in-house packaging and testing facilities in China is U.S. dollars and a significant portion of our capital expenditures are denominated in U.S. dollars. However, foreign currencies are required to fund our overseas operations, primarily in Taiwan and China. Operating expenses of overseas operations are denominated in their respective local currencies. In order to minimize exposure to foreign currencies, we maintained cash and cash equivalent balances in foreign currencies, including Chinese Yuan (“RMB”) as operating funds for our foreign operating expenses. For our subsidiaries which use the local currency as the functional currency, including the JV Company, the results and financial position are translated into U.S. dollar using exchange rates at balance sheet dates for assets and liabilities and using average exchange rates for income and expenses items. The resulting translation differences are presented as a separate component of accumulated other comprehensive income (loss) and noncontrolling interest in the consolidated statements of equity. Our management believes that our exposure to foreign currency translation risk is not significant based on a 10% sensitivity analysis in foreign currencies due to the fact that the net assets denominated in foreign currencies pertaining to foreign operations, principally in Taiwan and China, are not significant to our consolidated net assets.
Interest rate risk
Our interest-bearing assets comprise mainly interest-bearing short-term bank balances. We manage our interest rate risk by placing such balances in instruments with various short-term maturities. Borrowings expose us to interest rate risk. Borrowings are drawn down after due consideration of market conditions and expectation of future interest rate movements. As of June 30, 2022, we had $68.0 million outstanding under our loan and $4.7 million outstanding under our capital leases, which were subject to fluctuations in interest rates. For the year ended June 30, 2022, a hypothetical 10% increase in the interest rate could result in $0.2 million additional annual interest expense. The hypothetical assumptions made above will be different from what actually occurs in the future. Furthermore, the computations do not anticipate actions that may be taken by our management should the hypothetical market changes actually occur over time. As a result, actual impacts on our results of operations in the future will differ from those quantified above.

Commodity Price Risk

We are subject to risk from fluctuating market prices of certain commodity raw materials, particularly gold, that are used in our manufacturing process and incorporated into our end products. Supplies for such commodities may from time-to-time become restricted, or general market factors and conditions may affect the pricing of such commodities. Over the past few years, the price of gold increased significantly and certain of our supply chain partners assess surcharges to compensate for the rising commodity prices. We have been converting some of our products to use copper wires instead of gold wires. Our results of operations may be materially and adversely affected if we have difficulty obtaining these raw materials, the quality of available raw materials deteriorates, or there are significant price changes for these raw materials. For periods in which the prices of these raw materials are rising, we may be unable to pass on the increased cost to our customers which would result in decreased margins for the products in which they are used and could have a material adverse effect on our net earnings. We also may need to record losses for adverse purchase commitments for these materials in periods of declining prices. We do not enter into formal hedging arrangements to mitigate against commodity risk. We estimate that a 10% increase or decrease in the costs of raw materials subject to commodity price risk, such as gold, would decrease or increase our current year's net earnings by $0.7 million, assuming that such changes in our costs have no impact on the selling prices of our products and that we have no pending commitments to purchase metals at fixed prices.


65


Item 8.Financial Statements and Supplementary Data

See Part IV, Item 15 “Exhibits and Financial Statement Schedules” for our consolidated financial statements and the notes and schedules thereto filed as part of this annual report.

Item 9.Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
None.

Item 9A.Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, (the “Exchange Act”)), as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures as of June 30, 2022 have been designed and are functioning effectively to provide reasonable assurance that the information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’ rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Management’s Annual Report on Internal Control over Financial Reporting
    
Our management, including our Chief Executive Officer and Chief Financial Officer, is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act). Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of our financial statements for external purposes in accordance with generally accepted accounting principles, and includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets; (2) provide reasonable assurance that transactions are recorded to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are made only in accordance with authorizations of our management and directors; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our financial statements.

Our management conducted an assessment of the effectiveness of our internal control over financial reporting based on the criteria set forth in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), as amended from time to time. Based on the assessment, our management has concluded that our internal control over financial reporting was effective as of June 30, 2022 to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with U.S. GAAP.

The effectiveness of the Company’s internal control over financial reporting as of June 30, 2022 has been audited by BDO, USA LLP, an independent registered public accounting firm, as stated in their report, included on the following page.
Limitation on the Effectiveness of Controls    
While our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance that their respective objectives will be met, we do not expect that our disclosure controls and procedures or our internal control over financial reporting are or will be capable of preventing or detecting all errors and all fraud. Any control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system's objectives will be met.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting that occurred during the quarter ended June 30, 2022 that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting.
66


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


Shareholders and Board of Directors
Alpha and Omega Semiconductor Limited
Sunnyvale, California

Opinion on Internal Control over Financial Reporting

We have audited Alpha and Omega Semiconductor Limited (a Bermuda corporation) (the “Company’s”) internal control over financial reporting as of June 30, 2022, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (the “COSO criteria”). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of June 30, 2022, based on the COSO criteria.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), the consolidated balance sheets of the Company as of June 30, 2022 and 2021, the related consolidated statements of operations, comprehensive income (loss), equity, and cash flows for each of the three years in the period ended June 30, 2022, and the related notes and schedule and our report dated September 19, 2022 expressed an unqualified opinion thereon.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Item 9A, Management’s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit of internal control over financial reporting in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ BDO USA, LLP
San Jose, California
September 19, 2022
67




Item 9B.Other Information
None

Item 9C.     Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.
Not Applicable.

68


PART III
Certain information required by Part III is omitted from this Annual Report on Form 10-K because we intend to file our definitive proxy statement for our next annual general meeting of shareholders, pursuant to Regulation 14A of the Securities Exchange Act of 1934, as amended (the “2022 Proxy Statement”), no later than 120 days after the end of fiscal year 2022, and certain information to be included in the 2022 Proxy Statement is incorporated herein by reference.
Item 10.Directors, Executive Officers and Corporate Governance
    
The information required by this item concerning our directors, executive officers, Section 16 compliance and corporate governance matters is contained in part under the caption “Business - Executive Officers” in Part I of this report, and the remainder is incorporated by reference to the information set forth in the sections titled “Election of Directors” and “Delinquent Section 16(a) Reports” in the 2022 Proxy Statement.

Item 11.Executive Compensation

The information required by this item regarding executive compensation is incorporated by reference from the information set forth under the captions “Compensation of Non-Employee Directors” and “Executive Compensation,” in the 2022 Proxy Statement.

Item 12.Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
The information required by this item regarding security ownership of certain beneficial owners and management is incorporated by reference to the information set forth in the section titled “Security Ownership of Certain Beneficial Owners and Management” and “Equity Compensation Plan Information” in the 2022 Proxy Statement.
Item 13.Certain Relationships and Related Transactions, and Director Independence

The information required by this item regarding related party transactions and director independence is incorporated by reference from the information set forth under the captions “Board of Directors and Committees of the Board” and “Related Party Transactions” in the 2022 Proxy Statement.

Item 14.Principal Accounting Fees and Services
    The information required by this item regarding principal accountant fees and services is incorporated by reference from the information set forth under the caption “Principal Accounting Fees and Services” in the 2022 Proxy Statement.
69


PART IV

Item 15.Exhibits and Financial Statement Schedules

(a) The following documents are filed as part of this annual report:

(1) Consolidated Financial Statements. The index to the consolidated financial statements is below.
 

(2) Financial Statement Schedules.

(b) Exhibits

The exhibits listed on the accompanying Index to Exhibits in Item 15(b) below are filed as part of, or hereby incorporated by reference into, this Annual Report on Form 10-K.





70



REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Shareholders and Board of Directors
Alpha and Omega Semiconductor, Limited
Sunnyvale, California

Opinion on the Consolidated Financial Statements

We have audited the accompanying consolidated balance sheets of Alpha and Omega Semiconductor Limited (the “Company”) as of June 30, 2022 and 2021, the related consolidated statements of operations, comprehensive income (loss), equity, and cash flows for each of the three years in the period ended June 30, 2022, and the related notes and schedule (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at June 30, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended June 30, 2022, in conformity with accounting principles generally accepted in the United States of America.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), the Company's internal control over financial reporting as of June 30, 2022, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) and our report dated September 19, 2022 expressed an unqualified opinion thereon.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters

The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

Valuation of Inventories

As described in Note 1 to the consolidated financial statements, the Company’s consolidated inventories balance, which is stated at lower of cost (determined on a first-in, first-out basis) or net realizable value, was $158.0 million as of June 30, 2022. The valuation of inventories is made based on the Company’s periodic review of inventory quantities on hand as compared with sales forecasts, historical usage, aging of inventories, production yield levels and current product selling prices.

We identified the valuation of inventories as a critical audit matter due to the significant judgment and estimates required by Management. Determining whether a decline in value has occurred requires Management’s complex judgments related to sales forecasts based on historical sales, demand and expected future orders. Auditing these judgments is especially challenging and involved subjective auditor judgment due to fluctuations in sales trends and evolving customer demands.



71


The primary procedures we performed to address this critical audit matter included:

Testing the design and operating effectiveness of automated application controls relating to the inputs used in the analysis.
Evaluating the completeness and accuracy of data used in the determination of the valuation of inventories by testing the completeness of the inventories analyzed, the inputs used in the analysis, and recalculating the estimated valuation of inventories.
Analyzing the reasonableness of the methodology Management uses to estimate the valuation of inventories by evaluating quantitative and qualitative factors including excess units on hand based on ending inventory quantities compared to forecasted shipment quantities.
Evaluating the reasonableness of Management's assumptions related to future demand by (i) performing retrospective review of the Company’s prior year estimates to actual results, and (ii) evaluating the reasonableness of sales forecasts by comparing to current backlog and historical sales data used in the analysis.

Accounting for Equity Method Investment

As described in Notes 1 and 2 to the consolidated financial statements, on December 2, 2021, the Company sold 2.1% of its ownership interest in the JV Company to a third party for approximately $16.9 million contemporaneously with a change in governance of the JV Company that reduced the Company’s Board of Directors representation from four to three seats. Management evaluated the sale and determined that the JV Company was not a variable interest entity and that the Company no longer held voting control, resulting in the deconsolidation of the JV Company from the consolidated financial statements and recognition of a gain on the transaction in the amount of $399.1 million. Subsequent to the deconsolidation, the Company had significant influence and ownership requiring the application of equity method accounting for its remaining ownership interest.

We identified the accounting for the sale of the ownership interest and the accounting for the remaining ownership interest and the related disclosures as a critical audit matter. Identifying and applying complex generally accepted accounting principles, specifically the application of the variable interest model, to the fact pattern of the sale and the remaining ownership interest require significant management judgment. Auditing these elements involved especially challenging auditor judgment due to the nature and extent of audit effort required to address these matters, including the extent of specialized skills or knowledge needed.

The primary procedures we performed to address the critical audit matter included:

Analyzing applicable agreements and evaluating the applicable accounting standards relevant to the fact pattern of the sale, specifically focusing on management’s evaluation of whether its remaining ownership interest and board representation were determinative of control over the JV Company pursuant to the variable interest model.
Utilizing personnel with specialized skill and knowledge to assist in evaluating management’s technical accounting analysis relating to application of the variable interest model to the fact pattern of the sale.

Fair Value Determination of Basis Difference in Equity Method Investment

As described in Notes 1 and 2 to the consolidated financial statements, the Company deconsolidated the JV Company subsequent to the sale of the 2.1% equity interest in the JV Company. Management was required to determine the basis difference in the retained ownership interest in the JV Company as of December 2, 2021, as a significant component of accounting for the retained interest in the JV Company pursuant to the equity method.

We identified the determination of the difference between the carrying value of the investment in the JV Company and the Company’s underlying equity in the net assets of the JV Company as a critical audit matter. As part of determining this basis difference, management applied significant judgment in determining the appropriate valuation methodology and the unobservable inputs used in calculating the fair value of intellectual property owned by the JV Company, including projected revenues, discount factor, terminal factor, present value factor and tax amortization benefit. Auditing this element involved especially challenging auditor judgment due to the nature and extent of audit effort required to address these matters, including the extent of specialized skill or knowledge needed.

The primary procedures we performed to address the critical audit matter included:

Assessing the reasonableness of the forecasts of future revenue by evaluating historical inputs and challenging the revenue growth rate.
Utilizing personnel with specialized knowledge and skills in valuation to perform procedures to assist in (i) evaluating the valuation methodology used and (ii) assessing the reasonableness of the discount factor, terminal factor, present value factor and tax amortization benefit incorporated in the valuation model.


72




/s/ BDO USA, LLP

We have served as the Company's auditor since 2018.

San Jose, California
September 19, 2022


73

ALPHA AND OMEGA SEMICONDUCTOR LIMITED
CONSOLIDATED BALANCE SHEETS
(in thousands, except par value per share)

 
June 30,  
 20222021
ASSETS
Current assets:
Cash and cash equivalents$314,352 $202,412 
Restricted cash299 233 
Accounts receivable, net65,681 35,789 
Inventories158,040 154,293 
Other current assets11,220 14,595 
Total current assets549,592 407,322 
Property, plant and equipment, net318,666 436,977 
Operating lease right-of-use assets, net23,674 34,660 
Intangible assets, net10,050 13,410 
Equity method investment378,378  
Deferred income tax assets 592 5,167 
Restricted cash - long-term 2,168 
Other long-term assets17,677 18,869 
Total assets$1,298,629 $918,573 
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable$87,377 $80,699 
Accrued liabilities116,893 69,494 
Payable related to equity investee, net28,989  
Income taxes payable4,248 2,604 
Short-term debt25,563 58,030 
Finance lease liabilities802 16,724 
Operating lease liabilities3,850 5,679 
Total current liabilities267,722 233,230 
Long-term debt42,486 77,990 
Income taxes payable - long-term2,158 1,319 
Deferred income tax liabilities28,757 2,448 
Finance lease liabilities - long-term3,932 12,698 
Operating lease liabilities - long-term20,878 30,440 
Other long-term liabilities78,603 44,123 
Total liabilities444,536 402,248 
Commitments and contingencies (Note 15)
Equity:
Preferred shares, par value $0.002 per share:
Authorized: 10,000 shares; issued and outstanding: none at June 30, 2022 and 2021
  
Common shares, par value $0.002 per share:
Authorized: 100,000 shares; issued and outstanding: 33,988 shares and 27,371 shares, respectively at June 30, 2022 and 32,975 shares and 26,350 shares, respectively at June 30, 2021
68 66 
Treasury shares at cost; 6,617 shares at June 30, 2022 and 6,625 shares at June 30, 2021
(66,000)(66,064)
Additional paid-in capital288,951 259,993 
Accumulated other comprehensive income 1,080 2,315 
Retained earnings629,994 176,895 
Total Alpha and Omega Semiconductor Limited shareholders’ equity854,093 373,205 
Noncontrolling interest 143,120 
 Total equity854,093 516,325 
Total liabilities and equity$1,298,629 $918,573 

The accompanying notes are an integral part of these consolidated financial statements.
74

ALPHA AND OMEGA SEMICONDUCTOR LIMITED
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
 
Year Ended June 30,
 202220212020
Revenue$777,552 $656,902 $464,909 
Cost of goods sold508,996 452,359 362,178 
Gross profit268,556 204,543 102,731 
Operating expenses:
Research and development71,259 62,953 51,252 
Selling, general and administrative95,259 77,514 64,816 
Impairment of privately-held investment  600 
Total operating expenses166,518 140,467 116,668 
Operating income (loss)102,038 64,076 (13,937)
Other income (loss), net999 2,456 (1,229)
Interest expenses, net(3,920)(6,308)(2,743)
Gain on deconsolidation of the JV Company399,093   
Loss on changes of equity interest in the JV Company, net(3,140)  
Net income (loss) before income taxes495,070 60,224 (17,909)
Income tax expense 39,258 3,935 348 
Net income (loss) before loss from equity method investment455,812 56,289 (18,257)
Equity method investment loss from equity investee2,629   
Net income (loss)453,183 56,289 (18,257)
Net income (loss) attributable to noncontrolling interest20 (1,827)(11,661)
Net income (loss) attributable to Alpha and Omega Semiconductor Limited$453,163 $58,116 $(6,596)
Net income (loss) per common share attributable to Alpha and Omega Semiconductor Limited
Basic$16.93 $2.25 $(0.27)
Diluted$16.07 $2.13 $(0.27)
Weighted average number of common share attributable to Alpha and Omega Semiconductor Limited used to compute net income (loss) per share:
Basic26,764 25,786 24,840 
Diluted28,203 27,272 24,840 

The accompanying notes are an integral part of these consolidated financial statements.


75

ALPHA AND OMEGA SEMICONDUCTOR LIMITED
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(in thousands)
Year ended June 30,
202220212020
Net income (loss) including noncontrolling interest$453,183 $56,289 $(18,257)
Other comprehensive income (loss), net of tax
Foreign currency translation adjustment1,307 14,190 (4,839)
Cumulative translation adjustment removal due to deconsolidation of the JV Company(3,642)  
Comprehensive income (loss)450,848 70,479 (23,096)
    Less: Noncontrolling interest(1,080)4,921 (14,066)
Comprehensive income (loss) attributable to Alpha and Omega Semiconductor Limited$451,928 $65,558 $(9,030)


The accompanying notes are an integral part of these consolidated financial statements.

76

ALPHA AND OMEGA SEMICONDUCTOR LIMITED
CONSOLIDATED STATEMENTS OF EQUITY
(in thousands)
Preferred SharesCommon SharesTreasury StockAdditional Paid-In CapitalAccumulated Other Comprehensive Income (loss)Retained EarningsTotal AOS Shareholders' EquityNoncontrolling InterestTotal Equity
SharesAmountSharesAmountSharesAmount
Balance, June 30, 2019 $ 31,163 $62 (6,646)$(66,240)$234,410 $(2,693)$125,485 $291,024 $152,265 $443,289 
Exercise of common stock options and release of RSUs— — 562 1 — — 24 — — 25 25 
Reissuance of treasury stock upon exercise of common stock options and release of RSUs— — — — 7 56 — — (56) —  
Withholding tax on restricted stock units— — (181)— — — (1,509)— — (1,509)— (1,509)
Issuance of shares under Employee Stock Purchase Plan— — 400 1 — — 3,324 — — 3,325 — 3,325 
Share-based compensation expense— — — — — — 9,854 — — 9,854 — 9,854 
Net loss including noncontrolling interest
— — — — — — — — (6,596)(6,596)(11,661)(18,257)
Foreign currency translation adjustment— — — — — — — (2,434)— (2,434)(2,405)(4,839)
Balance, June 30, 2020  31,944 64 (6,639)(66,184)246,103 (5,127)118,833 293,689 138,199 431,888 
Exercise of common stock options and release of RSUs— — 857 1 — — 1,698 — — 1,699 — 1,699 
Reissuance of treasury stock upon exercise of common stock options and release of RSUs— — — — 14 120 — — (54)66 — 66 
Withholding tax on restricted stock units— — (225)— — — (6,924)— — (6,924)— (6,924)
Issuance of shares under Employee Stock Purchase Plan— — 399 1 — — 3,326 — — 3,327 — 3,327 
Share-based compensation expense— — — — — — 12,190 — — 12,190 — 12,190 
Restricted stock units settlement in connection with service— — — — — — 3,600 — — 3,600 — 3,600 
Net income (loss) including noncontrolling interest— — — — — — — — 58,116 58,116 (1,827)56,289 
Foreign currency translation adjustment— — — — — — — 7,442 — 7,442 6,748 14,190 
Balance, June 30, 2021  32,975 66 (6,625)(66,064)259,993 2,315 176,895 373,205 143,120 516,325 
Exercise of common stock options and release of RSUs— — 652 1 — — 897 — — 898 — 898 
Reissuance of treasury stock upon exercise of common stock options and release of RSUs— — — — 8 64 — — (64) —  
Withholding tax on restricted stock units— — (183)— — — (8,641)— — (8,641)— (8,641)
Issuance of shares under Employee Stock Purchase Plan— — 544 1 — — 5,244 — — 5,245 — 5,245 
Share-based compensation expense— — — — — — 31,058 — — 31,058 — 31,058 
Restricted stock units settlement in connection with service— — — — — — 400 — — 400 — 400 
Net income (loss) including noncontrolling interest through December 1, 2021— — — — — — — — 453,163 453,163 20 453,183 
Foreign currency translation adjustment— — — — — — — 558 — 558 749 1,307 
Deconsolidation of noncontrolling interest— — — — — — — (1,793)— (1,793)(143,889)(145,682)
Balance, June 30, 2022 $ 33,988 $68 (6,617)$(66,000)$288,951 $1,080 $629,994 $854,093 $ $854,093 
            
The accompanying notes are an integral part of these consolidated financial statements.
77

ALPHA AND OMEGA SEMICONDUCTOR LIMITED
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
Year Ended June 30,
202220212020
Cash flows from operating activities
Net income (loss) including noncontrolling interest$453,183 $56,289 $(18,257)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Gain on deconsolidation of the JV Company(399,093)  
Loss on changes of equity interest in the JV Company, net3,140   
Deferred income tax on deconsolidation and changes of equity interest in the JV Company29,973   
Depreciation and amortization42,851 52,685 45,090 
Loss on equity investment2,629   
Share-based compensation expense31,324 15,324 10,454 
Deferred income taxes, net1,592 1,551 85 
(Gain) loss on disposal of property and equipment18 426 (102)
Impairment of privately-held investment  600 
Changes in assets and liabilities:
Accounts receivable(30,085)(22,517)11,024 
Inventories(57,416)(18,765)(22,793)
Other current and long-term assets(9,408)(5,843)27,306 
Payable related to equity investee, net48,192   
Accounts payable23,755 (528)(1,777)
Income taxes payable(1,687)1,660 (270)
Income taxes payable on deconsolidation and changes of equity interest in the JV Company3,490   
Accrued and other liabilities76,407 48,462 10,955 
Net cash provided by operating activities218,865 128,744 62,315 
Cash flows from investing activities
Proceeds from sale of equity interest in the JV Company26,347   
Deconsolidation of cash and cash equivalents of the JV Company(20,734)  
Purchases of property and equipment (138,014)(72,700)(62,398)
Proceeds from sale of property and equipment135 42 295 
Government grant related to equipment 1,444 119 1,254 
Net cash used in investing activities(130,822)(72,539)(60,849)
Cash flows from financing activities
Withholding tax on restricted stock units(8,641)(6,924)(1,509)
Proceeds from exercise of stock options and ESPP6,143 5,092 3,350 
Proceeds from borrowings64,276 65,876 96,232 
Repayments of borrowings(35,748)(66,584)(49,394)
Principal payments on capital leases(4,176)(16,451)(11,028)
Net cash provided by (used in) financing activities21,854 (18,991)37,651 
Effect of exchange rate changes on cash, cash equivalents and restricted cash(59)4,895 (708)
Net increase in cash, cash equivalents and restricted cash109,838 42,109 38,409 
Cash, cash equivalents and restricted cash at beginning of year204,813 162,704 124,295 
Cash, cash equivalents and restricted cash at end of year$314,651 $204,813 $162,704 
78

ALPHA AND OMEGA SEMICONDUCTOR LIMITED
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
Year Ended June 30,
202220212020
Supplemental disclosures of cash flow information:
Cash paid for interest$3,404 $5,641 $2,223 
Cash paid for income taxes$5,768 $970 $2,258 
Supplemental disclosures of non-cash investing and financing information:
Property and equipment purchased but not yet paid $62,165 $20,204 $17,370 
Reissuance of treasury stock$64 $120 $56 
Reconciliation of cash, cash equivalents, and restricted cash:
Cash and cash equivalents$314,352 $202,412 $158,536 
Restricted cash 299 233 2,190 
Restricted cash - long-term 2,168 1,978 
Total cash, cash equivalents, and restricted cash$314,651 $204,813 $162,704 

The accompanying notes are an integral part of these consolidated financial statements.
79


ALPHA AND OMEGA SEMICONDUCTOR LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

1. The Company and Significant Accounting Policies
The Company

Alpha and Omega Semiconductor Limited and its subsidiaries (the “Company”, “AOS”, “we” or “us”) design, develop and supply a broad range of power semiconductors. The Company's portfolio of products targets high-volume applications, including personal computers, graphic cards, flat panel TVs, home appliances, smart phones, battery packs, quick chargers, home appliances, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment. The Company conducts its operations primarily in the United States of America (“USA”), Hong Kong, China, and South Korea.
Basis of Preparation

The consolidated financial statements include the accounts of the Company, its wholly-owned subsidiaries and a subsidiary in which it had a controlling interest until December 1, 2021. As of December 2, 2021, the Company ceased having control over this subsidiary. Therefore, the Company deconsolidated this subsidiary as of that date. Subsequently, the Company has accounted for it using the equity method of accounting. All intercompany account balances and transactions have been eliminated. The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”).
Reclassification
Certain reclassifications of prior period presentation to conform to current period presentation have been made with no changes made to balance sheet, income statement or statement of cash flows subtotals.
Joint Venture
On March 29, 2016, the Company entered into a joint venture contract (the “JV Agreement”) with two investment funds owned by the Municipality of Chongqing (the “Chongqing Funds”), pursuant to which the Company and the Chongqing Funds formed a joint venture, (the “JV Company”), for the purpose of constructing and operating a power semiconductor packaging, testing and 12-inch wafer fabrication facility in the Liangjiang New Area of Chongqing, China (the “JV Transaction”). As of December 1, 2021, the Company owned 51%, and the Chongqing Funds owned 49%, of the equity interest in the JV Company. The Joint Venture was accounted under the provisions of the consolidation guidance since the Company had controlling financial interest until December 1, 2021. If both parties agree that the termination of the JV Company is the best interest of each party or the JV Company is bankrupt or insolvent where either party may terminate early, after paying the debts of the JV Company, the remaining assets of the JV Company shall be paid to the Chongqing Funds to cover the principal of its total paid-in contributions plus interest at 10% simple annual rate prior to distributing the balance of the JV Company's assets to the Company. The JV Company has reached its targeted production of assembly and testing.
Effective December 1, 2021, the Company entered into a share transfer agreement (the “STA”) with a third-party investor (the “Investor”), pursuant to which the Company sold to the Investor approximately 2.1% of outstanding equity interest held by the Company in the JV Company for an aggregate purchase price of RMB 108 million or approximately $16.9 million (the “Transaction”). The Transaction was closed on December 2, 2021 (the “Closing Date”). As a result of the Transaction, as of the Closing Date, the Company’s equity interest in the JV Company decreased from 50.9% to 48.8%. Also, the Company’s right to designate directors on the board of JV Company was reduced to three (3) out of seven (7) directors from four (4) directors prior to the Transaction. As a result of the Transaction, AOS no longer had a controlling financial interest in the JV Company under generally accepted accounting principles. Loss of control is deemed to have occurred when, among other things, a parent company owns less than a majority of the outstanding equity interest in the subsidiary, lacks a controlling financial interest in the subsidiary and, is unable to unilaterally control the subsidiary through other means such as having, or the ability to obtain or represent, a majority of the subsidiary’s board of directors. Because of these factors, as of December 2, 2021, the Company ceased having control over the JV Company. Therefore, the Company deconsolidated the financial statements of the JV Company as of that date. Subsequently, the Company has accounted for its investment in the JV Company using the equity method of accounting.

On December 24, 2021, the Company entered into a share transfer agreement with another third-party investor, pursuant to which the Company sold to this investor 1.1% of outstanding equity interest held by the Company in the JV Company for an aggregate purchase price of RMB 60 million, or approximately $9.4 million. In addition, on December 30, 2021, the JV
80


Company adopted an employee equity incentive plan and issued an equity interest equivalent to 3.99% of the JV Company in exchange for cash. As a result, the Company owned 45.8% of the equity interest in the JV Company as of December 31, 2021.

On January 26, 2022, the JV Company completed a financing transaction pursuant to a corporate financing agreement (the “Financing Agreement”) between the JV Company and certain third-party investors (the “New Investors”). Under the Financing Agreement, the New Investors purchased newly issued equity interest of the JV Company for a total purchase price of RMB 509 million (or approximately $80 million based on the currency exchange rate as of January 26, 2022) (the “Investment”). Immediately following the closing of the Investment, the percentage of outstanding JV Company equity interest beneficially owned by the Company was further reduced to 42.2%.
Certain Significant Risks and Uncertainties Related to Outbreak of Coronavirus Disease 2019 (“COVID-19”)

The COVID-19 pandemic has had and continues to have a negative impact on business and economic activities across the globe. As a result of the COVID-19 pandemic and the global economic downturn and changing consumer behaviors due to various restrictions imposed by governments, the Company has experienced shifting market trends, including an increasing demand in the markets for notebooks, PCs and gaming devices and decreasing demand for mobile phone and industrial products, as more consumers are staying at and working from home. While the Company has recently benefited from the increasing demand of consumer electronics and PC related products, there is no guarantee that this trend will continue, and such increasing demand may discontinue or decline as government authorities relax and terminate COVID-19 related restrictions and consumer behaviors change. Furthermore, as the COVID-19 pandemic continues and global economic downturn and high unemployment persists, consumer spending may slow down substantially, in which case the Company may experience a significant decline of customer orders for its products, including those designed for PC-related applications, and such decline will adversely affect its financial conditions and results of operations. The full extent of the future impact of the COVID-19 pandemic on the Company’s operational and financial performance is uncertain and will depend on many factors outside the Company’s control, including, without limitation, the timing, extent, trajectory and duration of the pandemic; the availability, distribution and effectiveness of vaccines; the spread of new variants of COVID-19; the continued or renewed imposition of protective public safety measures and government mandates; the continuing disruption of global supply chain affecting the semiconductor industry; and the impact of the pandemic on the global economy and demand for consumer products.

In April 2022, the operations of our two packaging and testing facilities in Shanghai, China were suspended due to a strict lockdown of the city imposed by the local government in response to surging COVID cases. Our facilities in Shanghai were required to be shut down and production was halted beginning in early April. Transportation suspension in and out of Shanghai also interrupted the shipping of raw materials and finished parts to and from our facilities. We received permission to reopen our facilities partially in early May. We gradually ramped up production at these facilities in May and returned to normal operation in June 2022. The suspension of our Shanghai facilities, and the subsequent partial resumption of production, reduced our ability to complete orders from our customers in a timely manner, which adversely affected our revenue and results of operation for the three months ended June 30, 2022.
Risks and Uncertainties

The Company is subject to certain risks and uncertainties. The Company believes changes in any of the following areas could have a material adverse effect on the Company's future financial position or results of operations or cash flows: the timing and success of new product development, including market receptiveness, operation of in-house manufacturing facilities, litigation or claims against the Company based on intellectual property, patent, product regulatory or other factors, competition from other products, general economic conditions, the inability to attract and retain qualified employees, lack of control to the JV Company and ultimately to sustain profitable operations, risks associated with doing business in China, and ability to diversify products and develop digital business; the general state of the U.S., China and world economies; the highly cyclical nature of the industries the Company serves; the loss of any of its larger customers; restrictions on the Company’s ability to sell to foreign customers due to trade laws, regulations and requirements; disruptions of the supply chain of components needed for our products; inability to obtain additional financing; inability to meet certain debt covenants; fundamental changes in the technology underlying the Company’s products; successful and timely completion of product design efforts; and new product design introductions by competitors. Additional risks and uncertainties that the Company is unaware of, or that the Company currently believes are not material, may also become important factors that adversely affect its business.

The Company's revenue limited by its ability to utilize wafer production and packaging and testing capacity from its in-house facilities and obtain adequate wafer supplies from third-party foundries. The Company recently entered into a new agreement with the JV Company pursuant to which the JV Company agrees to provide us with a guaranteed supply of a fixed number of wafers until December 2023. Currently the Company's main third-party foundry is Shanghai Hua Hong Grace Electronic Company Limited, or HHGrace, located in Shanghai, China. HHGrace has been manufacturing wafers for the Company since 2002. HHGrace manufactured approximately 10.3%, 11.5% and 12.7% of the wafers used in the Company's products for the fiscal years ended June 30, 2022, 2021 and 2020, respectively. Although the Company believes that its volume
81


of production allows the Company to secure favorable pricing and priority in allocation of capacity in its third-party foundries, if the foundries' capacities are constrained due to market demands, HHGrace, together with other foundries from which the Company purchases wafers, may not be willing or able to satisfy all of the Company's manufacturing requirements on a timely basis and/or at favorable prices. The Company is also subject to the risks of service disruptions and raw material shortages by its foundries. Such disruptions, shortages and price increases could harm the Company’s operating results. In addition, manufacturing facilities' capacity affects the Company's gross margin because the Company has certain fixed costs associated with its Oregon Fab and the JV Company, as well as in-house packaging and testing facilities. If the Company fails to utilize its manufacturing facilities' capacity at a desirable level, its financial condition and results of operations will be adversely affected.
Use of Estimates
The preparation of the consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses. To the extent there are material differences between these estimates and actual results, the Company's condensed consolidated financial statements will be affected. On an ongoing basis, the Company evaluates the estimates, judgments and assumptions including those related to stock rotation returns, price adjustments, allowance for doubtful accounts, inventory reserves, warranty accrual, income taxes, leases, share-based compensation, recoverability of and useful lives for property, plant and equipment and intangible assets, as well as the economic implications of the COVID-19 pandemic.
Foreign Currency Transactions and Translation
Most of the Company's principal subsidiaries use U.S. dollars as their functional currency because their transactions are primarily conducted and settled in U.S. dollars. All of their revenues and a significant portion of their operating expenses are denominated in U.S. dollars. The functional currencies for the Company's in-house packaging and testing facilities in China are U.S. dollars, and a majority of their capital expenditures are denominated in U.S. dollars. Foreign currency transactions are translated into the functional currencies using the exchange rates prevailing at the dates of the transactions. Foreign exchange gains and losses, resulting from the settlement of such transactions and from the re-measurement of monetary assets and liabilities denominated in foreign currencies using exchange rates at balance sheet date and non-monetary assets and liabilities using historical exchange rates, are recognized in the consolidated statements of operations.
For the Company's subsidiaries which use the local currency as their functional currency, their results and financial position are translated into U.S. dollars using exchange rates at balance sheet dates for assets and liabilities and using average exchange rates for income and expenses items. The resulting translation differences are presented as a separate component of accumulated other comprehensive income (loss) and noncontrolling interest in the consolidated statements of equity.
Cash, Cash Equivalents and Restricted Cash
Cash and cash equivalents primarily consist of cash on hand and short-term bank deposits with original maturities of three months or less. Cash equivalents are highly liquid investments with stated maturities of three months or less as of the dates of purchase. The carrying amounts reported for cash and cash equivalents are considered to approximate fair values based upon their short maturities.

Cash and cash equivalents are maintained with reputable major financial institutions. If, due to current economic conditions or other factors, one or more of the financial institutions with which the Company maintains deposits fails, the Company's cash and cash equivalents may be at risk. Deposits with these banks may exceed the amount of insurance provided on such deposits; however, these deposits typically may be redeemed upon demand and, therefore, bear minimal risk.

The Company maintains restricted cash in connection with cash balances temporarily restricted for regular business operations, including the possibility of a dispute with a vendor. These balances have been excluded from the Company’s cash and cash equivalents balance and are classified as restricted cash in the Company’s consolidated balance sheets. As of June 30, 2022 and 2021, the amount of restricted cash was $0.3 million and $2.4 million, respectively.
Accounts Receivable, net
The allowance for doubtful accounts is based on assessment of the collectability of accounts receivable from customers. The Company reviews the allowance by considering factors such as historical collection experience, credit quality, age of the accounts receivable balances and current economic conditions that may affect a customer's ability to pay. The Company writes off a receivable and charges against its recorded allowance when it has exhausted its collection efforts without success.

82


Fair Value Measurements
    Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value, which are the following:
Level 1 - Quoted prices in active markets for identical assets or liabilities.
Level 2 - Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
Fair Value of Financial Instruments
The fair value of cash equivalents is based on observable market prices and have been categorized in Level 1 in the fair value hierarchy. Cash equivalents consist primarily of short-term bank deposits. The carrying values of financial instruments such as cash and cash equivalents, accounts receivable and accounts payable approximate their carrying values due to their short-term maturities. The carrying value of the company's debt is considered a reasonable estimate of fair value which is estimated by considering the current rates available to the Company for debt of the same remaining maturities, structure and terms of the debts.
Inventories

The Company carries inventories at the lower of cost (determined on a first-in, first-out basis) or net realizable value. Cost includes semiconductor wafer and raw materials, labor, depreciation expenses and other manufacturing expenses and overhead, and packaging and testing fees paid to third parties if subcontractors are used. Valuation of inventories are based on the Company's periodic review of inventory quantities on hand as compared with its sales forecasts, historical usage, aging of inventories, production yield levels and current product selling prices. If actual market conditions are less favorable than those forecasted by management, additional future inventory write-downs may be required that could adversely affect the Company's operating results. Adjustments to inventory once established are not reversed until the related inventory has been sold or scrapped.
Property, Plant and Equipment
Property, plant and equipment are stated at historical cost less accumulated depreciation. Historical cost includes expenditures that are directly attributable to the acquisition of the items and the costs incurred to make the assets ready for their intended use.
Depreciation is provided for on a straight-line basis over the estimated useful lives of the related assets as follows:

 
Building
20 years
Manufacturing machinery and equipment
8 to 10 years
Equipment and tooling
3 to 5 years
Computer hardware and software
3 to 5 years
Office furniture and equipment
5 years
Leasehold and building improvements
2 to 20 years
Vehicle
5 years


Equipment and construction in progress represent equipment received but the necessary installation has not been fully performed or building construction and leasehold improvements have been started but not yet completed. Equipment and construction in progress are stated at cost and transferred to respective asset class when fully completed and ready for their intended use.
83


Internal-use software development costs are capitalized to the extent that the costs are directly associated with the development of identifiable and unique software products controlled by the Company that will probably generate economic benefits beyond one year. Costs incurred during the application development stage are required to be capitalized. The application development stage is characterized by software design and configuration activities, coding, testing and installation. Training costs and maintenance are expensed as incurred, while upgrades and enhancements are capitalized if it is probable that such expenditures will result in additional functionality. Costs include employee costs incurred and fees paid to outside consultants for the software development and implementation. Internally developed software is amortized over its estimated useful life of three to five years starting from the date when it is ready for its intended use.
Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized as selling, general and administrative expenses in the consolidated statements of operations. Costs of maintenance and repairs that do not improve or extend the lives of the respective assets are expensed as incurred.
Government Grants
The Company occasionally receives government grants that provide financial assistance for certain eligible expenditures in China. These grants include reimbursements on interest expense on bank borrowings, payroll tax credits, credit for property, plant and equipment in a particular geographical location, employment credits as well as business expansion credits. Government grants are not recognized until there is reasonable assurance that the Company will comply with the conditions attaching to it, and that the grant will be received. The Company records such grants either as a reduction of the related expense, a reduction of the cost of the related asset, or as other income depending upon the nature of the grant. As a result of such grants, during the fiscal year ended June 30, 2022, the Company reduced interest expense by $0.9 million, property, plant and equipment by $1.4 million, and operating expenses by $0.2 million. During the fiscal year ended June 30, 2021, the Company reduced interest expense by $3.0 million, property, plant and equipment by $0.1 million, and operating expenses by $3.7 million. During the fiscal year ended June 30, 2020, the Company reduced interest expenses by $6.1 million, property, plant and equipment by $1.3 million, and operating expenses by $4.7 million.

Long-lived Assets

The Company reviews all long-lived assets whenever events or changes in circumstance indicate that these assets may not be recoverable. When evaluating long-lived assets, if the Company concludes that the estimated undiscounted cash flows attributable to the assets are less than their carrying value, the Company recognizes an impairment loss based on the excess of the carrying amount of the assets over their respective fair values, which could adversely affect our results of operations.

There was no impairment of long-lived assets for fiscal years 2022, 2021 and 2020.

Revenue Recognition

The Company determines revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract; and (5) recognition of revenue when, or as, a performance obligation is satisfied. The Company recognizes product revenue at a point in time when product is shipped to the customer, as determined by the agreed upon shipping terms, net of estimated stock rotation returns and price adjustments that it expects to provide to certain distributors. The Company presents revenue net of sales taxes and any similar assessments. Our standard payment terms range from 30 to 60 days.

The Company sells its products primarily to distributors, who in turn sell the products globally to various end customers. The Company allows stock rotation returns from certain distributors. Stock rotation returns are governed by contract and are limited to a specified percentage of the monetary value of products purchased by distributors during a specified period. The Company records an allowance for stock rotation returns based on historical returns, current expectations, and individual distributor agreements. The Company also provides special pricing to certain distributors, primarily based on volume, to encourage resale of the Company's products. Allowance for price adjustments is recorded against accounts receivable and the provision for stock rotation rights is included in accrued liabilities on the consolidated balance sheets.

The Company's performance obligations relate to contracts with a duration of less than one year. The Company elected to apply the practical expedient provided in ASC 606, “Revenue from Contracts with Customers”. Therefore, the Company is not required to disclose the aggregate amount of transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period.

84


The Company recognizes the incremental direct costs of obtaining a contract, which consist of sales commissions, when control over the products they relate to transfers to the customer. Applying the practical expedient, the Company recognizes commissions as expense when incurred, as the amortization period of the commission asset the Company would have otherwise recognized is less than one year.

Packaging and testing services revenue is recognized at a point in time upon shipment of serviced products to the customer.
Leases

The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets, current operating lease liabilities and long-term operating lease liabilities on the Company's consolidated balance sheets. Finance leases are included in property, plant and equipment, finance lease liabilities and long-term finance leases liabilities on the consolidated balance sheets.

Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. The Company determined its incremental borrowing rate based on the information available at the lease commencement date. The operating lease ROU assets also include any lease payments made and exclude lease incentives. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. Operating lease expense is generally recognized on a straight-line basis over the lease term. Variable lease payments are expensed as incurred and are not included within the operating lease ROU asset and lease liability calculation. The Company does not record leases on the consolidated balance sheet with a term of one year or less. The Company elected to combine its lease and non-lease components as a single lease component for all asset classes.

Product Warranty

The Company provides a standard one-year warranty for the products from the date of purchase by the end customers. The Company accrues for estimated warranty costs at the time revenue is recognized. The Company's warranty obligation is affected by product failure rates, labor and material costs for replacing defective parts, related freight costs for failed parts and other quality assurance costs. The Company monitors its product returns for warranty claims and maintains warranty reserves based on historical experiences and anticipated warranty claims known at the time of estimation.
Shipping and Handling Costs
Shipping and handling costs are included in cost of goods sold.
Research and Development
Research and development costs are expensed as incurred.
 
Provision for Income Taxes

Income tax expense or benefit is based on income or loss before taxes. Deferred tax assets and liabilities are recognized principally for the expected tax consequences of temporary differences between the tax basis of assets and liabilities and their reported amounts.

The Company is subject to income taxes in a number of jurisdictions. Significant judgment is required in determining the worldwide provision for income taxes. There are many transactions and calculations for which the ultimate tax determination is uncertain during the ordinary course of business. The Company establishes accruals for certain tax contingencies based on estimates of whether additional taxes may be due. While the final tax outcome of these matters may differ from the amounts that were initially recorded, such differences will impact the income tax and deferred tax provisions in the period in which such determination is made.

Significant management judgment is also required in determining whether deferred tax assets will be realized in full or in part. When it is more likely than not that all or some portion of specific deferred tax assets such as net operating losses or research and experimentation tax credit carryforwards will not be realized, a valuation allowance must be established for the amount of the deferred tax assets that cannot be realized. The Company considers all available positive and negative evidence on a jurisdiction-by-jurisdiction basis when assessing whether it is more likely than not that deferred tax assets are recoverable.
85


The Company considers evidence such as our past operating results, the existence of cumulative losses in recent years and our forecast of future taxable income.

The Financial Accounting Standards Board (FASB), issued guidance which clarifies the accounting for income taxes by prescribing a minimum probability threshold that a tax position must meet before a financial statement benefit is recognized. The minimum threshold is defined as a tax position that is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. The tax benefit to be recognized is measured as the largest amount of benefit that is greater than fifty percent likely to be realized upon ultimate settlement. Although the guidance on the accounting for uncertainty in income taxes prescribes the use of a recognition and measurement model, the determination of whether an uncertain tax position has met those thresholds will continue to require significant judgment by management. If the ultimate resolution of tax uncertainties is different from what is currently estimated, a material impact on income tax expense could result.

The Company's provision for income taxes is subject to volatility and could be adversely impacted by changes in earnings or tax laws and regulations in various jurisdictions. The Company is subject to the continuous examination of our income tax returns by the Internal Revenue Service and other tax authorities. The Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of our provision for income taxes. To the extent that the final tax outcome of these matters is different from the amounts recorded, such differences will impact the provision for income taxes in the period in which such determination is made. The provision for income taxes includes the impact of changes to reserves, as well as the related net interest and penalties.
Share-based Compensation Expense

The Company maintains an equity-settled, share-based compensation plan to grant restricted share units and stock options. The Company recognizes expense related to share-based compensation awards that are ultimately expected to vest based on estimated fair values on the date of grant. The fair value of restricted share units is based on the fair value of the Company's common share on the date of grant. For restricted stock awards subject to market conditions, the fair value of each restricted stock award is estimated at the date of grant using the Monte-Carlo pricing model. The fair value of stock options is estimated on the date of grant using the Black-Scholes option valuation model. Share-based compensation expense is recognized on the accelerated attribution basis over the requisite service period of the award, which generally equals the vesting period. The Black-Scholes option valuation model requires the input of subjective assumptions, including the expected term and stock price volatility. In addition, judgment is also required in estimating the number of stock-based awards that are expected to be forfeited. Forfeitures are estimated based on historical experience at the time of grant. Changes in estimated forfeitures are recognized in the period of change and impact the amount of stock compensation expenses to be recognized in future periods, which could be material if actual results differ significantly from estimates.

The Employee Share Purchase Plan (the “ESPP”) is accounted for at fair value on the date of grant using the Black-Scholes option valuation model.

Advertising

Advertising expenditures are expensed as incurred. Advertising expense was $0.2 million, $0.4 million and $0.7 million in the fiscal years ended June 30, 2022, 2021, and 2020, respectively.
Comprehensive Income (Loss)
Comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. The Company's accumulated other comprehensive income (loss) consists of cumulative foreign currency translation adjustments.

Recent Accounting Pronouncements
Recently Issued Accounting Standards not yet adopted

In November 2021, the FASB issued Accounting Standards Update (ASU) No. 2021-10, “Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance.” This ASU requires business entities to make annual disclosures about transactions with a government they account for by analogizing to a grant or contribution accounting model under ASC 958-605. The ASU is effective for all entities within their scope for financial statements issued for annual periods
86


beginning after December 15, 2021. The adoption will not have any impacts on the Company's consolidated financial position, results of operations or cash flows.

In August 2020, the FASB issued ASU No. 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity”, which, among other things, provides guidance on how to account for contracts on an entity’s own equity. This ASU simplifies the accounting for certain financial instruments with characteristics of liabilities and equity. Specifically, the ASU eliminated the need for the Company to assess (1) whether a contract on the entity’s own equity permits settlement in unregistered shares, (2) whether counterparty rights rank higher than shareholder’s rights, and (3) whether collateral is required. In addition, the ASU requires incremental disclosure related to contracts on the entity’s own equity and clarifies the treatment of certain financial instruments accounted for under this ASU on earnings per share. For public business entities, the ASU is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. The Company does not expect the adoption of this guidance will have a material impact on its consolidated financial position, results of operations or cash flows.
Recently Adopted Accounting Standards

In January 2020, the FASB issued ASU No. 2020-01, “Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.” The ASU is based on a consensus of the Emerging Issues Task Force and is expected to increase comparability in accounting for these transactions. ASU 2016-01 made targeted improvements to accounting for financial instruments, including providing an entity the ability to measure certain equity securities without a readily determinable fair value at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Among other topics, the amendments clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting. The adoption of ASU 2020-01 on July 1, 2021 had no material impact on the Company's Consolidated Financial Statements.

In December 2019, the FASB issued ASU No. 2019-12 “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”) by removing certain exceptions to the general principles. The Company adopted ASU 2019-12 as of July 1, 2021. ASU 2019-12 had no material impact on the Company's Consolidated Financial Statements.

87


2. Equity Method Investment in Equity Investee

On December 1, 2021 (the “Effective Date”), Alpha & Omega Semiconductor (Shanghai) Ltd. (“AOS SH”) and Agape Package Manufacturing (Shanghai) Limited (“APM SH”), each a wholly-owned subsidiary of the Company, entered into a share transfer agreement (“STA”) with a third-party investor to sell a portion of the Company's equity interest in the JV Company which consists of a power semiconductor packaging, testing and 12-inch wafer fabrication facility in Chongqing, China (the “Transaction”). The Transaction closed on December 2, 2021 (the “Closing Date”), which reduced the Company’s equity interest in the JV Company from 50.9% to 48.8%. Also, the Company’s right to designate directors on the board of JV Company was reduced to three (3) out of seven (7) directors, from four (4) directors prior to the Transaction. As a result of the Transaction and other factors, the Company no longer has a controlling financial interest in the JV Company and has determined that the JV Company was deconsolidated from the Company’s Consolidated Financial Statements effective as of the Closing Date. In connection with the deconsolidation and in accordance with ASC 810, the Company recorded a gain on deconsolidation of $399.1 million during the fiscal year ended June 30, 2022 in the Consolidated Statements of Income. The gain on deconsolidation of the JV Company was calculated as follows:


(in thousands)
Cash received for sales of shares in the JV Company
$16,924 
Fair value of retained equity method investment
393,124 
Carrying amount of non-controlling interest
143,889 
Cumulative translation adjustment removal
1,793 
Carrying amount of net assets of the JV Company at December 1, 2021
(156,637)
Gain on deconsolidation of the JV Company
$399,093 

The Company retained significant influence over the operating and financial policies of the JV Company and measured the fair value of the retained investment based on their share of the fair value of the JV Company, which was calculated using the market approach based on the Transaction.

On December 24, 2021, the Company entered into a share transfer agreement with another third-party investor, pursuant to which the Company sold to this investor 1.1% of outstanding equity interest held by the Company in the JV Company. In addition, on December 30, 2021, the JV Company adopted an employee equity incentive plan and issued an equity interest equivalent to 3.99% of the JV Company in exchange to cash. As a result of these two transactions, the Company owned 45.8% of the equity interest in the JV Company as of December 31, 2021.

On January 26, 2022, the JV Company completed a financing transaction pursuant to a corporate investment agreement (the “Investment Agreement”) between the JV and certain third-party investors (the “New Investors”). Under the Investment Agreement, the New Investors purchased newly issued equity interest of the JV Company, representing approximately 7.82% of post-transaction outstanding equity interests of the JV Company, for a total purchase price of RMB 509 million (or approximately USD 80 million based on the currency exchange rate as of January 26, 2022) (the “Investment”). Following the closing of the Investment and as of June 30, 2022, the percentage of outstanding JV Company equity interest beneficially owned by the Company was reduced to 42.2%.

88


The net loss associated with these sales of JV Company equity interest held by the Company were recorded in the fiscal year ended June 30, 2022 as follows:

(in thousands)
Gain on 1.1% equity interest sold
$475 
Loss on diluted equity interest from issuance of shares under the employee equity incentive plan
(8,116)
Gain on 7.82% equity interest sold4,501 
Loss on changes on equity interest of the JV Company, net
$(3,140)

The Company accounts for its investment in the JV Company as an equity method investment and reports its equity in earnings or loss of the JV Company on a three-month lag due to an inability to timely obtain financial information of the JV Company. During the fiscal year ended June 30, 2022, the Company recorded $2.6 million of its equity in loss of the JV Company, using lag reporting.

Summarized Financial Information

The following table presents summarized financial information for the JV Company as of and for the period from December 2, 2021 through March 31, 2022, using lag reporting (in thousands):

As of March 31, 2022
Current assets$198,323 
Non-current assets$364,777 
Current liabilities$251,988 
Non-current liabilities$76,207 
For the periods of December 2, 2021 to March 31, 2022
Revenue$68,972 
Gross loss$870 
Operating expenses$2,280 
Net loss$6,197 

3. Related Party Transactions

As of June 30, 2022, the Company owned 42.2% equity interest in the JV Company, which, by definition, is a related party to the Company. The JV Company supplies 12-inch wafers and provides assembly and testing services for 8-inch wafer products to AOS. Due to the right of offset of receivables and payables with the JV Company, as of June 30, 2022, AOS recorded the net amount of $29.0 million as a payable related to equity investee, net, in the Consolidated Balance Sheet. Since the December 2, 2021 deconsolidation of the JV Company and through the fiscal year ended June 30, 2022, the Company purchased finished goods and services of $117.6 million from the JV Company and AOS provided the JV Company with $36.4 million of 8-inch wafers.





89


4. Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited

Basic net income (loss) per share is computed using the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed using the weighted-average number of common shares outstanding, plus potential shares of common stock during the period. Potential shares of common stock include dilutive shares attributable to the assumed exercise of share options, ESPP shares and vesting of RSUs using the treasury stock method and contingent issuances of common shares related to convertible preferred shares, if dilutive. Under the treasury stock method, potential common shares outstanding are not included in the computation of diluted net income per share if their effect is anti-dilutive.
The following table presents the calculation of basic and diluted net income (loss) per share attributable to common shareholders:
 Year Ended June 30,  
 202220212020
(in thousands, except per share data)
Numerator:
Net income (loss) attributable to Alpha and Omega Semiconductor Limited$453,163 $58,116 $(6,596)
Denominator:
Basic:
Weighted average number of common shares used to compute basic net income per share26,764 25,786 24,840 
Diluted:
Weighted average number of common shares used to compute basic net income per share26,764 25,786 24,840 
Effect of potentially dilutive securities:
Stock options, RSUs and ESPP shares1,439 1,486  
Weighted average number of common shares used to compute diluted net income per share28,203 27,272 24,840 
Net income (loss) per share attributable to Alpha and Omega Semiconductor Limited:
Basic$16.93 $2.25 $(0.27)
Diluted$16.07 $2.13 $(0.27)
The following potential dilutive securities were excluded from the computation of diluted net income (loss) per share as their effect would have been anti-dilutive:
 Year Ended June 30,  
 202220212020
(in thousands)
Employee stock options and RSUs277 193 2,028 
ESPP21 71 834 
Total potential dilutive securities298 264 2,862 

90


5. Concentration of Credit Risk and Significant Customers
The Company manages its credit risk associated with exposure to distributors and direct customers on outstanding accounts receivable through the application of credit approvals, credit ratings and other monitoring procedures. In some instances, the Company also obtains letters of credit from certain customers.
Credit sales, which are mainly on credit terms of 30 to 60 days, are only made to customers who meet the Company's credit standards, while sales to new customers or customers with low credit ratings are usually made on an advance payment basis. The Company considers its financial assets to be of good credit quality because its key distributors and direct customers have long-standing business relationships with the Company and the Company has not experienced any significant bad debt write-offs of accounts receivable in the past. The Company closely monitors the aging of accounts receivable from its distributors and direct customers, and regularly reviews their financial positions, where available.

Summarized below are individual customers whose revenue or accounts receivable balances were 10% or higher than the respective total consolidated amounts:
   Year Ended June 30,
Percentage of revenue  2022 2021 2020
Customer A  24.6 % 28.7 % 29.3 %
Customer B  39.7 % 35.4 % 35.5 %
   June 30,
Percentage of accounts receivable  2022 2021
Customer A  24.6 % 12.4 %
Customer B  36.4 % 22.1 %
Customer C  * 21.9 %
Customer D12.0 %*
* Less than 10%

91



6. Balance Sheet Components
Accounts receivable, net
 
June 30,  
 20222021
(in thousands)
Accounts receivable$84,442 $48,234 
Less: Allowance for price adjustments(18,731)(12,415)
Less: Allowance for doubtful accounts(30)(30)
Accounts receivable, net$65,681 $35,789 
Inventories
 
June 30,
 20222021
(in thousands)
Raw materials$67,960 $68,900 
Work in-process80,720 68,824 
Finished goods9,360 16,569 
 $158,040 $154,293 

Other current assets
 
June 30,
 20222021
(in thousands)
VAT receivable$737 $1,539 
Other prepaid expenses3,954 1,465 
Prepaid insurance2,590 2,615 
Prepaid maintenance826 1,670 
Prepayments to supplier257 2,540 
Prepaid income tax2,086 2,221 
Interest receivable25 2,207 
Customs deposit 270 
Other receivables745 68 
 $11,220 $14,595 

92


Property, plant and equipment, net
 
June 30,  
 20222021
(in thousands)
Land$4,877 $4,877 
Building16,691 71,454 
Manufacturing machinery and equipment287,574 515,320 
Equipment and tooling28,052 27,017 
Computer equipment and software46,758 41,518 
Office furniture and equipment2,820 3,814 
Leasehold improvements35,254 74,733 
Land use rights 9,319 
 422,026 748,052 
Less: accumulated depreciation(233,340)(348,749)
 188,686 399,303 
Equipment and construction in progress129,980 37,674 
Property, plant and equipment, net$318,666 $436,977 
Total depreciation expense was $39.9 million, $49.3 million and $43.9 million for fiscal year 2022, 2021 and 2020, respectively.
The Company capitalized $0.3 million, $0.3 million and $1.0 million of software development costs during the fiscal year 2022, 2021 and 2020, respectively. Amortization of capitalized software development costs was $0.4 million in fiscal year 2022, $0.5 million in fiscal year 2021 and $0.5 million in fiscal year 2020. Unamortized capitalized software development costs in each of the periods presented at June 30, 2022 and 2021 were $0.8 million and $1.2 million, respectively.

Other long-term assets
June 30,  
 20222021
(in thousands)
Prepayments for property and equipment$6,890 $14,882 
Investments in privately held companies100 100 
Customs deposit 1,708 1,120 
Deposit with supplier6,396  
Other long-term deposits18 927 
Office leases deposits1,012 1,100 
Other1,553 740 
 $17,677 $18,869 

93


Intangible assets, net
 
June 30,  
 20222021
(in thousands)
Patents and technology rights$18,037 $18,037 
Trade name268 268 
Customer relationships1,150 1,150 
19,455 19,455 
Less: accumulated amortization(9,674)(6,314)
9,781 13,141 
Goodwill269 269 
Intangible assets, net$10,050 $13,410 

The Company is amortizing intangible assets of patents and technology rights related to a license agreement with STMicroelectronices International N.V. Amortization expense for intangible assets was $3.4 million, $3.4 million and $0.1 million for the years ended June 30, 2022, 2021 and 2020, respectively. The estimated useful lives for patents and technology rights and trade name were five years and ten years, respectively. Customer relationships are fully amortized.
Estimated future minimum amortization expense of intangible assets is as follows (in thousands):
Year ending June 30,
2023$3,286 
20243,249 
20253,246 
$9,781 
94


Accrued liabilities
 
June 30,  
 20222021
(in thousands)
Accrued compensation and benefits$34,681 $32,756 
Warranty accrual2,650 2,795 
Stock rotation accrual4,798 3,917 
Accrued professional fees2,659 3,017 
Accrued inventory2,491 1,138 
Accrued facilities related expenses2,421 2,536 
Accrued property, plant and equipment20,485 8,688 
Other accrued expenses5,159 6,793 
Customer deposit40,578 7,139 
ESPP payable971 715 
 $116,893 $69,494 
The activity in the warranty accrual, included in accrued liabilities is as follows:
Year Ended June 30,
202220212020
(in thousands)
Beginning balance$2,795 $709 $623 
Addition1,127 2,443 895 
Utilization(1,272)(357)(809)
Ending balance$2,650 $2,795 $709 
    The activity in the stock rotation accrual, included in accrued liabilities is as follows:
Year Ended June 30,
202220212020
(in thousands)
Beginning balance$3,917 $3,358 $1,921 
Addition5,817 4,742 9,441 
Utilization(4,936)(4,183)(8,004)
Ending balance$4,798 $3,917 $3,358 
95



Other long-term liabilities
 
June 30,  
 20222021
(in thousands)
Deferred payroll taxes$ $1,219 
Customer deposits 70,301 42,000 
Computer software liabilities8,302  
Other 904 
Other long-term liabilities$78,603 $44,123 
    Customer deposits are payments received from customers for securing future product shipments. As of June 30, 2022, $34.5 million were from Customer A and $21.9 million were from Customer B, and $13.9 million were from other customers. As of June 30, 2021, $21.0 million were from Customer A and $21.0 million were from Customer B.


7. Debt

Short-term bank borrowing

In October 2019, the Company's subsidiary in China entered into a line of credit facility with Bank of Communications Limited in China. This line of credit matured on February 14, 2021 and was based on the China Base Rate multiplied by 1.05, or 4.99% on October 31, 2019. The purpose of the credit facility is to provide short-term borrowings. The Company could borrow up to approximately RMB 60.0 million or $8.5 million based on the currency exchange rate between the RMB and the U.S. Dollar on October 31, 2019. In September 2021, this line of credit was renewed with maximum borrowings up to RMB 140.0 million with the same terms and a maturity date of September 18, 2022. During the three months ended December 31, 2021, the Company borrowed RMB 11.0 million, or $1.6 million, at an interest rate of 3.85% per annum, with principal due on November 18, 2022. As of June 30, 2022, there was $1.6 million outstanding balance under the loan.

On November 16, 2018, the Company's subsidiary in China entered into a line of credit facility with Industrial and Commercial Bank of China. The purpose of the credit facility was to provide short-term borrowings. The Company could borrow up to approximately RMB 72.0 million or $10.3 million based on currency exchange rate between RMB and U.S. Dollar on November 16, 2018. The RMB 72.0 million consists of RMB 27.0 million for trade borrowings with a maturity date of December 31, 2021, and RMB 45.0 million for working capital borrowings or trade borrowings with a maturity date of September 13, 2022. During the three months ended December 31, 2021, the Company borrowed RMB 5.0 million, or $0.8 million, at an interest rate of 3.7% per annum, with principal due on September 12, 2022. As of June 30, 2022, the total outstanding balance of this loan was $0.5 million.

Accounts Receivable Factoring Agreement

On August 9, 2019, one of the Company's wholly-owned subsidiaries (the "Borrower") entered into a factoring agreement with the Hongkong and Shanghai Banking Corporation Limited (“HSBC”), whereby the Borrower assigns certain of its accounts receivable with recourse. This factoring agreement allows the Borrower to borrow up to 70% of the net amount of its eligible accounts receivable of the Borrower with a maximum amount of $30.0 million. The interest rate is based on one month London Interbank Offered Rate ("LIBOR") plus 1.75% per annum. The Company is the guarantor for this agreement. The Company is accounting for this transaction as a secured borrowing under the Transfers and Servicing of Financial Assets guidance. In addition, any cash held in the restricted bank account controlled by HSBC has a legal right of offset against the borrowing. This agreement, with certain financial covenants required, has no expiration date. On August 11, 2021, the Borrower signed an agreement with HSBC to decrease the borrowing maximum amount to $8.0 million with certain financial covenants required. Other terms remain the same. The Borrower was in compliance with these covenants as of June 30, 2022. As of June 30, 2022, there was no outstanding balance and the Company had unused credit of approximately $8.0 million.



96


Debt financing

In September 2021, Jireh Semiconductor Incorporated (“Jireh”) entered into a financing arrangement agreement with a company (“Lender”) for the lease and purchase of a machinery equipment manufactured by a supplier. The total purchase price of this machinery equipment was euro 12.0 million, or $12.8 million based on the currency exchange rate between the euro and U.S. Dollar on June 30, 2022. In April 2021, Jireh made a down payment of euro 6.0 million, representing 50% of the total purchase price of the equipment, to the supplier. In June 2022, the equipment was delivered to Jireh after Lender paid 40% of the total purchase price, for euro 4.8 million, to the supplier on behalf of Jireh. Based on the terms of the agreement between Jireh and Lender, after the installation and configuration of the equipment for its intended use, Lender will make the remaining 10% payment for the total purchase price and reimburse Jireh for the down payment made to the supplier. By that time, the title of the equipment will be transferred to Lendor. This agreement has a 5 years term, after which Jireh has the option to purchase the equipment for $1. Jireh is required to make a monthly payment of interest at an implied interest rate of 4.75% per annum to Lessor. Principal payment is required to be paid monthly after the completion of the title transfer. The financing arrangement is secured by this machneray equipment which had the carrying amount of $12.8 million as of June 30, 2022. As of June 30, 2022, the outstanding balance of this debt financing was $5.0 million.

Long-term bank borrowings

On August 18, 2021, Jireh entered into a term loan agreement with a financial institution (the "Bank") in an amount up to $45.0 million for the purpose of expanding and upgrading the Company’s fabrication facility located in Oregon. The obligation under the loan agreement is secured by substantially all assets of Jireh and guaranteed by the Company. The agreement has a 5.5 years term and matures on February 16, 2027. Jireh is required to make consecutive quarterly payments of principal and interest. The loan accrues interest based on adjusted LIBOR plus the applicable margin based on the outstanding balance of the loan. This agreement contains customary restrictive covenants and includes certain financial covenants that the Company is required to maintain. Jireh drew down $45.0 million on February 16, 2022. As of June 30, 2022, Jireh was in compliance with these covenants and the outstanding balance of this loan was $45.0 million.

On May 1, 2018, Jireh entered into a loan agreement with the Bank that provided a term loan in an amount of $17.8 million. The obligation under the loan agreement is secured by certain real estate assets of Jireh and guaranteed by the Company.  The loan has a five-year term and matures on June 1, 2023. Beginning June 1, 2018, Jireh made consecutive monthly payments of principal and interest to the Bank. The outstanding principal shall accrue interest at a fixed rate of 5.04% per annum on the basis of a 360-day year. The loan agreement contains customary restrictive covenants and includes certain financial covenants that require the Company to maintain, on a consolidated basis, specified financial ratios. In August 2021, Jireh signed an amendment of this loan with the Bank to modify the financial covenants requirement to align with the new term loan agreement entered into on August 18, 2021 discussed above. The amendment was accounted for as a debt modification and no gain or loss was recognized. The Company was in compliance with these covenants as of June 30, 2022. As of June 30, 2022, the outstanding balance of the term loan was $14.2 million.

On August 15, 2017, Jireh entered into a credit agreement with the Bank that provided a term loan in an amount up to $30.0 million for the purpose of purchasing certain equipment for the fabrication facility located in Oregon.  The obligation under the credit agreement is secured by substantially all assets of Jireh and guaranteed by the Company.  The credit agreement has a five-year term and matures on August 15, 2022. In January 2018 and July 2018, Jireh drew down on the loan in the amount of $13.2 million and $16.7 million, respectively.  Beginning in October 2018, Jireh is required to pay to the Bank on each payment date, the outstanding principal amount of the loan in monthly installments.  The loan accrues interest based on an adjusted London Interbank Offered Rate ("LIBOR") as defined in the credit agreement, plus specified applicable margin in the range of 1.75% to 2.25%, based on the outstanding balance of the loan.  The credit agreement contains customary restrictive covenants and includes certain financial covenants that require the Company to maintain, on a consolidated basis, specified financial ratios and fixed charge coverage ratio. In August 2021, Jireh signed an amendment of this loan with the Bank to modify the financial covenants requirement to align with the new term loan agreement entered into on August 18, 2021, discussed above. The amendment was accounted for as a debt modification and no gain or loss was recognized. The Company was in compliance with these covenants as of June 30, 2022. As of June 30, 2022, the outstanding balance of the term loan was $1.9 million.










97




At June 30, 2022, maturities of short-term debt and long-term debt were as follows (in thousands):

Year ending June 30,
2023$25,638 
20249,952 
20259,999 
202610,047 
202712,348 
Thereafter234 
Total principal of debt68,218 
Less: debt issuance costs(169)
Total principal of debt, less debt issuance costs$68,049 

Short-term DebtLong-term DebtTotal
Principal amount$25,638 $42,580 $68,218 
Less: debt issuance costs(75)(94)(169)
Total debt, less debt issuance costs$25,563 $42,486 $68,049 

98




8. Leases

The Company evaluates contracts for lease accounting at contract inception and assesses lease classification at the lease commencement date. Operating leases are included in operating lease right-of-use ("ROU") assets, operating lease liabilities and operating lease liabilities - long-term on the Company's consolidated balance sheets. Finance leases are included in property, plant and equipment, finance lease liabilities and finance lease liabilities-long-term on the consolidated balance sheets. The Company recognizes a ROU asset and corresponding lease obligation liability at the lease commencement date where the lease obligation liability is measured at the present value of the minimum lease payments. As most of the leases do not provide an implicit rate, the Company uses its incremental borrowing rate at lease commencement. The Company uses an interest rate commensurate with the interest rate to borrow on a collateralized basis over a similar term with an amount equal to the lease payments. Operating leases are primarily related to offices, research and development facilities, sales and marketing facilities, and manufacturing facilities. In addition, long-term supply agreements to lease gas tank equipment and purchase industrial gases are accounted for as operating leases. Lease agreements frequently include renewal provisions and require the Company to pay real estate taxes, insurance and maintenance costs. For operating leases, the amortization of the ROU asset and the accretion of its lease obligation liability result in a single straight-line expense recognized over the lease term. The finance lease is related to the machinery lease financing with a vendor. In addition, the finance lease related to the RMB 400.0 million of lease financing of the JV Company with YinHai Leasing Company and The Export-Import Bank of China was not included in the Company’s Consolidated Balance Sheet at June 30, 2022 due to the deconsolidation of the JV Company on December 2, 2021. The Company does not record leases on the consolidated balance sheet with a term of one year or less.
The components of the Company’s operating and finance lease expenses are as follows for the years presented (in thousands):

Fiscal Year Ended June 30, 2022Fiscal Year Ended June 30, 2021
Operating leases:
     Fixed rent expense$6,262 $6,760 
     Variable rent expense946 815 
Finance lease:
     Amortization of equipment908 2,200 
     Interest976 2,168 
Short-term leases:
     Short-term lease expenses205 221 
               Total lease expenses$9,297 $12,164 

99


Supplemental balance sheet information related to the Company’s operating and finance leases is as follows (in thousands, except lease term and discount rate):

June 30, 2022June 30, 2021
Operating Leases:
     ROU assets associated with operating leases$23,674 $34,660 
Finance Lease:
     Property, plant and equipment, gross$4,831 $114,404 
     Accumulated depreciation(136)(96,470)
          Property, plant and equipment, net$4,695 $17,934 
Weighted average remaining lease term (in years)
     Operating leases7.428.44
     Finance lease5.001.72
Weighted average discount rate
     Operating leases4.27 %4.67 %
     Finance lease4.76 %5.46 %

Supplemental cash flow information related to the Company’s operating and finance lease is as follows (in thousands):

Fiscal Year Ended June 30, 2022Fiscal Year Ended June 30, 2021
Cash paid from amounts included in the measurement of lease liabilities:
     Operating cash flows from operating leases$6,480 $6,496 
     Operating cash flows from finance lease$976 $2,168 
     Financing cash flows from finance lease$4,176 $16,451 
Non-cash investing and financing information:
     Operating lease right-of-use assets obtained in exchange for lease obligations$5,852 $5,585 

Future minimum lease payments are as follows as of June 30, 2022 (in thousands):

Operating LeasesFinance Leases
2023$5,206 $993 
20244,053 1,083 
20253,222 1,083 
20263,176 1,083 
20273,147 1,076 
Thereafter10,337  
Total minimum lease payments29,141 5,318 
Less amount representing interest(4,413)(584)
Total lease liabilities$24,728 $4,734 

100



9. Shareholders' Equity
Common Shares

The Company's Bye-laws, as amended, authorized the Company to issue 100,000,000 common shares with par value of $0.002. Each common share is entitled to one vote. The holders of common shares are also entitled to receive dividends whenever funds are legally available and when and if declared by the board of directors. No dividends had been declared as of June 30, 2022

In September 2017, the board of directors approved a repurchase program (the “Repurchase Program”) that allowed the Company to repurchase its common shares from the open market pursuant to a pre-established Rule 10b5-1 trading plan or through privately negotiated transactions up to an aggregate of $30.0 million. The amount and timing of any repurchases under the Repurchase Program depend on a number of factors, including but not limited to, the trading price, volume and availability of the Company's common shares. Shares repurchased under this program are accounted for as treasury shares and the total cost of shares repurchased is recorded as a reduction of shareholders' equity. From time to time, treasury shares may be reissued as part of the Company's stock-based compensation programs. Gains on re-issuance of treasury stock are credited to additional paid-in capital; losses are charged to additional paid-in capital to offset the net gains, if any, from previous sales or re-issuance of treasury stock. Any remaining balance of the losses is charged to retained earnings.
During fiscal year 2022, 2021 and 2020, the Company did not repurchase any shares pursuant to the repurchase program.
As of June 30, 2022, the Company had repurchased an aggregate of 6,784,648 shares for a total cost of $67.3 million, at an average price of $9.92 per share, excluding fees and related expenses, since inception of the program. No repurchased shares have been retired. Of the 6,784,648 repurchased shares, 167,395 shares with a weighted average repurchase price of $10.06 per share, were reissued at an average price of $5.00 per share for option exercises and vested restricted stock units (“RSU”). As of June 30, 2022, $13.4 million remain available under the share repurchase program.

101



10. Share-based Compensation
2018 Omnibus Incentive Plan
The 2009 Share Option/Share Issuance Plan (the “2009 Plan”) was approved in September 2009 at the annual general meeting of shareholders in connection with the Company's IPO. At the annual general meeting of shareholders in November 2018, the 2009 Plan was approved to be terminated and the 2018 Omnibus Incentive Plan (the “2018 Plan”) was effective. No further awards will be made under the 2009 Plan. The 2018 Plan authorized the board of directors to grant incentive share options, non-statutory share options and restricted shares to employees, directors, non-employee directors and consultants of the Company and its subsidiaries for up to 2,065,000 common shares. The 2018 Plan does not include an evergreen authorization Therefore, the Company is not permitted to increase the number of shares reserved in the share pool without obtaining further shareholder approval. Outstanding shares under the 2018 Plan and awards granted under the 2009 Plan that expire, are forfeited or cancelled or terminate prior to the issuance of the shares subject to those awards or are settled in cash will be available for subsequent issuance under the 2018 Plan. At the annual general meeting of shareholders in November 2021, the 2018 Plan was approved to increase by 1,000,000 shares to a total of 3,065,000 shares. As of June 30, 2022, 537,260 shares were available for grant under the 2018 Plan.
Beginning with the 2014 Annual Shareholders Meeting, on the date of each annual shareholders meeting, each individual who commences service as a non-employee Board member by reason of his or her election to the Board at such annual meeting and each individual who is to continue to serve as a non-employee Board member, whether or not that individual is standing for re-election to the Board at that particular annual meeting, will automatically be granted an award in the form of restricted share units covering that number of common shares determined by dividing one hundred twenty-five thousand dollars ($125,000) by the average fair market value per share for the ninety (90)-day period preceding the grant date, up to a maximum of 10,000 shares.

Under the 2018 Plan, incentive share options and RSU are to be granted at a price that is not less than 100% and nonstatutory share options are to be granted at not less than 85% of the fair value of the common shares, at the date of grant for employees and consultants. Options and RSUs generally vest over a four-year to five-year period, and are exercisable for a maximum period of ten years after the date of grant.
The fair value of RSU, including time-based restricted stock units and performance-based restricted stock units is based on the market price of the Company's share on the date of grant.

Time-based Restricted Stock Units (“TRSU”)

The following table summarizes the Company's TRSU activities:
 
 Number of Restricted Stock
Units
Weighted Average
Grant Date Fair
Value Per Share
Weighted Average
Remaining
Recognition
Period (Years)
Aggregate Intrinsic Value
Nonvested at June 30, 2019906,341 $14.09 1.62$8,465,225 
Granted505,440 $8.51 
Vested(455,893)$13.53 
Forfeited(23,750)$13.19 
Nonvested at June 30, 2020932,138 $11.36 1.66$10,141,661 
Granted722,873 $29.85 
Vested(567,087)$15.70 
Forfeited(34,400)$14.88 
Nonvested at June 30, 20211,053,524 $21.60 1.73$32,016,594 
Granted597,381 $45.83 
Vested(410,670)$20.54 
Forfeited(70,626)$26.79 
Nonvested at June 30, 20221,169,609 $34.03 1.73$38,994,764 
102




Performance-based Restricted Stock Units (“PRSU”)

In March each year since fiscal year 2017, the Company granted PRSU to certain personnel. The number of shares to be ultimately earned under the PRSU is determined based on the level of attainment of predetermined financial goals. The PRSU vests in four equal annual installments from the first anniversary date after the grant date if certain predetermined financial goals were met. The Company recorded $4.6 million, $2.3 million and $1.5 million of expenses for these PRSUs during the years ended June 30, 2022, 2021 and 2020, respectively.

During the quarter ended June 30, 2019, the Company announced an incentive program. Under this program, each participant’s award is denominated in stock and subject to achievement of certain objective goals within certain timelines. In June 2020, the Company believed it was most likely that predetermined goal measures would be met. Therefore, the Company reported such expenses in the other current liabilities line on the condensed consolidated balance sheets as the amount of bonus is to be settled in variable number of RSU’s at the completion of the objective goals. Such non-cash compensation expense was recorded as part of share-based compensation expense in the condensed consolidated statements of operations. As of June 30, 2022 and 2021, the Company recorded nil and $0.1 million such expenses in the other current liabilities, respectively. During the fiscal years ended June 30, 2022, 2021 and 2020, the Company recorded $0.3 million, $3.1 million and $0.6 million of non-cash compensation expense, respectively. As of June 30, 2022, the Company granted RSUs valued at $4.0 million to participants, which were fully vested due to achievement of certain objective measures.

The following table summarizes the Company’s PRSU activities:
Number of Performance-based Restricted Stock
Units
Weighted Average
Grant Date Fair
Value Per Share
Weighted Average
Remaining
Recognition
Period (Years)
Aggregate Intrinsic Value
Nonvested at June 30, 2019596,724 $13.95 1.88$5,573,402 
Granted155,000 $7.36 
Vested(110,659)$16.68 
Forfeited(298,290)$11.32 
Nonvested at June 30, 2020342,775 $12.38 1.60$3,729,392 
Granted165,500 $36.27 
Vested(148,211)$14.24 
Forfeited(6,240)$17.23 
Nonvested at June 30, 2021353,824 $22.69 1.74$10,752,711 
Granted194,000 $48.65 
Vested(151,199)$19.44 
Forfeited(7,250)$40.33 
Nonvested at June 30, 2022389,375 $36.56 1.85$12,981,763 

Market-based Restricted Stock Units (“MSUs”)

In December 2021, the Company granted 1.0 million market-based restricted stock units (“MSUs”) to its certain personnel. The number of shares to be earned at the end of performance period is determined based on the Company’s achievement of specified stock prices and revenue thresholds during the performance period from January 1, 2022 to December 31, 2024 as well as the recipients remaining in continuous service with the Company through such period. The MSU vests in four equal annual installments after the end of performance period. The Company estimated the grant date fair values of its MSU with derived service periods of 4.1 to 7.1 years using a Monte-Carlo simulation model with the following assumptions: Risk-free interest rate of 1.0%, expected term of 3.1 years, expected volatility of 62.8% and dividend yield of 0%. The Company recorded approximately $4.5 million expenses for these MSUs during the fiscal year ended June 30, 2022.

During the quarter ended September 30, 2018, the Company granted 1.3 million market-based restricted stock units (“MSUs”) to certain personnel. The number of shares to be earned at the end of the performance period is determined based on the Company’s achievement of specified stock prices and revenue thresholds during the performance period from January 1, 2019 to December 31, 2021 as well as the recipients remaining in continuous service with the Company through such period.
103


The MSUs vest in four equal annual installments after the end of performance period. On August 31, 2020, the Compensation Committee of the Board approved a modification of the terms of MSU to (i) extend the performance period through December 31, 2022 and (ii) change the commencement date for the four-year time-based service period to January 1, 2023. The modified MSUs were valued immediately before and after the modification, using Morte Carlo simulation pricing model. The Morte Carlo simulation pricing model applied the following assumptions for pre-modification conditions: risk-free interest rate of 0.13%, expected term of 1.3 years, expected volatility of 66.7% and dividend yield of 0%; and for post-modification conditions: risk-free interest rate of 0.14%, expected term of 2.3 years, expected volatility of 59.1% and dividend yield of 0%. The fair value of these MSUs was recalculated to reflect the change as of August 31, 2020 and the unrecognized compensation amount was adjusted to reflect the increase in fair value. The Company recorded approximately $1.6 million, $1.2 million and $0.6 million of expense for these MSUs during the years ended June 30, 2022, 2021 and 2020, respectively.
Stock Option
The following table summarizes the Company's stock option activities:
Weighted
WeightedAverage
AverageRemaining
Number ofExercise PriceContractual Aggregate
SharesPer ShareTerm (in years)Intrinsic Value
Outstanding at June 30, 2019876,478 $10.98 3.06
Granted $ 
Exercised(2,500)$10.50 $4,726 
Canceled or forfeited(230,000)$17.11 
Outstanding at June 30, 2020643,978 $8.79 2.89
Granted $ 
Exercised(156,103)$11.31 $1,272,291 
Canceled or forfeited $ 
Outstanding at June 30, 2021487,875 $7.99 2.32
Granted $ 
Exercised(98,000)$9.15 $3,936,675 
Canceled or forfeited $ 
Outstanding at June 30, 2022389,875 $7.70 1.53$9,997,364 
Options vested and expected to vest389,875 $7.70 1.53$9,997,364 
Exercisable at June 30, 2022389,875 $7.70 1.53$9,997,364 

The aggregate intrinsic value for options outstanding at June 30, 2022 in the table above is based on the Company’s common stock closing price on June 30, 2022.
The 2018 Employee Share Purchase Plan
At the annual general meeting of shareholders in November 2018, the 2018 Employee Share Purchase Plan (“Purchase Plan” or “ESPP”) Plan was approved, under which 1,430,000 common shares are available for issuance. The Purchase Plan does not include an evergreen authorization, therefore the Company is not permitted to increase the number of shares reserved in the share pool without obtaining further shareholder approval. At the general meeting of shareholders in November 2021, the ESPP Plan was approved to increase from 1,430,000 shares to 2,500,000 shares. The Purchase Plan provided for a series of overlapping offering periods with a duration of 24 months, generally beginning on May 15 and November 15 of each year. The Purchase Plan allows employees to purchase common shares through payroll deductions of up to 15% of their eligible compensation. Such deductions will accumulate over a six-month accumulation period without interest. After such accumulation period, common shares will be purchased at a price equal to 85% of the fair market value per share on either the first day of the offering period or the last date of the accumulation period, whichever is less. The maximum number of shares that may be purchased by a participant on any purchase date may not exceed 875 shares for a total of 3,500 shares per a 24-
104


month offering period. In addition, no participant may purchase more than $25,000 worth of common stock in any one calendar year period. No more than 300,000 common shares may be purchased by all participants on any purchase date.
The ESPP is compensatory and results in compensation expense. The fair values of common shares to be issued under the ESPP were determined using the Black-Scholes option pricing model with the following assumptions:
Year Ended June 30,
202220212020
Volatility rate
66.4% - 69.9%
63.1% - 68.5%
46.4% - 58.3%
Risk-free interest rate
0.3% - 2.1%
0.1% - 0.2%
0.2% - 1.6%
Expected term1.3 years1.3 years1.3 years
Dividend yield%%%

The weighted-average estimated fair value of employee stock purchase rights granted pursuant to the ESPP during the years ended June 30, 2022, 2021 and 2020 was $16.48, $11.11 and $4.33 per share, respectively.
Share-based Compensation Expenses
The total share-based compensation expense related to TRSU, PSUs, MSUs, stock options and ESPP described above, recognized in the consolidated statements of operations for the years presented was as follows:
Year Ended June 30,
202220212020
(in thousands)
Cost of goods sold$5,125 $1,756 $1,530 
Research and development7,049 5,352 2,895 
Selling, general and administrative19,150 8,216 6,029 
$31,324 $15,324 $10,454 
Total unrecognized share-based compensation expense as of June 30, 2022 was $84.3 million including estimated forfeitures, which is expected to be recognized over a weighted-average period of 3.2 years.


11. Employee Benefit Plans
The Company maintains a 401(k) retirement plan for the benefit of qualified employees in the U.S. Employees who participate may elect to make salary deferral contributions to the plan up to 100% of the employees' eligible salary subject to annual Internal Revenue Code maximum limitations. The employer's contribution is discretionary. Effective from April 1, 2022, the Company begins to match 50% of employee contribution up to 4% of eligible compensation for a 2% maximum match. During the fiscal year ended June 30, 2022, the Company made employer match contributions of $0.3 million.
The Company makes mandatory contributions for its employees to the respective local governments in terms of retirement, medical insurance and unemployment insurance, where applicable, according to labor and social security laws and regulations of the countries and areas in which the Company operates. The retirement contribution rate is 7.7% in the U.S., 14.0% to 16.0% in China, and 6.0% in Taiwan. The Company has no obligations for the payment of such social benefits beyond the required contributions as set out above.

105


12. Income Taxes
    The provision for income taxes is comprised of:
Year Ended June 30, 
202220212020
(in thousands)
U.S. federal taxes:
Current$645 $31 $(1,673)
Deferred2,260 1,955 22 
Non-U.S. taxes:
Current7,749 2,344 1,940 
Deferred28,599 (396)58 
State taxes, net of federal benefit:
Current5 1 1 
Total provision for income taxes$39,258 $3,935 $348 
The reconciliation of the federal statutory income tax rate to our effective income tax rate is as follows (in percentage):

 Year Ended June 30,
 202220212020
United States statutory rate21.0 %21.0 %21.0 %
Stock-based compensation0.0 0.1  
Foreign taxes, net(14.3)(14.4)(36.1)
Outside basis difference on equity method investment1.2   
Research and development credit(0.3)(2.4)8.0 
Non-deductible expenses0.5 2.4 (1.0)
U.S. Tax Act deferred tax re-measurement  6.2 
Foreign Derived Intangible Income Deduction(0.3)  
Other0.1 (0.2) 
 7.9 %6.5 %(1.9)%
    The domestic and foreign components of income before taxes are:
 Year Ended June 30, 
 202220212020
(in thousands)
U.S. operations$16,684 $9,622 $3,549 
Non-U.S. operations478,386 50,602 (21,458)
Loss before income taxes$495,070 $60,224 $(17,909)
106


    Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of our deferred tax assets and liabilities are as follows:
 June 30, 
 20222021
(in thousands)
Deferred tax assets:
Accrued compensation$5,742 $3,954 
Net operating loss carryforwards61 22,539 
Depreciation4,365 7,924 
Tax credits15,079 15,550 
Operating lease liabilities5,807 7,292 
Capitalized intangible assets 9,982 
Accruals and reserves643 1,113 
Total deferred tax assets31,697 68,354 
Valuation allowance(5,755)(41,474)
Total deferred tax assets, net of valuation allowance25,942 26,880 
Deferred tax liabilities:
Depreciation and amortization(18,909)(17,193)
Right of use assets(5,579)(6,968)
Investments(29,619) 
Total deferred tax liabilities(54,107)(24,161)
Net deferred tax assets/(liabilities)
$(28,165)$2,719 
The breakdown between deferred tax assets and liabilities is as follows:
 June 30, 
 20222021
(in thousands)
Long-term deferred tax assets$592 $5,167 
Long-term deferred tax liabilities(28,757)(2,448)
Net deferred tax assets/(liabilities)$(28,165)$2,719 

The Company’s valuation allowance related to deferred income taxes as reflected in the consolidated balance sheets was $5.8 million and $41.5 million as of June 30, 2022 and 2021, respectively. The change in valuation allowance for June 30, 2022 and 2021 was a decrease of $35.7 million and an increase of $3.6 million, respectively.

At June 30, 2022 and 2021, the Company provided a valuation allowance for its state research and development credit carryforward deferred tax assets of $5.8 million for both years, as it generated more state tax credits each year than it can utilize. The Company intends to maintain a valuation allowance equal to the state research and development credit carryforwards in excess of the state net deferred tax liabilities on all other state book/tax differences and net operating loss carryforward.

At June 30, 2021, the Company provided a valuation allowance mainly for the net operating loss, fixed asset and intangible asset related to deferred tax assets of the JV Company totaling $35.7 million. The valuation allowance related to the deferred tax assets of the JV Company was reduced to $0 at June 30, 2022 as a result of the deconsolidation of the JV Company in December 2021.

At June 30, 2022, the Company had federal research and development tax credit carryforwards of approximately $8.9 million. The federal tax credits begin to expire in 2030, if not utilized.  At June 30, 2022, the Company had $0.9 million of state net operating loss carryforwards and had tax credit carryforwards of approximately $7.8 million. Approximately $0.2
107


million of the state tax credits begin to expire in 2023, if not utilized. The remaining $7.6 million of the state tax credits carryforward indefinitely.

The Company has not provided for withholding taxes on the undistributed earnings of its foreign subsidiaries because it intends to reinvest such earnings indefinitely. However, we have recorded a deferred tax liability of $29.6 million at June 30, 2022 related to our investment in the JV Company. As of June 30, 2022, the cumulative amount of undistributed earnings of its foreign entities considered permanently reinvested is $314.7 million. The determination of the unrecognized deferred tax liability on these earnings is not practicable. Should the Company decide to remit this income to its Bermuda parent company in a future period, its provision for income taxes may increase materially in that period.
A reconciliation of the beginning and ending amount of unrecognized tax benefits from July 1, 2019 to June 30, 2022 is as follows:
 Year Ended June 30, 
 202220212020
(in thousands)
Balance at beginning of year$7,645 $7,126 $7,150 
Additions based on tax positions related to the current year1,121 677 333 
Reductions based on tax positions related to prior years(40)(41)(114)
Reductions due to lapse of applicable statute of limitations(117)(117)(243)
Balance at end of year$8,609 $7,645 $7,126 
At June 30, 2022, the total unrecognized tax benefits of $8.6 million included $6.6 million of unrecognized tax benefits that have been netted against the related deferred tax assets. The remaining $2.0 million of unrecognized tax benefits was recorded within long-term income tax payable on the Company's consolidated balance sheet as of June 30, 2022. The Company cannot reasonably estimate the timing and amount of potential cash settlements on the unrecognized tax benefits.
The total unrecognized tax benefits of $8.6 million at June 30, 2022 included $5.6 million that, if recognized, would reduce the effective income tax rate in future periods. It is reasonably possible that the Company will recognize approximately $0.01 million reduction to its uncertain tax positions during the next twelve months, related to potential expiration of the relevant statute of limitations.
The Company recognizes interest and penalties related to uncertain tax positions in income tax expense. To the extent accrued interest and penalties do not ultimately become payable, amounts accrued will be reduced and reflected as a reduction of the overall income tax provision in the period that such determination is made. The amount of interest and penalties accrued at June 30, 2022 was $0.2 million, of which $32 thousand was recognized in the year ended June 30, 2022. The amount of interest and penalties accrued at June 30, 2021 was $0.1 million, of which $5 thousand was recognized in the year ended June 30, 2021.
The Company files its income tax returns in the United States and in various foreign jurisdictions. The tax years 2001 to 2022 remain open to examination by U.S. federal and state tax authorities. The tax years 2014 to 2022 remain open to examination by foreign tax authorities.

The Company's income tax returns are subject to examinations by the Internal Revenue Service and other tax authorities in various jurisdictions. In accordance with the guidance on the accounting for uncertainty in income taxes, the Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of its provision for income taxes. These assessments can require considerable estimates and judgments. If the Company's estimate of income tax liabilities proves to be less than the ultimate assessment, then a further charge to expense would be required. If events occur and the payment of these amounts ultimately proves to be unnecessary, the reversal of the liabilities would result in tax benefits being recognized in the period when the Company determines the liabilities are no longer necessary.

U.S. Tax Cuts and Jobs Act, Enacted December 22, 2017

On December 22, 2017, the United States enacted tax legislation commonly known as the Tax Cuts and Jobs Act (“the Tax Act”), which significantly changed the existing U.S. tax laws, including, but not limited to, (1) a reduction in the corporate tax rate from 35% to 21%, (2) a move from a worldwide tax system toward a territorial system through a “participation exemption” deduction for certain foreign-source dividends, (3) eliminating the corporate alternative minimum tax (AMT) and changing how existing AMT credits can be realized, (4) bonus depreciation that allows for full expensing of qualified property,
108


(5) creating a new limitation on deductible interest expense and (6) changing rules related to uses and limitations of net operating loss carryforwards created in tax years beginning after December 31, 2017.

The Company is not currently subject to the Base Erosion and Anti-Abuse (BEAT) tax, which is a tax imposed on certain entities who make payments to their non U.S. affiliates, where such payments reduce the U.S. tax base. The BEAT tax is imposed at a rate of 10% on Adjusted Taxable Income, excluding certain payments to foreign related entities. It is an incremental tax over and above the corporate income tax and is recorded as a period cost. It is possible that this tax could be applicable in future periods, which would cause an increase to the effective tax rate and cash taxes.

U.S. Coronavirus Aid, Relief and Economic Security Act” (“CARES Act”), Enacted March 27, 2020

On March 27, 2020, the United States enacted the CARES Act, which made the changes to existing U.S. tax laws, including, but not limited to, (1) allowing U.S. federal net operating losses originated in the 2018, 2019 or 2020 tax years to be carried back five years to recover taxes paid based upon taxable income in the prior five years, (2) eliminated the 80% of taxable income limitation on net operating losses for the 2018, 2019 and 2020 tax years (the 80% limitation will be reinstated for tax years after 2020), (3) accelerating the refund of prior year alternative minimum tax credits, (4) modifying the bonus depreciation for qualified improvement property and (5) modifying the limitation on deductible interest expense.

As a result of the ability to carryback net operating losses from the June 2018 and June 2019 years to the June 2015 to June 2017 tax years, net operating losses which were previously tax-effected using the current 21% U.S. federal tax rate were revalued to the U.S. tax rates in effect for the June 2015 to June 2017 tax years due to the ability of receiving tax refunds for the taxes paid in these years. Accordingly, we reported a discrete tax benefit of $1.1 million in the third quarter of fiscal year 2020 related to the re-measurement of the net operating losses that could be realized via the new net operating loss carryback provisions.

“U.S. Consolidated Appropriations Act, 2021” (“CAA 2021”), Enacted December 27, 2020

On December 27, 2020, the United States enacted the Consolidated Appropriations Act, 2021, which made changes to existing U.S. tax laws. There was no material impact of the tax law changes included in the Consolidated Appropriations Act, 2021 to the Company.

“The American Rescue Plan Act of, 2021”, Enacted March 11, 2021

On March 11, 2021, the United States enacted the American Rescue Plan Act of 2021, which made changes to existing U.S. tax laws. There was no material impact of the tax law changes included in the American Rescue Plan Act of 2021 to the Company.

“The Chip and Science Act of 2022”, Enacted August 2, 2022
In August 2022 the U.S. enacted the Chip and Science Act of 2022 (the Chips Act). The Chips Act provides incentives to semiconductor chip manufacturers in the United States, including providing a 25% manufacturing investment credits for investments in semiconductor manufacturing property placed in service after December 31, 2022, for which construction begins before January 1, 2027. Property investments qualify for the 25% credit if, among other requirements, the property is integral to the operation of an advanced manufacturing facility, defined as having a primary purpose of manufacturing semiconductors or semiconductor manufacturing equipment. Currently, we are evaluating the impact of the Chips Act to us.

Altera Litigation

On July 27, 2015, in Altera Corp. v. Commissioner, the U.S. Tax Court issued an opinion related to the treatment of stock-based compensation expense in an intercompany cost-sharing arrangement. In the July 2015 ruling, the Tax Court concluded that the sharing of the cost of employee stock compensation in a company’s cost-sharing arrangement was invalid under the U.S. Administrative Procedures Act. In June 2019, a panel of the Ninth Circuit of the U.S. Court of Appeals reversed this decision. In July 2019, Altera petitioned U.S. Court of Appeals for the Ninth Circuit to hold an en banc rehearing of the case. The petition was subsequently denied by the Ninth Circuit. Altera appealed the case to the U.S. Supreme Court in February 2020, but the U.S. Supreme Court declined to hear the case in June 2020, leaving intact the U.S. Court of Appeals for the Ninth Circuit’s decision. AOS has not recorded any benefit related to the Altera Corporation Tax Court decision in any period through June 2022. The Company will continue to monitor ongoing developments and potential impact to its financial statements.
109

13. Segment and Geographic Information
The Company is organized as, and operates in, one operating segment: the design, development and supply of power semiconductor products for computing, consumer electronics, communication and industrial applications. The chief operating decision-maker is the Chief Executive Officer. The financial information presented to the Company's Chief Executive Officer is on a consolidated basis, accompanied by information about revenue by customer and geographic region, for purposes of evaluating financial performance and allocating resources. The Company has one business segment, and there are no segment managers who are held accountable for operations, operating results and plans for products or components below the consolidated unit level. Accordingly, the Company reports as a single operating segment.

The Company sells its products primarily to distributors in the Asia Pacific region, who in turn sell these products to end customers. Because the Company's distributors sell their products to end customers which may have a global presence, revenue by geographical location is not necessarily representative of the geographical distribution of sales to end user markets.
The revenue by geographical location in the following tables is based on the country or region in which the products were shipped to: 
 Year Ended June 30, 
 202220212020
(in thousands)
Hong Kong$630,238 $537,553 $390,478 
China120,978 107,325 64,058 
South Korea11,802 5,497 3,303 
United States12,470 5,492 4,465 
Other countries2,064 1,035 2,605 
 $777,552 $656,902 $464,909 
During the fiscal year ended June 30, 2022, the Company corrected an immaterial error to reduce revenues in Hong Kong by $0.5 million, and to increase the revenues in China by $0.5 million for the fiscal year ended June 30, 2021.
The following is a summary of revenue by product type:
 Year Ended June 30, 
 202220212020
 (in thousands)
Power discrete$545,135 $482,718 $391,941 
Power IC220,882 161,726 66,360 
Packaging and testing services11,535 12,458 6,608 
 $777,552 $656,902 $464,909 

Long-lived assets, net consisting of property, plant and equipment and land use rights, net, as well as operating lease right-of-use assets, net by geographical area are as follows:
 June 30,
 20222021
(in thousands)
China$105,326 $350,387 
United States232,731 118,756 
Other countries4,283 2,494 
 $342,340 $471,637 
110

14. Restricted Net Assets
Laws and regulations in China permit payments of dividends by the Company's subsidiaries in China only out of their retained earnings, if any, as determined in accordance with China accounting standards and regulations. Each China subsidiary is also required to set aside at least 10% of its after-tax profit, if any, based on China accounting standards each year to its statutory reserves until the cumulative amount of such reserves reaches 50% of its registered capital. As a result of these China laws and regulations, the Company's China subsidiaries are restricted in their abilities to transfer a portion of their net assets to the Company. As of June 30, 2022 and 2021, such restricted portion amounted to approximately $92.4 million and $209.9 million, or 10.8% and 50.4%, of our total consolidated net assets attributable to the Company, respectively. As the Company's China subsidiaries are not revenue generating operating units, the Company does not expect to repatriate funds in the form of dividends, loans or advances from its China subsidiaries for working capital and other funding purposes.

15. Commitments and Contingencies
Purchase commitments
As of June 30, 2022 and 2021, the Company had approximately $89.9 million and $81.8 million, respectively, of outstanding purchase commitments primarily for purchases of semiconductor raw materials, wafers, spare parts, packaging and testing services and others.
As of June 30, 2022 and 2021, the Company had approximately $63.4 million, and $90.0 million, respectively, of commitments for the purchase of property and equipment.
Other commitments
See Notes 1, 7 and 8 to the Consolidated Financial Statements contained in this annual Report on Form 10-K for descriptions of commitments including Joint Venture, debt and leases.
Contingencies and indemnities

The Company has in the past, and may from time to time in the future, become involved in legal proceedings arising from the normal course of business activities.  The semiconductor industry is characterized by frequent claims and litigation, including claims regarding patent and other intellectual property rights as well as improper hiring practices. Irrespective of the validity of such claims, the Company could incur significant costs in the defense of such claims and suffer adverse effects on its operations.

As previously disclosed, U.S. Department of Justice (“DOJ”) commenced an investigation into the Company’s compliance with export control regulations relating to its business transactions with Huawei and its affiliates (“Huawei”), which were added to the “Entity List” by the Department of Commerce (“DOC”) in May 2019. The Company is cooperating fully with federal authorities in the investigation. The Company has continued to respond to inquiries and requests from DOJ for documents and information relating to the investigation, and the matter is currently pending at DOJ, and DOJ has not provided the Company with any specific timeline or indication as to when the investigation will be concluded or resolved. In connection with this investigation, DOC previously requested the Company to suspend shipments of its products to Huawei. The Company complied with such request, and the Company has not shipped any product to Huawei after December 31, 2019. The Company continues to work with DOC to resolve this issue and requested DOC to grant permission to reinstate the Company’s shipments to Huawei. As part of this process and in response to DOC’s request, the Company provided certain documents and materials relating to the Company’s supply chain and shipment process to DOC, and DOC is currently reviewing this matter. DOC has not informed the Company of any specific timeline or schedule under which DOC will provide a response to the Company’s request. Given the case is in still ongoing and neither DOJ nor DOC have provided the Company with any clear indication of the timing and schedule for the investigation, the Company cannot estimate the reasonably possible loss or range of loss that may occur. Also, the Company is unable to predict the duration, scope, result or related costs of the investigation, although the Company expects to incur additional professional fees as a result of this matter. In addition, the Company is unable to predict what, if any, further action that may be taken by the government in connection with the investigation, or what, if any, penalties, sanctions or remedial actions may be sought.

The Company is a party to a variety of agreements that it has contracted with various third parties. Pursuant to these agreements, the Company may be obligated to indemnify another party to such an agreement with respect to certain matters. Typically, these obligations arise in the context of contracts entered into by the Company, under which the Company customarily agrees to hold the other party harmless against losses arising from a breach of representations and covenants related to such matters as title to assets sold, certain intellectual property rights, specified environmental matters and certain income taxes. In these circumstances, payment by the Company is customarily conditioned on the other party making a claim pursuant
111


to the procedures specified in the particular contract, which procedures typically allow the Company to challenge the other party's claim. Further, the Company's obligations under these agreements may be limited in time and/or amount, and in some instances, the Company may have recourse against third parties for certain payments made by it under these agreements. The Company has not historically paid or recorded any material indemnifications, and no accrual was made at June 30, 2022 and 2021.

The Company has agreed to indemnify its directors and certain employees as permitted by law and pursuant to its Bye-laws, and has entered into indemnification agreements with its directors and executive officers. The Company has not recorded a liability associated with these indemnification arrangements, as it historically has not incurred any material costs associated with such indemnification obligations. Costs associated with such indemnification obligations may be mitigated by insurance coverage that the Company maintains. However, such insurance may not cover any, or may cover only a portion of, the amounts the Company may be required to pay. In addition, the Company may not be able to maintain such insurance coverage at reasonable cost, if at all, in the future.

Environmental matters

The Company is subject to various federal, state, local, and foreign laws and regulations governing environmental
matters, including the use, handling, discharge, and disposal of hazardous materials. The Company believes that it has been in material compliance with applicable environmental regulations and standards. Complying with current laws and regulations has not had a material adverse effect on the Company’s financial condition and results of operations. However, it is possible that additional environmental issues may arise in the future, which the Company cannot currently predict.


112


16. Cybersecurity Incident

In April 2022, the Company became aware of a cybersecurity incident involving unauthorized access to one email account at the Company, which caused the Company to make payments to unauthorized bank accounts. As a result, the Company recorded a loss of $1.5 million due to the incident for the three months ended March 31, 2022. The financial impact of this incident was not material, and there were no changes to previously released financial results or financial statements. Immediately following the discovery, the Company commenced an investigation, contained the incident and implemented additional protective measures and internal control policies and procedures. The Company has also retained a professional cybersecurity investigation firm to conduct a full forensic analysis of the incident, and concluded that there were no evidence of malware, persistence mechanisms or other compromised exchange on-premises accounts within the Company's environment. In addition, there was no evidence to suggest that these accounts were accessed via the user agent that has the capability to synchronize or download email messages to the user’s local host. This incident appears to be isolated and its financial impact identified to date was not material. The Company believes that it had not incurred other damages and losses based on the conclusion of the full investigation.




113


SCHEDULE II
ALPHA AND OMEGA SEMICONDUCTOR LIMITED
VALUATION AND QUALIFYING ACCOUNTS
(in thousands)

AllowanceAllowance Allowance
for Doubtfulfor Price for Deferred
Accounts AdjustmentsTax Assets
June 30, 2019$30 $24,075 $35,420 
Additions 140,413 2,407 
Reductions (134,396) 
June 30, 2020$30 $30,092 $37,827 
Additions 178,902 3,647 
Reductions (196,579) 
June 30, 2021$30 $12,415 $41,474 
Additions 170,651  
Reductions (164,335)(35,719)
June 30, 2022$30 $18,731 $5,755 


114


(b) Index to Exhibits:
NumberDescription
3.1
3.2
3.3

4.1
10.7††
10.8††
10.9††
10.10††
10.11
10.12††
10.13††
10.14

10.15
10.16††
10.17††
10.18

115


10.19
10.20
10.21(+)
10.22(+)
10.24
10.25(+)
10.27(+)
10.28††

10.29 (+)
10.30††

10.31††

10.32*††


10.33*††
10.34
10.35
10.36
10.37
116


10.38
10.39
10.40
10.41
10.43(+)
10.44(+)
10.45(+)
10.47(+)
10.48(+)
10.49
10.50
10.51
10.52
10.53
10.54*†

21.1*
23.1*
31.1*
31.2*
32.1*
32.2*
99.1*
117


101.INSXBRL Instance
101.SCHXBRL Taxonomy Extension Schema
101.CALXBRL Taxonomy Extension Calculation
101.DEFXBRL Taxonomy Extension Definition
101.LABXBRL Taxonomy Extension Labels
101.PREXBRL Taxonomy Extension Presentation
* Filed with this Annual Report on Form 10-K.
† Certain provisions in this exhibit have been omitted as confidential information.
†† Confidential treatment has been granted for certain information contained in this document pursuant to an order of the Securities and Exchange Commission. Such information has been omitted and filed separately with the Securities and Exchange Commission.
(+) Indicates management contract or compensatory plan or arrangement.



118


SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
September 19, 2022
ALPHA AND OMEGA SEMICONDUCTOR LIMITED
By:/s/ MIKE F. CHANG            
 Mike F. Chang
 Chief Executive Officer
 (Principal Executive Officer)

119


POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Mike F. Chang and Yifan Liang, and each or any one of them, his or her true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this report, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his or her substitutes or substitute, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
 
SignatureTitleDate
/s/    MIKE F. CHANG Chairman of the Board and Chief Executive OfficerSeptember 19, 2022
Mike F. Chang, Ph.D.
(Principal Executive Officer)
/s/    YIFAN LIANG        Chief Financial Officer and Corporate SecretarySeptember 19, 2022
Yifan Liang
(Principal Financial Officer and Principal Accounting Officer)
/s/    LUCAS S. CHANGDirectorSeptember 19, 2022
Lucas S. Chang
/s/    CLAUDIA CHENDirectorSeptember 19, 2022
Claudia Chen
/s/    YUEH-SE HODirectorSeptember 19, 2022
Yueh-Se Ho, Ph.D.
/s/    SO-YEON JEONGDirectorSeptember 19, 2022
So-Yeon Jeong
/s/    HANQING (HELEN) LIDirectorSeptember 19, 2022
Hanqing (Helen) Li
/s/    KING OWYANGDirectorSeptember 19, 2022
King Owyang
/s/    MICHAEL L. PFEIFFERDirectorSeptember 19, 2022
Michael L. Pfeiffer
/s/    MICHAEL J. SALAMEH    DirectorSeptember 19, 2022
Michael J. Salameh

120
EX-10.54 2 ex1054fy2022aoslshareholde.htm EX-10.54 FY 2022 10K Document

Exhibit 10.54

[*] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.

SHAREHOLDERS CONTRACT OF CHONGQING ALPHA AND OMEGA SEMICONDUCTOR LIMITED

Article 1 General Provisions

This Shareholders Contract (this “Contract”) is entered into in Chongqing on July 12, 2022 by and among:

1.1[*], a limited company duly established in [*] under the Laws of China.
1.2Alpha and Omega Semiconductor Limited (“AOS”), a company duly established under the laws of Bermuda.
1.3Alpha & Omega Semiconductor (Shanghai) Ltd. (“AOS Shanghai”), a company duly established in Shanghai under the laws of the People’s Republic of China (“China”).
1.4Agape Package Manufacturing (Shanghai) Limited. (“Agape”, together with AOS and AOS Shanghai collectively referred to as “AOS Parties”), a company duly established in Shanghai under the Laws of China.
1.5[*], a partnership duly established in [*] under the Laws of China.
1.6[*], a limited company duly established in [*] under the Laws of China.
1.7[*], a partnership duly established in [*] under the Laws of China.
1.8[*], a partnership duly established in [*] under the Laws of China.
1.9[*], a partnership duly established in [*] under the Laws of China.
1.10[*], a partnership duly established in [*] under the Laws of China.
1.11[*], a partnership duly established in [*] under the Laws of China.
1.12[*], a partnership duly established in [*] under the Laws of China.
1.13[*], together with [*], [*], [*], [*] and [*] collectively referred to as “Employee Stock Ownership Platform”), a partnership duly established in [*] under the Laws of China.
1.14[*], a partnership duly established in [*] under the Laws of China.
1.15[*], a partnership duly established in [*] under the Laws of China.
1.16[*], a partnership duly established in [*] under the Laws of China.
1.17[*], a partnership duly established in [*] under the Laws of China.
1.18[*], a partnership duly established in [*] under the Laws of China.
1.19[*], a partnership duly established in [*] under the Laws of China.
1


1.20[*], a partnership duly established in [*] under the Laws of China.
1.21Chongqing Alpha and Omega Semiconductor Limited (the “Company”), a company duly established in Chongqing under the Laws of China.

The parties above are hereinafter collectively referred to as the “Parties” or “Shareholders” and individually as one “Party”.

Whereas:

1.AOS, AOS Shanghai, Agape, Chongqing Strategic Emerging Industry Equity Investment Fund Partnership (L.P.) (“Strategic Industry Fund”) and Chongqing Liangjiang New Area Strategic Emerging Services Equity Investment Fund Partnership (L.P.) (“Liangjiang Strategic Fund”, together with Strategic Industry Fund collectively referred to as the “Fund Parties”; AOS Parties and the Fund Parties collectively referred to as the “Original Shareholders”) entered into the Joint Venture Contract for the Establishment of Chongqing Alpha and Omega Semiconductor Limited (the “Joint Venture Company”) (“Joint Venture Contract”) on March 29, 2016, and established the Company on April 22, 2016 based on the Joint Venture Contract;

2.The Original Shareholders have entered into the Supplementary Contract to the Joint Venture Contract for the Establishment of Chongqing Alpha and Omega Semiconductor Limited (the “Joint Venture Company”), the Second Supplementary Contract to the Joint Venture Contract for the Establishment of Chongqing Alpha and Omega Semiconductor Limited (the “Joint Venture Company”) and the Third Supplementary Contract to the Joint Venture Contract for the Establishment of Chongqing Alpha and Omega Semiconductor Limited (the “Joint Venture Company”), and the Original Shareholders and [*] have entered into the Fourth Supplementary Contract to the Joint Venture Contract for the Establishment of Chongqing Alpha and Omega Semiconductor Limited (the “Joint Venture Company”) (all the above Supplementary Contracts hereinafter collectively referred to as “Supplementary Contracts to the Joint Venture Contract”);

3.[*] entered into the Equity Transfer Agreement with AOS Shanghai and Agape on December 1, 2021, under which AOS Shanghai and Agape shall respectively transfer to [*] 1.05263% equity of the Company held by them. The change registration formalities for the equity transfer have been completed with the company registration authority.

4.On December 27, 2021, Liangjiang Strategic Fund and Strategic Industry Fund entered into the Equity Transfer Agreement with [*], under which Liangjiang Strategic Fund and Strategic Industry Fund shall respectively transfer 15.9885% equity of the Company (representing the registered capital contribution of the Company of USD 60,596,254) and 32.7177% equity of the Company (representing the registered capital contribution of the Company of USD 124,000,000) to [*]. After the equity transfer, [*] shall hold 48.7061% equity of the Company (representing the registered capital contribution of the Company of USD 184,596,254);

5.On December 27, 2021, Liangjiang Strategic Fund entered into the Equity Transfer Agreement with [*], under which Liangjiang Strategic Fund shall transfer 0.3704% equity of the Company it holds (representing the registered capital contribution of the Company of USD 1,403,746) to [*]. After the equity transfer, [*] shall hold 0.3704% equity of the Company (representing the registered capital contribution of the Company of USD 1,403,746);

6.On December 24, 2021, AOS Shanghai entered into the Equity Transfer Agreement with [*], under which AOS Shanghai shall transfer 1.1111% equity of the Company it holds (representing the registered capital contribution of the Company of USD 4,211,111) to [*].
2


After the equity transfer, [*] shall hold 1.1111% equity of the Company (representing the registered capital contribution of the Company of USD 4,211,111);

7.The Employee Stock Ownership Platform was established in December 2021, and has subscribed for a total of USD 15,752,900 of the new registered capital of the Company. As of the date of execution of this Shareholders Contract, it holds 3.9906% equity of the Company, and AOS Parties, [*], [*], [*] and [*] have their equity diluted under this capital increase by the Employee Stock Ownership Platform in proportion to their shareholding ratio in the Company.

8.[*], [*], [*], [*], [*], [*], [*] and [*] respectively entered into the Capital Increase Agreement of Chongqing Alpha and Omega Semiconductor Limited (“Capital Increase Agreement”) with the Company in January 2022, and subscribed for the new registered capital of USD [33,488,204.35] of the Company (the “Capital Increase”) at the capital increase price of RMB [509,000,000] (“Capital Increase Price”) according to the terms and conditions stipulated in the Capital Increase Agreement, specifically:

(a)[*] subscribed for USD [4,605,450.50] of the new registered capital at the subscription price of RMB [70,000,000];

(b)[*] subscribed for USD [6,908,175.75] of the new registered capital at the subscription price of RMB [105,000,000];

(c)[*] subscribed for USD [7,829,265.85] of the new registered capital at the subscription price of RMB [119,000,000];

(d)[*] subscribed for USD [5,263,372.00] of the new registered capital at the subscription price of RMB [80,000,000];

(e)[*] subscribed for USD [1,315,843.00] of the new registered capital at the subscription price of RMB [20,000,000];

(f)[*] subscribed for USD [3,289,607.50] of the new registered capital at the subscription price of RMB [50,000,000];

(g)[*] subscribed for USD [2,302,725.25] of the new registered capital at the subscription price of RMB [35,000,000];

(h)[*] subscribed for USD [1,973,764.50] of the new registered capital at the subscription price of RMB [30,000,000];

In accordance with the Foreign Investment Law of the People’s Republic of China (“Foreign Investment Law”), the Company Law of the People’s Republic of China (amended in 2018) (“Company Law”) and other relevant laws and regulations of China, and based on the principles of equality and mutual benefit, the Parties hereby reach the following agreement through consultation on the rights and obligations of Shareholders and the operation of the Company after the completion of the Capital Increase:

Article 2 Definitions

The following terms used herein shall have the following meanings:

2.1Claim” refers to any claim, appeal, lawsuit, arbitration, inquiry, proceedings or investigation brought by or to any national, provincial, municipal, local or similar government authorities or departments, regulatory authorities or departments, or administrative authorities or departments or any court, tribunal or judicial authorities or arbitration institutions in China;

3


2.2Affiliate(s)”, in respect of any person or entity, refers to any other person or entity that directly or indirectly controls, is controlled by, or is under common control with such person or entity by holding shares or equity or by any other arrangement. In respect of natural persons, Affiliate(s) also include their spouses, parents and parents of spouses, brothers and sisters and spouses of the brothers and sisters, children over 18 years of age and their spouses, brothers and sisters of their spouses and parents of children’s spouses, or any entity that such natural persons or their close family members directly or indirectly control or where they serve as directors, supervisors and officers; and other Affiliate(s) identified in accordance with the Accounting Standard for Business Enterprises – Basic Standard (Order No.76 of the Ministry of Finance of the People’s Republic of China) and Accounting Standard for Business Enterprises No.36 – Related Party Disclosure;
2.3Articles of Association” refers to the Articles of Association of the Company reviewed and approved by the Shareholder’s Meeting (by the board of directors before the establishment of the Shareholder’s Meeting), and any further amendments or supplements that may be made thereto from time to time thereafter;
2.4Shareholder’s Meeting” refers to the Shareholder’s Meeting of the Company;
2.5Board of Directors” refers to the board of directors of the Company;
2.6Business License” refers to the business license of the Company issued by the registration authority for the establishment of the Company and the subsequent registration change of the Company;
2.7Contract” or “Shareholders Contract” refers to this Shareholders Contract entered into by and among the Parties, and the amendments or supplements that may be made by the Parties from time to time;
2.8Capital Contribution Ratio” shall have the meaning specified in Article 6.1;
2.9Control” (including “controlled” and “under common control”), in respect of any person, means the right to direct or instruct others to direct the affairs or management of a person directly or indirectly through one or several intermediaries, or as a trustee, personal representative or executor, whether by owning voting securities, by contracts or otherwise;
2.10Days” means calendar days;
2.11Directors” refers to the directors of the Company;
2.12Establishment Date” refers to the date when the Company’s first Business License is issued;
2.13Generally Accepted Accounting Principles or US GAAP” refers to the US accounting reporting standards formulated by the US Accounting Standards Board, including US accounting standards and related interpretations;
2.14Background Technologies” refers to all unpatented or patented tangible or intangible proprietary and/or confidential know-hows, trade secrets, information, data and materials (i) developed, conceived, obtained or licensed by one Party before the effective date of this Contract and the Joint Venture Contract, or (ii) conceived or implemented by one Party completely beyond the performance of its obligations under this Contract or the Joint Venture Contract and without using the equipment, supplies, resources, trade secrets or confidential information and technologies of other Parties and the Company, or (iii) licensed by third parties to one Party, including but not limited to specifications, engineering and technical data, blueprints, diagrams, charts, computer programs, designs, technologies, methods, procedures, manufacturing data and marketing information and any matters related to the above items. For
4


the avoidance of doubt, the Background Technologies of AOS do not include the patents and technologies transferred to the Company as AOS’s capital contribution to the Company confirmed by the agreement between AOS and the Company or other Shareholders, and the Background Technologies of any Party do not include the technologies that are already in the public domain and against which no person may or is able to claim any rights;
2.15Person” refers to any individual, partnership, enterprise, company, association, trust, unincorporated organization or government authority;
2.16China” refers to Chinese mainland, excluding Hong Kong Special Administrative Region, Macao Special Administrative Region and Taiwan for the purpose of this Contract;
2.17China’s Accounting System” refers to all the financial and accounting laws, regulations, rules and systems in China and applicable to the Company;
2.18Laws of China” refers to any published and effective laws, administrative regulations, provincial or other local regulations, departmental rules and departmental normative documents in China;
2.19Registration Authority” refers to China’s State Administration for Market Regulation or its local counterpart it authorizes for company registration;
2.20Subsidiaries” refers to any entity (“Entity”) that, on the date when the relevant decision is made, meets one of the following conditions: (i) the Company owns fifty percent (50%) or more of the voting shares of the Entity for the election of Directors or other equities or the Company directly or indirectly owns or controls the profits or rights and interests in fifty percent (50%) or more of the registered capital of the Entity; or (ii) the assets of the Entity or part of its assets are combined with the net income of the Company, and recorded in the Company’s books according to China’s Accounting System and International Financial Reporting Standards and for the purpose of financial reporting; or (iii) the business and policies of the Entity are directly or indirectly controlled by the Company.
2.21Taxes” refers to any and all taxes, fees, impositions, taxation, duties, levies and other charges of any kind levied by any government department (together with any and all interest, fines, tax surcharges and extra amounts levied in connection with the foregoing), including but not limited to taxes or other charges related to income, franchise, mining right, unexpected income or other profits, total income, property, sales, use, share capital, salary, employment of personnel, social insurance fund, labor compensation, unemployment compensation, etc., or taxes or other charges with the nature of consumption tax, withholding tax, ad valorem tax, stamp duty, transfer tax, value-added tax, capital gains tax, and licensing fees, registration fees and documentation fees, as well as customs levies, duties and similar charges;
2.22Term” refers to the business term of the Company as stipulated in Article 12 of this Contract;
2.23Fund Parties” refers to Chongqing Strategic Emerging Industry Equity Investment Fund Partnership (L.P.) and Chongqing Liangjiang New Area Strategic Emerging Services Equity Investment Fund Partnership (L.P.);
2.24AOS Parties” refers to AOS, AOS Shanghai and Agape;
2.25Original Shareholders” refers to AOS Parties and Fund Parties;
2.26“[*]” refers to [*];
2.27“[*]” refers to [*];
5


2.28“[*]” refers to [*];
2.29“[*]” refers to [*];
2.30Employee Stock Ownership Platform” refers to the platform set up for the convenience of employee stock ownership of the Company, specifically referring to [*], [*], [*], [*], [*] and [*];
2.31New Investors” refers to [*], [*], [*], [*], [*], [*], [*] and [*];
2.32Shareholders of the Company” refers to AOS, AOS Shanghai, Agape, [*], [*], Employee Stock Ownership Platform, [*], [*] and New Investors;
2.33Capital Increase Agreement” refers to the Capital Increase Agreement of Chongqing Alpha and Omega Semiconductor Limited that the New Investors respectively entered into with the Company in January 2022;
2.34Investors’ Investment Unit Price” refers to the issue price of each USD of registered capital corresponding to the shares issued under the Capital Increase Agreement;
2.35USD” or “US/$” refers to the statutory currency of the United States of America;
2.36Qualified Listing” refers to the Company’s initial public offering and listing for trading of RMB ordinary shares at Shanghai Stock Exchange or Shenzhen Stock Exchange, excluding the listing and public transfer of the Company’s shares at the National Equities Exchange and Quotations, or the listing of the Company’s shares at other exchanges than Shanghai Stock Exchange or Shenzhen Stock Exchange, such as Beijing Stock Exchange, New York Stock Exchange, NASDAQ and Stock Exchange of Hong Kong Ltd.
2.37Officers” refers to the general manager, deputy general managers, financial directors, secretary of the Board of Directors (if any) and other personnel specified in the Articles of Association of the Company;
2.38Or more” is inclusive of the specified number, while “more than half” is not.

Article 3 Shareholders of the Company

Shareholders of the Company are as follows:

(1)    [*], an enterprise established under the Laws of China and existing as a limited company, with its registered address located at [*]. It is registered in [*] with a unified social credit code of [*].

Authorized Representative: Name: [*]
Title: Legal Representative
Nationality: [*]

(2)    AOS (Alpha and Omega Semiconductor Limited), a company established and existing under the laws of Bermuda, with its registered address located at Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda, and business registration number being 29275.

Authorized Representative: Name: [*]
Title: Chairman
Nationality: [*]
6



(3)    AOS Shanghai, a company established under the Laws of China and existing as an enterprise legal person, with its registered address located at Building 8/9, No.91, Lane 109, Rongkang Road, Xiaokunshan Town, Songjiang District, Shanghai China. It is registered in Shanghai with a unified social credit code of [*].

Authorized Representative: Name: [*]
Title: Legal Representative
Nationality: [*]

(4)    Agape, a company established under the Laws of China and existing as an enterprise legal person, with its registered address located at Type B1 Standard Workshop of Dongkai Real Estate Park, Zone B, Songjiang Export Processing Zone, Songjiang District, Shanghai. It is registered in Shanghai with a unified social credit code of [*].

Authorized Representative: Name: [*]
Title: Legal Representative
Nationality: [*]

(5)    [*], an enterprise established under the Laws of China and existing as a partnership, with its registered address located at [*]. It is registered in [*] with a unified social credit code of [*].

Authorized Representative: Name: [*]
Title: Representative Appointed by Managing Partner
Nationality: [*]

(6)    [*], an enterprise established under the Laws of China and existing as a limited company, with its registered address located at [*]. It is registered in [*], with a unified social credit code of [*].

Authorized Representative: Name: [*]
Title: Legal Representative
Nationality: [*]

(7)    [*], a partnership established under the Laws of China and existing as a partnership, with its main business place located at [*]. It is registered in [*], with a unified social credit code of [*].

Authorized Representative: Name: [*]
Title: Representative Appointed by Managing Partner
Nationality: [*]

(8)    [*], a partnership established under the Laws of China and existing as a partnership, with its main business place located at [*]. It is registered in [*], with a unified social credit code of [*].

Authorized Representative: Name: [*]
Title: Representative Appointed by Managing Partner
Nationality: [*]

(9)    [*], a partnership established under the Laws of China and existing as a partnership, with its main business place located at [*]. It is registered in [*], with a unified social credit code of [*].

Authorized Representative: Name: [*]
7


Title: Representative Appointed by Managing Partner
Nationality: [*]

(10)    [*], a partnership established under the Laws of China and existing as a partnership, with its main business place located at [*]. It is registered in [*], with a unified social credit code of [*].

Authorized Representative: Name: [*]
Title: Representative Appointed by Managing Partner
Nationality: [*]

(11)    [*], a partnership established under the Laws of China and existing as a partnership, with its main business place located at [*]. It is registered in [*], with a unified social credit code of [*].

Authorized Representative: Name: [*]
Title: Representative Appointed by Managing Partner
Nationality: [*]

(12)    [*], a partnership established under the Laws of China and existing as a partnership, with its main business place located at [*]. It is registered in [*], with a unified social credit code of [*].

Authorized Representative: Name: [*]
Title: Representative Appointed by Managing Partner
Nationality: [*]

(13)    [*], a partnership established under the Laws of China and existing as a partnership, with its main business place located at [*]. It is registered in [*], with a unified social credit code of [*].

Authorized Representative: Name: [*]
Title: Representative Appointed by Managing Partner
Nationality: [*]


(14)    [*], a partnership established under the Laws of China and existing as a partnership, with its registered address located at [*]. It is registered in [*] with a unified social credit code of [*].

Authorized Representative: Name: [*]
Title: Representative Appointed by Managing Partner
Nationality: [*]

(15)    [*], a partnership established under the Laws of China and existing as a partnership, with its registered address located at [*]. It is registered in [*] with a unified social credit code of [*].

Authorized Representative: Name: [*]
Title: Representative Appointed by Managing Partner
Nationality: [*]

(16)    [*], a partnership established under the Laws of China and existing as a partnership, with its registered address located at [*]. It is registered in [*] with a unified social credit code of [*].

Authorized Representative: Name: [*]
Title: Representative Appointed by Managing Partner
8


Nationality: [*]

(17)    [*], a partnership established under the Laws of China and existing as a partnership, with its registered address located at [*]. It is registered in [*] with a unified social credit code of [*].

Authorized Representative: Name: [*]
Title: Representative Appointed by Managing Partner
Nationality: [*]

(18)    [*], a partnership established under the Laws of China and existing as a partnership, with its registered address located at [*]. It is registered in [*] with a unified social credit code of [*].

Authorized Representative: Name: [*]
Title: Representative Appointed by Managing Partner
Nationality: [*]


(19)    [*], a partnership established under the Laws of China and existing as a partnership, with its registered address located at [*]. It is registered in [*] with a unified social credit code of [*].

Authorized Representative: Name: [*]
Title: Representative Appointed by Managing Partner
Nationality: [*]

20)    [*], a partnership established under the Laws of China and existing as a partnership, with its registered address located at [*]. It is registered in [*] with a unified social credit code of [*].

Authorized Representative: Name: [*]
Title: Representative Appointed by Managing Partner
Nationality: [*]


Article 4 Basic Information of the Company

4.1Basic Information of the Company

(a)The English name of the Company is “Chongqing Alpha and Omega Semiconductor Limited”.

(b)The Chinese name of the Company is “重庆万国半导体科技有限公司”.

(c)The legal address of the Company is No.288 Yuefu Avenue, Beibei District, Chongqing, China.

4.2Nature of the Company

The Company is a limited liability company with corporate legal personality under the Company Law. The establishment and activities of the Company shall be in compliance with the relevant provisions of Laws of China, and its legitimate rights and interests shall be protected by Laws of China.

4.3Limited Liability

As a limited liability company established under the Laws of China, the Company shall be liable for its debts with all its assets, and in any case, the Shareholders of the Company shall be liable to
9


the Company and share the risks only to the extent of their respective contributions to the Company’s registered capital expressly subscribed in accordance with the provisions of Article [6.1] below. In addition, the Shareholders of the Company shall not be individually or jointly and severally liable for any debts of the Company. Shareholders of the Company shall share the Company’s profits in proportion to their paid-in capital contribution to the Company and bear the Company’s losses in proportion to their subscribed capital contribution to the Company.

4.4Branches

The Company may, as required, set up Subsidiaries in and outside China with the approval of the Shareholder’s Meeting; or set up branches or representative offices in and outside China with the approval of the Board of Directors.


Article 5 Business Scope


5.1Business Scope

The business scope of the Company shall be summarized as follows: design, manufacture and sales of semiconductor chips; design, manufacture and sales of semiconductor chip packaging; undertaking processing and trade services for semiconductor chips or semiconductor chip packaging. (Items in the Company’s business scope that require approval as provided in laws and administrative regulations shall be approved in accordance with the law.)


Article 6 Registered Capital and Capital Contribution Ratio



6.1Registered Capital and Capital Contribution Ratio

After the Capital Increase is completed, the registered capital of the Company shall be USD (428,241,104.35), and the amount and proportion of capital contribution subscribed by Shareholders of the Company (“Capital Contribution Ratio”) are as follows:

No.
Investor’s NameSubscribed Capital Contribution (USD)Capital Contribution Ratio (%)Mode of Capital Contribution
1[*]
184,596,254.00
43.1057Cash
2
AOS Shanghai
22,799,415.005.3240In kind
3
Agape
39,010,526.009.1095In kind
4AOS119,000,000.0027.7881Patent, technology and cash
10


5[*]7,978,948.001.8632In kind
6[*]4,211,111.000.9834In kind
7[*]4,693,353.501.0960Cash
8[*]9,742,000.002.2749Cash
9[*]2,394,100.000.5591Cash
10
[*]1,323,900.000.3091Cash
11
[*]924,700.000.2159Cash
12
[*]740,600.000.1729Cash
13
[*]627,600.000.1466Cash
14[*]4,605,450.501.0754Cash
15[*]6,908,175.751.6132Cash
16[*]7,829,265.851.8282Cash
17[*]5,263,372.001.2291Cash
18[*]1,315,843.000.3073Cash
19[*]1,973,764.500.4609Cash
20[*]2,302,725.250.5377Cash
Total428,241,104.35100/

6.2Payment of Capital Contribution

(a)As of the execution date of this Contract, the Original Shareholders, [*] and [*] have completed the capital contribution in full, including contribution in cash, equipment and intellectual property, in accordance with the Joint Venture Contract, the Supplementary Contracts to the Joint Venture Contract or other relevant agreements or legal documents.

(b)The New Investors shall pay the subscription price to the account designated by the Company in accordance with the Capital Increase Agreement.

6.3Equity Transfer

(a)Before the listing of the Company, the Parties shall ensure that the equity transfer is carried out as provided by the Company Law and the Articles of Association in accordance with the
11


criteria for determining the ownership of control rights in relevant laws and regulations and on the premise that the Company has no actual controller.

(b)Shareholders of the Company may transfer all or part of their equity to each other.

(c)A Shareholder’s transfer of equity to persons other than Shareholders shall be approved by more than half of other Shareholders. The Shareholder shall notify other Shareholders in writing about the transfer of equity for approval. If other Shareholders fail to reply within 30 days from the date of receipt of the written notice, it will be deemed that they have agreed to the transfer. If half or more of other Shareholders don’t agree to the transfer, the Shareholders who don’t agree shall purchase the equity to be transferred; the Shareholders who don’t purchase shall be deemed to have agreed to the transfer.

(d)For the equity transferred with the consent of Shareholders, other Shareholders shall have the right of first refusal under the same conditions. If two or more Shareholders claim exercise of the right of first refusal, they shall determine their respective purchase proportions through consultation; if consultation fails, they shall exercise the right of first refusal in proportion to their paid-in capital contribution at the time of transfer.

(e)No Shareholder may transfer the equity of the Company it holds to the companies or enterprises listed in Schedule 1 to this Shareholders Contract.

(f)Where laws, regulations and the Articles of Association have other provisions on equity transfer, such provisions shall prevail.

6.4Equity Pledge

Without the unanimous consent of other Shareholders of the Company, no Party may use all or part of the Company’s equity corresponding to its subscribed capital contribution as pledge, nor as other forms of security.

6.5Qualified Listing

The Parties agree that they will use every effort to promote the listing process of the Company. For the purpose of listing, at the request of the Company and on the premise of abiding by Laws of China, the Company and the existing Shareholders shall reform the Company into a company limited by shares and actively promote the listing of the Company. For the purpose of listing and without prejudice to the listing, the Company and existing Shareholders agree to use every effort to actively cooperate and provide necessary assistance, and under the guidance and with the suggestions of the listing intermediaries, ensure that the Company, Shareholders (including indirect shareholders) and other aspects meet the listing conditions provided by the government departments and relevant stock exchanges in China, including but not limited to conditions on:

Equity adjustment: To reduce its shareholding ratio according to the fair market price recognized by the transferor and transferee, amend this Contract, the Articles of Association and handle relevant change registration according to the number of equity and timeline as planned in the equity adjustment plan approved by the internal authority of the Company and confirmed by AOS and [*];

Related party transactions: Shareholders shall adjust the proportion of related party transactions with the Company under the guidance and with suggestions of the Company’s listing intermediaries and the plan confirmed and agreed to by the Shareholders in writing that constitute related party transactions, so as to make it meet the relevant requirements of Qualified Listing.

All Shareholders warrant that the Company has the ability to directly face the market for going concern independently, and that the Company meets the requirements of independence such as asset integrity, personnel independence, financial independence, institutional independence and business independence.

Other matters that require the assistance of the Parties for Qualified Listing.

12




Article 7 Responsibilities of the Parties


7.1Shareholders of this Contract shall actively perform their obligations and responsibilities as stipulated in this Contract and the Articles of Association.

7.2Intellectual Property

(a)AOS’s intellectual property. AOS is the sole and exclusive owner of (i) AOS’s Background Technologies; and (ii) any improvements and modifications made by AOS to AOS’s Background Technologies; (iii) all rights, interests and benefits (including but not limited to all intellectual property rights that should be enjoyed according to Laws of China) under any new technology independently developed by AOS on and after the effective date of this Contract and the Joint Venture Contract related to the products operated by the Company and the improvements and modifications made thereto (collectively referred to as “AOS’s Intellectual Property”). Under the circumstances that the Company’s production, continuous production, OEM production, use, sale, offer for sale, import, export and other use of products or services are necessary to fulfill the orders of AOS or AOS’s Affiliates, AOS shall grant the Company free of charge the right to use AOS’s Intellectual Property required to complete such orders. However, if the Company requires to use AOS’s Intellectual Property beyond the above authorization scope, including but not limited to technology research and development, and providing any services or products to third parties, the Company shall consult with AOS in advance to obtain the license for using such intellectual property.

(b)The Company’s Intellectual property. The Company is the sole and exclusive owner of (i) the patents and technologies transferred by AOS to the Company as capital contribution; (ii) any improvement or modification made by the Company to the patents and technologies transferred by AOS to the Company as capital contribution; and (iii) all rights, interests and benefits (including but not limited to all intellectual property rights that should be enjoyed under the Laws of China) under any new technology independently developed by the Company on and after the effective date of this Contract and the Joint Venture Contract and the improvements or modifications thereto (collectively referred to as the “Company’s Intellectual Property”).

(c)For the purpose of Company’s Intellectual Property specified in Article 7.2(b)(i), the Company hereby agrees to grant the non-sublicensable, non-transferable right of use and license of the Intellectual Property to AOS, AOS’s Affiliates and processing agents for free for their production, continuous production, OEM production, use, sale, offer for sale, import, export and other use of any products or services. Notwithstanding the foregoing, the processing agents of AOS shall not provide the intellectual property and related products licensed by the Company free of charge to any third party with or without consideration.

According to the requirements of the laws, regulations and review rules in force then, if Article 7.2(c) of this Contract fails to meet the relevant laws, regulations and review requirements at the time when the Company applies for listing counseling and filing, the Parties agree to settle the matter through friendly consultation in accordance with the relevant rules and considering the interests of all Parties to meet the listing requirements, and the Parties will urge the securities traders to use every effort to communicate with the listing regulatory authorities on this clause.

(d)Technical improvement or modification
Without the permission of the other Party, AOS or the Company shall not make any modification or improvement to the intellectual property of the other Party; in case of
13


similar needs, the two Parties shall make a special agreement through friendly consultation in advance. For the avoidance of ambiguity, AOS shall, in accordance with the Joint Venture Contract, be the sole and exclusive owner of all rights, interests and benefits (all intellectual property rights that shall be enjoyed under the Laws of China) under any improvement or modification to AOS’s Background Technologies made by the Company alone or in cooperation with AOS before the execution and effectiveness of this Shareholders Contract.

(e)Technical cooperation and development.
Subject to Article 7.2(a) and (b), AOS and the Company may agree to jointly develop new technologies pursuant to a separate technical cooperation and development contract and/or make improvements and modifications thereto.

(f)Under the circumstances that the production, continuous production, OEM production, use, sale, offer for sale, import, export and other use of products or services by the Company, its Subsidiaries and branches are necessary to fulfill the orders of AOS or AOS’s Affiliates, AOS shall authorize the Company, Subsidiaries, branches and processing agents of the Company to use the trademark rights owned by AOS related to the products or services free of charge. However, if the Company intends to use AOS’s trademark beyond the above authorization scope, including but not limited to providing any services or products to third parties, the Company shall consult with AOS in advance to obtain the trademark use license.

(g)If the Company or AOS intends to use the intellectual property of the other Party beyond the scope stipulated in this Contract, the two Parties shall consult amicably and sign a technology license contract in accordance with Laws of China to set forth the specific content of the license.


Article 8 Shareholder’s Meeting

8.1Functions and Powers of Shareholder’s Meeting
The Shareholder’s Meeting is composed of all Shareholders of the Company. It is the authority of the Company and exercises the following functions and powers:

(a)To decide on the business policies and investment plans of Company;

(b)To elect and replace Directors and supervisors that are not appointed from representatives of staff and workers, and to decide on matters concerning the remuneration of Directors and supervisors;

(c)To review and approve reports of the Board of Directors;

(d)To review and approve reports of the board of supervisors;

(e)To review and approve the annual budget plan of routine connected transaction forecast;

(f)To review and approve the annual financial budget plan (except for the annual routine connected transaction forecast) and final accounting plan of the Company;

(g)To pass resolutions on the issuance of corporate bonds;

(h)To review and approve the Company’s annual profit distribution plan and plan for making up losses;

14


(i)To pass resolutions on the increase or reduction of registered capital or listing of the Company;

(j)To pass resolutions on the merger, division, dissolution, liquidation or change of corporate form of the Company;

(k)To amend the Articles of Association;

(l)To pass resolutions on the Company’s investment in other enterprises or providing security for others;

(m)To examine and approve the non-routine related party transactions (except for acceptance of cash assets as gifts, debts that simply relieve the Company’s obligations, and acceptance of securities and subsidies) that the Company intends to have with Affiliates and reach the following standard, and related party transactions that exceed the scope of annual routine connected transaction forecast in the annual financial budget and reach the following standard: transactions with a total transaction amount of more than RMB 50 million or a single transaction amount of more than RMB 10 million in a fiscal year;

(n)To decide to sell, transfer, license or otherwise dispose of the Company’s patents, trademarks or other intellectual property rights; or set encumbrance on the Company’s patents, trademarks or other intellectual property rights;

(o)To decide to engage or dismiss the accounting firm that undertakes the audit business of the Company;

(p)To examine and approve the Company’s equity incentive plan (including but not limited to establishing, revising or terminating the employee stock ownership plan or similar incentive plan, and issuing incentive equity or options through the Employee Stock Ownership Platform or other means);

(q)To examine and approve the Company’s single or cumulative purchase and sale of major assets or the security with an amount of more than 30% of the Company’s latest audited total assets within one year;

(r)To examine and approve the appointment of independent auditors to audit the Company’s accounts on behalf of Shareholders;

(s)To examine and approve the establishment of subsidiaries in China;

(t)Other functions and powers provided by laws, administrative regulations and Articles of Association.

8.2Resolution of Shareholder’s Meeting

The resolutions of the Shareholder’s Meeting on the matters discussed shall be adopted by Shareholders representing more than half of the voting rights. However, the matters involved in Article 8.1(e) to (n) shall be adopted by Shareholders representing two thirds or more of the voting rights.

The Shareholder’s Meeting shall be convened by the Board of Directors and presided over by the board chairman; if the chairman is unable to or does not perform his duty, the meeting shall be presided over by the vice chairman; if the vice chairman is unable to or does not perform his duty, the meeting shall be presided over by a Director jointly designated by more than half of the Directors.

15


An extraordinary Shareholder’s Meeting may be convened upon the proposal of Shareholders representing one tenth (1/10) or more of the voting rights, one third (1/3) or more of the Directors or the board of supervisors. The chairman shall convene and preside over the Shareholder’s Meeting within ten days after receipt of the proposal.


Article 9 Board of Directors, Board of Supervisors, General Manager and Management Organization

9.1Composition of the Board of Directors

The Parties agree that the Board of Directors is composed of seven (7) Directors, of whom three (3) are appointed by AOS; three (3) by Yujiangxin; and one (1) by the Employee Stock Ownership Platform. Shareholders of the Company shall vote in favor of the Directors appointed by other Parties in accordance with this Contract when considering the proposal of electing the Company’s Directors at the Shareholder’s Meeting. During the term of this Contract, if the Capital Contribution Ratio of Shareholders of the Company changes, the Parties may make corresponding amendments to this Contract, including but not limited to making appropriate amendments to the composition of the Bboard of Directors and the number of Directors appointed by the Parties according to the agreement reached by the Parties otherwise through consultation at the time.

9.2Term of Office

The term of office of Directors shall be specified in the Articles of Association, and each Director’s term of office shall be three (3) years. When the term of office of a Director expires, the Director may serve consecutive terms if re-elected. If an appointed Director is replaced, the Party that replaces the Director shall notify all Shareholders and the Company in writing. The change of Directors shall be decided by the Shareholder’s Meeting, and the change shall be registered and filed with the Registration Authority. Each Party shall take appropriate measures to maintain the number of Directors appointed by itself in the Board of Directors.

9.3Chairman and Vice Chairman

(a)The Board of Directors shall have a chairman and a vice chairman. The chairman and the vice chairman shall be elected by the Board of Directors.

(b)The functions and powers of the chairman include the following:

(i) To convene and preside over board meetings;

(ii)To perform other functions and powers granted by the Shareholder’s Meeting and the Board of Directors or specified in this Contract and the Articles of Association.


9.4Board Meeting

(a)The Board of Directors shall hold at least two (2) regular meetings every year. Upon the written request of one third (1/3) or more of the Directors, the chairman shall convene an extraordinary meeting of the Board of Directors to discuss related matters within thirty (30) days after receipt of the request.

(b)All board meetings shall be convened and presided over by the chairman or vice chairman or a Director (elected by more than half of the Directors). Fifteen (15) days before each board meeting, a written notice (including notice by email) shall be sent to each Director to inform the Director of the time, place and agenda of the meeting. The chairman shall formulate the agenda of the board meeting. At least ten (10) days before each meeting, documents related to the meeting (if any) shall be sent to each Director. Any board meeting held without proper and timely notice to each Director in accordance with this paragraph shall be deemed invalid, unless the Director who has not received proper and timely notice expresses to the chairman or vice chairman in writing to waive
16


the requirement for notice before, during or after the board meeting. Any Director who does not receive proper notice but attends the meeting shall be deemed to have waived the requirement for notice. With the mutual agreement among all Directors in writing, the notice period of board meeting and the sending period of meeting documents specified in this Contract and the Articles of Association may be shortened or exempted.

(c)Other details about the board meeting will be specified in the Articles of Association or the rules of procedure of the Board of Directors of the Company.

(d)Meeting method: on-the-spot meeting, through instant messaging such as video or telephone, or by written execution such as email (referring to the meeting method of making resolutions on proposals by sending them for examination or circulation respectively). The convener of the board meeting shall provide appropriate methods for Directors to attend the board meeting according to the convenience of Directors to attend the meeting.

9.5Quorum and Adoption of Resolutions

(a)The formal meeting of the Board of Directors may be held only when more than half of the Directors are present. For resolutions made by the Board of Directors, matters in (d) to (n) of Article 9.6 shall be adopted by two thirds or more of all the Directors, and other matters in Article 9.6 shall be adopted by more than half of all the Directors. Attending in person (including by telephone or video conference) and appointing a proxy to attend the meeting shall both be deemed as proper attendance. If the quorum is not met, the resolutions adopted by the board meeting will be invalid and have no effect. However, if the quorum of the duly convened board meeting cannot be reached due to the two consecutive absences of the Director appointed by each Party hereto or his proxy without reasonable reasons, even if the aforementioned Director fails to attend the meeting, the board meeting shall be deemed to have been duly held, and the resolutions adopted at the board meeting shall be deemed to be valid.

(b)Each Director attending the board meeting has one vote. If any Director is unable to attend the board meeting for any reason, the Director may entrust a proxy in writing to attend the board meeting on his behalf, and the proxy shall be a Director of the Company. Any appointed proxy enjoys the same rights as the Director who appoints the proxy, but one Director cannot act for two or more Directors at the same time. A proxy shall have one vote for each Director he represents, and he also has one vote for himself as a Director.

(c)The resolutions of the Board of Directors may be adopted in writing without a board meeting and executed by all Directors of the Board, but the written resolutions to be adopted must be sent to each Director. To this end, each Director may execute different copies of the same written resolution, all of which together constitute a valid written resolution, and for this purpose, the scanned or faxed copies of the Directors’ signatures shall be valid and binding. Such written resolutions shall have the same effect as those adopted at the duly held board meeting.

9.6Functions and Powers of the Board of Directors

The Board of Directors shall be responsible to Shareholder’s Meeting and exercise the following functions and powers:

(a)To convene the Shareholder’s Meeting and report its work to the Shareholder’s Meeting;

(b)To implement the resolutions of the Shareholder’s Meeting;

(c)To decide on the business plan and investment plan of the Company;

(d)To formulate the annual budget plan for routine connected transaction forecast;
17



(e)To formulate the annual financial budget plan (except for the annual routine connected transaction forecast) and final accounting plan of the Company;

(f)To formulate the Company’s annual profit distribution plan and plan for making up losses;

(g)To formulate plans for the increase or reduction of the registered capital of the Company;

(h)To formulate plans for merger, division, dissolution or change of corporate form, issuance of bonds or other securities and listing of the Company;

(i)To formulate the Company’s equity incentive plan (including but not limited to establishing, revising or terminating the employee stock ownership plan or similar incentive plan, and issuing incentive equity or options through the Employee Stock Ownership Platform or other means);

(j)To decide on the establishment of the Company’s internal management bodies;

(k)To decide on the Company’s investment, acquisition and sale of assets, mortgage of assets, provision of security and related party transactions within the scope authorized by the Shareholder’s Meeting;

(l)To examine and approve the following transactions (whether a single transaction or a series of related transactions) that exceed the annual budget of the Company: (i) loans or other debts of more than RMB 30 million beyond the annual budget; (ii) expenses of more than RMB 5 million beyond the annual budget; (iii) purchase or disposal of business or assets of more than RMB 5 million beyond the annual budget; (iv) other transactions beyond the annual budget and outside the normal business operation with a total amount of more than RMB 5 million in 12 consecutive months;

(m)To examine and approve the non-routine related party transactions of the Company which reach the following standards and related party transactions beyond the annual forecast range of routine related party transactions in the annual financial budget which reach the following standards: related party transactions with related natural persons with a total transaction amount of RMB 1 million or more in one fiscal year, or related party transactions with a single transaction amount of RMB 300,000 or more; related party transactions with related legal persons with a total transaction amount of RMB 10 million or more in one fiscal year or a single transaction amount of RMB 3 million or more (except for the Company’s provision of security and acceptance of cash assets as gifts, debts that simply relieve the Company’s obligations, and acceptance of securities and subsidies);

(n)To decide on the appointment or removal of the general manager of the Company and his remuneration, and to decide on the appointment or removal of deputy general manager, financial directors and other Officers of the Company according to the recommendation of the general manager and their remuneration; to set performance targets of Officers and make evaluation every year;

(o)To formulate the basic management system of the Company;

(p)To propose to the Shareholder’s Meeting to engage or replace the accounting firm that audits for the Company;

(q)To examine and approve the establishment of branches or representative offices of the Company in and outside China;

18


(r)Other functions and powers granted by laws, regulations, departmental rules or the Articles of Association of the Company.

9.7Directors

(a)The remuneration of serving Directors and their proxies shall be borne by the appointing Party. The expenses incurred by Directors and their proxies for attending board meetings shall be reimbursed by the Company in RMB or USD based on the reimbursement vouchers permitted by China’s Accounting System.

(b)All Directors, including the chairman and vice chairman, shall perform their duties in accordance with the relevant provisions of this Contract and the Articles of Association.

(c)Each Director shall faithfully perform his duties according to the provisions of this Contract and the Articles of Association, safeguard the interests of the Company and avoid conflicts with the interests of the Company.

(d)Directors and Officers shall not commit any of the following acts:

(i)Misappropriating the funds of the Company;

(ii)Depositing the funds of the Company in an account opened in his personal name or in the name of another individual;

(iii)In violation of the provisions of the Articles of Association, lending the funds of the Company to others or providing security for others with the property of the Company without the consent of the Shareholder’s Meeting or the Board of Directors;

(iv)Entering into a contract or transaction with the Company in violation of the provisions of the Articles of Association or without the consent of the Shareholder’s Meeting;

(v)Taking advantage of his position to seek for himself or others business opportunities that belong to the Company, or operating by himself or for others the same type of business as that of the Company without the consent of the Shareholder’s Meeting;

(vi)Accepting as his own the commissions of a transaction between another person and the Company;

(vii)Disclosing the secrets of the Company without authorization;

(viii)Other acts that violate his fiduciary obligation to the Company.

The income obtained by Directors and Officers in violation of the provisions of the preceding paragraph shall belong to the Company.

9.8Minutes of Board Meeting

The Board of Directors shall keep complete and correct meeting minutes in Chinese, including copies of all meeting notices; all meeting minutes and resolutions adopted shall be recorded by the meeting secretary appointed by the Board of Directors and submitted to all Directors for review within sixty (60) days after each meeting. All resolutions of the Board of Directors shall be executed by all voting Directors, kept by a special person appointed by the Board of Directors, and kept in the minutes book of the board meetings of the Company. The appointment and replacement of board members shall also be recorded in the minutes book of board meetings.

19


9.9Board of Supervisors

The Company shall have a board of supervisors, consisting of three supervisors, one appointed by AOS, one by Yujiangxin, and one employee supervisor elected by the congress of workers and staff. The board of supervisors of the Company shall have a chairman who is elected by the board of supervisors. The appointing Party may appoint or replace its nominated supervisor after notifying the Company in writing and sending a copy of the notice to other Parties. The term of office of the first supervisors shall start from the Establishment Date of the Company. The term of office of each supervisor shall be three (3) years. Upon expiration of the term of office, the supervisor may serve consecutive terms if re-elected. No supervisor may concurrently serve as a Director or Officer.

9.10Functions and Powers of the Board of Supervisors

The board of supervisors of the Company shall exercise the following functions and powers:

(a)To inspect the Company’s financial affairs;

(b)To supervise the behavior of Directors and Officers in performing their duties to the Company, and proposing the removal of Directors and Officers who violate laws, administrative regulations, the Articles of Association or the resolutions of the Shareholder’s Meeting;

(c)To request Directors and Officers to make corrections when their behavior harms the interests of the Company;

(d)To propose to convene an extraordinary Shareholder’s Meeting, and convene and preside over the Shareholder’s Meeting when the Board of Directors fails to fulfill the provisions of the Articles of Association in respect of convening and presiding over a Shareholder’s Meeting;

(e)To make proposals to the Shareholder’s Meeting;

(f)To bring a lawsuit against the Directors and Officers in accordance with the provisions of Article 151 of the Company Law;

(g)Other functions and powers provided by laws and administrative regulations, and granted by the Articles of Association or the Shareholder’s Meeting.

Supervisors may attend the board meeting as non-voting attendees, and make inquiries or suggestions on matters to be resolved by the Board of Directors. If supervisors discover material irregularities in the operation of the Company, they may conduct an investigation through the board of supervisors, or if necessary, jointly engage an accounting firm to assist them in their work, and the expenses incurred therefrom shall be borne by the Company.

9.11Meeting of Supervisors

The meeting of the board of supervisors shall be held at least once a year, and the time and place of the meeting shall be the same as that of the annual meeting of the Board of Directors. Upon the proposal of one or more supervisor, an extraordinary meeting of the board of supervisors shall be held. The meeting of the board of supervisors shall be held only when more than half of the supervisors are present. The resolutions made by the board of supervisors according to their functions and powers shall be valid only when they are approved by more than half of the supervisors.

When voting on a resolution of the board of supervisors, each supervisor present at the meeting shall have one vote. The board of supervisors shall make minutes of the decisions on the matters discussed, and the supervisors shall facilitate the complete and accurate minutes of all resolutions
20


in Chinese, and the minutes shall be executed by all supervisors; the Company shall, subject to the financial regulations of the Company, reimburse the supervisors for the reasonable expenses and costs (such as travel expenses and hotel accommodation expenses within reasonable limits) incurred in performing their duties and obligations under this Contract and the Articles of Association.

9.12Officers and Legal Representative

The Company shall have general manager, deputy general manager, financial directors, secretary of the Board of Directors (if any) and other personnel specified in the Articles of Association as Officers. The general manager of the Company shall be appointed by the Board of Directors, and other Officers shall be nominated by the general manager and appointed by the Board of Directors. The general manager of the Company shall serve as the legal representative.

If any Officer of the Company is removed from office by the Board of Directors, the Board of Directors shall formally appoint the succeeding Officers according to its rules of procedure within thirty (30) days after the removal. Within thirty (30) days before the expiration of each term of the Officers, the Board of Directors shall appoint the succeeding Officers.

9.13Management of the Company and Standing Committee of the Board of Directors

(a)The Company shall have a standing committee of the Board of Directors (“Board Committee”). The establishment of the Board Committee may be amended by the Board of Directors from time to time according to the needs of the Company. Each member of the Board Committee shall be appointed by the Board of Directors and may serve consecutive terms. The daily management and operation of the Company shall be carried out by Officers under the leadership of the general manager.

(b)The Board Committee shall have two committees: Audit Committee and Remuneration Committee. The establishment of the Board Committee and its rules of procedure shall be separately prepared and adopted by the Board of Directors.

(c)If any Officer concurrently serves as a Director, the member shall not vote as a Director on his personal remuneration, or on his removal from his position as a Director, or on his removal from his position as an Officer.

(d)The general manager shall prepare and submit reports on the Company’s operation, production, marketing, capital expenditure, personnel and other business matters to the Board of Directors.

(e)The financial director shall be responsible for preparing and submitting the annual financial report to the Board of Directors.

(f)The person in charge of internal audit of the Company shall report to the Board of Directors on a regular basis.

9.14Exemption of Personal Liability

Directors and Officers shall not bear any personal liability for their normal duties within their respective scope of office. The Company shall, to the maximum extent permitted by relevant Laws of China, protect and compensate the members of the management organization from any claims or accusations against them (including but not limited to compensation for their reasonable attorney fees, litigation and arbitration fees, etc.), except for claims or accusations caused by intentional misconduct, gross negligence or fraud of the members of the management organization. The Company shall purchase liability insurance for Directors and Officers at its own expense.


21


Article 10 Labor and Personnel Management

10.1Policy of Employee

Any policies, programs, and contracts regarding recruitment, employment, training, incentive, dismissal, resignation, wage, labor safety, social insurance or other benefit and labor discipline, and other matters related to the company’s employees shall be handled by the management bodies in accordance with relevant Chinese laws. The Company has autonomy over its employees and labor management. The Company shall sign a employment contract with each employee.

10.2Hiring of Employees

The Company should select the best employees according to the needs of its operation and development. If the Company recruits new employees through examinations or assessments, only candidates who have achieved excellent results in the examinations or assessments will be hired.

10.3Remuneration of Employees

The policies related to the wages, benefits and other treatment of the Company's employees shall be formulated by the Company in accordance with relevant Chinese laws and in light of the Company's actual situation. The Company enjoys the autonomy to decide employee’s remuneration and related benefits based on its operating and economic conditions.

10.4Termination of Labor Relationship

(a)Employees of the Company should be allowed to resign in accordance with relevant Chinese laws and their respective employment contracts. However, if an employee has participated in a training program sponsored by the Company and signed an agreement with the Company on the term of service, and the term of service has not expired, the employee must make compensation in accordance with relevant Chinese laws and the provisions of the agreement on service term before being allowed to resign. Unless otherwise provided by Chinese law, resigning employees shall notify the Company in writing at least thirty (30) days in advance.

(b)The Company shall ensure that: (i) its employment contract with each employee includes a non-disclosure clause whereby each employee shall keep confidential any confidential information he has learned during his employment with the Company, and an invention assignment agreement whereby the employee shall assign to the Company any and all intellectual property rights relating to the Company; and (ii) its employment contracts with employees who hold management positions or have access to the Company’s know-how or other confidential information shall include a non-compete clause whereby after termination of the employment contract with the Company, such employees shall not directly or indirectly work for any of the Company's competitors within the period permitted by relevant Chinese laws, provided that the Company shall pay them a certain amount of compensation in accordance with relevant labor laws and regulations.


Article 11 Tax, Accounting, Audit and Profit Distribution

11.1Tax

The Company shall pay various taxes in accordance with relevant Chinese laws applicable to it.

11.2Individual Income Tax

All employees of the Company shall pay individual income tax in accordance with the Individual Income Tax Law of the People's Republic of China and other applicable Chinese laws, and the Company shall withhold and pay the individual income tax.
22



11.3Accounting System

(a)The Company shall establish its financial and accounting system in accordance with the Chinese Accounting System. If required, the Company's financial and accounting system should be reported to the local financial department and taxation agency for the record.

(b)Subject to Chinese laws and regulations, the Company shall timely and accurately provide AOS with the annual audit report, quarterly audit report, and other information required for a US listed company to comply with the US GAAP, to meet the requirements on AOS’s financial reporting, quarterly review and annual audit, and U.S. regulatory agency’s disclosure requirements. AOS will assume additional charges of external auditors for quarterly and annual audits required by AOS.

(c)The Company shall use the accounting accrual basis and debit and credit accounting method for bookkeeping, and shall prepare complete and accurate quarterly and annual financial statements in accordance with the Chinese Accounting System.

(d)The Company's fiscal year is based on the Gregorian calendar, starting on January 1 and ending on December 31 each year. The first fiscal year of the Company shall start from the date of its establishment and end on December 31 of the same year.

11.4Shareholder’s Right to Information

(a)The Company shall engage a reputable accounting firm practicing in China as its external auditor. The external auditor shall review the Company's accounts and issue the Company's consolidated annual financial audit report in accordance with the Chinese Accounting System. The above report shall be submitted by the Company's general manager to the board of directors for approval. The Company shall provide the external auditor with all documents and accounting books required by the external auditor to conduct the normal external audit work. The external auditor must agree to keep confidential all information obtained during the audit.

(b)Shareholders may request to inspect the Company's accounting books. If a Shareholder requests to inspect the Company's accounting books, it shall submit a written request to the Company explaining the purpose. If the Company has reasonable grounds to believe that the Shareholder's inspection of the accounting books has an improper purpose and may damage the Company's legitimate interests, it may refuse the request, and shall reply to the Shareholder in writing and explain the reasons within 15 days from the date of the Shareholder's written request. If the Company so refuses, the Shareholder may request the people's court to order the Company to provide inspection.

(c)From the execution date hereof, the Company shall provide Shareholders with the following information and materials from time to time:

(i)Providing before April 30 of each year the financial statements and operating reports of the Company and the consolidated financial statements and operating reports of the Company and its subsidiaries for the previous fiscal year audited by an accounting firm;

(ii)Providing unaudited financial statements (including income statement, balance sheet, cash flow statement) of the Company and its subsidiaries respectively for each year within forty-five (45) days after the end of the year;

(iii)Providing unaudited financial statements (including income statement, balance sheet and cash flow statement) of the Company and its subsidiaries respectively for each quarter within thirty (30) days after the end of the quarter;
23



(iv)Providing the financial budget for each year before March 31 of the year;

(v)Providing, at the request of Shareholders of the Company, all information necessary to satisfy such Shareholders' tax filing, internal audit or compliance requirements within a reasonable time;

(vi)Promptly notifying Shareholders of the Company of material lawsuits brought against the Company, administrative penalties, material non-compliance notices issued by government authorities against any group member, and other events that may have a material adverse effect on the operations of any group member;

(vii)Providing other documents and materials required by the Shareholders.

(d)Upon the reasonable request of Shareholders or their appointed directors, they have the right to request relevant personnel of the Company to cooperate with them to understand relevant information of the Company, provided that the normal business activities of the Company shall not be affected.


11.5Foreign Exchange

All foreign exchange matters of the Company shall be handled in accordance with Chinese laws on foreign exchange. Subject to the applicable provisions on foreign exchange, the foreign exchange funds in the Company's foreign exchange account shall be used for the following purposes:

(a)Repayment of principal and interest of the Company’s foreign currency loans;

(b)Payment for the purchase of imported equipment and materials;

(c)Payment for profit distribution to AOS or damages as agreed in this Contract; and

(d)Other foreign exchange expenditures.

11.6Related Party Transactions

The Parties shall ensure the fairness of the Company's related party transactions, ensure that the Company's related party transactions will not harm the interests of the Company and all Shareholders, be in line with the principles of fairness, impartiality and openness, and meet relevant requirements for Qualified Listing. Subject to the above principles, the Company and AOS shall negotiate amicably a fair market price after considering the market conditions, purchase volume and other factors.

Since AOS is a major customer of the Company, the company shall provide AOS with a wafer production capacity guarantee of [*] wafers per month from the effective date of this Contract to December 31, 2023, and after the Company's wafer production capacity reaches [*] wafers per month, the Company shall provide AOS with a wafer production capacity guarantee of [*] wafers per month. Meanwhile, AOS shall provide the Company with a specific production capacity demand plan on a regular basis. The annual daily related party transaction plan prepared by the Company shall include the production capacity guarantee arrangement stipulated in this article, and all Shareholders shall vote for the production capacity guarantee arrangement at the Company's Shareholder’s Meeting. According to the current requirements of laws, regulations and review rules, if this article does not meet the relevant laws, regulations and review requirements at the time of listing counseling and filing, the Parties agree to negotiate amicably to resolve such issue to meet the listing requirements in accordance with relevant rules and considering the interests of the Parties, and the Parties will procure the securities firm to use its best efforts to communicate with the listing regulator on this article.


24


11.7Profit Distribution

(a)When the Company distributes the after-tax profits of the current year, 10% of its profits shall be allocated to its statutory reserve. If the accumulative amount of the Company's statutory reserve reaches 50% or more of the Company's registered capital, no more statutory reserve is required to withdraw;

(b)After the Company has withdrawn the statutory reserve from the after-tax profit, it can also withdraw any optional reserve from the after-tax profit upon a resolution of the Shareholder’s Meeting;

(c)The remaining after-tax profits of the Company after making up the losses and withdrawing the reserves shall be distributed according to the proportion of the actual capital contribution of each Party in the Company. If there is any loss in the previous year, the profit distribution shall be made after making up the loss. The undistributed distributable profits of previous years can be combined into the profits of the current year for distribution;

(d)The Company shall wire the profits distributed to the Parties to their respective bank accounts designated in writing. Among them, the profits distributed to AOS shall be paid in USD.


Article 12 Term of the Company

12.1Term of the Company

The Term of the Company shall be permanent starting from April 22, 2016.



Article 13 Dissolution and Liquidation

13.1Dissolution

The Company shall be dissolved for the following reasons:

(a)The business period stipulated in the Company's Articles of Association expires or other reasons for dissolution stipulated in the Company's Articles of Association occur;

(b)The Shareholder’s Meeting resolve to dissolve the Company;

(c)The Company is required to dissolve for merger or division;

(d)The Company has its business license revoked, is ordered to close down or is cancelled according to law;

(e)The Company is dissolved by the people’s court according to Article 182 of the Company Law.

13.2Liquidation Group

(a)If the Company is dissolved in accordance with the reasons stipulated in the Articles of Association, a liquidation group shall be established to start the liquidation within 15 days from the date of occurrence of the reasons for dissolution. The Company's liquidation group shall be composed of Shareholders. If a liquidation group is not established for liquidation within the time limit, the creditors may apply to the people's court to designate relevant personnel to form a liquidation group for liquidation.

25


(b)The costs and expenses of the liquidation group shall be paid by the Company.

(c)After the liquidation of the Company is completed, the liquidation group shall prepare a liquidation report, submit it to the Shareholder’s Meeting or the people's court for confirmation, and file it to the Company’s registration authority for cancelling the Company's registration and announcing termination of the Company.

13.3Survival

If this Contract is terminated early and the Company is required to be liquidated, any obligations and liabilities of either Party to the Company or the other Party arising before the date on which the Shareholder’s Meeting makes the decision to liquidate the Company shall survive and continue to be performed.

13.4Liquidation Preference

In the case of the Company’s liquidation due to early termination of the Company, the distribution of the remaining property of the Company after paying relevant expenses and debts stipulated in the Company Law and the Company's Articles of Association shall be made as follows:

(a)Priority shall be given to new investors in proportion to their respective total paid-in capital contributions under the capital increase agreement; provided however that the new investor’s total paid-in capital contributions under the capital increase agreement shall not be exceeded; then

(b)Distributed to other Shareholders other than the new investors in proportion to their paid-in capital contributions, provided however that the total paid-in capital contributions of such Shareholders shall not be exceeded; then

(c)The balance after the Company's distribution shall be distributed among all Shareholders of the Company according to the paid-in capital contribution ratio at the time of liquidation.

(d)The above-mentioned liquidation preference for new investors shall not apply to the capital contributions of the Original Shareholders assumed by the new investors.


Article 14 Breach and Liability

14.1Breach

If one Party fails to perform any of its obligations under this Contract or the Articles of Association, or if any of its representations or warranties under this Contract are untrue or inaccurate, it shall constitute a breach of this Contract.

14.2Liability for Breach

(a)In the event of a breach of this Contract or the Articles of Association, the breaching Party shall be liable for the direct actual loss of the other Parties arising from its breach.

(b)If either Party breaches this Contract, and the breaching Party fails to take remedial measures to the satisfaction of the non-breach Parties within 30 days after the breach, the breaching Party shall be liable for compensation. In the event of the above breach of contract, the non-breaching Party has the right to suspend the performance of the obligations under this Contract until the breaching Party takes remedial measures to the satisfaction of the non-breaching Parties or bears full compensation liability.

26


(c)If one Party fails to perform any of its obligations under this Contract or the Articles of Association, or if any representations or warranties it makes in this Contract are materially untrue or inaccurate, it shall constitute a breach of this Contract and the Party shall be the breaching Party. In such event, the other Parties shall notify the breaching Party in writing of the breach of this Contract, and where such breach is remediable, the breaching Party shall remedy its breach within thirty (30) days from the date of notification. If the breach cannot be remedied, or the breaching Party has not remedied the breach by the expiration of the thirty (30)-day period, the other Parties shall have the right to terminate this Contract by giving written notice to the breaching Party.

14.3Dispute over Remedies

If the breaching Party has a dispute over the other Party's right to terminate this Contract in accordance with the provisions hereof, the dispute shall be resolved in accordance with the provisions of Article 19 (Dispute Resolution) of this Contract.


Article 15 Insurances

The Company can purchase various insurances from foreign insurance companies or Chinese insurance companies that are registered in China and can provide insurances to the Company.


Article 16 Force Majeure

16.1Force Majeure Events

A force majeure event ("Force Majeure") means any act or event that is reasonably unforeseeable and unavoidable and beyond the control of the affected Party, including but not limited to earthquakes, typhoons, floods, other natural disasters, fires, wars, riots, terrorisms, COVID-19 pandemic and other public health emergencies, or any other unforeseeable or unavoidable acts or events that are recognized as force majeure events according to international business practices. However, for the purpose of this Contract, Force Majeure shall not include any shortage of funds, general change of economy or market or any labor disputes.

16.2Occurrence of Event

If one Party cannot perform any of its obligations and responsibilities under this Contract due to the occurrence of any force majeure event, it shall notify the other Parties in writing within thirty (30) days after the occurrence of the force majeure event, provide the other Parties with the details of and documents proving the event (including written evidence issued by a government department or judicial department or any other competent authority), explain the reasons for its inability to perform this Contract, and, where possible, take steps to mitigate losses.

16.3Exemption of Liability

In the event of a force majeure event, neither Party shall be liable for any damages, increased costs or losses that may be suffered by the other Parties due to the failure or delay in the performance of any of its obligations under this Contract, and such failure or delay in performance shall not be deemed a breach of this Contract. The Party claiming the occurrence of force majeure event shall take appropriate measures to reduce or eliminate the effects of force majeure, and try to resume performance of the obligations affected by the force majeure event as soon as possible.



Article 17 Representations, Warranties and Undertakings

27


17.1Representations, Warranties and Undertakings of [*]

(a)It is a limited partnership which is duly established, validly existing and in good standing under the Laws of China;

(b)It has full legal right, power and authority to execute, deliver and perform this Contract and all contracts, agreements and documents as mentioned herein to which it is a party;

(c)It has taken all appropriate and necessary actions (including shareholder’s resolutions and/or board resolutions, as the case may be) to authorize the execution, delivery and performance of this Contract and all contracts, agreements and documents as mentioned herein, and its representative signing this Contract has been fully authorized to sign this Contract and bind it under a valid power of attorney;

(d)It has obtained all necessary consents, approvals and authorizations of the Company, any third party or otherwise as required by laws and regulations for the valid execution, delivery and performance of this Contract and all contracts, agreements and documents as mentioned herein to which it is a party, and this Contract, upon entry into force, shall constitute its legal, valid and binding obligation which may be enforceable against it in accordance with the terms hereof;

(e)The execution and performance of this Contract or the consummation of the transaction contemplated by this Contract shall not violate or conflict with any term or provision of any Articles of Association, contracts, agreements, laws, and regulations to which it is a party or which bind it, shall not cause a violation of such term or provision, nor shall constitute a breach under such term or provision, including its constitutional documents, business license, rules of procedure or Articles of Association;

(f)There are no pending or threatened claims against it in respect of the matters under this Contract or any claims that may in any way affect its ability to enter into or perform this Contract;

(g)All documents, representations and information held by it relating to the transaction contemplated by this Contract that may have a material adverse effect on its ability to fully perform its obligations under this Contract, or, if disclosed to the other Parties, will have a material adverse effect on the other Parties’ willingness to enter into this Contract have been fully disclosed to the other Parties, and none of the documents previously provided by it to the other Parties contains any untrue statements of material facts, or has omitted any material facts necessary for the statements contained therein to be not misleading;

(h)It has no unfulfilled commitments or obligations (whether contractual or otherwise) that may in any way interfere with its ability or right to enter into and perform this Contract;

(i)It has not possessed or used and does not possess or use the Company’s property for free;

(j)It has paid all the registered capital subscribed by it to the Company and the capital contribution is legal. The source of funds used for its capital contribution is legal. If its capital contribution is made in any property other than cash, there is no over-valuation or under-valuation of such property.

17.2Representations, Warranties and Undertakings of [*]

(a)It is a limited liability company which is duly established, validly existing and in good standing under the Laws of China;

(b)It has full legal right, power and authority to execute, deliver and perform this Contract and all contracts, agreements and documents as mentioned herein to which it is a party;
28



(c)It has taken all appropriate and necessary actions to authorize the execution, delivery and performance of this Contract and all contracts, agreements and documents as mentioned herein, and its representative signing this Contract has been fully authorized to sign this Contract and bind it under a valid power of attorney;

(d)It has obtained all necessary consents, approvals and authorizations of the Company, any third party or otherwise as required by laws and regulations for the valid execution, delivery and performance of this Contract and all contracts, agreements and documents as mentioned herein to which it is a party, and this Contract, upon entry into force, shall constitute its legal, valid and binding obligation which may be enforceable against it in accordance with the terms hereof;

(e)The execution and performance of this Contract or the consummation of the transaction contemplated by this Contract shall not violate or conflict with any term or provision of any Articles of Association, contracts, agreements, laws, and regulations to which it is a party or which bind it, shall not cause a violation of such term or provision, nor shall constitute a breach under such term or provision, including its constitutional documents, business license, rules of procedure or Articles of Association;

(f)There are no pending or threatened claims against it in respect of the matters under this Contract or any claims that may in any way affect its ability to enter into or perform this Contract;

(g)All documents, representations and information held by it relating to the transaction contemplated by this Contract that may have a material adverse effect on its ability to fully perform its obligations under this Contract, or, if disclosed to the other Parties, will have a material adverse effect on the other Parties’ willingness to enter into this Contract have been fully disclosed to the other Parties, and none of the documents previously provided by it to the other Parties contains any untrue statements of material facts or has omitted any material facts necessary for the statements contained therein to be not misleading

(h)It has no unfulfilled commitments or obligations (whether contractual or otherwise) that may in any way interfere with its ability or right to enter into and perform this Contract;

(i)It has not possessed or used and does not possess or use the Company’s property for free;

(j)It has paid all the registered capital subscribed by it to the Company and the capital contribution is legal. The source of funds used for its capital contribution is legal. If its capital contribution is made in any property other than cash, there is no over-valuation or under-valuation of such property.

17.3Representations, Warranties and Undertakings of [*]

(a)It is a limited partnership which is duly established, validly existing and in good standing under the Laws of China;

(b)It has full legal right, power and authority to execute, deliver and perform this Contract and all contracts, agreements and documents as mentioned herein to which it is a party;

(c)It has taken all appropriate and necessary actions (including shareholder’s resolutions and/or board resolutions, as the case may be) to authorize the execution, delivery and performance of this Contract and all contracts, agreements and documents as mentioned herein, and its representative signing this Contract has been fully authorized to sign this Contract and bind it under a valid power of attorney;

29


(d)It has obtained all necessary consents, approvals and authorizations of the Company, any third party or otherwise as required by laws and regulations for the valid execution, delivery and performance of this Contract and all contracts, agreements and documents as mentioned herein to which it is a party, and this Contract, upon entry into force, shall constitute its legal, valid and binding obligation which may be enforceable against it in accordance with the terms hereof;

(e)The execution and performance of this Contract or the consummation of the transaction contemplated by this Contract shall not violate or conflict with any term or provision of any Articles of Association, contracts, agreements, laws, and regulations to which it is a party or which bind it, shall not cause a violation of such term or provision, nor shall constitute a breach under such term or provision, including its constitutional documents, business license, rules of procedure or Articles of Association;

(f)There are no pending or threatened claims against it in respect of the matters under this Contract or any claims that may in any way affect its ability to enter into or perform this Contract;

(g)All documents, representations and information held by it relating to the transaction contemplated by this Contract that may have a material adverse effect on its ability to fully perform its obligations under this Contract, or, if disclosed to the other Parties, will have a material adverse effect on the other Parties’ willingness to enter into this Contract have been fully disclosed to the other Parties, and none of the documents previously provided by it to the other Parties contains any untrue statements of material facts, or has omitted any material facts necessary for the statements contained therein to be not misleading;

(h)It has no unfulfilled commitments or obligations (whether contractual or otherwise) that may in any way interfere with its ability or right to enter into and perform this Contract;

(i)It has not possessed or used and does not possess or use the Company’s property for free;

(j)It has paid all the registered capital subscribed by it to the Company and the capital contribution is legal. The source of funds used for its capital contribution is legal. If its capital contribution is made in any property other than cash, there is no over-valuation or under-valuation of such property.


17.4Representations, Warranties and Undertakings of the Employee Stock Ownership Platform

(a)It is a limited partnership which is duly established, validly existing and in good standing under the Laws of China;

(b)It has full legal right, power and authority to execute, deliver and perform this Contract and all contracts, agreements and documents as mentioned herein to which it is a party;

(c)It has taken all appropriate and necessary actions to authorize the execution, delivery and performance of this Contract and all contracts, agreements and documents as mentioned herein, and its representative signing this Contract has been fully authorized to sign this Contract and bind it under a valid power of attorney;

(d)It has obtained all necessary consents, approvals and authorizations of the Company, any third party or otherwise as required by laws and regulations for the valid execution, delivery and performance of this Contract and all contracts, agreements and documents as mentioned herein to which it is a party, and this Contract, upon entry into force, shall constitute its legal, valid and binding obligation which may be enforceable against it in accordance with the terms hereof;

30


(e)The execution and performance of this Contract or the consummation of the transaction contemplated by this Contract shall not violate or conflict with any term or provision of any Articles of Association, contracts, agreements, laws, and regulations to which it is a party or which bind it, shall not cause a violation of such term or provision, nor shall constitute a breach under such term or provision, including its constitutional documents, business license, rules of procedure or Articles of Association;

(f)There are no pending or threatened claims against it in respect of the matters under this Contract or any claims that may in any way affect its ability to enter into or perform this Contract;

(g)All documents, representations and information held by it relating to the transaction contemplated by this Contract that may have a material adverse effect on its ability to fully perform its obligations under this Contract, or, if disclosed to the other Parties, will have a material adverse effect on the other Parties’ willingness to enter into this Contract have been fully disclosed to the other Parties, and none of the documents previously provided by it to the other Parties contains any untrue statements of material facts, or has omitted any material facts necessary for the statements contained therein to be not misleading;

(h)It has no unfulfilled commitments or obligations (whether contractual or otherwise) that may in any way interfere with its ability or right to enter into and perform this Contract;

(i)It has not possessed or used and does not possess or use the Company’s property for free;

(j)It has paid all the registered capital subscribed by it to the Company and the capital contribution is legal. The source of funds used for its capital contribution is legal. If its capital contribution is made in any property other than cash, there is no over-valuation or under-valuation of such property.

17.5Representations, Warranties and Undertakings of AOS

(a)It is a company which is duly established, validly existing and in good standing under the laws of its place of registration;

(b)It has full legal right, power and authority to execute, deliver and perform this Contract and all contracts, agreements and documents as mentioned herein to which it is a party;

(c)It has taken all appropriate and necessary actions to authorize the execution, delivery and performance of this Contract and all contracts, agreements and documents as mentioned herein, and its representative signing this Contract has been fully authorized to sign this Contract and bind it under a valid power of attorney;

(d)It has obtained all necessary consents, approvals and authorizations of the Company, any third party or otherwise as required by laws and regulations for the valid execution, delivery and performance of this Contract and all contracts, agreements and documents as mentioned herein to which it is a party, and this Contract, upon entry into force, shall constitute its legal, valid and binding obligation which may be enforceable against it in accordance with the terms hereof;

(e)The execution and performance of this Contract or the consummation of the transaction contemplated by this Contract shall not violate or conflict with any term or provision of any Articles of Association, contracts, agreements, laws, and regulations to which it is a party or which bind it, shall not cause a violation of such term or provision, nor shall constitute a breach under such term or provision, including its constitutional documents, business license, rules of procedure or Articles of Association;

31


(f)There are no pending or threatened claims against it in respect of the matters under this Contract or any claims that may in any way affect its ability to enter into or perform this Contract;

(g)All documents, representations and information held by it relating to the transaction contemplated by this Contract that may have a material adverse effect on its ability to fully perform its obligations under this Contract, or, if disclosed to the other Parties, will have a material adverse effect on the other Parties’ willingness to enter into this Contract have been fully disclosed to the other Parties, and none of the documents previously provided by it to the other Parties contains any untrue statements of material facts or has omitted any material facts necessary for the statements contained therein to be not misleading;

(h)It has no unfulfilled commitments or obligations (whether contractual or otherwise) that may in any way interfere with its ability or right to enter into and perform this Contract;

(i)It has not possessed or used and does not possess or use the Company’s property for free;

(j)It has paid all the registered capital subscribed by it to the Company and the capital contribution is legal. The source of funds used for its capital contribution is legal. If its capital contribution is made in any property other than cash, there is no over-valuation or under-valuation of such property.

17.6Representations, Warranties and Undertakings of [*]

(a)It is a limited liability company which is duly established, validly existing and in good standing under the Laws of China;

(b)It has full legal right, power and authority to execute, deliver and perform this Contract and all contracts, agreements and documents as mentioned herein to which it is a party;

(c)It has taken all appropriate and necessary actions to authorize the execution, delivery and performance of this Contract and all contracts, agreements and documents as mentioned herein, and its representative signing this Contract has been fully authorized to sign this Contract and bind it under a valid power of attorney;

(d)It has obtained all necessary consents, approvals and authorizations of the Company, any third party or otherwise as required by laws and regulations for the valid execution, delivery and performance of this Contract and all contracts, agreements and documents as mentioned herein to which it is a party, and this Contract, upon entry into force, shall constitute its legal, valid and binding obligation which may be enforceable against it in accordance with the terms hereof;

(e)The execution and performance of this Contract or the consummation of the transaction contemplated by this Contract shall not violate or conflict with any term or provision of any Articles of Association, contracts, agreements, laws, and regulations to which it is a party or which bind it, shall not cause a violation of such term or provision, nor shall constitute a breach under such term or provision, including its constitutional documents, business license, rules of procedure or Articles of Association;

(f)There are no pending or threatened claims against it in respect of the matters under this Contract or any claims that may in any way affect its ability to enter into or perform this Contract;

(g)All documents, representations and information held by it relating to the transaction contemplated by this Contract that may have a material adverse effect on its ability to fully perform its obligations under this Contract, or, if disclosed to the other Parties, will have a material adverse effect on the other Parties’ willingness to enter into this Contract
32


have been fully disclosed to the other Parties, and none of the documents previously provided by it to the other Parties contains any untrue statements of material facts or has omitted any material facts necessary for the statements contained therein to be not misleading;

(h)It has no unfulfilled commitments or obligations (whether contractual or otherwise) that may in any way interfere with its ability or right to enter into and perform this Contract;

(i)It has not possessed or used and does not possess or use the Company’s property for free;

(j)It has paid all the registered capital subscribed by it to the Company and the capital contribution is legal. The source of funds used for its capital contribution is legal. If its capital contribution is made in any property other than cash, there is no over-valuation or under-valuation of such property.

17.7Each of [*], [*], [*], [*], [*], [*] and [*] represents, warrants and undertakes that

(a)It is a [limited partnership] which is duly established, validly existing and in good standing under the laws of [China];

(b)It has full legal right, power and authority to execute, deliver and perform this Contract and all contracts, agreements and documents as mentioned herein to which it is a party;

(c)It has taken all appropriate and necessary actions (including shareholder’s resolutions and/or board resolutions, as the case may be) to authorize the execution, delivery and performance of this Contract and all contracts, agreements and documents as mentioned herein, and its representative signing this Contract has been fully authorized to sign this Contract and bind it under a valid power of attorney;

(d)It has obtained all necessary consents, approvals and authorizations of the Company, any third party or otherwise as required by laws and regulations for the valid execution, delivery and performance of this Contract and all contracts, agreements and documents as mentioned herein to which it is a party, and this Contract, upon entry into force, shall constitute its legal, valid and binding obligation which may be enforceable against it in accordance with the terms hereof;

(e)The execution and performance of this Contract or the consummation of the transaction contemplated by this Contract shall not violate or conflict with any term or provision of any Articles of Association, contracts, agreements, laws, and regulations to which it is a party or which bind it, shall not cause a violation of such term or provision, nor shall constitute a breach under such term or provision, including its constitutional documents, business license, rules of procedure or Articles of Association;

(f)There are no pending or threatened claims against it in respect of the matters under this Contract or any claims that may in any way affect its ability to enter into or perform this Contract;

(g)All documents, representations and information held by it relating to the transaction contemplated by this Contract that may have a material adverse effect on its ability to fully perform its obligations under this Contract, or, if disclosed to the other Parties, will have a material adverse effect on the other Parties’ willingness to enter into this Contract have been fully disclosed to the other Parties, and none of the documents previously provided by it to the other Parties contains any untrue statements of material facts, or has omitted any material facts necessary for the statements contained therein to be not misleading;

(h)It has no unfulfilled commitments or obligations (whether contractual or otherwise) that may in any way interfere with its ability or right to enter into and perform this Contract;
33



(i)It has not possessed or used and does not possess or use the Company’s property for free;

(j)It has paid all the registered capital subscribed by it to the Company and the capital contribution is legal. The source of funds used for its capital contribution is legal. If its capital contribution is made in any property other than cash, there is no over-valuation or under-valuation of such property.

(k)It hereby confirms that, in order to achieve the Qualified Listing of the Company, from the date when the Company submits the listing materials (“Listing Application”) to the relevant regulatory authorities and exchanges where the Company is listed, including but not limited to the China Securities Regulatory Commission, the Shanghai Stock Exchange or the Shenzhen Stock Exchange and such Listing Application is accepted by the aforementioned authorities, it shall terminate its special rights in this Contract or all other documents (including the right with respect to corporate governance, equity transfer restrictions, right of first refusal, right of co-sale, pre-emptive right, anti-dilution right, drag-along rights, liquidation preference, etc.), and actively cooperate with the Company to sign documents and issue relevant statements, commitments, etc.

Article 18 Confidentiality
18.1Confidentiality

Before the signing and during the term of this Contract, each Party has disclosed or may disclose confidential or proprietary information concerning its business, financial condition, know-how, research and development and other confidential matters to the other Parties, and during the term of this Contract, the Parties may also disclose the above information to the Company, and the Company's such information (including but not limited to this Contract and the Articles of Association) may also be disclosed to the Parties (hereinafter collectively referred to as "Confidential Information"). Each Party and Company receiving the Confidential Information shall, during the term of this Contract (including any renewal thereof) and for three (3) years after termination of this Contract:

(a)limit access to the Confidential Information to the directors, officers and employees who are required to access to such information for the performance of this Contract;

(b)not directly or indirectly disclose, communicate, assign, transfer, license or deliver any Confidential Information to any third party; and

(c)not use the Confidential Information for any purpose other than the performance of this Contract.

18.2Exceptions

Article 18.1 on non-disclosure does not apply to the following:

(a)Confidential communications with respective affiliates, professional advisers or banks of the Parties who assume equivalent obligation of confidentiality;

(b)Disclosures required by applicable laws and regulations; provided that the Party encountering such a request must promptly notify the Party providing the Confidential Information in writing of such a request;

(c)Information that has become public knowledge through no fault of the receiving Party of the confidential information;

(d)Submitting this Shareholders Contract for handling government filing, registration or approval procedures related to this Shareholders Contract, including but not limited submitting the same according to the requirements of the administration for market regulation or other relevant government departments;
34



(e)Providing this Shareholders Contract to relevant financier and its nominee (provided that the financier has properly and promptly signed a confidentiality agreement with the Company) according to the due diligence investigation required for or other legal procedure relating to the financing needs of the Company; and

(f)Any information disclosed in good faith to the recipient by a third party who is not bound by any obligation of confidentiality.

18.3Confidentiality Measures

The Parties shall ensure that the Company informs its directors, supervisors, officers and employees who have access to any Confidential Information of the existence and requirements of Article 18.1, and formulate rules and regulations to procure the directors, supervisors, officers, and employees of the Parties and their respective affiliates to comply with the confidentiality obligations set out in Article 18.1. The Parties shall, and shall ensure the Company to, sign confidentiality agreements with all directors, supervisors, officers and employees who have access to any Confidential Information (if the employment contracts or other relevant contracts or agreements that have been signed with such personnel include confidentiality terms, it shall be deemed that a confidentiality agreement has been signed).


Article 19 Dispute Resolution

19.1Dispute Resolution

Any disputes, controversies or claims arising out of or in connection with this Contract or any breach of this Contract (collectively the "Disputes") shall be submitted to the Hong Kong International Arbitration Centre ("HKIAC") for arbitration in accordance with its Arbitration Rules which shall be deemed to be incorporated into Article [19] of this Contract, except as amended by this Article [19]. The arbitration shall be conducted by an arbitral tribunal composed of three (3) arbitrators. Among them, the Party or Parties making the arbitration application shall appoint one arbitrator; the Party or Parties to which the arbitration application is made shall appoint another arbitrator; the third arbitrator shall be appointed by the above two arbitrators and shall serve as the presiding arbitrator . If the first two arbitrators are unable to appoint the third arbitrator within twenty one (21) days of the appointment of the second arbitrator, the third arbitrator shall be appointed by the Chairman of the HKIAC. The award made by the arbitral tribunal shall be final and binding on the Parties to the dispute.

19.2Place and Language of Arbitration

The place of arbitration shall be Hong Kong, and the language used in the arbitration proceedings shall be Chinese.

19.3Period for Making the Arbitral Award

The Parties irrevocably agree that the arbitral tribunal shall make a final award within six (6) months from the date of its constitution; however, the arbitral tribunal has the power to extend the above period at the well-founded request of either Party or as it deems necessary.

19.4Continue to Perform

During the dispute resolution period, the Parties shall continue to perform other terms of this Contract except the disputed matters.



Article 20 Special Arrangements
35



20.1Patent Maintenance

The Company shall be responsible for the costs of maintaining its patents, including existing and future sublicensed technology.

20.2Pre-emptive Right

After the completion of this transaction, if the Company increases capital or issues new shares before its listing filing, each Shareholder has the right to subscribe for the Company's new series of capital increase on the same conditions and in accordance with the proportion of each Shareholder's capital contribution to the Company before the capital increase or issuance of new shares, except for the issue of new shares for the purpose of employee equity incentives.

The Company shall, at least sixty (60) days prior to the proposed capital increase or issue of new shares, give each of the Company's Shareholders a written notice of the proposed capital increase or issue of new shares (the "Proposed Capital Increase Notice"), setting out (i) the amount, type and terms of the proposed capital increase; (ii) the consideration that the Company can receive after implementation of the proposed capital increase.

If each Party elects to exercise the pre-emptive right within twenty (20) days of receipt of the Proposed Capital Increase Notice (the "Subscription Period"), it shall submit a written notice to the Company (the "Exercise Notice") setting out the amount of the proposed capital increase that it intends to purchase. If any Shareholder of the Company fails to submit the Exercise Notice within the Subscription Period, it is deemed that such party (“Unsubscribing Shareholder”) has waived the exercise of the preemptive rights in relation to the proposed capital increase. The Company shall, within three (3) days after the expiration of the Subscription Period, notify other investors who have exercised their pre-emptive rights in full (“Subscribing Shareholders”) in writing of the Unsubscribing Shareholders’ failure to exercise their pre-emptive rights. Subscribing Shareholders may submit a written notice (“Second Subscription Notice”) to the Company within seven (7) days after receipt of the Company’s written notice (“Second Subscription Period”) confirming the purchase of the proposed capital increase unsubscribed by the Unsubscribing Shareholder ( "Unsubscribed Proposed Capital Increase"). If two or more Subscribing Shareholders reply in writing to the Company to continue the subscription, they shall purchase the Unsubscribed Proposed Capital Increase in proportion to their respective capital contributions. If the Subscribing Shareholders fail to submit a Second Subscription Notice to the Company within the Second Subscription Period, they shall be deemed to have waived purchase of the Unsubscribed Proposed Capital Increase.

20.3Anti-dilution Rights

20.3.1 If the Company increases its registered capital within [24] months after the signing of this Contract, and new investors subscribe for the Company's newly increased registered capital (the "Subsequent Financing") at a price per share lower than the Investors’ Investment Unit Price, New Investors have the right to require the Company to undertake anti-dilution obligations to them so that the New Investors obtain additional equity (“Compensation Equity”). The Compensation Equity shall be calculated and determined in accordance with the generalized weighted average method so that its investment unit price is consistent with the new issue price.

20.3.2 In order to obtain Compensation Equity, the Company shall actively promote the performance and implementation of the above-mentioned anti-dilution obligations in Article 20.3.1. The Company may choose one of the following methods to facilitate the New Investors to obtain Compensation Equity:

(a)To the extent permitted by the current applicable law, the Company shall issue additional equity to the New Investors at a price not lower than the nominal value of the registered capital (for the avoidance of doubt, the subscription price paid by the New Investors for
36


subscription of such newly increased registered capital shall be reimbursed by the Company); or

(b)To the extent permitted by the current applicable law, the Company will pay cash compensation directly to the New Investors. The amount of cash compensation is: the equivalent cash amount of the capital contribution corresponding to the difference between the equity to be obtained by the New Investors which is adjusted according to the consideration paid by the new investors who have subscribed for the new registered capital of the Subsequent Financing and the equity of the Company that the new investors have acquired through this capital increase.

20.3.3 Exceptions to Anti-dilution Rights

Issue of shares under the following circumstances is not subject to anti-dilution rights: (i) issue of new shares or increase of registered capital in accordance with the employee stock incentive plan approved by the board of directors; (ii) adjustment due to stock splits, dividend distributions, recapitalizations and similar transactions; (iii) any acquisition transaction of the Company in which the Company issues shares as consideration.



Article 21 Miscellaneous Provisions

21.1Effectiveness, Term and Extension

(a)This Contract shall become effective and binding upon the Parties after it is signed by the duly authorized representatives of the Parties. This Contract is made in [thirty (30)] counterparts.

(b)This Contract shall continue in effect until the expiry or early termination of the Company’s Term. When the Company’s Term is extended, the term of this Contract shall be extended accordingly.

21.2Applicable Law

The conclusion, validity, interpretation and performance of this Contract and the settlement of any disputes arising hereunder shall be governed by the Laws of China.

21.3Entire Agreement

This Contract supersedes all previous oral agreements, commitments and communications between the Parties based on the Joint Venture Contract for the Establishment of Chongqing Alpha and Omega Semiconductor Limited (the "Joint Venture") signed by the Original Shareholders on March 29, 2016. The rights and obligations before this Contract takes effect shall be understood and explained in accordance with the provisions of the Joint Venture Contract, and the rights and obligations after this Contract takes effect shall be understood and explained in accordance with the provisions of this Contract.

If the content of this Contract is inconsistent with relevant provisions of the Company's Articles of Association and the current laws and regulations, the provisions of the current relevant laws and regulations shall prevail.

21.4Headings

The headings in this Contract are for convenience only and shall not be taken into account when interpreting this Contract.

37


21.5Amendment

No amendment to this Contract shall become effective until the duly authorized representatives of the Parties sign a written agreement.

21.6Severability

If any term or provision of this Contract is held to be invalid or unenforceable in whole or in part under any applicable law, such term or provision shall be excluded from this Contract only to the extent of such invalidity or unenforceability, and all other terms and provisions shall remain in full force and effect. In such event, the Parties shall use their best efforts to enforce the letter and spirit of this Contract and shall substitute valid and enforceable term or provision that conform to the spirit and purpose of such invalid or unenforceable term or stipulation as far as possible.

21.7Successors and Assigns

This Contract shall bind and insure for the benefit of the Parties and their respective successors and managers as well as the assigns who receive the benefit of the Parties in the Company according to laws and the terms and conditions of this Contract.

21.8Costs and Expenses

(a)Each Party shall assume any costs, expenses or amounts incurred before the signing of this Contract, unless other Parties agree in writing to share the same or agree in writing that the Company shall assume the same.

(b)After the signing of this Contract, any expenses related to company registration incurred by either Party shall be borne by the Company if it is provided that the registered company shall assume such expenses according to the Chinese law; otherwise, the Company may assume such expenses upon the approval of the Shareholder’s Meeting.

(c)Unless as otherwise stipulated in this Article 21.8, if this Contract has any special provisions on costs and expenses, such special provisions shall apply.

21.9Waiver

The delay or failure by either Party to exercise any of its powers, rights or remedies hereunder shall be construed as a waiver of such powers, rights or remedies, and any single or partial exercise shall not preclude any other exercise. No waiver by one Party of any provision of this Contract shall be deemed a waiver of any other provision of this Contract, nor shall such waiver be construed as a waiver of such provision with respect to any other event or circumstance (whether past, present or future). In addition, the remedies provided in this Contract are cumulative and do not exclude any remedies provided by law.

21.10Notice

Any significant communications between the Parties and between a party and the Company shall be sent by (i) personal delivery or (ii) postage prepaid air express (using an internationally recognized express company such as FedEx, UPS, DHL, EMS, and EMS can only be used for mailing to addresses within China), respectively, to the following addresses of each Party and the Company or to the following e-mail addresses stipulated in this Contract. All the above notices shall be deemed to be effectively delivered or received (i) upon receipt in the case of personal delivery; (ii) on the tenth (10th) working day (subject to the working day in the recipient’s country) after delivery to an internationally recognized express company in the case of air express; (iii) upon receipt of the recipient’s confirmation of receiving the communication in the case of email.

(a)To [*]:

38


Email:[*]
Address:    [*]
Attention: [*]

Email:[*]
Address: [*]
Attention: [*]

(b)To [*]:

Email:[*]
Address: [*]
Attention: [*]

(c)To AOS:

Email:[*]
Address: [*]
Attention: [*]

(d)To [*]:

Email:[*]
Address: [*]
Attention: [*]

(e)To [*]:

Email:[*]
Address: [*]
Attention: [*]

(f)To [*]:

Email:[*]
Address: [*]
Attention: [*]

(g)To [*]:

Email:[*]
Address: [*]
Attention: [*]

(h)To [*]:

Email:[*]
Address: [*]
Attention: [*]

(i)To [*]:

Email:[*]
Address: [*]
Attention: [*]

(j)To [*]:

Email:[*]
39


Address: [*]
Attention: [*]

(k)To [*]:

Email:[*]
Address: [*]
Attention: [*]

(l)To [*]:

Email:[*]
Address: [*]
Attention: [*]

(m)To [*]:

Email:[*]
Address: [*]
Attention: [*]

(n)To [*]:

Email:[*]
Address: [*]
Attention: [*]


(o)To [*]:

Email:[*]
Address: [*]
Attention: [*]

(p)To [*]:

Email:[*]
Address: [*]
Attention: [*]

(q)To [*]:

Email:[*]
Address: [*]
Attention: [*]

(r)To [*]:

Email:[*]
Address: [*]
Attention: [*]

During the term of this Contract, either Party may change its address at any time, but it shall immediately notify the other investors and the Company in writing.





40








[Signature page follows]


41


(Signature page of Shareholders Contract of Chongqiong Alpha and Omega Semiconductor Limited)






[*]

Signature of Authorized Representative:
Name: [*]
Title: Legal Representative


(Enterprise Seal)








42


(Signature page of Shareholders Contract of Chongqiong Alpha and Omega Semiconductor Limited)







Alpha & Omega Semiconductor (Shanghai) Ltd.

Signature of Authorized Representative:
Name: Zhen Du
Title: Legal Representative



(Enterprise Seal)




43


(Signature page of Shareholders Contract of Chongqiong Alpha and Omega Semiconductor Limited)







Agape Package Manufacturing (Shanghai) Limited.

Signature of Authorized Representative:
Name: BING XUE
Title: Legal Representative



(Enterprise Seal)


44


(Signature page of Shareholders Contract of Chongqiong Alpha and Omega Semiconductor Limited)







Alpha and Omega Semiconductor Limited

Signature of Authorized Representative:
Name: MIKE FUSHING CHANG
Title: Chairman



45


(Signature page of Shareholders Contract of Chongqiong Alpha and Omega Semiconductor Limited)







[*]

Signature of Authorized Representative:
Name: [*]
Title: Representative Appointed by Managing Partner


(Enterprise Seal)






46


(Signature page of Shareholders Contract of Chongqiong Alpha and Omega Semiconductor Limited)







[*]

Signature of Authorized Representative:
Name: [*]
Title: Legal Representative



(Enterprise Seal)


47



(Signature page of Shareholders Contract of Chongqiong Alpha and Omega Semiconductor Limited)







[*]

Signature of Authorized Representative:
Name: [*]
Title: Representative Appointed by Managing Partner



(Enterprise Seal)














48


(Signature page of Shareholders Contract of Chongqiong Alpha and Omega Semiconductor Limited)







[*]

Signature of Authorized Representative:
Name: [*]
Title: Representative Appointed by Managing Partner



(Enterprise Seal)




49



(Signature page of Shareholders Contract of Chongqiong Alpha and Omega Semiconductor Limited)







[*]

Signature of Authorized Representative:
Name: [*]
Title: Representative Appointed by Managing Partner



(Enterprise Seal)




50



(Signature page of Shareholders Contract of Chongqiong Alpha and Omega Semiconductor Limited)







[*]

Signature of Authorized Representative:
Name: [*]
Title: Representative Appointed by Managing Partner



(Enterprise Seal)




51



(Signature page of Shareholders Contract of Chongqiong Alpha and Omega Semiconductor Limited)







[*]

Signature of Authorized Representative:
Name: [*]
Title: Representative Appointed by Managing Partner



(Enterprise Seal)



52



(Signature page of Shareholders Contract of Chongqiong Alpha and Omega Semiconductor Limited)







[*]

Signature of Authorized Representative:
Name: [*]
Title: Representative Appointed by Managing Partner



(Enterprise Seal)




53


(Signature page of Shareholders Contract of Chongqiong Alpha and Omega Semiconductor Limited)







[*]

Signature of Authorized Representative:
Name: [*]
Title: Representative Appointed by Managing Partner



(Enterprise Seal)




54



(Signature page of Shareholders Contract of Chongqiong Alpha and Omega Semiconductor Limited)







[*]

Signature of Authorized Representative:
Name: [*]
Title: Representative Appointed by Managing Partner



(Enterprise Seal)




55



(Signature page of Shareholders Contract of Chongqiong Alpha and Omega Semiconductor Limited)







[*]

Signature of Authorized Representative:
Name: [*]
Title: Representative Appointed by Managing Partner



(Enterprise Seal)



56



(Signature page of Shareholders Contract of Chongqiong Alpha and Omega Semiconductor Limited)







[*]

Signature of Authorized Representative:
Name: [*]
Title: Representative Appointed by Managing Partner



(Enterprise Seal)



57



(Signature page of Shareholders Contract of Chongqiong Alpha and Omega Semiconductor Limited)







[*]

Signature of Authorized Representative:
Name: [*]
Title: Representative Appointed by Managing Partner



(Enterprise Seal)



58



(Signature page of Shareholders Contract of Chongqiong Alpha and Omega Semiconductor Limited)







[*]

Signature of Authorized Representative:
Name: [*]
Title: Representative Appointed by Managing Partner



(Enterprise Seal)


59



(Signature page of Shareholders Contract of Chongqiong Alpha and Omega Semiconductor Limited)







[*]

Signature of Authorized Representative:
Name: [*]
Title: Representative Appointed by Managing Partner



(Enterprise Seal)



60



(Signature page of Shareholders Contract of Chongqiong Alpha and Omega Semiconductor Limited)







[*]

Signature of Authorized Representative:
Name: [*]
Title: Representative Appointed by Managing Partner



(Enterprise Seal)




61
EX-21.1 3 aoslex211fy2022listofsubsi.htm EX-21.1 FY 2022 10K Document

Exhibit 21.1
 
SUBSIDIARIES OF THE REGISTRANT
Subsidiary NameIncorporated LocationPercentage Owned
Alpha and Omega Semiconductor IncorporatedCalifornia, United States100% owned by AOS
Alpha and Omega Semiconductor (Cayman) Ltd.Cayman100% owned by AOS
Alpha and Omega Semiconductor (Shanghai) Co., Ltd.China100% owned by AOS
Alpha & Omega Semiconductor (Shenzhen) LimitedChina100% owned by AOS
Alpha & Omega Semiconductor (Hong Kong) LimitedHong Kong100% owned by AOS
Alpha & Omega Semiconductor (Macau), Ltd.Macau100% owned by AOS
Alpha & Omega Semiconductor (Taiwan) LimitedTaiwan100% owned by AOS
Alpha & Omega Semiconductor (Germany) GmbHGermany100% owned by AOS
Agape Package Manufacturing Ltd.Cayman100% owned by AOS
Agape Package Manufacturing (Shanghai) Ltd.China100% owned by AOS
Agape LimitedHong Kong100% owned by AOS
Jireh Semiconductor IncorporatedOregon, United States100% owned by AOS
Chongqing Alpha and Omega Semiconductor LimitedChongqing, China42% owned by AOS
Alpha and Omega Semiconductor International LP Canada100% owned by AOS
Alpha and Omega Semiconductor (Delaware) LLC Delaware, United States100% owned by AOS


EX-23.1 4 aoslex231fy2022bdoconsent.htm EX-23.1 FY 2022 10K Document

Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Alpha and Omega Semiconductor Limited
Sunnyvale, California

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-261036, 333-166403, 333-172173, 333-180126, 333-186480, 333-190935, 333-207987, and 333-228297) of Alpha and Omega Semiconductor Limited of our reports dated September 19, 2022, relating to the consolidated financial statements and schedule and the effectiveness of Alpha and Omega Semiconductor Limited’s internal control over financial reporting, which appear in this Form 10-K.

/s/ BDO USA, LLP
San Jose, California
September 19, 2022


EX-31.1 5 aoslex311fy202210k.htm EX-31.1 FY 2022 10K Document

Exhibit 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Mike F. Chang, certify that:
1.    I have reviewed this report on Form 10-K of Alpha and Omega Semiconductor Limited;
2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.    The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.    Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.    Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.    The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a.    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date: September 19, 2022
 
/s/    MIKE F. CHANG
Mike F. Chang
Chief Executive Officer


EX-31.2 6 aoslex312fy202210k.htm EX-31.2 FY 2022 10K Document

Exhibit 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Yifan Liang, certify that:
1.    I have reviewed this report on Form 10-K of Alpha and Omega Semiconductor Limited;
2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.    The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.    Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.    Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.    The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a.    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date: September 19, 2022
 
/s/    YIFAN LIANG     
Yifan Liang
Chief Financial Officer
and Corporate Secretary


EX-32.1 7 aoslex321fy202210k.htm EX-32.1 FY 2022 10K Document

Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. § 1350, AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

I, Mike F. Chang, the chief executive officer of Alpha and Omega Semiconductor Limited (the “Company”), certify for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge,

a.the Annual Report of the Company on Form 10-K for the fiscal year ended June 30, 2022 (the “Report”), fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
b.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: September 19, 2022
 
/s/    MIKE F. CHANG   
Mike F. Chang
 Chief Executive Officer



EX-32.2 8 aoslex322fy202210k.htm EX 32.2 FY 2022 10K Document

Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. § 1350, AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

I, Yifan Liang, the chief financial officer of Alpha and Omega Semiconductor Limited (the “Company”), certify for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge,

a.the Annual Report of the Company on Form 10-K for the fiscal year ended June 30, 2022 (the “Report”), fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
b.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 

Date: September 19, 2022

/s/    YIFAN LIANG
Yifan Liang
Chief Financial Officer
and Corporate Secretary



EX-99.1 9 ex991fy2022cqreportofindep.htm EX-99.1 FY2022 10K Document

Exhibit 99.1

Chongqing Alpha and Omega Semiconductor Limited
Index to Financial Statements

Page
F-2
F-4
F-5
Statement of Equity for the Period from December 1, 2021 through December 31, 2021
F-6
F-7
Notes to Financial Statements
F-8


F-1


REPORT OF INDEPENDENT AUDITOR
The Board of Directors of Chongqing Alpha and Omega Semiconductor Limited
Opinion on the Financial Statements
We have audited the accompanying financial statements of Chongqing Alpha and Omega Semiconductor Limited ("the Company") which comprise the balance sheet as of December 31, 2021, and the related statements of operations, equity and cash flows for the period from December 1, 2021 to December 31, 2021, and the related notes to the financial statements (collectively referred to as the "financial statements").
In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021, and the results of its operations and its cash flows for the period from December 1, 2021 to December 31, 2021 in accordance with accounting principles generally accepted in the United States of America.
Basis for Opinion
We conducted our audit in accordance with auditing standards generally accepted in the United States of America (GAAS). Our responsibilities under those standards are further described in the Auditor's Responsibilities for the Audit of the Financial Statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities, in accordance with the relevant ethical requirements relating to our audit. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.
The accompanying financial statements of the Company have been prepared with the purpose of providing financial information to Alpha and Omega Semiconductor Limited ("AOS") to assist AOS in satisfying its reporting responsibilities under Regulation S-X, Rule 3-09.
Convenience Translation
Our audit also comprehended the translation of Renminbi amounts into United States dollar amounts and, in our opinion, such translation has been made in conformity with the basis stated in Note 1(d) to the financial statements. Such United States dollar amounts are presented solely for the convenience of readers outside the People's Republic of China.
Management's Responsibility for the Financial Statements
Management is responsible for the preparation and fair presentation of the financial statements in accordance with accounting principles generally accepted in the United States of America, and for the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern for one year after the date that the financial statements are issued.
Auditors' Responsibility for the Audit of the Financial Statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the financial statements.

F-2


In performing an audit in accordance with GAAS, we:
Exercise professional judgment and maintain professional skepticism throughout the audit.
Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control. Accordingly, no such opinion is expressed.
Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the financial statements.
Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern for a reasonable period of time.
We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control-related matters that we identified during the audit.

/s/ Deloitte Touche Tohmatsu Certified Public Accountants LLP
Shanghai, the People's Republic of China
August 26, 2022
F-3


CHONGQING ALPHA AND OMEGA SEMICONDUCTOR LIMITED
BALANCE SHEET
(In thousands)

December 31,
2021
NotesRMB
US$ (Note 1(d))
ASSETS
Current assets:
Cash and cash equivalents3132,25620,763
Accounts receivable, net961151
Amounts due from related parties, net313,42949,205
Inventories4326,79551,304
Prepaid and other current assets532,2535,063
Total current assets805,694126,486
Property, plant and equipment, net61,816,887285,235
Land use right, net54,3328,530
Intangible assets, net7400,02362,800
Operating lease right-of-use assets, net1074,31411,667
Restricted cash - long-term14,0002,198
Other Long-term assets5,847917
Total non-current assets
2,365,403371,347
Total assets3,171,097497,833
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable191,77930,108
Amounts due to related parties489,15976,793
Accrued liabilities8142,44422,363
Short-term debt9291,99445,840
Finance lease liabilities108,00016,955
Operating lease liabilities109,7601,533
Total current liabilities1,233,136193,592
Long-term debt9329,36351,707
Finance lease liabilities - long-term28,0004,396
Operating lease liabilities - long-term1065,38010,263
Total non-current liabilities422,74366,366
Total liabilities1,655,879259,958
Commitments and contingencies (Note 13)
Equity:
Paid-in capital2,525,474396,476
Additional paid-in capital12,4661,957
Accumulated deficit(1,022,722)(160,558)
Total equity
1,515,218
237,875
Total liabilities and equity3,171,097497,833

The accompanying notes are an integral part of the financial statements.
F-4


CHONGQING ALPHA AND OMEGA SEMICONDUCTOR LIMITED
STATEMENT OF OPERATIONS
(In thousands)

Notes
Period from December 1, 2021 to
December 31,2021
RMB
US$ (Note 1(d))
Revenue1(n)123,13719,331
Cost of goods sold125,95019,773
Gross profit (loss)
(2,813)(442)
Operating expenses:
Research and development30247
Selling, general and administrative8,5181,337
Total operating expenses8,8201,384
Operating loss(11,633)(1,826)
Interest expense and other loss, net(3,194)(501)
Net loss before income taxes(14,827)(2,327)
Income tax expense11--
Net loss(14,827)(2,327)

The accompanying notes are an integral part of the financial statements.
F-5


CHONGQING ALPHA AND OMEGA SEMICONDUCTOR LIMITED
    Statements of Equity     
(In thousands)

Paid-in capital
Additional
paid-in capital
Accumulated
deficit
Total
RMBRMBRMBRMB
US$
(Note 1(d))
Balance at December 1, 20212,525,47412,466(1,007,895)1,530,045240,202
Net loss--(14,827)(14,827)(2,327)
Balance at December 31, 20212,525,47412,466(1,022,722)1,515,218237,875

The accompanying notes are an integral part of the financial statements.
F-6


CHONGQING ALPHA AND OMEGA SEMICONDUCTOR LIMITED
STATEMENT OF CASH FLOWS
(In thousands)

Period from
December 1, 2021 to December 31, 2021
RMB
US$ (Note 1(d))
Cash flows from operating activities
Net loss(14,827)(2,327)
Adjustments to reconcile net loss to net cash provided
  by operating activities:
Allowance for credit loss30848
Inventory write-down42266
Impairment of property, plant and equipment4,814756
Depreciation and amortization18,7612,947
Loss on disposal of property, plant and equipment4,479703
Changes in assets and liabilities:
Accounts receivable27142
Amounts due from related parties6,8911,082
Inventories10,0051,571
Prepayments and other current assets2,618411
Accounts payable(4,724)(742)
Amounts due to related parties16,8602,647
Accrued liabilities21934
Operating lease liabilities27643
Net cash provided by operating activities46,3737,281
Cash flows from investing activities:
Purchase of property, plant and equipment(5,644)(886)
Net cash used in investing activities(5,644)(886)
Cash flows from financing activities:
Proceed from borrowings9615
Principal payments on capital leases(27,000)(4,239)
Net cash used in financing activities(26,904)(4,224)
Cash, cash equivalents and restricted cash as of
  December 1, 2021
132,43120,790
Net increase in cash, cash equivalents and restricted cash13,8252,171
Cash, cash equivalents and restricted cash as of
  December 31, 2021
146,25622,961
Supplemental disclosures of cash flow information:
Cash and cash equivalents132,25620,763
Restricted cash, non-current14,0002,198
Total cash and cash equivalents and restricted cash146,25622,961
Cash paid for interest8,5151,337
Supplemental disclosures of non-cash investing and
  financing information:
Property, plant and equipment purchased
  but not yet paid
2,206346

The accompanying notes are an integral part of the financial statements.

F-7

CHONGQING ALPHA AND OMEGA SEMICONDUCTOR LIMITED
FOR THE ONE-MONTH PERIOD ENDED DECEMBER 31, 2021
NOTES TO FINANCIAL STATEMENTS
(In Thousands of Renminbi, unless otherwise indicated)

1. The Company and Significant Accounting Policies
(a) History and Principal Activities
Chongqing Alpha and Omega Semiconductor Limited ("CQAOS", "the Company") was incorporated in Chongqing, China on April 22, 2016. It was invested by Alpha and Omega Semiconductor Limited ("AOS") with two investment funds owned by the Municipality of Chongqing (the "Chongqing Funds") by entering into a joint venture contract, for the purpose of constructing and operating a power semiconductor packaging, testing and wafer fabrication facility in the Liangjiang New Area of Chongqing, People of Republic China. Before December 2021, the AOS Group (collectively AOS and its subsidiaries) and the Chongqing Funds owned 50.9% and 49.1%, respectively, of the equity interest in the Company. On December 2, 2021, AOS Group disposed of partial equity interest in CQAOS to certain third-party investors. As a result, the Company was deconsolidated from the AOS Group.
(b) Basis of presentation
The financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP").
(c) Use of Estimates
The preparation of the financial statements in conformity with U.S. GAAP requires the Company to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses. To the extent there are material differences between these estimates and actual results, the Company's financial statements will be affected. On an ongoing basis, the Company evaluates the estimates, judgments and assumptions including principal-versus-agent determination for revenue recognition, allowance for credit loss, inventory reserves, warranty accrual, income taxes, leases, recoverability of and useful lives for property, plant and equipment and intangible assets.
(d) Foreign currency transaction and translation
Foreign currency transactions are translated into the functional currencies using the exchange rates prevailing at the beginning of the month. Foreign exchange gains and losses, resulting from the settlement of such transactions and from the re-measurement of monetary assets and liabilities denominated in foreign currencies using exchange rates at month end and non-monetary assets and liabilities using historical exchange rates, are recognized in the statements of operations.
The Company's reporting currency and functional currency is Renminbi ("RMB"). Translations of balances in the balance sheets, statements of operations and statements of cash flows from RMB into U.S. Dollars ("US$") as of and for one month ended December 31, 2021 are solely for the convenience of the reader and were calculated at the rate of US$1.00 = RMB6.3698 representing the average buying and selling spot rate set forth in the statistical release of the China Foreign Exchange Trade System on December 31, 2021.
(e) Cash, cash equivalents and restricted cash
Cash and cash equivalents primarily consist of cash on hand and short-term bank deposits with original maturities of three months or less. Cash equivalents are highly liquid investments with stated maturities of three months or less as of the dates of purchase. The carrying amounts reported for cash and cash equivalents are considered to approximate fair values based upon their short maturities.
Cash and cash equivalents are maintained with reputable major financial institutions. If, due to current economic conditions or other factors, one or more of the financial institutions with which the Company maintains deposits fails, the Company's cash and cash equivalents may be at risk. Deposits with these banks may exceed the amount of insurance provided on such deposits; however, these deposits typically may be redeemed upon demand and, therefore, bear minimal risk.











F-8


CHONGQING ALPHA AND OMEGA SEMICONDUCTOR LIMITED
FOR THE ONE-MONTH PERIOD ENDED DECEMBER 31, 2021
NOTES TO FINANCIAL STATEMENTS
(In Thousands of Renminbi, unless otherwise indicated)

(e) Cash, cash equivalents and restricted cash - continued
As a condition of the loan arrangements, the Company is required to keep a compensating balance at the issuing bank. In addition, the Company maintains restricted cash in connection with cash balances temporarily restricted for regular business operations, including the possibility of a dispute with a vendor. These balances have been excluded from the Company's cash and cash equivalents balance and are classified as restricted cash in the Company's balance sheets.
(f) Accounts receivable, net
The allowance for credit loss is based on assessment of the collectability of accounts receivable from customers. The Company reviews the allowance by considering factors such as historical collection experience, credit quality, aging of the accounts receivable balances and current economic conditions that may affect a customer's ability to pay. The Company writes off a receivable and charges against its recorded allowance when it has exhausted its collection efforts without success.
(g) Fair Value Measurements
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value, which are the following:
•Level 1 - Quoted prices in active markets for identical assets or liabilities.
•Level 2 - Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
•Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
(h) Fair Value of Financial Instruments and others
The fair value of cash equivalents is based on observable market prices and have been categorized in Level 1 in the fair value hierarchy. Cash equivalents consist primarily of short-term bank deposits. The carrying values of financial instruments such as cash and cash equivalents, accounts receivable and accounts payable approximate their carrying values due to their short-term maturities. The carrying value of the company's debt is considered a reasonable estimate of fair value which is estimated by considering the current rates available to the Company for debt of the same remaining maturities, structure and terms of the debts.
The Company measures certain long-lived assets or long-term investments at fair value on a non-recurring basis in periods after initial measurement in circumstances when the fair value of such assets is below its recorded cost and impairment is required. Fair value of the property and equipment in impairment testing were determined by the Company based on the income approach using the discounted cash flows associated with the underlying assets, which incorporated certain assumptions including projected revenue, growth rates and projected operating costs, expectation of management and projected trends of current operating results.
The Company recorded impairment charges of RMB4,814(US$756) for certain property, plant and equipment during the month ended December 31, 2021. The impairment was recorded in cost of goods sold in its statements of operations.

F-9

CHONGQING ALPHA AND OMEGA SEMICONDUCTOR LIMITED
FOR THE ONE-MONTH PERIOD ENDED DECEMBER 31, 2021
NOTES TO FINANCIAL STATEMENTS
(In Thousands of Renminbi, unless otherwise indicated)


(i) Inventories
The Company carries inventories at the lower of cost or net realizable value. Cost of inventory includes semiconductor wafer and raw materials, labor, depreciation expenses and other manufacturing expenses and overhead, and packaging and testing fees paid to third parties if subcontractors are used. Valuation of inventories are based on the Company's periodic review of inventory quantities on hand as compared with its sales forecasts, historical usage, aging of inventories, production yield levels and current product selling prices. If actual market conditions are less favorable than those forecasted by management, additional future inventory write-downs may be required. Adjustments to inventory once established are not reversed until the related inventory has been sold or scrapped.
(j) Property, plant and equipment, net
Property, plant and equipment are stated at historical cost less accumulated depreciation. Historical cost includes expenditures that are directly attributable to the acquisition of the items and the costs incurred to make the assets ready for their intended use.

Depreciation is provided for on a straight-line basis over the estimated useful lives of the related assets as follows:
Useful life
Building20 ~ 30 years
Manufacturing machinery and equipment10 ~ 15 years
Equipment and tooling10 ~ 15 years
Software2 ~ 10 years
Office furniture and equipment3 ~ 5 years
Vehicle and other fix asset4 years
In March 2017, the CQAOS received the land use right certificate from the PRC government. The land use right will expire on November 30, 2066.
Construction in progress represent equipment received but the necessary installation has not been fully performed or building construction and leasehold improvements that have been started but not yet completed. Equipment and construction in progress are stated at cost and transferred to respective asset class when fully completed and ready for their intended use.
Software is externally purchased which is amortized over two to ten years on a straight-line basis. Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized as selling, general and administrative expenses in the statements of operations. Costs of maintenance and repairs that do not improve or extend the lives of the respective assets are expensed as incurred.
(k) Land use right, net
The land use rights represent the operating lease prepayments for the rights to use the land in the PRC under ASC 842, which are amortized on a straight-line basis over the remaining term of the land certificates. In March 2017, the CQAOS received the land use right certificate from the PRC government with the consideration of RMB60,178 (US$9,447). The land use right will expire on November 30, 2066. Amortization expense of land use rights for the one month ended December 31, 2021 amounted to RMB101 (US$16).

F-10

CHONGQING ALPHA AND OMEGA SEMICONDUCTOR LIMITED
FOR THE ONE-MONTH PERIOD ENDED DECEMBER 31, 2021
NOTES TO FINANCIAL STATEMENTS
(In Thousands of Renminbi, unless otherwise indicated)

(l) Impairment of Long-lived Assets
Long-lived assets are reviewed for impairment in accordance with authoritative guidance for impairment or disposal of long-lived assets. Long-lived assets are reviewed for events or changes in circumstances, which indicate that their carrying value may not be recoverable. Long-lived assets with definite lives are not impaired unless undiscounted cash flow is less than the carrying value, at which time impairment is recorded for the difference between carrying value and fair value. For the one month ended December 31, 2021, RMB4,814 was recognized as impairment loss and recoded in cost of goods sold.

(m) Government Grants
The Company occasionally receives government grants that provide financial assistance for certain eligible expenditures in China. The grant is reimbursement on interest expense on bank borrowings, payroll tax credits, credit for property, plant and equipment, employment credits, as well as business expansion credits. Grants received with no performance obligation or other restriction as to the use are recognized when cash is received. Grants received with government specified performance obligations are recognized when all the obligations have been fulfilled. If such obligations are not satisfied, the Company may be required to refund the subsidy. The Company records such grants either as a reduction of the related expense, a reduction of the cost of the related asset, or as other income depending upon the nature of the grant.
(n) Revenue Recognition
The Company’s revenue is derived from the sales of silicon chips and wafer, providing assembly and testing ("A&T") service, and other revenue.
The Company determines revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract; and (5) recognition of revenue when, or as, a performance obligation is satisfied. The Company recognizes product revenue at a point in time when product is shipped to customer, and service revenue once rendered. The Company presents revenue net of sales taxes. The standard payment terms range from 30 to 90 days.
The Company's performance obligations relate to contracts with a duration of less than one year. The Company elected to apply the practical expedient provided in ASC 606, “Revenue from Contracts with Customers”. Therefore, the Company is not required to disclose the aggregate amount of transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period.
The following is a summary of revenue by type:

Period from December 1, 2021 to
December 31,2021

RMBUS$
Product
116,98218,365
Service6,155966
Total123,13719,331
(o) Cost of goods sold
Cost of goods sold primarily consists of costs associated with semiconductor wafers, packaging and testing, shipping and handling, personnel, overhead attributable to manufacturing, impairment loss on manufacturing equipment, operations and procurement, and costs associated with yield improvements, capacity utilization, warranty and valuation of inventories.

F-11

CHONGQING ALPHA AND OMEGA SEMICONDUCTOR LIMITED
FOR THE ONE-MONTH PERIOD ENDED DECEMBER 31, 2021
NOTES TO FINANCIAL STATEMENTS
(In Thousands of Renminbi, unless otherwise indicated)

(p) Leases
The Company determines if an arrangement is a lease at inception. Right-of-use ("ROU") assets and lease liabilities are recognized for all leases based on the present value of the future minimum lease payments over the lease term at commencement date. The Company uses an estimate of its incremental borrowing rate based on the information available at the lease commencement date. ROU assets also include any lease payments made and exclude lease incentives. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options.
The Company classifies its leases in to operating lease and finance lease. Operating leases are included in operating lease ROU assets and operating lease liabilities on the Company's balance sheets. Finance lease are included in property, plant and equipment and finance lease liabilities on the balance sheets. Operating lease expense is recognized on a straight-line basis over the lease term, lease liability is amortized using the effective interest method over the lease period. The Company does not record leases on the balance sheet with a term of one year or less.
(q) Product Warranty
The Company provides a standard two-year warranty for the products from the date of purchase by the customers. The Company accrues for estimated warranty costs at the time revenue is recognized. The Company's warranty obligation is affected by product failure rates, labor and material costs for replacing defective products, related freight costs for failed parts and other quality assurance costs. The Company monitors its product returns for warranty claims and maintains warranty reserves based on historical experiences and anticipated warranty claims known at the time of estimation.
(r) Provision for Income Taxes
Income tax expense or benefit is based on income or loss before taxes. Deferred tax assets and liabilities are recognized principally for the expected tax consequences of temporary differences between the tax basis of assets and liabilities and their reported amounts.
Significant management judgment is required in determining whether deferred tax assets will be realized in full or in part. When it is more likely than not that all or some portion of specific deferred tax assets such as net operating losses or research and experimentation tax credit carry-forwards will not be realized, a valuation allowance must be established for the amount of the deferred tax assets that cannot be realized. The Company considers all available positive and negative evidence when assessing whether it is more likely than not that deferred tax assets are recoverable. The Company considers evidence such as our past operating results, the existence of cumulative losses in recent years and our forecast of future taxable income.
The Financial Accounting Standards Board, or FASB, issued guidance which clarifies the accounting for income taxes by prescribing a minimum probability threshold that a tax position must meet before a financial statement benefit is recognized. The minimum threshold is defined as a tax position that is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. The tax benefit to be recognized is measured as the largest amount of benefit that is greater than fifty percent likely to be realized upon ultimate settlement. Although the guidance on the accounting for uncertainty in income taxes prescribes the use of a recognition and measurement model, the determination of whether an uncertain tax position has met those thresholds will continue to require significant judgment by management.
The Company's provision for income taxes is subject to volatility and could be adversely impacted by changes in earnings or tax laws and regulations in various jurisdictions. The Company is subject to the continuous examination of its income tax returns by the tax authorities. The Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of our provision for income taxes. To the extent that the final tax outcome of these matters is different from the amounts recorded, such differences will impact the provision for income taxes in the period in which such determination is made. The provision for income taxes includes the impact of changes to reserves, as well as the related net interest and penalties.

F-12

CHONGQING ALPHA AND OMEGA SEMICONDUCTOR LIMITED
FOR THE ONE-MONTH PERIOD ENDED DECEMBER 31, 2021
NOTES TO FINANCIAL STATEMENTS
(In Thousands of Renminbi, unless otherwise indicated)

(s) Recent Accounting Pronouncements not yet adopted
In November 2021, the FASB issued ASU 2021-10, Government Assistance (Topic 832) — Disclosures by Business Entities about Government Assistance. The amendments in this ASU require disclosures about transactions with a government that have been accounted for by analogizing to a grant or contribution accounting model to increase transparency about (1) the types of transactions, (2) the accounting for the transactions, and (3) the effect of the transactions on an entity's financial statements. The amendments in this ASU are effective for all entities within their scope for financial statements issued for annual period beginning after December 15, 2021. Early application of the amendments is permitted. The Company does not expect this ASU to have a material impact on the financial statements.
2. Concentration of Credit Risk and Significant Customers
The Company manages its credit risk associated with exposure to customers on outstanding accounts receivable through the application of credit approvals, credit ratings and other monitoring procedures.
Credit sales, which are mainly on credit terms of 30 to 90 days, are only made to customers who meet the Company's credit standards, while sales to new customers or customers with low credit ratings are usually made on an advance payment basis. The Company considers its financial assets to be of good credit quality because its customers have long-standing business relationships with the Company and the Company has not experienced any significant bad debt write-offs of accounts receivable in the past. The Company closely monitors the aging of accounts receivable from customers, and regularly reviews their financial positions, where available.
The only customer whose revenue or accounts receivable balances were 10% or higher than the respective total amounts is the Company's related party, AOS Group. See note 12 for details of balance and transaction with AOS Group.
3.    Cash and cash equivalents
December 31, 2021
RMBUS$
Cash at bank132,25620,763
Denominated in:
US$66,68710,469
RMB65,56910,294
Certain cash and bank balances denominated in US$ were deposited with banks in the PRC. The conversion of these US$ denominated balances into foreign currencies is subject to the rules and regulations of foreign exchange control promulgated by the PRC government.
4.    Inventories
December 31, 2021
RMBUS$
Raw materials159,91525,105
Work in progress117,47918,443
Finished goods49,4017,756
Inventories326,79551,304
The Company write-down inventory for any excess or obsolete inventories or when the Company believe that the net realizable value of inventories is less than the carrying value. For the one month ended December 31, 2021, the Company wrote-down inventory of RMB422 (US$66).

F-13

CHONGQING ALPHA AND OMEGA SEMICONDUCTOR LIMITED
FOR THE ONE-MONTH PERIOD ENDED DECEMBER 31, 2021
NOTES TO FINANCIAL STATEMENTS
(In Thousands of Renminbi, unless otherwise indicated)

5.    Prepaid and other current assets

December 31, 2021
RMBUS$
Prepaid maintenance7,0051,100
Prepayment to supplier5,567874
VAT receivable13,0772,053
Others6,6041,036
Prepaid and other current assets32,2535,063

6.    Property, plant and equipment, net
Property and equipment, net consist of the following:

December 31, 2021
RMBUS$
Building368,55657,860
Manufacturing machinery and equipment1,680,985263,899
Equipment and tooling256,33040,242
Software37,9705,961
Office furniture and equipment22,1783,482
Vehicle and other fix asset7,4811,174
less: accumulated depreciation(694,444)(109,021)
Equipment and construction in progress137,83121,638
Property and equipment, net1,816,887285,235
Depreciation expenses from December 1, 2021 to December 31, 2021 was RMB13,170 (US$2,068). For the month ended December 31, 2021, RMB4,814 (US$756) was recognized as impairment loss on manufacturing equipment.
7.    Intangible assets, net
Intangible assets, net consist of the following:

December 31, 2021
RMBUS$
Patents and technology rights571,24289,680
Less: accumulated amortization(171,219)(26,880)
Intangible assets, net400,02362,800
The Company amortizes its intangible assets of patents and technology rights relating to power device semiconductors and wafer production over their estimated useful lives of 7 to 15 years. Amortization expense from December 1, 2021 to December 31, 2021 was RMB4,955.
Amortization expenses of the above intangible assets are expected to be approximately RMB59,458, RMB59,458, RMB59,458, RMB59,458 and RMB162,190 for the years ending December 31, 2022, 2023, 2024, 2025, 2026 and thereafter, respectively.

F-14

CHONGQING ALPHA AND OMEGA SEMICONDUCTOR LIMITED
FOR THE ONE-MONTH PERIOD ENDED DECEMBER 31, 2021
NOTES TO FINANCIAL STATEMENTS
(In Thousands of Renminbi, unless otherwise indicated)

8.    Accrued Liabilities
December 31, 2021
RMBUS$
Accrued compensation and benefits57,5079,028
Accrued property, plant and equipment34,8535,472
Warranty accruals11,8401,859
Accrued interest1,918301
Advance from customer5,338838
Others30,9884,865
Accrued Liabilities142,44422,363
9.    Bank borrowings
Short-term debt
On June 29, 2021, the Company entered into a one-year loan agreement with China Citic Bank to borrow a maximum of US$7.7 million. Interest payments are due on the 20th of the last month in each quarter starting September 20, 2021, and the entire principal is due on June 29, 2022. As of December 31, 2021, the outstanding balance of this loan was US$7.7 million at an interest rate of 3.4926% per annum.
On April 14, 2021, the Company entered into a loan agreement with China Everbright Bank in China to borrow a maximum of RMB100 million. The borrowing can be in either RMB or US$ and be repaid in the same currency. The loan consists of RMB50 million for working capital borrowings in RMB and RMB50 million for trade financing in US$. The loan is collateralized by eligible accounts receivable of RMB50million. On April 19, 2021, the Company borrowed RMB50 million for working capital borrowing, at an interest rate of 5.1% annum. The interest payments are due quarterly with the entire principal due no later than May 19, 2022. On November 23, 2021 and December 23, 2021, the Company also borrowed US$4.2 million and US$3.4 million for trade financing at interest rate of 2.7% per annum, with principal due on February 15, 2022 and March 2, 2022, respectively. As of December 31, 2021, the total outstanding balance of these loans were RMB50 million and US$7.6 million.
Long-term debt
On April 26, 2020, the Company entered into a loan agreement with China Development Bank, Agricultural Bank of China, China Merchants Bank and Chongqing Rural Commercial Bank (collectively, "the Banks") in the aggregate principal amount of RMB250 million. The obligation under the loan agreement is secured by certain assets of the Company with a net carrying value of RMB1,129 million as of December 31, 2021. In addition, this loan shares collateral rights with the US$24 million loan signed on November 28, 2019. Beginning December 18, 2020, the Company is required to make consecutive semi-annual payments of principal until December 8, 2024. Interest payment is due on March 20, June 20, September 20 and December 20 of each year based on China one-year loan prime rate ("LPR") plus 1.3%. During the period from April 26, 2020 to December 31, 2021, the Company drew down RMB250 million and repaid RMB50 million. As of December 31, 2021, the outstanding balance of the loan was RMB200 million.
On December 18, 2019, the Company entered into a loan agreement with China Development Bank in the amount of US$24 million. The obligation under the loan agreement is secured by certain assets of the Company with a net carrying value of RMB1,129 million as of December 31, 2021. In addition, this loan shares collateral rights with the RMB 250 million loan signed on April 26, 2020. Beginning December 18, 2020, the Company will make consecutive semi-annual payments of principal until December 8, 2024. The interest is accrued based on the LIBOR of 6 months rate plus 2.8%. The interest is required to be paid on March 21 and September 21 each year. As of December 31, 2021, the outstanding balance of the loan was US$16.8 million.

F-15

CHONGQING ALPHA AND OMEGA SEMICONDUCTOR LIMITED
FOR THE ONE-MONTH PERIOD ENDED DECEMBER 31, 2021
NOTES TO FINANCIAL STATEMENTS
(In Thousands of Renminbi, unless otherwise indicated)

On March 12, 2019, the Company entered into a loan agreement with The Export-Import Bank of China in the aggregate principal amount of RMB200 million. The loan will expire on February 20, 2025. The Company drew down RMB190 million and RMB10 million in March 2019 and December 2019, respectively. The loan withdraw window expired on February 28, 2020. The interest is accrued based on the China Base Rate (base interest rate published by the People's Bank of China) multiplied by 1.1 (5.39% for 2021). The loan requires quarterly interest payments. The principal payments are required to be paid every 6 months over the term of loan commencing in October 2019. This loan is secured by the land, buildings and certain equipment owned by the Company with a net carrying value of RMB592 million as of December 31, 2021. In addition, this loan shares the collateral rights with the rent factoring of RMB 379 million signed on March 22, 2019 which under YinHai financing lease. As a condition of the loan arrangements, RMB14 million of cash is held as restricted cash by the Company as a cash deposit at the bank until the principal is paid. On June 24, 2020, a modification of this loan was signed as a result of a change in the bank reference rate, pursuant to which the interest rate was changed to be based on the five-year loan prime rate in China plus 0.74% (5.39% for the fiscal year 2021). Other terms of this loan remain the same. As of December 31, 2021, the outstanding balance of the loan was RMB171 million.
Financing lease
On May 9, 2018 (the "Effective Date"), the Company entered into a lease finance agreement and a security agreement (the "Agreements") with YinHai Leasing Company and China Import/Export Bank (the "Lenders"). Pursuant to the Agreements, the Lenders agree to provide an aggregate of RMB400 million of financing to the Company (the "Lease Financing"). In exchange for the Lease Financing, the Company agrees to transfer title of its assembly and testing equipment to the Lenders, and the Lenders lease such equipment to the Company under a five-year lease arrangement, pursuant to which the Company makes quarterly lease payments to the Lenders consisting of principal and interest based on a repayment schedule mutually agreed by the parties. The interest under the Lease Financing is accrued based on the China Base Rate multiplied by 1.15 (5.4625% for 2021). Under the Agreements, at the end of the five-year lease term, the Lenders agree to sell such equipment back to the Company for a nominal amount RMB1. The Company's obligations under the Lease Financing that rent factoring of RMB379 million are secured by the land and building owned by the Company (the "Collateral"). In addition, this rent factoring shares the collateral rights with the loan of RMB 200 million signed on March 12, 2019. The proceeds from the Lease Financing will be used primarily for the acquisition and installation of the 12-inch fabrication equipment and other expenses of the Company relating to the completion of the fabrication facility located in Chongqing. The Agreements contain customary representation, warranties and covenants, including restrictions on the transfer of the Collateral. The Agreements also contain customary events of default, including but are not limited to, failure to make payments and breach of material terms under the Agreements. On June 28, 2020, the parties entered into a modification to this agreement as a result of a change in the bank reference rate, pursuant to which the interest rate was changed to be the five-year loan prime rate in China plus 0.8125% (5.4625% for 2021). Other terms of this agreement remain the same. As of December 31, 2021, the outstanding balance of the Lease Financing of RMB136 million was recorded under short-term and long-term finance lease liabilities.
As of December 31, 2021, maturities of short-term debt and long-term debt were as follows:

December 31,RMBUS$
2022294,25246,195
2023149,25423,432
2024159,15424,986
202523,0003,610
2016 and thereafter--
Total principal of debt625,66098,223
Less: debt issuance costs(4,303)(676)
Total principal of debt, less debt issuance costs621,357
         97,547


F-16

CHONGQING ALPHA AND OMEGA SEMICONDUCTOR LIMITED
FOR THE ONE-MONTH PERIOD ENDED DECEMBER 31, 2021
NOTES TO FINANCIAL STATEMENTS
(In Thousands of Renminbi, unless otherwise indicated)

Short-Term Debt
Long-Term Debt
Total
RMB
US$
RMBUS$RMBUS$
Principal amount294,25246,195331,40852,028625,66098,223
Less: debt issuance costs(2,258)(355)(2,045)(321)(4,303)(676)
Total291,99445,840329,36351,707621,35797,547

10.    Lease
The Company evaluates contracts for lease accounting at contract inception and assesses lease classification at the lease commencement date. Operating leases are included in operating lease right-of-use ("ROU") assets, operating lease liabilities and operating lease liabilities - long-term on the Company's balance sheets. Finance leases are included in property, plant and equipment, finance lease liabilities and finance lease liabilities-long-term on the balance sheets. The Company recognizes a ROU asset and corresponding lease obligation liability at the lease commencement date where the lease obligation liability is measured at the present value of the minimum lease payments. As most of the leases do not provide an implicit rate, the Company uses its incremental borrowing rate at lease commencement. The Company uses an interest rate commensurate with the interest rate to borrow on a collateralized basis over a similar term with an amount equal to the lease payments. Operating leases are primarily related to offices facilities, employee apartments, and gas tank equipment. Lease agreements frequently include renewal provisions and require the Company to pay real estate taxes, insurance and maintenance costs. For operating leases, the amortization of the ROU asset and the accretion of its lease obligation liability result in a single straight-line expense recognized over the lease term. The finance lease is related to YinHai Leasing Company. The Company does not record leases on the balance sheet with a term of one year or less.
The components of the Company's operating and finance lease expenses are as follows for the period presented:

Period from December 1, 2021 to
December 31, 2021
RMBUS$
Operating leases:
Fixed rent expense53684
Finance lease:
Amortization of equipment3,484547
Interest726114
Total lease expenses4,746745


F-17

CHONGQING ALPHA AND OMEGA SEMICONDUCTOR LIMITED
FOR THE ONE-MONTH PERIOD ENDED DECEMBER 31, 2021
NOTES TO FINANCIAL STATEMENTS
(In Thousands of Renminbi, unless otherwise indicated)

Supplemental balance sheet information related to the Company's operating and finance leases is as follows (in thousands, except lease term and discount rate):

As of December 31, 2021
RMBUS$
Operating leases:
ROU assets associated with operating leases74,31411,667
Finance Lease:
Property, plant and equipment, gross552,07886,671
Accumulated depreciation373,16958,584
Property and equipment, net178,90928,087
Weighted average remaining lease term (in years)
Operating leases10.8210.82
Finance leases1.251.25
Weighted average discount rate
Operating leases5.39%5.39%
Finance leases5.46%5.46%
Supplemental cash flow information related to the Company's operating and finance lease is as follows:

Period from December 1, 2021 to
December 31, 2021
RMBUS$
Cash paid from amounts included in the measurement of
  lease liabilities:
Operating cash flows from operating leases16526
Operating cash flows from finance lease2,251353
Financing cash flows from finance lease27,0004,239
Future minimum lease payments are as follows as of December 31, 2021:


Operating Lease PaymentOperating Lease Payment
Finance Lease
Payment
Finance Lease
Payment
Total Lease Payment
Total Lease Payment
Years ending December 31,
RMBUS$RMBUS$RMBUS$
202211,1901,757113,28317,784124,47319,541
20239,9231,55828,3824,45638,3056,014
20248,5821,347--8,5821,347
20258,4171,321--8,4171,321
20268,4171,321--8,4171,321
Thereafter52,6048,259--52,6048,259
Total lease payments99,13315,563141,66522,240240,79837,803
Less: imputed interest(23,993)(3,767)(5,665)(889)(29,658)(4,656)
Total lease liabilities75,14011,796136,00021,351211,14033,147

F-18

CHONGQING ALPHA AND OMEGA SEMICONDUCTOR LIMITED
FOR THE ONE-MONTH PERIOD ENDED DECEMBER 31, 2021
NOTES TO FINANCIAL STATEMENTS
(In Thousands of Renminbi, unless otherwise indicated)

11.    Income Tax
Under PRC's Enterprise Income Tax Law ("EIT Law"), the statutory income tax rate is 25%, and the EIT rate will be reduced to 15% for the encouraged enterprises located in the western region which CQAOS met the requirement, according to the taxation No.23 in 2020 announced by China development and Reform Commission of the Ministry of Finance and the State Administration, from January 1, 2021 to December 31, 2030. No provision for income taxes has been required to be accrued because CQAOS is in cumulative loss positions for the period presented.
The Company recorded a full valuation allowance against deferred tax assets because it was in a cumulative loss position as of December 31, 2021. No unrecognized tax benefits and related interest and penalties were recorded in the period presented.
12.    Related party transactions
The table below sets forth the major related parties and the relationship with the Company as of December 31, 2021:
Company NameRelationship with the Company
Chongqing Yujiangxin Enterprise Management Co., LTD.
  ("Yujiangxin")
Shareholder
Alpha and Omega Semiconductor Limited and its
  subsidiaries ("AOS Group")
Shareholder
(a)Amounts due from related parties

AccountsName of related partiesDecember 31, 2021December 31, 2021
RMBUS$
Amounts due from related parties, netAOS Group313,42949,205
The balance of amounts due from related parties as of December 31, 2021 is related to sale of finished goods to AOS Group.
(b)Amounts due to related parties

AccountsName of related partiesDecember 31, 2021December 31, 2021
RMBUS$
Amounts due to related partiesAOS Group489,15976,793

The balance of amounts due to related parties as of December 31, 2021 is related to purchase of raw materials from AOS Group.
(c)Sales and purchase with related parties
AccountsName of related partiesDecember 31, 2021December 31, 2021
RMBUS$
Revenue from related partyAOS Group117,27218,411
Purchase from related partyAOS Group31,7394,983

For the one month ended December 31 2021, all of the related party balance and transaction are as above.

F-19

CHONGQING ALPHA AND OMEGA SEMICONDUCTOR LIMITED
FOR THE ONE-MONTH PERIOD ENDED DECEMBER 31, 2021
NOTES TO FINANCIAL STATEMENTS
(In Thousands of Renminbi, unless otherwise indicated)

13.    Commitments and Contingencies
Liabilities for loss contingencies arising from claims, assessments, litigation, fines, and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount can be reasonably estimated. If a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material, is disclosed. Legal costs incurred in connection with loss contingencies are expensed as incurred.
14.    Subsequent events
The subsequent events were evaluated through August 26, 2022, which is the issuance date of the audited financial statements.
On January 26, 2022, the Company entered into an investment agreement with certain third-party investors and received a total consideration of RMB509 million (US$80 million).
On December 30, 2021, the Company approved a Share Incentive Plan. Pursuant to the Share Incentive Plan, restricted shares ("RS") were granted to certain employees of the Company as approved by the board of directors through the employee stock holding platforms (the “Platform”) which are several limited partnerships. Registration of shares granted to employees through the Platform were completed on January 8, 2022. Vesting of the RS granted are subject to service condition and certain performance conditions.

F-20
EX-101.SCH 10 aosl-20220630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 0002002 - Document - Audit Information link:presentationLink link:calculationLink link:definitionLink 1001003 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 1002004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1003005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 1004006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) link:presentationLink link:calculationLink link:definitionLink 1005007 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 1006008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 2101101 - Disclosure - The Company and Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2202201 - Disclosure - The Company and Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - The Company and Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 2404401 - Disclosure - The Company and Significant Accounting Policies - Basis of Presentation Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - The Company and Significant Accounting Policies - Risks and Uncertainties Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2406403 - Disclosure - The Company and Significant Accounting Policies - Joint Venture Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2407404 - Disclosure - The Company and Significant Accounting Policies - Restricted Cash Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2408405 - Disclosure - The Company and Significant Accounting Policies - Property and Equipment Useful Lives (Details) link:presentationLink link:calculationLink link:definitionLink 2409406 - Disclosure - The Company and Significant Accounting Policies - Government Grants (Details) link:presentationLink link:calculationLink link:definitionLink 2410407 - Disclosure - The Company and Significant Accounting Policies - Government Grants Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2411408 - Disclosure - The Company and Significant Accounting Policies - Long-lived Assets Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2412409 - Disclosure - The Company and Significant Accounting Policies - Product Warranty Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2413410 - Disclosure - The Company and Significant Accounting Policies - Advertising Expense Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2114102 - Disclosure - Equity Method Investment in Equity Investee link:presentationLink link:calculationLink link:definitionLink 2315302 - Disclosure - Equity Method Investment in Equity Investee (Tables) link:presentationLink link:calculationLink link:definitionLink 2416411 - Disclosure - Equity Method Investment in Equity Investee - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2417412 - Disclosure - Equity Method Investment in Equity Investee - Schedule of Gain on Deconsolidation (Details) link:presentationLink link:calculationLink link:definitionLink 2418413 - Disclosure - Equity Method Investment in Equity Investee - Equity Method Investment, Summarized Financial Information (Details) link:presentationLink link:calculationLink link:definitionLink 2119103 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 2420414 - Disclosure - Related Party Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 2121104 - Disclosure - Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited link:presentationLink link:calculationLink link:definitionLink 2322303 - Disclosure - Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited (Tables) link:presentationLink link:calculationLink link:definitionLink 2423415 - Disclosure - Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited - Basic and Diluted Income Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2424416 - Disclosure - Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited - Potential Dilutive Shares (Details) link:presentationLink link:calculationLink link:definitionLink 2125105 - Disclosure - Concentration of Credit Risk and Significant Customers link:presentationLink link:calculationLink link:definitionLink 2326304 - Disclosure - Concentration of Credit Risk and Significant Customers (Tables) link:presentationLink link:calculationLink link:definitionLink 2427417 - Disclosure - Concentration of Credit Risk and Significant Customers - Schedule of Concentration Risk (Details) link:presentationLink link:calculationLink link:definitionLink 2128106 - Disclosure - Balance Sheet Components link:presentationLink link:calculationLink link:definitionLink 2329305 - Disclosure - Balance Sheet Components (Tables) link:presentationLink link:calculationLink link:definitionLink 2430418 - Disclosure - Balance Sheet Components - Accounts receivable (Details) link:presentationLink link:calculationLink link:definitionLink 2431419 - Disclosure - Balance Sheet Components - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 2432420 - Disclosure - Balance Sheet Components - Other Current Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2433421 - Disclosure - Balance Sheet Components - Property, plant, and equipment (Details) link:presentationLink link:calculationLink link:definitionLink 2434422 - Disclosure - Balance Sheet Components - Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 2435423 - Disclosure - Balance Sheet Components - Other long term assets (Details) link:presentationLink link:calculationLink link:definitionLink 2436424 - Disclosure - Balance Sheet Components - Future amortization expense of intangible assets (Details) link:presentationLink link:calculationLink link:definitionLink 2437425 - Disclosure - Balance Sheet Components - Intangible assets (Details) link:presentationLink link:calculationLink link:definitionLink 2438426 - Disclosure - Balance Sheet Components - Accrued liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2439427 - Disclosure - Balance Sheet Components - Product Warranty Accrual (Details) link:presentationLink link:calculationLink link:definitionLink 2440428 - Disclosure - Balance Sheet Components - Stock Rotation Accrual (Details) link:presentationLink link:calculationLink link:definitionLink 2441429 - Disclosure - Balance Sheet Components - Impairment of long-lived assets, intangible assets, and goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 2442430 - Disclosure - Balance Sheet Components - Other long-term liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2143107 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 2344306 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 2445431 - Disclosure - Debt - Short-term borrowing (Details) link:presentationLink link:calculationLink link:definitionLink 2446432 - Disclosure - Debt - Accounts Receivable Factoring Agreement (Details) link:presentationLink link:calculationLink link:definitionLink 2447433 - Disclosure - Debt - Debt Financing (Details) link:presentationLink link:calculationLink link:definitionLink 2448434 - Disclosure - Debt - Credit Facilities and Long-term Debt Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2449435 - Disclosure - Debt - Maturities of Short-tem and Long-term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2150108 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 2351307 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 2452436 - Disclosure - Leases - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2453437 - Disclosure - Leases - Schedule of Lease Cost (Details) link:presentationLink link:calculationLink link:definitionLink 2454438 - Disclosure - Leases - Schedule of Lease Supplemental Balance Sheet Information (Details) link:presentationLink link:calculationLink link:definitionLink 2455439 - Disclosure - Leases - Schedule of Lease Supplemental Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink 2456440 - Disclosure - Leases - Schedule of Lease Maturities - Topic 842 (Details) link:presentationLink link:calculationLink link:definitionLink 2456440 - Disclosure - Leases - Schedule of Lease Maturities - Topic 842 (Details) link:presentationLink link:calculationLink link:definitionLink 2157109 - Disclosure - Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 2458441 - Disclosure - Shareholders' Equity (Details) link:presentationLink link:calculationLink link:definitionLink 2159110 - Disclosure - Share-based Compensation link:presentationLink link:calculationLink link:definitionLink 2360308 - Disclosure - Share-based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 2461442 - Disclosure - Share-based Compensation - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2462443 - Disclosure - Share-based Compensation - Restricted Stock and Performance-based Restrcited Stock Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2463444 - Disclosure - Share-based Compensation - Summary of Stock Option Activities (Details) link:presentationLink link:calculationLink link:definitionLink 2464445 - Disclosure - Share-based Compensation - Fair Value Weighted Average Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 2465446 - Disclosure - Share-based Compensation - Employee Share Purchase Plan (Details) link:presentationLink link:calculationLink link:definitionLink 2466447 - Disclosure - Share-based Compensation - Share-based Compensation Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 2167111 - Disclosure - Employee Benefit Plans link:presentationLink link:calculationLink link:definitionLink 2468448 - Disclosure - Employee Benefit Plans (Details) link:presentationLink link:calculationLink link:definitionLink 2169112 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2370309 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 2471449 - Disclosure - Income Taxes - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2472450 - Disclosure - Income Taxes - Income Tax Schedules (Details) link:presentationLink link:calculationLink link:definitionLink 2472450 - Disclosure - Income Taxes - Income Tax Schedules (Details) link:presentationLink link:calculationLink link:definitionLink 2173113 - Disclosure - Segment and Geographic information link:presentationLink link:calculationLink link:definitionLink 2374310 - Disclosure - Segment and Geographic information (Tables) link:presentationLink link:calculationLink link:definitionLink 2475451 - Disclosure - Segment and Geographic information Segment Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2476452 - Disclosure - Segment and Geographic information - Revenue by Geographical Segment (Details) link:presentationLink link:calculationLink link:definitionLink 2477453 - Disclosure - Segment and Geographic information - Revenue by Product Type (Details) link:presentationLink link:calculationLink link:definitionLink 2478454 - Disclosure - Segment and Geographic information Location and Net Book Value of Long-Lived Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2179114 - Disclosure - Restricted Net Assets link:presentationLink link:calculationLink link:definitionLink 2480455 - Disclosure - Restricted Net Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2181115 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 2482456 - Disclosure - Commitments and Contingencies - Purchase Commitments (Details) link:presentationLink link:calculationLink link:definitionLink 2483457 - Disclosure - Commitments and Contingencies - Contingencies and Indemnities (Details) link:presentationLink link:calculationLink link:definitionLink 2184116 - Disclosure - Cybersecutiy Incident link:presentationLink link:calculationLink link:definitionLink 2485458 - Disclosure - Cybersecutiy Incident (Details) link:presentationLink link:calculationLink link:definitionLink 2186117 - Disclosure - Schedule II - Valuation and Qualifying Accounts link:presentationLink link:calculationLink link:definitionLink 2487459 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 11 aosl-20220630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 12 aosl-20220630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 13 aosl-20220630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Jireh Jireh [Member] Jireh Indemnification Agreement Indemnification Agreement [Member] Current Current Foreign Tax Expense (Benefit) Terms of credit sales, (in days) Concentration of Credit Risk, Terms of Sales on Credit Concentration of Credit Risk, Terms of Sales on Credit Foreign Currency Transactions and Translation Foreign Currency Transactions and Translations Policy [Policy Text Block] Related Party Transactions [Abstract] Principal amount Long-Term Debt, Gross Granted, value Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other than Options, Value Of Grants in Period Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other than Options, Value Of Grants in Period Property, plant and equipment, net Finance Lease, Right-of-Use Asset, after Accumulated Amortization Patents and exclusive technology rights Patents and Patented Technology [Member] Patents and Patented Technology [Member] Preferred stock, shares outstanding (in shares) Balance (in shares) Balance (in shares) Preferred Stock, Shares Outstanding Jireh Semiconductor Incorporated Jireh Semiconductor Incorporated [Member] Jireh Semiconductor Incorporated Debt Instrument [Axis] Debt Instrument [Axis] Finance Lease: Finance Lease Right Of Use Asset [Abstract] Finance Lease Right Of Use Asset [Abstract] Total lease liabilities Finance Lease, Liability Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Additional paid-in capital Additional Paid in Capital Finance lease: Finance Lease Cost1 [Abstract] Finance Lease Cost1 [Abstract] Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate 2024 Finance Lease, Liability, to be Paid, Year Four Less: debt issuance costs Debt Issuance Costs, Gross, Current Depreciation expense Depreciation Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Net deferred tax assets/(liabilities) Deferred Tax Assets, Net Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Operating leases Operating Lease, Weighted Average Discount Rate, Percent Stated interest rate Debt Instrument, Interest Rate, Stated Percentage Provision for (benefit from) income taxes Income Tax Expense (Benefit), Continuing Operations, by Jurisdiction [Abstract] Accounts receivable Accounts Receivable, before Allowance for Credit Loss Current Current State and Local Tax Expense (Benefit) Cash paid for income taxes Income Taxes Paid 2023 Finance Lease, Liability, to be Paid, Year Three PPE and land use rights PropertyPlantEquipmentAndLandUseRights Amount after accumulated depreciation, depletion and amortization of property, plant equipment, and land use rights Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Potential dilutive securities (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Sale Leaseback Transaction [Table] Sale Leaseback Transaction [Table] Lessee, Operating Lease, Liability, Payment, Due [Abstract] Lessee, Operating Lease, Liability, to be Paid [Abstract] Share Repurchase Program [Domain] Share Repurchase Program [Domain] Other Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five Equity Component [Domain] Equity Component [Domain] 2023 Long-Term Debt And Short-Term Debt Combined Amount, Maturity, Year One Long-Term Debt And Short-Term Debt Combined Amount, Maturity, Year One Secured Debt Secured Debt [Member] Net income (loss) per share attributable to common shareholders: Earnings Per Share Reconciliation [Abstract] Acquired Finite-Lived Intangible Assets [Line Items] Acquired Finite-Lived Intangible Assets [Line Items] Ownership [Axis] Ownership [Axis] Additions based on tax positions related to the current year Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Investment, Name [Domain] Investment, Name [Domain] Amortization of equipment Finance Lease, Right-of-Use Asset, Amortization Effective income tax rate reconciliation Effective Income Tax Rate Reconciliation, Percent [Abstract] Operating Lease Right Of Use Asset [Abstract] Operating Lease Right Of Use Asset [Abstract] Operating Lease Right Of Use Asset [Abstract] Related Party [Domain] Related Party [Domain] Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Lease term, buyout option amount Sale Leaseback Transaction, Lease Term, Buyout Option Amount Sale Leaseback Transaction, Lease Term, Buyout Option Amount Tax Credit Carryforward, Name [Domain] Tax Credit Carryforward, Name [Domain] Supplemental disclosures of cash flow information: Supplemental Cash Flow Information [Abstract] Valuation Allowance by Deferred Tax Asset [Axis] Valuation Allowance by Deferred Tax Asset [Axis] Depreciation and amortization Deferred Tax Liabilities, Depreciation and Amortization Amount of deferred tax liability attributable to fixed and intangible assets. Other Customers Other Customers [Member] Other Customers Plan Name [Domain] Plan Name [Domain] Non-current liabilities Liabilities, Noncurrent Employee Stock Employee Stock [Member] Outstanding, Weighted Average Remaining Contractual Term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Short-term Debt Debt, Current [Abstract] Award Type [Axis] Award Type [Axis] Operating lease liabilities Operating Lease, Liability, Current Lease Financing Lease Financing [Member] Lease Financing [Member] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] Prepaid maintenance Prepaid Maintenance, Current Prepaid Maintenance, Current Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Joint venture cumulative percentage ownership after all transactions Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions Lender Name [Axis] Lender Name [Axis] Long-term debt Long-Term Debt, Excluding Current Maturities Basis spread multiple Debt Instrument, Basis Spread on Variable Rate, Multiple Debt Instrument, Basis Spread on Variable Rate, Multiple Total liabilities Liabilities Operating leases Operating Lease, Weighted Average Remaining Lease Term Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Cash flows from investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Risks and Uncertainties [Abstract] Risks and Uncertainties [Abstract] Document Type Document Type Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Property, plant and equipment, useful life Property, Plant and Equipment, Useful Life Raw materials, wafers, and packaging and testing services purchase commitments [Member] Inventories and Services [Member] Inventories and Services [Member] Canceled or forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Utilization Standard Product Warranty Accrual, Decrease for Payments Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Nonvested (in dollars per share) Nonvested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Finance Lease, Liability, Payment, Due [Abstract] Finance Lease, Liability, to be Paid [Abstract] Deferred income tax on deconsolidation and changes of equity interest in the JV Company Deferred Income Tax Expense (Benefit) Down payment amount received Sale Leaseback Transaction, Down Payment Amount Sale Leaseback Transaction, Down Payment Amount Unrecognized tax benefit, amount netted against deferred tax assets Unrecognized Tax Benefit, Amount Netted Against Deferred Tax Assets The gross amount of unrecognized tax benefits that have been netted against deferred tax assets Accrued compensation and benefits Accrued Salaries, Current Retirement Plan Name [Domain] Retirement Plan Name [Domain] Interest receivable Interest Receivable, Current Sales-Lease Back Transaction with Jireh Semiconductor Incorporated Sales-Lease Back Transaction with Jireh Semiconductor Incorporated [Member] Sales-Lease Back Transaction with Jireh Semiconductor Incorporated Debt Disclosure [Abstract] Debt Disclosure [Abstract] Accounts Receivable Accounts Receivable [Policy Text Block] Income Statement Location [Axis] Income Statement Location [Axis] Customer A Customer A [Member] Customer A [Member] Accrued liabilities Accrued liabilities Accrued Liabilities, Current Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Variable rent expense Variable Lease, Cost Equity: Stockholders' Equity Attributable to Parent [Abstract] Foreign taxes, net Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent Major Customers [Axis] Customer [Axis] Finance lease liabilities - long-term Finance Lease, Liability, Noncurrent Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Provision for (benefit from) income taxes Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Weighted Average Remaining Recognition Period (Years) Recognition period of share-based compensation expense (in years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Exercisable, Weighted Average Remaining Contractual Term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Schedule of Finite-Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Gross profit Gross loss Gross Profit Land use rights Land Use Rights [Member] Land Use Rights [Member] Entity Registrant Name Entity Registrant Name Supplier Concentration Risk Supplier Concentration Risk [Member] Other countries Other Countries [Member] Other Countries [Member] Industrial And Commercial Bank of China Industrial And Commercial Bank of China [Member] Industrial And Commercial Bank of China [Member] Dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Sale Leaseback Transaction, Description [Axis] Sale Leaseback Transaction, Description [Axis] Leases [Abstract] Leases [Abstract] Foreign subsidiaries, restricted statutory reserves percent of parent consolidated net assets Foreign Subsidiaries, Restricted Statutory Reserves, Percent of Parent Consolidated Net Assets Foreign Subsidiaries, Restricted Statutory Reserves, Percent of Parent Consolidated Net Assets Total equity Balance Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards Packaging and testing services Packaging and testing services [Member] Packaging and testing services [Member] Minimum Minimum [Member] Entity Emerging Growth Company Entity Emerging Growth Company Retirement Plan, 401-K Retirement Plan, 401-K [Member] Retirement Plan, 401-K [Member] Income taxes payable on deconsolidation and changes of equity interest in the JV Company Increase (Decrease) in Income Taxes Payable from Deconsolidation and Changes of Equity Interest in the JV Company Increase (Decrease) in Income Taxes Payable from Deconsolidation and Changes of Equity Interest in the JV Company Common shares, par value (in dollars per share) Common Stock, Par or Stated Value Per Share SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] 2018 Omnibus Incentive Plan Two Thousand Eighteen Plan [Member] Two Thousand Eighteen Plan [Member] Investment, Name [Axis] Investment, Name [Axis] Trading Symbol Trading Symbol Entity File Number Entity File Number Government Grants Government Grants, Policy [Policy Text Block] Government Grants, Policy [Policy Text Block] Research and development credit Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent Treasury stock acquired, average price per share (in dollars per share) Treasury Stock Acquired, Average Cost Per Share Less: Noncontrolling interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Deferred Deferred Foreign Income Tax Expense (Benefit) Stock rotation accrual Beginning balance Ending balance Stock Rotation Accrual, Current Stock Rotation Accrual, Current Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Proceeds from lines of credit Proceeds from Lines of Credit Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Use of Estimates Use of Estimates, Policy [Policy Text Block] Addition Stock Rotation Accrual, Stock Issued Stock Rotation Accrual, Stock Issued Accounts payable Increase (Decrease) in Accounts Payable Other Liabilities, Other Than Long-Term Debt, Noncurrent, Other Liabilities, Other Than Long-Term Debt, Noncurrent, Other Percent of wafers manufactured Concentration risk, percentage Concentration Risk, Percentage Volatility rate, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Income Taxes Income Tax Disclosure [Text Block] Revenue from related parties Revenue from Related Parties Payable to related party Due to Related Parties Finished goods Inventory, Finished Goods, Net of Reserves Credit Facility [Domain] Credit Facility [Domain] Basic (in dollars per share) Earnings Per Share, Basic Purchase Commitment, Excluding Long-term Committment [Line Items] Purchase Commitment, Excluding Long-Term Commitment [Line Items] Award requisite service period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period Equipment and construction in progress Construction in Progress, Gross Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Revenues from External Customers and Long-Lived Assets [Line Items] Revenues from External Customers and Long-Lived Assets [Line Items] Accrued compensation Deferred Tax Assets, Accrued Compensation Amount before allocation of valuation allowances of deferred tax asset attributable to accrued compensation. Non-U.S. taxes: Foreign Income Tax Expense (Benefit), Continuing Operations [Abstract] Ownership [Domain] Ownership [Domain] Entity Interactive Data Current Entity Interactive Data Current Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Changes in assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Down payment percent Sale Leaseback Transaction, Down Payment, Percent Sale Leaseback Transaction, Down Payment, Percent 2025 Finance Lease, Liability, to be Paid, Year Five Maximum value of common stock that may be purchased in any one calendar year Share-Based Compensation Arrangement By Share-based Payment Award, Value of Common Stock That May Be Purchased in Any One Calendar Year Share-Based Compensation Arrangement By Share-based Payment Award, Value of Common Stock That May Be Purchased in Any One Calendar Year Percent of compensation allowed for purchase of options Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate Share-based Compensation, Allocation of Recognized Period Costs Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Class of Stock [Axis] Class of Stock [Axis] Thereafter Long-Term Debt, Maturity, after Year Five Provision for Income Taxes Income Tax, Policy [Policy Text Block] Retirement Plan Sponsor Location Retirement Plan Sponsor Location [Axis] Third Party Investors Third Party Investors [Member] Third Party Investors Discontinued Operations and Disposal Groups [Abstract] Current assets: Assets, Current [Abstract] Income tax interest and penalties expense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense Market-based Restricted Stock Units (MSU) Market-based Restricted Stock Units (MSU) [Member] Market-based Restricted Stock Units (MSU) [Member] Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender [Domain] Retained earnings Retained Earnings (Accumulated Deficit) Line of Credit Facility, Trade Borrowings Line of Credit Facility, Trade Borrowings [Member] Line of Credit Facility, Trade Borrowings Scenario [Domain] Scenario [Domain] Treasury stock reissued average price per share Treasury Stock Reissued, Average Price Per Share Treasury Stock Reissued, Average Price Per Share Exercisable (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Related Party Transactions Related Party Transactions Disclosure [Text Block] Domestic and foreign components of income (loss) before taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract] Document Fiscal Year Focus Document Fiscal Year Focus Foreign Plan Foreign Plan [Member] Cash flows from operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Financing cash flows from finance lease Finance Lease, Principal Payments Equipment and tooling Equipment and Tooling [Member] Equipment and Tooling [Member] Stock Rotation Accrual Increae (Decrease) [Roll Forward] Stock Rotation Accrual Increae (Decrease) [Roll Forward] Stock Rotation Accrual Increase (Decrease) [Roll forward] Loss Contingencies [Table] Loss Contingencies [Table] Impairment of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Utilization Stock Rotation Accrual, Payments Stock Rotation Accrual, Payments Options vested and expected to vest (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Stock-based compensation Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent Investments in privately held companies Investments in Privately Held Companies Investments in Privately Held Companies Inventories Increase (Decrease) in Inventories Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Goodwill Goodwill Proceeds from sale of property and equipment Proceeds from Sale of Other Property, Plant, and Equipment Prepaid income tax Prepaid Taxes Balance Sheet Related Disclosures [Abstract] Balance Sheet Related Disclosures [Abstract] Treasury shares (in shares) Balance (in shares) Balance (in shares) Treasury Stock, Shares Computer software development Computer Software Development [Member] Computer Software Development Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Income tax expense Income tax benefit Total provision for income taxes Income Tax Expense (Benefit) Geographical [Domain] Geographical [Domain] Valuation allowance Valuation allowance Deferred Tax Assets, Valuation Allowance Entity Public Float Entity Public Float Balance Sheet Location [Domain] Balance Sheet Location [Domain] Government grants, reduction recorded to operating expenses Government Grants, Reduction Recorded To Operating Expenses Government Grants, Reduction Recorded To Operating Expenses 7.82% equity interest sold Third Party Investors, Transaction 2 [Member] Third Party Investors, Transaction 2 Less accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Concentration of Credit Risk and Significant Customers Concentration Risk Disclosure [Text Block] Audit Information [Abstract] Audit Information Loss Contingencies [Line Items] Loss Contingencies [Line Items] Accounts Receivable Accounts Receivable [Member] Authorized: 100,000 shares; issued and outstanding: 33,988 shares and 27,371 shares, respectively at June 30, 2022 and 32,975 shares and 26,350 shares, respectively at June 30, 2021 Common Stock, Value, Issued Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Preferred Shares Preferred Stock [Member] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Cash, cash equivalents and restricted cash at beginning of year Cash, cash equivalents and restricted cash at end of year Total cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Non-U.S. operations Income (Loss) from Continuing Operations before Income Taxes, Foreign Current liabilities: Liabilities, Current [Abstract] Options, vested and expected to vest, Weighted Average Remaining Contractual Term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Interest Finance Lease, Interest Expense Employer matching contribution, percent of employees' gross pay Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay Total AOS Shareholders' Equity Parent [Member] Income Statement Location [Domain] Income Statement Location [Domain] Amendment Flag Amendment Flag Finite-lived intangible asset, useful life Finite-Lived Intangible Asset, Useful Life Fixed rent expense Operating Lease, Cost SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] Deferred tax assets: Components of Deferred Tax Assets [Abstract] Delivery payment received Sale Leaseback Transaction, Delivery Payment, Amount Sale Leaseback Transaction, Delivery Payment, Amount Other long-term assets Other long-term assets Other Assets, Noncurrent Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Grant price, percent of fair value of common stock at date of grant Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Mandatory employer contributions according to labor and social security laws and regulations, percent Mandatory Employer Contributions According to Labor and Social Security Laws and Regulations Mandatory Employer Contributions According to Labor and Social Security Laws and Regulations State research and development credit carryforward State Research And Development Credit Carryforward [Member] State Research And Development Credit Carryforward [Member] Counterparty Name [Axis] Counterparty Name [Axis] Intangible assets, net Intangible assets, net Intangible Assets, Net (Including Goodwill) Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Operating cash flows from operating leases Operating Lease, Payments Stock Options Share-Based Payment Arrangement, Option [Member] Customs deposit Customs deposit Customs deposit Domestic Plan Domestic Plan [Member] Treasury shares at cost; 6,617 shares at June 30, 2022 and 6,625 shares at June 30, 2021 Treasury Stock, Value Volatility rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Restricted Statutory Reserves [Table] Restricted Statutory Reserves [Table] Restricted Statutory Reserves [Table] Less: Allowance for doubtful accounts Accounts Receivable, Allowance for Credit Loss, Current Common shares, authorized (in shares) Common Stock, Shares Authorized Weighted average remaining lease term (in years) Weighted Average Remaining Lease Term [Abstract] Weighted Average Remaining Lease Term [Abstract] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Income taxes payable Accrued Income Taxes, Current Total operating expenses Operating Expenses Maximum Maximum [Member] Exercise of common stock options and release of RSUs Stock Issued During Period, Value, Stock Options Exercised and Restricted Stock Units Released Stock Issued During Period, Value, Stock Options Exercised and Restricted Stock Units Released Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Carrying amount of non-controlling interest Noncontrolling Interest, Period Increase (Decrease) Shareholders' Equity Stockholders' Equity Note Disclosure [Text Block] Outside basis difference on equity method investment Effective Income Tax Rate Reconciliation, Tax Credit, Investment, Percent Net income (loss) before loss from equity method investment Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Line of Credit Facility [Table] Line of Credit Facility [Table] Fiscal Year Maturity Schedule Contractual Obligation, Fiscal Year Maturity [Table Text Block] Accounts receivable Increase (Decrease) in Accounts Receivable Short-term debt Total debt, less debt issuance costs Short-Term Debt Title of 12(b) Security Title of 12(b) Security Schedule of Retirement Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Unrecognized tax benefits rollforward Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Net operating loss, fixed asset and intangible asset Net Operating Loss, Fixed Asset And Intangible Asset [Member] Net Operating Loss, Fixed Asset And Intangible Asset [Member] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Cumulative translation adjustment removal due to deconsolidation of the JV Company Other Comprehensive Income (Loss), Reclassification Adjustment, Realized upon Sale or Liquidation Other Comprehensive Income (Loss), Reclassification Adjustment, Realized upon Sale or Liquidation Segment and Geographic Information Segment Reporting Disclosure [Text Block] Line of Credit Facility, Working Capital Borrowings Line of Credit Facility, Working Capital Borrowings [Member] Line of Credit Facility, Working Capital Borrowings Selling, general and administrative Selling, General and Administrative Expenses [Member] Entity Address, Country Entity Address, Country Net deferred tax assets/(liabilities) Deferred Tax Liabilities, Net Supplier [Axis] Supplier [Axis] LIABILITIES AND EQUITY Liabilities and Equity [Abstract] Cumulative translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Canceled or forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Total debt, less debt issuance costs Debt, Long-Term And Short-Term, Combined Amount, Net Debt, Long-Term And Short-Term, Combined Amount, Net Weighted average number of common share attributable to Alpha and Omega Semiconductor Limited used to compute net income (loss) per share: Diluted: Weighted Average Number of Shares Outstanding, Diluted [Abstract] (Gain) loss on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Inventories Inventories Inventory, Net Accounts payable Accounts Payable, Current Restricted Net Assets Restricted Assets Disclosure [Text Block] Income Tax Authority [Axis] Income Tax Authority [Axis] Options, vested and expected to vest, outstanding, aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Equity Method Investment, Number of Directors Equity Method Investment, Number of Directors Equity Method Investment, Number of Directors Basic (in shares) Weighted average number of common shares used to compute basic net income (loss) per share Weighted Average Number of Shares Outstanding, Basic Debt instrument, collateral amount Debt Instrument, Collateral Amount Indemnification accrual Loss Contingency Accrual Interest rate Short-Term Debt, Percentage Bearing Fixed Interest Rate Equity Method Investment, Ownership Percentage Equity Method Investment, Ownership Percentage Property, plant and equipment excluding equipment and construction in progress, net Property, Plant and Equipment Excluding Equipment and Construction In Progress, Net Property, Plant and Equipment Excluding Equipment and Construction In Progress, Net Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss YinHai Leasing Company and China Import/Export Bank YinHai Leasing Company and China Import/Export Bank [Member] YinHai Leasing Company and China Import/Export Bank [Member] Authorized: 10,000 shares; issued and outstanding: none at June 30, 2022 and 2021 Preferred Stock, Value, Issued Cash paid from amounts included in the measurement of lease liabilities: Cash Paid From Amounts Included In The Measurement Of Lease Liabilities [Abstract] Cash Paid From Amounts Included In The Measurement Of Lease Liabilities [Abstract] Restricted Stock [Member] Restricted Stock [Member] Government grants, reduction recorded to interest expense Government Grants, Reduction Recorded To Interest Expense Government Grants, Reduction Recorded To Interest Expense Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Share-based Payment Arrangement, Noncash Expense [Abstract] Share-Based Payment Arrangement, Noncash Expense [Abstract] Short-term Debt, Type [Domain] Short-Term Debt, Type [Domain] Accrued property, plant and equipment Accrued Property, Plant and Equipment Accrued Property, Plant and Equipment Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Income taxes payable Increase (Decrease) in Income Taxes Payable Less: debt issuance costs Debt Issuance Cost, Gross, Noncurrent Employer matching contribution, percent of match Defined Contribution Plan, Employer Matching Contribution, Percent of Match Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Leases Lessee, Leases [Policy Text Block] Property and equipment purchase commitments [Member] Capital Addition Purchase Commitments [Member] Non-current assets Assets, Noncurrent Loss before income taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Share-based Compensation Share-Based Payment Arrangement [Text Block] Work in-process Inventory, Work in Process, Net of Reserves Deferred income taxes, net Increase (Decrease) in Deferred Income Taxes Customer D Customer D [Member] Customer D [Member] Maximum number of common shares that may be purchased per a 24-month offering period by a participant (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Common Shares that May Be Purchased Per a 24-Month Offering Period Share-based Compensation Arrangement by Share-based Payment Award, Number of Common Shares that May Be Purchased Per a 24-Month Offering Period Noncontrolling Interest Noncontrolling Interest [Member] Interest expenses, net Interest Income (Expense), Net Components of deferred tax assets and liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Debt term Debt Instrument, Term Lease term (in years) Sale Leaseback Transaction, Lease Terms Related Party [Axis] Related Party [Axis] Fair value of retained equity method investment Equity Method Investment, Fair Value of Equity Retained Equity Method Investment, Fair Value of Equity Retained Land Land [Member] Stock options, RSUs and ESPP shares Incremental common shares attributable to dilutive effect of share-based payment arrangements (USD per share) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] Market-based Restricted Stock Units (MSU), Pre-Modification Market-based Restricted Stock Units (MSU), Pre-Modification [Member] Market-based Restricted Stock Units (MSU), Pre-Modification Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Government grants, reduction recorded to property, plant and equipment Government Grants, Reduction Recorded To Property, Plant And Equipment Government Grants, Reduction Recorded To Property, Plant And Equipment Current Fiscal Year End Date Current Fiscal Year End Date Intangible assets, net (excluding goodwill) Intangible Assets, Net (Excluding Goodwill) Maximum number of shares authorized for purchase per purchase date (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number Of Shares Authorized For Purchase Per Purchase Period Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number Of Shares Authorized For Purchase Per Purchase Period Share-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Power discrete Power Discrete [Member] Power Discrete [Member] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Total current liabilities Current liabilities Liabilities, Current Risk-free interest rate, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Property, plant and equipment, gross Finance Lease, Right-of-Use Asset, before Accumulated Amortization Schedule of Accounts, Notes, Loans and Financing Receivable Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Customer Concentration Risk Customer Concentration Risk [Member] Income taxes payable - long-term Accrued Income Taxes, Noncurrent Equity Method Investment, Number of Appointments to Board of Directors Equity Method Investment, Number of Appointments to Board of Directors Equity Method Investment, Number of Appointments to Board of Directors Tax credit carryforward, subject to expiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration Equity Method Investment in Equity Investee Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Unrecognized tax benefits that would reduce effective income tax rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate Stock options exercisable term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Risk-free interest rate, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Income Tax Authority [Domain] Income Tax Authority [Domain] Operating expenses Cost of Revenue Share-based Payment Arrangement, Option, Exercise Price Range [Table] Share-Based Payment Arrangement, Option, Exercise Price Range [Table] Historical cost Sale Leaseback Transaction, Historical Cost Valuation allowance increase Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Finance lease Finance Lease, Weighted Average Remaining Lease Term Credit Facility [Axis] Credit Facility [Axis] Treasury Stock Reissued Treasury Stock Reissued [Member] Treasury Stock Reissued [Member] Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract] Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract] Company contributions to retirement plan Defined Contribution Plan, Employer Discretionary Contribution Amount Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Other receivables Other Receivables, Net, Current Entity Tax Identification Number Entity Tax Identification Number Shares authorized under plan (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Schedule of Short-term Debt [Table] Schedule of Short-Term Debt [Table] Power IC Power IC [Member] Power IC [Member] Consolidated Entities [Domain] Consolidated Entities [Domain] Withholding tax on restricted stock units (in shares) Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Effective income tax rate reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Net increase in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cost of Goods and Service, Product and Service Benchmark Cost of Goods and Service, Product and Service Benchmark [Member] Entity Central Index Key Entity Central Index Key Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Debt receivable amount Sale Leaseback Transaction, Debt Receivable Amount Sale Leaseback Transaction, Debt Receivable Amount Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Withholding tax on restricted stock units Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Unamortized capitalized software development costs Capitalized Computer Software, Net Entity [Domain] Entity [Domain] Treasury stock acquired less handling fees Treasury Stock, Value, Acquired, Cost Method Less Handling Fees Treasury Stock, Value, Acquired, Cost Method Less Handling Fees Customer C Customer C [Member] Customer C [Member] City Area Code City Area Code Accrued professional fees Accrued Professional Fees, Current ASSETS Assets [Abstract] Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Noncontrolling Interest Other prepaid expenses Other Prepaid Expense, Current Operating lease liabilities Deferred Tax Assets, Operating Lease Liabilities Deferred Tax Assets, Operating Lease Liabilities Supplemental disclosures of non-cash investing and financing information: Non-cash investing and financing information: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Share-based compensation expense Share-Based Payment Arrangement, Noncash Expense Carrying amount of net assets of the JV Company at December 1, 2021 Equity Method Investment, Underlying Equity in Net Assets Variable Rate [Axis] Variable Rate [Axis] Other long-term liabilities Other Liabilities, Noncurrent Equity method investment loss from equity investee Income (Loss) from Equity Method Investments Customer B Customer B [Member] Customer B [Member] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment 2023 Finite-Lived Intangible Asset, Expected Amortization, Year One Thereafter Finance Lease, Liability, to be Paid, after Year Five Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Operating lease right-of-use assets obtained in exchange for lease obligations Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Name of Major Customer [Domain] Customer [Domain] Number of votes per each common share Number of Votes Per Each Common Share Number of Votes Per Each Common Share Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Total minimum lease payments Lessee, Operating Lease, Liability, to be Paid Net income (loss) Net income (loss) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Entity Address, Postal Zip Code Entity Address, Postal Zip Code Customer deposit Accrued Customer Deposit Accrued Customer Deposit Sale Leaseback Transaction, Name [Domain] Sale Leaseback Transaction, Name [Domain] Unrecognized tax benefits rollforward Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] 2024 Long-Term Debt, Maturity, Year Two Duration of offering periods for ESPP (in months) Duration of Offering Periods For Employee Share Purchase Plan Duration of Offering Periods For Employee Share Purchase Plan Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Restrictions for Consolidated and Unconsolidated Subsidiaries [Abstract] Restrictions for Consolidated and Unconsolidated Subsidiaries [Abstract] Treasury stock retired (in shares) Treasury Stock, Shares, Retired Loss recorded in the period from cyber security incident Loss Contingency, Loss in Period Reductions SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Accounts Receivable Factoring Agreement, maximum borrowing capacity Accounts Receivable Factoring Agreement, Maximum Borrowing Capacity Accounts Receivable Factoring Agreement, Maximum Borrowing Capacity Statistical Measurement [Domain] Statistical Measurement [Domain] Proceeds from borrowings Proceeds from Issuance of Debt Short-term Debt, Type [Axis] Short-Term Debt, Type [Axis] Deferred payroll taxes Accrued Payroll Taxes Reductions due to lapse of applicable statute of limitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations Federal Domestic Tax Authority [Member] Repayments of borrowings Repayments of Debt Net income (loss) attributable to Alpha and Omega Semiconductor Limited Net income (loss) attributable to AOS Net Income (Loss) Attributable to Parent Employee Stock Purchase Plan, Valuation Assumptions Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] Leases Lessee, Finance Leases [Text Block] Prepaid insurance Prepaid Insurance Scenario [Axis] Scenario [Axis] Leases Lessee, Operating Leases [Text Block] Facility in Liangjiang New Area of Chongqing (the 'Joint Venture') Facility in Liangjiang New Area of Chongqing (the 'Joint Venture') [Member] Facility in Liangjiang New Area of Chongqing (the 'Joint Venture') [Member] Plan Name [Axis] Plan Name [Axis] Payroll deduction accumulation period (in months) Share-based Compensation Arrangement by Share-based Payment Award, Payroll Deduction Accumulation Period Share-based Compensation Arrangement by Share-based Payment Award, Payroll Deduction Accumulation Period Number of operating segments Number of Operating Segments Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Delivery payment percent Sale Leaseback Transaction, Delivery Payment, Percent Sale Leaseback Transaction, Delivery Payment, Percent Prepayments for property and equipment Prepayment for Property and Equipment Prepayment for Property and Equipment Basic: Weighted Average Number of Shares Outstanding, Basic [Abstract] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Principal payments on capital leases Principal Payments on Capital Leases Principal Payments on Capital Leases Restricted Stock Units Activity Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Principal amount Short-Term Debt, Gross Short-Term Debt, Gross Non-deductible expenses Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent Accrued facilities related expenses Accrued Facility Expenses Accrued Facility Expenses Employee maximum salary deferral contribution, percent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Foreign Derived Intangible Income Deduction Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent Document Annual Report Document Annual Report Legal Entity [Axis] Legal Entity [Axis] Subsidiaries [Member] Subsidiaries [Member] Geographical [Axis] Geographical [Axis] Operating leases: Operating Leases, Income Statement [Abstract] Schedule of deferred tax assets and liabilities, current and noncurrent Schedule of Deferred Tax Assets and Liabilities, Current and Noncurrent [Table Text Block] Schedule of Deferred Tax Assets and Liabilities, Current and Noncurrent [Table Text Block] Property, Plant and Equipment Property, Plant and Equipment [Table Text Block] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Debt Debt Disclosure [Text Block] Deconsolidation of cash and cash equivalents of the JV Company Cash Divested from Deconsolidation Employee Benefit Plans Compensation and Employee Benefit Plans [Text Block] Product and Service [Domain] Product and Service [Domain] Entity Shell Company Entity Shell Company Accrued and other liabilities Increase (Decrease) in Accrued Liabilities Reductions based on tax positions related to prior years Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Concentration Risk [Table] Concentration Risk [Table] 2021 Lessee, Operating Lease, Liability, to be Paid, Year One 2025 Long-Term Debt, Maturity, Year Three Deferred tax liabilities: Components of Deferred Tax Liabilities [Abstract] Vehicles Vehicles [Member] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] Bank Of Communications Limited Bank Of Communications Limited [Member] Bank Of Communications Limited [Member] Revenue Benchmark Revenue Benchmark [Member] Document Period End Date Document Period End Date Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] Warranty accrual Beginning balance Ending balance Product Warranty Accrual, Current Customs deposit Custom deposit non current Custom deposit non current Total assets Assets Implied interest rate, percent Sale Leaseback Transaction, Implied Interest Rate, Percent Sale Leaseback Transaction, Implied Interest Rate, Percent Supplier [Domain] Supplier [Domain] Net income (loss) per common share attributable to Alpha and Omega Semiconductor Limited Earnings Per Share [Abstract] Term Loan Term Loan [Member] Term Loan [Member] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 2025 Lessee, Operating Lease, Liability, to be Paid, Year Five Share repurchase program, authorized amount Stock Repurchase Program, Authorized Amount Stockholders' Equity Note [Abstract] Stockholders' Equity Note [Abstract] Deferred income tax liabilities Long-term deferred tax liabilities Deferred Tax Liabilities, Net Of Valuation Allowance, By Jurisdiction Deferred Tax Liabilities, Net Of Valuation Allowance, By Jurisdiction Net income (loss) before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Short-term leases: Short Term Lease Cost [Abstract] Short Term Lease Cost [Abstract] Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited Earnings Per Share [Text Block] U.S. federal taxes: Federal Income Tax Expense (Benefit), Continuing Operations [Abstract] Comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Award Type [Domain] Award Type [Domain] Loss from Cyber Security Incident Loss from Cyber Security Incident [Member] Loss from Cyber Security Incident Computer equipment and software Computer Equipment [Member] Schedule of Other Assets, Noncurrent Schedule of Other Assets, Noncurrent [Table Text Block] Tax Credit Carryforward [Line Items] Tax Credit Carryforward [Line Items] Right of use assets Deferred Tax Liabilities, Operating Lease Right-Of-Use Assets Deferred Tax Liabilities, Operating Lease Right-Of-Use Assets China CHINA Software Development Software Development [Member] Customer relationships Customer Relationships [Member] Entity Address, City or Town Entity Address, City or Town Deconsolidation of noncontrolling interest Noncontrolling Interest, Decrease from Deconsolidation Payable related to equity investee, net Increase (Decrease) in Accounts Receivable, Related Parties Operating expenses: Operating Expenses [Abstract] Noncontrolling interest Stockholders' Equity Attributable to Noncontrolling Interest Restricted cash Restricted Cash and Cash Equivalents, Current Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Raw materials Inventory, Raw Materials, Net of Reserves Risks and Uncertainties Risks and Uncertainties [Policy Text Block] Risks and Uncertainties [Policy Text Block] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Auditor Name Auditor Name Net operating loss carryforwards Operating Loss Carryforwards Average fair market value per share period Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other than Options, Average Fair Market Value Per Share Period Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other than Options, Average Fair Market Value Per Share Period Customer deposits Contract with Customer, Liability, Noncurrent Investments Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals Research and development Research and Development Expense Equipment and tooling Equipment [Member] Research Tax Credit Carryforward Research Tax Credit Carryforward [Member] Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Options vested and expected to vest (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Parent Company Parent Company [Member] LIBOR London Interbank Offered Rate (LIBOR) [Member] The Company and Significant Accounting Policies Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Revenue Revenues Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Amortization expense Amortization of Intangible Assets Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Office leases deposits Office Lease Deposit Assets, Noncurrent Office Lease Deposit Assets, Noncurrent 2023 Lessee, Operating Lease, Liability, to be Paid, Year Three Retirement Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Total principal of debt Principal amount Debt, Long-Term and Short-Term, Combined Amount Purchase Commitment, Excluding Long-term Commitment [Axis] Purchase Commitment, Excluding Long-Term Commitment [Axis] Inventories Inventory, Policy [Policy Text Block] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Counterparty Name [Domain] Counterparty Name [Domain] Treasury Stock Treasury Stock [Member] Total Alpha and Omega Semiconductor Limited shareholders’ equity Balance Balance Stockholders' Equity Attributable to Parent Computer software liabilities Computer Software Liability, Noncurrent Computer Software Liability, Noncurrent Tax credit carryforward Tax Credit Carryforward, Amount Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Payable related to equity investee, net Due to Affiliate, Current Prepayments to supplier Prepayment to Supplier Prepayment to Supplier Total Debt, Long-Term and Short-Term, Combined Amount [Abstract] Government grant related to equipment Proceeds From Government Grant Related To Equipment In Joint Venture Company Proceeds From Government Grant Related To Equipment In Joint Venture Company Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Tax credits Deferred Tax Assets, Tax Credit Carryforwards Less accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Deferred Tax Asset [Domain] Deferred Tax Asset [Domain] 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Three Other Other Assets, Miscellaneous, Noncurrent 2027 Long-Term Debt, Maturity, Year Five Restricted Statutory Reserves [Line Items] Restricted Statutory Reserves [Line Items] Restricted Statutory Reserves [Line Items] Retained Earnings Retained Earnings [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] External Board Members External Board Members [Member] External Board Members [Member] Total lease expenses Lease, Cost Common Shares Common Stock [Member] Schedule of Operating and Finance Lease Expense Lease, Cost [Table Text Block] Number of shares available for grant (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Revenue Recognition Revenue [Policy Text Block] Property, plant, and equipment excluding equipment and construction In progress, gross Property, Plant, and Equipment Excluding Equipment and Construction In Progress, Gross Property, Plant, and Equipment Excluding Equipment and Construction In Progress, Gross Statement [Table] Statement [Table] Purchase Commitment, Excluding Long-term Commitment [Domain] Purchase Commitment, Excluding Long-Term Commitment [Domain] Schedule of deconsolidation Disposal Groups, Including Discontinued Operations [Table Text Block] Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Loss on changes of equity interest in the JV Company, net Loss on changes of equity interest in the JV Company, net Gain on equity interest sold Equity Method Investment, Realized Gain (Loss) on Disposal Office furniture and equipment Furniture and Fixtures [Member] Operating lease liabilities - long-term Operating Lease, Liability, Noncurrent Stock Rotation Accrual Stock Rotation Accrual [Table Text Block] Stock Rotation Accrual [Table Text Block] Hong Kong HONG KONG Statistical Measurement [Axis] Statistical Measurement [Axis] Treasury stock acquired, shares repurchased (in shares) Treasury Stock, Shares, Acquired Purchase Commitment, Excluding Long-term Committment [Table] Purchase Commitment, Excluding Long-Term Commitment [Table] Exercise of common stock options and release of RSUs (in shares) Share-based Compensation Arrangement By Share-based Payment Award, Exercise of Stock Options and Release of Restricted Stock Units in Period Share-based Compensation Arrangement By Share-based Payment Award, Exercise of Stock Options and Release of Restricted Stock Units in Period Leasehold improvements Leasehold Improvements [Member] Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Equity Components [Axis] Equity Components [Axis] Comprehensive Income (loss) Comprehensive Income, Policy [Policy Text Block] Restricted stock units settlement in connection with service APIC, Share-Based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition Tax Credit Carryforward [Axis] Tax Credit Carryforward [Axis] Statement [Line Items] Statement [Line Items] Nonvested (in shares) Nonvested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Variable Rate [Domain] Variable Rate [Domain] Intangible assets, gross Finite-Lived Intangible Assets, Gross Selling, general and administrative Selling, General and Administrative Expense Operating lease right-of-use assets, net ROU assets associated with operating leases Operating Lease, Right-of-Use Asset Accumulated Other Comprehensive Income (loss) AOCI Attributable to Parent [Member] Cybersecurity Incident Contingencies Disclosure [Text Block] ESPP payable Employee Stock Purchase Plan Payable, Current Employee Stock Purchase Plan Payable, Current Auditor Firm ID Auditor Firm ID Document Transition Report Document Transition Report Local Phone Number Local Phone Number Summary of Stock Option Activities Share-Based Payment Arrangement, Option, Activity [Table Text Block] Operating income (loss) Net loss Operating Income (Loss) Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Effect of potentially dilutive securities: Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract] Employee Incentive Plan Employee Incentive Plan [Member] Employee Incentive Plan State State and Local Jurisdiction [Member] 1.1% equity interest sold Third Party Investors, Transaction 1 [Member] Third Party Investors, Transaction 1 Deferred compensation share-based arrangements, liability, current Deferred Compensation Share-Based Arrangements, Liability, Current Performance Based Restricted Stock Units (PRSUs) Performance Based Restricted Stock Units (PRSUs) Member [Member] Performance Based Restricted Stock Units (PRSUs) Member [Member] Adjustments to reconcile net income (loss) to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Property, Plant and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Aggregate intrinsic value, nonvested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested Schedule of Product Warranty Liability Schedule of Product Warranty Liability [Table Text Block] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share 2024 Lessee, Operating Lease, Liability, to be Paid, Year Four Proceeds from short-term debt Proceeds from Short-Term Debt Income Statement [Abstract] Income Statement [Abstract] Grants in period (in shares) Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Market-based Restricted Stock Units (MSU), Post-Modification Market-based Restricted Stock Units (MSU), Post-Modification [Member] Market-based Restricted Stock Units (MSU), Post-Modification Deferred Deferred Federal Income Tax Expense (Benefit) Additional Paid-In Capital Additional Paid-in Capital [Member] Document Fiscal Period Focus Document Fiscal Period Focus Restricted cash - long-term Restricted Cash, Noncurrent Aggregate Intrinsic Value, Exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Proceeds from sale of equity interest in the JV Company Cash received for sales of shares in the JV Company Proceeds from Sale of Equity Method Investments Diluted (in shares) Weighted average number of common shares used to compute diluted net income (loss) per share Weighted Average Number of Shares Outstanding, Diluted Volatility rate, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Accounts Receivable Factoring Agreement August Ninth Two Thousand Nineteen Accounts Receivable Factoring Agreement August Ninth Two Thousand Nineteen [Member] Accounts Receivable Factoring Agreement August Ninth Two Thousand Nineteen [Member] Schedule of Inventory, Current Schedule of Inventory, Current [Table Text Block] Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Less: debt issuance costs Less: debt issuance costs Debt Issuance Costs, Gross Base Rate Base Rate [Member] Granted (in dollars per share) Weighted-average grant date fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Short-term Debt [Line Items] Short-Term Debt [Line Items] Exercisable, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Short-term lease expenses Short-Term Lease, Cost Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Decrease in unrecognized tax benefits is reasonably possible Decrease in Unrecognized Tax Benefits is Reasonably Possible Net income (loss) attributable to noncontrolling interest Net Income (Loss) Attributable to Noncontrolling Interest Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Defined Contribution Plan, Employer Matching Contribution, Eligible Compensation Maximum Match, Percent Defined Contribution Plan, Employer Matching Contribution, Eligible Compensation Maximum Match, Percent Defined Contribution Plan, Employer Matching Contribution, Eligible Compensation Maximum Match, Percent Summarized financial information of joint venture Equity Method Investments [Table Text Block] Common stock, shares issued (in shares) Balance (in shares) Balance (in shares) Common Stock, Shares, Issued Concentration Risk [Line Items] Concentration Risk [Line Items] Equity method investment Equity Method Investments Property and equipment purchased but not yet paid Capital Expenditures Incurred but Not yet Paid Finance lease liabilities Finance Lease, Liability, Current Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities South Korea KOREA, REPUBLIC OF Issuance of common shares under Employee Stock Purchase Plan Stock Issued During Period, Value, Employee Stock Purchase Plan Comprehensive income (loss) attributable to Alpha and Omega Semiconductor Limited Comprehensive Income (Loss), Net of Tax, Attributable to Parent Proceeds from exercise of stock options and ESPP Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised Treasury Shares Treasury Stock, Number of Shares and Restriction Disclosures [Abstract] Entity Current Reporting Status Entity Current Reporting Status HHGrace HHGrace [Member] HHGrace Tax credit carryforward, not subject to expiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration Chongqing Funds Chongqing Funds [Member] Chongqing Funds [Member] Transactions with related party Related Party Transaction, Purchases from Related Party 2021 Finance Lease, Liability, to be Paid, Year One Other long-term deposits Security Deposit Long-term Income Tax Payable Long-term Income Tax Payable [Member] Long-term Income Tax Payable [Member] United States statutory rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Foreign subsidiaries, minimum percent of after-tax profit required annually in statutory reserves Percent of After-tax Profit Required Annually in Statutory Reserves Percent of After-tax Profit Required Annually in Statutory Reserves Reissuance of Treasury Stock Stock Issued During Period, Value, Treasury Stock Reissued Additions SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense Addition Standard Product Warranty Accrual, Increase for Warranties Issued Issuance of common shares under Employee Stock Purchase Plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Deferred income tax assets Long-term deferred tax assets Deferred Tax Assets, Net Of Valuation Allowance, By Jurisdiction Deferred Tax Assets, Net Of Valuation Allowance, By Jurisdiction Outstanding (in shares) Outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number U.S. Tax Act deferred tax re-measurement Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act of 2017, Deferred Tax Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act of 2017, Deferred Tax Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] 2022 Finance Lease, Liability, to be Paid, Year Two Components of deferred tax assets and liabilities Components of Deferred Tax Assets and Liabilities [Abstract] Basis of Preparation Basis of Accounting, Policy [Policy Text Block] Effect of exchange rate changes on cash, cash equivalents and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Property, plant and equipment, net Property, plant and equipment, net Property, Plant and Equipment, Net Capitalized intangible assets Deferred Tax Assets, Capitalized Intangible Assets Deferred Tax Assets, Capitalized Intangible Assets Depreciation and amortization Depreciation, Amortization and Accretion, Net Schedule of Finite-Lived Intangible Assets, Future Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Office furntiture and equipment Office Equipment [Member] Preferred shares, par value $0.002 per share: Preferred Stock, Number of Shares, Par Value and Other Disclosure [Abstract] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Long-term debt Total principal of debt, less debt issuance costs Long-Term Debt Interest expenses, net Other Nonoperating Income (Expense) Balance Sheet Location [Axis] Balance Sheet Location [Axis] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Corporate Joint Venture Corporate Joint Venture [Member] Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Net of Tax Amount outstanding Line of Credit Facility, Fair Value of Amount Outstanding Treasury stock reissued (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture Cash and Cash Equivalents, Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Total current assets Current assets Assets, Current Maximum number of common shares that may be purchased on any purchase date by a participant (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Common Shares That May be Purchased On Any Purchase Date Share-based Compensation Arrangement by Share-based Payment Award, Number of Common Shares That May be Purchased On Any Purchase Date Depreciation Deferred Tax Assets, Depreciation Amount before allocation of valuation allowances of deferred tax asset attributable to fixed assets. Entity Small Business Entity Small Business State taxes, net of federal benefit: State and Local Income Tax Expense (Benefit), Continuing Operations [Abstract] Common stock, dividends declared per share Common Stock, Dividends, Per Share, Declared Credit Facility, 3 Point 85 Percent, Due November 18, 2022 Credit Facility, 3 Point 85 Percent, Due November 18, 2022 [Member] Credit Facility, 3 Point 85 Percent, Due November 18, 2022 Intangible assets, net Finite-Lived Intangible Assets, Net Accounts Receivable Factoring Agreement, remaining borrowing capacity Accounts Receivable Factoring Agreement, Remaining Borrowing Capacity Accounts Receivable Factoring Agreement, Remaining Borrowing Capacity Restricted cash Restricted Cash Unrecognized compensation expense Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Schedules of Concentration of Risk, by Risk Factor Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Simple annual interest rate to noncontrolling interest if joint venture is early terminated and liquidated Simple Annual Interest Rate to Noncontrolling Interest if Joint Venture is Early Terminated and Liquidated Simple Annual Interest Rate to Noncontrolling Interest if Joint Venture is Early Terminated and Liquidated Shipping and Handling Costs Shipping and Handling Cost, Policy [Policy Text Block] Allowance for Price Adjustments Allowance for Price Adjustments [Member] Allowance for Price Adjustments [Member] Aggregate Intrinsic Value, Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Sale Leaseback Transaction [Line Items] Sale Leaseback Transaction [Line Items] Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Nonstatutory Stock Options Nonstatutory Stock Options [Member] Nonstatutory Stock Options [Member] Schedule of Other Long-Term Liabilities Other Noncurrent Liabilities [Table Text Block] Retirement Plan Sponsor Location [Domain] Retirement Plan Sponsor Location [Domain] Consolidated Entities [Axis] Consolidated Entities [Axis] Accumulated depreciation Accumulated depreciation Finance Lease, Right-of-Use Asset, Accumulated Amortization Other long-term liabilities Liabilities, Other than Long-Term Debt, Noncurrent Debt Instrument [Line Items] Debt Instrument [Line Items] Common shares, par value $0.002 per share: Common Shares Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract] Class of Stock [Line Items] Class of Stock [Line Items] Total lease liabilities Operating Lease, Liability Balance Balance SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount Share-based Compensation Expense Share-Based Payment Arrangement [Policy Text Block] Total minimum lease payments Finance Lease, Liability, to be Paid Schedule of Finance Lease Liability Maturities Finance Lease, Liability, Fiscal Year Maturity [Table Text Block] 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Two Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Current and non-current deferred tax assets and liabilities Deferred Tax Assets, Net [Abstract] Accrued inventory Accrued Inventory Accrued Inventory Other current and long-term assets Increase (Decrease) in Other Operating Assets 2026 Long-Term Debt, Maturity, Year Four Auditor Location Auditor Location Accounts Receivable Factoring Agreement, maximum borrowing capacity, percent of net accounts receivable Accounts Receivable Factoring Agreement, Maximum Borrowing Capacity, Percent Of Net Accounts Receivable Accounts Receivable Factoring Agreement, Maximum Borrowing Capacity, Percent Of Net Accounts Receivable Foreign Line of Credit Foreign Line of Credit [Member] Entity Filer Category Entity Filer Category Current Current Federal Tax Expense (Benefit) United States UNITED STATES Share-based Payment Arrangement, Expense Allocated share-based compensation expense Share-Based Payment Arrangement, Expense Commitments and contingencies (Note 15) Commitments and Contingencies Security Exchange Name Security Exchange Name Outstanding (in dollars per share) Outstanding (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Variable Interest Rate Term Loan Maturing August 2022 Variable Interest Rate Term Loan Maturing August 2022 [Member] Variable Interest Rate Term Loan Maturing August 2022 [Member] Reissuance of treasury stock Stock Issued Revenue Revenue from Contract with Customer, Excluding Assessed Tax SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member] Cover [Abstract] Cover [Abstract] Entity Voluntary Filers Entity Voluntary Filers Cumulative translation adjustment removal Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease) Taiwan TAIWAN Undistributed earnings of foreign subsidiaries Undistributed Earnings of Foreign Subsidiaries Finance lease Finance Lease, Weighted Average Discount Rate, Percent Accounts Receivable Factoring Agreement, reduction of maximum borrowing capacity Accounts Receivable Factoring Agreement, Reduction Of Maximum Borrowing Capacity Accounts Receivable Factoring Agreement, Reduction Of Maximum Borrowing Capacity Segment Reporting [Abstract] Segment Reporting [Abstract] Schedule of Other Current Assets Schedule of Other Current Assets [Table Text Block] Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Retirement Plan Name [Axis] Retirement Plan Name [Axis] Withholding tax on restricted stock units Payment, Tax Withholding, Share-Based Payment Arrangement Total liabilities and equity Liabilities and Equity Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Less: Allowance for price adjustments Allowance for Price Adjustments Receivable, Current Allowance for Price Adjustments Receivable, Current Share repurchase program, remaining authorized amount Stock Repurchase Program, Remaining Authorized Repurchase Amount Product Warranty Standard Product Warranty, Policy [Policy Text Block] Total deferred tax assets Deferred Tax Assets, Gross Reissuance of Treasury Stock (in shares) Stock Issued During Period, Shares, Treasury Stock Reissued Domestic and foreign components of income (loss) Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Income tax interest and penalties accrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Less amount representing interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Employee stock options and RSUs Stock Options and Restricted Stock Units (RSUs) [Member] Stock Options and Restricted Stock Units (RSUs) [Member] Diluted (in dollars per share) Earnings Per Share, Diluted Award vesting period (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Location [Domain] Location [Domain] Accounts Receivable Factoring Agreement, borrowed amount outstanding Accounts Receivable Factoring Agreement, Borrowed Amount Outstanding Accounts Receivable Factoring Agreement, Borrowed Amount Outstanding 2022 Lessee, Operating Lease, Liability, to be Paid, Year Two Other current assets Total other current assets Other Assets, Current Total deferred tax assets, net of valuation allowance Deferred Tax Assets, Net of Valuation Allowance Unrecognized tax benefits Balance at beginning of year Balance at end of year Unrecognized Tax Benefits Share Repurchase Program [Axis] Share Repurchase Program [Axis] U.S. operations Income (Loss) from Continuing Operations before Income Taxes, Domestic Loss on changes on equity interest of the JV Company, net Loss on changes on equity interest of the JV Company, net Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Schedule of Operating Lease Liability Maturities Lessee, Operating Lease, Liability, Maturity [Table Text Block] Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, Address Line One Entity Address, Address Line One Long-term Debt Long-Term Debt, Excluding Current Maturities [Abstract] Product and Service [Axis] Product and Service [Axis] Accruals and reserves Deferred Tax Assets, Accruals and Reserves Amount before allocation of valuation allowances of deferred tax asset attributable to accruals and reserves. Class of Stock [Domain] Class of Stock [Domain] Trade name Trade Names [Member] Tax Credit Carryforward [Table] Tax Credit Carryforward [Table] Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Manufacturing machinery and equipment Machinery and Equipment [Member] Building Building [Member] Impairment of privately-held investment Equity Method Investment, Other than Temporary Impairment Entity by Location [Axis] Entity by Location [Axis] Advertising expense Advertising Expense Total deferred tax liabilities Deferred Tax Liabilities, Gross Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward] Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward] Gain on deconsolidation of the JV Company Gain on deconsolidation of the JV Company Deconsolidation, Gain (Loss), Amount Operating cash flows from finance lease Finance Lease, Interest Payment on Liability Weighted average discount rate Weighted Average Lease Discount Rate [Abstract] Weighted Average Lease Discount Rate [Abstract] Deferred tax liability Deferred Tax Liabilities, Tax Deferred Income Valuation and Qualifying Accounts SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Deposit with supplier Deposits With Supplier Deposits With Supplier VAT receivable Local VAT Receivable Local VAT (Value Added Tax) Receivable Research and Development Research and Development Expense, Policy [Policy Text Block] SEC Schedule, 12-09, Allowance, Credit Loss SEC Schedule, 12-09, Allowance, Credit Loss [Member] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Joint Venture Joint Venture [Policy Text Block] Joint Venture [Policy Text Block] Other accrued expenses Other Accrued Liabilities, Current Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Retirement Benefits [Abstract] Retirement Benefits [Abstract] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Share-based payment arrangement, expense, non-cash Share-Based Payment Arrangement, Expense, Non-Cash Share-Based Payment Arrangement, Expense, Non-Cash Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Advertising Advertising Cost [Policy Text Block] Cash flows from financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Foreign subsidiaries, statutory reserves maximum cumulative amount as a percent of registered capital Statutory Reserves, Cumulative Amount as a Percent of Registered Capital Statutory Reserves, Cumulative Amount as a Percent of Registered Capital Length of product warranty Length of Product Warranty Length of Product Warranty Less amount representing interest Finance Lease, Liability, Undiscounted Excess Amount Purchase price financing amount, percent Sale Leaseback Transaction, Purchase Price Financing, Percent Sale Leaseback Transaction, Purchase Price Financing, Percent Impairment of long-lived assets Asset Impairment Charges Research and development Research and Development Expense [Member] Purchase commitment, amount Purchase Commitment, Remaining Minimum Amount Committed Cost of goods sold Cost of Sales [Member] Foreign subsidiaries, restricted statutory reserves Foreign Subsidiaries, Restricted Statutory Reserves, Amount Foreign Subsidiaries, Restricted Statutory Reserves, Amount EX-101.PRE 14 aosl-20220630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 15 aosl-20220630_g1.jpg GRAPHIC begin 644 aosl-20220630_g1.jpg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

S-X.3R6?#=YE#*G M?5![ 2ER?HY\B2&D?]9^&6\4=@MZ-Y\+$:]>=M\ ML#QI>P!]2S*:?$A]\RF$?;A^I2'9?RQ_5VYF='B!?F3P=:"!E5L"=J*!+J ]3P<>@. S#*&>VB KRF0?0* C2($?I^ :&W<%[$7Z=\R$\3O/>3:$ S)<>K:#(BF9?&R"."(G?BV!36UR M(>&[3)#>B6%12F3>_N# MFR)#?=&""&D@BN157& ,BB-9'%:-B7UR@BET\"[,@A)W62:G@AQY[!_?@CU\B&7' M@,=Q+%SQ@.-RH%/"@.!T#4I7@,IU>D#?@+YW #=S@,MXGBZ[@.9Z3B;%@2!\ M&2 J@6Q]X643?O5W\EQ-?S5XUE,S?T]YHTG9?UAZ9D![?VI[-S=2?Y1\'RZW M?]Q]%2;A@$5^%B!I@+Q_#61V?61^?5N[?T (?56"X3<&?;^"6RZT?CV!ZB<7?N^!:R#'?[6 Y6.:>RJ+!5L/>\J* M3U(=?".)&DCY?%&'K#_;?)6&53;P?0Z%%BZQ?::#ZB!E%[C MDXA4V5:>DA58DTX*D*I<9D4=CR5@83P$C7YDCC,4B\AH^BK+BA9MF"--B']R MA1TFAQQWD%X(D/M;@U7WC\9>MTUWCG9B T2QC09E<#O(BWEI"3,*B>ILV"KV MB&1PTB.JAOYU#!VOA RBL_@9. Q"3;@3* L!^7@0R BEHSA$B'2%*!A">&ZTIY@Z:&"4)? M@L^$]#IB@?N$#C*@@5J#32M\@-^"I23]@+*!ZA^]@*R!+U3F%-=IT55EBIA"CVDD[EDGC7ID0]H:"YACEUL;">%B[5PE2%AB3]T M]QQMAR!Y4E-]E[]@E$Q,E?QC6D39D_UF/3TYD:=I4C6LCR%LC2Y:C)EO^R>W MBA]SA2'"A]QW.QSRA>]ZX5,(E5)FHTO)DZ]H[$1.D=!K43S5%*CH=^&4I!C8U^>D,?C!)^H3O]BC5^NC3YB$5^]"XXAG5_12@X MA+I_JB+=@U!__QZ.@CJ .5$1C7^#FTH-C*"#?4+TBSV# #OEB6N":S3]AW^! M_"Y1A;R!J2A4A!N!:2+]@M&!(!ZY@=> U:(U5IM/JI/D6BE4(X5"7;]8F'8= M87A="V:'96AAAU;&:9IF(T=F;@IJ]CAWQ@NG3L7AAD0V5]8GQGU%7J9R-KA4:^; UO9S@:<5ASIRK/=NIX;)Y- M37%CBY"34?EF*()M5G=HPW.76PMK8F1>7]5N#E4&9.IPV$8=:D1SRC?(< !W M"RK7=?AZL9QW28-M58[B3GQO!8#64UAPNG)46$AR ;M1Z3RK>=2)\SIJT1?YV^XU@2V!WR7^"4)QXFW$:5>!Y;6)M6V9Z M2U-]83][/$439UM\/S=$;=-]:BKC=&I^O9DJ0NZ =HP92*^ 97YX3D" 5' \ M4]> 0F&H6:> -%+\7\F -$2W9C> /#<5;/J 4RKH<\V >9?B0$R)O8L-1F&( MPGVD3#Z'R6^14AN&T6$/6#&%W%*#7I6$ZD1T94&#]S;S;$."_"KL0P"8.WR!24>5:FZR3X:2LF!A5?Z0 U'T7,>-0T0$ M8]>*:S:[:S2':BKRF=V,)5Z6,=9:HC'7$E<_WM;7\U@CVU; M8VMD'E[B9SMGM5!,:TYK;D(F;Z%O6#2+=%ASJ"A,>4]X?9.Z5)IBS(<86))E M@WGN7'QH-FP-8'UJZEW,9+-MJD]R:3%PBD&/;?!SDC1&%=ZII(( M4-)L$(5_53)M['AS67=OR&KI7=%QI%S28FMSBDZU9TMUBT$4;&UWJS00<>9Z M""A[=WU\II!V375U-X0<4C!V/W8\C2HY^/(+U3Y=^<78X5(-^FFCH67Y^O5M*7K5^ MY4V:9#A_'4!=:?]_8C/$=B& &8X/2!2'"X(&36.&:'5M4I"%LF@[ M5\V$]5JQ74>$/4TF8PJ#C4 D:0R"XS.N;UF"-2BK=9V!A(TY1@R/BX%+2Y.. M$'3+4/:,>6>S5F>*V%H[7!:)0$R\8A2'JS_?:$J&%C.<;L.$;BBU=3""NXRB M1'J7EH#!2BN52'1.3[22SV=)54N03EGK6R&-VTR&84>+9C^O9ZJ(Z3-\;DZ& M42B^=-F#O(R^9%U08X!P9LE4MW.Z:519#F9^; %=:%C>;MAAU4LE<>AF;3W@ M=3%K/S$E>-=P@"7 ?+UV6(KL7_A9,G\78N5YMXBXE46_%B#7VG7U-DV'%]8JEGH&21 M9A%J:%=/::AM/TGZ;81P-CTD<9US5S#K=@MVRB8<>IQZF8?"6%%JSGPO7!1L MSW 37\!NSV-Z8WUPS59@9W=RU4E(:[)T^CRS<"AW/S#"=.MYP29!>;Q\?H98 M51IS='KD62UTL&[G72MUXV)J83IW$56J98-X2DBX:A=YF#Q=;N!Z_#"H<^U\ MB29A>/Q^-H4J4E-[_'G75JU\=&W\6O)\V&&:7TI],E3X8]I]DDA*:+%^!3P; M;<-^B#"3%E_O80V3_>$37C]5(R$ FT\60V#DV#R7:2#%%1D8G2" MG4?=9XB",COM;-"!TC")+LD-]K:BVM>])P MKR-[?OAV>X!B9V%9 '5Q:;AEESP"/ ?:]=IW%"C;LQL MSD1@0EVL2/\?,-ZBWV(8 UIB7+"8RUKJ&>:9CMMQUP. M:59OZD_[;*1R%D/R<"MT8#AS<^1VS"V;=]]Y=B0Q>]U\5GPZ7/QQL7&I8&=S M&6:58\!T>EL,9R9UUD]):L!W/T-D;IUXP#@?Q9]]7LG M6E-YNW"M7?UZ<&6U89A[#EI&941[H$ZD:2%\/$,";3Q\[3?J<8E]KRU_=@A^ MA22">F]_8WI(6 Z!CF_E6_"!D&4#7\*!:%FI8ZB!+4X<9\" ^T*B;!: V#?' M<)6 Q"V =4R M"2A>>2 H'F;5BZ)&6])6D"(;F1Q7C^'?EDI8E&&<$VI9IN% M;D(^:R>$>3>/;]2#D"U]=+*"H"2Z>7.!K7D>5+202F[66.V._6/^70Z-15B^ M84"+8$U59:N)B4(':EV'P3=@;S>& BUC=$"$/B3.>1B"BG=L/!B'3^R>K%FO32O?)AKF"I7?L1PX"%D@1-VF778 M;QA8O6O/<-5<3&$N'YK,#2&>L%O3RIL?41S MRR&]?]IXG72':W%@@FJ4;9)C:F T;ZUF5E5!<=%I2TH.=!-L6#[C=H9OC#1/ M>2%R["IU>_)VEB(*?LAZ>W-,:!YH.6EG:I)J=5\7;/ELM51\;V1N^TELLEY.")-?=E\+W(?92EOXVA29^5Q<1[J2*%?0Q]MW$A8IQW=F>"99=X M85UP:']Y-U+Z:W!Z!$A>;HEZWCW1<=A[TC/5=4M\V"J0>.9]\B*U?&!_#W!3 M8&M^TF;%8YQ_&5S'9KE_-5)E:>!_0$??;3%_5SUY<+5_@C.Z=%=_O2J9>"A_ M_2+<>]& .&^P7IF%Y68T8?>%C5Q!94&$[U'P:).$,T=X;!&#A#TA;\F"YS.- MUV!,F\Y722,JF7'8*J+OUO69!:*95&.9XB(VT#1B,5>P"!_VS2>LU1%6-*>X=5+EEM?&)98$\I M?45=KT2D?BUB)3HP?RUFU3!5@$IKOB#Q; MY5B5>5Y?@TZ$>H)C-40O>[-G"3GN?01K#S!*?G)O1R=H@!)SUA_L@;]XHFI M[=HMEF$W&=_1HJ$.E>7!KUCF:>Q)O+S P?-!RLB>*?KEV M>R!)@*%Z:VDH<'IFWV =5=S,3 - M>V%U^B>A?8UX^""9?ZI\"F@D;:1N"U\S;ZEOQE7D<9EQ@DQ&AMY&2>Z?(9[2"#>?M=]?&<[:RIU)EY?;6UV1%4M;YEW5$NW M<<1X84(U= =Y?3C-=G)ZN2_R>/I\!B?4>Z!]9B$7?B5^P69\:0=\$5W#:X=\ MF%2K;>=\^$M&<$%]2T'. 5^OB?G>MY_3R%&?9)_UV7D M9SV"N5TY:>Z"K%0O;'R"7$K>;OZ!\D%V<9R!G#@Z=&J!7"_ =T*!+B?U>C^ M^R%L?1J P65R9%.S@7^TD%@,?.%A MGD^$?9!DN4:/?BYG[#V ?M!K0S28?XQNR2Q:@%QR=B3B@4]V81Z^@DEZ6U]4 M>0YE7EA=GV4ZE>P-J7T7P>^1L^CT'?,YOLC14?=)RD2Q.?NEUCR4-@!QX MNQ\<@4E[YUYP=D]L'U9.=YAN!DWC>,%O\T5&>=QQZCRE>P9T #07?$YV-BQ" M?:-X@24P?Q%ZZA]K@&Y]1UVE<^1RRU67=6QT(4U'=LYU;D3">"%VP3Q!>7YX M*#/Z>O1YKBQ%?(%[1B53?BA\Z1^M?[=^>EST<#5\%#/0>=A\YBQ=>X5]RB5Y?5]^KQ_C?Q]_@%QF< )_C%2(<@=_ MQTQG<]%_QD09=7-_LCO'=QQ_NS.F>.Q_W2Q">L& %"6/?+R 0" /?J2 7%O\ M;I"%FE0D<+^%3$P+"F"CRP]>B*"#R6;?$*! MC" R?D*!#UB*BSI085#XBI14@4D:B@!8OD#=B5Y=*SAQB*=ATS RA^YFP2B= MAT)KY"'8AK9Q51Q@AE%VV5=QA_U6UU 5A[A:@4A,AUI>14 ^AN)B+C@0AEAF M2# 2A==JGBB_A69O("(UA1MSXASMA/%XIU:8A-5=24\[A-A@=4>OA"AJG"_J@^AN6"C5@[ER-B*!@Z]V1AUG@[YZ3%72@=UCKTYV@AUF M4T;<@C=I!S\C@C1KV#=0@BANSR^_@BQQ["C@@C]U)2*^@G)X@1W0@K9[QU41 M?REJ#4W!?ZML)D8Y?_YN3#Z7@#%P@C<*@&%RX2^;@*1U7RCH@/1W[B+Q@6!Z MD1XI@=1]%U1??,1P6TT=?8IQZD6Q?A=S>CXM?GQU%3:^?MQVS2^(?TUXIRCS M?])ZBR,<@'1\=!YS@1=^.U/%>K-V>4R4>[AW@$5"?'MX=#W9?0QY;C9[?9=Z M@R]K?C)[LBD(?M9\[B-$?ZI^(1ZP@'M_,U-!>.=\64P6>B]\UD35>R9]+3V& M>^!]@C9 ?(Q]\B\Z?5)^>"D#?@]_#B-O?O]_EA[A?_V U+@=W&"'DO,>/:" M%T2@>A^!OSUQ>NV!6#95>Z.!&B]H?'R ^"DG?6. Z".*?GZ SA\(?YB K$[8 MD_U/HTA*DH13TD%QD1%8'3H]CX5]MQT3&A?%OE3Y A9EQ;C?$A/9S7C%SA#EU<"MC@XEWI"7P@O%YVB$F@HQ\ M"1UA@DY^ TJ\@]!SDT1,A"!TW#WDA )V(C>&@XMW>S%,@O5X\BM:@FUZ@B82 M@?=\%R%;@I\ M,BM%@8M]("8:@3)^%B&$@1E^^1W:@2Q_M$G[@'Q^I4.7@5)^VSU5@9U^YC'EZ>WQ]?G^ M@8*#A(6&AXB)BHN,C8Z/D)&2DY25EI>8F9J;G)V>GZ"AHJ.DI::GJ*FJJZRM MKJ^PL;*SM+6VM[BYNKN\O;Z_P,'"P\3%QL?(R+CY.7FY^CIZNOL[>[O\/'R\_3U]O?X^?K[_/W^_P ! 0(" P,$ M! 4&!@<'" @)"0H+"PP,#0T.#P\0$!$1$A,3%!05%A87%Q@9&1H:&QP<'1X> M'R @(2(B(R0D)28F)R@I*2HK+"TM+B\P,3(R,S0U-C7Q^@8.&B8N.D)*5EYF;G9^A MHZ6GJ*JLK:^PLK.UMK>YNKN\O;_ P<+#Q,7&Q\C)RLO,SW]_@X>'BX^/DY>7FYN?HZ.GIZNOK[.SM[N[O[_#P\?+R M\_/T]/7V]O?W^/CY^?K[^_S\_?W^_O\ 0$" @,#! 0%!@8'!P@("0D*"PL, M# T-#@\/$! 1$1(3$Q04%186%Q<8&1D:&AL<'!T>'A\@("$B(B,D)"4F)B9FYV?H:.EIZBJK*VOL+*SM;:W MN;J[O+V_P,'"P\3%QL?(RKKZ^SL[>[N[^_P\/'R\O/S]/3U]O;W]_CX^?GZ M^_O\_/W]_O[__Z8Y,O^B1DK]H$U@\:1,E9+'$IV^V MP:=XN[VG@<"ZI8?&MJ.'R[.@A]"OG8C6JYJ+W:67E>:EEY7FI9>5YJ67E>:E MEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67 ME>:EEY7F_Z8Y,O^B1DK]H$U@\:1,E9+'$IV^VP:=X MN[VG@<"ZI8?&MJ.'R[.@A]"OG8C6JYJ+W:67E>:EEY7FI9>5YJ67E>:EEY7F MI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:E MEY7F_Z8Y,O^B1DK]H$U@\:1,E9+'$IV^VP:=XN[VG M@<"ZI8?&MJ.'R[.@A]"OG8C6JYJ+W:67E>:EEY7FI9>5YJ67E>:EEY7FI9>5 MYJ67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7F M_Z8Y,O^B1DK]H$U@\:1,E9+'$IV^VP:=XN[VG@<"Z MI8?&MJ.'R[.@A]"OG8C6JYJ+W:67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67 ME>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7F_Z8Y M,O^B1DK]H$U@\:1,E9+'$IV^VP:=XN[VG@<"ZI8?& MMJ.'R[.@A]"OG8C6JYJ+W:67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:E MEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7F_Z8Y,O^B M1DK]H$U@\:1,E9+'$IV^VP:=XN[VG@<"ZI8?&MJ.' MR[.@A]"OG8C6JYJ+W:67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7F MI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7F_Z8Y,O^B1DK] MH$U@\:1,E9+'$IV^VP:=XN[VG@<"ZI8?&MJ.'R[.@ MA]"OG8C6JYJ+W:67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7FI9>5 MYJ67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7F_Z8Y,O^B1DK]H$U@ M\:1,E9+'$IV^VP:=XN[VG@<"ZI8?&MJ.'R[.@A]"O MG8C6JYJ+W:67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67 ME>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7F_Z8Y,O^B1DK]H$U@\:1, ME9+'$IV^VP:=XN[VG@<"ZI8?&MJ.'R[.@A]"OG8C6 MJYJ+W:67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:E MEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7F_Z8Y,O^B1DK]H$U@\:1,E9+'$IV^VP:=XN[VG@<"ZI8?&MJ.'R[.@A]"OG8C6JYJ+ MW:67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7F MI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7F_Z8Y,O^B1DK]H$U@\:1,E9+'$IV^VP:=XN[VG@<"ZI8?&MJ.'R[.@A]"OG8C6JYJ+W:67 ME>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7FI9>5 MYJ67E>:EEY7FI9>5YJ67E>:EEY7F_Z8Y,O^B1DK]H$U@\:1,E9+'$IV^VP:=XN[VG@<"ZI8?&MJ.'R[.@A]"OG8C6JYJ+W:67E>:E MEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67 ME>:EEY7FI9>5YJ67E>:EEY7F_Z8Y,O^B1DK]H$U@\:1,E9+'$IV^VP:=XN[VG@<"ZI8?&MJ.'R[.@A]"OG8C6JYJ+W:67E>:EEY7F MI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:E MEY7FI9>5YJ67E>:EEY7F_Z8Y,O^B1DK]H$U@\:1,E M9+'$IV^VP:=XN[VG@<"ZI8?&MJ.'R[.@A]"OG8C6JYJ+W:67E>:EEY7FI9>5 MYJ67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7F MI9>5YJ67E>:EEY7F_Z8Y,O^B1DK]H$U@\:1,E9+'$ MIV^VP:=XN[VG@<"ZI8?&MJ.'R[.@A]"OG8C6JYJ+W:67E>:EEY7FI9>5YJ67 ME>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7FI9>5 MYJ67E>:EEY7F_Z8Y,O^B1DK]H$U@\:1,E9+'$IV^V MP:=XN[VG@<"ZI8?&MJ.'R[.@A]"OG8C6JYJ+W:67E>:EEY7FI9>5YJ67E>:E MEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67 ME>:EEY7F_Z8Y,O^B1DK]H$U@\:1,E9+'$IV^VP:=X MN[VG@<"ZI8?&MJ.'R[.@A]"OG8C6JYJ+W:67E>:EEY7FI9>5YJ67E>:EEY7F MI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:EEY7FI9>5YJ67E>:E MEY7F_Z8Y,O^B14K]H4Q@\J5+<>:I2H/:JDV5SZE6I:J2(+;K4J3T*Q2H\FL7:_&KV>SP[%QN+^S>;VX MKX'$LJJ'RZRFAM"EHX;5G9^&VI.=B]Z3G8O>DYV+WI.=B]Z3G8O>DYV+WI.= MB]Z3G8O>DYV+WI.=B]Z3G8O>DYV+WI.=B]Z3G8O>DYV+WI.=B]Z3G8O>_ZL1H'2TK!.H+ZRKH'% MK:J'RZ>GA<^@I(33F*&%UX^?B-J/GXC:CY^(VH^?B-J/GXC:CY^(VH^?B-J/ MGXC:CY^(VH^?B-J/GXC:CY^(VH^?B-J/GXC:CY^(VH^?B-J/GXC:_Z,"MKH'&J:J& MRJ*HA,Z;I831E*.$U(RAA]>,H8?7C*&'UXRAA]>,H8?7C*&'UXRAA]>,H8?7 MC*&'UXRAA]>,H8?7C*&'UXRAA]>,H8?7C*&'UXRAA]>,H8?7_Z\ZI$;NFQ07_?N#Z.UKU"F\_#2J3"OEROMK=LN:ZQ>,&IKH'&I:N%R9ZI MA,R8IX//D:6$THJCAM2*HX;4BJ.&U(JCAM2*HX;4BJ.&U(JCAM2*HX;4BJ.& MU(JCAM2*HX;4BJ.&U(JCAM2*HX;4BJ.&U(JCAM2*HX;4_Z@W,O^D1$O^ID9> M]*U";>JT/GWAO3N+VL8\ELK&2*2YO%RRK[9MNZFQ><&EKH+%H:R$R)NJ@\N5 MJ8/-CZ>$SXFFAM&)IH;1B::&T8FFAM&)IH;1B::&T8FFAM&)IH;1B::&T8FF MAM&)IH;1B::&T8FFAM&)IH;1B::&T8FFAM&)IH;1_Z@W,O^D0TO_J$-=]:\_ M;.RX.GKDPS>'W=,UD,'$2:>QNEZUJ;5NO*2Q>L"BKX+$G:V$QYBLA,F2JH3+ MC:F%S8BHALZ(J(;.B*B&SHBHALZ(J(;.B*B&SHBHALZ(J(;.B*B&SHBHALZ( MJ(;.B*B&SHBHALZ(J(;.B*B&SHBHALZ(J(;._ZDV,O^E0DO_JD%<]K([:NZ] M-G?HRS. T-(SD[C#2ZBJN6"VI+5PO*&R>\">L(/#FJZ$Q96MA,>0K(3)BZN% MRH>JALR'JH;,AZJ&S(>JALR'JH;,AZJ&S(>JALR'JH;,AZJ&S(>JALR'JH;, MAZJ&S(>JALR'JH;,AZJ&S(>JALR'JH;,_ZDU,O^E0DO_K#U:^+L MA\F'K(?)AZR'R8>LA\F'K(?)AZR'R8>LA\F'K(?)AZR'R8>LA\F'K(?)AZR' MR8>LA\F'K(?)AZR'R8>LA\F'K(?)_ZHT,O^F0$O_L#E8^;TQ8N?.+6G0X"1_ MN<\WEZ?"4JF>NF:UFK5SNYBS?;Z7LH/ E+&%P9"PA<.-KX7$B:Z&Q8:NA\:& MKH?&AJZ'QH:NA\:&KH?&AJZ'QH:NA\:&KH?&AJZ'QH:NA\:&KH?&AJZ'QH:N MA\:&KH?&AJZ'QH:NA\:&KH?&_ZLS,O^J.TG_MC)3\,(6;"WR2"K9O&BREK=UN)2T?;V3LX.^D;*%OXZRAL"+L8;!B+"'PH:PB,.&L(C# MAK"(PX:PB,.&L(C#AK"(PX:PB,.&L(C#AK"(PX:PB,.&L(C#AK"(PX:PB,.& ML(C#AK"(PX:PB,.&L(C#_ZTQ,O^P,T7XP"E,W]8C3*-^Q7NE?,1]IGO$?J=YPX"H>,*"J7?"@ZIWPH.J=\*#JG?"@ZIW MPH.J=\*#JG?"@ZIWPH.J=\*#JG?"@ZIWPH.J=\*#JG?"@ZIWPH.J=\*#JG?" M@ZIWPH.J^KX<*-;=#B/ \!0_K/T>5YSP+6J/Y3YYAMY.@X'87XM_U&N0>M%P ME'?/=)=USG>8<\UYFG+->YMQS'V;<,M_G&_+@)UORX"=;\N G6_+@)UORX"= M;\N G6_+@)UORX"=;\N G6_+@)UORX"=;\N G6_+@)UORX"=;\N G6_+@)UO MRX"=V=(+&,3M#BFP_19!G_\D59'T-66'ZT9P?^54>7OA87]VW6B$8UIUGJ.:-5\CF?5?H]GU7Z/9]5^CV?5?H]GU7Z/9]5^ MCV?5?H]GU7Z/9]5^CV?5?H]GU7Z/9]5^CV?5?H]GU7Z/9]5^CV?5?H]GU7Z/ M_Z,Y*O^?1D#_G5!5^J!09>^C477DI%.&VJ);EM"@9:3(G7"PQ9Q[M<*<@[F_ MFHF^O)6+PKJ0C,6XC(_)MHB2S+.$E\^R@9_2K7^BTZU_HM.M?Z+3K7^BTZU_ MHM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3_Z,Y M*O^?1D#_G5!5^J!09>^C477DI%.&VJ);EM"@9:3(G7"PQ9Q[M<*<@[F_FHF^ MO)6+PKJ0C,6XC(_)MHB2S+.$E\^R@9_2K7^BTZU_HM.M?Z+3K7^BTZU_HM.M M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3_Z,Y*O^? M1D#_G5!5^J!09>^C477DI%.&VJ);EM"@9:3(G7"PQ9Q[M<*<@[F_FHF^O)6+ MPKJ0C,6XC(_)MHB2S+.$E\^R@9_2K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3 MK7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3_Z,Y*O^?1D#_ MG5!5^J!09>^C477DI%.&VJ);EM"@9:3(G7"PQ9Q[M<*<@[F_FHF^O)6+PKJ0 MC,6XC(_)MHB2S+.$E\^R@9_2K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^B MTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3_Z,Y*O^?1D#_G5!5 M^J!09>^C477DI%.&VJ);EM"@9:3(G7"PQ9Q[M<*<@[F_FHF^O)6+PKJ0C,6X MC(_)MHB2S+.$E\^R@9_2K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_ MHM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3_Z,Y*O^?1D#_G5!5^J!0 M9>^C477DI%.&VJ);EM"@9:3(G7"PQ9Q[M<*<@[F_FHF^O)6+PKJ0C,6XC(_) MMHB2S+.$E\^R@9_2K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3_Z,Y*O^?1D#_G5!5^J!09>^C M477DI%.&VJ);EM"@9:3(G7"PQ9Q[M<*<@[F_FHF^O)6+PKJ0C,6XC(_)MHB2 MS+.$E\^R@9_2K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3 MK7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3_Z,Y*O^?1D#_G5!5^J!09>^C477D MI%.&VJ);EM"@9:3(G7"PQ9Q[M<*<@[F_FHF^O)6+PKJ0C,6XC(_)MHB2S+.$ ME\^R@9_2K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^B MTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3_Z,Y*O^?1D#_G5!5^J!09>^C477DI%.& MVJ);EM"@9:3(G7"PQ9Q[M<*<@[F_FHF^O)6+PKJ0C,6XC(_)MHB2S+.$E\^R M@9_2K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_ MHM.M?Z+3K7^BTZU_HM.M?Z+3_Z,Y*O^?1D#_G5!5^J!09>^C477DI%.&VJ); MEM"@9:3(G7"PQ9Q[M<*<@[F_FHF^O)6+PKJ0C,6XC(_)MHB2S+.$E\^R@9_2 MK7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M M?Z+3K7^BTZU_HM.M?Z+3_Z,Y*O^?1D#_G5!5^J!09>^C477DI%.&VJ);EM"@ M9:3(G7"PQ9Q[M<*<@[F_FHF^O)6+PKJ0C,6XC(_)MHB2S+.$E\^R@9_2K7^B MTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3 MK7^BTZU_HM.M?Z+3_Z,Y*O^?1D#_G5!5^J!09>^C477DI%.&VJ);EM"@9:3( MG7"PQ9Q[M<*<@[F_FHF^O)6+PKJ0C,6XC(_)MHB2S+.$E\^R@9_2K7^BTZU_ MHM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^B MTZU_HM.M?Z+3_Z,Y*O^?1D#_G5!5^J!09>^C477DI%.&VJ);EM"@9:3(G7"P MQ9Q[M<*<@[F_FHF^O)6+PKJ0C,6XC(_)MHB2S+.$E\^R@9_2K7^BTZU_HM.M M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_ MHM.M?Z+3_Z,Y*O^?1D#_GD]4^J%.9.^D3W7EIE&%VJ58E=&B8J/)GVVOQ9]W MM<*>@+F_G8B^O)F)P[F4B\>VCXW+LXJ0S[&&EM2N@Z#7IX&AU:>!H=6G@:'5 MIX&AU:>!H=6G@:'5IX&AU:>!H=6G@:'5IX&AU:>!H=6G@:'5IX&AU:>!H=6G M@:'5_Z,Y*O^@1D#_GDY4^J)-9/"E3G3EJ$^$VZ=5E-*E7Z'*HVFMQ:)TM,*A M?;F_H(6^NYV(P[B8BKB_ MI(*]NZ*'P[B=A\FSF(G/L)2.U:N2E]J@BISV):.GMB6CI[8EHZ>V):.GMB6 MCI[8EHZ>V):.GMB6CI[8EHZ>V):.GMB6CI[8EHZ>V):.GMB6CI[8_Z0X*O^@ M14#_H$M3^Z5*8_&I27+GK4J!WK!-D-6P59S.L%ZGR;!HK\:R<[/#LGRXO;" MP;:L@LFNIX7/I:&*U9RV9&4GMF1E)[9D92>V9&4GMF1E)[9 MD92>V9&4GMF1E)[9D92>V9&4GMF1E)[9D92>V9&4GMF1E)[9_Z0X*O^@14#_ MH4I3^Z9(8O*K2''HKTB W[-*CM:U49K0MEJDS+AEJ\J]<:[!N7NVM[* P*ZL MA,BFJ(7.G:2'U)2@CMB.GYG;C)N>V8R;GMF,FY[9C)N>V8R;GMF,FY[9C)N> MV8R;GMF,FY[9C)N>V8R;GMF,FY[9C)N>V8R;GMF,FY[9_Z0X*O^A14#_HDE3 M_*='8?*M1G#ILD9_X+='C-F[3I?3OU>?T,5CI,7 <*VZN'FWL+* P*FMA<>@ MJ(3-EZ6%THZAB=>'H)+9AZ&AG-B'H9S8AZ&AG-B'H9S8AZ&A MG-B'H9S8AZ&AG-B'H9S8AZ&AG-B'H9S8_Z0W*O^A1$#_HTA2_*E% M8?.N1&_JM4-]XKQ$B=S"2I/8RE29RL9BI+R];K"RMGBYJK& P:2MA<>;J83, MDZ:$T(JCA]2#HH[6@J*6UH*BEM:"HI;6@J*6UH*BEM:"HI;6@J*6UH*BEM:" MHI;6@J*6UH*BEM:"HI;6@J*6UH*BEM:"HI;6_Z4W*O^A1$'_I$92_:I$8/2Q M0F[KN$%[Y,%"AM_,1HW3SU*7P<1AI[.[;;.KM7B[I;& P9^NA,:8JX3*D*B$ MSHBFAM&"I(S3@*22TX"DDM. I)+3@*22TX"DDM. I)+3@*22TX"DDM. I)+3 M@*22TX"DDM. I)+3@*22TX"DDM. I)+3_Z4W*O^A1$'_I451_JQ"7_6T/VSM MO#YXY\= @>#61H?)S5&:N,)@JJRZ;;6EM7B\H+& P9NNA,65K(3(CJJ$RX>H MALZ"IXO/?Z:/T'^FC]!_IH_0?Z:/T'^FC]!_IH_0?Z:/T'^FC]!_IH_0?Z:/ MT'^FC]!_IH_0?Z:/T'^FC]!_IH_0_Z4V*O^B0T'_IT-0_ZX_7?>W/&GPPCMS MYM _>=/9/XJ^RU&=K\!AK*6Y;K:@M7F\G+*!P)BOA,.2KH3&C*R%R(>JA\J" MJ8K,?ZF.S7^ICLU_J8[-?ZF.S7^ICLU_J8[-?ZF.S7^ICLU_J8[-?ZF.S7^I MCLU_J8[-?ZF.S7^ICLU_J8[-_Z8V*O^B0D'_J4!/_[([6_F].&7LRSAMW-PU M>,?6/HZSR5*@I\!CK9^Y<+::M7J\F+*!OY2QA<*/KX7$BZZ&Q8:MA\>"K(K( M?ZN-R7^KC,Q?+K3 M/Y&IR%2AG\!EK9FZAF,%GJY2\<[*2N'RWD+:"NHZTA;R+LX:^B+*'P(6QB<&#L8K!@;",PH&P MC,*!L(S"@;",PH&PC,*!L(S"@;",PH&PC,*!L(S"@;",PH&PC,*!L(S"@;", MPH&PC,*!L(S"_ZDR*O^K.#W_N"]%[L@I2-;?)5+#["ELL=\Q@J'219*7REJ? MD<-IIXZ_=*V-O'RQB[J!M(BY@[:%N(2X@[>&N8&VA[I_M8F[?K6+O'ZUB[Q^ MM8N\?K6+O'ZUB[Q^M8N\?K6+O'ZUB[Q^M8N\?K6+O'ZUB[Q^M8N\?K6+O'ZU MB[Q^M8N\_ZLP*O^Q+SCVPB8\W-H?.\;K(U>S["IOH]\U@I;42I"/S5V:B\AK MH8G$=::&PGNJ@\!^K(&_@*Y_OH*P?;V#L7N\A;)ZNX>S>;N(LWF[B+-YNXBS M>;N(LWF[B+-YNXBS>;N(LWF[B+-YNXBS>;N(LWF[B+-YNXBS>;N(LWF[B+-Y MNXBS_ZTN*OZ[)3#CTAHMR>@;0;;W(UJE["YOEN$\?XS83XN'TE^3A,ULF8'* M=)Y^R'BA>\=[HWG&?:1XQ7^E=L2!IG7#@Z=TPX2H<\*&J7/"AJESPH:I<\*& MJ7/"AJESPH:I<\*&J7/"AJESPH:I<\*&J7/"AJESPH:I<\*&J7/"AJESPH:I M_[0D)>S*%B/-Y1,LN?8;1J?Z)EN8[C5LC.5$>H3>4X. V6**?-5LCWC2<9-U MT'65<\]XEW'.>IAPS7R9;\U^FF[,@)MMS(*<;,N$G&S+A)QLRX2<;,N$G&S+ MA)QLRX2<;,N$G&S+A)QLRX2<;,N$G&S+A)QLRX2<;,N$G&S+A)QLRX2<]<$5 M&='?#!B\\Q,QJO\>1YK\+%F.\CQGA.I+(MIUWJ,:-9\C6?6?HYFU8".9=6!CV75@8]EU8&/9=6!CV75@8]E MU8&/9=6!CV75@8]EU8&/9=6!CV75@8]EU8&/9=6!CV75@8]EU8&/TM(*";_H M#1VM_Q4SG?\C19#_,U2%]T-??O%1:'?L7&]PZ6)T:^=G=VCE;7EFY'![9>-S M?6/B=GUBX7A^8N%Y?V'A>W]@X'V 7^!_@5_@?X%?X'^!7^!_@5_@?X%?X'^! M7^!_@5_@?X%?X'^!7^!_@5_@?X%?X'^!7^!_@5_@?X%?X'^!_Z Y(?^<1C;_ MFE%*_YU26?>?5&GMH%=XXY]JS&M7JLQK5ZK,:U>JS&M7JL MQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&_Z Y(?^<1C;_FE%* M_YU26?>?5&GMH%=XXY]JS&M7JLQK5ZK,:U>JS&M7JLQK5Z MK,:U>JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&_Z Y(?^<1C;_FE%*_YU2 M6?>?5&GMH%=XXY]JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U M>JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&_Z Y(?^<1C;_FE%*_YU26?>? M5&GMH%=XXY]JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U>JS& MM7JLQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&_Z Y(?^<1C;_FE%*_YU26?>?5&GM MH%=XXY]JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&M7JL MQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&_Z Y(?^<1C;_FE%*_YU26?>?5&GMH%=X MXY]JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&M7JLQK5Z MK,:U>JS&M7JLQK5ZK,:U>JS&_Z Y(?^<1C;_FE%*_YU26?>?5&GMH%=XXY]< MA]J<9Y72F7"AS)9[J\:4A+/$DXNVPH^/NL"+DKR^AY6_O8.8P;R!F\.[?J#$ MNGRFQK=ZK,:U>JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U M>JS&M7JLQK5ZK,:U>JS&_Z Y(?^<1C;_FE%*_YU26?>?5&GMH%=XXY]JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U>JS& MM7JLQK5ZK,:U>JS&_Z Y(?^<1C;_FE%*_YU26?>?5&GMH%=XXY]JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&M7JL MQK5ZK,:U>JS&_Z Y(?^<1C;_FE%*_YU26?>?5&GMH%=XXY]JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&M7JLQK5ZK,:U>JS&M7JLQK5Z MK,:U>JS&_Z Y(?^=1C;_FE!*_YY16?>@4FCMH59XY*%:AMN>9)32FVZ@S)AX MJL:5@;+$E8FVP9&.NK^,D+V]B)/ O(27P[J!F\6Y?J#'N'RGR+)[JLBP>ZK( ML'NJR+![JLBP>ZK(L'NJR+![JLBP>ZK(L'NJR+![JLBP>ZK(L'NJR+![JLBP M>ZK(_Z X(O^=1C?_FT]*_Y]/6?BB4&CNHU-WY:17A=RB8)/3GFJ?S9MTJ<>8 M?;'$EX:VP92,NK^/CKZ\BI+"NH:5Q;B"FLBW?Z#+M'RGS*Q\JK#$ MFH*VP9B*NKZ2C+^[C8_$N(B3R+:#F M13?_GDQ)_Z)+5_FF3&;PJ4YTYZM1@M^K5X[7JE^:T*AII,NE13?_ MGDM)_Z-*5_JG2V7PJTQSZ*U/@."O5(W9KER8TJUFH!M[ZA MA,"UFXG&KI6/S*B1E<^BCI[2FHFBTY:'I<^5AZ;.E8>FSI6'ILZ5AZ;.E8>F MSI6'ILZ5AZ;.E8>FSI6'ILZ5AZ;.E8>FSI6'ILZ5AZ;._Z$W(O^>1#?_GTI) M_Z1)5OJH263QK$MRZ;!-?^&S48O:LUJ5U+-CGL^S;J7+LWBKPZQ\M[BE@;^O MGH;&J)F,RZ&5DM";DIO3E8ZBU)&,I="1BZ;.D8NFSI&+ILZ1BZ;.D8NFSI&+ MILZ1BZ;.D8NFSI&+ILZ1BZ;.D8NFSI&+ILZ1BZ;._Z$W(O^>1#?_H$E(_Z5( M5ONJ2&3RKDEQZK),?>*V3XG2UKIAFM.];:#)N'6KOK!ZMK.I?[^JHH3& MHIV*RYN:D,^5EYG2D)6BU(V0I=",D*;/C)"FSXR0IL^,D*;/C)"FSXR0IL^, MD*;/C)"FSXR0IL^,D*;/C)"FSXR0IL^,D*;/_Z$W(O^>1#?_H$E(_Z9'5?NK M1V/SL$APZ[5*?.2Z3H;>OU6/VL-@E=+$;9S%NW.JN;-XMJZM?;^EIX+%G:*( MRY:?CL^/G);2BYRBTXB5I-")E*7/B92ESXF4I<^)E*7/B92ESXF4I<^)E*7/ MB92ESXF4I<^)E*7/B92ESXF4I<^)E*7/_Z(W(O^?1#?_H4A(_Z=&5?RL16+T MLD9N[+A(>N:_3(/AQU.*W,UBCL[(;)O OW&JM+=WM:FQ?+Z?K('%EZ>&RI"D MC,Z*HI71AJ*ATH2;I="%FJ7/A9JESX6:I<^%FJ7/A9JESX6:I<^%FJ7/A9JE MSX6:I<^%FJ7/A9JESX6:I<^%FJ7/_Z(V(O^?0S?_HD9'_ZA$5/VN0V'UM41L M[KQ&=^G$2W_CSU2$V=1EB,C+:YJZPG"IKKIWM*.T?+V:KX'#DJR%R(NIBLR$ MIY+/@*:C<#,:9NSPW*HI[MYLYZU?[N7L8/"CJV%QH>KB,J!J8W- M?*B6SGNHHLU[J:;->ZFFS7NIILU[J:;->ZFFS7NIILU[J:;->ZFFS7NIILU[ MJ:;->ZFFS7NIILU[J:;-_Z,V(O^?0S?_I4-&_ZQ 4O^T/EWYO3]F[LA#;>/6 M36_5W4Z!Q--9D;7)9I^IP7&KH+MYLYFV@+J4LH7 C*^&Q(:MB,> JXS)?*J2 MRGJKG,IYJY_*>:N?RGFKG\IYJY_*>:N?RGFKG\IYJY_*>:N?RGFKG\IYJY_* M>:N?RGFKG\IYJY_*_Z,U(O^@0C?_ID%%_Z\]4/ZX.UGSQ#QAYM%#9-G?0W/( MW$J%M]!7E:K'9:*@P'"LF;IYM)2V@+J1LX6^B[&&P86PB,.!KHO%?:V0QGJM ME\9ZK9K&>JV:QGJMFL9ZK9K&>JV:QGJMFL9ZK9K&>JV:QGJMFL9ZK9K&>JV: MQGJMFL9ZK9K&_Z0T(O^A03?_J3U#_[,Y3?F^-U7JS#I9V]T[8LOE/W>[V4B) MJ\Y7F*#&9:28P'&LD[MZLY"X@;B,M82[B+.&OH6RB<"!L8O!?K"/PGNPE,-Z ML);#>K"6PWJPEL-ZL);#>K"6PWJPEL-ZL);#>K"6PWJPEL-ZL);#>K"6PWJP MEL-ZL);#_Z0T(O^C/C;_K3E!_[@T2/#&,TW?V390S>4V9[[D.WNMUTB,H,U8 MF9?&9Z22P7*KCKU[L(RZ@;2(N(.WA+>%N8*UB+M_M(J]?+.-OGJSD;]ZLY._ M>K.3OWJSD[]ZLY._>K.3OWJSD[]ZLY._>K.3OWJSD[]ZLY._>K.3OWJSD[]Z MLY.__Z8R(O^F.C3_LC,]]\ N0N32+T'/Y"Y5O^\S:Z_A.WZ@UDJ-ELY;F9#( M::&,PW.HB;B+MW>WC[AWMY"Y=[>0 MN7>WD+EWMY"Y=[>0N7>WD+EWMY"Y=[>0N7>WD+EWMY"Y=[>0N7>WD+EWMY"Y M_ZEHG+:YV& MQW2B@\1ZIG_#?:E\P8"K>L""K'F_A*UWOH:O=;Z)L'.]C+%SO8VQ<[V-L7.] MC;%SO8VQ<[V-L7.]C;%SO8VQ<[V-L7.]C;%SO8VQ<[V-L7.]C;%SO8VQ_ZDN M(?^S*BORQ2(LUMX<+R^2M=HNPV;Y7B0GV+VE*(A=1@D(+0;)9^S'.; M>\IWGGC)>Z!VR'ZB=,> HW/&@J1QQ82E<,2'IF[$BJ=NPXNG;L.+IV[#BZ=N MPXNG;L.+IV[#BZ=NPXNG;L.+IV[#BZ=NPXNG;L.+IV[#BZ=NPXNG_ZPJ(/J] M'R+L:,[3Z(TJC^2Y>E>X\;8KE27F#WU:"?MIDB7K6;(YVTW&1<])U ME''0>95OSWN7;&.30#A/( MZ1$@M?D;-Z7_)DN7^C1:H-NW'"&;-MTB&K9 M=XEHV7F+9]A\BV;7?HQEUH"-9-:"CF/5A8]BU86/8M6%CV+5A8]BU86/8M6% MCV+5A8]BU86/8M6%CV+5A8]BU86/8M6%CV+5A8]BU86/Z<<-#,K:"P^W]Q(D MI_\=.9C_*TF,_CI7@_9)87SP56EU[%YO;NEC=&KG:7=GY6YY9>1R>V/C=7QB MXG=]8>)Y?F#A>W]?X7U_7^!_@%[@@H%=WX.!7=^#@5W?@X%=WX.!7=^#@5W? M@X%=WX.!7=^#@5W?@X%=WX.!7=^#@5W?@X%=WX.!R] ) [KB"Q.H_Q0FFO\A M-XW_,46$_T!0?/Q.6'3X5U]M]%UD9_)B9V/P:&IA[FQL7^UP;5WM7%:ZWIQ6>I\N299X?+*]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.] MNWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]_YPX&O^:1BW_EU%!_YI33_Z<55[U MG%IL[)M?>N299X?+*]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBS MO;MXL[V[>+.]NWBSO;MXL[V[>+.]_YPX&O^:1BW_EU%!_YI33_Z<55[UG%IL M[)M?>N299X?+*]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MX ML[V[>+.]NWBSO;MXL[V[>+.]_YPX&O^:1BW_EU%!_YI33_Z<55[UG%IL[)M? M>N299X?+*]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[ M>+.]NWBSO;MXL[V[>+.]_YPX&O^:1BW_EU%!_YI33_Z<55[UG%IL[)M?>N29 M9X?+*]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.] MNWBSO;MXL[V[>+.]_YPX&O^:1BW_EU%!_YI33_Z<55[UG%IL[)M?>N299X?< MEG&2U9-[G,^0A*3+CHRKR(J0L,6'E+3#A)BWPH&;N<%_GKK!?:*[P'NFO,!Y MJ[V_>+*]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBS MO;MXL[V[>+.]_YPX&O^:1BW_EU%!_YI33_Z<55[UG%IL[)M?>N299X?+*]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MX ML[V[>+.]_YPX&O^:1BW_EU%!_YI33_Z<55[UG%IL[)M?>N299X?+*] MNWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[ M>+.]_YTX&O^:12[_EU!!_YM13_^=5%WUGEAK[)U=>>2;9(;XPH*:NL%_GKO ?:*]OWNGOK]YK;Z[>+&^MGFR MOK9YLKZV>;*^MGFROK9YLKZV>;*^MGFROK9YLKZV>;*^MGFROK9YLKZV>;*^ M_YTX&O^:12[_F$] _YU03O^?4ESVH%5J[:!:>.6?8(7=G&J1UIASF]"5?:3+ MDH6KQX^-L<2,D;;"AY6YP8.9N[]_G;Z^?:*_O7JHP+QYK\&T>;#!L'JPP+!Z ML,"P>K# L'JPP+!ZL,"P>K# L'JPP+!ZL,"P>K# L'JPP+!ZL,"P>K# _YTW M&O^;12[_F4Y _YY.3O^A4%OWHE-I[J-7=^:B78/>GV:/UYQOFM&8>:/+E8*K MQY*)L<2.C[;"B9.ZOX28O;V G<"\?:/"NWNJQ+1ZK<2M>Z[#JGNOP:I[K\&J M>Z_!JGNOP:I[K\&J>Z_!JGNOP:I[K\&J>Z_!JGNOP:I[K\&J>Z_!_YXW&O^; M1"[_FDU _Y]-3?^B3EOWI%%H[Z55=>>E6H+?HV*-V*!KF-*<=:',F7ZIR)6& ML,22C;;!C)&[OH:6O[R!G,.Z?J3%MWRKQZU[J\:G?*W$I'VNPZ1]KL.D?:[# MI'VNPZ1]KL.D?:[#I'VNPZ1]KL.D?:[#I'VNPZ1]KL.D?:[#_YXW&O^;1"[_ MFTQ _Z!,3?^D35KXID]G\*A3=.BH5X#@IUZ,VJ1HEM.A<9_.G7JGR9F#K\65 MBK7!CX^[O8F5P;J%G<2V@J3'L("JR*=]JLBB?JS%GW^NPY]_KL.??Z[#GW^N MPY]_KL.??Z[#GW^NPY]_KL.??Z[#GW^NPY]_KL.??Z[#_YXW&O^;1"[_G$L_ M_Z%*3/^E2UGYJ$YF\:I1<^FK57_BJUN*VZEEE-6F;IW/HW>ERI^ K,69AK2_ MDXR\N(V3P;*)F<6NAJ'(JH2IR:& JJN5'WCKUF(W:YBD=:M:YK1JG6BRZ5]J\&=@[2YEHF\ MLI&0P:R,EL:GB9W(HX>FRIN#J,N8@ZO'EH2MQ9:$K<66A*W%EH2MQ9:$K<66 MA*W%EH2MQ9:$K<66A*W%EH2MQ9:$K<66A*W%_YXV&O^<0R[_G4D__Z-(2_^G M25CZJTMD\JY.<.NQ4GODLU>%W[1@CMFS:I;1L76>QJA[J[R@@;2SFH>\K)2- MPJ:0E,:@C9O)G(NDRY:'J,N3AZO(DH>LQ9*'K,62AZS%DH>LQ9*'K,62AZS% MDH>LQ9*'K,62AZS%DH>LQ9*'K,62AZS%_Y\V&O^<0R[_GD@__Z-'2_^H2%?[ MK4EC\[!,;^RT4'GFN%:#X;M>B]J[:I+-M'.>P:MYJK>D?[2NG82\IIB*P:"4 MD<::D9C)EH^ARY&,J,R/BJK(CHJLQHZ*K,:.BJS&CHJLQHZ*K,:.BJS&CHJL MQHZ*K,:.BJS&CHJLQHZ*K,:.BJS&_Y\V&O^<0R[_GD<^_Z1&2O^J1E;\KDAB M]+-+;>ZX3W?HO55_X<%>AM; ;([(MW&=O:YWJK*G?;2IH8*[H9R(P9J8C\:4 MEI;)D)2?RXR2J,R*CZK)BHZLQHJ.K,:*CJS&BHZLQHJ.K,:*CJS&BHZLQHJ. MK,:*CJS&BHZLQHJ.K,:*CJS&_Y\V&O^<0R[_GT8^_Z5%2O^K157\L$9A]K9) M:_"\3G3GPE5[W\AA@-'#:HW$NG"=N+)UJ:VK>[.CI8"[FZ&&P92=C<6.FY3( MBIF=RH:9J,N&E*K)AI*KQH:2J\:&DJO&AI*KQH:2J\:&DJO&AI*KQH:2J\:& MDJO&AI*KQH:2J\:&DJO&_Y\U&O^=0B[_H$4]_Z=$2?^M0U3^LT1?][I':._! M37#ER59UW,YD>LS&:8V^OFZP>;*>JWZZE::$P(ZCB\2(H9+'A)^: MR8"?I\J!FJK(@IBKQH*8J\:"F*O&@IBKQH*8J\:"F*O&@IBKQH*8J\:"F*O& M@IBKQH*8J\:"F*O&_Z U&O^=0B[_H40]_ZA"2/^O05/_MD)=][Y&9>S'36OC MTEAMUM-A>L?*9XRYPFV;K+QRIZ&V=[&8L7VYCZV"OHBJB<."J)#&?:>9R'JG MIK,9]GJS&?9ZLQGV>K,9]GJS&?9ZLQGV>K,9]GJS&?9ZL MQGV>K,9]GJS&_Z U&O^=0B[_HD(\_ZI 1_^R/E']ND!9\\-$8.C/3F/?W%EG MS]A@><#/9HJRR&N:IL)PIIN\=J^1N'NWB;6!O(*RA\!]L([#>*Z6Q7:MH<9U MK*S&=Z:MQ7>FK<5WIJW%=Z:MQ7>FK<5WIJW%=Z:MQ7>FK<5WIJW%=Z:MQ7>F MK<5WIJW%_Z T&O^>02[_I$ [_ZP]1?^U.T[WOSY5[,M$6>':3UK4WU%LQMI: M?;C38HNKSFF8G\9QI)7 =ZV.NWZTA[>#N8&TA[U\LHR_>;&3P7:PF\)TL*;" M02__ISTZ_[ Z0_VZ.$KPQCM/X]5%3M7A1E_(XDMQNMU2@:S5 M6X^?S&:;EL9PI(_ >*N*O'^QA+F#M8"WA[A\MHN[>;20O'>TE[UVM*&]=+.E MOG2SI;YTLZ6^=+.EOG2SI;YTLZ6^=+.EOG2SI;YTLZ6^=+.EOG2SI;YTLZ6^ M_Z(S&O^@/B[_JCDW_[0U/_; -43GSSE%U]\\4,GG062[Y49VK-Q.A9_36I*5 MS&>:J%OWZN@+R"LGVZAK1ZN8JV=[B.N'6WD[ESMYJY<[>@N7.W MH+ESMZ"Y<[>@N7.WH+ESMZ"Y<[>@N7.WH+ESMZ"Y<[>@N7.WH+ESMZ"Y_Z,R M&O^C.BS_KC0T_KHQ.NW*,#O:W3(_RN:: PGVJ?,"!K7F^A:]WO8BP=+R+LG*[D+-PNY6T;[J:M&^ZFK1O MNIJT;[J:M&^ZFK1ONIJT;[J:M&^ZFK1ONIJT;[J:M&^ZFK1ONIJT_Z0P&O^G M-2K_M"\P],,J,=[8*RW,YBY%O?(U6JWN.VR?Y$1[D]M1AXO47I"&SVJ8@LMS MG7[(>*%ZQGRD=\2 IG7#@ZASPH:I<<&)JV_ C:QMP)*M;+^5K6R_E:ULOY6M M;+^5K6R_E:ULOY6M;+^5K6R_E:ULOY6M;+^5K6R_E:ULOY6M_Z4O&O^M+27\ MO"\]REW?- M=YITRWN<'HFO&BJ-IQHZD:,61I6C%D:5HQ9&E:,61 MI6C%D:5HQ9&E:,61I6C%D:5HQ9&E:,61I6C%D:5HQ9&E_Z!8@'W<9(9XV&N+<]5QCG#3=9%N MTGF3;-%\E&K0?Y9ISX*7:,^%F&;.B)EES8R:9,V.FF3-CIIDS8Z:9,V.FF3- MCIIDS8Z:9,V.FF3-CIIDS8Z:9,V.FF3-CIIDS8Z:_ZXD%O7!%Q34WPX0P.\8 M)K#](SRA_RU.E/DZ78GQ1VB!ZU)Q>N9=>'3B9'UPWVN!;=UPA&K<=(9HVWB( M9MI[B679?8IDV("+8MB#C&'6A8U@UHF.7]6+CE_5BXY?U8N.7]6+CE_5BXY? MU8N.7]6+CE_5BXY?U8N.7]6+CE_5BXY?U8N._KD6#=32"P;"[@X6L?P9*J+_ M)3V4_S),B?Q 68'V36)Z\%AI<^Q?;VSI9'-HYVIV9N5O>63D-Y M?6#B>WY?X7Y^7N& ?UW@@X!R^Q 9H_\<*Y7_*#N* M_SA(@?]%4GK\4EIR]UE@:_1>9&;R9&AB\&EJ8.YM;%[M<6U<[71N6^QV;UKL M>7!9ZWMQ6.M]<5CJ?W)7ZH)S5NF$Y74CH2=T(J+ MH\V&D:G*@I:MR'Z;L,9[H+/%>::UQ'>LML-VL[>^=[>WMWBVN+)YMKBR>;:X MLGFVN+)YMKBR>;:XLGFVN+)YMKBR>;:XLGFVN+)YMKBR>;:X_Y@S%/^70R7_ METTW_YM-0_^?4%#_H%-=]Z!8:>^?777HG62 X9INB]N6=Y35D8"J>WPGBNN+6YL7FUN:QZM;FL>K6YK'JU MN:QZM;FL>K6YK'JUN:QZM;FL>K6YK'JUN:QZM;FL>K6Y_Y@S%/^80R7_F$PV M_YQ,0_^@3D__HE%<^*-5:/"B6W3IH6%_XIYJB=R:JBYP7BQN[EXL[RQ>;.[JWJTNZ=[M;JG>[6ZIWNUNJ=[ MM;JG>[6ZIWNUNJ=[M;JG>[6ZIWNUNJ=[M;JG>[6Z_YDS%/^80R7_F4LV_YY+ M0O^A3$[_I$];^:539O&E6'+JI%Y]XZ)FA]V><)'7F7B9TI6!H[NGJPO;)ZLKZK>[*]IGRSO*-]M+JC?;2ZHWVTNJ-]M+JC M?;2ZHWVTNJ-]M+JC?;2ZHWVTNJ-]M+JC?;2Z_YDS%/^80R;_F4HV_Y]*0O^C M2T[_IDY9^JA19?*H5G#KJ%Q[Y:=BA=^C;([9GW67TYI^G\V3AJC%C8VOOX>4 MM;F#G+FU?Z.\L7VLOJQ\L;^E?+&_H7ZSO9Y^M+N>?K2[GGZTNYY^M+N>?K2[ MGGZTNYY^M+N>?K2[GGZTNYY^M+N>?K2[_YDS%/^90R;_FDDU_Z!(0?^D24W_ MITQ8^JI09/.K5&[MK%IYYJQ@@N"J:8O:IG.4SY]\G<:7@ZB^D(JPN(N1MK*& MF+JM@Z"]J8&HOZ6 L,"??[# G("RO9J!L[N:@;.[FH&SNYJ!L[N:@;.[FH&S MNYJ!L[N:@;.[FH&SNYJ!L[N:@;.[_YHS%/^90R;_FT@U_Z%'0?^E2$S_J4I7 M^ZQ.8O6O4FSNL%AVZ+%>?]^P:(C5K'20RJ-ZG<";@:BXE(>PL8^.MJN*E;NF MAYV^HH6EP)^$K\&9@:_!EX*ROI6#L[R5@[.\E8.SO)6#L[R5@[.\E8.SO)6# ML[R5@[.\E8.SO)6#L[R5@[.\_YHS%/^90R;_G$?-VV:H//KW*0Q:9XG;N>?J>RF(6PJY.+MJ6.D[N?BYJ^ MFXFBP9B(K,*3A:_"DH:QOY&&L[R1AK.\D8:SO)&&L[R1AK.\D8:SO)&&L[R1 MAK.\D8:SO)&&L[R1AK.\_YHS%/^90B;_G$8T_Z-%0/^H14K_K4=5_K%*7_6U M4&CKN59PX[U>=]F[:H#+LG"0P*EVG;:B?*>MG(*OI9>)MIZ3D+N9CYB^E(V@ MP9&,J<*-BJ["C8FQOXV)LKV-B;*]C8FRO8V)LKV-B;*]C8FRO8V)LKV-B;*] MC8FRO8V)LKV-B;*]_YLS%/^:0B;_G44T_Z1$/_^J1$G_KT53_+1)7?*Y3V7I MOE9LX<-@J>GH("OGYN&M9B7CKN3E96^CI*=P8J2 MI\*(D*["B(ZPP(B-LKV(C;*]B(VRO8B-LKV(C;*]B(VRO8B-LKV(C;*]B(VR MO8B-LKV(C;*]_YLS%/^:0B;_GD0S_Z5"/O^K0DC_L412^K=(6O"]3F'FQ%9G MWLEB;<[!9W_!N6V.MK%RFZNJ>*:BI7ZNF:"$M9*=B[J,FI.^AYB;P(27I,*" MEJ_"@Y.PP(21LKZ$D;*^A)&ROH21LKZ$D;*^A)&ROH21LKZ$D;*^A)&ROH21 MLKZ$D;*^_YLS%/^:02;_GT(S_Z9 /?^M0$?_M$)/][M'5^W#35WDS%A@VHL%[GJ_! M?9FPP'^6LKY_EK*^?Y:ROG^6LKY_EK*^?Y:ROG^6LKY_EK*^?Y:ROG^6LKY_ MEK*^_YPS%/^:02;_H$$R_Z@_//^P/D7_MT%-],!%4^K)3E;BU5I7TM%>:\3) M9'VVP6J,JKMOF9^U=*26L'JLC:R LH:IA[=_IXZ[>J:6OG>EH+]TIJV_=Z&Q MOWJ=LKYZG;*^>IVROGJ=LKYZG;*^>IVROGJ=LKYZG;*^>IVROGJ=LKYZG;*^ M_YTS%/^;02;_HC\Q_ZH\.O^S/$+[NSY)\,9$3>;23TWN=Y4;JS96WR?U&*(E-!H MDXK,;YN"QW>B?,-^J'; A*QROHJO;[R1L6V\F+)KNZ&S:KNMLF>ZMK1GNK:T M9[JVM&>ZMK1GNK:T9[JVM&>ZMK1GNK:T9[JVM&>ZMK1GNK:T_Y\R%/^@.B3_ MJC0L_[4R,?/#,C/CU#@PT^$\/\;H0E*YY4ACK.)-?>,9]I'3$@Z=PPHBI;L&.JVS E*QJOYNM:;^EK6B_KJUHOZZM:+^N MK6B_KJUHOZZM:+^NK6B_KJUHOZZM:+^NK6B_KJUHOZZM_Z P%/^C-B+_KS H M^[PM*^C-+"C5X# PQ^DX1+GL/E>LZ45GGN=+=9+@4X")V5Z)@M1HD7S0<99X MS'>;=,I]GG#(@J%NQX>C:\6+I6G$D*9HQ):G9L.>J&7#I:AEPZ6H9<.EJ&7# MI:AEPZ6H9<.EJ&7#I:AEPZ6H9<.EJ&7#I:AEPZ6H_Z$O%/^H+Q__M2HB\,8D M(=C=(R#(Z2TUNO(U2:SQ/%J>\$-IDNA,=8CA57^!VV&'>]=JC7;3<9%RT7>5 M;\]\EVS-@)IJS(6;:,N)G6;*C9YER9*?8\F8H&+(GJ%BR)ZA8LB>H6+(GJ%B MR)ZA8LB>H6+(GJ%BR)ZA8LB>H6+(GJ%BR)ZA_Z,M%/^N*1KXOR :WM88$\GH M(B6Z]"LZK/@T39[W/%R2\49IB.E0SYF87L^9F%[/F9A>SYF8 M7L^9F%[/F9A>SYF87L^9F%[/F9A>SYF8_Z0C%O6E(U;UI2-6]:4C5O6E(U;UI2-6]:4 MC5O6E(U;UI2-6]:4C5O6E(U;UI2-_[ >"^W&#@C-VPL(N_,5&JS_(2Z>_RP_ MDO\W38?]1%A_]D]A>/%9:''M7VUJZV1Q9^AJ=&3G;W=BY71Y8.1X>E_C>WM= MXWY\7.*!?5OAA'Y:X8A_6>",@%C@CX%8X(^!6."/@5C@CX%8X(^!6."/@5C@ MCX%8X(^!6."/@5C@CX%8X(^!\[T-!,S/"0&]Y0P,K/\7'I[_)"^2_R\]A_\] M27__25)X_%1:6]8['QP M5^M^<%;K@7%5ZH1R5.J(^V1;6_EH75GX;%Y7]W!@5O=S857V=F)4]7AB4_5[ M8U+T?611](!D4/.#94_SAF9/\X9F3_.&9D_SAF9/\X9F3_.&9D_SAF9/\X9F M3_.&9D_SAF9/\X9FO7_:59&KODFQUZ8YV?N2*@(??A8>.VX".E-A\ ME)C5>9J]<<*GO7'" MI[UQPJ>]<<*GO7'"I[UQPJ>]<<*GO7'"I[UQPJ>]<<*G_X\M#O^./A[_D$HM M_Y=/.O^944;_FU92_II;7O>886GPE6ATZI%Q?N2.?(;?B82.VX.+E-=_DIK4 M>YB>TG>>H=!TI*3.)E=:!D)K3?9:? MT'F=H\YUHZ;-7&;RG&)QZYAI>^64]KJQWO:ZL=[VN MK'>]KJQWO:ZL=[VNK'>]KJQWO:ZL=[VN_Y M#O^0/A[_E4DL_YM*./^>3$/_ MH4]/_Z)46OJA667SH%]O[)UF>>:8;X/@DWF,VXZ"D]:'BIO2@9*ASWR:ILIX MHJK'=:NMPW.TK[]SO+"W=;RPL'>[L*IXN["G>;RPIWF\L*=YO+"G>;RPIWF\ ML*=YO+"G>;RPIWF\L*=YO+"G>;RP_Y$M#O^1/A[_ED@L_YQ(-_^@2D+_HTU- M_Z126/NE5V/TI%UM[J%C=^B>:X#BF'6)W))^DM.,AYK,AH^AQH"7I\%\GJR] M>::ON7:OL;=VNK*O=[JRJGFZLJ5ZNK*B>[NQHGN[L:)[N[&B>[NQHGN[L:)[ MN[&B>[NQHGN[L:)[N[&B>[NQ_Y$M#O^1/A[_F$GW.'U)A]D,N1A)K$BHRBOH23J+B FJVT?**P ML'JKLZUYM;2H>KFTI'NYM*!]N;.=?;JSG7VZLYU]NK.=?;JSG7VZLYU]NK.= M?;JSG7VZLYU]NK.=?;JS_Y(M#O^2/A[_F$8K_YY&-O^C1T'_ITE+_ZI.5?JK M4U[RK%EHZ:Q@<>*I:'K9I7.#S9QZC\65@9J]CHBBMXB0J;&$EZZL@)^QJ'ZG MM*5]L;6A?;BVG7ZXM9I_N;29@+JSF8"ZLYF NK.9@+JSF8"ZLYF NK.9@+JS MF8"ZLYF NK.9@+JS_Y(M#O^2/A[_F44K_Y]$-?^D14#_J4A)_ZQ,4_BN4ESO ML%AEYK%?;=ZP:7;2J7&"R*!XC[^8?IJWDH6BL(R,J:J(E*ZDA9RRH(*DM9V! MKK::@+>WEX&WMI6"N;24@KFSE(*YLY2"N;.4@KFSE(*YLY2"N;.4@KFSE(*Y MLY2"N;.4@KFS_Y,M#O^2/1[_FD0J_Z!#-?^F1#[_JT9(_ZY+4?6R4%GLM5=A MY+=>:=JT:7/-K&^"PJ1VC[FB9FRF8>AM9:%J[>3 MA;:WD82WMY"%N+60A;FTD(6YM)"%N;20A;FTD(6YM)"%N;20A;FTD(6YM)"% MN;20A;FT_Y,M#O^3/1[_FT,J_Z)"-/^H0CW_K45&_+%*3_*U3U;INE9=X;U@ M9-2X9W+(KVV!O:=TCK2@>IFKFH"BI)6'J9V1CJZ7CI:RDHN?M8^*J+>,BK.X MBXFWMXN(N+6+B+FTBXBYM(N(N;2+B+FTBXBYM(N(N;2+B+FTBXBYM(N(N;2+ MB+FT_Y,M#O^3/1[_G$$J_Z- ,_^I03S_KT1%^K1(3/"Z3E/GOU99WL)@8,^[ M9G'#LVR!N*MRCJZD>)BEGGZAGIJ$J)>6C*Z1DY2RC)&%C[&XA8ZV MMX:-N+:'C+BUAXRXM8>,N+6'C+BUAXRXM8>,N+6'C+BUAXRXM8>,N+6'C+BU M_Y0L#O^4/1[_G4 I_Z0^,O^K/SO_L4)"^+A'2>V^3D_EQE=3VL9>7\N^9'&^ MMFJ LZ]PC:FI=IB@HWRAF)^"J)&;B:V*F9*RA9::M8&5I+=_E:ZW?I2WMX&1 MM[:"D+BU@I"XM8*0N+6"D+BU@I"XM8*0N+6"D+BU@I"XM8*0N+6"D+BU_Y0L M#O^4/1[_GC\H_Z8],?^M/CG_M$% ]+Q&1>O$34GBSEA+T\I<7L;"8W"YNFA_ MKK1NC*.N=)>:J7J?DJ6 IXJAAZR$GX^Q?YV7M'NTU5*SLU;7<#&86ZTOV=^J+EM MBIVTBZM^I82HA:I]IHRO>*25LG2CG[1QHZJU<*.XM7.>N;1VF[FS M=INYLW:;N;-VF[FS=INYLW:;N;-VF[FS=INYLW:;N;-VF[FS_Y8L#O^7/![_ MHCHF_ZHY+O^S.C3YO3PX[LA#.>/54#?7VE)(R-)97+K+7VVMQ65\HZ M<).-MG:2JVBWG*UEMZ>N9+>TKF6SO:YHK;VN:*V]KFBM MO:YHK;VN:*V]KFBMO:YHK;VN:*V]KFBMO:YHK;VN_Y@L#O^=.1S_IS0C_[$S M*/F],BKJRSTV)WDL]G@HC+;8Q^R7.4 M=L=YFG#%@9]JQ(FB9L.2I6+#G*=@PZ:H7\.TJ%_!PJAANL&I8;K!J6&ZP:EA MNL&I8;K!J6&ZP:EANL&I8;K!J6&ZP:EANL&I_YDL#O^@-1K_JC$@_[8N(_#% M+2+?V#,56R2VUQWA]AC@7[5:HEVU'&/;]%Y ME&O.@)AGS(B;9,J0G6+)F)]@R:&@7\FKH%_)N9]!@?W;<:89PV'&+:]5XCVC3 M?Y)ET8:48L^-EF#.E)A>SIN97:6\VWFEO-MYI;S;>:6\VW MFEO-MYI;S;>:6\VWFEO-MYI;S;>:_YTL#O^H*Q3_MR05Z\H<$=/@'A/$ZRLF MM_$T.*KP/$F=[T17D>Y+8X;M4FU]Z%MU=>-B?'#@:X%KW7*%:-IXB&39?HMB MUX2-7]6*CE[4D)!WA;Y7]Y6>2$ M>ECCB'Q7XXQ]5N*1?E3AEW]3X9Q_4^&&Q7[7QN5>R ;U3L MA'!3ZXAQ4NN,<5'JD7)0Z95S4.F55?AR7U3W=F!2]GEA4?9]8E#U@&-/ M](1D3O2'9$WSC&5,\Y!F3/.09DSSD&9,\Y!F3/.09DSSD&9,\Y!F3/.09DSS MD&9,\Y!FQ,(& +;1!P"H[0L&F_\7$Y#_)1^%_S$J?/\\-'/_1CMJ_TQ!8_]3 M1E[_64E:_UY,5O]C3E3_:%!2_VQ14/]O4D__(M]YW22@N1QF(7B;YV(X6VBB^!KIXW?::R.WFBQD-UGMY'=9KV1W&7%DMQE MS9+49M&2SVC2DL]HTI+/:-*2SVC2DL]HTI+/:-*2SVC2DL]HTI+/:-*2_X(H M"?^".1;_@4@E_XI/,?^.5CW_CUQ)_XYC5/Z*:E[XA7%H\H!Z<.Y\@W?J>(M] MYW22@N1QF(7B;YV(X6VBB^!KIXW?::R.WFBQD-UGMY'=9KV1W&7%DMQES9+4 M9M&2SVC2DL]HTI+/:-*2SVC2DL]HTI+/:-*2SVC2DL]HTI+/:-*2_X(H"?^" M.1;_@4@E_XI/,?^.5CW_CUQ)_XYC5/Z*:E[XA7%H\H!Z<.Y\@W?J>(M]YW22 M@N1QF(7B;YV(X6VBB^!KIXW?::R.WFBQD-UGMY'=9KV1W&7%DMQES9+49M&2 MSVC2DL]HTI+/:-*2SVC2DL]HTI+/:-*2SVC2DL]HTI+/:-*2_X(H"?^".1;_ M@4@E_XI/,?^.5CW_CUQ)_XYC5/Z*:E[XA7%H\H!Z<.Y\@W?J>(M]YW22@N1Q MF(7B;YV(X6VBB^!KIXW?::R.WFBQD-UGMY'=9KV1W&7%DMQES9+49M&2SVC2 MDL]HTI+/:-*2SVC2DL]HTI+/:-*2SVC2DL]HTI+/:-*2_X(H"?^#.1;_@THI^YG:1@^1SEX?B M<)V*X&ZBC-]KIX[=:JR0W6BRD=QGN)/;9K^3VV;'E-EFT)3/:-"3RVG0E,MI MT)3+:="4RVG0E,MIT)3+:="4RVG0E,MIT)3+:="4_X,H"?^#.1?_AD8D_XY- M,/^35#S_E%A'_Y)>4_^095WXC&UG\H9U<.V!?WCI?8=^Y7F/A.)UE8C@WCI@(1_Y7N,A>)WDXK?'?I@X%_Y'Z*A>%YD8O>=9B/W'&?D]IN MII;8;*Z8UVJVFM9HP9O3:!\CXO==Y>0VW.>E=AOIIC6 M;*^:U6JYG-1IQIW+;,F=PVW)GKQOR)^U<,B?LG'(G[)QR)^R<!_C(S=>961V72=EM1PI9K0;JZ= MS6RWG\MKPZ##;L>@NV_'H;5QQJ&O1S;_H4I _Z-02OZC553V MHEQ=[Z!B9^B<:7#AEG1YVI!]@M&)AHO*@HV3Q7V5F,2EH7C$I:%XQ*6A>,2EH7C$ MI:%XQ*6A>,2E_X@G"?^(.!?_DT$B_YM$+/^@137_HTD__Z5.2/NG5%'SIEI; MZZ5@9..B:&WJ&CKW>IIJMVLZ>I M=L"HI'?"J*%YPJ>=>L.GFWK#IIMZPZ:;>L.FFWK#IIMZPZ:;>L.FFWK#IIMZ MPZ:;>L.F_X@G"?^).!?_E4 A_YU"*_^B1#3_I4@]_ZA,1OBJ4D_OJUA7YZM? M8."H:6G4H7!URYEX@<*2?XN[BX:4M8:.FJ^"E:"J?IVDIGNFIZ-ZL*F@>;RJ MG7K!J9I\P:F8?<*HEGW"IY9]PJ>6?<*GEGW"IY9]PJ>6?<*GEGW"IY9]PJ>6 M?<*G_XDG"?^).!?_EC\A_YY!*O^C0C/_IT8[_JM+1/6N44SLL%=4Y+%>7-NM M:&;/I6YUQ9UU@;R6?(NUD(.4KHJ+FZB&DJ"C@IJEGH"BJ)M^K*J8?KBKEG[ MJY1_P*J3@,&HDH#"J)* PJB2@,*HDH#"J)* PJB2@,*HDH#"J)* PJB2@,*H M_XDG"?^*.!?_F#\@_Y\_*?^E03+_JD4Z_*Y)0?*Q3TGIM590X;=?5]6Q967* MJ&QTP*%S@+>:>HNOE(&4J(^(FZ**CZ"EEX2@J)2"J:J1@K6KCX*_JXZ# MP*J-@\&IC8/!J(V#P:B-@\&HC8/!J(V#P:B-@\&HC8/!J(V#P:B-@\&H_XHG M"?^+.!?_F3X@_Z$^*/^F0##_K$,X^;%(/_"U3D7GNE5+WKM>5-"T9&7%K&MS MNZ1Q@+&>>(JIF'Z3HI.%FIN/C:"6C)6ED8F=J(V'IZN*A[*LB(>_K(B'P*N( MAL"IB(;!J(B&P:B(AL&HB(;!J(B&P:B(AL&HB(;!J(B&P:B(AL&H_XHG"?^, M-Q?_FST?_Z(])_^H/R__KD(V][1'/.VZ34'DP%9&V;]<4\NW8V3 KVESMJAO M?ZRB=8JDG'R3G)B#FI64BJ"/D9*EBHZ;J(:-I*N#C*^L@8V]K(*,OZN#BL"I M@XK!J8.*P:F#BL&I@XK!J8.*P:F#BL&I@XK!J8.*P:F#BL&I_XLG"?^.-Q?_ MG#P?_Z,[)O^J/2W_L4 S]+A%..J_3#SBQU5 T\):4L>Z86.[LV=RL*UM?J>G MH7J2EIV F8^:B)^)EY"DA)28J'^3HJI\DJVK>I*ZK'N1P*M]C\&I?H[! MJ'Z.P:A^CL&H?H[!J'Z.P:A^CL&H?H[!J'Z.P:A^CL&H_XPG"?^/-A;_G3H> M_Z4Z)?^M.RO\M#XP\;Q#-.?%3#;>RU(_SL994<*^8&*VN&9PJ[%L?:&L)/"J'B3 MPJAXD\*H>)/"J'B3PJAXD\*H>)/"J'B3PJAXD\*H_XPG"?^1-1;_GS@=_ZI2X;H2+M'2-@[%Z ME'RN@9IUK(B><*N1HFNIFZ1HJ::F9JFSIF:JPZ5II,2E:Z'$I6NAQ*5KH<2E M:Z'$I6NAQ*5KH<2E:Z'$I6NAQ*5KH<2E_XXF"?^7,Q3_HS0:_ZTS'OZX,B#P MQ34@X],_'-C>12;*VTTZO=-43+#.6UVCR6%KF,1G=XW ;(&$O7*)?+IXD'6X M?Y9OMH>::K60G66TFJ!BLZ6A8;2QHF"UPJ%BK\:B9*O&HF2KQJ)DJ\:B9*O& MHF2KQJ)DJ\:B9*O&HF2KQJ)DJ\:B_Y F"?^;,1+_IC$7_[$N&O>^+1KGSC$7 MV=XY&W()A+:W"D.S.0V M'<'F0"ZVXT@^JN!.3)[=5EF2VEUEB-9C;W[4:GAVTG!_;M!WA6C/?XECSH>- M7\Z0D%O-FI)9S:635\ZRDU;/PI-6R]"45\7/E5?%SY57Q<^55\7/E5?%SY57 MQ<^55\7/E5?%SY57Q<^5_Y,F"?^C+ [_L"8/]< ?#=_5&P?-Y"<3P>LT([7J M/3.IYT5"G>5+4)'C4ER&XEAF?.!?;G3?9G5LWFUZ9MYU?V'=?8)=W(:%6MN/ MB%C9F(I6V*&+5-BLBU38MXQ3V,F+4];6BU/6UHM3UM:+4];6BU/6UHM3UM:+ M4];6BU/6UHM3UM:+_YQ+4H;L4EQ\ZUED<^M>:VKJ9'!EZ&QU8>9T>%[D?'M;XH-]6>"+?U;? MDH%5WIJ#4]ZB@U+=JH11W;:$4=V_A%'=OX11W;^$4=V_A%'=OX11W;^$4=V_ MA%'=OX11W;^$_Y\A!O^P&P7IQ0T#T-D+ L#N& RS]B8MT<%KJ>G-8Z(%T5N>'=E3FC7A3 MY91Y4>2;>E#DH7M/XZI\3N.P?$[CL'Q.X[!\3N.P?$[CL'Q.X[!\3N.P?$[C ML'Q.X[!\_Z@< NN\# '-S D P> ,!++Z&1"E_"<@FOTR+H_]/3N%_D5%>_]- M3G+_5%5K^UI:9/A@7V#V9V)<]&UE6?)R9U?Q>&E5\'YJ4^^#;%'NB6U0[8]N M3NR4;TWKFG!,ZZ%Q2^JF\.!J3_&Q.9_RDACO\T+H3_/SE[_T=!9DCSGF9(\YYF2/.>9DCSGF9(\YYF2/.>9DCSGF9(\YYF MS;L% +W'!@"QV ?\X)6[_/BUF_T4R7_],-UG_4CM5_U@^ M4?]=0$__8D),_V9#2O]J1$G_;D5'_W)&1O]V1T7_>DA#_WY(0O^"24'_ADI M_XM+/_^/2S__CTL__X]+/_^/2S__CTL__X]+/_^/2S__CTL__X]+K\8" *+6 M @"6]PH"B_\6!X+_) ]W_RT7;/\S'F/_.B1<_T(H5O])+%'_3R]._U4Q2_]: M,TC_7C5&_V(V1/]F-T/_:3A!_VPX0/]P.3__NMDJGSJ8J]]Z6&U?NA@NW_H7\. YU_+@>9>U8'@8-N!UV+> M@=1CWX'48]^!U&/?@=1CWX'48]^!U&/?@=1CWX'48]^!_W4D!O]V-1#_=T,< M_X!*)_^%4C/_AED^_X5@2/^!:%+_?&]:_'=Y8O=S@VCT;XQN\6R3NMDJGSJ8J]]Z6&U?NA@NW_H7\. YU_+@>9>U8'@8-N!UV+>@=1C MWX'48]^!U&/?@=1CWX'48]^!U&/?@=1CWX'48]^!_W4D!O]V-1#_=T,<_X!* M)_^%4C/_AED^_X5@2/^!:%+_?&]:_'=Y8O=S@VCT;XQN\6R3NMDJGSJ8J]]Z6&U?NA@NW_H7\. YU_+@>9>U8'@8-N!UV+>@=1CWX'4 M8]^!U&/?@=1CWX'48]^!U&/?@=1CWX'48]^!_W8D!O]W-1#_>4(<_X)))_^' M43+_B%@]_X=?2/^#9E'_?FY:^WEW8O=U@FGT<8IN\6V2<^YKF7;L:)]YZV:D M>^IDJGWI8Z]_Z&*U@.=AO('G8,2"YE_.@N-?UX/<8=N#TF/=@\]DW8//9-V# MSV3=@\]DW8//9-V#SV3=@\]DW8//9-V#_WD?NAF MJH#G9+""YF*V@^5AOH3E8,>%Y6#3A=UBV8739-R%S&7;ALEEVX;)9=N&R67; MALEEVX;)9=N&R67;ALEEVX;)9=N&_W@D!O]X-1#_?D ;_XA')O^-3C'_CU4\ M_XY;1O^+8E#_AFE9_(!Q8O=[>VGS=H5P[W*.=>QNE7GJ:YQ]Z&FC@.=FJ8+E M9;"$Y&.WA>1BP(?C8&GR>8)P[W2+=NMPDWOI;9M_YVJB@N5GJ83D9;"& MXV2YB.)BPXGB8M"*V&38BLYFV(K'9]>+P&C6C+YIUHR^:=:,OFG6C+YIUHR^ M:=:,OFG6C+YIUHR^:=:,_WDC!O]Z-!#_@SX;_XU%)?^33"__E5$Z_Y171/^2 M74[_CF58_(AK8?>"=&GR?']P[G>(=NMSD7SH;YF YFNAA.1HJ8?B9K&)X62[ MB^!CQXS<8]2,SV;6C,=HU8W :=2.NFK4CKAKU(ZX:]2.N&O4CKAKU(ZX:]2. MN&O4CKAKU(ZX:]2._WHC!O][-!#_A3T:_X]$)/^62B[_ETXX_Y=40O^56DS_ MDF%6_(YI7_:'<&CR@7IP[7N%=^IVCGSF<9>!XVV?AN!JJ(G=9[",VF:[C=9E MQX[19M2/QVC3C[]JTY"Y:]*1LVS2D;)MTI&R;=*1LFW2D;)MTI&R;=*1LFW2 MD;)MTI&R;=*1_WLC!O]\-!'_B#P:_Y)#)/^82"W_FDPW_YI20?^96$K\EU]4 M]I-F7?"-;F;KAW=OYH"!=N%[BWW<=9.#UW&=[FLR9E'K,F91ZS)F4>LR9E'K,F91ZS)F4>LR9_WXB!O^" M,A#_DC<7_YP]'_^A0"?_ID0N^ZE)-?&L3SSIKE5#X:]=2]6H9%G+H6MGPIES M<[F3>GVRC8&%K(B)C*:$D)&A@)B6G7V@FIE\JIR6>[:=E'O$GI)\RIV1?FI* IYV/?[*>C8#!GHR R9Z+@,J=BH#+ MFXJ RYN*@,N;BH#+FXJ RYN*@,N;BH#+FXJ RYN*@,N;_W\B!O^%, __E386 M_Y\['?^E/23_JT$J];!%+^RU3#3CNE0YV+=92,NO85C!J&AFMZ%O;FHN%I9V(A+"?AH2^GX6%R9Z%A,F=A83*G(6$ MRYN%A,N;A83+FX6$RYN%A,N;A83+FX6$RYN%A,N;_X B!O^'+P__ES46_Z Z M'/^G/"+^K3\G\[-$+.FZ2S#AOU(UT[I81\>S7U>\K&9ELJ5M<:F?>(^XGW>0R9YYCLJ=>HS+FWN,RYM[C,N; M>XS+FWN,RYM[C,N;>XS+FWN,RYM[C,N;_X$B!O^++0[_FS04_Z0W&?^L.![X MM#HA[;U (^3&22/7QTPSR<%51;VZ7%6RM&-CJ*YI;Y^I;WF6I7:"CJ%\B8>= M@X^!FXN4?)B4F'>7G9MSEJB=<9:UGG"6QIURE,J<=)++FW61RYIUD0JW2 B*=ZAX&D@8U[ MHHF2=:"1EG">FYEMG::;:IVSG&F>PYQKG,N;;IC,FF^7S)EOE\R9;Y?,F6^7 MS)EOE\R9;Y?,F6^7S)EOE\R9_X,A!O^0*PW_H#,1_ZDR%?VS,1?POC07Y0 M;ZB/DVJGF99GIJ289*:QF6.GP9EDI[=V@72U?8=NLX6+:+*. MCV2QF))AL*.47K"PE5VQOY5=L="48*K0E&&HT)1AJ-"48:C0E&&HT)1AJ-"4 M8:C0E&&HT)1AJ-"4_X8A!O^7* K_IBP-_[$H#O+ )@SCT"@'U-\R"\G?/AF] MVTG*&P75WB $R>4P#[[C/1VTX48L MJ-Y..IS:54B1UEM5AM-A8'S09VETSFYP;@O%++G.B*GY4,QF^-* M/I#A4$J&WU=4?-Y>773=961LVVQJ9MMT;V':?'-579F'M3VJ-\ M4=JP?5#;OGU0W--\4-3@?E'0X']1T.!_4=#@?U'0X']1T.!_4=#@?U'0X']1 MT.!__Y4: _^I'P/[NA("U,T+ ,GF#P*\[2 +L.TN&:7L.2>:ZT(UC^I)087I M4$M[Z%=3FQ7YX)N4^>+<5#GE7).Z)]T3.BJ M=4OHM79*Y\-V2NC==DODX'5+Y.!U2^3@=4ODX'5+Y.!U2^3@=4ODX'5+Y.!U M_YT6 ?^Q$@'3PPD Q]$* +OR$02O\R$/H_,N'9GS.2J.\T(VA/-*07OS4DER M\U=0:?-<5F/S8UI=\VE>6?-P857S=V-2\W]F3_*'9TWPCVE+[YAK2N^@;$GN MJ6U([K-M1^W ;D;MQVY&[<=N1NW';D;MQVY&[<=N1NW';D;MQVY&[<=N_ZOU,/G']445H_59+ M8?Y;3US^8E-7_FA65/UO6%'[=5I.^GQ<3/F#74KXBE](]Y%@1_:984;VH&)% M]:=C1/2Q9$/TM61#]+5D0_2U9$/TM61#]+5D0_2U9$/TM61#]+5DUK($ ,2^ M!@"WS 8 K-P) :#_%@B5_R44B_\R'X+_/"EY_T4R;_]*.6?_3S]?_U5#6O]; M1U7_84I2_V=,3_]L3DW_1PXUKF<-Q=Z'#<7>AP MW%WH<-Q=Z'#<7>APW%WH<-Q=Z'#<7>AP_VHD!/]I,@K_;#X4_W9&'O][32G_ M?%4S_WI=/?]V9D;_<6Y-_VUY5/]JA%K^9HU?^V.58OEAG&7X7Z)H]UZH:O9< MK6OU6[-L]%JY;O-9P6[S6,EO\EC4<.]8X'#I6>1PXUKF<-Q=Z'#<7>APW%WH M<-Q=Z'#<7>APW%WH<-Q=Z'#<7>AP_VHC!/]I,0K_;CX4_W=%'O]\32C_?E0S M_WQQ9X7'F6N1QX%SG<=A=Z''87NAQV%[H<=A> MZ''87NAQV%[H<=A>Z''87NAQ_VLC!/]J,0K_<3P4_WI#'?^ 2RC_@5,R_X!: M//]\8D7_=VI._W%T5?]N?UO]:HE@^F:29/ADF6CV8:!K]5^G;?->K6_R7+-P M\ENZVA-_W1Q5?]P?%O\;(=A^6B09O=EF&GU8Y]L\V&F;_)?K''Q7;-R\%R[ M=.];Q77O6M!UZEK?=N)5WRF'E=\IAY7?*8>5W MRF'E=\IAY7?*8>5W_VTB!/]L,0O_=CH4_X!!'?^%2"?_B$\Q_X=7._^$7D3_ M?V9-_WAN5?]S>5S\;H1B^6J-9_9GEFOT9)YN\F*E-Q?XWC28.1XRV'D><1CXWK$8^-ZQ&/C>L1CXWK$8^-ZQ&/C M>L1CXWK$8^-Z_VXB!/]M,0O_>#@3_X,_'/^)1R;_BTXP_XM5.?^(7$/_@V-, M_WUK5/]V=5S\>QM)AXWO*8N)\Q&/B?;YEX7V]9>%]O67A?;UEX7V]9>%]O67A?;UE MX7V]9>%]_VXB!/]N, O_>S<3_X8^'/^,127_CTPN_X]3./^-6D'_B&%+_X-I M4_I\<5OW=GQB\W&':/!MD&WM:9EQZF:A=>ACJ7CF8;)ZY&"[>^)?QWS@7]I] MU&+A?#:.=RC&[D;95SX&J==]UGIGK:9:Y\UF.X?M-BPX#18M.!RF3? M@<%EWH*[9]V"M6C=@[!IW8.P:=V#L&G=@[!IW8.P:=V#L&G=@[!IW8.P:=V# M_W A!/]R+PO_@302_XP[&O^30R+_ETLK_Y=1-/^65SWZDUU&\XYD3^Z(:UCH M@G5@XWQ_:-YWB6[9=!KH7W,:*F R6:R@L=EO8/%9>/:57AB7-> MVX)\9M-\A6_-=XUUR7*5>L5OG7_!;*6"OFJMA;MIN(>Y:<2(MVG8B+!KV8BK M;-F(IVW9B*-OVH>C;]J'HV_:AZ-OVH>C;]J'HV_:AZ-OVH>C;]J'_W$@!/]V M+ K_AC(1_Y(Z&/^90B#_G$4CCPG5A Z9I?2>*59U+:CW!0?+MTF("W<:"$M&^IA[%MLXFN;+^*K&S/BZANUXND;]B* MH'#8BIUQV8F=<=F)G7'9B9UQV8F=<=F)G7'9B9UQV8F=<=F)_W(@!/]X*PK_ MB# 0_Y0Y%_^;01[_GT4E_:%*+?2B4#3LHE8\Y*!<1=R;94_2DVUF^V MA8)WL(&)?:M]D8*F>9F&HG>ABI]UJXV<=+:.FG3%CYAUU(Z5=M6-DW?5C9)W MUHN2=]:+DG?6BY)WUHN2=]:+DG?6BY)WUHN2=]:+_W,@!/]\*0G_C2\/_Y@X M%?^?/1O_I$$A]ZA&)^VK3"WEK5(SW*I9/]"C84W&G&E:OI5P9;:/=V^OBG]V MJ86&?:2!CH*??I:'FWN>BY=YJ(Z4>+./DGC!D)!YTY"/>M2/CGK5C8Q[UHR, M>]:,C'O6C(Q[UHR,>]:,C'O6C(Q[UHR,>]:,_W0?!/]^* G_CBX._YLX%/^A M/!G_IS\?]*M$).JO2BGBLU$NUJY7/LNG7TW!H&=:N9EN9;&3=6ZJCGQVHXJ# M?9Z&BX*9@Y.'E(";BY!^I8Z-?;"0BGV]D8E^T)&(?M./B'[4CH=^U8V'?M6- MAW[5C8=^U8V'?M6-AW[5C8=^U8V'?M6-_W0?!/^ )PC_D"X._YTW$_^C.AC\ MJ3T<\:]"(.>T2"3?MTXLT;%5/<>J7DR]HV59M)UL9*N76Y1A_:NTLKS;14/,*N7$NXIV-8KZ%J8Z:<<6V?EW=UF)-^?)*0AH*, MC8Z'AXJ6BX.(H(Y_AZN0?8>XD7N'R9%\A].0?(;4CWV%U8U]A=6-?875C7V% MU8U]A=6-?875C7V%U8U]A=6-_W4?!/^$)0C_E"T,_Z U$/^H-A3VKS@7Z[<] M&.*_11G5ODDJR+A3.[VQ6TJSJV)7JJ9H8J&A;VR9G'5TDIA\>XR5@X&&DHN& M@9"4BWR.GHYYC:B0=HRUD72-QI%UC=.0=HO4CWB)U8UXB=6->(G5C7B)U8UX MB=6->(G5C7B)U8UXB=6-_W8> _^&) ?_ERP+_Z(R#_^K,Q'RLS43Z+PZ$][% M/Q?0P4@IQ+M1.;FU64BNL&!5I:IG89RF;6N4HG1SC9YZ>H:;@8" F(F%>Y:2 MB7:4FXURDZ:/;Y.SD&Z3PY!ND]./<)'4CG*.U8URCM6- _^)(@?_F2P*_Z4P#?RN+P[ON#$.Y,,W#=G*.Q;+ MQ48GO[]0.+.Z6$>IM5]4G[!E7Y:L:VF.J')QAJ5X>("B?WYZGX>#=)V/B&^; MF8MLFJ2-:9JPCF>;P(YGF]6.:9C5C6R4UHQLE-:,;)36C&R4UHQLE-:,;)36 MC&R4UHQLE-:,_W@> _^,(0;_G2L(_Z@L"OBS*@OJORL)X,PR!M'..17%R44E MN<1.-JZ_5D6CNUU2F;9C79"R:6>'KW!O@*QV=GFI?7QSIX2!;J6-A6FDEXAE MHZ**8Z.NC&&COHQ@I-*+8Z#7BV6;1TWAML(-]:*^+@6.NE81?K:"& M7:VMAUNMO(=:KM"'7*K:AU^EVH=?I=J'7Z7:AU^EVH=?I=J'7Z7:AU^EVH=? MI=J'_WX: _^4'P3_I28%_;$@!.S!&@/?TQG-GNX)W8KJ*>UZYE'Y:N)^ 6+BL M@5:YNX%5NL^!5K;>@EBPW8)8K]V"6*_=@EBOW8)8K]V"6*_=@EBOW8)8K]V" M_X07 O^9' +_JA\#];D5 M[-# #0WQ( Q> F!;O?-@ZPW4 =I-E)+9C543N- MT5A(@\]>4GO,95ISRVMA;,ER9V;(>6QAQX%P7<:*=%G&E'96Q9]X4\:L>5+& MNWI1Q\]Y4<3C>E.\XGQ3O.)\4[SB?%.\XGQ3O.)\4[SB?%.\XGQ3O.)\_XH4 M ?^?& '_L!0!V,,* ,[1"@#$Y10!N>0F"*[D-!.DXC\@F>!'+8_>3SF%W%9$ M>]I=3'/99%1LUVM:9M9R7V'5>61=',(/F3CIZY51#<>1: M2FGD85!DXVA57^-P65KC>%Q6XX!?4^.)8E#CDV1-Y)UE2^2I9TKEMF=)Y<9G M2.;?9TK@[&=*W^QG2M_L9TK?[&=*W^QG2M_L9TK?[&=*W^QG_YP- -NQ!@#* MO0< O\H' +7:"@"J[QD%H/ H#Y;P-1N,\#\F@O!',7GP3CEP[U1 :.]:1F'O M8$M=[V=/6.]N4E3O=551\'U73O"%64OPCUM(\9E<1O&C7D3RKU]#\KM?0O/, M8$'SYV!!\^A@0?/H8$'SZ&!!\^A@0?/H8$'SZ&!!\^A@WJ<" ,NV!0"]P04 MLL\' *?J#0&=]QP'E/@K$HKX-AR!^4 F>/I(+V_Z339G^E,\8/I80%O[7T16 M^V5'4OML24_\_U$U6/]7.%/_73M/_V,^ M3/]H0$G_;D%&_W5#0_]\1$#_A$8]_XQ'//^42#O_G4DZ_Z5*.?^M2SC_N4LX M_[E+./^Y2SC_N4LX_[E+./^Y2SC_N4LX_[E+OK4" +# @"DS@, E]X% (__ M% *&_R,(??\N$'/_-1AJ_SP>8O]")%O_2"A5_TXL4/]4+TS_6C%(_U\S1?]D M-4+_:C8__W W/?]V.3O_?#HY_X,[./^+/#;_DSTU_YH^-/^A/C/_JC\S_ZH_ M,_^J/S/_JC\S_ZH_,_^J/S/_JC\S_ZH_L;H! */( "6U@ B_0) 8/_%@)Y M_R &;_\H#&?_,!)?_S<76/\^&U+_1!],_THB2/]0)$3_529!_UHG/O]?*3O_ M9"HZ_VDK./]N+#;_="TT_WHN,_^!+S'_B# P_X\P+O^6,2W_GC(M_YXR+?^> M,BW_GC(M_YXR+?^>,BW_GC(M_YXRI,( );/ "(WP @/\, 77_$@)J_Q@# M8O\A!UK_*0M3_S$/3?\X$DC_/A5#_T07/_]*&3S_3QHY_U,;-_]8'#7_7!TS M_V$>,?]E'S#_:B N_W @+?]V(2O_?"(J_X(C*/^((R?_D"0G_Y D)_^0)"?_ MD"0G_Y D)_^0)"?_D"0G_Y D_V E!/];, ;_83H-_VI!%O]O2A__<5(I_V]; M,O]K9#K_9VY!_V1Z1_]@A$S_78Y0_UJ64_]8GE;_5Z58_U6K6O]4L5O_4[=< M_U*^7?Y1QU[\4=%?^U#@7_A0Z5_S4>U?[E/P7^A4\5_D5O)?Y%;R7^16\E_D M5O)?Y%;R7^16\E_D5O)?_V E!/];, ;_8CD-_VQ %O]Q21__J7/Y6L%[]5+=?_5._8/Q3 MR6'Z4M9B^%'D8O-2ZF+M5.YBYE;O8N!8\&+;6/%CVUCQ8]M8\6/;6/%CVUCQ M8]M8\6/;6/%C_V(E!/]=+P;_9S8-_W$^%?]W1A[_>$XH_W=6,?]T7SK_;FA! M_VIS2/]F?D[_8HE3_U^25O]+P;_:C4-_W0\%?]Z1![_?$PG_WM4,/]W7#G_T[_9(93_V"06/]=F5O^6Z%>_5FH8/Q8L&+[5KAC^E7!9/E4S67W4]YF M\E3G9NI6ZV;B6>YFVEKN9]%;[VC,7/!HS%SP:,Q<\&C,7/!HS%SP:,Q<\&C, M7/!H_V,D!/]?+@;_;3,,_W-9[&C:6^UIT%SN:LE=[FO%7NYKQ5[N:\5>[FO%7NYKQ5[N:\5>[FO%7NYK M_V0C!/]A+0;_<#(,_WLX%/^!0!S_A$DE_X11+O^!63?_?&% _W9I2/]PUMR%[L;L)?[&Z^8.QOOF#L;[Y@[&^^8.QOOF#L;[Y@[&^^8.QO_V4C M!/]D*P;_7--NV5WF;LY>ZV_& M7^IQOV'J<;IBZ7*V8^ERMF/IBP*_X8T$?^-/1G_D44@_Y)-*/V14S'VCEHZ\(EA0NJ#:4OE?G13X'A]6MIS MAF#4;H]FT&N7:LQHGV[)9J=QQV2O<\1CN77"8L9VP&+:=[IDYG>S9>5WKF;E M=ZIHY7>H:.9WJ&CF=ZAHYG>H:.9WJ&CF=ZAHYG>H:.9W_V_Y=+)OB64B[QE%@VZI!>/^2*9TC=A'%0U7UY6L]X@F'* MK%GXWJK:.-ZIVKC>J-K MY'FA:^1YH6OD>:%KY'FA:^1YH6OD>:%KY'FA:^1Y_V@A!/]O) 7_@"D)_XPS M#_^4.Q;_F4,<_9M)(_2;3RKLF54SY99<.]Z19474B6U0S(-V6L=]?F'!>(9H MO72.;;AQEG*U;IUUL6RF>*YKKWNL:KM\JFG*?:AJX7VC;.)\GVWB?)QNXGN: M;N-[FF[C>YINXWN:;N-[FF[C>YINXWN:;N-[_VDA _]Q(P7_@B@)_X\R#O^7 M.Q3_G$(:^9Y&(/"?3"?HGU(NX)U:-M:5843-CFI/QHAR6;^">F*Y?8)HM'F* M;K!VDG.LJ5OJWVB;K9^H&W%?YYNVW^;;^!^F'#A?I9QX7V4<>)\ ME''B?)1QXGR4<>)\E''B?)1QXGR4<>)\_VDA _]T(@3_A2@(_Y$Q#?^:.A+_ MGS\7]:)$'>RD2B/DI% IVZ%7-<^:7T/'DVA/OXQP6;B'=V&R@G]HK7Z&;JEZ MCG.D=Y9XH'6>>YUSJ'Z:.!^BGC@?HIX MX'Z*>.!^BGC@?HIXX'Z*>.!^_VH@ _]X'P3_B28'_Y8P"_^?-P_ZI#H3[ZD_ M%^:M11K!;IN#B'27@)!X MDGZ9?(Y\HG^+>JV"B'JZ@X=ZRX.&>]Z"A7O>@85[WX"%>^!_A7O@?X5[X'^% M>^!_A7O@?X5[X'^%>^!__VL@ _]Z'@3_BR8&_Y@O"O^A-0WWIS@0[*T\$^.R M0A;7L4@7]_WX" ?N!_@'[@?X!^X'^ ?N!_ M@'[@?X!^X'^ ?N!__VP@ _]\' /_C24&_YHN"?^C,POTJC0-Z;$Y#]^W/Q+2 MM$8BQZY0,;VH63^SHF!+JYUG5J.8;E^X2U@WF$Q81XA=V#>83>@7J#WX!Z@N!_>H+@?WJ"X']Z@N!_>H+@ M?WJ"X']Z@N!__VT? _]^&P/_CR0%_YTL!_ZF, GPKC$+Y;8U"]N\.1'.MT4@ MP[)/,+BL5SZOIU]*IJ%E59Z=;%Z7F7-FD)5Z;(J2@7*%D(EW@(V1?'N+FW]W MBJ6"=(FR@W*)PH-RBMJ#@72'WX!UAN!_=8;@?W6&X']UAN!_=8;@?W6& MX']UAN!__V\> _^ &P/_DB,$_Z K!OJI+ ?MLBP'XKPQ!]7 -A#)NT,?OK9- M+K2P5CRJJUU)H:9D5)FB:EV1GG%EBIMX:X28?W%_EH9V>9./>G61F'YQD*.! M;I"O@FR0OX-KD=6";8_>@6^-WX!PB^!_<(O@?W"+X']PB^!_<(O@?W"+X']P MB^!__W$< _^#&0+_E2$#_Z,I!?:M)P7HMR8$WL,J ]##-0[$OT$=N;I,+:ZU M5#NEL%M'FZQB4I.H:5N+I6]CA:)V:GZ??&]XG(1T6^9EGQKEZ%_:)>M M@&:7O(%EF-& 9I;??VB3X'YJD>%^:I'A?FJ1X7YJD>%^:I'A?FJ1X7YJD>%^ M_W4: O^'& +_F" #_Z8E _*R( /DOAX"U\DB LK',PV^PT FURI()R;:**=FBAE'EDH)]\89^K?E^@ MNGY?H,Y^7Y_A?6*;X7UCF.)\8YCB?&.8XGQCF.)\8YCB?&.8XGQCF.)\_W@8 M O^+%P'_G1T"_:L> NRX%P'>R!$ S\T? L3,, NXR#X9K<5(**/!43:8O5A" MC[E?38:V959_LVM=>+%R9'*O>6ELK8!N9ZR)EJIN7I9 MJLQZ6*GD>ENDY'I=H>1Y7:'D>5VAY'E=H>1Y7:'D>5VAY'E=H>1Y_WT5 O^0 M% '_H1@!]K$4 -G!"P#2SPL R-(< ;S1+@FQSCL7ILM&)9S(3S.1Q%8_B,%= M28"_8U)XO&I9<;IP7VNY=V1FMW]I8;:';5VUD7!9M9QR5K2I=%2TN'13MIUCD4G]-$(I3032^*S50[@QO4+GL;U"Y[&]0N>QO4+GL;U"Y[&]0N>QO_XD0 ?^=#@#:KP@ MS;L( ,3'!P"\U@L L]\: :K?*P>@WCD2EMU#'HS:2RJ"V%,U>=5:/W'3849J MTFA,9=%O4F#0=E9;T'Y:5\^'75//D5]0SYQA3L^I8TS/N&-+T,MC3-#E8DK. M\F5+R/)F2\CR9DO(\F9+R/)F2\CR9DO(\F9+R/)F_Y(- -ZF! #.M 8 PK\& M +G," "PW0P I^4= Y[E+0N4Y3D6BN1"(('C2BIWXE S;^%8.VG@7T%CX&9& M7M]N2EK?=4Y6WWU14M^&4T_?D%9-WYM72^"G6$G@M5E(X<992.'?64??\%E& MW/5;1MSU6T;<]5M&W/5;1MSU6T;<]5M&W/5;[9P$ -&M! #"N 4 M\,% *W1 M" "D[1 !F^T@!9+M+@Z)[#H8@.Q#(7;L2BIN[% Q9NM6-V#K7#Q;ZV1 5^MK M0U/KR#2TKLC$U([)9.1>VA4$/MKE%"[KQ10>_,4D'OY5) [?%1 M0.WQ44#M\5% [?%10.WQ44#M\5% [?%1U*4 ,2R P"VO , J\D% *#8" "7 M]!,!C_4D!X?U,0]^]CL8=/9"(&SV2"=E]D\M7O=5,5GW6S55]V(X4?=H.TWX M;SU*^'8_1_A^043YAT-"^9%%0/J;1C[ZID<\^[%(._N^23K\STDY_.-).?SC M23G\XTDY_.-).?SC23G\XTDY_.-)QZT +>W @"JPP( GM $ )/C"0",_1@" MA/XG!WO_,0]R_S@6:?] '&+_1B)<_TTF5O]3*E+_62U._U\P2O]E,D?_:S1$ M_W$U0?]Y-S__@3@\_XHZ.O^3.SC_G3PV_Z<]-?^Q/C3_OCXS_\H_,__*/S/_ MRC\S_\H_,__*/S/_RC\S_\H_N+( *J] "=R@ D=@" (C[#0%__QD"=O\D M!F[_+0QF_S427_\\%UC_0QM3_TD>3O]/(4K_521&_ULF0_]@)T#_9BD^_VLJ M._]R*SG_>2TV_X$N-/^*+S'_E# P_YPQ+O^E,BW_KS,L_[!&'_ M)PA:_R\,5/\W$$[_/A-)_T061?]*&$'_3QD^_U4;._]9'#G_7QTV_V0>-/]I M'S+_<" O_W/8" &__#0%D_Q("7/\9 U3_( 1. M_R<&2/\O"$/_-@H__SP,//]"#CC_1P\U_TP0,_]1$3#_5A(N_UH3+/]?%"K_ M910H_VL5)O]Q%B/_>1!1 M_TGK4?Y)\E+Y2_=2\TWY4>U/^E'F4/I2Y5#Z4N50^E+E4/I2Y5#Z4N50^E+E M4/I2_U!2^E7@4OI5X%+Z5>!2^E7@4OI5 M_U@F _]4, 7_73$'_V_VY2)_]J7"__968V_V%Q//]=?4'_ M68A&_U:22?]4G$S_4J1._U"K4/]/LU'_3KM2_TW$4_]-SU3^3.!5^TSK5?A, M]%7P3_=5Z5'X5>)2^%;;5/E7V53Y5]E4^5?95/E7V53Y5]E4^5?95/E7_UDF M _]7+@7_8"\'_VHV#?]Q/A7__W)1)O]O6B[_:F,V_V5N//]A>D+_785' M_UJ/2O]7F$W_5:!0_U2H4OY2KU/]4;=5_%# 5OI/RU;X3]Q7]4_I5_)/\U?J M4O97X5/W6-I5^%G15OA:SU;X6L]6^%K/5OA:SU;X6L]6^%K/5OA:_UDF _]: M+ 7_9"T'_VXS#?]U/17_>$8=_W=/)?]T6"W_<& U_VIJ//]F=D+_8H%'_EZ+ M2_M;E$_Y69U2^%>D5/96K%;U5+17\U.\6/)3QUGP4M5:[%+F6NE3\EGA5/5; MUU;V7,]7]UW(6?A=QUGX7<=9^%W'6?A=QUGX7<=9^%W'6?A=_UHE _]=*@7_ M9RH&_W(R#/]Y.Q3_?$4<_WQ-)/]Z52S_=5XT_V]G//QJY6^A6PUSF5M%ULS^79D.O5P;D'Q;'E([6B#3>IDC%'G M8955Y5^=6.-=I5KA6ZU%IB%+=9I%7 MV6.96M5@H5W27ZA@SUVQ8LUO M8?%GKF+Q9ZYB\6>N8O%GKF+Q9ZYB\6>N8O%G_UTD _]F) 3_'%&VW-[3=5N@U/0:HQ8S&>4 M7_7\%HO5_0:;I@YFFU8>]JKV+O:JMC[VJG9.]I MIF7P::9E\&FF9?!IIF7P::9E\&FF9?!I_UXC _]I(@3_=B,$_X(L"?^+-@[_ MCSX4_9%%&_213"+MCE,JYHI:,M^%93O7?FU%T'AV32($_X4K"/^.- S_DSP2 M^)9#&.^62A[GE5 FX)%8+M>*83K.A&I%R'YS3<)Y>U6^=8-;N7&+8+5NDF2R M;)IGKVJC:JQHK&RI9[9NIV?$;Z5GVF^B:.MOGFGL;YMJ[&Z9:^UMF&OM;9AK M[6V8:^UMF&OM;9AK[6V8:^UM_U\C _]N'@/_>R$$_X@J!_^1,@O_ESH/])I! M%>N;1QKCFTTAVI95+<^/7CG(B6=$P8-O3;M^=U6V>7];L7:'8*USCV6I<)9H MIFZ?;*-LJ&Z@:[)PG6O <9QKTG*:;.EQEVWJ<)1MZW"2;NQODF[L;I)N[&Z2 M;NQNDF[L;I)N[&Z2;NQN_V$A _]P'0/_?B #_XLI!O^5,0G[FS@-\)X^$>>@ M1!;?H$H=TYI2*\J37#C"C61#NX=M3;2"=%2O?GQ;JGJ$8:9WBV6B=)-IGG*; M;9IPI'"7;Z]RE6^\MPC''K<(QQZW",<>MP MC''K<(QQZW",<>MP_V,@ _]R&P/_@!\#_XXG!?^7+PCXGC8+[:([#N2E0!+: MI$8]D6)"M8QJ3*^'9!JEW>8;9-U MH7"0IQAW7J<(=UZG"'=>IPAW7J M<(=UZG"'=>IP_V4? _]T&@+_@QX"_Y F!/^:+0;TH30)Z:8W"^"J/0[4IT0; MR:%/*<";6#:XE6!"L)!H2ZF+;U.CAW9:GH-^8)F A664?8UJD'N6;HQYGW&) M>*ESAG>U=81WQ7:#>-]U@WCH=()XZ7.">.IQ@GCJ<8)XZG&">.IQ@GCJ<8)X MZG&">.IQ_V<= _]W&0+_A1P"_Y,D _^=*P7QI# &YJHS"-RN-PS/JD,:Q:5. M*+R?5S6SF5]!JY1F2J20;5.>BW1:F(A[8).%@V6.@HMJBH"3;H9^G'&"?:=T M?WRS=7U\PW9\?=MV?'WH='U\Z'-]?.ER?7SJ<7U\ZG%]?.IQ?7SJ<7U\ZG%] M?.IQ_VD< O]Y& +_AQL"_Y4C _N@*03NJ"P$XZ\O!=>R- O+K4$9P:A,)[>C M532OG5U IYED29^4:U*9D')9DXUY7XZ*@&2)AXAIA(61;8"#FG%\@J1T>8&Q M=G>!P'9V@=9V=H'G='>!Z'-X@.ER>'_J<7A_ZG%X?^IQ>'_J<7A_ZG%X?^IQ M_VL; O][%P+_BAH!_Y@A OBC)@/JK"<#W[0I ]*U,@K'L$ 8O*Q+)K.G4S.J MHEL^HIUC2)J9:5&4E7!8CI)W7HB/?F2#C89I?HJ.;7J)F'%VAZ)S ?2G(@+FL" !VKHA :$^.FVY7B)AU78*5?&-]DX1H>)",;'2/E7!PC:!R;8RL=&J,NW5I MCIQ;8CJ<6V(ZG%MB.IQ;8CJ<6V(ZG%MB.IQ_W 7 O^! M%0'_D!8!_YX: ?"K&P'BMA8 T[T= F%WF8%F*:FZ6DVYJE)YQ9I2J.ZG!GCNIP9X[J<&>.ZG!GCNIP_W,5 O^%$P'_ ME!0 _*,5 .JP$@#9O@P S<$; <+ +0>XO3H3KKE&(:2U3RV:L58YDJY>0XJK M9$R#J&I3?*5Q67:C>%]QH7]C;)^':&B>D6MDG9QN8)RH<%ZQO897L;V&5[&]AE>QO_W<2 ?^)$0'_F1$ M\Z@. ->U"@#/P0H QL48 +S$*@6RPC@1I[]$'IZ[32N4N%4VB[5<0(2R8DE\ MKVE0=JUO5G"K=EMKJGU@9JB&9&*GCV=>IIIJ6Z6F;%BEM6U7IL=M5Z;B;%>D M[6Q:G^UL6I[M;%J>[6Q:GNUL6I[M;%J>[6Q:GNUL_WP0 ?^.$ #VG@T V*T) M ,VX"0#'Q @ OLH4 +7*)P2KR#8/H<5!&Y?"2RB-OU,SA;U:/'VZ845VN&=+ M<+=M46JU=%9EM'Q;8+*$7URQCF)8L9EE5;"E9E.PLV=2L<9G4K'A9U&O\6A3 MJO!H5*GP:%2I\&A4J?!H5*GP:%2I\&A4J?!H_X(. /^4# #;I08 SK$' ,6[ M!P"]QP< M= 0 *S0(P.CSS,,F]C5M4O9A=4;RD7T^\ MLV!-O<5@3;W@7TR\\&%-M_5B3;;U8DVV]6)-MO5B3;;U8DVV]6)-MO5B_XD+ M .&< P#0J@4 Q;4% +N_! "RRP@ J]@- */9( *:V"\)D-8\%(?41A]^TD\I M=M!6,F_/7CEHS60_8\QK1%[,3$;:[4Q$V/E/0]C[3T/8^T]#V/M/0]C[3T/8^T]#V/M/VYH ,JI @"[ MLP( L+T# *7)!0";U@D E.@4 8SI)02$Z#,+>^@\%'/H1!MKZ$LB9.=2*%[G M62U9YV R5>=H-5+G;SA/YW<[3.> /4GGB3]'Z)1!1.B?0D+IK$-!Z;I$0.K- M1$#JY$1 Z/5$0.?X0T#G^$- Y_A#0.?X0T#G^$- Y_A#S:, +VN 0"PN $ MI,0" )G0!0"/X0H B?$: 8'Q* 5X\C(,_/#GX MSSPX]^@\./?L/#CW[#PX]^P\./?L/#CW[#PX]^P\OZH +&S "DOP F,H! M (S8! "$^@X ?/L; G3[)@5L_# *9?PX$%[]0!58_D<94_Y-'4__5"!+_UHB M2/]A)47_9R9"_VTH0/]U*CW_?2LZ_X8M./^1+C;_FR\T_Z8P,_^R,3+_OC(Q M_] R,?_6,C'_UC(Q_]8R,?_6,C'_UC(Q_]8RLJ\ *6Z "8Q@ B]( '_? M @!Y_Q$!;_\9 F?_(@1@_RP'6O\T#%3_/ ]/_T,32O])%4?_3Q=#_U490/]; M&S[_81P[_V8>.?]M'S;_=" T_WTA,?^&(R__D20M_YLE+/^E)BO_KR8J_[LG M*?^^)RG_OB_PT M5O\2 4__&0))_R #0_\G!#__+@4Z_S0&-_\Z!S/_/P9.?]&H3O_1:D\_T2P/O]#MS__0L _ M_T+)0/]!U4'_0>1!_T'N0O]!]D+_0?U"_T+_0?E$_T'T1O]"[T?_0N]'_T+O M1_]"[T?_0N]'_T+O1_]"_TTI _]*,@3_43(&_U3?]*WDW_2MY- M_TK>3?]*_T\H _]2+ 3_6BP%_V$O!_]G.@[_:D05_VI.'/]G5R3_8F$K_UYM M,?];>#;_5X,Z_U2-/?]2ED#_4)Y"_D^E1/Q.K47[3;1'^DR\2/E,QTCV2]1) M\TOE2?!+\$GM3/E(Z4S_2N%._TO:3_],TU#_3=-0_TW34/]-TU#_3=-0_TW3 M4/]-_U H _]5*@3_72D%_V4M!_]L. W_;T(4_V]+'/]L52/_:%XJ_V-I,?]? M=#;]7'\[^UF)/_E6DD+W5)I$]5.B1O12J4CR4;%)\5"Y2N]/PTON3\]+ZT_B M2^=/[DOD3_A-WT_^3M51_T_.4O]0R5/_4,E3_U#)4_]0R5/_4,E3_U#)4_]0 M_U$G _]8)P3_82<$_VHL!O]Q-@S_=$ 3_W1)&O]R4B+_;ELI_6AD,/EE<#;V M87L[\UZ%0/!;CD/N699&[%>>2.I5IDKH5*U,YU.U3>53OT[C4\Q.X5/?3MU3 M[4_84O=1T5/]4LI4_E/$5O]3OU?_4[]7_U._5_]3OU?_4[]7_U._5_]3_U(G M _];)0/_920$_VXJ!O]V- O_>CT1_WI&&/]X3R#[=%@H]F]A+_%K;#;M9W8\ MZ6. 0.9@BD7D79)(X5N:2M]9HDW=6*I/VE>R4-A6O%'55V6OU7MEK]5[9:_5>V6OU7_U,F _]? M(@/_:2$#_W,H!?][,@K_?SL0_X!$%OM^3![T>U0E[G9=+>EQ:#3D;7([X&E\ M0=QEA4;88HY*U%^63=%=G5#.7*52S%JM5,E9ME;'6<)7QEG05\)9YEB_6?-9 MNUK[6;5;^UJP7?M:K5W[6:U=^UFM7?M9K5W[6:U=^UFM7?M9_U8D _]B( /_ M;2 #_W]^+1A?HB$X>X817)ME^83'1>&HZRW-S0L9O?$C" M;(1-OFF,4;MFDU6X9)M8M6.C6K-AK%RP8+=>KF#$7ZQ@V%^I8>M?IV'W7Z)C M]U^?9/=?G63X7IUD^%Z=9/A>G63X7IUD^%Z=9/A>_UL@ O]H' +_=!T"_WXC M _^(*P7]C30)\Y [#NJ00Q3BCTH:VHI4)="#73#)?F$BY<8!. MM6Z(4K)KCU:O:9=:K&>?7*EEJ%^F9+)AI&2_8J)DT&*@9.=BGF7U8IIF]6&8 M9_9@EFCV8)9H]F"6:/9@EFCV8)9H]F"6:/9@_UT? O]J&@+_=QP"_X(A O^+ M*03YD3$'[Y4X"^:6/Q#=E$<7THY1),J(6R_"@V0YO'YL0;=Y=$BR=7Q.KG*$ M4ZIOBU>F;9-;HVN;7J!JI&"=:*YCFVBZ9)EHRV67:.-DE6GS9)-J]&.1:_5B MD&OU89!K]6&0:_5AD&OU89!K]6&0:_5A_U\= O]M& +_>AL"_X4? O^.)P/U ME2X%ZYDU".&<.PS6F$,6S)-/(L2-6"Z]AV$XMH)I0;!^<4BK>GE.IW> 4Z-T MB%B?<9!;FV^87YANH6*5;:MDDFRW9I!LQF:/;-]FCFWQ98QN\V2+;O1CBF[T M8HIN]&**;O1BBF[T8HIN]&**;O1B_V$< O]O%@+_?!H!_X@> ?^1) +RF2L$ MYYXQ!=V@-@G1G$$5QY=-(;^15BVWC%\WL8=G0*N";DBE?G9.H'M]4YQXA5B8 M=HU@@W--FX![4Y9]@E>2>HI< MCGB28(IVFV.'=:5FA'2Q9X)TP&B =-5H@'7L9W]V\F9_=?-E?W7S9']U\V1_ M=?-D?W7S9']U\V1_=?-D_V49 O]T% '_@1,?X=J-F?GFO:'MYO6EZ>=%I>7KJ:'IZ\F9Z>?)E>GGS9'IY\V1Z>?-D M>GGS9'IY\V1Z>?-D_V<7 O]V% '_A!8!_Y 7 ?6;&@'GI!T!VZL? &A(5;@H*-7WZ MEV-Z?Z%F=WZL:'5]NVES?LYI%0#CJ!8 U:X; 49D20D6U+BXYT48:,>U:!B8-;?(>+7WB&E&)T MA)]E<8.J9V^#N&EM@\MI;8/F:&Z#\F9O@O)E<('S9'"!\V1P@?-D<('S9'"! M\V1P@?-D_VL4 ?][$@'_BA( _Y82 .VB$ #>K0X T+$9 ,6P*P6[K3D/LJE$ M&ZFE3B>@H58RF9U>.Y*:9$.+EVM*AI1R4("2>55[CX!:=XV)7G*,DF%NBIQD M:XFH9VF)MFAGBF83^ I&=&>J%N3'6?=5%PG7Q5:YR$6F::CEUCF9A@7YBD8EV8 MLF1;F,-D6YC>8UN8\&-D_5B7I/U8EZ3]6)>D_5B_W4. M /^�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

' AB@ &HT& !6/#0 3D!, $I : !*0(@ 1 MD"H $)$R !"1.P /D40 #I%/ V17 ,D6H "Y%Z J1C0 (D)\ !Y"S >/ MR0 'C^8 !X[T B-_ (C?\ B7, 'MS !O

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

5 "P'IP K![H *P?2 M "L'ZP K!_< ?1 &P1 !?$P 5!0 $P4 !&% 0A, #X2 \$ M.@X! #H-!@ Z"@P . D0 #8(% U"!D - D? #()) Q"2D , DO "\*-@ N M"CT +0I% "P+3@ K"UD *0QE "@,

!( &@4 !;%@ 41< $@7 !"%@ /18 #D5 W$P -1$ M #,0 P S#@@ ,@T- # -$0 O#18 +0T; "P-(0 K#2< *@TM "D.- H#CL M)PY$ "4.3@ D#UD (Q!E "$0

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

$0 GQ8 * > "B* HC4 *-$ "C50 HVD ** "BF@ H;, M *#8 "@]@ G_\ )__ &YQ !?<@ 474 $1Y W?@ +(0 "&* 7 MCP $)0 J9 !G0 * "D IP *@ "I J@ *P& "M M"P KQ + 5 "R'@ M"D +0Y "T2@ M5T +5S "UC@ M:@ +3& M "S[0 LO\ ++_ &9Z !7?0 28( #R' OC@ (Y0 !B: 0GP M":0 "I K0 + "T MP +@ "Y NP +P "^ @ MP @ ,(. #$% QQX ,@L #)/0 RE ,IF #*?P RIL ,JX #* MW0 RO4 ,K_ %Z& !/BP 09$ #.8 GGP &Z4 !&K )L +4 M "Y O0 ,$ #& R ,D #+ S ,X #0 T@ M -0% #9# W1( .$> #B+@ XT( .17 #E;P YHP .:H #EQ0 MY>< .;V %:4 !(FP .J( "RI ?L $[8 N\ P0 ,4 #) M S0 -( #6 V@ -L #> X .( #D YP .D M #M \ H /01 #X'P ^3( /I( #[7P _'H /V7 #]KP _<< M /WD /\ #@#_ T _P , /\ #@#_ !, _P > /\ *@#_ #8 _P!" /\ 30#_ M %< _P!? /\ 9P#_ &X _P!T /\ >@#_ ($ _0"' /P C0#Z )0 ^0"< /< MI0#U *\ ] "\ /, SP#Q .P \ #^ .\ _P#O /\ XP#_ -< _P#. /\ R@#_ M /\ "@#_ 8 _P $ /\ " #_ ! _P 9 /\ )0#_ #$ _P ] /\ 1P#^ %$ M^P!9 /D 80#V &@ ] !N /, = #Q 'H [P"! .X AP#L (X Z@"6 .@ GP#F M *D XP"U .( Q@#@ ., WP#X -T _P#= /\ U #_ ,D _P#" /\ O@#_ /\ M P#_ _P /\ 0#_ T _P 4 /T ( #Z "L ]P V /, 00#O $L [ !4 M .@ 6P#F &( XP!H .$ ;@#? '0 W !Z -H @0#8 (@ U "0 -( F #/ *( MS0"N ,L O #) -, QP#P ,8 _P#$ /\ Q #_ +L _P"V /\ LP#_ /\ #_ M _P /\ #W @ \ 0 .L &@#G "4 Y P .$ .P#< $4 U0!- -$ M50#. %L RP!B ,D 9P#' &T Q0!S ,, >@#! ($ OP") +T D@"[ )P N0"G M +< M0"U ,@ LP#F +( ^P"Q /\ L #_ *X _P"J /\ IP#_ /\ #_ M_@ /$ #E ( W - -, % #- !\ R@ J ,< - #$ #X P !' +P 3@"Z M %4 MP!; +4 80"S &< L@!M + 0!\ (0 >P"0 'D G0!X *P =@"^ M '4 W0!S /0 #@ MEPL ),& "0 L C 1 (D &@"& "0 @P N ($ -@!_ #X ?0!$ 'P 2P!Z M %$ >0!7 '< 70!V &0 = !L ',!=0!Q 8 ;P*- &X"F@!L ZH :P.[ &D$ MU@!H!O$ : ?_ &<'_P!G!_\ 9P?_ -\4 ##%P KA< )X6 "3%0 BQ( M (80 "$# ( @P8- ( #% !\!1X >0 M#O, 70[_ %T._P!=#O\ 70[_ -0< "Y'0 I!X )4= ")' @1H 'L7 M !X$P >! & '<-#P!S#A@ < XB &X/*P!L$#, :A [ &D00@!G$4D 9A%/ M &015@!C$ET 81)F & 2;P!>$GL 7!.( %L3EP!9$Z< 5Q2Z %84U0!5%?, M5!7_ %05_P!4%?\ 5!3_ ,HB "P(@ G2, (TC "!(@ >2$ ',> !O M&P ;A< &T3# !J%!0 9Q4> &46)P!C%B\ 81&$4 71A+ %P9 M4@!:&5H 61EB %<:; !6&G< 5!J% %(;E !1&Z0 3QNW $X;T !-'/$ 3!S_ M $P<_P!-'/\ 31O_ ,,F "J)P EB< (L .BW_ #HM_P Z+/\ M.BS_ +(P ";,0 B#( 'DR !M,@ 9#( %TQ !8+P 52P %$L !/ M+0D 3"T1 $HN&0!)+R( 1R\J $8P,0!%,#@ 0S _ $(Q1P!!,4\ 0#%7 #XQ M80 ],FT .S)[ #DRBP X,IP -C*O #4RQP T,ND -#+_ #4Q_P U,?\ -3#_ M *TS "6- A#4 '4U !I-0 8#4 %DT !4,P 4# $PQ !),08 M1S(/ $4S%@!#,Q\ 0C0G $ T+@ _-38 /C4] #TU1 \-DP .C95 #DV7P W M-FL -C9X #0WB0 R-YH ,3>M "\WQ0 O-^@ +S;^ # U_P P-?\ ,#3_ *DV M "2-@ @#< '(X !F. 73< %8W !0-@ 2S0 $#T &H] !?/0 5CT $\] !)/0 0CT #P^ Y/P -D$( #1!#P R M0A8 ,4(> "]#)0 N0RT +4,T "Q$/ K1$0 *D1- "A$6 G16, )45Q "-% M@@ B194 ($6H !]%OP >1., 'T3[ !]#_P @0O\ (4'_ )H^ "%/P =$ M &= !<0 4T $Q !&0 /D$ #A# T10 ,$8# "U'#0 K2!( M*D@: "E((@ H22D )TDQ "5).0 D24$ (TI* ")*50 @2F$ 'TIO !U*?P ; M2I( &DJF !A*O0 72N &$GZ !E(_P :1_\ &D?_ )5" " 0@ <$, &-# M !80P 4$, $E# !"1 .T4 #5' P20 *TL "9-"0 D3A (DX6 M "%/'0 @3R4 'T\L !Y/-0 =3ST '%!' !I040 94%T %U!K !90? 44(\ M$U"D !%0N@ 14-X $4_X !)._P 33?\ %$W_ (]% ![1@ :T8 %]' !5 M1P 34< $9' _1P -TH #%, K3@ )E "!3 P <50P &E81 !E6 M& 75B %E8G !56, 45CD $U=" !)730 15UD $%=H ]7>0 .5XP #5>@ M M7M@ +5M0 "U;T Q5_P -5/\ #E/_ (A) !V2@ 9TH %M* !12@ M2DH $-* [3 ,TX "Q1 F5 (58 !M9 57 < $5X- !!>$P 0 M7AH #EXB Y>*@ -7C, #%X] M>2 *7E0 "%YB =>

ML0 "7

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� (AD] " 91@ >&5$ '1E= !L::P 9&GP %QJ/ !4:HP 4&;H $AG; !,9 M]@ 4&?\ %1C_ 'T: !K'0 7!\ % @ !'( /R #D? T'P ,1X M "T= K' *1L "<;!0 E&PP )!P1 "(<%@ A'!T (!TC !\=*@ >'3( M'!XZ !L>1 9'DX %QY; !8>:0 4'WH $AZ- !$>H@ 0'K@ #A[8 \>]0 0 M'?\ $1W_ 'H= !G'P 62$ $TB !$(@ /"( #8B R(0 +B$ "H@ M G( )!\ "(@ @ @( H 'B$/ !TA% <(1H &R(A !DB)P 8(B\ %R(X M !4C00 4(TP $B-8 !$C9P 0(W@ #B.+ TCGP ,([0 "R/0 LB\ ,(O\ M#2'_ '8? !D(@ 5B, $LD !!) .B0 #0D O(P *R, "@C D M(P (", !TD ;)0< &28- ! !0G)0 3)RP $B0 'L M !] @ , (,( "� B1, (H= "**P B3P (A/ "&9@ A8$ M (2@ ""P@ @? '__ $9+ Z3 +D\ "-3 86 $%X ED M:0 &\ !T > 'P "! A (< "( BP (X "0 M DP )8 "9!P G0T *$4 "@(0 H#$ )Y$ "=6P G'8 )F6 M "9M0 EN4 )7^ #]2 R50 )EH !M@ 19P "6T !T >P M ($ "& BP ) "4 EP )D "< GP *$ "D MIP *H "M L08 +4- "X%@ MR8 +8Y "U4 M&H +*) "P MJ@ KL\ *WU #=< K80 'F@ !-P +> ( "' C@ )4 M ": GP *0 "H K *T "P LP +4 "X NP M +\ ## QP ,L% #1#@ T1L - N #/10 S5\ ,M^ #)G@ MR+X ,7I "]I C< %GD V! !BP ), "; H@ *@ "N M M +@ "] P ,( #% R ,L #. T0 -8 M #; WP .0 #H!@ ZQ$ .HC #J.@ Z50 .=R #EDP X[, M ./4 /\ #_ _P /\ ! #_ L _P 0 /\ %P#_ "$ _P K /\ -0#_ M #X _P!' /\ 3@#_ %4 _ !; /H 80#X &8 ]@!M /0 ,, K@# ,4 O0#K +L _P"P /\ I #_ )P _P"8 /\ E0#_ /\ M #Z ] /$ #R Z@ % .< #@#B !4 X0 > .$ * #8 #$ T Y M ,L 0 #( $< Q0!- ,( 4P"_ %@ O0!> +L 9 "Y &L M@!S +0 ? "Q (@ MK@"5 *L I "H +@ I@#< *, ^P"? /\ E0#_ (\ _P"+ /\ B0#_ /D #O M YP -\ #/ R ,$ "@"_ !$ O 8 +L (0"Y "H M R +$ M.@"N $ JP!& *@ 3 "F %$ HP!6 *$ 7 "? &, G0!J )L 0!( '@ 3@!V %0 =0!; ', 8P!Q &X ;P!Z &T B0!L M )H :@"N &D S !H /8 9P#_ &4 _P!D /\ 8P#_ ,H "T H0 ), M ") @@ 'L !X 4 =@ , '4 $0!T !@

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�!XQAX <\8N VW%.@AGQ$4.8L-.$UW#5AA9PEX=5<%F M(5'!;B1.P'L<$ &_/"0!KT14 9]$F 6/1- 1>T$ (6=!*#%7/4Q!1SUL43L]C&$O. M:QM(SG4>1WA$ 6]X@ %?>+0)3WSH$4-]$!DS?3@E)WU<,1M]?#T/?:!%! MWW$3/M]\%3S?B1^1HTW?\;--S_&S3< M_QLTW/\;--S_&S3<_QNYG JJ0 )ZK "2M0 A;X 'G' !MSP 8M8# M %CA" !5ZA, 4>L@ $WK*P%)ZS4"1>P^!$+L1P4_[$\'/>U8"3KM8 HX[6H, M-NYT#3/N@ XR[HX/,.^=$"[OK1$M\, 1+?#>$2SN\1$L[/X1+.O_$"SK_Q L MZ_\0+.O_$"SK_Q"MH@ H*D ).S "&O0 ><8 &S/ !@V 5=X $[S M"@!*]Q, 1O@= $/X)P$_^# "._DX CCY0 ,U^D<$,_I/!3#[5P4N^U\&*_QI M!RG\= @G_(())?V0"23]H HC_K *(O[$"R'_X LA_?(*(/S\"B#\_ H@_/P* M(/S\"B#\_ JBIP E;$ (>[ !YQ@ ;,\ %_9 !2WP 2.@ $/_" _ M_Q ._\9 #?_(0 T_RD!,/\P 2W_-P(J_SX")_]$ B7_2P,B_U,#(/]< QW_ M9@0;_W($&?^ !1?_CP46_Y\&%?^O!A3_P 84_]8&$__I!A/_Z083_^D&$__I M!A/_Z0:7KP B+H 'K% !LSP 7MH %#@ !$Y@ //4 #?_! S_PT M+_\3 "O_&@ H_R$ )?\G 2'_+0$>_S(!&_\X 1G_/P$6_T8"%/]- A'_5@(0 M_V "#O]L @S_>P,+_XL#"O^: PK_J ,)_[4#"/_" PC_P@,(_\(#"/_" PC_ MP@.*N >\, &S. !>VP 3^( $+G V[ ,?\ "S_ G_P< (_\. M "#_$@ <_Q@ &/\= !7_(0 2_R8 $/\L 0[_,0$-_ST#/\GNPS_)\0,_R?.#/\HW@O_*.D+_RCS M"_\H^PO_*/\*_RG_"O\I_PK_*?\*_RC_"O\H_PK_*/\*_RC_"O\H_PK_,"T" M_S8J O\Y*@+_.RX"_SHT _\X/ 3_-DD&_S-6!_\Q8PG_+W$*_RU^"_\MB@S_ M+)0,_RR<#?\LI W_+*L-_RRQ#?\LN0W_*\$-_RS+#?\LV@W_+.<-_RSQ#?\L M^@W_+/\,_BW_#/TM_PS]+?\,_2S_"_TL_PO]+/\+_2S_"_TL_PO_,BL!_SDH M O\]* +_/RH"_SXP _\].@3_/$8&_SE3"/\W8 G_-6T+_S-Z#/\RA@W_,9 . M_S&9#O\QH0__,:@/_S"N#_\PM0__,+T0_S#'$/\PU!#_,.00_S'O$/XQ^0_[ M,?\/^3'_#_@Q_P[W,?\.]S'_#O8Q_P[V,?\.]C'_#O8Q_P[_-2@!_SPE ?] M) +_0R<"_T,L _]$-P3_0D,&_T!/"/\]7 K_.VD,_SEV#?\X@@__-XP0_S>5 M$?\VG1'_-J02_S:K$O\VLA/_-;H3_S7#$_\USQ/\->$3^3;M$_8V]Q/S-O\3 M\3;_$O V_Q+P-_\1[S?_$>\W_Q#O-_\0[S?_$.\W_Q#_.24!_T A ?]%( '_ M1R("_TDI O]*- 3_23\%_T9+"/]$6 K_0F4-_T!Q#_\^?1'_/8<2_SV1%/X\ MF17]/* 5_#NG%OH[KA?Y.[87^#N_%_8[RACT.]P8\#OJ&.T[]ACJ._\7Z#S_ M%^<\_Q;F/?\5Y3W_%.4]_Q3E/?\4Y3W_%.4]_Q3_/2(!_T0> ?])' '_31X! M_U F O]1, /_4#L%_TY&"/]+4PO_2& ._T9L$?M%>!/X1((5]D.,%_1"E!CS M09P9\4&C&^] JAON0+(<[3^['>L_QA[I/]4>Y3_H'^) ]![?0/X=W4'_&]M" M_QK90O\8V$+_%]A"_Q?80O\7V$+_%]A"_Q?_0!\!_T@: ?].& '_4AL!_U8C M O]8+ /_5S<$_U5"!_]230OY4%H.]4UG$O%,(.-$IB+A1*XCX$.W)-Y#PB7<0] FUT/E)M-$\R301?XBS4;_(,Q'_Q[* M1_\O4W_'KU-_Q[_1Q@!_T\3 ?]6$0#_7A4 _V(< ?]E) '^ M92T"]&0X!>UA0PGF7U$.X%Q=%-I8:!K45G(>T%1[(LQ2A";*4(PHQT^4*L5. MFRS#3J,NP4VL+[],MC"]3,(QNTS3,KA,Z3&V3O@MM%#_*K-1_R>S4O\DLE+_ M(K)2_R*R4O\BLE+_(K)2_R+_2A4!_U,1 /];#P#_8A( _V@7 /]J'P'V:R@! M[&LR ^1I/@?<9DP-TV)8%,U?8QO(7&T@Q%IV),%8?BB^5H8KNU6.+KE3EC"V M4IXRM%*F,[)1L#6P4;PVKE#+-ZQ0XS>J4O0SJ53_+JA6_RNH5_\HJ%?_):A7 M_R6H5_\EJ%?_):A7_R7_31, _U8. /]?#0#_9Q _VP3 /MP&0#O<2(!Y'$L M MMP.@71;$@,R6A4%,-E7QN^8F@ANE]Q)K9=>2JS6X$ML%J),*Y8D3.K5YDU MJ5:A-Z=6JSBE5;8ZHU7%.Z%5W3N?5O WGUC^,I]:_RZ>6_\KGES_*)Y<_RB> M7/\HGES_*)Y<_RC_4!$ _UD, /]C# #_:PT _W 0 /5T$P#H=AH W7_S&67_\MEF#_*I9@_RJ68/\J MEF#_*I9@_RK_4@\ _UP* /]F"0#_;@H ]G0, .]X#@#A>Q( U'P@ ,I[,P3! M=T$+NG1-$[1P6!NN;&$AJ6II)Z9G<2NB97@OGV2 ,YQBB#:989 XEE^9.Y1> MHCV17JT_CUV[0(U=S4&,7N@_C6'Y.(UB_S..9/\PCF3_+(YE_RR.9?\LCF7_ M+(YE_RS_50X _U\& /]I!@#T<@8 XG@& -M\"0#9?PP S8$= ,1_, .[?#\* MM'A+$JUU51JH<5XAHVYF)I]L;BN;:G4OF&A],Y5GA#:298PYCV25/(QCGSZ) M8JI AV&W0H5AR4*$8N1!A63W.X9F_S6'9_\QAVC_+H=I_RV':?\MAVG_+8=I M_RW_5PP _V$$ /YL P#D=0$ VWL% -. " #0@PH QX4: +Z$+0.V@3P)KWU( M$JAY4AFB=EL@G7-C)IEP:RN5;G(OD6UY,XYK@3:+:8DZB&B2/(5GG#^"9J=! M@&:T0WYFQ41\9N%#?FCU/']J_S> :_\S@6S_+X%L_R^!;/\O@6S_+X%L_R__ M60L _V,! /1O #?> U'\$ ,Z#!@#*AP@ PH@8 +F'*P*QA3H(JH%&$:-^ M4!B=>ED?F'=A)9-U:"J/6JQ M1'=JPD1V:MU$>&SS/GEN_SAZ;_\T>W#_,'QP_S!\P SX(# ,F'!0#$B@8 O(P5 +2+* *LB3@'I85$$)Z"3AB8 M?U<>DWQ?)(YY9BJ*=VTNAG5T,H)T?#9_35Z=X(Y=G:+/'-UE4!P=*!";7.M1&MSO45J M<]5%;'3O0&YV_CIO=_\V<7C_,G%X_S%Q>/\Q<7C_,7%X_S'_7P( ]VP -YW M #0@0 QX@! ,"- P"YD0, LI,1 *N3(P&CD3,&G(Y #96+2A6/B%,9Y":'BK1&9XNT5D>-%% M9GGN0&A[_3IJ>_\V:WS_,FM\_S)K?/\R:WS_,FM\_S+_80 ZF\ -EZ #, MA PXL +N1 0"TE0$ K)<. *67(0&>EC$%EY,^#)"02!2*CE$;A(M9(7^) M8"=[AVAO\V7X?_,E^'_S)?A_\R7X?_,E^'_S+]: X'8 ,V" #"C N9, M +"9 "HG0 GZ ) )FA&@"3H"L#C)\X"(6=0Q!_FDP7>9A4'7277")PE6,G M:Y-J+&>2<3!DD7DS8(^"-UR.C3I9C9D]5XVF/U2-MD!3CFGL/0IRJD<0;*E/%F>H5QMCIUX?7Z9E)%ND M;2=8I'4K5*-_+E&BB3%.H98T2Z&D-DFAM#9(H<@W2*#G-4F@^3)*G_\P2Y__ M+DN?_RU+G_\M2Y__+4N?_RW=>0 R88 +R2 "QF@ IJ )RF "1K MAK( 'VV#0!YMAT =;8L F^U.09JM$,+9;-,$6"R5!942 $/E'@!!YBH /N8U 3OG/@$YYT<"-^=0 S3H600RZ&(%,.AM!B[I>0 MI@ D:\ (.Y !UP@ 9\L %K3 !-V@ 0M\ #CE U^P< ,?\/ "[_ M%@ K_Q\ *?\F "7_+0 C_S0 (/\[ 1[_0P$;_TL!&?]3 1;_70(4_VH"$O]X M A'_B (0_YH"$/^K P[_O@,._]4##O_M P[_\ ,.__ ##O_P P[_\ .3K@ MA+@ ';" !GS 6M4 $S< _X0 ->8 "WT J_P( )O\+ "/_$0 @ M_Q< '?\= !G_(P 6_RD %/\O !+_-0 0_ST #O]% 0S_3@$*_U@!!_]E 07_ M= $#_X4! O^6 0'_I@$ _[4! /_& 0#_R@$ _\H! /_* 0#_R@&&MP =\$ M &C, !:UP 2]X #[D RZ0 )^T "/_ ?_P &_\% !?_# 4_Q M$?\4 __& -_QT "_\B C_* %_RX O\U #_/0 _T< /]2 #_7@ M_VT /]^ 0#_C@$ _YL! /^I 0#_JP$ _ZL! /^K 0#_JP'_*BT!_RXK ?\P M*P'_,"X"_RXU O\I/0/_)4D$_R-7!/\A9 7_'W(&_QU_!O\=B@;_'90&_QV< M!_\4&_QWO!O\=^07_'?\% M_QW_!?\=_P7_'?\%_QW_!?\=_P7_'?\%_QW_!?\=_P7_+"L!_S H ?\S* '_ M,RL"_S$Q O\M.@/_*T<$_RA4!?\F807_)&\&_R)\!_\BAP?_(I$'_R&9!_\A MH0C_(:<(_R&N"/\AM0C_(;P(_R'&!_\AT0?_(>('_R+M!_\B]P?_(O\&_2+_ M!OPB_P;\(O\&_"+_!OLB_P;[(O\&^R+_!OLB_P;_+B@!_S,E ?\V)0'_-R6"?\GG0G_ M)Z0)_R>K"?\GL@G_)[D)_R?""?\GS0G_)]X)_R?K"?PG]@CY*/X(]RC_"/8H M_PCU*/\(]2C_"/4H_PCU*/\(]2C_"/4H_PC_,B4!_S ?\_'0'_0!\!_T(F ?]" M,0+_0#P#_SY(!?\[50;_.6((_S=N"O\V>0O_-80,_32-#?PTE0WZ-)P.^3.C M#O$U_PWA-?\-X37_#>$U_PW_.1X!_S\: ?]#& '_1AH!_TDC ?])+0+_ M2#@#_T5$!?]#4 ?_0%T)^SYI"_@]= WU/'\.\SN(#_$[D!#O.I@1[3J?$NPY MIA/J.:X3Z3FV%.#.%+:1#=2703V4A]%M5&AAC218X:T$66',Y$G1W,1*4> MRD.M'\A#MB#&0\,AQ4/3(<%#Z2&^1/X M1_\7N$?_%[A'_Q?_1!0 _TL0 /]1#@#_5Q$ _UL6 /]='@#Y72@![ULS N=9 M/P3@5TT(VE19#=-29!+.4&X6RDYW&<=,@!S%2X@>PDJ0(,!*ER&^29\CO$BG M)+I(L"6X2+PFMTC+)[1'XR>R2?,EL$K_(JY+_Q^N3/\=K4S_&ZU-_QJM3?\: MK4W_&JU-_QK_1Q$ _T\- /]6# #_7 X _V 2 /UB& #P8R$ YF(L =Y@.@/4 M7D@'S5M4#<=87Q/#5FD7OU1R&[Q2>AZY48(AME"*([1/D26R3IDGL$VB**Y- MJRJL3+8KJDS$+*A,VRRF3>\JI$_])J10_R.C4?\@HU+_'J)2_QVB4O\=HE+_ M':)2_QW_2@\ _U(* /]:"0#_8 L _V4. /5G$0#H:!@ W66Q.Y7&08M5IM'+%8=2"N5WTCK%6$):E4C"BG4Y0JI5*=+*-2IBVA M4;$OGU&^,)U1T3";4>HOFE/Z*II5_R:95O\CF5;_(9E7_Q^95_\?F5?_'YE7 M_Q__30T _U4& /]=!0#[9 < [VD) .EK# #A;! TVT> ,EL,0+":D 'NV=, M#;5D5Q.P86 9K%]I':A=<2&E7'@DHEJ )Z!9ARJ=6) LFU>8+IE6HC"65:PR ME%6Y,Y-5RC.15>4SD5?W+9%9_RF16O\ED5O_(Y%;_R&16_\AD5O_(9%;_R'_ M3PL _U<" /]A @#J: $ WFT$ -AP" #5< L RW(; ,)Q+@*Z;ST&M&Q)#:YI M5!.I9UT9I&1E':%B;2&=870EFE]\*)A>@RN578LMDEN4,)!;GC*-6J@TBUFU M-8I9QC:(6>$VB%ST,(A=_RN)7O\HB5__)8E?_R.)7_\CB5__(XE?_R/_40D M_UH /5D #@; UW$# -!T!@#-=0D Q'87 +QV*@&T=#H%KG%&#*=N41*B M:UH8GFEB'9IG:2&697$EDV1X*)!B@"N-88@NBV"1,8A?FC.&7J4U@UZR-X)> MPC> 7MPX@%_R,X%A_RV"8O\I@F/_)H)D_R6"9/\E@F3_)8)D_R7_4P8 _UT M .=G #;;P T'0" ,IX!0#&>0< OGH5 +9Z* &O>#<%J'9$"Z)S3A*<<%<8 MF&U?'91K9R&0:FXEC6AU*(IG?2N'984NA&2.,8%CES1_8J(V?&*O.'IBOCEY M8M4Y>6/O-'IE_B][9O\K?&?_*'QG_R9\9_\F?&?_)GQG_R;_50, _V .-J M #5<@ S'@! ,5[ P# ?04 N7X2 +%^)0&J?34$HWI!"IUW3!&7=%47DG)= M'(YP9""*;FLDAVQR*(1K>BN!:H(N?FF+,7MGE31X9Z V=F:L.'1FO#ES9M$Z M5,6C79;&XET M8B"%&V(,75LDC1S:YXW<&JJ.6YJN3IM:LXZ;6OK M-V]M_#%P;O\M<6[_*G%O_RAQ;_\H<6__*'%O_RC_60 ZV4 -MP #-> MQ'X +R" 0"VA $ KH4. *>&( "@A3 #FH(]"). 2 ^.?5$5B7M9&H1Y8!^ M=VP P(( M +B& "QB J8D- ***'0"'ML)G1Y'LM;G>$,&MVCC-H=9HV972F.&-TM3EA=,DZ873G.&-V^3)E M=O\N9G?_*V=W_REG=_\I9W?_*6=W_RG_7P XVP -!V #%?P O(4 +2* M "LC HXX* )V.&@"7CBL"D(PX!HJ*0PR$ATP2?X55&'J$7!UV@F,AY@U7WJD-UUZLSA<>L_\N M8'S_*V%\_REA?/\I87S_*6%\_RGU8@ WF\ ,QZ # @P MXD *^. "F MD0 G9(& )>3%P"1DR@!BY(V!86000M_CDH1>HQ2%G6*6AMQB&$?;8=H(VJ& M;R=FA'?$ "#GR ?I\O GB=.P=SG$4,;IM-$6F9519EF%P:89=C'EZ6:B%;E7(E M5Y1\*%23ABM1DI(N3I*@,$R2KS%+DL(Q2I'@,4R1]2U-D?\J3I#_*$Z0_R9. MD/\F3I#_)DZ0_R;>< R7T +R) "RD@ IY< )V; "3GP AJ0 'ZF M# !ZIAL =:8J 7"F-P1LI4$)9Z-*#6.B4A)?H5D66Z%A&5B@:!U4GW @49YZ M(TZ=A"9+G9$I2)R>*D::_R1'FO\D M1YK_)$>:_R34=P PH0 +:/ "KE@ H9P ):@ "+I0 ?ZH '2N!0!O MKQ0 ;*\D &BO,@)DKCT%7ZU&"5NL3PU8K%815*M>%%&J9A=.JFX:2ZEX'4BI M@R!%J(\B0ZB=)$&HK25 J, E/ZC?)3^F]"- I?\B0*7_(4"D_R! I/\@0*3_ M($"D_R#*?@ NXL *^5 "DFP F:$ (ZF ""K =[$ &JV !CN X M8;@= %ZX+ %:N#@"5[A"!5.X2PA0MU,+3;=;#DJV8Q!'MFL31+5U%D*U@1@_ MM8X:/;6<'#NUK!PZM< =.;7?'#FS]!PYLO\<.;'_&SFP_QLYL/\;.;#_&SFP M_QO!A@ M), *>: "@2/ R/E MH00BY;0$(>7-!"#D[ 0@XOL$'^'_!1_@_P4?X/\%'^#_!1_@_P6DG@ F*4 M (NN !]M@ <+X &/& !6RP 2] $#5 VW +^4' "WM$ K[A@ M*>XB "?O*P E[S0 (_ \ "'P10 ?\4X '?)8 1OR9 $9\W$!&/.! 1?TD@(5 M]*4"%/6Z A/UU@(3].\"$O+\ A+P_P(2\/\"$O#_ A+P_P*:I C:T '^V M !QOP 8\< %;. !)TP /=H #/? JXP )O0% "3[#0 A_!, 'OT; M !S](@ 9_BD %_XQ !7_.0 3_T$ $?]* !#_50 ._V$ #/]O 0S_@ $*_Y,! M"?^F 0C_N@$'_]0!!__K 0;_]@$&__8!!O_V 0;_]@&/K @+8 '*_ !C MR0 5M$ $C8 [W0 ,.( ";F ?\ '/\ !G_"0 6_PX %/\3 !'_ M&0 /_QX #?\D O_*P )_S( !O\[ /_1 _T\ /]< #_:P _WT /^0 M #_HP _[0 /_& #_U@ _]8 /_6 #_U@""M0 <[\ &3) !6TP M1]L #K@ NY0 (^D !KM 5_0 $O\ !#_ @ ._PD "_\- C_$ $ M_Q, ?\8 #_'@ _R0 /\K #_,P _ST /]) #_5@ _V8 /]X #_ MB@ _YL /^H #_L0 _[$ /^Q #_L0#_)2L!_R@I ?\I*0'_*"P!_R,R M ?\>.P+_&D<"_Q=5 _\58@/_$W #_Q)\ _\2AP/_$I$#_Q*9 _\2H /_$J<# M_Q*M _\1M /_$;L#_Q'$ _\1S@/_$=\#_Q'K O\2]@+_$OX"_Q+_ O\2_P+_ M$O\"_Q+_ O\2_P+_$O\"_Q+_ O\2_P+_*"D!_RLF ?\L)@'_*RD!_R@O ?\B M. +_($0"_QU2 _\;7P/_&&P#_Q=Y!/\7A 3_%XX$_Q>6!/\6G03_%J0$_Q:J M!/\6L03_%K@$_Q; _\6R@/_%ML#_Q;H _\7] /_%_T#_!?_ OL7_P/[%_\# M^A?_ _H7_P/Z%_\#^A?_ _H7_P/_*B8!_RXC ?\O(@'_+R4!_RPK ?\J-0+_ M)T$"_R1. _\B6P/_(&@$_QYT!/\=@ 3_'8H$_QV2!?\=F@7_':$%_QVG!?\= MK07_';0$_QV]!/\=QP3_'=0$_AWF!/L=\@3W'OL#]1[_!/0>_P3S'O\$\Q[_ M!/(>_P3R'O\$\A[_!/(>_P3_+B(!_S(? ?\T'@'_,R !_S(F ?\R,@'_+SX" M_RQ* _\J5P/_)V0$_R9P!?\E>P7_)(4%_R2.!O\DE@;_))T&_R2C!O\DJ@;] M)+$&_"2Y!OLDPP;Y),\&]B3C!O(D\ 7N)?H%[27_!NLE_P;J)?\&Z27_!NDE M_P;I)?\&Z27_!NDE_P;_,AX!_S8; /\X&0#_.!L!_SHC ?\Y+0'_.#H"_S5& M _\R4@3_,%\$_RYK!?\M=@;]+( '^BR)!_DKD0?W*YD(]2N?"/0KI@CS*ZT( M\2NU"/ KOPCN*\L(ZRO?". L_PG>+/\(WBS_"-TL_PC= M+/\(W2S_"-TL_PC_-1H _SH6 /\]% #_/Q< _T$? /]!*0'_0#0!_SU! O\Z M30/\.%H%^#9E!O0U<0?Q-'L([S.$">TSC0GK,I0*Z3*;"N@RH@OF,JH+Y#*R M#.,RNPSA,L@,WS+<#-HR[ W5,_@-TC/_#= S_PS.,_\,S33_"\PT_PO,-/\+ MS#3_"\PT_PO_.18 _SX2 /]!$ #_11, _T@; /]() #_1R\!_D0[ O="1P/Q M/U0%[#Y@!N@\:PCE.W8)XCM_"^ ZB S=.9 -VSF7#MDXG@_6.*80U#BN$=(X MMQ'0.,,2SCC3$LHXZ!+'.?<2Q#G_$<(Z_Q#!.O\/P#K_#K\Z_PZ_.O\.OSK_ M#K\Z_P[_/1, _T(/ /]�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

"J;@ JH$ *J5 "IJ@ J<$ *CD "H]@ I_\ *?_ M "G_P"5BP C) '^5 !QF@ 8YX %:B !*I@ /:@ #&J FJP M':T !2P .L@ ";4! *V"@ M@\ +85 "W'0 MR4 +20 WEH -]N #?A0 WYP -^R #>RP WN8 -_T #?] !YH0 M:Z@ %RO !.M0 0+L #&^ DP0 &<4 !#( )S ,\ #3 MV0 -P #= WP .$ #B!0 Y L .80 #H%@ ZB .TK #P M.@ \4L /%> #R

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

;EL M'6YG !QN=@ :;H< &6^: !AOK@ 6;\8 %F[I !=M_ 8;/\ &&O_ !AK_P"D M:0 FG$ )!V "&>0 ?'L '%[ !D>P 5WH $IY _> -7@ "MW M B=@< '78/ !QW%@ ;=QX &G%8 $WAC M !)X<@ 1>(, $'B7 ]XJP .>,, #G?F YV^@ /=?\ $'7_ !!T_P"?<0 ME7@ (M\ ""?P =X$ &J" !=@@ 4(( $2" X@@ +H( "2" < M@@ %(() !&#$ 0@Q8 $(,> Z#)P .@S #8,Y V#1 ,@U "X-= F# M; (@WX !H.1 6"I0 #@KL !('; 2!\@ %@/\ !G__ 9__P":>0 D'X M (:# !]A0 ;X< &*) !5B@ 28L #V, QC )HP !V- 5C@ M#X\# J0# &D!$ !(\8 ./( !CRD (\R "0/0 D$D (]6 "/90 MCW8 (^* ".GP CK0 (W/ ",[@ C/L (O_ "+_P"4@ BX4 (*) M !TC 9H\ %F1 !,DP 0)4 #26 HE@ 'I< !68 /F@ "IL M *<"0 G X )P3 "<&@ G"( )TK "=-0 G4 )U. "=7 G6X M )R! "Y, &V7 !?G M4: $2D VI@ *J@ !ZI 4JP #:X :P L@ +4 "U MM0, +8) "W#@ N!( +@9 "Z(0 NRL +PX "]1P O5@ +UK "] M@0 O9D +VP "]S O.H +SW "[_@!^E0 <)L &*@ !3I0 1JH M #BM JKP 'K$ !.T ,MP [D "\ OP ,( #" PP M ,0 #&!@ QPP ,@0 #*%@ S" ,\K #0.@ T4L -%> #2

#@ X1, .0= #H*@ Z#P .E/ #I9 ZGP M .N5 #KK Z\( .S5 #LY0!FI@ 6*P $FS [N0 *[P !W 1 MQ "<@ #, SP -, #9 W0 . #A XP .4 #G M Z@ .P #N! \0L /42 #X' ^RL /T^ #^4P _FH /^# M #_FP _ZX /^^ #_R@#_ !( _P 0 /\ $0#_ !, _P 9 /\ )@#_ #0 M_P!! /\ 30#_ %@ _P!B /\ :P#_ ', _P!Z /\ @0#_ (< _P"- /\ DP#_ M )D _P"@ /\ IP#^ *\ _ "Z /H R0#Y .$ ^ #S /< _P#V /\ ]0#_ /$ M_P#I /\ Y #_ .$ _P#_ \ _P - /\ #0#_ X _P 4 /\ (0#_ "X _P \ M /\ 2 #_ %, _P!= /\ 9@#^ &T _ !U /L >P#Y (( ^ "( /< C@#V )0 M] "; /, H@#Q *H [P"T .T P0#K -4 Z@#L .@ _ #G /\ Y0#_ .8 _P#@ M /\ V0#_ -0 _P#_ L _P ( /\ !@#_ D _P 0 /\ ' #_ "D _P V /\ M0@#[ $X ]P!7 /0 8 #R &@ [P!O .T =@#L 'P Z@"" .@ B #G (X Y0"5 M ., G #A *0 WP"N -T N0#: ,H UP#D -0 ]@#1 /\ T #_ - _P#/ /\ MRP#_ ,< _P#_ , _P /\ #_ 0 _P - /H %@#V ", \P P / / #M M $< Z0!1 .4 6@#B &( WP!I -T ;P#: '8 V !\ -0 @@#2 (@ T "/ ,T ME@#+ )X R0"H ,< LP#% ,$ P@#8 , [P"_ /X O@#_ +T _P"\ /\ O #_ M +P _P#_ @ _P /\ #_ ] ' .T $0#H !P XP I -\ -0#; $$ MU@!+ -$ 5 #- %P R@!C ,@ :0#& &\ PP!U ,$ >P"_ (( O@"( +P D "Z M )@ N "B +4 K "S +D L0#+ *\ YP"N /@ K #_ *L _P"L /\ K #_ *L M_P#_! _P /8 #N YP -\ # #6 !4 SP B ,H +@#' #H PP!$ M , 30"\ %4 N0!< +< 8P"U &D LP!O +$ =0"O 'L K0"" *L B@"I )( MIP"< *4 I@"C +, H0## )\ W@"> /( G0#_ )P _P"< /\ FP#_ )L _P#_ M!P ]@D .D+ #?"@ U00 ,X !0#& ! P : +L )P"W #( LP ] + M1@"M $\ J@!6 *@ 7 "F &, I !H *( ;P"A '4 GP!\ )T A "; (T F0"7 M )< H@"5 *X DP"] )$ TP"0 .T CP#\ (X _P"- ?\ C0'_ (T!_P#Y#@ MZA( -P5 #-%0 Q!$ +X, "Z @H M 2 *X '@"J "H I@ U *( /P"@ M $@ G0%0 )L"5@"9 EP EP-C )4#:0"3 V\ D01V ) $?P".!8@ C 62 (H& MG@"(!JH A@>Z (4(SP"$"NL @@O\ ($,_P" #/\ @ S_ ( ,_P#Q%0 X!T M ,T@ #!(0 N!T +$7 "L$ J D- *('%@"="2, F0HN )4+. "3#$$ MD Q) (X-4 ",#5< B@U= (@-8P"'#6H A0YQ (,.>@""#H0 @ Z/ 'X/FP!\ M#Z@ >Q"X 'H0S@!X$>P =A+_ '42_P!T$_\ =!/_ '03_P#H'@ TR8 ,,J M "X*@ KB@ *15L '<5= !V%GX =!:* '(7E@!Q%Z0 M;QBT &X8R0!M&>@ :QK\ &H;_P!J&_\ :AO_ &H;_P#@)@ RBT +PQ "P M,P IS$ )\L "7)@ D!\ (H7# "%&!8 @1DB 'X:+ ![&S8 >1L^ '<< M10!U'$P < !K'GH :AZ% &@?D@!G'Z 92"P M &0AQ0!C(>0 8B+Z &$B_P!A(O\ 82+_ &$B_P#7+ PS0 +8X "J.0 MH3@ )@U "0+P B"@ ( A" ![(!( =R$= '0B)P!Q(C$ ;R,Y &TC00!K M(T@ :2-. &@D50!F)%L 921C &,E:P!B)74 826! %\FC@!>)IT 72>M %LH MP0!;*. 6BGW %DI_P!9*?\ 62G_ %DH_P#/,@ OCD +$] "F/P G#\ M ),\ "*-@ @3 'DJ P!R)@\ ;B<9 &LH(P!I*"P 9BDU &4I/ !C*4, M82I* & J40!>*E< 72I? %PK: !:*W( 62Q] %@LBP!6+9H 52VJ %0NO0!3 M+MP 4B_U %(O_P!2+O\ 4B[_ %(N_P#*-@ NCT *U" "B1 F$0 (]! M "%/ >S< '(Q !K+ P 9RT5 &0M'P!A+B@ 7RXQ %TN.0!<+T 6B]& M %@O30!7+U0 5C!< %4P9 !3,6X 4C%Z %$QB !0,I< 3C*H $TSNP!---@ M3#3S $PT_P!,-/\ 3#/_ $PS_P#&.@ MD( *E& ">20 E4D (M' "! M0@ =ST &TW !D,@D 8#(2 %TR' !:,B4 6#,M %8S-0!5,SP 4S1# %(T M2@!1-%$ 4#19 $\U80!--6P 3#9W $LVA0!*-Y4 2#>F $ #-)L0 R2 #M*)@ Z2BX .4HU #A+/0 W2T0 -DM- #1,5@ S M3& ,DQL #%->@ P38L +DV< "U.KP L3L< +$[I "Q-_0 M3?\ +4S_ "U, M_P"P4 I%@ )E= "/80 AF( 'MA !P7P 8EL %A8 !.50 0U$! M #M/# X3Q, -D\; #5/(P T4"L ,U R #)0.@ Q4$( ,%%* "Y14P M4ET M+%)I "M2> I4H@ *%.: "=3K0 F4\4 )E/G "93_ G4O\ )U'_ "=1_P"L M50 H%P )9B "-9@ @V< 'AF !M90 8&$ %5> !*6P /U@ #56 M" Q51 ,%87 "Y6'P M5B< +%8O "M7-@ J5SX *5=' "A74 F6%H )5AG M "18=0 C688 (5F8 "!9JP ?6<( 'UGE !]8^@ @6/\ (%?_ "%7_P"H6@ MG6( )-G "*:P ?VP '5L !J:P 76@ %%E !&8P .V #%> P J M70T *%T3 "9=&P E7B, )%XJ "->,@ B7CH (5Y# "!?3 ?7U< 'E]C !Q@ M<0 ;8(( &6"5 !A@J0 78, %F#B !=?^0 87O\ &5[_ !E=_P"D8 F6@ M )!N "&< ?'( ')R !F<0 6&X $QL !!:P -FD "UG C9@@ M'V8/ !UF%0 <9AT &V8E !IF+0 99S4 &&<^ !=G2 69U, %6A? !-H;@ 2 M:'\ $6B2 !!HI@ /:+T #FC@ !!G]P 09O\ $67_ !%E_P"?9P EF\ (QS M ""=@ >'@ &UX !@=P 4W8 $9T [

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

$@&) !' M!BH 10

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

I7 'UH !57 .5@ !U0 !3 0 4@8 M %$+ !1#@ 4!$ $\6 !/'@ 3R< $\R !//P 3TT $Y= !.;P M3H4 $V= !,M0 2]@ $KU !*_P"%90 ?&D '1L !M;@ 8FT %1K M !':0 .F< "UE B9 &&( !!@ )7P %X !> 70, %P( M !;# 6@\ %H3 !9&0 62( %DM !9.@ 64@ %A8 !8:P 5X$ M %>9 !6L@ 5=( %3T !3_P"!; >7 '-S !H

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�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ⅅ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�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end GRAPHIC 16 aosl-20220630_g2.jpg GRAPHIC begin 644 aosl-20220630_g2.jpg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�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�!S'_ @=A_STG_[ZC_\ C5 !_P ('8?\])_^^H__ M (U0 ?\ "!V'_/2?_OJ/_P"-4 '_ @=A_STG_[ZC_\ C5 !_P ('8?\])_^ M^H__ (U0 Y? E@IR7G..Q9,'\HP?R- '8Q1K"BQH-JH JCT & /P% #Z "@ MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * " M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ MH R=9_U*_P"^/_06H S]&_US?[A_]"6@#IJ "@ H * "@ H * "@ H * "@ MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * M"@ H * "@"AJ?_'L_P#P'_T(4 4-#_Y:?\!_]FH WJ "@ H * "@ H * "@ MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * " M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * " M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * ,G6?]2O\ MOC_T%J ,_1O]S_ / ? M_0A0!0T/_EI_P'_V:@#>H * "@ H * "@ H * "@ H * "@ H * "@ H * " M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * " M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ MH * "@ H * "@ H * "@ H * "@ H R=9_U*_P"^/_06H S]&_US?[A_]"6@ M#IJ "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * M"@ H * "@ H * "@ H * "@ H * "@ H * "@"AJ?_'L_P#P'_T(4 4-#_Y: M?\!_]FH WJ "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * " M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * " M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ M H * "@ H * "@ H * ,G6?]2O\ OC_T%J ,_1O]S_ / ?_0A0!BZ=>I9[]X8[MN,8[9]2/6@#3_MF M'^Z_Y+_\50 ?VS#_ '7_ "7_ .*H /[9A_NO^2__ !5 !_;,/]U_R7_XJ@ _ MMF'^Z_Y+_P#%4 ']LP_W7_)?_BJ #^V8?[K_ )+_ /%4 ']LP_W7_)?_ (J@ M _MF'^Z_Y+_\50 ?VS#_ '7_ "7_ .*H /[9A_NO^2__ !5 !_;,/]U_R7_X MJ@ _MF'^Z_Y+_P#%4 ']LP_W7_)?_BJ #^V8?[K_ )+_ /%4 ']LP_W7_)?_ M (J@ _MF'^Z_Y+_\50 ?VS#_ '7_ "7_ .*H /[9A_NO^2__ !5 !_;,/]U_ MR7_XJ@ _MF'^Z_Y+_P#%4 ']LP_W7_)?_BJ #^V8?[K_ )+_ /%4 ']LP_W7 M_)?_ (J@ _MF'^Z_Y+_\50 ?VS#_ '7_ "7_ .*H /[9A_NO^2__ !5 !_;, M/]U_R7_XJ@ _MF'^Z_Y+_P#%4 ']LP_W7_)?_BJ #^V8?[K_ )+_ /%4 ']L MP_W7_)?_ (J@ _MF'^Z_Y+_\50 ?VS#_ '7_ "7_ .*H /[9A_NO^2__ !5 M!_;,/]U_R7_XJ@ _MF'^Z_Y+_P#%4 ']LP_W7_)?_BJ #^V8?[K_ )+_ /%4 M ']LP_W7_)?_ (J@ _MF'^Z_Y+_\50 ?VS#_ '7_ "7_ .*H /[9A_NO^2__ M !5 !_;,/]U_R7_XJ@ _MF'^Z_Y+_P#%4 ']LP_W7_)?_BJ #^V8?[K_ )+_ M /%4 ']LP_W7_)?_ (J@ _MF'^Z_Y+_\50 ?VS#_ '7_ "7_ .*H /[9A_NO M^2__ !5 !_;,/]U_R7_XJ@ _MF'^Z_Y+_P#%4 ']LP_W7_)?_BJ #^V8?[K_ M )+_ /%4 ']LP_W7_)?_ (J@ _MF'^Z_Y+_\50 ?VS#_ '7_ "7_ .*H /[9 MA_NO^2__ !5 !_;,/]U_R7_XJ@ _MF'^Z_Y+_P#%4 ']LP_W7_)?_BJ #^V8 M?[K_ )+_ /%4 ']LP_W7_)?_ (J@ _MF'^Z_Y+_\50 ?VS#_ '7_ "7_ .*H M /[9A_NO^2__ !5 !_;,/]U_R7_XJ@ _MF'^Z_Y+_P#%4 ']LP_W7_)?_BJ M#^V8?[K_ )+_ /%4 ']LP_W7_)?_ (J@ _MF'^Z_Y+_\50 ?VS#_ '7_ "7_ M .*H /[9A_NO^2__ !5 !_;,/]U_R7_XJ@ _MF'^Z_Y+_P#%4 ']LP_W7_)? M_BJ #^V8?[K_ )+_ /%4 ']LP_W7_)?_ (J@ _MF'^Z_Y+_\50 ?VS#_ '7_ M "7_ .*H /[9A_NO^2__ !5 !_;,/]U_R7_XJ@ _MF'^Z_Y+_P#%4 ']LP_W M7_)?_BJ #^V8?[K_ )+_ /%4 ']LP_W7_)?_ (J@ _MF'^Z_Y+_\50 ?VS#_ M '7_ "7_ .*H /[9A_NO^2__ !5 !_;,/]U_R7_XJ@ _MF'^Z_Y+_P#%4 '] MLP_W7_)?_BJ #^V8?[K_ )+_ /%4 ']LP_W7_)?_ (J@ _MF'^Z_Y+_\50 ? MVS#_ '7_ "7_ .*H /[9A_NO^2__ !5 !_;,/]U_R7_XJ@ _MF'^Z_Y+_P#% M4 ']LP_W7_)?_BJ #^V8?[K_ )+_ /%4 ']LP_W7_)?_ (J@ _MF'^Z_Y+_\ M50 ?VS#_ '7_ "7_ .*H /[9A_NO^2__ !5 !_;,/]U_R7_XJ@ _MF'^Z_Y+ M_P#%4 ']LP_W7_)?_BJ #^V8?[K_ )+_ /%4 ']LP_W7_)?_ (J@ _MF'^Z_ MY+_\50 ?VS#_ '7_ "7_ .*H /[9A_NO^2__ !5 !_;,/]U_R7_XJ@ _MF'^ MZ_Y+_P#%4 ']LP_W7_)?_BJ #^V8?[K_ )+_ /%4 ']LP_W7_)?_ (J@ _MF M'^Z_Y+_\50 ?VS#_ '7_ "7_ .*H /[9A_NO^2__ !5 !_;,/]U_R7_XJ@ _ MMF'^Z_Y+_P#%4 ']LP_W7_)?_BJ #^V8?[K_ )+_ /%4 ']LP_W7_)?_ (J@ M _MF'^Z_Y+_\50 ?VS#_ '7_ "7_ .*H /[9A_NO^2__ !5 !_;,/]U_R7_X MJ@ _MF'^Z_Y+_P#%4 ']LP_W7_)?_BJ #^V8?[K_ )+_ /%4 ']LP_W7_)?_ M (J@ _MF'^Z_Y+_\50 ?VS#_ '7_ "7_ .*H /[9A_NO^2__ !5 !_;,/]U_ MR7_XJ@ _MF'^Z_Y+_P#%4 ']LP_W7_)?_BJ #^V8?[K_ )+_ /%4 ']LP_W7 M_)?_ (J@ _MF'^Z_Y+_\50 ?VS#_ '7_ "7_ .*H /[9A_NO^2__ !5 !_;, M/]U_R7_XJ@ _MF'^Z_Y+_P#%4 ']LP_W7_)?_BJ #^V8?[K_ )+_ /%4 ']L MP_W7_)?_ (J@ _MF'^Z_Y+_\50 ?VS#_ '7_ "7_ .*H /[9A_NO^2__ !5 M!_;,/]U_R7_XJ@ _MF'^Z_Y+_P#%4 ']LP_W7_)?_BJ #^V8?[K_ )+_ /%4 M ']LP_W7_)?_ (J@ _MF'^Z_Y+_\50 ?VS#_ '7_ "7_ .*H /[9A_NO^2__ M !5 !_;,/]U_R7_XJ@ _MF'^Z_Y+_P#%4 ']LP_W7_)?_BJ #^V8?[K_ )+_ M /%4 ']LP_W7_)?_ (J@ _MF'^Z_Y+_\50 ?VS#_ '7_ "7_ .*H /[9A_NO M^2__ !5 !_;,/]U_R7_XJ@ _MF'^Z_Y+_P#%4 ']LP_W7_)?_BJ #^V8?[K_ M )+_ /%4 ']LP_W7_)?_ (J@ _MF'^Z_Y+_\50 ?VS#_ '7_ "7_ .*H /[9 MA_NO^2__ !5 !_;,/]U_R7_XJ@ _MF'^Z_Y+_P#%4 ']LP_W7_)?_BJ #^V8 M?[K_ )+_ /%4 ']LP_W7_)?_ (J@ _MF'^Z_Y+_\50 ?VS#_ '7_ "7_ .*H M /[9A_NO^2__ !5 !_;,/]U_R7_XJ@ _MF'^Z_Y+_P#%4 ']LP_W7_)?_BJ M#^V8?[K_ )+_ /%4 ']LP_W7_)?_ (J@ _MF'^Z_Y+_\50 ?VS#_ '7_ "7_ M .*H /[9A_NO^2__ !5 !_;,/]U_R7_XJ@ _MF'^Z_Y+_P#%4 ']LP_W7_)? M_BJ #^V8?[K_ )+_ /%4 ']LP_W7_)?_ (J@ _MF'^Z_Y+_\50 ?VS#_ '7_ M "7_ .*H /[9A_NO^2__ !5 !_;,/]U_R7_XJ@ _MF'^Z_Y+_P#%4 ']LP_W M7_)?_BJ #^V8?[K_ )+_ /%4 ']LP_W7_)?_ (J@ _MF'^Z_Y+_\50 ?VS#_ M '7_ "7_ .*H /[9A_NO^2__ !5 !_;,/]U_R7_XJ@ _MF'^Z_Y+_P#%4 '] MLP_W7_)?_BJ #^V8?[K_ )+_ /%4 ']LP_W7_)?_ (J@ _MF'^Z_Y+_\50 ? MVS#_ '7_ "7_ .*H /[9A_NO^2__ !5 !_;,/]U_R7_XJ@ _MF'^Z_Y+_P#% M4 ']LP_W7_)?_BJ #^V8?[K_ )+_ /%4 ']LP_W7_)?_ (J@ _MF'^Z_Y+_\ M50 ?VS#_ '7_ "7_ .*H /[9A_NO^2__ !5 !_;,/]U_R7_XJ@ _MF'^Z_Y+ M_P#%4 ']LP_W7_)?_BJ #^V8?[K_ )+_ /%4 ']LP_W7_)?_ (J@ _MF'^Z_ MY+_\50 ?VS#_ '7_ "7_ .*H /[9A_NO^2__ !5 !_;,/]U_R7_XJ@ _MF'^ MZ_Y+_P#%4 ']LP_W7_)?_BJ #^V8?[K_ )+_ /%4 ']LP_W7_)?_ (J@ _MF M'^Z_Y+_\50 ?VS#_ '7_ "7_ .*H /[9A_NO^2__ !5 !_;,/]U_R7_XJ@ _ MMF'^Z_Y+_P#%4 ']LP_W7_)?_BJ #^V8?[K_ )+_ /%4 ']LP_W7_)?_ (J@ M _MF'^Z_Y+_\50 ?VS#_ '7_ "7_ .*H /[9A_NO^2__ !5 !_;,/]U_R7_X MJ@ _MF'^Z_Y+_P#%4 ']LP_W7_)?_BJ #^V8?[K_ )+_ /%4 ']LP_W7_)?_ M (J@ _MF'^Z_Y+_\50 ?VS#_ '7_ "7_ .*H /[9A_NO^2__ !5 !_;,/]U_ MR7_XJ@ _MF'^Z_Y+_P#%4 ']LP_W7_)?_BJ #^V8?[K_ )+_ /%4 ']LP_W7 M_)?_ (J@ _MF'^Z_Y+_\50 ?VS#_ '7_ "7_ .*H /[9A_NO^2__ !5 !_;, M/]U_R7_XJ@ _MF'^Z_Y+_P#%4 ']LP_W7_)?_BJ #^V8?[K_ )+_ /%4 ']L MP_W7_)?_ (J@ _MF'^Z_Y+_\50 ?VS#_ '7_ "7_ .*H /[9A_NO^2__ !5 M!_;,/]U_R7_XJ@ _MF'^Z_Y+_P#%4 ']LP_W7_)?_BJ #^V8?[K_ )+_ /%4 M ']LP_W7_)?_ (J@ _MF'^Z_Y+_\50 ?VS#_ '7_ "7_ .*H /[9A_NO^2__ M !5 !_;,/]U_R7_XJ@ _MF'^Z_Y+_P#%4 ']LP_W7_)?_BJ #^V8?[K_ )+_ M /%4 ']LP_W7_)?_ (J@ _MF'^Z_Y+_\50 ?VS#_ '7_ "7_ .*H /[9A_NO M^2__ !5 !_;,/]U_R7_XJ@ _MF'^Z_Y+_P#%4 ']LP_W7_)?_BJ #^V8?[K_ M )+_ /%4 ']LP_W7_)?_ (J@ _MF'^Z_Y+_\50 ?VS#_ '7_ "7_ .*H /[9 MA_NO^2__ !5 !_;,/]U_R7_XJ@ _MF'^Z_Y+_P#%4 ']LP_W7_)?_BJ #^V8 M?[K_ )+_ /%4 :,$RW""1<@-GKUX)';/I0!+0 4 % !0 4 % !0 4 % &3K/ M^I7_ 'Q_Z"U &?HW^N;_ '#_ .A+0!TU !0 4 % !0 4 % !0 4 % !0 4 % M !0 4 % !0 4 % !0 4 % !0 4 % ')^-8=6GTMX]")6\+Q[=K(C;0P+A6=ON+=U MV[& ^5)&8G=C&!P<'@#- 'NU !0 4 % !0 4 % !0 4 % !0 4 % %#4_P#C MV?\ X#_Z$* ,73K)+O?O+#;MQC ZY]0?2@#3_L:'^\_YK_\ $T ']C0_WG_- M?_B: #^QH?[S_FO_ ,30 ?V-#_>?\U_^)H /[&A_O/\ FO\ \30 ?V-#_>?\ MU_\ B: #^QH?[S_FO_Q- !_8T/\ >?\ -?\ XF@ _L:'^\_YK_\ $T ']C0_ MWG_-?_B: #^QH?[S_FO_ ,30 ?V-#_>?\U_^)H /[&A_O/\ FO\ \30 ?V-# M_>?\U_\ B: #^QH?[S_FO_Q- !_8T/\ >?\ -?\ XF@ _L:'^\_YK_\ $T ' M]C0_WG_-?_B: #^QH?[S_FO_ ,30 ?V-#_>?\U_^)H /[&A_O/\ FO\ \30 M?V-#_>?\U_\ B: #^QH?[S_FO_Q- !_8T/\ >?\ -?\ XF@ _L:'^\_YK_\ M$T ']C0_WG_-?_B: #^QH?[S_FO_ ,30 ?V-#_>?\U_^)H /[&A_O/\ FO\ M\30 ?V-#_>?\U_\ B: #^QH?[S_FO_Q- !_8T/\ >?\ -?\ XF@ _L:'^\_Y MK_\ $T ']C0_WG_-?_B: #^QH?[S_FO_ ,30 ?V-#_>?\U_^)H /[&A_O/\ MFO\ \30 ?V-#_>?\U_\ B: #^QH?[S_FO_Q- !_8T/\ >?\ -?\ XF@ _L:' M^\_YK_\ $T ']C0_WG_-?_B: #^QH?[S_FO_ ,30 ?V-#_>?\U_^)H /[&A_ MO/\ FO\ \30 ?V-#_>?\U_\ B: #^QH?[S_FO_Q- !_8T/\ >?\ -?\ XF@ M_L:'^\_YK_\ $T 9>HV:694(6.[.?\ -?\ XF@ _L:'^\_YK_\ $T ']C0_WG_-?_B: #^QH?[S_FO_ M ,30 ?V-#_>?\U_^)H /[&A_O/\ FO\ \30 ?V-#_>?\U_\ B: #^QH?[S_F MO_Q- !_8T/\ >?\ -?\ XF@ _L:'^\_YK_\ $T ']C0_WG_-?_B: #^QH?[S M_FO_ ,30 ?V-#_>?\U_^)H /[&A_O/\ FO\ \30 ?V-#_>?\U_\ B: #^QH? M[S_FO_Q- !_8T/\ >?\ -?\ XF@ _L:'^\_YK_\ $T ']C0_WG_-?_B: #^Q MH?[S_FO_ ,30 ?V-#_>?\U_^)H /[&A_O/\ FO\ \30 ?V-#_>?\U_\ B: # M^QH?[S_FO_Q- !_8T/\ >?\ -?\ XF@ _L:'^\_YK_\ $T ']C0_WG_-?_B: M #^QH?[S_FO_ ,30 ?V-#_>?\U_^)H /[&A_O/\ FO\ \30 ?V-#_>?\U_\ MB: #^QH?[S_FO_Q- !_8T/\ >?\ -?\ XF@ _L:'^\_YK_\ $T ']C0_WG_- M?_B: #^QH?[S_FO_ ,30 ?V-#_>?\U_^)H /[&A_O/\ FO\ \30 ?V-#_>?\ MU_\ B: #^QH?[S_FO_Q- !_8T/\ >?\ -?\ XF@ _L:'^\_YK_\ $T ']C0_ MWG_-?_B: #^QH?[S_FO_ ,30 ?V-#_>?\U_^)H /[&A_O/\ FO\ \30 ?V-# M_>?\U_\ B: #^QH?[S_FO_Q- !_8T/\ >?\ -?\ XF@#"2%6G\DYV[]OOC./ MS_"@#=_L:'^\_P":_P#Q- !_8T/]Y_S7_P")H /[&A_O/^:__$T ']C0_P!Y M_P U_P#B: #^QH?[S_FO_P 30 ?V-#_>?\U_^)H /[&A_O/^:_\ Q- !_8T/ M]Y_S7_XF@ _L:'^\_P":_P#Q- !_8T/]Y_S7_P")H /[&A_O/^:__$T ']C0 M_P!Y_P U_P#B: #^QH?[S_FO_P 30 ?V-#_>?\U_^)H /[&A_O/^:_\ Q- ! M_8T/]Y_S7_XF@ _L:'^\_P":_P#Q- !_8T/]Y_S7_P")H /[&A_O/^:__$T M']C0_P!Y_P U_P#B: #^QH?[S_FO_P 30 ?V-#_>?\U_^)H /[&A_O/^:_\ MQ- !_8T/]Y_S7_XF@ _L:'^\_P":_P#Q- !_8T/]Y_S7_P")H /[&A_O/^:_ M_$T ']C0_P!Y_P U_P#B: #^QH?[S_FO_P 30 ?V-#_>?\U_^)H /[&A_O/^ M:_\ Q- !_8T/]Y_S7_XF@ _L:'^\_P":_P#Q- !_8T/]Y_S7_P")H /[&A_O M/^:__$T ']C0_P!Y_P U_P#B: #^QH?[S_FO_P 30 ?V-#_>?\U_^)H /[&A M_O/^:_\ Q- !_8T/]Y_S7_XF@ _L:'^\_P":_P#Q- !_8T/]Y_S7_P")H /[ M&A_O/^:__$T ']C0_P!Y_P U_P#B: #^QH?[S_FO_P 30 ?V-#_>?\U_^)H M/[&A_O/^:_\ Q- !_8T/]Y_S7_XF@ _L:'^\_P":_P#Q- $%QI44,;.I?*@D M9(Q_Z#0!GZ?:)=N5P% $ECIT=S%O?\U_\ B: #^QH?[S_FO_Q- !_8T/\ >?\ -?\ XF@ _L:' M^\_YK_\ $T ']C0_WG_-?_B: #^QH?[S_FO_ ,30 ?V-#_>?\U_^)H /[&A_ MO/\ FO\ \30 ?V-#_>?\U_\ B: #^QH?[S_FO_Q- !_8T/\ >?\ -?\ XF@ M_L:'^\_YK_\ $T ']C0_WG_-?_B: #^QH?[S_FO_ ,30 ?V-#_>?\U_^)H / M[&A_O/\ FO\ \30 ?V-#_>?\U_\ B: #^QH?[S_FO_Q- !_8T/\ >?\ -?\ MXF@ _L:'^\_YK_\ $T ']C0_WG_-?_B: #^QH?[S_FO_ ,30 ?V-#_>?\U_^ M)H /[&A_O/\ FO\ \30 ?V-#_>?\U_\ B: #^QH?[S_FO_Q- !_8T/\ >?\ M-?\ XF@ _L:'^\_YK_\ $T ']C0_WG_-?_B: #^QH?[S_FO_ ,30 ?V-#_>? M\U_^)H /[&A_O/\ FO\ \30 ?V-#_>?\U_\ B: #^QH?[S_FO_Q- !_8T/\ M>?\ -?\ XF@ _L:'^\_YK_\ $T ']C0_WG_-?_B: #^QH?[S_FO_ ,30 ?V- M#_>?\U_^)H /[&A_O/\ FO\ \30 ?V-#_>?\U_\ B: #^QH?[S_FO_Q- !_8 MT/\ >?\ -?\ XF@ _L:'^\_YK_\ $T ']C0_WG_-?_B: #^QH?[S_FO_ ,30 M ?V-#_>?\U_^)H /[&A_O/\ FO\ \30!A3PK%,8AG 8#GKV_STH W?[&A_O/ M^:__ !- !_8T/]Y_S7_XF@ _L:'^\_YK_P#$T ']C0_WG_-?_B: #^QH?[S_ M )K_ /$T ']C0_WG_-?_ (F@ _L:'^\_YK_\30 ?V-#_ 'G_ #7_ .)H /[& MA_O/^:__ !- !_8T/]Y_S7_XF@ _L:'^\_YK_P#$T ']C0_WG_-?_B: #^QH M?[S_ )K_ /$T ']C0_WG_-?_ (F@ _L:'^\_YK_\30 ?V-#_ 'G_ #7_ .)H M /[&A_O/^:__ !- !_8T/]Y_S7_XF@ _L:'^\_YK_P#$T ']C0_WG_-?_B: M#^QH?[S_ )K_ /$T ']C0_WG_-?_ (F@ _L:'^\_YK_\30 ?V-#_ 'G_ #7_ M .)H /[&A_O/^:__ !- !_8T/]Y_S7_XF@ _L:'^\_YK_P#$T ']C0_WG_-? M_B: #^QH?[S_ )K_ /$T ']C0_WG_-?_ (F@ _L:'^\_YK_\30 ?V-#_ 'G_ M #7_ .)H /[&A_O/^:__ !- !_8T/]Y_S7_XF@ _L:'^\_YK_P#$T ']C0_W MG_-?_B: #^QH?[S_ )K_ /$T ']C0_WG_-?_ (F@ _L:'^\_YK_\30 ?V-#_ M 'G_ #7_ .)H /[&A_O/^:__ !- !_8T/]Y_S7_XF@ _L:'^\_YK_P#$T '] MC0_WG_-?_B: #^QH?[S_ )K_ /$T ']C0_WG_-?_ (F@ _L:'^\_YK_\30 ? MV-#_ 'G_ #7_ .)H /[&A_O/^:__ !- $4^DQ1QLX+Y521DCL"?[M %31O\ M7-_N'_T): .FH * "@ H * "@ H * "@#)UG_4K_ +X_]!:@#/T;_7-_N'_T M): .FH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ M H * "@ H * "@ H * "@ H * "@ H * "@ H * *&I_\>S_ / ?_0A0!0T/ M_EI_P'_V:@#>H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * M "@ H P-;ZQ_1OZ4 :6F_P#'NGT/_H1H NT % !0 4 % !0 4 % !0 4 % ! M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 M% !0 4 % !0 4 % !0 4 % !0 4 V>N/<>E %FVA^SQK'G.W/.,=R>G- $] !0 4 M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % ! M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % &2NE;9O.W_Q; ML;??.,[OZ4 :U !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % ! M0 4 % $4\7G1M'G&X$9ZXS0!3LM/^QL6W;LC'3'?ZF@#1H * "@ H * "@ H M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * " M@ H * "@ H * "@ H * "@ H * "@ H * "@ H IWMG]L4+NV[3GIG^HH =9 MVWV2/R\[N2)(WFTR;STB8*YV2)@D9 Q(B'D=P,4 ;E !0 4 % !0 4 % !0 4 % !0 4 M % ',W/C+2+34%TB:X"WKLB"+9(?GDQL4NJ&-2VX8!8=1GK0!TU !0 4 % ! M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 M% !0 4 % !0!@:[XITSPR(SJ@4#))]@!DT <]H?B[2O$CO%IDXG>$ N-DJ8!. ?WB(",_P!W M- '24 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 M4 % !0 4 % !0 4 % !0 4 % ',?\)GHXU#^Q_M ^V[]GE!)3\^,[=X3R\^V M_@\=>* .GH * "@ H * "@ H * "@ H * "@ H R-:UZQ\.P"ZU*401,P0,5 M=B6() "HK,3@$\#@#F@"QI>IVVLVR7MD_FV\P)1P&7.&*GA@K##*000#D4 7 MZ "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ M H * "@ H * "@ H * (+JYBLH7N)V$<4*,[L>BJH)8GZ $T 8^A>*-,\3"0 MZ7,)Q 5$GR2)MW[MO$B(2#M;!&1P: -^@ H * "@ H * "@ H * "@ H * " M@#F-2\9Z/H]VNG7EP(KE]N(]DK??.%RR(RKG_:8<<]* .GH * "@ H * "@ MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * M"@ H * ,37/$FG>&HUFU.86Z2,53Y7:A(((%(4L0S-K#P?$&NB9)Y 3' A&]@/XB3PB9XW'J0[HY-Q((0@$,,''![ 'L] !0 4 >)_&S6_LFGPZ7&/ MO< _\LHL$ CT:0J1G^X?3@ ZWX9:)_8FA0!AB6Z'VF3@9_> % ?I&$!!Z'/3 MI0!W] 'EWC+XHV7A:5K&&,W=X@&Y0=D<9(R [X)+8(.U5/!P64T >=S?%[Q' M$OGM8P);_P!YH;D#!_Z:>:%_'% 'H7@CXGVWBJ46-Q']EO""44-NCEP"6V$@ M%6 &=C9X!(8X( !ZG0 4 <]XE\36?A2T-Y?,<$[8XUY>1\9VJ.!TY+$A5'4\ M@$ \0?XQZU?NQTNPB,2GH4GG8#_::-HP/^^: -30/C3YEP+;7+=;<,0IFBW@ M1GI\\3EF"^I#$K_=/8 ]Z1UD4.A#*P!!!R"#R""."".01UH =0 4 07=S'90 MR7,QVQPHTCGT5%+,?P - 'S'\-;5_%7B:;6+D96 R7+ \@22$K$O_ I !)(% 'AEY\:M0NI"ND MV*;%Z>:))6QZE8FC"Y],M]30 NE?&^Y28)JUK'Y><,UOO1TYY.R1GW8'\.]# MGOVH ^@;"_@U.WCN[5Q)#,H=&'<'Z\@CH0>0001D4 6Z G')XQ0!X=XE^,L M5E.;/181=NK;3*Y81E@2"L:+AG&<8?GE MW$)([[6D=QGWVG'H: /:O"?B^R\7VQN+3*21D"6%\;XR>G3AE;!VL.#@Y (( M !U5 !0!1U+4[71X&NKV5((4ZNYP,]@!U9CV506/8&@#R2S^,MOJ&J0Z=;6C MM#<3QP+.TH5OWCA _E>6W&2#CS <=<'B@#VF@ H HZI?#2[.>]*F06T,DQ4' M!81HS[0><$[< T >$?\ "^/^H;_Y-_\ W-0 ?\+X_P"H;_Y-_P#W-0 O_"^/ M^H;_ .3?_P!S4 >^6=P+R".X VB6-) #SC>H;'X9H L4 % !0 4 % !0 4 % M 'D/BWXMV>A3-9:?']MN4)5VW;8D;^[N )D8=&"X /&[(( !R?\ PLWQ:$^T M?V6OD==WV6[VXZ??\S;U[X]J /3O 7C-O&-M+)+!]FEMG$;@,65B03D9 9>A M!4YQ_>.< [R@ H * /ECQQ*WC/Q:FE0G]W%(EH".VTEKA\>J$N#ZB,4 ?4< M,26Z+%& J1J%51T"J, #V &* ":9+>-I92$2-2S,>@51DD^P R: /"=8^-): M;[/H5J;GG DE#?/_ +D*8?'H68''510!B?\ "Y=5*G;+$V-\;XS@XX(/56'##L""H .EH * /,_ M&OQ,L_";FTB0W5[@$QAMJ1@C(,CX)R>"$49(ZLF02 >;-\7_ !$J_:/L, M^ MNXPW.,?]=/-V_CB@#T?P3\3+7Q6_V.9/LE[@D)NW)( ,GRVP#N Y*,,XY#-@ MX /3J "@ H \U^*^M_V/H4D2'$MZ1;KS@[6!,IX[>6"I[?.,]<4 9/P9T3^S M]);4'&)+Z0E3@9\J(E%]^7\P]L@J<=R >P4 %R6!/!(XR >S4 % &9K&L6N@VKWU\_ MEPQ#D]22> J@54 M\4 4)/BWXATEU.K::D2$CY3%<6[$=PK2M(,^GRGZ&@#V3PGXML_%UJ;FTRC1 MD++$^-T;$9&<<%6YVL.#@]"" =10 4 % !0 4 % !0 4 5KV]@TV![JZ=8H M8E+.[' 4#^9/0 9)) )(% 'A.H_&>XN9S;Z#9>?C.UI0[L_N(8B"!]7)]0# M0!4D^*WB72R'U33%CCX)S#]*OQJEG!?*I1;F&.8*3 MDJ)$5PI(ZD;L$T 7Z "@#/U;48](LYKZ7[EO$\A[9V@D+]6.%'J2* /G3X0Z M=)K>M7&MW/SF#<^X\YGN"W///"^83W!*\CC(!]-T 8'B3Q+9^%;0WM\Q"D[4 M1!EY'()"J,@= 222% ')Z9 /$IOC'K%^['2-/0QJ?XUFG;'^UY1C )ZXYQTR M>M $ND?&V=)Q#K-JB)G:SP;U:/GDF.1G+8[@,#Z G@@'T#;7$=Y$EQ P>*55 M=&'1E894CV(.: )J &NZQJ7$:]\:!'.;70K<76# MM$LF_:Y_Z9Q)M#MDC; >-^NU@,]>JL,AAT.00 #HJ "@ H ^9_C)J;ZIJM MMHMO\Q@"Y4=YK@KM7\$V$?[YH ^A=%TQ-%L8+"+&VWB2/(XW$#YF^K-EC[DT M := 'B/B/XS6UC*UKI,)NW5BIE0OESQL1[,TK#\=O^% 'LO@WQS9^,8F, ,%Q$ 9(&()4$X#*P #H>F<* M0>"HR"0#M: "@#AO&7CVR\'(JR@SW4@W1P(0I(SC<[D$(O4 [68D<*0"0 >2 M?\+?\0SJ9[>Q@, _B\FX<#!Y_>+*J^W3K^5 '9>#?BU;Z_.MAJ,8M+F0[8W5 MB8I&/1?F^:-CT4$L&/&X$@$ ]BH * "@#RCQ3\6].\/R_9K-/[1F4XDV2!(T M]O,V/N;V52!T+ \4 =OX6UX>)M,AU01F 3A_W9;?M*2/&?FVKD$H2#M'!Z4 M=!0 4 1AU"@D !+[#PC )KQBTCY M$4*8,DA'H"0%4<;G/ SW) (!X^OQ:\0:L['1]-66-3T$5Q'D/Y^6I]G- %OX1Z)_96AI<.,2WS&<^NS[L0^F MT;Q_UT- 'J% 'F_C/XE67A)_L@1KJ\VAO+4[50,,J9'(."1R%56..3M!!(!Y MG)\7O$07[0MA"MOUW-#:J].^,=Z .X\%?%:#Q).MA?1BTNI.(RI+1 M2'KM&?F1_P"Z#N#>AQTR>M %S1OC7*LX@U MRU6%20&DA#J8SZM%(68CN<.& Z*QXH ]]@GCNHUFA8/'(H9&4Y#*PR"#Z$-_&#ZC*,PQ2-=$'G"1D); MKSZ'RACT4\#' !]4T 9FLZQ:Z#:27UZ_EPQ 9.,DDG"JH')9B0 /Q) !( /" M;_XUWEQ(4T:R4J.AFWR.1ZE(BFWCMO;ZT 0:?\;[V&;9JEI$4!PWD;XW7WVR M/(&(_NDKGU% 'O\ I.JVVMVL=]9/YD,PRIZ$=BK#LRG(8=B* -&@ H \7\6? M%^#2+AK'2HA>31MM>1B1$'!P54+\TA!X)!5<_=+4 C*1@.A/ 8 $'AE7(R = ME0 C,$!9B ,DG@ #J2>P% 'A>O?&J&"0V^C6YNB#@2RDJC=?N1J-[ ]BQ0_ M[/>@#FQ\:=:M9 +RSM@IYVA)XF(]F>1Q^.PT >U^$/&5GXPMS-:YCEBP)87Q MN0GH01PR'!VL,="" >* .NH * /./&OQ(L_"!^RJANKTJ&\H':J ]&D?!QGJ M$ +$:%_'% 'H7@GXH6OBF46-RGV M2\()1=VZ.7 R0C$ AL9.QL\#AFY /4Z "@ H * "@ H * "@ H \K\9?%.R M\,RM96J?;+M.' ;;'$?[KL 26'=%''1F5N* .)'Q.\6R+]HCTM3;]=PM;MAC M_KH) O?KB@#T;X?^-Y?&*7"7$ MI[,QA]K$JWF>9C"L R$>6002W4'/8 'HE M !0 4 ?+WQ1O)/$OB*#1;8[A 4MUQR/.F*ESV'R@HK>FPY/' !]+V%G'IUO% M:0C$<$:QH/\ 910HZ=\#GWH LLP0%F( R2> .YH \,UWXT1Q3&UT.W-VP) M EDW!&(S_JXU^=@>H)9#_L\YH YY_C'KU@X^WV,"*W13'<0L1WPSR./QVF@# MV?PAXRL_&%LT]L#%+$0)H6(+(3G:01PR-@[6 '0@@$8H ZZ@ H \]\:_$2S\ M'X@VFYO'7<(5;:%4YPTCX.T''"@%CUP 0: /+#\7_$3K]HCL8/L_7=Y-RPQ_ MUT$H7\<4 =]X*^*=MXFF%C>1BTO&_P!7AMT4I'.U20"KXZ(V=V.&)(6@#U>@ M H * .%^(^M?V'H5Q*IVRSC[/'_O2Y!(]UC#L/=: .(^".B?9[*?57'S7+^5 M&>XCB^\0?1I#@^\8H ]QH XCQAX\L?!RJEP'FN)5W1PIP2N<;F8\*N01GYB2 M#A3S0!X_-\9];E!FM;*W6$9Y9)Y,?5UDC7CO\HH ZCPK\9(=3G6SU:);5Y6V MI-&28MQP%5U;+(">-^YADC(49:@#V^@ H SM5U6VT2U>]O7$4,0RQZGT 4#D MLQX ')- '@UY\9]0O9S'HMBKH.GFK)+(0/XBD+(%X[;GQ_>- "Z=\:KRUG$. MM6:HN<.81)'(G/7RY6?=@?P[DSUSVH ]^T^_@U2WCN[1Q+#,H9&'0@_J"#D$ M'!!!! (H MT 8?B+Q%9^%[0WU^S+'N"*%&YW<@D(HR!DA6/) !)(H \-NOC M5J5W(1I5C'L7_GH)9FQZD1-&%SZ9./4T 2:/\<)Q,(]7M8Q&3AGM]ZLG/),< MC/NQW&]3]>E 'T%9W<-_"ES;.)(9E#HZ]&4C(/K]0<$'@@&@"Q0 4 8>O>([ M#PU ;G4)1&O\*CF20_W43JQ]^ .K$#F@#S_PK\5D\4:HNF):- L@D*RF8,<( MI?YHQ&H&0.SM@^O6@#UR@ H * "@ H * "@ H * (;FYBLXFGG98XHU+.['" MJHY))/0"@#PK5_C0SS_9M!M#<\X$DH M:CIBQ1=3NM[J#@=?GD=P/KM.* /B*.,L<'J0 M 22 ": /#[GXRZI?2,NC6"LB_\ /199GQZL(2@7/IEL>IH ;IWQMNX)Q%K% MHBH#AS 'CD3W\N5GW$#^$LF?44 ?0%A?0:G;QW=JPDAF4.C#N#['D'L0>0<@ M\T 6Z G')XQ0!X=XE^,L5E.;/181=NK;3*Y81E@2"L:+AG&<8?GEW$)([[6D=QGWVG'H: /:O"?B^R\7VQN+3*21D"6 M%\;XR>G3AE;!VL.#@Y (( !U5 !0 4 ?.GQNUDS3VVC0G.P>?(HYR[Y2($>H M7>0.N''KR >U^%=&'A_2[;3P &AC'F8QS(WS2'CKERV.3QCF@#H* /%O$WQC MM=,F:TTN$WDL;%&D8E(@P."% !>3!XS\@_NEAS0!QK?&?7;9@;BTME0] 8YT M)'LS2D=.^WWQVH ]A\%^/;/QDC+&I@NHANDA8[OESC>C # 5) (Y!(! MW5 !0!Q7C'QS9>#8E,X,UQ*"8H$."P!P69B"$3/&[!).0JG!P >0?\+@\0W( M,UK80F =_*N) ,>LBR*O_CHH Z[PA\7H-:G2QU.);2>4A8Y%8F)F/12&^:,D M\+DL"3@E>,@'LU !0!YWXR^(]CX1?[*4:YO"H;RE.U5!Z&1R#C/8*K-Z@ @T M >52_&?72/.CL[98/5HYV_\ (@E1?_': .X\&_%FW\03I87\0M+F4A8V4EHI M&/1>?F1CT4$L&/&X$@$ ]AH * .,\7^.;'P=&OVD-+/*"8X4ZL!P69C\J+GC M/)_NJV#@ \8 M0JSQ$F,$\#>C991_M!F [@#) ![K0 4 % !0 4 % !0 4 % !0 4 % !0 4 M% &3K/\ J5_WQ_Z"U &?HW^N;_ MZCEK=,SR)DX*!@L, YR%Z9YY5&YW'- 'U7#"ENBQ1*L:(,*J@*J@= , >@ M% #BBL0Q ++G!(&1GK@]L]\=: '4 % !0!\K>(6/COQDMDAW6\* /JA5" *H & !P !V% "T +SKNX8-NE MPZQ$*%_=+@!2< ECN8'.U@.* .I=%D4HX#*P(((R"#P00>""."#UH ^.KZT3 M0_%_D6'R+#J$7E*O.T-(AV H8D$_W4'% 'TUI6E6VBVR65D@BAB& !U/JS'^)F/+,>2: M/'OC3X=AELDUF)0L\#K'*P&"\3Y"[CW*/M"D]F(SP!0!T'PBU9M2T)8I#N>S MD:#GKL 5T_ !]@]EQVH ]1H * /*/C!K?]F:+]D0XEOW$0'?RUP\A^GW4/\ MOT /^$.B?V7H@NG&);]S*?7RQ\D0_$ N/9_P !ZI0!@^(_#=IXHMEL[[?Y22 MI+A&VDE PVDX)VD,0<8;T8'F@#0T[2[72(A;V426\2]%10H^I[L?5F))[F@# MQGXV:);&RBU95"W*S+"S 8+HR.0&]2A0;2>0"1TQ0!I?!.ZDFT:6)\E(+IPA M/3#)&Y4?1B6//\?0=P#V*@#SCXJ:V^BZ%)Y)VRW;+;J0<$!PS2$=_P#5JRY[ M%@>N* .3^"_AJ"*R;6ID#3S.T<+,,[(T^5BGHSON5CUP@ ."P(![+J6FV^KV MTEG=H)(9E*LI]^X]&'56'((!% 'RSX#FE\*>+/[.GWU1A M[$@=: /K2@ H ^<(_!WB'X@WS76O/)96<;L$1UVL%!^[#"<8R, S./FZ_O,8 MH XR33(-&\9P6-J"L,&H6:H"2QQOA)))ZDDDGMD\ # H ^PJ "@!&4,"K $$ M8(/((/8T 9O]B:?_ ,^UO_WYC_\ B: $;1M.0%FMK< #))BC '<_+0!\K+ MGC_Q5Y5LBQV;2X C4(JVT/5L 8#2 $_]=) .F* /KQ5" *H & !P !T '8" M@!: "@ H * "@ H * //OB9XA?P[HLCP-LN+EA;Q$'E=X)=QWRL:M@C[K%3Z M9 .(^#W@^!;8:]=H))I686VX9$:(2ID&?XV<, <955RI^8T >\4 -6-4)*@ MLVB7]O+:R9"3QO&Q7@[74J<$ M@@'!XR#SVH Q_#WA;3O#$/DZ?$$.,/*V#+)_OO@$^NT84=E% %/QSI5OJNBW M:7*@^5!+-&Q RDD:,ZL">G(PV",J2N<&@#Q+X&RN-1NXP3Y;6P9AVW+(H4GW M 9\?4T ?35 %'5+Y=+LY[V3[MM%)*1TR$4MCZG&![F@#YB^&6CCQ?KDVI:F/ M/6#,[AAE7FD8[ P/\(P[!>GR*I!7(H ^JBH(VD#&,8[8],>E 'R1\0M+_P"$ M,\1+/)1_+NX0O 1MQ#J ,87>A.T?.5+=/1?+!_NE6SCF@#Z2TZQCT MRUBLX1B.WC2-?HBA03[G&3ZGF@"Y0!R=]X*TO4]2&KWD?VB98UC5)"#"-A)# M>7CYFY(^ZL;>>7_62P1._P#O-&K-Z=R> MU &C0!\T?&G6)+S4(-'B)*0(LC*/XII20OUVIC;Z;VH ]U\+>'+?PQ81V5NH M#!09G'627'SL3U/.0H_A7 '2@#D?BQX=AU;1Y+T*/M-B/,1\?-Y8(\Q"?[NT ME\ZC8 M:5++HT;2WA**@1#(RAG 9P@!R54GJ"%^\> : /&[3X77#V5UK7B.5Y+K[/-, ML.\LP=8V96GDYR00/D0X' +$92@"M\#/^0A=_P#7NO\ Z,% 'TQ0 4 >7_&" MXE@\/2+$2!+-$CXX^3);\BRJ#ZY],T 9/P3M;9-)EN8PIN7N&25OX@JJA1/9 M>2P]2QZXX /3/$=I;WNFW,5XJM"8)"V[&%VH3N!/0KC<&Z@C(H ^>_@<9!JM MR!GROLI+>F\2Q[/QP9,?C0!]/4 % !0 4 % !0 4 % 'S?\ &77)KV]@T"V) M*H$>11QOFD.(U//.U2"/>3/88 /9_"/A2U\)V26L"J9BH,\V/FED[G)YV \( MO11VW%B0#J&4,"K $$8(/((/8T "J$ 50 , #@ #L* %H * /&/C5K?V+3( M]-0X>]DRX!_Y9188Y';=(8\>NUASS@ Z3X7:)_8NA0[QMEN\W+^O[P#RQZ\1 M!..Q)]Z /0Z .=\1>%K+Q0L,>H!VCMY?-"*VT.=I7:_&[80>=I5L@?-C((!M M6EG!I\2V]K&D,2#"I&H51] !_C0!X-\<=,MTCM=050MP[M$[ %T"[EW>NP MC /HV"<8P =S\)I9)?#EOYA)"-,J9_NB5L#W .1^&.U 'I% 'E'QAUM]+T86 ML)*R7TGE$C_GDHW2<^_RH?56- %3X/>&8;'3%U:1 ;J\+[7/)2%6*!5_N[RI M9B.6!4'I0!Z;K>C6^OV0?P/!(H ^9_A3?2Z'XC M;39#M6X$MO(O;S(MS*?J"C*/]\CO0!]6T % $-S<):1//*=L<2,[MZ*H+,?P M )H ^8?AY;OXN\4RZO./DA9[HYZ!V.V%._W<[A[1]?4 ^I* "@#DO#_@C2O# M1:2TBW3NQ8S2X>7DYPK8 11TP@7./F+'F@#9UG1[;7K22QO$#Q2@CD)K>./+!S-$X'&4\MR2>O"E0^/\ 9ZCK0!]AT (2 M%&3P!R2>U 'R7H<'_"Q/%C2W>7MV=YG7G_41<1Q]L*?W:-C!^9CU- 'UE%$D M"".-0B( %50 H Z 8 [ 4 ?,'QC\/QZ1J$.I6BB);P,7"?*!-&5)<8Q@N& M4\=65FZDT ?07A35#K6DVE\_+S0J7/JZ_+(?Q=6H Z"@#R'XCQ>(M6N8='T5 M9$M9XBT\JY1,[F!22;^%0H!**=S[L;6X% 'EOCGP!;^#-*MY-YGNYI]LDGW4 M $;'9&GIG^)LL< _*/EH ]N^%7_(LV?_ &\?^E4] 'H5 !0!\G^.I9/%'BX: M:6(C6:&S3GA 2HD8 \9WL[=,D #G H ^I;"Q@TR!+6U18H8E"HJC '\R>I) MY)R2230!XI\;- B>TAUB-0LT<@AE8#!>-P=A;U*,NU3UPY'0# !V7PLU9M6T M" R$M):EK=B3G(CP4_*-D'X?A0!Z)0 4 % !0 4 % !0 C,$!9B ,DG@ #J M2>P% 'RAIL#_ !/\4O)W18HHQM1$ 55'H ./\3S0!*T:N06 )4Y!(!P>F1Z'Z4 .H * "@#Y:\?SO MXP\5QZ3 H!]06\"6L201#;'$JHH]%4 ?@ * M ): .5D\%Z7/JCZU<1>?/*5)H)8U7CRW=8Y<*!T Z1)9R$L;*;:N3TCD&]1^#B3';& .E 'L- !0!YS\4];_L;0IE0XEO" M+9.><."9#ZX\L,,]BR^HR 8/P6T3[#I,X/!!P0 6=*T:RT2$6^GP MI;QC'"#DX[LQRSG_ &F)/O0!Y9\9M$MI]+&I[ MS;R(H<#!9'.THQ[@$AESG M;@@8W&@"C\#+F1[&\MVSY<4R,F>@,B$.!_WPI_'..3D ]SH XGXB:V^@Z'<7 M$1*S2 0Q$=0TIVEAZ%4W,#Z@4 >8_!;PS#+'+K=P@>19/*MRW.S:H,C@?WCN M"ANHPV.M 'OEW:0W\+VURBRPRJ5=&&0P/8_T/4'D; M_%/)AYFZ]7P-HQQM0(OJ,Y) )O%>B6VNZ;/;72!@(W9&Q\T;JI*NIZ@@@9QU M&5/!- 'S;\';F2#Q D29V3PRK(.V%7>"?HR@#Z]>2" ?6M %6^NTL+>6ZD^Y M!&\C?[J*6/Z"@#Y:^'NE_P#";>();_4P)DCW7,JG[K2,P$:$?W 22%Z;4"XQ MQ0!]7!0!M &,8QVQZ8]* /DSXF:0/"FO)>:>/(68+5?![PC#>J^O7RB9A(4MU?Y@&7!>8@Y M!;)VH3RI#-UVD 'T/0 T(JDL S8R0!DXZ9/?';/2@!U !0!2U._CTJUFO9C MB.WC>1NV0BDX'N<8 [D@#F@#YO\ A+82:]KMQK=T-WD;Y2QZ&>X+ =?13(?8 M[>G% 'T[0!'+$)D:-ONNI4X]",&@#G/#?@_3/"L?EV$0\S&&FDPTS_[SX&!_ MLH%7OMSDT 6O$^F6^KZ9<6UVH:,Q.P) ^1E4E9%/9D/(/X'@D4 ?.'P5ED37 M'C0G8]K)O'; >,@GTP<8/OCO0!]64 0W-PEI$\\G"1(SL?\ 94%C^@H ^4_! M&G_\)[XDDO-1'F1+ON94/W3\P6*+_=!91MZ%$*GK0!]8JH0!5 P . .@ M[ 4 ?*/Q6T1/#>LQWM@/(6Y43J$^4)-&WSE<=,G8_&,,QP ,4 ?3FBZ@-6L+ M>]&/](ACD..@+H"1^!)'X4 := !0!\U_&?57U'4;;1;?YS" S*.\TY 1?J$V MD?\ 72@#W[0=*30]/M]/CQBWB5"1W8#+MV^\Y9OQH UJ .5U;P9IFNW\6I7\ M9GDMX_+2-B/*(W%@63'S$%CP6V$'E3P: .GCB2%1'&H1%& J@ >@ X ^E ' MR7\7-$MM&U@-:*(DNH1,R*,*'+NK%1T ;:&(&!DGUH ^E_"=U)>Z/93S9\R2 MUA+$]6/EK\W_ /[WX]3UH Z"@#YN^-VMO+=6^CQD^7&GGR*,_-(Y94!]2B@ MD4CYB3W"DE4&I4IN.W^\%/44 <;\#M7:6"ZTQR2(62:,>@DRL M@'H-RH<=,LQZDT >]4 <_P"(_#5GXI@CM;_>8HIEGVHVW22: /#_ (W:';);0:O&BI<& M802,HP9%:-W4MZE/+(!ZX;!. #H_@Q?[A6.3CT&^1_Q MS0!ZS0!GZO//:V-Q-:*9+B*"5XD +%Y%1BBA1RQ9@!@4?_P"S-%^R(<2W[B(#OY:X>0_3[J'_ 'Z M'_"'1/[+T073C$M^YE/KY8^2(?B 7'L_X ]4H P?$7ART\46ZV=]O\ *259 M<(P4L4##:3@G:0Q!QAO1A0!I6&GVVEPK;6<200IT2-0H],G'4G'+')/4DF@# MQSXW:5;MI\.H[0MRDZP[P "T;I(Q4GJ=I0%>NT;L#YB: -CX,RN^@;7)*QW, MJIGLI",0/;>S'ZDT >KT >9VCA9AG9&GRL4]&=]RL>N$ !P6! /9=2TVWU>VD ML[M!)#,I5E/OW'HPZJPY! (H ^6? &Y(C;T^^J,/8 MD#K0!]:4 % ",P0%F(55!)). .I)/0#N: /E?PTA\=>,FOW!:"*5KGGM%"0 MMNISQU$0([C<<=: /JF@ H Y+0O ^E>'Y7N;:+?<2.SF:7#R+N);:AP BC/& MT!B/O,QYH W=5TJVUJV>RO4$L,HP0>H/9E/\++U5AR#0!\C_ _DDTSQ1;11 M$G]]) W;F: /LB@ H ^2K2/_A8GBX_:"6MFE=B,XQ;0 [$ M&.F\!5)'\3LW4YH ^L((([:-8856..,!550 J@= . !Z"@#YJ^-'AZ+3KN# M5+91&+O"=+OM3.L7<7VBX*(H60AHEV@ P /I0!\J?&'1+; M2-5CEM$$0NXO,=%&%\P.RLP X&X8) _BR>] 'T-X(NI+S0K&:;)DC+&1^(8@^U 'SMX"\=0^#+>Y40/&W12D4Y]0-@SWWMT[ M@'T30 4 ^65Q,Y15A56;(&23O>, #ZYR>!UP >7ZO\ '&V\ MIETNVE,Q7"O<;$5#Z[(WD+X]-RY/?CD R?AEX1?6+_\ X2+49HIF20S+&DJ2 M2-,Q)$DH1CY>UOG53ABV"0%&& /I"@ H ^3?"V=0\=!Y."U[>2>N"JSR #/; M*@#T'TH ^LJ .&^)<7F^'+U3VC1N?]F6-OZ<>] 'GOP)]T % 'RW\1KF3Q9XHBT>W.5@:.U4]@[D-,_P#P'(5O:+C- 'T[:VT= MG"EO"-L<*+&@]%0!5'X 4 3T % !0!\Y_&SQ$D\D.B0G<86\^?'9RI6)#[A M&9B/1UH ]0^&^@2>'=$B@G!2>8M/*IZJTF %/NL:H&]&!% '>4 >"_'60BVL M8QT:29C]55 /_0C0!Z%\-HQ%X-F_%I78_J: .XH ^2?%"FP\<%DQN6^ MM)1Z9802<_\ ?7/KS0!];4 % !0!\FZS_P CZO\ V$[3_P!#AH ^LJ "@ H M* /,_BMXB_L/1GAB;;<7Q,"8X(3&9F'T0[.N09%(H YOX*^'?L=G+K$HP]V? M+BSVA0_,1[/(,?\ ;,&@#W"@ H * "@ H * "@ H ^>OCM<\V%N,_P#+>0^G M_+)5_+YL\=Q0!1TOXIRZ?86NDZ)8O(])93JFG1PHW0/# M.@#O/AUHG]A:';PL,2S+]HE_WY<, ?=4V(?=: .WH * /-_$/Q2TKPU?2:;= M1W4DT(0L8DC*?.BN "\R$G:PS\N.V: /)_%WQ1E\5P_V3IL0M(;@A9))Y(T9 MUSG:68K'$A(^8ESN'RY )# 'J_PT\'1^%[$SM)'/,AHU5<[8XW'W@" M268<,W R%!(!Z30!Q'Q(D,7AR^9>IC5?P:1%/Z$T >>? F,"WOI.[20K^"K( M1_Z$: />J /G+X[0;9[";CYTG3W^1HC^7[SC\: /9/!$K3:#8,W46L*_@J!1 M^@&?>@#J: *FH7L>FVTMY-Q';QO(WT12Q_$XP/>@#YK^%=C)XD\0SZU=#=]G MWS$GD>=.6"#MT7S&'IM7 ] #Z?H * "@!KNL2EW(55!+,3@ #DDD\ 18T./NV\0 ,A]/E#28/=MHYP* /K^*)8$6*,;410JC MT & /P H ?0!\F^*,W_CKRY. U]9Q>H"CR$Z'VY(Z$DT ?65 &/XBB\[2[R, M]'M9UYZ _ S_ )"%W_U[K_Z,% 'TQ0 4 9>MZ1!KUE+I]T,Q3KM)'53U5A[JP##W M% 'RY+'K?PCU'C6*1V M$-P563S)E'F'@X:5@@6,$<*HW2<#DG90![GX(\&P>#K,PH?-N9L-/+C&Y@.% M4=1&F3MSR22QQG .TH * "@ H * "@ H * /D'7=7BM/&9;:-YI.$C5G;'/"@D\?04 >.R_'#1 MU4F*WO&<= R0JI^K"9B/^^30!YC?ZE??%;5(XB\%E;QG;%'),@V!B-Q"L5>: M5L#A% ^4#Y0": /J/1M*AT.RAT^V&(K= @SU)ZLQ_P!IV)9L<9)QQ0!I4 ?. MGQVF8RV$/\*I._U+&(<]N O'U- 'LG@J$6^A:>HZ&T@?TY>-7/ZL?KUH Z>@ M#Y*"_9O'N%QSJF?^_DN3^/S'\: /K6@ H \M^+NM_P!E:(UNAQ+?N(1ZB,?- M*?IM 0_]=* (/@[HG]FZ-]L<8DOW,GOY:92,'\=[CV<4 >LT % !0!RWC/Q% M'X8TN:]8@2[3' O=IG!" >NWEV_V5- 'A/P7T"2[U%]7<$0VBLB,?XII%VD M]]L;,6]-R^M 'T_0!DZ_(8=-NY%ZI;3L/J(F(H ^>?@;&#J=U)W6UV_@TJ$_ M^@B@#ZD;SJ/IYSM M_-C^&* /2J "@#Q#XY?\@ZT_Z^3_ .BVH ZWX5?\BS9_]O'_ *53T >A4 % M'R5XX63PQXO-^5++Y\-XG&-ZY5G _P"!JZ9![=N@ /J'2M:LM:@6ZL94FC90 MWRD97V=>J,.A# $&@#S'XL>(M+?1IM.$\5*RHS%]A(0; P&_& M21@$\@ J? UV.F729^4760/A'./YT =/X,^+,.OW"Z M?J$0M+F4[8F0DQ2,>B<_,C$\*"6#'C<#@$ ]BH * ,K7-431+"?4),;;>)GP M?XF ^5?^!-A1[F@#Y^^#6EOJ>IW.MW'S&$$!CU,TY)=OJ$W@_P#704 ?2U ! M0!SGBCQ1:^$;07UZLKQM(L06)59BS*S#AG1<81B26_.@#RW4OCE9)&?[.M9W ME(X,^R- >Q(C>0L!UP"I/3(ZT -X/M&@WZ<<6LS\_\ 3-"_Y_+Q[T >.? F5EFOXOX62!C]5:4#]&.?PH ^ MC* "@#YC^+>H2:YKEOHEK\Q@V1A0>#/<%3V]%,8[XRWO0!]&Z5IT>D6D-C#_ M *NWC2->,9V@#)]V/)]R: +] !0 4 >!_&SQ$B0PZ)$09'83S8_A501&I]"Y M)?!Y 53T84 =A\*/#[Z'HJR3KLFO7\]@>JH0!$I';Y1OQU&\@\C /3* /%? MCA,R:3;1#[KW08_\!BDP/I\V?J!0!T7PEA$7ANV8?\M7G<_43R)^/"#^7:@# MTB@#Y*^)Z_9_%;R+C)^RO^(1%&?^^?RH ^M: "@ H X7XB>(D\.Z-,^1Y]RK M00KW+.I#-CTC4EB>F0H/WA0!Y5\$O#[O/-K4JXCC0P0D_P 3L09&'^XH"YZ9 M_CO",:?*,9_TE3ZD?N2/P'S?G0!ZG\/G,GAZQ)[0 ?@ MI*C] * .QH * "@ H * "@ H \*^.EP5LK.#)VO/(Y';,:!0?P\PX^IH YG0 M/B>VBZ5;:1I-FUS<0HV]FR5W,[NVV.,%W&7ZEDYSP>M %VX^*_B;2B'U'38X M(STWP74!/T:20C_QV@#USP=XVL_&,#26X,,\6/-@8@LN>C*P #H<$!L @C#* M.,@'94 % 'CGQGUO[!I2:?&<27TGS8/_ "RBPS?FYC'N,T ;?PJT/^QM"BD< M8EO2;A^.=KX$0^GEA6[8+'ZD ](H * ///$OQ,TSPK>&PNX[F24(KDPI&5 ; M.!EY8SG R< CD4^+/BV^OV[:;I,36R7&4>:9T5RC<%0,[(]PX9C(>" M0,=: /0?A;X,3P[;-?RR13W-VH7="ZR1QQ@YV*ZDJY9L%R,C*J%Z$L >L4 < MQXUF:WT*_=.OV69?IN0J2,=P#D>] 'C?P(A#2ZA-W1+=!]',Q//_ ?7\* M/HN@#P/X[19@L)/[LDZ^_P RQG_V7^5 'H?PUT;C\%ED _04 =S0! M'-,EO&TTIVI&I9F/0*HR3^ &: /EWP)"_C+Q9)JTX_=PN]V0>Q!VVZ?5"5(] MHS0!]34 % !0 $XY/&* /D+QA?2>/O$OV?3_ -XA9;6 CD%$+%I.WR;C))G^ MYC/2@#ZSL;1-/MXK2+[D$:1+_NHH4?H* +5 'R;\0/\ 2?&;0M]T362>O#1P M$\'W8\=* /K*@#.UB+SK&XC/\<$J\].8V'- 'S;\#W(UFX3L;)S^(F@ _P#0 MC0!]1T % !0!\U?&GQ"E[.VYL=H * /EOXC7,GBSQ1%H]N@ H \;F^-VC)N$<%X[#(&4A53@^OG%@#_N MY]10!Y?K?B"]^*-_%9H8+&VB/[M)ID4 MP78MM:5\# 2-3M' '+,0#Z9\.Z% M#X;L(M.M_F6%>6( +NQ+.YQW9B<#)P,+D@"@#;H \%^.LA%M8QCHTDS'ZJJ M?^A&@#T+X;1B+PY8J.\;-^+2NQ_4T =Q0!\D^*%-AXX+)C: /K:@ H \^^)^M_V)H4Q0XENL6T?.#^\!WG\(P_XXYH Y?X*:']CTV7 M4Y!A[R3:AQ_RRBRN0?\ :D+@_P"X#D]@#VF@ H * .<\6>((_#.FS7\A&Y%* MQ*?XY6!"*/QY;T4,>U 'S[\'-"DU+5FU:4$Q608[C_%/*I4#W(1G8#Z9#?S M)H ]3H * (YIDMT:64A$C4LS'@*JC))/8 DT ?($PD^(_BD^2#Y5Q,.?[EM M$ I<],'RUSC(R[!0:D_C?Q&+7 M3OWJH5M(,=&(8EWSTV[V8[NGEJ&/% 'U9I=@FE6D-E%REM$D2G&,A%"Y(]3C M)Y/)ZF@"]0 4 % !0 4 % !0 4 % !0 4 % !0 4 9.L_P"I7_?'_H+4 9^C M?ZYO]P_^A+0!TU !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 <- M\2D+^'+X#M&A_!98V/Z"@#S7X&VMM*EY.T:-<1/$%D*@LBNK\*QY7)4YQC.! MG- 'T'0!\A_$2U3PUXG,]D!$ T-TBIP%?(9L 8QEU+8' SQQ0!]>4 % '@'Q MPUO;';:/&>7)N)1[#*1#UP29"1ZJIY[ 'JG@?1/^$>T:VLV&V4)YDO&#YLGS MN#[J3L^BB@#JZ "@"E?:;::F@CO88KE%.X+-&DBAL8R X(!P2,CG!H YZ^\ MZ!J"&.2QMX\@C=#&L+#W#1!#D=LY'J,4 ?-GB33;KX9:ZK:=*P7:LT#-C+1L M2&CE P&&Y65N &&& 4D8 /K'2=075;*"^CX6YBCE SG&]0VW/JI.#[@T :% M'R5X:)TWQR$;&5OKJ+G.#O\ .CR._.[*_AVH ^M: .$^)DP@\.7I) W(B#/< MO+&N![\_U/ - '!_ J$K:7LW9YHD'IE$8G_T,?I0![O0!FZSJ2:-93W\N-MO M$\F#W*@[5^K-A1[D4 ?/'P>TQ]7U>YUNY^8P!CN/>>X+9/.>B>9GN"ZG/J ? M3- !0 4 >?>/O'4/A"VV1%9+^8?N8CSM'3S9!V1>PXWL,#@,0 >7?#7P1/KE MU_PD>LAGCWF6(24G/FMG_ )9JW(XP[8Q\JX(!])4 % '@OQUC)MK&3LLL MRGZLJ$?^@F@#T#X9S";PY9,,<(Z\>J2R+^?'^10!W5 'R9X@SJGCO8/XK^UC M)7L(_)C8\]P$)/J0<4 ?6= !0 4 ?)NL_P#(^K_V$[3_ -#AH ^LJ "@ H * M /DSQU?R^-_$RZ=9G='%(+2''W;;1-(54 O)L D9B.6)?<S'CT /JN@ H ^5-1_XK[QH(!\]LDPBR.GV>VR9""0#ZK MQP.,4 % !0!D7GA_3-0D,]W:6MQ*0 7E@BD<@< %F4G ' YXH XSQ#\+=&UB M%Q;0I8W."4DA&Q0W8-&/D*9Z@*& ^Z10!XY\,/$5UX?UE='F8FWN9&A>,G(2 M8$A73T)8;&QPP.2"57 !]6T <1\2(S+X^T ?./QVN-UQ8PQ:-6(_ G'X4 =)0!Y#\9=;_L[2%L$.)+^0*1W\J/#N?7EO M+7W#,/J :7PGT/\ L?0XYG&);YC<-D8.P@+$/H4 )",[C\@XW;@#O?AQX&7PG:FXN0#?W* MCS3P1$G!$2D9!Y +L.&8 #A02 >E4 % 'R5XL)TWQN96Q\E[:3 G.,8@D^N! MT..X.* /K6@#%\23"VTJ\E) "6L[<].(FQ^O8'=19G5MZP%S\\4D8),1)/W" M%8*#DJP"KPV ?1= !0 4 % !0 4 % !0!\C3VT4OCEH+I%DBDU(AD8 JP>3 MY0P/!!W#(/!ZYT$QN21;W4L2Y[*5CEP/;=*U 'K- M&%XGUA?#^EW.H' ,$3%,]#(WRQCGL9"H/MG@T >'_!+1FN+FYUJ8$^6/(C8] MY'P\K9_O*NT'VD/X@'T;0 4 (0&&#R#P0: .=?P?H;@J=/LN?2VA!_ A 1]0 M,_$OX;66E63:OI*F 0LOG0[B4V,P4.FXEE8,1E>2 >P4 ?.GQVA(EL)OX62=/H5 M,1Y^N[CZ&@#V'P-/]IT&P?CBUB3C_IFHC_/Y>??I0!U5 'R9;_Z?X]RG.-2< M\>D+L2>?9#D]^H[4 ?6= !0!\N_$RZD\4^)8=&MCD0%+=<<@2RE6E8_[H*JW M3'EG/2@#Z9L[2.P@CM81MC@18T'HJ*%'3'84 6: "@"GJ.HV^DV[W=VZQ0Q+ MN9FZ >@[DD\*HR6) )- 'RWJ-YJ/Q:UE;>U4Q6<).P'E88B?FFDZ R/@?*# MDX"+P"U 'TUH>BV_A^SCT^T&V*$8R?O,QY9V/=F.2?R& * -:@#)U^,S:;= MQKU>VG4?4Q,!0!\[_ Z8+JMS%QE[7H \2^.5QLTRU@ MX^>ZW^_[N)UX[8_><_ACO0!U'PHMS;^&[4GK(9GQZ S.!^84'\: /1: "@#Q M#XY?\@ZT_P"OD_\ HMJ .M^%7_(LV?\ V\?^E4] 'H5 !0!S'B?PCI_BR$0W MZ'='GRY4.V2,GKM.""#W5@RG@XR 0 >32? A"V4U!E3T-L&/_?0G4?\ CM & M3XP^'.F>#M#ENB\ES>2/%%$[D(J$N&8K&O4F-''SLW!R,$ T =O\%;3R-$DF M(YGNI&!]55(T'Y,K\^^.U 'K] !0 4 % !0 4 % '+>-XFFT&_5>HM9F_!4+ M'] <>] 'BGP.MK6>YO'FC1YXE@:%V4$QC,HD*D\J2=G(YP.H[@'TI0!\G?%S M3(]&UU;BT B^T1)<';QB4.ZE@.@)V*Q/=B3[D ^I["X-W;17!&#+&CD#H"RA ML=_6@"U0!XA\;=;^S6,&E(?FNG\R0=_+BQM!]FD((_ZYF@#L_AMHG]AZ%;QL M-LMP/M$GKNEP5!]"L812#W!^@ .\H * *E[86VHQ^3>117$60VR5%D7(Z':X M(R,\'&10!S]WX%T&]3RY+"V4<\Q1+"W/^U$$;Z<\4 ?-OC+0)OASJ\4VES.B M./-@?/SK@X>-^ ' XZC#(P# G.0#ZC\.:N->TVWU$ *;B(,RCHK]' ]@X(&> M<=>: -J@#Y+D/V/QYE^,ZF.O'$L@Q^CC!Z=^E 'UI0!RGCFX^RZ#?OP,VLJ< M_P#313'V[_-Q[XSQ0!Y%\";<[[^X/ @0>A),K'\L+^= 'T10!6O;N/3X)+J M8[8H$:1SZ*BECUQV'K0!\S_#&SD\4>))M:N1D0%[AN/E\V8L(U]!M!=E]/+& M!Z 'U#0 4 % '%>-O&EMX/M#(V)+N4$00YY8]-[8Y$:]6/&[[JG)R #Q?P#X M.N?&5\VOZUN>W\PR?,/^/B0'H!VA3 !P-IP(UX#;0#Z=H * /%OCA"6TFWE' M1+L*?^!128/T^7'U(H WOA'/YWAR!./W,DZ<>\K2<^_S]NV.] 'I= 'R9\2/ M].\7&!.3OM8ACU9(SCTSE\?H>0: /K.@ H S=7U>UT*U>]O7$4,0R2>I/95' M5F8\*HY)]LF@#Y@*ZC\7=:W8,-G#QGJEO#G\ TTF,^K-Z1I\H!]1Z7IL&CVL M=C:+LA@4*@_4DGNS$EF/=B3WH O4 O\ H[@=R/WP;VX^7\Z /H6@#YZ^.\XSI\ (W#[0Y'.0#Y*J M?3!PWOQV[@'K'@.W:VT"P1N";9'_ D&\=/9A[^O- '6T % !0 4 % !0 4 M>"?'9";>Q?L))Q^)6,C_ -!- '=?#"UMH?#]K-!&B/,C&1U4!G99'4EF'+8Q M@9/ XXZ4 =Q>V<.H0/:W*"2&52CJPR"#_G(/4'!'(H ^5OABSZ5XK%DA.UC= M6[>XC1W&?^!1*: /K*@ H ^6/&4C>-O%Z:9"28HI$M01SA4)>X?C/W3YG/H@ MSCL ?4D4:PHL<8"H@"J!T P /8#B@!] !0!E7N@Z;J4GG7EI;7,@ 4/+!'( MVT9P-SJ3@9.!G')H Y/6_ACH6L1,J6Z6TXXS&N(V7/4%02.C*>: M /"? NM7G@W7_P"RIG_<27/V6XCS\F_?Y:RKG@%6P=W=,@]B #ZWH YCQK"; MC0K]%Z_9)F^NU"V/J<8'O0!XQ\"9]L]_!Q\\<#^_R-(OTQ^\Y_#WH ^CJ / M?CM,!#80Y&6>=\=\*(AGZ?-^/;H: /2?AU";?P[8J>"82_X.[./T88]J .UH M \Q^+6M_V3H;PH<2WS"!1WV'YI3]-@V'_?% %#X-Z)_9VD-?.,27\A8?]#!'CJ[?=D(Z M [!\Q;: =#\,? 7_ C4/]H7R_Z?<+C:LT % ' MR7\0R;3QB\[<#S;.09SC"Q0C\LJ>E 'UI0!FZU,+>PN93@".WF;GI\L;'GVX MH ^;(/0?P*?OG_9#4 >=?##P-+J5P/$6L!F!8R0+)UED)SY[YY*@\ID?.V' M^Z!N /HR@ H * "@#Y-^''_(WK_OW?\ Z!+0!]94 % !0 4 % !0 4 % !0! M\C^+((T\;-'=J'A:]M3(IY#1N(693TZHV"/J,T ?6D,$=L@BA58XT&%1 %51 MZ!0 /8"@#S+XN:1#?:%+=LH\ZS:-XWQR TBHZYZX*MG'0LJ_6@#%^!]X\NF M7%LW*P7&Y?82(,CZ90GZL?P /:Z ,W6=231K*>_EQMMXGDP>Y4':OU9L*/@?#.83>'+)ACA'7CU261?SX_P B M@#NJ /DSQ!G5/'>P?Q7]K&2O81^3&QY[@(2?4@XH ^LZ "@#YF^,&I2:SK%M MHEK\Y@"KM'>>X*X7C.<)Y>.X+-QZ@'T/H^FQZ-906$7W+:)(P>F2H +?5CEC M[DT :5 !0!6O;V#38'NKIUBAB4L[L']"MO#=E'I]H/DC'+'[SN?O M.WNQ_(8 X H VJ *.J1-/9SQ)RSPR* !DY9& X')Y/2@#YG^",XCUJ:,\>9: M/CW*RPG'_?.X_A0!]34 >-_&Z<1Z-#%D;I+M#CG[JQ2DD=N"5'/K^0!K?"&W M:#P[$S<"669Q]-Y3^:'K_+% 'IU !0!\X_$KQR^N2_\ ".Z'F9'<),\629I, M\0QXZH#C@6@ M#T2@ H * /#?BC\0!9JVA:4VZYEREQ(G)B!X\I".LKY(?'W!P/G/R &E\+_ M!\/1?VGJ"XOIEPD9ZP1GL?\ IHX^]W4?)UW4 >P4 % !0 4 % !0 4 % !0 M4 % !0 4 % !0!DZS_J5_P!\?^@M0!GZ-_KF_P!P_P#H2T =-0 4 % !0 4 M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 M 4 % !0 4 % !0 4 % !0 4 % !0 4 % &;K.G#5K&XL6P!*<&&4MP(IHF.PO[ ET)[;]Q(4&@#Z9N?$.F MV<)NIKJ!80,[_,0@C_9P26)[!023P 30!\NRN_Q(\5A[=6$$DB=1@I;0X#,W M) 9E!.,_?<*#TH ^NJ "@#Y4MO\ BOO&GF'Y[5)B_M]GMN%Z,S2W,"1@9W&5 N.O7=0!\I_$+74\:ZVB:6K3(BI;0X4@RL78E@#S@L^% MR!\H#$#- 'U7H>G?V1I]M8\$VT$<1([LB!6;_@1!/XT :E 'RC\2+&?PMXE7 M58 0DTD=W$W8R(5,BG_@8W$?W7&,[74(H]%TZ19_P!X))WC.Y05R$C5@2&.26?&=I51 MG)8 ]0^'.@/X=T2&"8;9YB9Y5[JTF,*?=8U16_V@: .ZH \5^->N?8].BTR M,X>\DW.!_P \HL'!_P!Z0H1S_ 1SV .J^&.A_P!B:% '&V6Z_P!)D]?W@&P? MA$$!'8YX!S0!Z!0 4 #[ W3+YD\A\N"/H&?&NR-#I]S'<2(N]E7.0N0,X('&2!QZCU MH WZ /.?BGH;ZUH4GDKNEM&6X4 XD*&##+]-\/6KW5Q-&Q4'9$C MJ9)&[*J@D\GJV-JCDG% '@?PMTN?Q)K\FN7(RD#R3NV#M,\N[:H_W=S/UXVK MGJ* /J.@ H Y:7QOH4#M')?6RNC%6'F#@@X(_ B@#YHU75+67QFNH)*C6HO[ M63S@?DV*\19L^B@'/I@T ?35MXST2\E2W@O;>265@B('&69C@*!W)/ 'XFUN9&\LGT4,3P. "C\)O&5G)IJZ3=S)#<6I81B1@@DB9B MR[2Q +*6*E1SM"D9&< '8^,O'-CX;LI'2:.2[=66"*-E9MY'RNP!.U%/S$G& M<8&20* /*?@CH4CW,^L2*1%&A@C)R-TCE63 MY8!]F&>N #Z"H * ,K7-8A\/V4NHW(=HH "PC +_ #,J# 9E'5AG+#C/TH S M=)\9Z-K2![2[A)./D=A'(,]BC[6Z\9 (ST)H -=\8Z7X?MVN+F>-F4?+$CJT MCG'"J@)//]X@*O5B* /FOX[<1P2M=S,!E5)+,BY]6D( [X#$#Y M30!]=T 4=4L%U2SGLI.%N(I(B?0.I7/U&H(;!]L9SVH ^ M7=;NG^)GB9(K,-]G)6&,D'Y8(R6DE8=LEG< X/*H>: /K2*)846.,;40!5 Z M 8 _ 4 /H ^6?'4S^,O%L>DPG,<+I:C';!W7#_\ )<'VC% 'U%#"EO&L,0V MI&H15'0*HP!^ &* )* "@#PKXK?$"33"VA:<=DS(/M$HZHKKD1IZ,R$%F_A5 M@%^8Y4 P_APOASPVHU'4;V!M0+.X_V66@#UJ@" MK>WT&FPM#@>^.: /I/2_$.G:TS) MI]Q%("8H))HW/H91&4)]OW3#/ MJ0._(!T_PQ\4V%_I%O8^:D=U:IY3Q.P5C@G:R GYPRXR5SAL@XXR =YJVN66 MAPM<7TR0HB[L,PW-[(OWF)/ "@DF@#YD\!1R>(_%YU*)2D0GN+Q^^Q9#(54G MIDLZK^9 .#0!]84 % !0 4 % !0 4 % 'RO\5=/GT#Q"FKPC:MP8IXV&<":# M:&'^\"J.?]\'Z 'T%H?B[3=>M4NK>>)2R@O&SJ'C; W*ZD@_*>-V-K=5)!H M\;^+_C.TOX4T:PD6F?#/0Y-!T.&* M<%9IRUPZGJIDQM4^A$:IN'4-D'I0!WU '@GQPUORH+;2(SS*3<2C_87*1CZ, MQ<_5!0!Z7X"T3^P-%MK5AME9/-E]?,E^<@^Z@A../EH ["@ H Y/7_&FG>&+ MB"UU%GB^U!F60)NC7:0/G()<9+<$(PP#DB@#7M==TZ^026]S;RJ1G*RH>OJ- MV0?4'!'0C- 'D_Q6\:Z>-,DTBTE2XN+DH'\LAUB165R6925W,5"AKEO ME)R5(VY"G !Z-XG\:Z?X;LWN&FCDGVGR858,TCX^4;5.0F<;V. %SC+8! /% M_@YHDVHZG-KLX.R .%8_QSS9#8_W49MWNZ^] 'TQ0!0U748](M)KZ;_5V\;R M-VSM!.!UY8\#@\D<4 ?.?PCTZ37-;N-;NOG,&]RQ[SW!;G\$\P^Q*].,@'TW M0 4 ,ED6%&DD(5$!9B>@ &23[ X,\N M 3G&=J ':#M +$D@'L/A?7?"7A.S%G:7L))^:64AM\KXP6;Y>!V51PHXY)+$ M Z9?B%X>X_P!@!5 ;IA6?.TT ?36BZ8FC M6,%A'RMM$D>?4JH#-_P)LL?^*'\?ZC!I&C*TL$;D1G!'G2MP9,'E8T7.TL M 0I=FP#@ 'T?X?TB/0-/@TZ+E;>,*3_>;[SM_P "\MEO8)+:3[DR/&W^ZZE3^AH ^3O VK'P%X@DMM3_=1G?:SG&0A# I)Q MU7O\2?$ MJ16 ;R6*01$C!$*$L\K#'"Y:23D9"X!&>* /KB*-846-!A4 51Z # '//2@! M] 'RMK9/CWQF+1?GMHY1!P>!!;Y:8@\<,1*5/^TH&>,@'U0 %&!P!P .U "T M % '$P_$+16O9M-FF^RSVTK1'SP$1RIP2DF2F,]-[(Q_NT =*VL6,:>:US L M?7<98PN/][=C]: /EKXG^)8/%FIQ0Z;F:.W7RD90?WLCMSL&,E<[57CYCDC@ M@D ^E?">E-H>DVMA)_K(85#^SM\[CCT9B,]\9H Z&@#Y:^+VE3:1K::O"-J7 M0C=7 X6:$*I'IG:J./7+>AH ]Y\-^,M.\16B7,4T:2E1YL+.JO&^/F!4D';G M[K=&'0YR >8?%SQK:26?]BV$JS23,K3M&P941#N";ER-[.%) /RJI##YA0! MV/PJ\/OH6C*TZ[)[QC.P/!52 (U/_ 1NQU!<@]* /2J /)OC%K?]FZ,+-#B2 M_D$?_;),/(?SV(?9S0!8^$>B?V5HBW#C$M\QF/KL^[$/3&T%Q_OT >HT % ' M,^+O$T/A/3WOYAO;(CBCZ;Y6!*KGL,*S,?[JG&3@4 ?+VE2VWB_5GU'Q/>)! M"""RDD,X'W88PH.R-1P6ZXZ$N2P /HV#Q[X9M8UAAO((XXU"HJA@%51@ #;P M .* -C2O%NDZW-]FL+J.>4*6V+D':, D9 SC(Z<]^@- '14 <3\0]#?7]#N+ M>$%IHP)HE'4M&=Q4#N63M 'U70!!=7,=E#)6UD^Y/&\3?[KJ5/Z&@#Y.\$:N? M /B"2WU+,<9WVUP<$A/F!248Y*@J#D9S&Q(SQ0!]3'7M.6'[2;JW\G&[?YJ; M<=IP" >(?!S1YM1 MU:7690?+ME<;N@::;(('KA"Y;'3*_P!X4 ?3U &+XCU9=!TVYU!O^7>)F7W< M_+&O_ G*K^- 'A/P5TAKR]N=:G^8Q#RT8]Y93ND;ZA, _P#73\@#Z0H * ,_ M5M3BT:SFOYPS16Z-(P0 L0O4*"5!/IE@/>@##T?QQHNN(&MKJ)6/6.5A%(/; M8Y!/U7<.G/(H MZMXJTO1(6GN[F)0HR%5U:1SS@(BDLQ.,=,#N0,F@#Y?\+6 MTWC'Q4MVJ8C:Z-Y*,95(UD\S:Q_VCMC'J6H ^P: (;FW2ZB>"3E)49&'^RP* MG]#0!\D>%-2;X=^(WAO\I$I>VG.,_(Q#)*!C)7*HX(Y*$XZX(!]4#7M.,/VD M75OY.-V_S4VXZYSNQ0!\P^,]5;XB>((K/2\O"N+>%L$ \EI9B.H0PP%,:MSQL;)'. #Z4L+*/3;:*T@&([>-(T'^RBA1^.!SZF@"W0 4 M>-_%'X@/H"_V3IYQ>3)F27_GC&V0-O\ TT<9P?X%PP^9E*@'#?#>+P]HI75M M7O(3>GF*([B(,_QL0I#2GMR1&#W<_* >T_\ "Q?#O_/]#_X__P#$T =%I6KV M>MP_:;"5;B(,4W)G 88)!R 00"#TZ$&@#2H ^;OC?H;QW-OJ\:_NY4\B0C/# MH69"WIO5B!_US_, ]3\$^-[+Q#I\1DF2.\C14GCD<*Y=1@NH8@LKXW C.,[2 M6XC8,(HC]\N5. S#Y IYPQ8C Y #X->'WTS M39-1G7:]^RE 1SY,>X*?4;V9SCNH1N01@ ]CH XGQWXPC\'6/GA1)FZYJ#ZMXIO(U&_>8G)W3OU^8*"%B7@;1 MC*!>74J16X:Y/F,<+\Z2!>?]HD8^M 'U%I_BK2=5F%M97<, M\Q!(1'!8@#)P.^!R?;F@#?H * "@ H * "@ H * /F'XSZ3+8:K#JT60ERBC M>/X9H>/PRFPKGKAL=. #V_PQXRT_Q%91W"S1),4'G0LZJZ2 #>-I(.W.=K8P MPQWR >9_%SQK9RV1T2QD6>69D:=HV#(B(V\(6&1O9PIP#\H4[L9 H ZSX2Z M%)HNBB2=2DM[(9\'((0JJQ@CME5WCOAQD]@ >GT >*_&O7/L>G1:9&2;G M _YY18.#_O2%".?X".>P!U7PQT/^Q-"@#C;+=?Z3)Z_O -@_"((".QSP#F@# MT"@ H YCQ'XNL/"K0#42Z)=,ZJZIN5-@4DN =^/F&-JN>N0* +]EXATW44$E MK=02J>?EE3(^HSD'V(!H \Y^)OC73[72YM-MY4N+J[3R]D;!Q&I(W,Y7(4[< MA5)W$D'&W)H YSX'Z++&+G5I 5CD"P1$C[^&W2$'T!"+QP3N'5: /H&@#SGX MIZ&^M:%)Y*[I;1EN% ')"!ED [_ZMF;'OZ]XOTWP]:O=7$T;%0=D2.IDD;LJJ M"3R>K8VJ.2<4 >!_"W2Y_$FOR:YHH ^HZ M (+JYCLH9+B8[8X4:1SZ*BEF/X &@#YC^&]M)XL\3RZQ@DP% 'R5XX\;R>-;U;""1;;38Y,( MTA*JY&1Y\IP3@#)1 "0#T+G /6?"6L^$_"-F+6VOH6D;#32D.&E<#J?EX4< MA%'"CU8LQ .J'Q$\/$X^W0_^/#_V6@#LP<\B@ H ^00[_#GQ67D4^3#,QP!] M^VF! ([$A&S@'_6(5/0T ?4]KX@TV\A%S!=0/"1G=YB ?[62"I'<, 1T(% M'S;\3/$B^,M2M],TG_2(H"40IR)9Y2 =OJBA556Z$[R/EP2 ?2/A_25T+3K? M3U(/V>)4)'1FQEV'LSEF_&@#8H \"^*WQ DM&?0=..URH%U,.H#C/DIZ$J1Y MC=0#L&#NP 4OAR?#?A=!?7U[ ^HR+C W%8%80F[!W M0PL6;RC_ ,])"%(,IZJ,G9U/S_< /;_^%B^'?^?Z'_Q__P")H Z'2=:LM&('&X%6Z M9) H X6+X$1JV9=09D]%MPI_P"^C,X_\=H ];\-^$M.\*0F'3XRK/CS)7.Z M23&<;FP!@9X50JCKC))(!TE '%_$'6_[ T2YN%.)9%\B+UWR_+D>Z+N[T % !0!Y7XA^$>DZW,]U M"TEE/*Q=_+PT;,QRS&-NA)YPCJO7CF@#DE^ Z!LMJ)*^@M@#CZ^>1_X[^% ' MH_A;X>:5X4;SH%:>ZQCSYL,RYZ^6H 6//3(&_!(+$$T =U0 4 8NO>'[+Q); M&SU"/S(R-.P>W#G_OI9HP?^^1 M0!UWA?X4Z7X=F6[E9[VXC.4:0!8T(Z,L8S\X[%F8 X*A6 - 'J% !0!\K>)' M/CKQDM@AW01RK;#!R!%#EIV&..2)2#W^7F@#ZH50@"J JJ , < #H!V% M "T % '*^*_!]EXPAC@OFE00.71H656R1@@[T=2#Q_#GC@]<@'#?\*0T3_GO M??\ ?R#_ .1J #_A2&B?\][[_OY!_P#(U '3^%?AWIWA"Y>\LGN)))(S$?.> M-@%+*YP$BCY)1>23P* .\H * /(O$7P>TS6)VN;.1["20EG5%#Q%CSE8R4*9 M.20K[?15H P[/X%6T;@W=])-&.JQPK$3[;FDEQ_WS0![1I.D6NAVR65C&(88 M^BCN3U9B^_P"_D'_R-0!=TWX/:/I=U#>Q2WC26TJ3('DA*EHV#KN" MP*2,@9 89]: /5J "@#D?%G@NS\8I#'?23QK;EV40NBY+A0=P>.0'&WY< $9 M/K0!KZ%H=MX=LX]/L@1%%G!8@NQ8EF9R ,L2>N!Q@ "@#7H * "@ H * " M@ H * "@!LD:RJ8Y '1P596 (((P00>""."#P10!XOK/P3T^]E:6PGDL@QSY M9031J?\ 8!>-@/8NV.W'% $&F? ZQMY ]]=2W2*<[$C$ ;V8[Y&QZ[2I]"* M/:+.R@TZ%+6U1888EVHBC 4#_.23R2222230!9H ^>?C?K19K;1XCTS<2@'J M3E(@0._^L.#ZJ: /8?!^BCP_I%M8X >.,-+QC]Z_SR9]<,Q4$\X ':@#I: " M@"GJ&GV^JV[V=V@E@F&UT.0",YZ@@@@@$$$$$ @YH \;U'X'6$S%K*ZFM@?X M9$68#Z8,38^I)]Z *MI\"K:-P;J^DE0'E8X5B)'IN:24#_ODT >PZ'X?L?#= MO]ETZ(0IU8\EW;^\['+,?J<#HH XH V: "@#@O%WP[TWQ:PGFW6]T %\Z+&6 M Z"12,. . ?E8# W;0!0!YXGP(C#Y;4&*9Z"V ;'^\9R,^^W\* /5O"W@W3O M",1CL5)DDQYDTA#2/CH"0 %4=E4 =SD\T =50!D:_JJ:%I]QJ#X(MXF< ]&; M&$7M]YRJ_C0!X%\%]*;4-1N=:N/G,(*JQZF:?\ EIW[ 'TI0 4 M% 'FWB'X6Z5XEOI-2N9+J.:8('$3QA#L14! >%R#M4 _-CC..M &+_PI#1/^ M>]]_W\@_^1J #_A2&B?\][[_ +^0?_(U 'HOAOP[;>%K,:?9F1HU9GW2D,Y9 MCDY*JB^@&%' [G)H WJ *&IZ9;:Q;O9WL:S02C#*WZ$$8*L#R&!!!Y!H \6O M?@7;22%K2]DA0G(62%92!Z;A)%G\1GUSUH V- ^#6F:5*MQ>R/?LA!5&41Q9 M'=D!S*PH ]@ QP.,4 % &/K^B0>([&73;HNL,^W<8R XV.L@VEE8 M?>0=5/&10!YI_P *0T3_ )[WW_?R#_Y&H /^%(:)_P ][[_OY!_\C4 =7X4\ M :?X/EEGLGN)'G0(WG,C '=\H2./DGKG/3C'- '<4 5KRR@U"%[6Z19895V MNC#((/\ G((Y! (((!H \9U/X'V%PY>QN9;53R$=!,J^RG=&V/3O^'_ U8>&+?[+IT?EJ3EV)W/(P[ MNQY..<#A5R=H&: -V@ H * "@ H * "@ H QM=\/V7B2V-GJ$8DCSE2.'1NS M(PY5OT(X((R* /&[CX$PLY-O?O''GA7MUD8#W998P?KL'TH ZSPU\)]*T"5; MJ8O?7"'*&0!8T(P0RQC.6!Z%V8#J " : /4: "@#Y4/_ !7WC7'WK9)O^ _9 M[7\^)2O_ 'U+V[ 'U70 4 % '+^)_!^G>+8UCU!&W19\N2-MLB;L9 ."I!P. M&5AD9 S0!Y3/\"(6;,%^Z+Z/;AS^:S1C_P =H V-&^"NF6,@EOII+[;@A,"* M,G_:"LSD>V\#LQ0PI;HL42K'&@"JJ@*JJ. % P . ,"@"2@!&4,"K M$$8(/((/8T >-ZY\%]-U*9I[&9[#>23&$$L0)_N*61E'^SO*CHH4<4 9VG_ MRTAD#7MY)<(#DI'$L.?8L7E./7 !QT(/- 'M6GZ?;Z5;I:6<:PP1#"(O0#\< MDDGDL268DDDDDT 7* /&?C3K?V'3(].C.'O9,M@\^5%ACD=?F&3E)%9&QQ M\K @\]N#0!Y"?@AHG_/:^'_;2#_Y'H /^%(:)_SWOO\ OY!_\C4 *OP1T-2" M9KU@"#@R0X/L<6X.#WP0?0T >Q4 % '(^*_!6G^+XU6\5DFC!$!(H/.TY M!#)GG:P..=I4DF@#RQO@0F[*Z@P3T-L"?^^O/ _\=H ](\)_#_3?"),MN&FN M6&#/+@L >JH J ]\98]"Q'% '^_[^0?_ "-0 M!Z7H&B0>'+&+3;4NT,&[:9""YWNTC;BJJ/O.>BCC H V* /-_&'PTLO%MP+U MI9+:Y"!"RA61@N<%D.#N&<9#J,8R">: .'B^!$:MF74&9?1;8*?S,[C_ ,=H M ]1\+^"-,\)J39(6F88:>0AI"/0' "+[(!GOG H Z^@ H * "@ H * "@ H M* .#\6_#S3?%K">;=;W0 GBQE@.@D4C#@#@'A@, -M&* /.T^!$8;+Z@Q3T M%L%./]XSL/\ QW\* /5?"_@S3O"496Q0F5P!)-(=TC@ZUF49(Q;Q MD\G<<22G)[X\L9')W,#[@'T/0 4 % 'F?B7X5Z3XBF>\!DM+F4[G>,@J['JS M1N",GOL*9/)R220#B?\ A0Z[L_VB=OI]E&?S^T8_\=H ] \+_#32?"[BY0-< MW2_=FFP=A]8T "J?]H[G'9@"10!Z%0 4 9>L:-::]:M97T8EA?L>"K#HRL.5 M8=B/<'()! /&+OX$V[N3:WTD29.%D@61@.PW++$#CUVC/I0!T7ASX0Z9HDRW M5T[WTL9R@=0D0(Z-Y8+;B.VYV7OMS@@ ]9H * /EKXA7#^+_ !5%I$!^2%X[ M53V#,VZ9^_W%[3Q;:+8WID2-)%E5HF56#*K*.65UP5=@05/7(P10!Y_P#\*0T3_GO??]_( M/_D:@ _X4AHG_/>^_P"_D'_R-0!T'AKX9Z9X5O!?VDES)*$9 )GC*@-C)PD4 M9SC@9)')XS@@ ]#H * /*O$WPDTS7IVN[=WL9Y"2_EJ&C9CU8QDKM8]]K*"> M2N220#F+7X$P(X-S?R21Y&5C@6)B.X#-+*!]=IQZ&@#V71-"L_#MLMEI\8BB M7D]V=CU=V/+,<=3T& % ->@"K?V4>HVTMG-GRKB-XGP<';(I1L'L<$X/: M@#R;_A2&B?\ />^_[^0?_(U !_PI#1/^>]]_W\@_^1J )[7X+Z+:S).LMXQB M=7"M)#M)4@@-M@4X..<$''0B@#UR@ H X;Q;\/\ 3?%Q$L^Z"Z4;1/%C<0.B MNI&' [9PPZ!@.* /-U^!"!LG4&*>@M@#_P!]>>1_X[0!ZIX5\%:=X0C9;)6: M:0 232$-(PZ[<@ *F>=J@9P"VX@&@#K: "@ H * "@ H * "@!&4,"K $$8( M/((/8T >.:[\%]-U*4SV$SV!@_#W1/[!T. MV@88EE7SY?\ ?EPV#TY5-J'_ '>IZT =K0 4 5[NTBOH7MKA1)%*I1T/1E88 M(/X=QR.HYH \;U/X(:=<,6L;B:U!_@95F4?[N3&^/]YV/O0!GVWP)@1@;B_> M1,\B.!8SCV9I90/KM/T- 'KOA[PQI_A>#[/IT0C#8+N?FDD(Z%W/)QSA1A5R M=JC)H WZ "@#B?%O@+3O%P#W(:&Y086>/ ?']UP00Z^@/(YVL,G(!YH/@0F[ M/]H-L]/LPW?]]>?C_P =H ]0\*>!M-\(*39JTD[C#SRD&0CKM7 "HF>=JC)X MW%BH( .QH I:E?QZ7:S7DW$=O&\C?.6"]?1?,([@A<4 ?3U !0 4 >>>)?AGI?BF\-_=R7,, M*0O .'BD.<<<$#CIG)(!S_\ PI#1/^>]]_W\@_\ D:@ _P"%(:)_SWOO^_D' M_P C4 >@>%_"]IX1M&L;)I'C>1I6:5E9BS*JGE408PB@ +^= '1T 4]0T^WU M6![2\C6:"4;71NA'X8((/(8$%3@@@C- 'BM]\"[260M9WDD"$Y"21+-@>@82 M1?AD$XZY/- &EH7P7TW395GOI7ORA!"%1%$2/[RAG9AG^'>%/1@PH ]C50@" MJ !@ < = !V H 6@#DO%G@RR\8I%'?--']G9F0PLJGYP P.]) 0=H[ C'7 MK0!Q/_"D-$_Y[WW_ '\@_P#D:@ _X4AHG_/>^_[^0?\ R-0!U/A3X?:=X/GD MN;)[B229/+/G.C +N#':$CCY) SG/3C'- '=4 5KRU2^@DM9<[)XWC;'!VNI M4X/.#@\<&@#R7_A2&B?\][[_ +^0?_(U !_PI#1/^>]]_P!_(/\ Y&H W/#G MPOTOPQ>IJ-K)=/+&'51*\13YU*DX2%#G!./FQ[4 >CT % !0 4 % !0 4 % M&9K&C6FO6S65_&)87['@J1T96'*L.S YZCH2" >+W?P)MW: .B\._"#2]&E6YNG>_E0@J)%"1 CH3&"VX^SLR_P"S0!ZS M0 4 ?*WB1SXZ\9+8(=T$*H!;Z@A81DF-T8J\9. 2IZ<@8(8,IXXR 0 > M2W/P)@9LVU_)&G820+(RNI]Z /9+6UBLHEM[=%BBC 5$0!54#L .!0!/0 4 >1>(O@]IFL3M[$DF@#1H \J^+^M_V7HIM4.);]Q$/ M41K\\I^A 5#[24 )\']$_LS11=N,2W[F4^OEKE(P?R9QUXD_ 'JU !0 R2- M95,;C*L"I'3((P1QST]* /(#\$-$)R)KT>PDAX_.W)_,T )_PI#1/^>]]_W\ M@_\ D:@ 'P0T0'_77Q_[:0?_ "/0![#'&L2A$&%4 >@ P!^5 #J .4\4^#= M/\71+'>J5DCSYHC4 ! >A/+D$C?M)% '>4 % 'F6N M_"C2=?O9-1GDNHY9R"ZQ21A,A0N0'A=AG&3\V,] !Q0!D_\ "D-$_P">]]_W M\@_^1J #_A2&B?\ />^_[^0?_(U 'I'A[0+;PS9)IUF7:*,L=TA#.2[%B6*J MJ]\#"@8 [Y) -N@#S_Q1\-M,\5W0OKM[B*41B,^2Z!2%)()#Q2<\XX(&,<9Y M(!SG_"D-$_Y[WW_?R#_Y&H /^%(:)_SWOO\ OY!_\C4 =YX5\)6?A"W>UL6E M=99/,9IF5FSM"@?(B* ./ESDG)/& #IZ "@ H * "@ H * "@ H * "@ H M* "@#)UG_4K_ +X_]!:@#/T;_7-_N'_T): .FH * "@ H * "@ H * "@ H M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ M H * "@ H * "@ H * "@ H * "@ H * .%\=>"V\:0PP?:3:+ [.1Y7F!R0 M%&1YD>"HW8.3]X\4 =)H.CQ:!80:= 2R6Z!=Q&"Q)+,Q Z%F);';.* -:@ H M * "@ H * "@ H * "@ H * &2*S*50[&((#8!VDC@X/!P><'@T >:>"_AI' MX2O)-0>Y-Y+(A17L#,&9O]9)N8X S\O!/K0!Z=0 4 % !0 4 % !0 4 % M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 M4 >7:A\,TU37AKUU=%T$DHT % !0 M4 % !0 4 % !0 4 % !0 4 9N"9.TKO3C=AL[ MARHH ?X1\,1>$=/73XG,QWM(\A7;O=L<[06V@*%4#<>%ZT =/0 4 % !0 4 M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 M 4 % !0!6O8&NK>6!',32QN@D R4+*5# <9*DY ]J . \#?#J+P7+-<>>;J6 M9!&&\OR@B [F&-\F2Q"DG(^Z.* /2* "@ H * "@ H * "@ H * "@ H * / M,/%_PV'B_4([Z>[:**)%C\D1!LJ&9FVOYB[2Q8Y)1B..P !Z:B+$H1 %50 M .@ & ![ 4 .H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ M H * "@ H * "@ H * "@ H * "@ H XWQOX2;QC9I9"X-HJ2B4D1B0.0K* M1OC/&XG[V,]0<# !I^&/#\7AC3XM-A;S!%N+.1M+LS%F8C)QR< 9.% &3B@# M?H * "@ H * "@ H * "@ H * "@ H \N\+_ S3P]JKZQ-=->2MYA4&(1[7 ME)W.6\Q]QVEAP%'S$^U 'J- !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % ! M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!Y=XB^&:>)-875KFZ M81+Y0-OY0.4CQE!)Y@P'.XG]V2-QH ]1H * "@ H * "@ H * "@ H * "@ MH YWQ5H+>)=.ETU9C:^?MW.$#\*P;;MW)P2!G# XXZ$@@%+P7X0B\&V36<] '7T % !0 4 % !0 4 % !0 4 % !0 4 M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ,D5F4JAV,0 M0&P#M)'!P>#@\X/!H \T\%_#2/PE>2:@]R;R61"BYB\O8&8,S?ZR3 M"?6@#TZ@ H * "@ H * "@ H * "@ H * "@#S;QO\//^$TN89WNVMDMT*>6 M(A)G+;F8-YB;2PV@Y##Y0: /0K2VCLH8[:$;8X46-!Z*BA5'X "@">@ H * M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H M * "@ H * "@ H * ,G6?]2O^^/_ $%J ,_1O]_P#L: #^V_\ IG_X]_\ 8T ' M]M_],_\ Q[_[&@ _MO\ Z9_^/?\ V- !_;?_ $S_ /'O_L: #^V_^F?_ (]_ M]C0 ?VW_ -,__'O_ +&@ _MO_IG_ ./?_8T ']M_],__ ![_ .QH /[;_P"F M?_CW_P!C0 ?VW_TS_P#'O_L: #^V_P#IG_X]_P#8T ']M_\ 3/\ \>_^QH / M[;_Z9_\ CW_V- !_;?\ TS_\>_\ L: #^V_^F?\ X]_]C0 ?VW_TS_\ 'O\ M[&@ _MO_ *9_^/?_ &- !_;?_3/_ ,>_^QH /[;_ .F?_CW_ -C0 ?VW_P!, M_P#Q[_[&@ _MO_IG_P"/?_8T ']M_P#3/_Q[_P"QH /[;_Z9_P#CW_V- !_; M?_3/_P >_P#L: #^V_\ IG_X]_\ 8T ']M_],_\ Q[_[&@ _MO\ Z9_^/?\ MV- !_;?_ $S_ /'O_L: #^V_^F?_ (]_]C0 ?VW_ -,__'O_ +&@ _MO_IG_ M ./?_8T ']M_],__ ![_ .QH /[;_P"F?_CW_P!C0 ?VW_TS_P#'O_L: #^V M_P#IG_X]_P#8T ']M_\ 3/\ \>_^QH /[;_Z9_\ CW_V- !_;?\ TS_\>_\ ML: #^V_^F?\ X]_]C0 ?VW_TS_\ 'O\ [&@ _MO_ *9_^/?_ &- !_;?_3/_ M ,>_^QH /[;_ .F?_CW_ -C0 ?VW_P!,_P#Q[_[&@ _MO_IG_P"/?_8T ']M M_P#3/_Q[_P"QH /[;_Z9_P#CW_V- !_;?_3/_P >_P#L: #^V_\ IG_X]_\ M8T ']M_],_\ Q[_[&@ _MO\ Z9_^/?\ V- !_;?_ $S_ /'O_L: #^V_^F?_ M (]_]C0 ?VW_ -,__'O_ +&@ _MO_IG_ ./?_8T ']M_],__ ![_ .QH /[; M_P"F?_CW_P!C0 ?VW_TS_P#'O_L: #^V_P#IG_X]_P#8T ']M_\ 3/\ \>_^ MQH /[;_Z9_\ CW_V- !_;?\ TS_\>_\ L: #^V_^F?\ X]_]C0 ?VW_TS_\ M'O\ [&@ _MO_ *9_^/?_ &- !_;?_3/_ ,>_^QH /[;_ .F?_CW_ -C0 ?VW M_P!,_P#Q[_[&@ _MO_IG_P"/?_8T ']M_P#3/_Q[_P"QH /[;_Z9_P#CW_V- M !_;?_3/_P >_P#L: #^V_\ IG_X]_\ 8T ']M_],_\ Q[_[&@ _MO\ Z9_^ M/?\ V- !_;?_ $S_ /'O_L: #^V_^F?_ (]_]C0 ?VW_ -,__'O_ +&@ _MO M_IG_ ./?_8T ']M_],__ ![_ .QH /[;_P"F?_CW_P!C0 ?VW_TS_P#'O_L: M #^V_P#IG_X]_P#8T ']M_\ 3/\ \>_^QH /[;_Z9_\ CW_V- !_;?\ TS_\ M>_\ L: #^V_^F?\ X]_]C0 ?VW_TS_\ 'O\ [&@ _MO_ *9_^/?_ &- !_;? M_3/_ ,>_^QH /[;_ .F?_CW_ -C0 ?VW_P!,_P#Q[_[&@ _MO_IG_P"/?_8T M ']M_P#3/_Q[_P"QH /[;_Z9_P#CW_V- !_;?_3/_P >_P#L: #^V_\ IG_X M]_\ 8T ']M_],_\ Q[_[&@ _MO\ Z9_^/?\ V- !_;?_ $S_ /'O_L: #^V_ M^F?_ (]_]C0 ?VW_ -,__'O_ +&@ _MO_IG_ ./?_8T ']M_],__ ![_ .QH M /[;_P"F?_CW_P!C0 ?VW_TS_P#'O_L: #^V_P#IG_X]_P#8T ']M_\ 3/\ M\>_^QH /[;_Z9_\ CW_V- !_;?\ TS_\>_\ L: #^V_^F?\ X]_]C0 ?VW_T MS_\ 'O\ [&@ _MO_ *9_^/?_ &- !_;?_3/_ ,>_^QH /[;_ .F?_CW_ -C0 M ?VW_P!,_P#Q[_[&@ _MO_IG_P"/?_8T ']M_P#3/_Q[_P"QH /[;_Z9_P#C MW_V- !_;?_3/_P >_P#L: #^V_\ IG_X]_\ 8T ']M_],_\ Q[_[&@ _MO\ MZ9_^/?\ V- !_;?_ $S_ /'O_L: #^V_^F?_ (]_]C0 ?VW_ -,__'O_ +&@ M _MO_IG_ ./?_8T ']M_],__ ![_ .QH /[;_P"F?_CW_P!C0 ?VW_TS_P#' MO_L: #^V_P#IG_X]_P#8T ']M_\ 3/\ \>_^QH /[;_Z9_\ CW_V- !_;?\ MTS_\>_\ L: #^V_^F?\ X]_]C0 ?VW_TS_\ 'O\ [&@ _MO_ *9_^/?_ &- M!_;?_3/_ ,>_^QH /[;_ .F?_CW_ -C0 ?VW_P!,_P#Q[_[&@ _MO_IG_P"/ M?_8T ']M_P#3/_Q[_P"QH /[;_Z9_P#CW_V- !_;?_3/_P >_P#L: #^V_\ MIG_X]_\ 8T ']M_],_\ Q[_[&@ _MO\ Z9_^/?\ V- !_;?_ $S_ /'O_L: M#^V_^F?_ (]_]C0 ?VW_ -,__'O_ +&@ _MO_IG_ ./?_8T ']M_],__ ![_ M .QH /[;_P"F?_CW_P!C0 ?VW_TS_P#'O_L: #^V_P#IG_X]_P#8T ']M_\ M3/\ \>_^QH /[;_Z9_\ CW_V- !_;?\ TS_\>_\ L: #^V_^F?\ X]_]C0 ? MVW_TS_\ 'O\ [&@ _MO_ *9_^/?_ &- !_;?_3/_ ,>_^QH /[;_ .F?_CW_ M -C0 ?VW_P!,_P#Q[_[&@ _MO_IG_P"/?_8T ']M_P#3/_Q[_P"QH /[;_Z9 M_P#CW_V- !_;?_3/_P >_P#L: #^V_\ IG_X]_\ 8T ']M_],_\ Q[_[&@ _ MMO\ Z9_^/?\ V- !_;?_ $S_ /'O_L: #^V_^F?_ (]_]C0 ?VW_ -,__'O_ M +&@ _MO_IG_ ./?_8T ']M_],__ ![_ .QH /[;_P"F?_CW_P!C0 ?VW_TS M_P#'O_L: #^V_P#IG_X]_P#8T ']M_\ 3/\ \>_^QH /[;_Z9_\ CW_V- !_ M;?\ TS_\>_\ L: #^V_^F?\ X]_]C0 ?VW_TS_\ 'O\ [&@ _MO_ *9_^/?_ M &- !_;?_3/_ ,>_^QH /[;_ .F?_CW_ -C0 ?VW_P!,_P#Q[_[&@ _MO_IG M_P"/?_8T ']M_P#3/_Q[_P"QH /[;_Z9_P#CW_V- !_;?_3/_P >_P#L: #^ MV_\ IG_X]_\ 8T ']M_],_\ Q[_[&@ _MO\ Z9_^/?\ V- !_;?_ $S_ /'O M_L: #^V_^F?_ (]_]C0 ?VW_ -,__'O_ +&@ _MO_IG_ ./?_8T ']M_],__ M ![_ .QH /[;_P"F?_CW_P!C0 ?VW_TS_P#'O_L: #^V_P#IG_X]_P#8T '] MM_\ 3/\ \>_^QH /[;_Z9_\ CW_V- !_;?\ TS_\>_\ L: #^V_^F?\ X]_] MC0 ?VW_TS_\ 'O\ [&@ _MO_ *9_^/?_ &- !_;?_3/_ ,>_^QH /[;_ .F? M_CW_ -C0 ?VW_P!,_P#Q[_[&@ _MO_IG_P"/?_8T ']M_P#3/_Q[_P"QH /[ M;_Z9_P#CW_V- !_;?_3/_P >_P#L: #^V_\ IG_X]_\ 8T ']M_],_\ Q[_[ M&@ _MO\ Z9_^/?\ V- !_;?_ $S_ /'O_L: #^V_^F?_ (]_]C0 ?VW_ -,_ M_'O_ +&@ _MO_IG_ ./?_8T ']M_],__ ![_ .QH /[;_P"F?_CW_P!C0 ?V MW_TS_P#'O_L: #^V_P#IG_X]_P#8T ']M_\ 3/\ \>_^QH /[;_Z9_\ CW_V M- !_;?\ TS_\>_\ L: #^V_^F?\ X]_]C0 ?VW_TS_\ 'O\ [&@ _MO_ *9_ M^/?_ &- !_;?_3/_ ,>_^QH /[;_ .F?_CW_ -C0 ?VW_P!,_P#Q[_[&@ _M MO_IG_P"/?_8T ']M_P#3/_Q[_P"QH /[;_Z9_P#CW_V- !_;?_3/_P >_P#L M: #^V_\ IG_X]_\ 8T ']M_],_\ Q[_[&@ _MO\ Z9_^/?\ V- !_;?_ $S_ M /'O_L: #^V_^F?_ (]_]C0 ?VW_ -,__'O_ +&@ _MO_IG_ ./?_8T ']M_ M],__ ![_ .QH /[;_P"F?_CW_P!C0 ?VW_TS_P#'O_L: #^V_P#IG_X]_P#8 MT ']M_\ 3/\ \>_^QH /[;_Z9_\ CW_V- !_;?\ TS_\>_\ L: #^V_^F?\ MX]_]C0 ?VW_TS_\ 'O\ [&@ _MO_ *9_^/?_ &- !_;?_3/_ ,>_^QH /[;_ M .F?_CW_ -C0 ?VW_P!,_P#Q[_[&@ _MO_IG_P"/?_8T ']M_P#3/_Q[_P"Q MH /[;_Z9_P#CW_V- !_;?_3/_P >_P#L: #^V_\ IG_X]_\ 8T ']M_],_\ MQ[_[&@ _MO\ Z9_^/?\ V- !_;?_ $S_ /'O_L: #^V_^F?_ (]_]C0 ?VW_ M -,__'O_ +&@ _MO_IG_ ./?_8T ']M_],__ ![_ .QH /[;_P"F?_CW_P!C M0 ?VW_TS_P#'O_L: #^V_P#IG_X]_P#8T ']M_\ 3/\ \>_^QH /[;_Z9_\ MCW_V- !_;?\ TS_\>_\ L: #^V_^F?\ X]_]C0 ?VW_TS_\ 'O\ [&@ _MO_ M *9_^/?_ &- !_;?_3/_ ,>_^QH /[;_ .F?_CW_ -C0 ?VW_P!,_P#Q[_[& M@ _MO_IG_P"/?_8T ']M_P#3/_Q[_P"QH /[;_Z9_P#CW_V- !_;?_3/_P > M_P#L: #^V_\ IG_X]_\ 8T ']M_],_\ Q[_[&@ _MO\ Z9_^/?\ V- !_;?_ M $S_ /'O_L: #^V_^F?_ (]_]C0 ?VW_ -,__'O_ +&@ _MO_IG_ ./?_8T M']M_],__ ![_ .QH /[;_P"F?_CW_P!C0 ?VW_TS_P#'O_L: #^V_P#IG_X] M_P#8T ']M_\ 3/\ \>_^QH /[;_Z9_\ CW_V- !_;?\ TS_\>_\ L: #^V_^ MF?\ X]_]C0 ?VW_TS_\ 'O\ [&@ _MO_ *9_^/?_ &- !_;?_3/_ ,>_^QH M/[;_ .F?_CW_ -C0 ?VW_P!,_P#Q[_[&@ _MO_IG_P"/?_8T ']M_P#3/_Q[ M_P"QH /[;_Z9_P#CW_V- !_;?_3/_P >_P#L: #^V_\ IG_X]_\ 8T ']M_] M,_\ Q[_[&@ _MO\ Z9_^/?\ V- !_;?_ $S_ /'O_L: #^V_^F?_ (]_]C0 M?VW_ -,__'O_ +&@ _MO_IG_ ./?_8T ']M_],__ ![_ .QH /[;_P"F?_CW M_P!C0 ?VW_TS_P#'O_L: #^V_P#IG_X]_P#8T ']M_\ 3/\ \>_^QH /[;_Z M9_\ CW_V- !_;?\ TS_\>_\ L: #^V_^F?\ X]_]C0 ?VW_TS_\ 'O\ [&@ M_MO_ *9_^/?_ &- !_;?_3/_ ,>_^QH /[;_ .F?_CW_ -C0 ?VW_P!,_P#Q M[_[&@ _MO_IG_P"/?_8T ']M_P#3/_Q[_P"QH /[;_Z9_P#CW_V- !_;?_3/ M_P >_P#L: #^V_\ IG_X]_\ 8T ']M_],_\ Q[_[&@ _MO\ Z9_^/?\ V- ! M_;?_ $S_ /'O_L: #^V_^F?_ (]_]C0 ?VW_ -,__'O_ +&@ _MO_IG_ ./? M_8T ']M_],__ ![_ .QH /[;_P"F?_CW_P!C0 ?VW_TS_P#'O_L: #^V_P#I MG_X]_P#8T ']M_\ 3/\ \>_^QH /[;_Z9_\ CW_V- !_;?\ TS_\>_\ L: # ?^V_^F?\ X]_]C0!4O=1^UH$V;<-G.[/8CT'K0!__V0$! end XML 17 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Cover - USD ($)
$ in Millions
12 Months Ended
Jun. 30, 2022
Jul. 31, 2022
Dec. 31, 2021
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Jun. 30, 2022    
Current Fiscal Year End Date --06-30    
Document Transition Report false    
Entity File Number 001-34717    
Entity Registrant Name Alpha and Omega Semiconductor Limited    
Entity Incorporation, State or Country Code D0    
Entity Tax Identification Number 77-0553536    
Entity Address, Address Line One Clarendon House    
Entity Address, Address Line Two 2 Church Street    
Entity Address, City or Town Hamilton    
Entity Address, Postal Zip Code HM 11    
Entity Address, Country BM    
City Area Code 408    
Local Phone Number 830-9742    
Title of 12(b) Security Common Shares, $0.002 par value per share    
Trading Symbol AOSL    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 1,327
Entity Common Stock, Shares Outstanding (in shares)   27,397,273  
Entity Central Index Key 0001387467    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Amendment Flag false    
ICFR Auditor Attestation Flag false    

XML 18 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Audit Information
12 Months Ended
Jun. 30, 2022
Audit Information [Abstract]  
Auditor Firm ID 243
Auditor Name BDO USA, LLP
Auditor Location San Jose, California
XML 19 R3.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2022
Jun. 30, 2021
Current assets:    
Cash and cash equivalents $ 314,352 $ 202,412
Restricted cash 299 233
Accounts receivable, net 65,681 35,789
Inventories 158,040 154,293
Other current assets 11,220 14,595
Total current assets 549,592 407,322
Property, plant and equipment, net 318,666 436,977
Operating lease right-of-use assets, net 23,674 34,660
Intangible assets, net 10,050 13,410
Equity method investment 378,378 0
Deferred income tax assets 592 5,167
Restricted cash - long-term 0 2,168
Other long-term assets 17,677 18,869
Total assets 1,298,629 918,573
Current liabilities:    
Accounts payable 87,377 80,699
Accrued liabilities 116,893 69,494
Payable related to equity investee, net 28,989 0
Income taxes payable 4,248 2,604
Short-term debt 25,563 58,030
Finance lease liabilities 802 16,724
Operating lease liabilities 3,850 5,679
Total current liabilities 267,722 233,230
Long-term debt 42,486 77,990
Income taxes payable - long-term 2,158 1,319
Deferred income tax liabilities 28,757 2,448
Finance lease liabilities - long-term 3,932 12,698
Operating lease liabilities - long-term 20,878 30,440
Other long-term liabilities 78,603 44,123
Total liabilities 444,536 402,248
Commitments and contingencies (Note 15)
Preferred shares, par value $0.002 per share:    
Authorized: 10,000 shares; issued and outstanding: none at June 30, 2022 and 2021 0 0
Common shares, par value $0.002 per share:    
Authorized: 100,000 shares; issued and outstanding: 33,988 shares and 27,371 shares, respectively at June 30, 2022 and 32,975 shares and 26,350 shares, respectively at June 30, 2021 68 66
Treasury shares at cost; 6,617 shares at June 30, 2022 and 6,625 shares at June 30, 2021 (66,000) (66,064)
Additional paid-in capital 288,951 259,993
Accumulated other comprehensive income 1,080 2,315
Retained earnings 629,994 176,895
Total Alpha and Omega Semiconductor Limited shareholders’ equity 854,093 373,205
Noncontrolling interest 0 143,120
Total equity 854,093 516,325
Total liabilities and equity $ 1,298,629 $ 918,573
XML 20 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Jun. 30, 2022
Jun. 30, 2021
Preferred stock, par value (in dollars per share) $ 0.002 $ 0.002
Preferred stock, shares authorized (in shares) 10,000,000 10,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common shares, par value (in dollars per share) $ 0.002 $ 0.002
Common shares, authorized (in shares) 100,000,000 100,000,000
Common stock, shares issued (in shares) 33,988,000 32,975,000
Common stock, shares outstanding (in shares) 27,371,000 26,350,000
Treasury shares (in shares) 6,617,000 6,625,000
XML 21 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Income Statement [Abstract]      
Revenue $ 777,552 $ 656,902 $ 464,909
Operating expenses 508,996 452,359 362,178
Gross profit 268,556 204,543 102,731
Operating expenses:      
Research and development 71,259 62,953 51,252
Selling, general and administrative 95,259 77,514 64,816
Impairment of privately-held investment 0 0 600
Total operating expenses 166,518 140,467 116,668
Operating income (loss) 102,038 64,076 (13,937)
Interest expenses, net 999 2,456 (1,229)
Interest expenses, net (3,920) (6,308) (2,743)
Gain on deconsolidation of the JV Company 399,093 0 0
Loss on changes of equity interest in the JV Company, net (3,140) 0 0
Net income (loss) before income taxes 495,070 60,224 (17,909)
Income tax expense 39,258 3,935 348
Net income (loss) before loss from equity method investment 455,812 56,289 (18,257)
Equity method investment loss from equity investee 2,629 0 0
Net income (loss) 453,183 56,289 (18,257)
Net income (loss) attributable to noncontrolling interest 20 (1,827) (11,661)
Net income (loss) attributable to Alpha and Omega Semiconductor Limited $ 453,163 $ 58,116 $ (6,596)
Net income (loss) per common share attributable to Alpha and Omega Semiconductor Limited      
Basic (in dollars per share) $ 16.93 $ 2.25 $ (0.27)
Diluted (in dollars per share) $ 16.07 $ 2.13 $ (0.27)
Weighted average number of common share attributable to Alpha and Omega Semiconductor Limited used to compute net income (loss) per share:      
Basic (in shares) 26,764 25,786 24,840
Diluted (in shares) 28,203 27,272 24,840
XML 22 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Statement of Comprehensive Income [Abstract]      
Net income (loss) $ 453,183 $ 56,289 $ (18,257)
Foreign currency translation adjustment 1,307 14,190 (4,839)
Cumulative translation adjustment removal due to deconsolidation of the JV Company (3,642) 0 0
Comprehensive income (loss) 450,848 70,479 (23,096)
Less: Noncontrolling interest (1,080) 4,921 (14,066)
Comprehensive income (loss) attributable to Alpha and Omega Semiconductor Limited $ 451,928 $ 65,558 $ (9,030)
XML 23 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Total AOS Shareholders' Equity
Preferred Shares
Common Shares
Treasury Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (loss)
Retained Earnings
Noncontrolling Interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Balance $ 443,289                
Balance (in shares) at Jun. 30, 2019     0            
Balance (in shares) at Jun. 30, 2019       31,163,000          
Balance (in shares) at Jun. 30, 2019         (6,646,000)        
Balance at Jun. 30, 2019   $ 291,024 $ 0 $ 62 $ (66,240) $ 234,410 $ (2,693) $ 125,485 $ 152,265
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of common stock options and release of RSUs (in shares)       562,000          
Exercise of common stock options and release of RSUs 25 25   $ 1   24      
Reissuance of Treasury Stock (in shares)         7,000        
Reissuance of Treasury Stock 0 0     $ 56     (56)  
Withholding tax on restricted stock units (in shares)       (181,000)          
Withholding tax on restricted stock units (1,509) (1,509)       (1,509)      
Issuance of common shares under Employee Stock Purchase Plan (in shares)       400,000          
Issuance of common shares under Employee Stock Purchase Plan 3,325 3,325   $ 1   3,324      
Share-based compensation expense 9,854 9,854       9,854      
Net income (loss) attributable to AOS (6,596) (6,596)           (6,596)  
Cumulative translation adjustment   (2,434)         (2,434)    
Net income (loss) attributable to noncontrolling interest (11,661)               (11,661)
Foreign currency translation adjustment                 (2,405)
Foreign currency translation adjustment (4,839)                
Net income (loss) (18,257)                
Balance (in shares) at Jun. 30, 2020     0            
Balance (in shares) at Jun. 30, 2020       31,944,000          
Balance (in shares) at Jun. 30, 2020         (6,639,000)        
Balance at Jun. 30, 2020   293,689 $ 0 $ 64 $ (66,184) 246,103 (5,127) 118,833 138,199
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Balance 431,888                
Exercise of common stock options and release of RSUs (in shares)       857,000          
Exercise of common stock options and release of RSUs 1,699 1,699   $ 1   1,698      
Reissuance of Treasury Stock (in shares)         14,000        
Reissuance of Treasury Stock 66 66     $ 120     (54)  
Withholding tax on restricted stock units (in shares)       (225,000)          
Withholding tax on restricted stock units (6,924) (6,924)       (6,924)      
Issuance of common shares under Employee Stock Purchase Plan (in shares)       399,000          
Issuance of common shares under Employee Stock Purchase Plan 3,327 3,327   $ 1   3,326      
Share-based compensation expense 12,190 12,190       12,190      
Net income (loss) attributable to AOS 58,116 58,116           58,116  
Cumulative translation adjustment   7,442         7,442    
Net income (loss) attributable to noncontrolling interest (1,827)               (1,827)
Restricted stock units settlement in connection with service 3,600 3,600       3,600      
Foreign currency translation adjustment                 6,748
Foreign currency translation adjustment 14,190                
Net income (loss) $ 56,289                
Balance (in shares) at Jun. 30, 2021 0   0            
Balance (in shares) at Jun. 30, 2021 32,975,000     32,975,000          
Balance (in shares) at Jun. 30, 2021 (6,625,000)       (6,625,000)        
Balance at Jun. 30, 2021 $ 373,205 373,205 $ 0 $ 66 $ (66,064) 259,993 2,315 176,895 143,120
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Balance 516,325                
Exercise of common stock options and release of RSUs (in shares)       652,000          
Exercise of common stock options and release of RSUs 898 898   $ 1   897      
Reissuance of Treasury Stock (in shares)         8,000        
Reissuance of Treasury Stock 0 0     $ 64     (64)  
Withholding tax on restricted stock units (in shares)       (183,000)          
Withholding tax on restricted stock units (8,641) (8,641)       (8,641)      
Issuance of common shares under Employee Stock Purchase Plan (in shares)       544,000          
Issuance of common shares under Employee Stock Purchase Plan 5,245 5,245   $ 1   5,244      
Share-based compensation expense 31,058 31,058       31,058      
Net income (loss) attributable to AOS 453,163 453,163           453,163  
Cumulative translation adjustment   558         558    
Net income (loss) attributable to noncontrolling interest 20               20
Restricted stock units settlement in connection with service 400 400       400      
Foreign currency translation adjustment                 749
Foreign currency translation adjustment 1,307                
Deconsolidation of noncontrolling interest (145,682) (1,793)         (1,793)   (143,889)
Net income (loss) $ 453,183                
Balance (in shares) at Jun. 30, 2022 0   0            
Balance (in shares) at Jun. 30, 2022 33,988,000     33,988,000          
Balance (in shares) at Jun. 30, 2022 (6,617,000)       (6,617,000)        
Balance at Jun. 30, 2022 $ 854,093 $ 854,093 $ 0 $ 68 $ (66,000) $ 288,951 $ 1,080 $ 629,994 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Balance $ 854,093                
XML 24 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Cash flows from operating activities      
Net income (loss) $ 453,183 $ 56,289 $ (18,257)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Gain on deconsolidation of the JV Company (399,093) 0 0
Loss on changes of equity interest in the JV Company, net 3,140 0 0
Deferred income tax on deconsolidation and changes of equity interest in the JV Company 29,973 0 0
Depreciation and amortization 42,851 52,685 45,090
Equity method investment loss from equity investee 2,629 0 0
Share-based compensation expense 31,324 15,324 10,454
Deferred income taxes, net 1,592 1,551 85
(Gain) loss on disposal of property and equipment 18 426 (102)
Impairment of privately-held investment 0 0 600
Changes in assets and liabilities:      
Accounts receivable (30,085) (22,517) 11,024
Inventories (57,416) (18,765) (22,793)
Other current and long-term assets (9,408) (5,843) 27,306
Payable related to equity investee, net 48,192 0 0
Accounts payable 23,755 (528) (1,777)
Income taxes payable (1,687) 1,660 (270)
Income taxes payable on deconsolidation and changes of equity interest in the JV Company 3,490 0 0
Accrued and other liabilities 76,407 48,462 10,955
Net cash provided by operating activities 218,865 128,744 62,315
Cash flows from investing activities      
Proceeds from sale of equity interest in the JV Company 26,347 0 0
Deconsolidation of cash and cash equivalents of the JV Company (20,734) 0 0
Purchases of property and equipment (138,014) (72,700) (62,398)
Proceeds from sale of property and equipment 135 42 295
Government grant related to equipment 1,444 119 1,254
Net cash used in investing activities (130,822) (72,539) (60,849)
Cash flows from financing activities      
Withholding tax on restricted stock units (8,641) (6,924) (1,509)
Proceeds from exercise of stock options and ESPP 6,143 5,092 3,350
Proceeds from borrowings 64,276 65,876 96,232
Repayments of borrowings (35,748) (66,584) (49,394)
Principal payments on capital leases (4,176) (16,451) (11,028)
Net cash provided by (used in) financing activities 21,854 (18,991) 37,651
Effect of exchange rate changes on cash, cash equivalents and restricted cash (59) 4,895 (708)
Net increase in cash, cash equivalents and restricted cash 109,838 42,109 38,409
Cash, cash equivalents and restricted cash at beginning of year 204,813 162,704 124,295
Cash, cash equivalents and restricted cash at end of year 314,651 204,813 162,704
Supplemental disclosures of cash flow information:      
Cash paid for interest 3,404 5,641 2,223
Cash paid for income taxes 5,768 970 2,258
Supplemental disclosures of non-cash investing and financing information:      
Property and equipment purchased but not yet paid 62,165 20,204 17,370
Reissuance of treasury stock 64 120 56
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]      
Cash and cash equivalents 314,352 202,412 158,536
Restricted cash 299 233 2,190
Restricted cash - long-term 0 2,168 1,978
Total cash, cash equivalents, and restricted cash $ 314,651 $ 204,813 $ 162,704
XML 25 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
The Company and Significant Accounting Policies
12 Months Ended
Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
The Company and Significant Accounting Policies The Company and Significant Accounting Policies
The Company

Alpha and Omega Semiconductor Limited and its subsidiaries (the “Company”, “AOS”, “we” or “us”) design, develop and supply a broad range of power semiconductors. The Company's portfolio of products targets high-volume applications, including personal computers, graphic cards, flat panel TVs, home appliances, smart phones, battery packs, quick chargers, home appliances, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment. The Company conducts its operations primarily in the United States of America (“USA”), Hong Kong, China, and South Korea.
Basis of Preparation

The consolidated financial statements include the accounts of the Company, its wholly-owned subsidiaries and a subsidiary in which it had a controlling interest until December 1, 2021. As of December 2, 2021, the Company ceased having control over this subsidiary. Therefore, the Company deconsolidated this subsidiary as of that date. Subsequently, the Company has accounted for it using the equity method of accounting. All intercompany account balances and transactions have been eliminated. The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”).
Reclassification
Certain reclassifications of prior period presentation to conform to current period presentation have been made with no changes made to balance sheet, income statement or statement of cash flows subtotals.
Joint Venture
On March 29, 2016, the Company entered into a joint venture contract (the “JV Agreement”) with two investment funds owned by the Municipality of Chongqing (the “Chongqing Funds”), pursuant to which the Company and the Chongqing Funds formed a joint venture, (the “JV Company”), for the purpose of constructing and operating a power semiconductor packaging, testing and 12-inch wafer fabrication facility in the Liangjiang New Area of Chongqing, China (the “JV Transaction”). As of December 1, 2021, the Company owned 51%, and the Chongqing Funds owned 49%, of the equity interest in the JV Company. The Joint Venture was accounted under the provisions of the consolidation guidance since the Company had controlling financial interest until December 1, 2021. If both parties agree that the termination of the JV Company is the best interest of each party or the JV Company is bankrupt or insolvent where either party may terminate early, after paying the debts of the JV Company, the remaining assets of the JV Company shall be paid to the Chongqing Funds to cover the principal of its total paid-in contributions plus interest at 10% simple annual rate prior to distributing the balance of the JV Company's assets to the Company. The JV Company has reached its targeted production of assembly and testing.
Effective December 1, 2021, the Company entered into a share transfer agreement (the “STA”) with a third-party investor (the “Investor”), pursuant to which the Company sold to the Investor approximately 2.1% of outstanding equity interest held by the Company in the JV Company for an aggregate purchase price of RMB 108 million or approximately $16.9 million (the “Transaction”). The Transaction was closed on December 2, 2021 (the “Closing Date”). As a result of the Transaction, as of the Closing Date, the Company’s equity interest in the JV Company decreased from 50.9% to 48.8%. Also, the Company’s right to designate directors on the board of JV Company was reduced to three (3) out of seven (7) directors from four (4) directors prior to the Transaction. As a result of the Transaction, AOS no longer had a controlling financial interest in the JV Company under generally accepted accounting principles. Loss of control is deemed to have occurred when, among other things, a parent company owns less than a majority of the outstanding equity interest in the subsidiary, lacks a controlling financial interest in the subsidiary and, is unable to unilaterally control the subsidiary through other means such as having, or the ability to obtain or represent, a majority of the subsidiary’s board of directors. Because of these factors, as of December 2, 2021, the Company ceased having control over the JV Company. Therefore, the Company deconsolidated the financial statements of the JV Company as of that date. Subsequently, the Company has accounted for its investment in the JV Company using the equity method of accounting.

On December 24, 2021, the Company entered into a share transfer agreement with another third-party investor, pursuant to which the Company sold to this investor 1.1% of outstanding equity interest held by the Company in the JV Company for an aggregate purchase price of RMB 60 million, or approximately $9.4 million. In addition, on December 30, 2021, the JV
Company adopted an employee equity incentive plan and issued an equity interest equivalent to 3.99% of the JV Company in exchange for cash. As a result, the Company owned 45.8% of the equity interest in the JV Company as of December 31, 2021.

On January 26, 2022, the JV Company completed a financing transaction pursuant to a corporate financing agreement (the “Financing Agreement”) between the JV Company and certain third-party investors (the “New Investors”). Under the Financing Agreement, the New Investors purchased newly issued equity interest of the JV Company for a total purchase price of RMB 509 million (or approximately $80 million based on the currency exchange rate as of January 26, 2022) (the “Investment”). Immediately following the closing of the Investment, the percentage of outstanding JV Company equity interest beneficially owned by the Company was further reduced to 42.2%.
Certain Significant Risks and Uncertainties Related to Outbreak of Coronavirus Disease 2019 (“COVID-19”)

The COVID-19 pandemic has had and continues to have a negative impact on business and economic activities across the globe. As a result of the COVID-19 pandemic and the global economic downturn and changing consumer behaviors due to various restrictions imposed by governments, the Company has experienced shifting market trends, including an increasing demand in the markets for notebooks, PCs and gaming devices and decreasing demand for mobile phone and industrial products, as more consumers are staying at and working from home. While the Company has recently benefited from the increasing demand of consumer electronics and PC related products, there is no guarantee that this trend will continue, and such increasing demand may discontinue or decline as government authorities relax and terminate COVID-19 related restrictions and consumer behaviors change. Furthermore, as the COVID-19 pandemic continues and global economic downturn and high unemployment persists, consumer spending may slow down substantially, in which case the Company may experience a significant decline of customer orders for its products, including those designed for PC-related applications, and such decline will adversely affect its financial conditions and results of operations. The full extent of the future impact of the COVID-19 pandemic on the Company’s operational and financial performance is uncertain and will depend on many factors outside the Company’s control, including, without limitation, the timing, extent, trajectory and duration of the pandemic; the availability, distribution and effectiveness of vaccines; the spread of new variants of COVID-19; the continued or renewed imposition of protective public safety measures and government mandates; the continuing disruption of global supply chain affecting the semiconductor industry; and the impact of the pandemic on the global economy and demand for consumer products.

In April 2022, the operations of our two packaging and testing facilities in Shanghai, China were suspended due to a strict lockdown of the city imposed by the local government in response to surging COVID cases. Our facilities in Shanghai were required to be shut down and production was halted beginning in early April. Transportation suspension in and out of Shanghai also interrupted the shipping of raw materials and finished parts to and from our facilities. We received permission to reopen our facilities partially in early May. We gradually ramped up production at these facilities in May and returned to normal operation in June 2022. The suspension of our Shanghai facilities, and the subsequent partial resumption of production, reduced our ability to complete orders from our customers in a timely manner, which adversely affected our revenue and results of operation for the three months ended June 30, 2022.
Risks and Uncertainties

The Company is subject to certain risks and uncertainties. The Company believes changes in any of the following areas could have a material adverse effect on the Company's future financial position or results of operations or cash flows: the timing and success of new product development, including market receptiveness, operation of in-house manufacturing facilities, litigation or claims against the Company based on intellectual property, patent, product regulatory or other factors, competition from other products, general economic conditions, the inability to attract and retain qualified employees, lack of control to the JV Company and ultimately to sustain profitable operations, risks associated with doing business in China, and ability to diversify products and develop digital business; the general state of the U.S., China and world economies; the highly cyclical nature of the industries the Company serves; the loss of any of its larger customers; restrictions on the Company’s ability to sell to foreign customers due to trade laws, regulations and requirements; disruptions of the supply chain of components needed for our products; inability to obtain additional financing; inability to meet certain debt covenants; fundamental changes in the technology underlying the Company’s products; successful and timely completion of product design efforts; and new product design introductions by competitors. Additional risks and uncertainties that the Company is unaware of, or that the Company currently believes are not material, may also become important factors that adversely affect its business.

The Company's revenue limited by its ability to utilize wafer production and packaging and testing capacity from its in-house facilities and obtain adequate wafer supplies from third-party foundries. The Company recently entered into a new agreement with the JV Company pursuant to which the JV Company agrees to provide us with a guaranteed supply of a fixed number of wafers until December 2023. Currently the Company's main third-party foundry is Shanghai Hua Hong Grace Electronic Company Limited, or HHGrace, located in Shanghai, China. HHGrace has been manufacturing wafers for the Company since 2002. HHGrace manufactured approximately 10.3%, 11.5% and 12.7% of the wafers used in the Company's products for the fiscal years ended June 30, 2022, 2021 and 2020, respectively. Although the Company believes that its volume
of production allows the Company to secure favorable pricing and priority in allocation of capacity in its third-party foundries, if the foundries' capacities are constrained due to market demands, HHGrace, together with other foundries from which the Company purchases wafers, may not be willing or able to satisfy all of the Company's manufacturing requirements on a timely basis and/or at favorable prices. The Company is also subject to the risks of service disruptions and raw material shortages by its foundries. Such disruptions, shortages and price increases could harm the Company’s operating results. In addition, manufacturing facilities' capacity affects the Company's gross margin because the Company has certain fixed costs associated with its Oregon Fab and the JV Company, as well as in-house packaging and testing facilities. If the Company fails to utilize its manufacturing facilities' capacity at a desirable level, its financial condition and results of operations will be adversely affected.
Use of Estimates
The preparation of the consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses. To the extent there are material differences between these estimates and actual results, the Company's condensed consolidated financial statements will be affected. On an ongoing basis, the Company evaluates the estimates, judgments and assumptions including those related to stock rotation returns, price adjustments, allowance for doubtful accounts, inventory reserves, warranty accrual, income taxes, leases, share-based compensation, recoverability of and useful lives for property, plant and equipment and intangible assets, as well as the economic implications of the COVID-19 pandemic.
Foreign Currency Transactions and Translation
Most of the Company's principal subsidiaries use U.S. dollars as their functional currency because their transactions are primarily conducted and settled in U.S. dollars. All of their revenues and a significant portion of their operating expenses are denominated in U.S. dollars. The functional currencies for the Company's in-house packaging and testing facilities in China are U.S. dollars, and a majority of their capital expenditures are denominated in U.S. dollars. Foreign currency transactions are translated into the functional currencies using the exchange rates prevailing at the dates of the transactions. Foreign exchange gains and losses, resulting from the settlement of such transactions and from the re-measurement of monetary assets and liabilities denominated in foreign currencies using exchange rates at balance sheet date and non-monetary assets and liabilities using historical exchange rates, are recognized in the consolidated statements of operations.
For the Company's subsidiaries which use the local currency as their functional currency, their results and financial position are translated into U.S. dollars using exchange rates at balance sheet dates for assets and liabilities and using average exchange rates for income and expenses items. The resulting translation differences are presented as a separate component of accumulated other comprehensive income (loss) and noncontrolling interest in the consolidated statements of equity.
Cash, Cash Equivalents and Restricted Cash
Cash and cash equivalents primarily consist of cash on hand and short-term bank deposits with original maturities of three months or less. Cash equivalents are highly liquid investments with stated maturities of three months or less as of the dates of purchase. The carrying amounts reported for cash and cash equivalents are considered to approximate fair values based upon their short maturities.

Cash and cash equivalents are maintained with reputable major financial institutions. If, due to current economic conditions or other factors, one or more of the financial institutions with which the Company maintains deposits fails, the Company's cash and cash equivalents may be at risk. Deposits with these banks may exceed the amount of insurance provided on such deposits; however, these deposits typically may be redeemed upon demand and, therefore, bear minimal risk.

The Company maintains restricted cash in connection with cash balances temporarily restricted for regular business operations, including the possibility of a dispute with a vendor. These balances have been excluded from the Company’s cash and cash equivalents balance and are classified as restricted cash in the Company’s consolidated balance sheets. As of June 30, 2022 and 2021, the amount of restricted cash was $0.3 million and $2.4 million, respectively.
Accounts Receivable, net
The allowance for doubtful accounts is based on assessment of the collectability of accounts receivable from customers. The Company reviews the allowance by considering factors such as historical collection experience, credit quality, age of the accounts receivable balances and current economic conditions that may affect a customer's ability to pay. The Company writes off a receivable and charges against its recorded allowance when it has exhausted its collection efforts without success.
Fair Value Measurements
    Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value, which are the following:
Level 1 - Quoted prices in active markets for identical assets or liabilities.
Level 2 - Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
Fair Value of Financial Instruments
The fair value of cash equivalents is based on observable market prices and have been categorized in Level 1 in the fair value hierarchy. Cash equivalents consist primarily of short-term bank deposits. The carrying values of financial instruments such as cash and cash equivalents, accounts receivable and accounts payable approximate their carrying values due to their short-term maturities. The carrying value of the company's debt is considered a reasonable estimate of fair value which is estimated by considering the current rates available to the Company for debt of the same remaining maturities, structure and terms of the debts.
Inventories

The Company carries inventories at the lower of cost (determined on a first-in, first-out basis) or net realizable value. Cost includes semiconductor wafer and raw materials, labor, depreciation expenses and other manufacturing expenses and overhead, and packaging and testing fees paid to third parties if subcontractors are used. Valuation of inventories are based on the Company's periodic review of inventory quantities on hand as compared with its sales forecasts, historical usage, aging of inventories, production yield levels and current product selling prices. If actual market conditions are less favorable than those forecasted by management, additional future inventory write-downs may be required that could adversely affect the Company's operating results. Adjustments to inventory once established are not reversed until the related inventory has been sold or scrapped.
Property, Plant and Equipment
Property, plant and equipment are stated at historical cost less accumulated depreciation. Historical cost includes expenditures that are directly attributable to the acquisition of the items and the costs incurred to make the assets ready for their intended use.
Depreciation is provided for on a straight-line basis over the estimated useful lives of the related assets as follows:

 
Building
20 years
Manufacturing machinery and equipment
8 to 10 years
Equipment and tooling
3 to 5 years
Computer hardware and software
3 to 5 years
Office furniture and equipment
5 years
Leasehold and building improvements
2 to 20 years
Vehicle
5 years


Equipment and construction in progress represent equipment received but the necessary installation has not been fully performed or building construction and leasehold improvements have been started but not yet completed. Equipment and construction in progress are stated at cost and transferred to respective asset class when fully completed and ready for their intended use.
Internal-use software development costs are capitalized to the extent that the costs are directly associated with the development of identifiable and unique software products controlled by the Company that will probably generate economic benefits beyond one year. Costs incurred during the application development stage are required to be capitalized. The application development stage is characterized by software design and configuration activities, coding, testing and installation. Training costs and maintenance are expensed as incurred, while upgrades and enhancements are capitalized if it is probable that such expenditures will result in additional functionality. Costs include employee costs incurred and fees paid to outside consultants for the software development and implementation. Internally developed software is amortized over its estimated useful life of three to five years starting from the date when it is ready for its intended use.
Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized as selling, general and administrative expenses in the consolidated statements of operations. Costs of maintenance and repairs that do not improve or extend the lives of the respective assets are expensed as incurred.
Government Grants
The Company occasionally receives government grants that provide financial assistance for certain eligible expenditures in China. These grants include reimbursements on interest expense on bank borrowings, payroll tax credits, credit for property, plant and equipment in a particular geographical location, employment credits as well as business expansion credits. Government grants are not recognized until there is reasonable assurance that the Company will comply with the conditions attaching to it, and that the grant will be received. The Company records such grants either as a reduction of the related expense, a reduction of the cost of the related asset, or as other income depending upon the nature of the grant. As a result of such grants, during the fiscal year ended June 30, 2022, the Company reduced interest expense by $0.9 million, property, plant and equipment by $1.4 million, and operating expenses by $0.2 million. During the fiscal year ended June 30, 2021, the Company reduced interest expense by $3.0 million, property, plant and equipment by $0.1 million, and operating expenses by $3.7 million. During the fiscal year ended June 30, 2020, the Company reduced interest expenses by $6.1 million, property, plant and equipment by $1.3 million, and operating expenses by $4.7 million.

Long-lived Assets

The Company reviews all long-lived assets whenever events or changes in circumstance indicate that these assets may not be recoverable. When evaluating long-lived assets, if the Company concludes that the estimated undiscounted cash flows attributable to the assets are less than their carrying value, the Company recognizes an impairment loss based on the excess of the carrying amount of the assets over their respective fair values, which could adversely affect our results of operations.

There was no impairment of long-lived assets for fiscal years 2022, 2021 and 2020.

Revenue Recognition

The Company determines revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract; and (5) recognition of revenue when, or as, a performance obligation is satisfied. The Company recognizes product revenue at a point in time when product is shipped to the customer, as determined by the agreed upon shipping terms, net of estimated stock rotation returns and price adjustments that it expects to provide to certain distributors. The Company presents revenue net of sales taxes and any similar assessments. Our standard payment terms range from 30 to 60 days.

The Company sells its products primarily to distributors, who in turn sell the products globally to various end customers. The Company allows stock rotation returns from certain distributors. Stock rotation returns are governed by contract and are limited to a specified percentage of the monetary value of products purchased by distributors during a specified period. The Company records an allowance for stock rotation returns based on historical returns, current expectations, and individual distributor agreements. The Company also provides special pricing to certain distributors, primarily based on volume, to encourage resale of the Company's products. Allowance for price adjustments is recorded against accounts receivable and the provision for stock rotation rights is included in accrued liabilities on the consolidated balance sheets.

The Company's performance obligations relate to contracts with a duration of less than one year. The Company elected to apply the practical expedient provided in ASC 606, “Revenue from Contracts with Customers”. Therefore, the Company is not required to disclose the aggregate amount of transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period.
The Company recognizes the incremental direct costs of obtaining a contract, which consist of sales commissions, when control over the products they relate to transfers to the customer. Applying the practical expedient, the Company recognizes commissions as expense when incurred, as the amortization period of the commission asset the Company would have otherwise recognized is less than one year.

Packaging and testing services revenue is recognized at a point in time upon shipment of serviced products to the customer.
Leases

The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets, current operating lease liabilities and long-term operating lease liabilities on the Company's consolidated balance sheets. Finance leases are included in property, plant and equipment, finance lease liabilities and long-term finance leases liabilities on the consolidated balance sheets.

Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. The Company determined its incremental borrowing rate based on the information available at the lease commencement date. The operating lease ROU assets also include any lease payments made and exclude lease incentives. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. Operating lease expense is generally recognized on a straight-line basis over the lease term. Variable lease payments are expensed as incurred and are not included within the operating lease ROU asset and lease liability calculation. The Company does not record leases on the consolidated balance sheet with a term of one year or less. The Company elected to combine its lease and non-lease components as a single lease component for all asset classes.

Product Warranty

The Company provides a standard one-year warranty for the products from the date of purchase by the end customers. The Company accrues for estimated warranty costs at the time revenue is recognized. The Company's warranty obligation is affected by product failure rates, labor and material costs for replacing defective parts, related freight costs for failed parts and other quality assurance costs. The Company monitors its product returns for warranty claims and maintains warranty reserves based on historical experiences and anticipated warranty claims known at the time of estimation.
Shipping and Handling Costs
Shipping and handling costs are included in cost of goods sold.
Research and Development
Research and development costs are expensed as incurred.
 
Provision for Income Taxes

Income tax expense or benefit is based on income or loss before taxes. Deferred tax assets and liabilities are recognized principally for the expected tax consequences of temporary differences between the tax basis of assets and liabilities and their reported amounts.

The Company is subject to income taxes in a number of jurisdictions. Significant judgment is required in determining the worldwide provision for income taxes. There are many transactions and calculations for which the ultimate tax determination is uncertain during the ordinary course of business. The Company establishes accruals for certain tax contingencies based on estimates of whether additional taxes may be due. While the final tax outcome of these matters may differ from the amounts that were initially recorded, such differences will impact the income tax and deferred tax provisions in the period in which such determination is made.

Significant management judgment is also required in determining whether deferred tax assets will be realized in full or in part. When it is more likely than not that all or some portion of specific deferred tax assets such as net operating losses or research and experimentation tax credit carryforwards will not be realized, a valuation allowance must be established for the amount of the deferred tax assets that cannot be realized. The Company considers all available positive and negative evidence on a jurisdiction-by-jurisdiction basis when assessing whether it is more likely than not that deferred tax assets are recoverable.
The Company considers evidence such as our past operating results, the existence of cumulative losses in recent years and our forecast of future taxable income.

The Financial Accounting Standards Board (FASB), issued guidance which clarifies the accounting for income taxes by prescribing a minimum probability threshold that a tax position must meet before a financial statement benefit is recognized. The minimum threshold is defined as a tax position that is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. The tax benefit to be recognized is measured as the largest amount of benefit that is greater than fifty percent likely to be realized upon ultimate settlement. Although the guidance on the accounting for uncertainty in income taxes prescribes the use of a recognition and measurement model, the determination of whether an uncertain tax position has met those thresholds will continue to require significant judgment by management. If the ultimate resolution of tax uncertainties is different from what is currently estimated, a material impact on income tax expense could result.

The Company's provision for income taxes is subject to volatility and could be adversely impacted by changes in earnings or tax laws and regulations in various jurisdictions. The Company is subject to the continuous examination of our income tax returns by the Internal Revenue Service and other tax authorities. The Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of our provision for income taxes. To the extent that the final tax outcome of these matters is different from the amounts recorded, such differences will impact the provision for income taxes in the period in which such determination is made. The provision for income taxes includes the impact of changes to reserves, as well as the related net interest and penalties.
Share-based Compensation Expense

The Company maintains an equity-settled, share-based compensation plan to grant restricted share units and stock options. The Company recognizes expense related to share-based compensation awards that are ultimately expected to vest based on estimated fair values on the date of grant. The fair value of restricted share units is based on the fair value of the Company's common share on the date of grant. For restricted stock awards subject to market conditions, the fair value of each restricted stock award is estimated at the date of grant using the Monte-Carlo pricing model. The fair value of stock options is estimated on the date of grant using the Black-Scholes option valuation model. Share-based compensation expense is recognized on the accelerated attribution basis over the requisite service period of the award, which generally equals the vesting period. The Black-Scholes option valuation model requires the input of subjective assumptions, including the expected term and stock price volatility. In addition, judgment is also required in estimating the number of stock-based awards that are expected to be forfeited. Forfeitures are estimated based on historical experience at the time of grant. Changes in estimated forfeitures are recognized in the period of change and impact the amount of stock compensation expenses to be recognized in future periods, which could be material if actual results differ significantly from estimates.

The Employee Share Purchase Plan (the “ESPP”) is accounted for at fair value on the date of grant using the Black-Scholes option valuation model.

Advertising

Advertising expenditures are expensed as incurred. Advertising expense was $0.2 million, $0.4 million and $0.7 million in the fiscal years ended June 30, 2022, 2021, and 2020, respectively.
Comprehensive Income (Loss)
Comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. The Company's accumulated other comprehensive income (loss) consists of cumulative foreign currency translation adjustments.

Recent Accounting Pronouncements
Recently Issued Accounting Standards not yet adopted

In November 2021, the FASB issued Accounting Standards Update (ASU) No. 2021-10, “Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance.” This ASU requires business entities to make annual disclosures about transactions with a government they account for by analogizing to a grant or contribution accounting model under ASC 958-605. The ASU is effective for all entities within their scope for financial statements issued for annual periods
beginning after December 15, 2021. The adoption will not have any impacts on the Company's consolidated financial position, results of operations or cash flows.

In August 2020, the FASB issued ASU No. 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity”, which, among other things, provides guidance on how to account for contracts on an entity’s own equity. This ASU simplifies the accounting for certain financial instruments with characteristics of liabilities and equity. Specifically, the ASU eliminated the need for the Company to assess (1) whether a contract on the entity’s own equity permits settlement in unregistered shares, (2) whether counterparty rights rank higher than shareholder’s rights, and (3) whether collateral is required. In addition, the ASU requires incremental disclosure related to contracts on the entity’s own equity and clarifies the treatment of certain financial instruments accounted for under this ASU on earnings per share. For public business entities, the ASU is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. The Company does not expect the adoption of this guidance will have a material impact on its consolidated financial position, results of operations or cash flows.
Recently Adopted Accounting Standards

In January 2020, the FASB issued ASU No. 2020-01, “Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.” The ASU is based on a consensus of the Emerging Issues Task Force and is expected to increase comparability in accounting for these transactions. ASU 2016-01 made targeted improvements to accounting for financial instruments, including providing an entity the ability to measure certain equity securities without a readily determinable fair value at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Among other topics, the amendments clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting. The adoption of ASU 2020-01 on July 1, 2021 had no material impact on the Company's Consolidated Financial Statements.

In December 2019, the FASB issued ASU No. 2019-12 “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”) by removing certain exceptions to the general principles. The Company adopted ASU 2019-12 as of July 1, 2021. ASU 2019-12 had no material impact on the Company's Consolidated Financial Statements.
XML 26 R10.htm IDEA: XBRL DOCUMENT v3.22.2.2
Equity Method Investment in Equity Investee
12 Months Ended
Jun. 30, 2022
Discontinued Operations and Disposal Groups [Abstract]  
Equity Method Investment in Equity Investee Equity Method Investment in Equity Investee
On December 1, 2021 (the “Effective Date”), Alpha & Omega Semiconductor (Shanghai) Ltd. (“AOS SH”) and Agape Package Manufacturing (Shanghai) Limited (“APM SH”), each a wholly-owned subsidiary of the Company, entered into a share transfer agreement (“STA”) with a third-party investor to sell a portion of the Company's equity interest in the JV Company which consists of a power semiconductor packaging, testing and 12-inch wafer fabrication facility in Chongqing, China (the “Transaction”). The Transaction closed on December 2, 2021 (the “Closing Date”), which reduced the Company’s equity interest in the JV Company from 50.9% to 48.8%. Also, the Company’s right to designate directors on the board of JV Company was reduced to three (3) out of seven (7) directors, from four (4) directors prior to the Transaction. As a result of the Transaction and other factors, the Company no longer has a controlling financial interest in the JV Company and has determined that the JV Company was deconsolidated from the Company’s Consolidated Financial Statements effective as of the Closing Date. In connection with the deconsolidation and in accordance with ASC 810, the Company recorded a gain on deconsolidation of $399.1 million during the fiscal year ended June 30, 2022 in the Consolidated Statements of Income. The gain on deconsolidation of the JV Company was calculated as follows:


(in thousands)
Cash received for sales of shares in the JV Company
$16,924 
Fair value of retained equity method investment
393,124 
Carrying amount of non-controlling interest
143,889 
Cumulative translation adjustment removal
1,793 
Carrying amount of net assets of the JV Company at December 1, 2021
(156,637)
Gain on deconsolidation of the JV Company
$399,093 

The Company retained significant influence over the operating and financial policies of the JV Company and measured the fair value of the retained investment based on their share of the fair value of the JV Company, which was calculated using the market approach based on the Transaction.

On December 24, 2021, the Company entered into a share transfer agreement with another third-party investor, pursuant to which the Company sold to this investor 1.1% of outstanding equity interest held by the Company in the JV Company. In addition, on December 30, 2021, the JV Company adopted an employee equity incentive plan and issued an equity interest equivalent to 3.99% of the JV Company in exchange to cash. As a result of these two transactions, the Company owned 45.8% of the equity interest in the JV Company as of December 31, 2021.

On January 26, 2022, the JV Company completed a financing transaction pursuant to a corporate investment agreement (the “Investment Agreement”) between the JV and certain third-party investors (the “New Investors”). Under the Investment Agreement, the New Investors purchased newly issued equity interest of the JV Company, representing approximately 7.82% of post-transaction outstanding equity interests of the JV Company, for a total purchase price of RMB 509 million (or approximately USD 80 million based on the currency exchange rate as of January 26, 2022) (the “Investment”). Following the closing of the Investment and as of June 30, 2022, the percentage of outstanding JV Company equity interest beneficially owned by the Company was reduced to 42.2%.
The net loss associated with these sales of JV Company equity interest held by the Company were recorded in the fiscal year ended June 30, 2022 as follows:

(in thousands)
Gain on 1.1% equity interest sold
$475 
Loss on diluted equity interest from issuance of shares under the employee equity incentive plan
(8,116)
Gain on 7.82% equity interest sold4,501 
Loss on changes on equity interest of the JV Company, net
$(3,140)

The Company accounts for its investment in the JV Company as an equity method investment and reports its equity in earnings or loss of the JV Company on a three-month lag due to an inability to timely obtain financial information of the JV Company. During the fiscal year ended June 30, 2022, the Company recorded $2.6 million of its equity in loss of the JV Company, using lag reporting.

Summarized Financial Information

The following table presents summarized financial information for the JV Company as of and for the period from December 2, 2021 through March 31, 2022, using lag reporting (in thousands):

As of March 31, 2022
Current assets$198,323 
Non-current assets$364,777 
Current liabilities$251,988 
Non-current liabilities$76,207 
For the periods of December 2, 2021 to March 31, 2022
Revenue$68,972 
Gross loss$870 
Operating expenses$2,280 
Net loss$6,197 
XML 27 R11.htm IDEA: XBRL DOCUMENT v3.22.2.2
Related Party Transactions
12 Months Ended
Jun. 30, 2022
Related Party Transactions [Abstract]  
Related Party Transactions Related Party TransactionsAs of June 30, 2022, the Company owned 42.2% equity interest in the JV Company, which, by definition, is a related party to the Company. The JV Company supplies 12-inch wafers and provides assembly and testing services for 8-inch wafer products to AOS. Due to the right of offset of receivables and payables with the JV Company, as of June 30, 2022, AOS recorded the net amount of $29.0 million as a payable related to equity investee, net, in the Consolidated Balance Sheet. Since the December 2, 2021 deconsolidation of the JV Company and through the fiscal year ended June 30, 2022, the Company purchased finished goods and services of $117.6 million from the JV Company and AOS provided the JV Company with $36.4 million of 8-inch wafers.
XML 28 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited
12 Months Ended
Jun. 30, 2022
Earnings Per Share [Abstract]  
Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited
Basic net income (loss) per share is computed using the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed using the weighted-average number of common shares outstanding, plus potential shares of common stock during the period. Potential shares of common stock include dilutive shares attributable to the assumed exercise of share options, ESPP shares and vesting of RSUs using the treasury stock method and contingent issuances of common shares related to convertible preferred shares, if dilutive. Under the treasury stock method, potential common shares outstanding are not included in the computation of diluted net income per share if their effect is anti-dilutive.
The following table presents the calculation of basic and diluted net income (loss) per share attributable to common shareholders:
 Year Ended June 30,  
 202220212020
(in thousands, except per share data)
Numerator:
Net income (loss) attributable to Alpha and Omega Semiconductor Limited$453,163 $58,116 $(6,596)
Denominator:
Basic:
Weighted average number of common shares used to compute basic net income per share26,764 25,786 24,840 
Diluted:
Weighted average number of common shares used to compute basic net income per share26,764 25,786 24,840 
Effect of potentially dilutive securities:
Stock options, RSUs and ESPP shares1,439 1,486 — 
Weighted average number of common shares used to compute diluted net income per share28,203 27,272 24,840 
Net income (loss) per share attributable to Alpha and Omega Semiconductor Limited:
Basic$16.93 $2.25 $(0.27)
Diluted$16.07 $2.13 $(0.27)
The following potential dilutive securities were excluded from the computation of diluted net income (loss) per share as their effect would have been anti-dilutive:
 Year Ended June 30,  
 202220212020
(in thousands)
Employee stock options and RSUs277 193 2,028 
ESPP21 71 834 
Total potential dilutive securities298 264 2,862 
XML 29 R13.htm IDEA: XBRL DOCUMENT v3.22.2.2
Concentration of Credit Risk and Significant Customers
12 Months Ended
Jun. 30, 2022
Risks and Uncertainties [Abstract]  
Concentration of Credit Risk and Significant Customers Concentration of Credit Risk and Significant Customers
The Company manages its credit risk associated with exposure to distributors and direct customers on outstanding accounts receivable through the application of credit approvals, credit ratings and other monitoring procedures. In some instances, the Company also obtains letters of credit from certain customers.
Credit sales, which are mainly on credit terms of 30 to 60 days, are only made to customers who meet the Company's credit standards, while sales to new customers or customers with low credit ratings are usually made on an advance payment basis. The Company considers its financial assets to be of good credit quality because its key distributors and direct customers have long-standing business relationships with the Company and the Company has not experienced any significant bad debt write-offs of accounts receivable in the past. The Company closely monitors the aging of accounts receivable from its distributors and direct customers, and regularly reviews their financial positions, where available.

Summarized below are individual customers whose revenue or accounts receivable balances were 10% or higher than the respective total consolidated amounts:
   Year Ended June 30,
Percentage of revenue  2022 2021 2020
Customer A  24.6 % 28.7 % 29.3 %
Customer B  39.7 % 35.4 % 35.5 %
   June 30,
Percentage of accounts receivable  2022 2021
Customer A  24.6 % 12.4 %
Customer B  36.4 % 22.1 %
Customer C  * 21.9 %
Customer D12.0 %*
* Less than 10%
XML 30 R14.htm IDEA: XBRL DOCUMENT v3.22.2.2
Balance Sheet Components
12 Months Ended
Jun. 30, 2022
Balance Sheet Related Disclosures [Abstract]  
Balance Sheet Components Balance Sheet Components
Accounts receivable, net
 
June 30,  
 20222021
(in thousands)
Accounts receivable$84,442 $48,234 
Less: Allowance for price adjustments(18,731)(12,415)
Less: Allowance for doubtful accounts(30)(30)
Accounts receivable, net$65,681 $35,789 
Inventories
 
June 30,
 20222021
(in thousands)
Raw materials$67,960 $68,900 
Work in-process80,720 68,824 
Finished goods9,360 16,569 
 $158,040 $154,293 

Other current assets
 
June 30,
 20222021
(in thousands)
VAT receivable$737 $1,539 
Other prepaid expenses3,954 1,465 
Prepaid insurance2,590 2,615 
Prepaid maintenance826 1,670 
Prepayments to supplier257 2,540 
Prepaid income tax2,086 2,221 
Interest receivable25 2,207 
Customs deposit— 270 
Other receivables745 68 
 $11,220 $14,595 
Property, plant and equipment, net
 
June 30,  
 20222021
(in thousands)
Land$4,877 $4,877 
Building16,691 71,454 
Manufacturing machinery and equipment287,574 515,320 
Equipment and tooling28,052 27,017 
Computer equipment and software46,758 41,518 
Office furniture and equipment2,820 3,814 
Leasehold improvements35,254 74,733 
Land use rights— 9,319 
 422,026 748,052 
Less: accumulated depreciation(233,340)(348,749)
 188,686 399,303 
Equipment and construction in progress129,980 37,674 
Property, plant and equipment, net$318,666 $436,977 
Total depreciation expense was $39.9 million, $49.3 million and $43.9 million for fiscal year 2022, 2021 and 2020, respectively.
The Company capitalized $0.3 million, $0.3 million and $1.0 million of software development costs during the fiscal year 2022, 2021 and 2020, respectively. Amortization of capitalized software development costs was $0.4 million in fiscal year 2022, $0.5 million in fiscal year 2021 and $0.5 million in fiscal year 2020. Unamortized capitalized software development costs in each of the periods presented at June 30, 2022 and 2021 were $0.8 million and $1.2 million, respectively.

Other long-term assets
June 30,  
 20222021
(in thousands)
Prepayments for property and equipment$6,890 $14,882 
Investments in privately held companies100 100 
Customs deposit 1,708 1,120 
Deposit with supplier6,396 — 
Other long-term deposits18 927 
Office leases deposits1,012 1,100 
Other1,553 740 
 $17,677 $18,869 
Intangible assets, net
 
June 30,  
 20222021
(in thousands)
Patents and technology rights$18,037 $18,037 
Trade name268 268 
Customer relationships1,150 1,150 
19,455 19,455 
Less: accumulated amortization(9,674)(6,314)
9,781 13,141 
Goodwill269 269 
Intangible assets, net$10,050 $13,410 

The Company is amortizing intangible assets of patents and technology rights related to a license agreement with STMicroelectronices International N.V. Amortization expense for intangible assets was $3.4 million, $3.4 million and $0.1 million for the years ended June 30, 2022, 2021 and 2020, respectively. The estimated useful lives for patents and technology rights and trade name were five years and ten years, respectively. Customer relationships are fully amortized.
Estimated future minimum amortization expense of intangible assets is as follows (in thousands):
Year ending June 30,
2023$3,286 
20243,249 
20253,246 
$9,781 
Accrued liabilities
 
June 30,  
 20222021
(in thousands)
Accrued compensation and benefits$34,681 $32,756 
Warranty accrual2,650 2,795 
Stock rotation accrual4,798 3,917 
Accrued professional fees2,659 3,017 
Accrued inventory2,491 1,138 
Accrued facilities related expenses2,421 2,536 
Accrued property, plant and equipment20,485 8,688 
Other accrued expenses5,159 6,793 
Customer deposit40,578 7,139 
ESPP payable971 715 
 $116,893 $69,494 
The activity in the warranty accrual, included in accrued liabilities is as follows:
Year Ended June 30,
202220212020
(in thousands)
Beginning balance$2,795 $709 $623 
Addition1,127 2,443 895 
Utilization(1,272)(357)(809)
Ending balance$2,650 $2,795 $709 
    The activity in the stock rotation accrual, included in accrued liabilities is as follows:
Year Ended June 30,
202220212020
(in thousands)
Beginning balance$3,917 $3,358 $1,921 
Addition5,817 4,742 9,441 
Utilization(4,936)(4,183)(8,004)
Ending balance$4,798 $3,917 $3,358 
Other long-term liabilities
 
June 30,  
 20222021
(in thousands)
Deferred payroll taxes$— $1,219 
Customer deposits 70,301 42,000 
Computer software liabilities8,302 — 
Other— 904 
Other long-term liabilities$78,603 $44,123 
    Customer deposits are payments received from customers for securing future product shipments. As of June 30, 2022, $34.5 million were from Customer A and $21.9 million were from Customer B, and $13.9 million were from other customers. As of June 30, 2021, $21.0 million were from Customer A and $21.0 million were from Customer B.
XML 31 R15.htm IDEA: XBRL DOCUMENT v3.22.2.2
Debt
12 Months Ended
Jun. 30, 2022
Debt Disclosure [Abstract]  
Debt Debt
Short-term bank borrowing

In October 2019, the Company's subsidiary in China entered into a line of credit facility with Bank of Communications Limited in China. This line of credit matured on February 14, 2021 and was based on the China Base Rate multiplied by 1.05, or 4.99% on October 31, 2019. The purpose of the credit facility is to provide short-term borrowings. The Company could borrow up to approximately RMB 60.0 million or $8.5 million based on the currency exchange rate between the RMB and the U.S. Dollar on October 31, 2019. In September 2021, this line of credit was renewed with maximum borrowings up to RMB 140.0 million with the same terms and a maturity date of September 18, 2022. During the three months ended December 31, 2021, the Company borrowed RMB 11.0 million, or $1.6 million, at an interest rate of 3.85% per annum, with principal due on November 18, 2022. As of June 30, 2022, there was $1.6 million outstanding balance under the loan.

On November 16, 2018, the Company's subsidiary in China entered into a line of credit facility with Industrial and Commercial Bank of China. The purpose of the credit facility was to provide short-term borrowings. The Company could borrow up to approximately RMB 72.0 million or $10.3 million based on currency exchange rate between RMB and U.S. Dollar on November 16, 2018. The RMB 72.0 million consists of RMB 27.0 million for trade borrowings with a maturity date of December 31, 2021, and RMB 45.0 million for working capital borrowings or trade borrowings with a maturity date of September 13, 2022. During the three months ended December 31, 2021, the Company borrowed RMB 5.0 million, or $0.8 million, at an interest rate of 3.7% per annum, with principal due on September 12, 2022. As of June 30, 2022, the total outstanding balance of this loan was $0.5 million.

Accounts Receivable Factoring Agreement

On August 9, 2019, one of the Company's wholly-owned subsidiaries (the "Borrower") entered into a factoring agreement with the Hongkong and Shanghai Banking Corporation Limited (“HSBC”), whereby the Borrower assigns certain of its accounts receivable with recourse. This factoring agreement allows the Borrower to borrow up to 70% of the net amount of its eligible accounts receivable of the Borrower with a maximum amount of $30.0 million. The interest rate is based on one month London Interbank Offered Rate ("LIBOR") plus 1.75% per annum. The Company is the guarantor for this agreement. The Company is accounting for this transaction as a secured borrowing under the Transfers and Servicing of Financial Assets guidance. In addition, any cash held in the restricted bank account controlled by HSBC has a legal right of offset against the borrowing. This agreement, with certain financial covenants required, has no expiration date. On August 11, 2021, the Borrower signed an agreement with HSBC to decrease the borrowing maximum amount to $8.0 million with certain financial covenants required. Other terms remain the same. The Borrower was in compliance with these covenants as of June 30, 2022. As of June 30, 2022, there was no outstanding balance and the Company had unused credit of approximately $8.0 million.
Debt financing

In September 2021, Jireh Semiconductor Incorporated (“Jireh”) entered into a financing arrangement agreement with a company (“Lender”) for the lease and purchase of a machinery equipment manufactured by a supplier. The total purchase price of this machinery equipment was euro 12.0 million, or $12.8 million based on the currency exchange rate between the euro and U.S. Dollar on June 30, 2022. In April 2021, Jireh made a down payment of euro 6.0 million, representing 50% of the total purchase price of the equipment, to the supplier. In June 2022, the equipment was delivered to Jireh after Lender paid 40% of the total purchase price, for euro 4.8 million, to the supplier on behalf of Jireh. Based on the terms of the agreement between Jireh and Lender, after the installation and configuration of the equipment for its intended use, Lender will make the remaining 10% payment for the total purchase price and reimburse Jireh for the down payment made to the supplier. By that time, the title of the equipment will be transferred to Lendor. This agreement has a 5 years term, after which Jireh has the option to purchase the equipment for $1. Jireh is required to make a monthly payment of interest at an implied interest rate of 4.75% per annum to Lessor. Principal payment is required to be paid monthly after the completion of the title transfer. The financing arrangement is secured by this machneray equipment which had the carrying amount of $12.8 million as of June 30, 2022. As of June 30, 2022, the outstanding balance of this debt financing was $5.0 million.

Long-term bank borrowings

On August 18, 2021, Jireh entered into a term loan agreement with a financial institution (the "Bank") in an amount up to $45.0 million for the purpose of expanding and upgrading the Company’s fabrication facility located in Oregon. The obligation under the loan agreement is secured by substantially all assets of Jireh and guaranteed by the Company. The agreement has a 5.5 years term and matures on February 16, 2027. Jireh is required to make consecutive quarterly payments of principal and interest. The loan accrues interest based on adjusted LIBOR plus the applicable margin based on the outstanding balance of the loan. This agreement contains customary restrictive covenants and includes certain financial covenants that the Company is required to maintain. Jireh drew down $45.0 million on February 16, 2022. As of June 30, 2022, Jireh was in compliance with these covenants and the outstanding balance of this loan was $45.0 million.

On May 1, 2018, Jireh entered into a loan agreement with the Bank that provided a term loan in an amount of $17.8 million. The obligation under the loan agreement is secured by certain real estate assets of Jireh and guaranteed by the Company.  The loan has a five-year term and matures on June 1, 2023. Beginning June 1, 2018, Jireh made consecutive monthly payments of principal and interest to the Bank. The outstanding principal shall accrue interest at a fixed rate of 5.04% per annum on the basis of a 360-day year. The loan agreement contains customary restrictive covenants and includes certain financial covenants that require the Company to maintain, on a consolidated basis, specified financial ratios. In August 2021, Jireh signed an amendment of this loan with the Bank to modify the financial covenants requirement to align with the new term loan agreement entered into on August 18, 2021 discussed above. The amendment was accounted for as a debt modification and no gain or loss was recognized. The Company was in compliance with these covenants as of June 30, 2022. As of June 30, 2022, the outstanding balance of the term loan was $14.2 million.

On August 15, 2017, Jireh entered into a credit agreement with the Bank that provided a term loan in an amount up to $30.0 million for the purpose of purchasing certain equipment for the fabrication facility located in Oregon.  The obligation under the credit agreement is secured by substantially all assets of Jireh and guaranteed by the Company.  The credit agreement has a five-year term and matures on August 15, 2022. In January 2018 and July 2018, Jireh drew down on the loan in the amount of $13.2 million and $16.7 million, respectively.  Beginning in October 2018, Jireh is required to pay to the Bank on each payment date, the outstanding principal amount of the loan in monthly installments.  The loan accrues interest based on an adjusted London Interbank Offered Rate ("LIBOR") as defined in the credit agreement, plus specified applicable margin in the range of 1.75% to 2.25%, based on the outstanding balance of the loan.  The credit agreement contains customary restrictive covenants and includes certain financial covenants that require the Company to maintain, on a consolidated basis, specified financial ratios and fixed charge coverage ratio. In August 2021, Jireh signed an amendment of this loan with the Bank to modify the financial covenants requirement to align with the new term loan agreement entered into on August 18, 2021, discussed above. The amendment was accounted for as a debt modification and no gain or loss was recognized. The Company was in compliance with these covenants as of June 30, 2022. As of June 30, 2022, the outstanding balance of the term loan was $1.9 million.
At June 30, 2022, maturities of short-term debt and long-term debt were as follows (in thousands):

Year ending June 30,
2023$25,638 
20249,952 
20259,999 
202610,047 
202712,348 
Thereafter234 
Total principal of debt68,218 
Less: debt issuance costs(169)
Total principal of debt, less debt issuance costs$68,049 

Short-term DebtLong-term DebtTotal
Principal amount$25,638 $42,580 $68,218 
Less: debt issuance costs(75)(94)(169)
Total debt, less debt issuance costs$25,563 $42,486 $68,049 
XML 32 R16.htm IDEA: XBRL DOCUMENT v3.22.2.2
Leases
12 Months Ended
Jun. 30, 2022
Leases [Abstract]  
Leases Leases
The Company evaluates contracts for lease accounting at contract inception and assesses lease classification at the lease commencement date. Operating leases are included in operating lease right-of-use ("ROU") assets, operating lease liabilities and operating lease liabilities - long-term on the Company's consolidated balance sheets. Finance leases are included in property, plant and equipment, finance lease liabilities and finance lease liabilities-long-term on the consolidated balance sheets. The Company recognizes a ROU asset and corresponding lease obligation liability at the lease commencement date where the lease obligation liability is measured at the present value of the minimum lease payments. As most of the leases do not provide an implicit rate, the Company uses its incremental borrowing rate at lease commencement. The Company uses an interest rate commensurate with the interest rate to borrow on a collateralized basis over a similar term with an amount equal to the lease payments. Operating leases are primarily related to offices, research and development facilities, sales and marketing facilities, and manufacturing facilities. In addition, long-term supply agreements to lease gas tank equipment and purchase industrial gases are accounted for as operating leases. Lease agreements frequently include renewal provisions and require the Company to pay real estate taxes, insurance and maintenance costs. For operating leases, the amortization of the ROU asset and the accretion of its lease obligation liability result in a single straight-line expense recognized over the lease term. The finance lease is related to the machinery lease financing with a vendor. In addition, the finance lease related to the RMB 400.0 million of lease financing of the JV Company with YinHai Leasing Company and The Export-Import Bank of China was not included in the Company’s Consolidated Balance Sheet at June 30, 2022 due to the deconsolidation of the JV Company on December 2, 2021. The Company does not record leases on the consolidated balance sheet with a term of one year or less.
The components of the Company’s operating and finance lease expenses are as follows for the years presented (in thousands):

Fiscal Year Ended June 30, 2022Fiscal Year Ended June 30, 2021
Operating leases:
     Fixed rent expense$6,262 $6,760 
     Variable rent expense946 815 
Finance lease:
     Amortization of equipment908 2,200 
     Interest976 2,168 
Short-term leases:
     Short-term lease expenses205 221 
               Total lease expenses$9,297 $12,164 
Supplemental balance sheet information related to the Company’s operating and finance leases is as follows (in thousands, except lease term and discount rate):

June 30, 2022June 30, 2021
Operating Leases:
     ROU assets associated with operating leases$23,674 $34,660 
Finance Lease:
     Property, plant and equipment, gross$4,831 $114,404 
     Accumulated depreciation(136)(96,470)
          Property, plant and equipment, net$4,695 $17,934 
Weighted average remaining lease term (in years)
     Operating leases7.428.44
     Finance lease5.001.72
Weighted average discount rate
     Operating leases4.27 %4.67 %
     Finance lease4.76 %5.46 %

Supplemental cash flow information related to the Company’s operating and finance lease is as follows (in thousands):

Fiscal Year Ended June 30, 2022Fiscal Year Ended June 30, 2021
Cash paid from amounts included in the measurement of lease liabilities:
     Operating cash flows from operating leases$6,480 $6,496 
     Operating cash flows from finance lease$976 $2,168 
     Financing cash flows from finance lease$4,176 $16,451 
Non-cash investing and financing information:
     Operating lease right-of-use assets obtained in exchange for lease obligations$5,852 $5,585 

Future minimum lease payments are as follows as of June 30, 2022 (in thousands):

Operating LeasesFinance Leases
2023$5,206 $993 
20244,053 1,083 
20253,222 1,083 
20263,176 1,083 
20273,147 1,076 
Thereafter10,337 — 
Total minimum lease payments29,141 5,318 
Less amount representing interest(4,413)(584)
Total lease liabilities$24,728 $4,734 
Leases Leases
The Company evaluates contracts for lease accounting at contract inception and assesses lease classification at the lease commencement date. Operating leases are included in operating lease right-of-use ("ROU") assets, operating lease liabilities and operating lease liabilities - long-term on the Company's consolidated balance sheets. Finance leases are included in property, plant and equipment, finance lease liabilities and finance lease liabilities-long-term on the consolidated balance sheets. The Company recognizes a ROU asset and corresponding lease obligation liability at the lease commencement date where the lease obligation liability is measured at the present value of the minimum lease payments. As most of the leases do not provide an implicit rate, the Company uses its incremental borrowing rate at lease commencement. The Company uses an interest rate commensurate with the interest rate to borrow on a collateralized basis over a similar term with an amount equal to the lease payments. Operating leases are primarily related to offices, research and development facilities, sales and marketing facilities, and manufacturing facilities. In addition, long-term supply agreements to lease gas tank equipment and purchase industrial gases are accounted for as operating leases. Lease agreements frequently include renewal provisions and require the Company to pay real estate taxes, insurance and maintenance costs. For operating leases, the amortization of the ROU asset and the accretion of its lease obligation liability result in a single straight-line expense recognized over the lease term. The finance lease is related to the machinery lease financing with a vendor. In addition, the finance lease related to the RMB 400.0 million of lease financing of the JV Company with YinHai Leasing Company and The Export-Import Bank of China was not included in the Company’s Consolidated Balance Sheet at June 30, 2022 due to the deconsolidation of the JV Company on December 2, 2021. The Company does not record leases on the consolidated balance sheet with a term of one year or less.
The components of the Company’s operating and finance lease expenses are as follows for the years presented (in thousands):

Fiscal Year Ended June 30, 2022Fiscal Year Ended June 30, 2021
Operating leases:
     Fixed rent expense$6,262 $6,760 
     Variable rent expense946 815 
Finance lease:
     Amortization of equipment908 2,200 
     Interest976 2,168 
Short-term leases:
     Short-term lease expenses205 221 
               Total lease expenses$9,297 $12,164 
Supplemental balance sheet information related to the Company’s operating and finance leases is as follows (in thousands, except lease term and discount rate):

June 30, 2022June 30, 2021
Operating Leases:
     ROU assets associated with operating leases$23,674 $34,660 
Finance Lease:
     Property, plant and equipment, gross$4,831 $114,404 
     Accumulated depreciation(136)(96,470)
          Property, plant and equipment, net$4,695 $17,934 
Weighted average remaining lease term (in years)
     Operating leases7.428.44
     Finance lease5.001.72
Weighted average discount rate
     Operating leases4.27 %4.67 %
     Finance lease4.76 %5.46 %

Supplemental cash flow information related to the Company’s operating and finance lease is as follows (in thousands):

Fiscal Year Ended June 30, 2022Fiscal Year Ended June 30, 2021
Cash paid from amounts included in the measurement of lease liabilities:
     Operating cash flows from operating leases$6,480 $6,496 
     Operating cash flows from finance lease$976 $2,168 
     Financing cash flows from finance lease$4,176 $16,451 
Non-cash investing and financing information:
     Operating lease right-of-use assets obtained in exchange for lease obligations$5,852 $5,585 

Future minimum lease payments are as follows as of June 30, 2022 (in thousands):

Operating LeasesFinance Leases
2023$5,206 $993 
20244,053 1,083 
20253,222 1,083 
20263,176 1,083 
20273,147 1,076 
Thereafter10,337 — 
Total minimum lease payments29,141 5,318 
Less amount representing interest(4,413)(584)
Total lease liabilities$24,728 $4,734 
XML 33 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
Shareholders' Equity
12 Months Ended
Jun. 30, 2022
Stockholders' Equity Note [Abstract]  
Shareholders' Equity Shareholders' Equity
Common Shares

The Company's Bye-laws, as amended, authorized the Company to issue 100,000,000 common shares with par value of $0.002. Each common share is entitled to one vote. The holders of common shares are also entitled to receive dividends whenever funds are legally available and when and if declared by the board of directors. No dividends had been declared as of June 30, 2022

In September 2017, the board of directors approved a repurchase program (the “Repurchase Program”) that allowed the Company to repurchase its common shares from the open market pursuant to a pre-established Rule 10b5-1 trading plan or through privately negotiated transactions up to an aggregate of $30.0 million. The amount and timing of any repurchases under the Repurchase Program depend on a number of factors, including but not limited to, the trading price, volume and availability of the Company's common shares. Shares repurchased under this program are accounted for as treasury shares and the total cost of shares repurchased is recorded as a reduction of shareholders' equity. From time to time, treasury shares may be reissued as part of the Company's stock-based compensation programs. Gains on re-issuance of treasury stock are credited to additional paid-in capital; losses are charged to additional paid-in capital to offset the net gains, if any, from previous sales or re-issuance of treasury stock. Any remaining balance of the losses is charged to retained earnings.
During fiscal year 2022, 2021 and 2020, the Company did not repurchase any shares pursuant to the repurchase program.
As of June 30, 2022, the Company had repurchased an aggregate of 6,784,648 shares for a total cost of $67.3 million, at an average price of $9.92 per share, excluding fees and related expenses, since inception of the program. No repurchased shares have been retired. Of the 6,784,648 repurchased shares, 167,395 shares with a weighted average repurchase price of $10.06 per share, were reissued at an average price of $5.00 per share for option exercises and vested restricted stock units (“RSU”). As of June 30, 2022, $13.4 million remain available under the share repurchase program.
XML 34 R18.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-based Compensation
12 Months Ended
Jun. 30, 2020
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Share-based Compensation Share-based Compensation
2018 Omnibus Incentive Plan
The 2009 Share Option/Share Issuance Plan (the “2009 Plan”) was approved in September 2009 at the annual general meeting of shareholders in connection with the Company's IPO. At the annual general meeting of shareholders in November 2018, the 2009 Plan was approved to be terminated and the 2018 Omnibus Incentive Plan (the “2018 Plan”) was effective. No further awards will be made under the 2009 Plan. The 2018 Plan authorized the board of directors to grant incentive share options, non-statutory share options and restricted shares to employees, directors, non-employee directors and consultants of the Company and its subsidiaries for up to 2,065,000 common shares. The 2018 Plan does not include an evergreen authorization Therefore, the Company is not permitted to increase the number of shares reserved in the share pool without obtaining further shareholder approval. Outstanding shares under the 2018 Plan and awards granted under the 2009 Plan that expire, are forfeited or cancelled or terminate prior to the issuance of the shares subject to those awards or are settled in cash will be available for subsequent issuance under the 2018 Plan. At the annual general meeting of shareholders in November 2021, the 2018 Plan was approved to increase by 1,000,000 shares to a total of 3,065,000 shares. As of June 30, 2022, 537,260 shares were available for grant under the 2018 Plan.
Beginning with the 2014 Annual Shareholders Meeting, on the date of each annual shareholders meeting, each individual who commences service as a non-employee Board member by reason of his or her election to the Board at such annual meeting and each individual who is to continue to serve as a non-employee Board member, whether or not that individual is standing for re-election to the Board at that particular annual meeting, will automatically be granted an award in the form of restricted share units covering that number of common shares determined by dividing one hundred twenty-five thousand dollars ($125,000) by the average fair market value per share for the ninety (90)-day period preceding the grant date, up to a maximum of 10,000 shares.

Under the 2018 Plan, incentive share options and RSU are to be granted at a price that is not less than 100% and nonstatutory share options are to be granted at not less than 85% of the fair value of the common shares, at the date of grant for employees and consultants. Options and RSUs generally vest over a four-year to five-year period, and are exercisable for a maximum period of ten years after the date of grant.
The fair value of RSU, including time-based restricted stock units and performance-based restricted stock units is based on the market price of the Company's share on the date of grant.

Time-based Restricted Stock Units (“TRSU”)

The following table summarizes the Company's TRSU activities:
 
 Number of Restricted Stock
Units
Weighted Average
Grant Date Fair
Value Per Share
Weighted Average
Remaining
Recognition
Period (Years)
Aggregate Intrinsic Value
Nonvested at June 30, 2019906,341 $14.09 1.62$8,465,225 
Granted505,440 $8.51 
Vested(455,893)$13.53 
Forfeited(23,750)$13.19 
Nonvested at June 30, 2020932,138 $11.36 1.66$10,141,661 
Granted722,873 $29.85 
Vested(567,087)$15.70 
Forfeited(34,400)$14.88 
Nonvested at June 30, 20211,053,524 $21.60 1.73$32,016,594 
Granted597,381 $45.83 
Vested(410,670)$20.54 
Forfeited(70,626)$26.79 
Nonvested at June 30, 20221,169,609 $34.03 1.73$38,994,764 
Performance-based Restricted Stock Units (“PRSU”)

In March each year since fiscal year 2017, the Company granted PRSU to certain personnel. The number of shares to be ultimately earned under the PRSU is determined based on the level of attainment of predetermined financial goals. The PRSU vests in four equal annual installments from the first anniversary date after the grant date if certain predetermined financial goals were met. The Company recorded $4.6 million, $2.3 million and $1.5 million of expenses for these PRSUs during the years ended June 30, 2022, 2021 and 2020, respectively.

During the quarter ended June 30, 2019, the Company announced an incentive program. Under this program, each participant’s award is denominated in stock and subject to achievement of certain objective goals within certain timelines. In June 2020, the Company believed it was most likely that predetermined goal measures would be met. Therefore, the Company reported such expenses in the other current liabilities line on the condensed consolidated balance sheets as the amount of bonus is to be settled in variable number of RSU’s at the completion of the objective goals. Such non-cash compensation expense was recorded as part of share-based compensation expense in the condensed consolidated statements of operations. As of June 30, 2022 and 2021, the Company recorded nil and $0.1 million such expenses in the other current liabilities, respectively. During the fiscal years ended June 30, 2022, 2021 and 2020, the Company recorded $0.3 million, $3.1 million and $0.6 million of non-cash compensation expense, respectively. As of June 30, 2022, the Company granted RSUs valued at $4.0 million to participants, which were fully vested due to achievement of certain objective measures.

The following table summarizes the Company’s PRSU activities:
Number of Performance-based Restricted Stock
Units
Weighted Average
Grant Date Fair
Value Per Share
Weighted Average
Remaining
Recognition
Period (Years)
Aggregate Intrinsic Value
Nonvested at June 30, 2019596,724 $13.95 1.88$5,573,402 
Granted155,000 $7.36 
Vested(110,659)$16.68 
Forfeited(298,290)$11.32 
Nonvested at June 30, 2020342,775 $12.38 1.60$3,729,392 
Granted165,500 $36.27 
Vested(148,211)$14.24 
Forfeited(6,240)$17.23 
Nonvested at June 30, 2021353,824 $22.69 1.74$10,752,711 
Granted194,000 $48.65 
Vested(151,199)$19.44 
Forfeited(7,250)$40.33 
Nonvested at June 30, 2022389,375 $36.56 1.85$12,981,763 

Market-based Restricted Stock Units (“MSUs”)

In December 2021, the Company granted 1.0 million market-based restricted stock units (“MSUs”) to its certain personnel. The number of shares to be earned at the end of performance period is determined based on the Company’s achievement of specified stock prices and revenue thresholds during the performance period from January 1, 2022 to December 31, 2024 as well as the recipients remaining in continuous service with the Company through such period. The MSU vests in four equal annual installments after the end of performance period. The Company estimated the grant date fair values of its MSU with derived service periods of 4.1 to 7.1 years using a Monte-Carlo simulation model with the following assumptions: Risk-free interest rate of 1.0%, expected term of 3.1 years, expected volatility of 62.8% and dividend yield of 0%. The Company recorded approximately $4.5 million expenses for these MSUs during the fiscal year ended June 30, 2022.

During the quarter ended September 30, 2018, the Company granted 1.3 million market-based restricted stock units (“MSUs”) to certain personnel. The number of shares to be earned at the end of the performance period is determined based on the Company’s achievement of specified stock prices and revenue thresholds during the performance period from January 1, 2019 to December 31, 2021 as well as the recipients remaining in continuous service with the Company through such period.
The MSUs vest in four equal annual installments after the end of performance period. On August 31, 2020, the Compensation Committee of the Board approved a modification of the terms of MSU to (i) extend the performance period through December 31, 2022 and (ii) change the commencement date for the four-year time-based service period to January 1, 2023. The modified MSUs were valued immediately before and after the modification, using Morte Carlo simulation pricing model. The Morte Carlo simulation pricing model applied the following assumptions for pre-modification conditions: risk-free interest rate of 0.13%, expected term of 1.3 years, expected volatility of 66.7% and dividend yield of 0%; and for post-modification conditions: risk-free interest rate of 0.14%, expected term of 2.3 years, expected volatility of 59.1% and dividend yield of 0%. The fair value of these MSUs was recalculated to reflect the change as of August 31, 2020 and the unrecognized compensation amount was adjusted to reflect the increase in fair value. The Company recorded approximately $1.6 million, $1.2 million and $0.6 million of expense for these MSUs during the years ended June 30, 2022, 2021 and 2020, respectively.
Stock Option
The following table summarizes the Company's stock option activities:
Weighted
WeightedAverage
AverageRemaining
Number ofExercise PriceContractual Aggregate
SharesPer ShareTerm (in years)Intrinsic Value
Outstanding at June 30, 2019876,478 $10.98 3.06
Granted— $— 
Exercised(2,500)$10.50 $4,726 
Canceled or forfeited(230,000)$17.11 
Outstanding at June 30, 2020643,978 $8.79 2.89
Granted— $— 
Exercised(156,103)$11.31 $1,272,291 
Canceled or forfeited— $— 
Outstanding at June 30, 2021487,875 $7.99 2.32
Granted— $— 
Exercised(98,000)$9.15 $3,936,675 
Canceled or forfeited— $— 
Outstanding at June 30, 2022389,875 $7.70 1.53$9,997,364 
Options vested and expected to vest389,875 $7.70 1.53$9,997,364 
Exercisable at June 30, 2022389,875 $7.70 1.53$9,997,364 

The aggregate intrinsic value for options outstanding at June 30, 2022 in the table above is based on the Company’s common stock closing price on June 30, 2022.
The 2018 Employee Share Purchase Plan
At the annual general meeting of shareholders in November 2018, the 2018 Employee Share Purchase Plan (“Purchase Plan” or “ESPP”) Plan was approved, under which 1,430,000 common shares are available for issuance. The Purchase Plan does not include an evergreen authorization, therefore the Company is not permitted to increase the number of shares reserved in the share pool without obtaining further shareholder approval. At the general meeting of shareholders in November 2021, the ESPP Plan was approved to increase from 1,430,000 shares to 2,500,000 shares. The Purchase Plan provided for a series of overlapping offering periods with a duration of 24 months, generally beginning on May 15 and November 15 of each year. The Purchase Plan allows employees to purchase common shares through payroll deductions of up to 15% of their eligible compensation. Such deductions will accumulate over a six-month accumulation period without interest. After such accumulation period, common shares will be purchased at a price equal to 85% of the fair market value per share on either the first day of the offering period or the last date of the accumulation period, whichever is less. The maximum number of shares that may be purchased by a participant on any purchase date may not exceed 875 shares for a total of 3,500 shares per a 24-
month offering period. In addition, no participant may purchase more than $25,000 worth of common stock in any one calendar year period. No more than 300,000 common shares may be purchased by all participants on any purchase date.
The ESPP is compensatory and results in compensation expense. The fair values of common shares to be issued under the ESPP were determined using the Black-Scholes option pricing model with the following assumptions:
Year Ended June 30,
202220212020
Volatility rate
66.4% - 69.9%
63.1% - 68.5%
46.4% - 58.3%
Risk-free interest rate
0.3% - 2.1%
0.1% - 0.2%
0.2% - 1.6%
Expected term1.3 years1.3 years1.3 years
Dividend yield—%—%—%

The weighted-average estimated fair value of employee stock purchase rights granted pursuant to the ESPP during the years ended June 30, 2022, 2021 and 2020 was $16.48, $11.11 and $4.33 per share, respectively.
Share-based Compensation Expenses
The total share-based compensation expense related to TRSU, PSUs, MSUs, stock options and ESPP described above, recognized in the consolidated statements of operations for the years presented was as follows:
Year Ended June 30,
202220212020
(in thousands)
Cost of goods sold$5,125 $1,756 $1,530 
Research and development7,049 5,352 2,895 
Selling, general and administrative19,150 8,216 6,029 
$31,324 $15,324 $10,454 
Total unrecognized share-based compensation expense as of June 30, 2022 was $84.3 million including estimated forfeitures, which is expected to be recognized over a weighted-average period of 3.2 years.
XML 35 R19.htm IDEA: XBRL DOCUMENT v3.22.2.2
Employee Benefit Plans
12 Months Ended
Jun. 30, 2022
Retirement Benefits [Abstract]  
Employee Benefit Plans Employee Benefit Plans
The Company maintains a 401(k) retirement plan for the benefit of qualified employees in the U.S. Employees who participate may elect to make salary deferral contributions to the plan up to 100% of the employees' eligible salary subject to annual Internal Revenue Code maximum limitations. The employer's contribution is discretionary. Effective from April 1, 2022, the Company begins to match 50% of employee contribution up to 4% of eligible compensation for a 2% maximum match. During the fiscal year ended June 30, 2022, the Company made employer match contributions of $0.3 million.
The Company makes mandatory contributions for its employees to the respective local governments in terms of retirement, medical insurance and unemployment insurance, where applicable, according to labor and social security laws and regulations of the countries and areas in which the Company operates. The retirement contribution rate is 7.7% in the U.S., 14.0% to 16.0% in China, and 6.0% in Taiwan. The Company has no obligations for the payment of such social benefits beyond the required contributions as set out above.
XML 36 R20.htm IDEA: XBRL DOCUMENT v3.22.2.2
Income Taxes
12 Months Ended
Jun. 30, 2022
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
    The provision for income taxes is comprised of:
Year Ended June 30, 
202220212020
(in thousands)
U.S. federal taxes:
Current$645 $31 $(1,673)
Deferred2,260 1,955 22 
Non-U.S. taxes:
Current7,749 2,344 1,940 
Deferred28,599 (396)58 
State taxes, net of federal benefit:
Current
Total provision for income taxes$39,258 $3,935 $348 
The reconciliation of the federal statutory income tax rate to our effective income tax rate is as follows (in percentage):

 Year Ended June 30,
 202220212020
United States statutory rate21.0 %21.0 %21.0 %
Stock-based compensation0.0 0.1 — 
Foreign taxes, net(14.3)(14.4)(36.1)
Outside basis difference on equity method investment1.2 — — 
Research and development credit(0.3)(2.4)8.0 
Non-deductible expenses0.5 2.4 (1.0)
U.S. Tax Act deferred tax re-measurement— — 6.2 
Foreign Derived Intangible Income Deduction(0.3)— — 
Other0.1 (0.2)— 
 7.9 %6.5 %(1.9)%
    The domestic and foreign components of income before taxes are:
 Year Ended June 30, 
 202220212020
(in thousands)
U.S. operations$16,684 $9,622 $3,549 
Non-U.S. operations478,386 50,602 (21,458)
Loss before income taxes$495,070 $60,224 $(17,909)
    Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of our deferred tax assets and liabilities are as follows:
 June 30, 
 20222021
(in thousands)
Deferred tax assets:
Accrued compensation$5,742 $3,954 
Net operating loss carryforwards61 22,539 
Depreciation4,365 7,924 
Tax credits15,079 15,550 
Operating lease liabilities5,807 7,292 
Capitalized intangible assets— 9,982 
Accruals and reserves643 1,113 
Total deferred tax assets31,697 68,354 
Valuation allowance(5,755)(41,474)
Total deferred tax assets, net of valuation allowance25,942 26,880 
Deferred tax liabilities:
Depreciation and amortization(18,909)(17,193)
Right of use assets(5,579)(6,968)
Investments(29,619)— 
Total deferred tax liabilities(54,107)(24,161)
Net deferred tax assets/(liabilities)
$(28,165)$2,719 
The breakdown between deferred tax assets and liabilities is as follows:
 June 30, 
 20222021
(in thousands)
Long-term deferred tax assets$592 $5,167 
Long-term deferred tax liabilities(28,757)(2,448)
Net deferred tax assets/(liabilities)$(28,165)$2,719 

The Company’s valuation allowance related to deferred income taxes as reflected in the consolidated balance sheets was $5.8 million and $41.5 million as of June 30, 2022 and 2021, respectively. The change in valuation allowance for June 30, 2022 and 2021 was a decrease of $35.7 million and an increase of $3.6 million, respectively.

At June 30, 2022 and 2021, the Company provided a valuation allowance for its state research and development credit carryforward deferred tax assets of $5.8 million for both years, as it generated more state tax credits each year than it can utilize. The Company intends to maintain a valuation allowance equal to the state research and development credit carryforwards in excess of the state net deferred tax liabilities on all other state book/tax differences and net operating loss carryforward.

At June 30, 2021, the Company provided a valuation allowance mainly for the net operating loss, fixed asset and intangible asset related to deferred tax assets of the JV Company totaling $35.7 million. The valuation allowance related to the deferred tax assets of the JV Company was reduced to $0 at June 30, 2022 as a result of the deconsolidation of the JV Company in December 2021.

At June 30, 2022, the Company had federal research and development tax credit carryforwards of approximately $8.9 million. The federal tax credits begin to expire in 2030, if not utilized.  At June 30, 2022, the Company had $0.9 million of state net operating loss carryforwards and had tax credit carryforwards of approximately $7.8 million. Approximately $0.2
million of the state tax credits begin to expire in 2023, if not utilized. The remaining $7.6 million of the state tax credits carryforward indefinitely.

The Company has not provided for withholding taxes on the undistributed earnings of its foreign subsidiaries because it intends to reinvest such earnings indefinitely. However, we have recorded a deferred tax liability of $29.6 million at June 30, 2022 related to our investment in the JV Company. As of June 30, 2022, the cumulative amount of undistributed earnings of its foreign entities considered permanently reinvested is $314.7 million. The determination of the unrecognized deferred tax liability on these earnings is not practicable. Should the Company decide to remit this income to its Bermuda parent company in a future period, its provision for income taxes may increase materially in that period.
A reconciliation of the beginning and ending amount of unrecognized tax benefits from July 1, 2019 to June 30, 2022 is as follows:
 Year Ended June 30, 
 202220212020
(in thousands)
Balance at beginning of year$7,645 $7,126 $7,150 
Additions based on tax positions related to the current year1,121 677 333 
Reductions based on tax positions related to prior years(40)(41)(114)
Reductions due to lapse of applicable statute of limitations(117)(117)(243)
Balance at end of year$8,609 $7,645 $7,126 
At June 30, 2022, the total unrecognized tax benefits of $8.6 million included $6.6 million of unrecognized tax benefits that have been netted against the related deferred tax assets. The remaining $2.0 million of unrecognized tax benefits was recorded within long-term income tax payable on the Company's consolidated balance sheet as of June 30, 2022. The Company cannot reasonably estimate the timing and amount of potential cash settlements on the unrecognized tax benefits.
The total unrecognized tax benefits of $8.6 million at June 30, 2022 included $5.6 million that, if recognized, would reduce the effective income tax rate in future periods. It is reasonably possible that the Company will recognize approximately $0.01 million reduction to its uncertain tax positions during the next twelve months, related to potential expiration of the relevant statute of limitations.
The Company recognizes interest and penalties related to uncertain tax positions in income tax expense. To the extent accrued interest and penalties do not ultimately become payable, amounts accrued will be reduced and reflected as a reduction of the overall income tax provision in the period that such determination is made. The amount of interest and penalties accrued at June 30, 2022 was $0.2 million, of which $32 thousand was recognized in the year ended June 30, 2022. The amount of interest and penalties accrued at June 30, 2021 was $0.1 million, of which $5 thousand was recognized in the year ended June 30, 2021.
The Company files its income tax returns in the United States and in various foreign jurisdictions. The tax years 2001 to 2022 remain open to examination by U.S. federal and state tax authorities. The tax years 2014 to 2022 remain open to examination by foreign tax authorities.

The Company's income tax returns are subject to examinations by the Internal Revenue Service and other tax authorities in various jurisdictions. In accordance with the guidance on the accounting for uncertainty in income taxes, the Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of its provision for income taxes. These assessments can require considerable estimates and judgments. If the Company's estimate of income tax liabilities proves to be less than the ultimate assessment, then a further charge to expense would be required. If events occur and the payment of these amounts ultimately proves to be unnecessary, the reversal of the liabilities would result in tax benefits being recognized in the period when the Company determines the liabilities are no longer necessary.

U.S. Tax Cuts and Jobs Act, Enacted December 22, 2017

On December 22, 2017, the United States enacted tax legislation commonly known as the Tax Cuts and Jobs Act (“the Tax Act”), which significantly changed the existing U.S. tax laws, including, but not limited to, (1) a reduction in the corporate tax rate from 35% to 21%, (2) a move from a worldwide tax system toward a territorial system through a “participation exemption” deduction for certain foreign-source dividends, (3) eliminating the corporate alternative minimum tax (AMT) and changing how existing AMT credits can be realized, (4) bonus depreciation that allows for full expensing of qualified property,
(5) creating a new limitation on deductible interest expense and (6) changing rules related to uses and limitations of net operating loss carryforwards created in tax years beginning after December 31, 2017.

The Company is not currently subject to the Base Erosion and Anti-Abuse (BEAT) tax, which is a tax imposed on certain entities who make payments to their non U.S. affiliates, where such payments reduce the U.S. tax base. The BEAT tax is imposed at a rate of 10% on Adjusted Taxable Income, excluding certain payments to foreign related entities. It is an incremental tax over and above the corporate income tax and is recorded as a period cost. It is possible that this tax could be applicable in future periods, which would cause an increase to the effective tax rate and cash taxes.

U.S. Coronavirus Aid, Relief and Economic Security Act” (“CARES Act”), Enacted March 27, 2020

On March 27, 2020, the United States enacted the CARES Act, which made the changes to existing U.S. tax laws, including, but not limited to, (1) allowing U.S. federal net operating losses originated in the 2018, 2019 or 2020 tax years to be carried back five years to recover taxes paid based upon taxable income in the prior five years, (2) eliminated the 80% of taxable income limitation on net operating losses for the 2018, 2019 and 2020 tax years (the 80% limitation will be reinstated for tax years after 2020), (3) accelerating the refund of prior year alternative minimum tax credits, (4) modifying the bonus depreciation for qualified improvement property and (5) modifying the limitation on deductible interest expense.

As a result of the ability to carryback net operating losses from the June 2018 and June 2019 years to the June 2015 to June 2017 tax years, net operating losses which were previously tax-effected using the current 21% U.S. federal tax rate were revalued to the U.S. tax rates in effect for the June 2015 to June 2017 tax years due to the ability of receiving tax refunds for the taxes paid in these years. Accordingly, we reported a discrete tax benefit of $1.1 million in the third quarter of fiscal year 2020 related to the re-measurement of the net operating losses that could be realized via the new net operating loss carryback provisions.

“U.S. Consolidated Appropriations Act, 2021” (“CAA 2021”), Enacted December 27, 2020

On December 27, 2020, the United States enacted the Consolidated Appropriations Act, 2021, which made changes to existing U.S. tax laws. There was no material impact of the tax law changes included in the Consolidated Appropriations Act, 2021 to the Company.

“The American Rescue Plan Act of, 2021”, Enacted March 11, 2021

On March 11, 2021, the United States enacted the American Rescue Plan Act of 2021, which made changes to existing U.S. tax laws. There was no material impact of the tax law changes included in the American Rescue Plan Act of 2021 to the Company.

“The Chip and Science Act of 2022”, Enacted August 2, 2022
In August 2022 the U.S. enacted the Chip and Science Act of 2022 (the Chips Act). The Chips Act provides incentives to semiconductor chip manufacturers in the United States, including providing a 25% manufacturing investment credits for investments in semiconductor manufacturing property placed in service after December 31, 2022, for which construction begins before January 1, 2027. Property investments qualify for the 25% credit if, among other requirements, the property is integral to the operation of an advanced manufacturing facility, defined as having a primary purpose of manufacturing semiconductors or semiconductor manufacturing equipment. Currently, we are evaluating the impact of the Chips Act to us.

Altera Litigation

On July 27, 2015, in Altera Corp. v. Commissioner, the U.S. Tax Court issued an opinion related to the treatment of stock-based compensation expense in an intercompany cost-sharing arrangement. In the July 2015 ruling, the Tax Court concluded that the sharing of the cost of employee stock compensation in a company’s cost-sharing arrangement was invalid under the U.S. Administrative Procedures Act. In June 2019, a panel of the Ninth Circuit of the U.S. Court of Appeals reversed this decision. In July 2019, Altera petitioned U.S. Court of Appeals for the Ninth Circuit to hold an en banc rehearing of the case. The petition was subsequently denied by the Ninth Circuit. Altera appealed the case to the U.S. Supreme Court in February 2020, but the U.S. Supreme Court declined to hear the case in June 2020, leaving intact the U.S. Court of Appeals for the Ninth Circuit’s decision. AOS has not recorded any benefit related to the Altera Corporation Tax Court decision in any period through June 2022. The Company will continue to monitor ongoing developments and potential impact to its financial statements.
XML 37 R21.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segment and Geographic information
12 Months Ended
Jun. 30, 2022
Segment Reporting [Abstract]  
Segment and Geographic Information Segment and Geographic Information
The Company is organized as, and operates in, one operating segment: the design, development and supply of power semiconductor products for computing, consumer electronics, communication and industrial applications. The chief operating decision-maker is the Chief Executive Officer. The financial information presented to the Company's Chief Executive Officer is on a consolidated basis, accompanied by information about revenue by customer and geographic region, for purposes of evaluating financial performance and allocating resources. The Company has one business segment, and there are no segment managers who are held accountable for operations, operating results and plans for products or components below the consolidated unit level. Accordingly, the Company reports as a single operating segment.

The Company sells its products primarily to distributors in the Asia Pacific region, who in turn sell these products to end customers. Because the Company's distributors sell their products to end customers which may have a global presence, revenue by geographical location is not necessarily representative of the geographical distribution of sales to end user markets.
The revenue by geographical location in the following tables is based on the country or region in which the products were shipped to: 
 Year Ended June 30, 
 202220212020
(in thousands)
Hong Kong$630,238 $537,553 $390,478 
China120,978 107,325 64,058 
South Korea11,802 5,497 3,303 
United States12,470 5,492 4,465 
Other countries2,064 1,035 2,605 
 $777,552 $656,902 $464,909 
During the fiscal year ended June 30, 2022, the Company corrected an immaterial error to reduce revenues in Hong Kong by $0.5 million, and to increase the revenues in China by $0.5 million for the fiscal year ended June 30, 2021.
The following is a summary of revenue by product type:
 Year Ended June 30, 
 202220212020
 (in thousands)
Power discrete$545,135 $482,718 $391,941 
Power IC220,882 161,726 66,360 
Packaging and testing services11,535 12,458 6,608 
 $777,552 $656,902 $464,909 

Long-lived assets, net consisting of property, plant and equipment and land use rights, net, as well as operating lease right-of-use assets, net by geographical area are as follows:
 June 30,
 20222021
(in thousands)
China$105,326 $350,387 
United States232,731 118,756 
Other countries4,283 2,494 
 $342,340 $471,637 
XML 38 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
Restricted Net Assets
12 Months Ended
Jun. 30, 2022
Restrictions for Consolidated and Unconsolidated Subsidiaries [Abstract]  
Restricted Net Assets Restricted Net Assets Laws and regulations in China permit payments of dividends by the Company's subsidiaries in China only out of their retained earnings, if any, as determined in accordance with China accounting standards and regulations. Each China subsidiary is also required to set aside at least 10% of its after-tax profit, if any, based on China accounting standards each year to its statutory reserves until the cumulative amount of such reserves reaches 50% of its registered capital. As a result of these China laws and regulations, the Company's China subsidiaries are restricted in their abilities to transfer a portion of their net assets to the Company. As of June 30, 2022 and 2021, such restricted portion amounted to approximately $92.4 million and $209.9 million, or 10.8% and 50.4%, of our total consolidated net assets attributable to the Company, respectively. As the Company's China subsidiaries are not revenue generating operating units, the Company does not expect to repatriate funds in the form of dividends, loans or advances from its China subsidiaries for working capital and other funding purposes.
XML 39 R23.htm IDEA: XBRL DOCUMENT v3.22.2.2
Commitments and Contingencies
12 Months Ended
Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Purchase commitments
As of June 30, 2022 and 2021, the Company had approximately $89.9 million and $81.8 million, respectively, of outstanding purchase commitments primarily for purchases of semiconductor raw materials, wafers, spare parts, packaging and testing services and others.
As of June 30, 2022 and 2021, the Company had approximately $63.4 million, and $90.0 million, respectively, of commitments for the purchase of property and equipment.
Other commitments
See Notes 1, 7 and 8 to the Consolidated Financial Statements contained in this annual Report on Form 10-K for descriptions of commitments including Joint Venture, debt and leases.
Contingencies and indemnities

The Company has in the past, and may from time to time in the future, become involved in legal proceedings arising from the normal course of business activities.  The semiconductor industry is characterized by frequent claims and litigation, including claims regarding patent and other intellectual property rights as well as improper hiring practices. Irrespective of the validity of such claims, the Company could incur significant costs in the defense of such claims and suffer adverse effects on its operations.

As previously disclosed, U.S. Department of Justice (“DOJ”) commenced an investigation into the Company’s compliance with export control regulations relating to its business transactions with Huawei and its affiliates (“Huawei”), which were added to the “Entity List” by the Department of Commerce (“DOC”) in May 2019. The Company is cooperating fully with federal authorities in the investigation. The Company has continued to respond to inquiries and requests from DOJ for documents and information relating to the investigation, and the matter is currently pending at DOJ, and DOJ has not provided the Company with any specific timeline or indication as to when the investigation will be concluded or resolved. In connection with this investigation, DOC previously requested the Company to suspend shipments of its products to Huawei. The Company complied with such request, and the Company has not shipped any product to Huawei after December 31, 2019. The Company continues to work with DOC to resolve this issue and requested DOC to grant permission to reinstate the Company’s shipments to Huawei. As part of this process and in response to DOC’s request, the Company provided certain documents and materials relating to the Company’s supply chain and shipment process to DOC, and DOC is currently reviewing this matter. DOC has not informed the Company of any specific timeline or schedule under which DOC will provide a response to the Company’s request. Given the case is in still ongoing and neither DOJ nor DOC have provided the Company with any clear indication of the timing and schedule for the investigation, the Company cannot estimate the reasonably possible loss or range of loss that may occur. Also, the Company is unable to predict the duration, scope, result or related costs of the investigation, although the Company expects to incur additional professional fees as a result of this matter. In addition, the Company is unable to predict what, if any, further action that may be taken by the government in connection with the investigation, or what, if any, penalties, sanctions or remedial actions may be sought.

The Company is a party to a variety of agreements that it has contracted with various third parties. Pursuant to these agreements, the Company may be obligated to indemnify another party to such an agreement with respect to certain matters. Typically, these obligations arise in the context of contracts entered into by the Company, under which the Company customarily agrees to hold the other party harmless against losses arising from a breach of representations and covenants related to such matters as title to assets sold, certain intellectual property rights, specified environmental matters and certain income taxes. In these circumstances, payment by the Company is customarily conditioned on the other party making a claim pursuant
to the procedures specified in the particular contract, which procedures typically allow the Company to challenge the other party's claim. Further, the Company's obligations under these agreements may be limited in time and/or amount, and in some instances, the Company may have recourse against third parties for certain payments made by it under these agreements. The Company has not historically paid or recorded any material indemnifications, and no accrual was made at June 30, 2022 and 2021.

The Company has agreed to indemnify its directors and certain employees as permitted by law and pursuant to its Bye-laws, and has entered into indemnification agreements with its directors and executive officers. The Company has not recorded a liability associated with these indemnification arrangements, as it historically has not incurred any material costs associated with such indemnification obligations. Costs associated with such indemnification obligations may be mitigated by insurance coverage that the Company maintains. However, such insurance may not cover any, or may cover only a portion of, the amounts the Company may be required to pay. In addition, the Company may not be able to maintain such insurance coverage at reasonable cost, if at all, in the future.

Environmental matters

The Company is subject to various federal, state, local, and foreign laws and regulations governing environmental
matters, including the use, handling, discharge, and disposal of hazardous materials. The Company believes that it has been in material compliance with applicable environmental regulations and standards. Complying with current laws and regulations has not had a material adverse effect on the Company’s financial condition and results of operations. However, it is possible that additional environmental issues may arise in the future, which the Company cannot currently predict.
XML 40 R24.htm IDEA: XBRL DOCUMENT v3.22.2.2
Cybersecutiy Incident
12 Months Ended
Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
Cybersecurity Incident Cybersecurity Incident In April 2022, the Company became aware of a cybersecurity incident involving unauthorized access to one email account at the Company, which caused the Company to make payments to unauthorized bank accounts. As a result, the Company recorded a loss of $1.5 million due to the incident for the three months ended March 31, 2022. The financial impact of this incident was not material, and there were no changes to previously released financial results or financial statements. Immediately following the discovery, the Company commenced an investigation, contained the incident and implemented additional protective measures and internal control policies and procedures. The Company has also retained a professional cybersecurity investigation firm to conduct a full forensic analysis of the incident, and concluded that there were no evidence of malware, persistence mechanisms or other compromised exchange on-premises accounts within the Company's environment. In addition, there was no evidence to suggest that these accounts were accessed via the user agent that has the capability to synchronize or download email messages to the user’s local host. This incident appears to be isolated and its financial impact identified to date was not material. The Company believes that it had not incurred other damages and losses based on the conclusion of the full investigation.
XML 41 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
Schedule II - Valuation and Qualifying Accounts
12 Months Ended
Jun. 30, 2022
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
Valuation and Qualifying Accounts
AllowanceAllowance Allowance
for Doubtfulfor Price for Deferred
Accounts AdjustmentsTax Assets
June 30, 2019$30 $24,075 $35,420 
Additions— 140,413 2,407 
Reductions— (134,396)— 
June 30, 2020$30 $30,092 $37,827 
Additions— 178,902 3,647 
Reductions— (196,579)— 
June 30, 2021$30 $12,415 $41,474 
Additions— 170,651 — 
Reductions— (164,335)(35,719)
June 30, 2022$30 $18,731 $5,755 
XML 42 R26.htm IDEA: XBRL DOCUMENT v3.22.2.2
The Company and Significant Accounting Policies (Policies)
12 Months Ended
Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Preparation
Basis of Preparation

The consolidated financial statements include the accounts of the Company, its wholly-owned subsidiaries and a subsidiary in which it had a controlling interest until December 1, 2021. As of December 2, 2021, the Company ceased having control over this subsidiary. Therefore, the Company deconsolidated this subsidiary as of that date. Subsequently, the Company has accounted for it using the equity method of accounting. All intercompany account balances and transactions have been eliminated. The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”).
Reclassification
Certain reclassifications of prior period presentation to conform to current period presentation have been made with no changes made to balance sheet, income statement or statement of cash flows subtotals.
Joint Venture The Joint Venture was accounted under the provisions of the consolidation guidance since the Company had controlling financial interest until December 1, 2021.
Risks and Uncertainties
Certain Significant Risks and Uncertainties Related to Outbreak of Coronavirus Disease 2019 (“COVID-19”)

The COVID-19 pandemic has had and continues to have a negative impact on business and economic activities across the globe. As a result of the COVID-19 pandemic and the global economic downturn and changing consumer behaviors due to various restrictions imposed by governments, the Company has experienced shifting market trends, including an increasing demand in the markets for notebooks, PCs and gaming devices and decreasing demand for mobile phone and industrial products, as more consumers are staying at and working from home. While the Company has recently benefited from the increasing demand of consumer electronics and PC related products, there is no guarantee that this trend will continue, and such increasing demand may discontinue or decline as government authorities relax and terminate COVID-19 related restrictions and consumer behaviors change. Furthermore, as the COVID-19 pandemic continues and global economic downturn and high unemployment persists, consumer spending may slow down substantially, in which case the Company may experience a significant decline of customer orders for its products, including those designed for PC-related applications, and such decline will adversely affect its financial conditions and results of operations. The full extent of the future impact of the COVID-19 pandemic on the Company’s operational and financial performance is uncertain and will depend on many factors outside the Company’s control, including, without limitation, the timing, extent, trajectory and duration of the pandemic; the availability, distribution and effectiveness of vaccines; the spread of new variants of COVID-19; the continued or renewed imposition of protective public safety measures and government mandates; the continuing disruption of global supply chain affecting the semiconductor industry; and the impact of the pandemic on the global economy and demand for consumer products.

In April 2022, the operations of our two packaging and testing facilities in Shanghai, China were suspended due to a strict lockdown of the city imposed by the local government in response to surging COVID cases. Our facilities in Shanghai were required to be shut down and production was halted beginning in early April. Transportation suspension in and out of Shanghai also interrupted the shipping of raw materials and finished parts to and from our facilities. We received permission to reopen our facilities partially in early May. We gradually ramped up production at these facilities in May and returned to normal operation in June 2022. The suspension of our Shanghai facilities, and the subsequent partial resumption of production, reduced our ability to complete orders from our customers in a timely manner, which adversely affected our revenue and results of operation for the three months ended June 30, 2022.
Risks and Uncertainties

The Company is subject to certain risks and uncertainties. The Company believes changes in any of the following areas could have a material adverse effect on the Company's future financial position or results of operations or cash flows: the timing and success of new product development, including market receptiveness, operation of in-house manufacturing facilities, litigation or claims against the Company based on intellectual property, patent, product regulatory or other factors, competition from other products, general economic conditions, the inability to attract and retain qualified employees, lack of control to the JV Company and ultimately to sustain profitable operations, risks associated with doing business in China, and ability to diversify products and develop digital business; the general state of the U.S., China and world economies; the highly cyclical nature of the industries the Company serves; the loss of any of its larger customers; restrictions on the Company’s ability to sell to foreign customers due to trade laws, regulations and requirements; disruptions of the supply chain of components needed for our products; inability to obtain additional financing; inability to meet certain debt covenants; fundamental changes in the technology underlying the Company’s products; successful and timely completion of product design efforts; and new product design introductions by competitors. Additional risks and uncertainties that the Company is unaware of, or that the Company currently believes are not material, may also become important factors that adversely affect its business.

The Company's revenue limited by its ability to utilize wafer production and packaging and testing capacity from its in-house facilities and obtain adequate wafer supplies from third-party foundries. The Company recently entered into a new agreement with the JV Company pursuant to which the JV Company agrees to provide us with a guaranteed supply of a fixed number of wafers until December 2023. Currently the Company's main third-party foundry is Shanghai Hua Hong Grace Electronic Company Limited, or HHGrace, located in Shanghai, China. HHGrace has been manufacturing wafers for the Company since 2002. HHGrace manufactured approximately 10.3%, 11.5% and 12.7% of the wafers used in the Company's products for the fiscal years ended June 30, 2022, 2021 and 2020, respectively. Although the Company believes that its volume
of production allows the Company to secure favorable pricing and priority in allocation of capacity in its third-party foundries, if the foundries' capacities are constrained due to market demands, HHGrace, together with other foundries from which the Company purchases wafers, may not be willing or able to satisfy all of the Company's manufacturing requirements on a timely basis and/or at favorable prices. The Company is also subject to the risks of service disruptions and raw material shortages by its foundries. Such disruptions, shortages and price increases could harm the Company’s operating results. In addition, manufacturing facilities' capacity affects the Company's gross margin because the Company has certain fixed costs associated with its Oregon Fab and the JV Company, as well as in-house packaging and testing facilities. If the Company fails to utilize its manufacturing facilities' capacity at a desirable level, its financial condition and results of operations will be adversely affected.
Use of Estimates
Use of Estimates
The preparation of the consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses. To the extent there are material differences between these estimates and actual results, the Company's condensed consolidated financial statements will be affected. On an ongoing basis, the Company evaluates the estimates, judgments and assumptions including those related to stock rotation returns, price adjustments, allowance for doubtful accounts, inventory reserves, warranty accrual, income taxes, leases, share-based compensation, recoverability of and useful lives for property, plant and equipment and intangible assets, as well as the economic implications of the COVID-19 pandemic.
Foreign Currency Transactions and Translation
Foreign Currency Transactions and Translation
Most of the Company's principal subsidiaries use U.S. dollars as their functional currency because their transactions are primarily conducted and settled in U.S. dollars. All of their revenues and a significant portion of their operating expenses are denominated in U.S. dollars. The functional currencies for the Company's in-house packaging and testing facilities in China are U.S. dollars, and a majority of their capital expenditures are denominated in U.S. dollars. Foreign currency transactions are translated into the functional currencies using the exchange rates prevailing at the dates of the transactions. Foreign exchange gains and losses, resulting from the settlement of such transactions and from the re-measurement of monetary assets and liabilities denominated in foreign currencies using exchange rates at balance sheet date and non-monetary assets and liabilities using historical exchange rates, are recognized in the consolidated statements of operations.
For the Company's subsidiaries which use the local currency as their functional currency, their results and financial position are translated into U.S. dollars using exchange rates at balance sheet dates for assets and liabilities and using average exchange rates for income and expenses items. The resulting translation differences are presented as a separate component of accumulated other comprehensive income (loss) and noncontrolling interest in the consolidated statements of equity.
Cash and Cash Equivalents, Restricted Cash
Cash, Cash Equivalents and Restricted Cash
Cash and cash equivalents primarily consist of cash on hand and short-term bank deposits with original maturities of three months or less. Cash equivalents are highly liquid investments with stated maturities of three months or less as of the dates of purchase. The carrying amounts reported for cash and cash equivalents are considered to approximate fair values based upon their short maturities.

Cash and cash equivalents are maintained with reputable major financial institutions. If, due to current economic conditions or other factors, one or more of the financial institutions with which the Company maintains deposits fails, the Company's cash and cash equivalents may be at risk. Deposits with these banks may exceed the amount of insurance provided on such deposits; however, these deposits typically may be redeemed upon demand and, therefore, bear minimal risk.
The Company maintains restricted cash in connection with cash balances temporarily restricted for regular business operations, including the possibility of a dispute with a vendor. These balances have been excluded from the Company’s cash and cash equivalents balance and are classified as restricted cash in the Company’s consolidated balance sheets. As of June 30, 2022 and 2021, the amount of restricted cash was $0.3 million and $2.4 million, respectively.
Accounts Receivable Accounts Receivable, netThe allowance for doubtful accounts is based on assessment of the collectability of accounts receivable from customers. The Company reviews the allowance by considering factors such as historical collection experience, credit quality, age of the accounts receivable balances and current economic conditions that may affect a customer's ability to pay. The Company writes off a receivable and charges against its recorded allowance when it has exhausted its collection efforts without success.
Fair Value Measurements
Fair Value Measurements
    Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value, which are the following:
Level 1 - Quoted prices in active markets for identical assets or liabilities.
Level 2 - Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
The fair value of cash equivalents is based on observable market prices and have been categorized in Level 1 in the fair value hierarchy. Cash equivalents consist primarily of short-term bank deposits. The carrying values of financial instruments such as cash and cash equivalents, accounts receivable and accounts payable approximate their carrying values due to their short-term maturities. The carrying value of the company's debt is considered a reasonable estimate of fair value which is estimated by considering the current rates available to the Company for debt of the same remaining maturities, structure and terms of the debts.
Inventories
Inventories

The Company carries inventories at the lower of cost (determined on a first-in, first-out basis) or net realizable value. Cost includes semiconductor wafer and raw materials, labor, depreciation expenses and other manufacturing expenses and overhead, and packaging and testing fees paid to third parties if subcontractors are used. Valuation of inventories are based on the Company's periodic review of inventory quantities on hand as compared with its sales forecasts, historical usage, aging of inventories, production yield levels and current product selling prices. If actual market conditions are less favorable than those forecasted by management, additional future inventory write-downs may be required that could adversely affect the Company's operating results. Adjustments to inventory once established are not reversed until the related inventory has been sold or scrapped.
Property, Plant and Equipment
Property, Plant and Equipment
Property, plant and equipment are stated at historical cost less accumulated depreciation. Historical cost includes expenditures that are directly attributable to the acquisition of the items and the costs incurred to make the assets ready for their intended use.
Depreciation is provided for on a straight-line basis over the estimated useful lives of the related assets as follows:

 
Building
20 years
Manufacturing machinery and equipment
8 to 10 years
Equipment and tooling
3 to 5 years
Computer hardware and software
3 to 5 years
Office furniture and equipment
5 years
Leasehold and building improvements
2 to 20 years
Vehicle
5 years


Equipment and construction in progress represent equipment received but the necessary installation has not been fully performed or building construction and leasehold improvements have been started but not yet completed. Equipment and construction in progress are stated at cost and transferred to respective asset class when fully completed and ready for their intended use.
Internal-use software development costs are capitalized to the extent that the costs are directly associated with the development of identifiable and unique software products controlled by the Company that will probably generate economic benefits beyond one year. Costs incurred during the application development stage are required to be capitalized. The application development stage is characterized by software design and configuration activities, coding, testing and installation. Training costs and maintenance are expensed as incurred, while upgrades and enhancements are capitalized if it is probable that such expenditures will result in additional functionality. Costs include employee costs incurred and fees paid to outside consultants for the software development and implementation. Internally developed software is amortized over its estimated useful life of three to five years starting from the date when it is ready for its intended use.
Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized as selling, general and administrative expenses in the consolidated statements of operations. Costs of maintenance and repairs that do not improve or extend the lives of the respective assets are expensed as incurred.
Government Grants Government GrantsThe Company occasionally receives government grants that provide financial assistance for certain eligible expenditures in China. These grants include reimbursements on interest expense on bank borrowings, payroll tax credits, credit for property, plant and equipment in a particular geographical location, employment credits as well as business expansion credits. Government grants are not recognized until there is reasonable assurance that the Company will comply with the conditions attaching to it, and that the grant will be received. The Company records such grants either as a reduction of the related expense, a reduction of the cost of the related asset, or as other income depending upon the nature of the grant.
Impairment of Long-Lived Assets
Long-lived Assets

The Company reviews all long-lived assets whenever events or changes in circumstance indicate that these assets may not be recoverable. When evaluating long-lived assets, if the Company concludes that the estimated undiscounted cash flows attributable to the assets are less than their carrying value, the Company recognizes an impairment loss based on the excess of the carrying amount of the assets over their respective fair values, which could adversely affect our results of operations.
Revenue Recognition
Revenue Recognition

The Company determines revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract; and (5) recognition of revenue when, or as, a performance obligation is satisfied. The Company recognizes product revenue at a point in time when product is shipped to the customer, as determined by the agreed upon shipping terms, net of estimated stock rotation returns and price adjustments that it expects to provide to certain distributors. The Company presents revenue net of sales taxes and any similar assessments. Our standard payment terms range from 30 to 60 days.

The Company sells its products primarily to distributors, who in turn sell the products globally to various end customers. The Company allows stock rotation returns from certain distributors. Stock rotation returns are governed by contract and are limited to a specified percentage of the monetary value of products purchased by distributors during a specified period. The Company records an allowance for stock rotation returns based on historical returns, current expectations, and individual distributor agreements. The Company also provides special pricing to certain distributors, primarily based on volume, to encourage resale of the Company's products. Allowance for price adjustments is recorded against accounts receivable and the provision for stock rotation rights is included in accrued liabilities on the consolidated balance sheets.

The Company's performance obligations relate to contracts with a duration of less than one year. The Company elected to apply the practical expedient provided in ASC 606, “Revenue from Contracts with Customers”. Therefore, the Company is not required to disclose the aggregate amount of transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period.
The Company recognizes the incremental direct costs of obtaining a contract, which consist of sales commissions, when control over the products they relate to transfers to the customer. Applying the practical expedient, the Company recognizes commissions as expense when incurred, as the amortization period of the commission asset the Company would have otherwise recognized is less than one year. Packaging and testing services revenue is recognized at a point in time upon shipment of serviced products to the customer.
Leases
Leases

The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets, current operating lease liabilities and long-term operating lease liabilities on the Company's consolidated balance sheets. Finance leases are included in property, plant and equipment, finance lease liabilities and long-term finance leases liabilities on the consolidated balance sheets.
Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. The Company determined its incremental borrowing rate based on the information available at the lease commencement date. The operating lease ROU assets also include any lease payments made and exclude lease incentives. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. Operating lease expense is generally recognized on a straight-line basis over the lease term. Variable lease payments are expensed as incurred and are not included within the operating lease ROU asset and lease liability calculation. The Company does not record leases on the consolidated balance sheet with a term of one year or less. The Company elected to combine its lease and non-lease components as a single lease component for all asset classes.
Product Warranty
Product Warranty

The Company provides a standard one-year warranty for the products from the date of purchase by the end customers. The Company accrues for estimated warranty costs at the time revenue is recognized. The Company's warranty obligation is affected by product failure rates, labor and material costs for replacing defective parts, related freight costs for failed parts and other quality assurance costs. The Company monitors its product returns for warranty claims and maintains warranty reserves based on historical experiences and anticipated warranty claims known at the time of estimation.
Shipping and Handling Costs
Shipping and Handling Costs
Shipping and handling costs are included in cost of goods sold.
Research and Development Research and Development Research and development costs are expensed as incurred.
Provision for Income Taxes
Provision for Income Taxes

Income tax expense or benefit is based on income or loss before taxes. Deferred tax assets and liabilities are recognized principally for the expected tax consequences of temporary differences between the tax basis of assets and liabilities and their reported amounts.

The Company is subject to income taxes in a number of jurisdictions. Significant judgment is required in determining the worldwide provision for income taxes. There are many transactions and calculations for which the ultimate tax determination is uncertain during the ordinary course of business. The Company establishes accruals for certain tax contingencies based on estimates of whether additional taxes may be due. While the final tax outcome of these matters may differ from the amounts that were initially recorded, such differences will impact the income tax and deferred tax provisions in the period in which such determination is made.

Significant management judgment is also required in determining whether deferred tax assets will be realized in full or in part. When it is more likely than not that all or some portion of specific deferred tax assets such as net operating losses or research and experimentation tax credit carryforwards will not be realized, a valuation allowance must be established for the amount of the deferred tax assets that cannot be realized. The Company considers all available positive and negative evidence on a jurisdiction-by-jurisdiction basis when assessing whether it is more likely than not that deferred tax assets are recoverable.
The Company considers evidence such as our past operating results, the existence of cumulative losses in recent years and our forecast of future taxable income.

The Financial Accounting Standards Board (FASB), issued guidance which clarifies the accounting for income taxes by prescribing a minimum probability threshold that a tax position must meet before a financial statement benefit is recognized. The minimum threshold is defined as a tax position that is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. The tax benefit to be recognized is measured as the largest amount of benefit that is greater than fifty percent likely to be realized upon ultimate settlement. Although the guidance on the accounting for uncertainty in income taxes prescribes the use of a recognition and measurement model, the determination of whether an uncertain tax position has met those thresholds will continue to require significant judgment by management. If the ultimate resolution of tax uncertainties is different from what is currently estimated, a material impact on income tax expense could result.

The Company's provision for income taxes is subject to volatility and could be adversely impacted by changes in earnings or tax laws and regulations in various jurisdictions. The Company is subject to the continuous examination of our income tax returns by the Internal Revenue Service and other tax authorities. The Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of our provision for income taxes. To the extent that the final tax outcome of these matters is different from the amounts recorded, such differences will impact the provision for income taxes in the period in which such determination is made. The provision for income taxes includes the impact of changes to reserves, as well as the related net interest and penalties.
Share-based Compensation Expense
Share-based Compensation Expense

The Company maintains an equity-settled, share-based compensation plan to grant restricted share units and stock options. The Company recognizes expense related to share-based compensation awards that are ultimately expected to vest based on estimated fair values on the date of grant. The fair value of restricted share units is based on the fair value of the Company's common share on the date of grant. For restricted stock awards subject to market conditions, the fair value of each restricted stock award is estimated at the date of grant using the Monte-Carlo pricing model. The fair value of stock options is estimated on the date of grant using the Black-Scholes option valuation model. Share-based compensation expense is recognized on the accelerated attribution basis over the requisite service period of the award, which generally equals the vesting period. The Black-Scholes option valuation model requires the input of subjective assumptions, including the expected term and stock price volatility. In addition, judgment is also required in estimating the number of stock-based awards that are expected to be forfeited. Forfeitures are estimated based on historical experience at the time of grant. Changes in estimated forfeitures are recognized in the period of change and impact the amount of stock compensation expenses to be recognized in future periods, which could be material if actual results differ significantly from estimates.
The Employee Share Purchase Plan (the “ESPP”) is accounted for at fair value on the date of grant using the Black-Scholes option valuation model.
Advertising
Advertising

Advertising expenditures are expensed as incurred. Advertising expense was $0.2 million, $0.4 million and $0.7 million in the fiscal years ended June 30, 2022, 2021, and 2020, respectively.
Comprehensive Income (loss) Comprehensive Income (Loss) Comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. The Company's accumulated other comprehensive income (loss) consists of cumulative foreign currency translation adjustments.
Recent Accounting Pronouncements
Recent Accounting Pronouncements
Recently Issued Accounting Standards not yet adopted

In November 2021, the FASB issued Accounting Standards Update (ASU) No. 2021-10, “Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance.” This ASU requires business entities to make annual disclosures about transactions with a government they account for by analogizing to a grant or contribution accounting model under ASC 958-605. The ASU is effective for all entities within their scope for financial statements issued for annual periods
beginning after December 15, 2021. The adoption will not have any impacts on the Company's consolidated financial position, results of operations or cash flows.

In August 2020, the FASB issued ASU No. 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity”, which, among other things, provides guidance on how to account for contracts on an entity’s own equity. This ASU simplifies the accounting for certain financial instruments with characteristics of liabilities and equity. Specifically, the ASU eliminated the need for the Company to assess (1) whether a contract on the entity’s own equity permits settlement in unregistered shares, (2) whether counterparty rights rank higher than shareholder’s rights, and (3) whether collateral is required. In addition, the ASU requires incremental disclosure related to contracts on the entity’s own equity and clarifies the treatment of certain financial instruments accounted for under this ASU on earnings per share. For public business entities, the ASU is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. The Company does not expect the adoption of this guidance will have a material impact on its consolidated financial position, results of operations or cash flows.
Recently Adopted Accounting Standards

In January 2020, the FASB issued ASU No. 2020-01, “Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.” The ASU is based on a consensus of the Emerging Issues Task Force and is expected to increase comparability in accounting for these transactions. ASU 2016-01 made targeted improvements to accounting for financial instruments, including providing an entity the ability to measure certain equity securities without a readily determinable fair value at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Among other topics, the amendments clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting. The adoption of ASU 2020-01 on July 1, 2021 had no material impact on the Company's Consolidated Financial Statements.

In December 2019, the FASB issued ASU No. 2019-12 “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”) by removing certain exceptions to the general principles. The Company adopted ASU 2019-12 as of July 1, 2021. ASU 2019-12 had no material impact on the Company's Consolidated Financial Statements.
XML 43 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
The Company and Significant Accounting Policies (Tables)
12 Months Ended
Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Property, Plant and Equipment
Depreciation is provided for on a straight-line basis over the estimated useful lives of the related assets as follows:

 
Building
20 years
Manufacturing machinery and equipment
8 to 10 years
Equipment and tooling
3 to 5 years
Computer hardware and software
3 to 5 years
Office furniture and equipment
5 years
Leasehold and building improvements
2 to 20 years
Vehicle
5 years
Property, plant and equipment, net
 
June 30,  
 20222021
(in thousands)
Land$4,877 $4,877 
Building16,691 71,454 
Manufacturing machinery and equipment287,574 515,320 
Equipment and tooling28,052 27,017 
Computer equipment and software46,758 41,518 
Office furniture and equipment2,820 3,814 
Leasehold improvements35,254 74,733 
Land use rights— 9,319 
 422,026 748,052 
Less: accumulated depreciation(233,340)(348,749)
 188,686 399,303 
Equipment and construction in progress129,980 37,674 
Property, plant and equipment, net$318,666 $436,977 
Schedule of Finite-Lived Intangible Assets
Intangible assets, net
 
June 30,  
 20222021
(in thousands)
Patents and technology rights$18,037 $18,037 
Trade name268 268 
Customer relationships1,150 1,150 
19,455 19,455 
Less: accumulated amortization(9,674)(6,314)
9,781 13,141 
Goodwill269 269 
Intangible assets, net$10,050 $13,410 
XML 44 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
Equity Method Investment in Equity Investee (Tables)
12 Months Ended
Jun. 30, 2022
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of deconsolidation The gain on deconsolidation of the JV Company was calculated as follows:
(in thousands)
Cash received for sales of shares in the JV Company
$16,924 
Fair value of retained equity method investment
393,124 
Carrying amount of non-controlling interest
143,889 
Cumulative translation adjustment removal
1,793 
Carrying amount of net assets of the JV Company at December 1, 2021
(156,637)
Gain on deconsolidation of the JV Company
$399,093 
The net loss associated with these sales of JV Company equity interest held by the Company were recorded in the fiscal year ended June 30, 2022 as follows:

(in thousands)
Gain on 1.1% equity interest sold
$475 
Loss on diluted equity interest from issuance of shares under the employee equity incentive plan
(8,116)
Gain on 7.82% equity interest sold4,501 
Loss on changes on equity interest of the JV Company, net
$(3,140)
Summarized financial information of joint venture
The following table presents summarized financial information for the JV Company as of and for the period from December 2, 2021 through March 31, 2022, using lag reporting (in thousands):

As of March 31, 2022
Current assets$198,323 
Non-current assets$364,777 
Current liabilities$251,988 
Non-current liabilities$76,207 
For the periods of December 2, 2021 to March 31, 2022
Revenue$68,972 
Gross loss$870 
Operating expenses$2,280 
Net loss$6,197 
XML 45 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited (Tables)
12 Months Ended
Jun. 30, 2022
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table presents the calculation of basic and diluted net income (loss) per share attributable to common shareholders:
 Year Ended June 30,  
 202220212020
(in thousands, except per share data)
Numerator:
Net income (loss) attributable to Alpha and Omega Semiconductor Limited$453,163 $58,116 $(6,596)
Denominator:
Basic:
Weighted average number of common shares used to compute basic net income per share26,764 25,786 24,840 
Diluted:
Weighted average number of common shares used to compute basic net income per share26,764 25,786 24,840 
Effect of potentially dilutive securities:
Stock options, RSUs and ESPP shares1,439 1,486 — 
Weighted average number of common shares used to compute diluted net income per share28,203 27,272 24,840 
Net income (loss) per share attributable to Alpha and Omega Semiconductor Limited:
Basic$16.93 $2.25 $(0.27)
Diluted$16.07 $2.13 $(0.27)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following potential dilutive securities were excluded from the computation of diluted net income (loss) per share as their effect would have been anti-dilutive:
 Year Ended June 30,  
 202220212020
(in thousands)
Employee stock options and RSUs277 193 2,028 
ESPP21 71 834 
Total potential dilutive securities298 264 2,862 
XML 46 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
Concentration of Credit Risk and Significant Customers (Tables)
12 Months Ended
Jun. 30, 2022
Risks and Uncertainties [Abstract]  
Schedules of Concentration of Risk, by Risk Factor
Summarized below are individual customers whose revenue or accounts receivable balances were 10% or higher than the respective total consolidated amounts:
   Year Ended June 30,
Percentage of revenue  2022 2021 2020
Customer A  24.6 % 28.7 % 29.3 %
Customer B  39.7 % 35.4 % 35.5 %
   June 30,
Percentage of accounts receivable  2022 2021
Customer A  24.6 % 12.4 %
Customer B  36.4 % 22.1 %
Customer C  * 21.9 %
Customer D12.0 %*
* Less than 10%
XML 47 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
Balance Sheet Components (Tables)
12 Months Ended
Jun. 30, 2022
Balance Sheet Related Disclosures [Abstract]  
Schedule of Accounts, Notes, Loans and Financing Receivable
Accounts receivable, net
 
June 30,  
 20222021
(in thousands)
Accounts receivable$84,442 $48,234 
Less: Allowance for price adjustments(18,731)(12,415)
Less: Allowance for doubtful accounts(30)(30)
Accounts receivable, net$65,681 $35,789 
Schedule of Inventory, Current
Inventories
 
June 30,
 20222021
(in thousands)
Raw materials$67,960 $68,900 
Work in-process80,720 68,824 
Finished goods9,360 16,569 
 $158,040 $154,293 
Schedule of Other Current Assets
Other current assets
 
June 30,
 20222021
(in thousands)
VAT receivable$737 $1,539 
Other prepaid expenses3,954 1,465 
Prepaid insurance2,590 2,615 
Prepaid maintenance826 1,670 
Prepayments to supplier257 2,540 
Prepaid income tax2,086 2,221 
Interest receivable25 2,207 
Customs deposit— 270 
Other receivables745 68 
 $11,220 $14,595 
Property, Plant and Equipment
Depreciation is provided for on a straight-line basis over the estimated useful lives of the related assets as follows:

 
Building
20 years
Manufacturing machinery and equipment
8 to 10 years
Equipment and tooling
3 to 5 years
Computer hardware and software
3 to 5 years
Office furniture and equipment
5 years
Leasehold and building improvements
2 to 20 years
Vehicle
5 years
Property, plant and equipment, net
 
June 30,  
 20222021
(in thousands)
Land$4,877 $4,877 
Building16,691 71,454 
Manufacturing machinery and equipment287,574 515,320 
Equipment and tooling28,052 27,017 
Computer equipment and software46,758 41,518 
Office furniture and equipment2,820 3,814 
Leasehold improvements35,254 74,733 
Land use rights— 9,319 
 422,026 748,052 
Less: accumulated depreciation(233,340)(348,749)
 188,686 399,303 
Equipment and construction in progress129,980 37,674 
Property, plant and equipment, net$318,666 $436,977 
Schedule of Other Assets, Noncurrent
Other long-term assets
June 30,  
 20222021
(in thousands)
Prepayments for property and equipment$6,890 $14,882 
Investments in privately held companies100 100 
Customs deposit 1,708 1,120 
Deposit with supplier6,396 — 
Other long-term deposits18 927 
Office leases deposits1,012 1,100 
Other1,553 740 
 $17,677 $18,869 
Schedule of Finite-Lived Intangible Assets
Intangible assets, net
 
June 30,  
 20222021
(in thousands)
Patents and technology rights$18,037 $18,037 
Trade name268 268 
Customer relationships1,150 1,150 
19,455 19,455 
Less: accumulated amortization(9,674)(6,314)
9,781 13,141 
Goodwill269 269 
Intangible assets, net$10,050 $13,410 
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
Estimated future minimum amortization expense of intangible assets is as follows (in thousands):
Year ending June 30,
2023$3,286 
20243,249 
20253,246 
$9,781 
Schedule of Accrued Liabilities Accrued liabilities
 
June 30,  
 20222021
(in thousands)
Accrued compensation and benefits$34,681 $32,756 
Warranty accrual2,650 2,795 
Stock rotation accrual4,798 3,917 
Accrued professional fees2,659 3,017 
Accrued inventory2,491 1,138 
Accrued facilities related expenses2,421 2,536 
Accrued property, plant and equipment20,485 8,688 
Other accrued expenses5,159 6,793 
Customer deposit40,578 7,139 
ESPP payable971 715 
 $116,893 $69,494 
Schedule of Product Warranty Liability
The activity in the warranty accrual, included in accrued liabilities is as follows:
Year Ended June 30,
202220212020
(in thousands)
Beginning balance$2,795 $709 $623 
Addition1,127 2,443 895 
Utilization(1,272)(357)(809)
Ending balance$2,650 $2,795 $709 
Stock Rotation Accrual The activity in the stock rotation accrual, included in accrued liabilities is as follows:
Year Ended June 30,
202220212020
(in thousands)
Beginning balance$3,917 $3,358 $1,921 
Addition5,817 4,742 9,441 
Utilization(4,936)(4,183)(8,004)
Ending balance$4,798 $3,917 $3,358 
Schedule of Other Long-Term Liabilities
Other long-term liabilities
 
June 30,  
 20222021
(in thousands)
Deferred payroll taxes$— $1,219 
Customer deposits 70,301 42,000 
Computer software liabilities8,302 — 
Other— 904 
Other long-term liabilities$78,603 $44,123 
    Customer deposits are payments received from customers for securing future product shipments. As of June 30, 2022, $34.5 million were from Customer A and $21.9 million were from Customer B, and $13.9 million were from other customers. As of June 30, 2021, $21.0 million were from Customer A and $21.0 million were from Customer B.
XML 48 R32.htm IDEA: XBRL DOCUMENT v3.22.2.2
Debt (Tables)
12 Months Ended
Jun. 30, 2022
Debt Disclosure [Abstract]  
Fiscal Year Maturity Schedule
At June 30, 2022, maturities of short-term debt and long-term debt were as follows (in thousands):

Year ending June 30,
2023$25,638 
20249,952 
20259,999 
202610,047 
202712,348 
Thereafter234 
Total principal of debt68,218 
Less: debt issuance costs(169)
Total principal of debt, less debt issuance costs$68,049 

Short-term DebtLong-term DebtTotal
Principal amount$25,638 $42,580 $68,218 
Less: debt issuance costs(75)(94)(169)
Total debt, less debt issuance costs$25,563 $42,486 $68,049 
XML 49 R33.htm IDEA: XBRL DOCUMENT v3.22.2.2
Leases (Tables)
12 Months Ended
Jun. 30, 2022
Leases [Abstract]  
Schedule of Operating and Finance Lease Expense
The components of the Company’s operating and finance lease expenses are as follows for the years presented (in thousands):

Fiscal Year Ended June 30, 2022Fiscal Year Ended June 30, 2021
Operating leases:
     Fixed rent expense$6,262 $6,760 
     Variable rent expense946 815 
Finance lease:
     Amortization of equipment908 2,200 
     Interest976 2,168 
Short-term leases:
     Short-term lease expenses205 221 
               Total lease expenses$9,297 $12,164 
Supplemental balance sheet information related to the Company’s operating and finance leases is as follows (in thousands, except lease term and discount rate):

June 30, 2022June 30, 2021
Operating Leases:
     ROU assets associated with operating leases$23,674 $34,660 
Finance Lease:
     Property, plant and equipment, gross$4,831 $114,404 
     Accumulated depreciation(136)(96,470)
          Property, plant and equipment, net$4,695 $17,934 
Weighted average remaining lease term (in years)
     Operating leases7.428.44
     Finance lease5.001.72
Weighted average discount rate
     Operating leases4.27 %4.67 %
     Finance lease4.76 %5.46 %

Supplemental cash flow information related to the Company’s operating and finance lease is as follows (in thousands):

Fiscal Year Ended June 30, 2022Fiscal Year Ended June 30, 2021
Cash paid from amounts included in the measurement of lease liabilities:
     Operating cash flows from operating leases$6,480 $6,496 
     Operating cash flows from finance lease$976 $2,168 
     Financing cash flows from finance lease$4,176 $16,451 
Non-cash investing and financing information:
     Operating lease right-of-use assets obtained in exchange for lease obligations$5,852 $5,585 
Schedule of Operating Lease Liability Maturities
Future minimum lease payments are as follows as of June 30, 2022 (in thousands):

Operating LeasesFinance Leases
2023$5,206 $993 
20244,053 1,083 
20253,222 1,083 
20263,176 1,083 
20273,147 1,076 
Thereafter10,337 — 
Total minimum lease payments29,141 5,318 
Less amount representing interest(4,413)(584)
Total lease liabilities$24,728 $4,734 
Schedule of Finance Lease Liability Maturities
Future minimum lease payments are as follows as of June 30, 2022 (in thousands):

Operating LeasesFinance Leases
2023$5,206 $993 
20244,053 1,083 
20253,222 1,083 
20263,176 1,083 
20273,147 1,076 
Thereafter10,337 — 
Total minimum lease payments29,141 5,318 
Less amount representing interest(4,413)(584)
Total lease liabilities$24,728 $4,734 
XML 50 R34.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-based Compensation (Tables)
12 Months Ended
Jun. 30, 2022
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Summary of Stock Option Activities
The following table summarizes the Company's stock option activities:
Weighted
WeightedAverage
AverageRemaining
Number ofExercise PriceContractual Aggregate
SharesPer ShareTerm (in years)Intrinsic Value
Outstanding at June 30, 2019876,478 $10.98 3.06
Granted— $— 
Exercised(2,500)$10.50 $4,726 
Canceled or forfeited(230,000)$17.11 
Outstanding at June 30, 2020643,978 $8.79 2.89
Granted— $— 
Exercised(156,103)$11.31 $1,272,291 
Canceled or forfeited— $— 
Outstanding at June 30, 2021487,875 $7.99 2.32
Granted— $— 
Exercised(98,000)$9.15 $3,936,675 
Canceled or forfeited— $— 
Outstanding at June 30, 2022389,875 $7.70 1.53$9,997,364 
Options vested and expected to vest389,875 $7.70 1.53$9,997,364 
Exercisable at June 30, 2022389,875 $7.70 1.53$9,997,364 
Restricted Stock Units Activity
The following table summarizes the Company's TRSU activities:
 
 Number of Restricted Stock
Units
Weighted Average
Grant Date Fair
Value Per Share
Weighted Average
Remaining
Recognition
Period (Years)
Aggregate Intrinsic Value
Nonvested at June 30, 2019906,341 $14.09 1.62$8,465,225 
Granted505,440 $8.51 
Vested(455,893)$13.53 
Forfeited(23,750)$13.19 
Nonvested at June 30, 2020932,138 $11.36 1.66$10,141,661 
Granted722,873 $29.85 
Vested(567,087)$15.70 
Forfeited(34,400)$14.88 
Nonvested at June 30, 20211,053,524 $21.60 1.73$32,016,594 
Granted597,381 $45.83 
Vested(410,670)$20.54 
Forfeited(70,626)$26.79 
Nonvested at June 30, 20221,169,609 $34.03 1.73$38,994,764 
The following table summarizes the Company’s PRSU activities:
Number of Performance-based Restricted Stock
Units
Weighted Average
Grant Date Fair
Value Per Share
Weighted Average
Remaining
Recognition
Period (Years)
Aggregate Intrinsic Value
Nonvested at June 30, 2019596,724 $13.95 1.88$5,573,402 
Granted155,000 $7.36 
Vested(110,659)$16.68 
Forfeited(298,290)$11.32 
Nonvested at June 30, 2020342,775 $12.38 1.60$3,729,392 
Granted165,500 $36.27 
Vested(148,211)$14.24 
Forfeited(6,240)$17.23 
Nonvested at June 30, 2021353,824 $22.69 1.74$10,752,711 
Granted194,000 $48.65 
Vested(151,199)$19.44 
Forfeited(7,250)$40.33 
Nonvested at June 30, 2022389,375 $36.56 1.85$12,981,763 
Employee Stock Purchase Plan, Valuation Assumptions
The ESPP is compensatory and results in compensation expense. The fair values of common shares to be issued under the ESPP were determined using the Black-Scholes option pricing model with the following assumptions:
Year Ended June 30,
202220212020
Volatility rate
66.4% - 69.9%
63.1% - 68.5%
46.4% - 58.3%
Risk-free interest rate
0.3% - 2.1%
0.1% - 0.2%
0.2% - 1.6%
Expected term1.3 years1.3 years1.3 years
Dividend yield—%—%—%
Share-based Compensation, Allocation of Recognized Period Costs
Share-based Compensation Expenses
The total share-based compensation expense related to TRSU, PSUs, MSUs, stock options and ESPP described above, recognized in the consolidated statements of operations for the years presented was as follows:
Year Ended June 30,
202220212020
(in thousands)
Cost of goods sold$5,125 $1,756 $1,530 
Research and development7,049 5,352 2,895 
Selling, general and administrative19,150 8,216 6,029 
$31,324 $15,324 $10,454 
XML 51 R35.htm IDEA: XBRL DOCUMENT v3.22.2.2
Income Taxes (Tables)
12 Months Ended
Jun. 30, 2022
Income Tax Disclosure [Abstract]  
Provision for (benefit from) income taxes The provision for income taxes is comprised of:
Year Ended June 30, 
202220212020
(in thousands)
U.S. federal taxes:
Current$645 $31 $(1,673)
Deferred2,260 1,955 22 
Non-U.S. taxes:
Current7,749 2,344 1,940 
Deferred28,599 (396)58 
State taxes, net of federal benefit:
Current
Total provision for income taxes$39,258 $3,935 $348 
Effective income tax rate reconciliation
The reconciliation of the federal statutory income tax rate to our effective income tax rate is as follows (in percentage):

 Year Ended June 30,
 202220212020
United States statutory rate21.0 %21.0 %21.0 %
Stock-based compensation0.0 0.1 — 
Foreign taxes, net(14.3)(14.4)(36.1)
Outside basis difference on equity method investment1.2 — — 
Research and development credit(0.3)(2.4)8.0 
Non-deductible expenses0.5 2.4 (1.0)
U.S. Tax Act deferred tax re-measurement— — 6.2 
Foreign Derived Intangible Income Deduction(0.3)— — 
Other0.1 (0.2)— 
 7.9 %6.5 %(1.9)%
Domestic and foreign components of income (loss) The domestic and foreign components of income before taxes are:
 Year Ended June 30, 
 202220212020
(in thousands)
U.S. operations$16,684 $9,622 $3,549 
Non-U.S. operations478,386 50,602 (21,458)
Loss before income taxes$495,070 $60,224 $(17,909)
Components of deferred tax assets and liabilities Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of our deferred tax assets and liabilities are as follows:
 June 30, 
 20222021
(in thousands)
Deferred tax assets:
Accrued compensation$5,742 $3,954 
Net operating loss carryforwards61 22,539 
Depreciation4,365 7,924 
Tax credits15,079 15,550 
Operating lease liabilities5,807 7,292 
Capitalized intangible assets— 9,982 
Accruals and reserves643 1,113 
Total deferred tax assets31,697 68,354 
Valuation allowance(5,755)(41,474)
Total deferred tax assets, net of valuation allowance25,942 26,880 
Deferred tax liabilities:
Depreciation and amortization(18,909)(17,193)
Right of use assets(5,579)(6,968)
Investments(29,619)— 
Total deferred tax liabilities(54,107)(24,161)
Net deferred tax assets/(liabilities)
$(28,165)$2,719 
Schedule of deferred tax assets and liabilities, current and noncurrent
The breakdown between deferred tax assets and liabilities is as follows:
 June 30, 
 20222021
(in thousands)
Long-term deferred tax assets$592 $5,167 
Long-term deferred tax liabilities(28,757)(2,448)
Net deferred tax assets/(liabilities)$(28,165)$2,719 
Unrecognized tax benefits rollforward
A reconciliation of the beginning and ending amount of unrecognized tax benefits from July 1, 2019 to June 30, 2022 is as follows:
 Year Ended June 30, 
 202220212020
(in thousands)
Balance at beginning of year$7,645 $7,126 $7,150 
Additions based on tax positions related to the current year1,121 677 333 
Reductions based on tax positions related to prior years(40)(41)(114)
Reductions due to lapse of applicable statute of limitations(117)(117)(243)
Balance at end of year$8,609 $7,645 $7,126 
XML 52 R36.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segment and Geographic information (Tables)
12 Months Ended
Jun. 30, 2022
Segment Reporting [Abstract]  
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas
The revenue by geographical location in the following tables is based on the country or region in which the products were shipped to: 
 Year Ended June 30, 
 202220212020
(in thousands)
Hong Kong$630,238 $537,553 $390,478 
China120,978 107,325 64,058 
South Korea11,802 5,497 3,303 
United States12,470 5,492 4,465 
Other countries2,064 1,035 2,605 
 $777,552 $656,902 $464,909 
During the fiscal year ended June 30, 2022, the Company corrected an immaterial error to reduce revenues in Hong Kong by $0.5 million, and to increase the revenues in China by $0.5 million for the fiscal year ended June 30, 2021.
The following is a summary of revenue by product type:
 Year Ended June 30, 
 202220212020
 (in thousands)
Power discrete$545,135 $482,718 $391,941 
Power IC220,882 161,726 66,360 
Packaging and testing services11,535 12,458 6,608 
 $777,552 $656,902 $464,909 

Long-lived assets, net consisting of property, plant and equipment and land use rights, net, as well as operating lease right-of-use assets, net by geographical area are as follows:
 June 30,
 20222021
(in thousands)
China$105,326 $350,387 
United States232,731 118,756 
Other countries4,283 2,494 
 $342,340 $471,637 
XML 53 R37.htm IDEA: XBRL DOCUMENT v3.22.2.2
The Company and Significant Accounting Policies - Basis of Presentation Narrative (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Property and equipment purchased but not yet paid $ 62,165 $ 20,204 $ 17,370
XML 54 R38.htm IDEA: XBRL DOCUMENT v3.22.2.2
The Company and Significant Accounting Policies - Risks and Uncertainties Narrative (Details)
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Cost of Goods and Service, Product and Service Benchmark | Supplier Concentration Risk | HHGrace      
Concentration Risk [Line Items]      
Percent of wafers manufactured 10.30% 11.50% 12.70%
XML 55 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
The Company and Significant Accounting Policies - Joint Venture Narrative (Details)
$ in Thousands, ¥ in Millions
1 Months Ended 12 Months Ended
Jun. 30, 2022
Jan. 26, 2022
USD ($)
Jan. 26, 2022
CNY (¥)
Dec. 31, 2021
Dec. 24, 2021
USD ($)
Dec. 24, 2021
CNY (¥)
Dec. 02, 2021
director
Dec. 01, 2021
Nov. 30, 2021
director
Dec. 31, 2021
USD ($)
Dec. 31, 2021
CNY (¥)
Jun. 30, 2022
USD ($)
Jun. 30, 2021
USD ($)
Jun. 30, 2020
USD ($)
Related Party Transaction [Line Items]                            
Joint venture cumulative percentage ownership after all transactions   42.20% 42.20%                      
Proceeds from sale of equity interest in the JV Company | $                       $ 26,347 $ 0 $ 0
Equity Method Investment, Number of Appointments to Board of Directors | director             3   4          
Equity Method Investment, Number of Directors | director             7              
Corporate Joint Venture                            
Related Party Transaction [Line Items]                            
Joint venture cumulative percentage ownership after all transactions 42.20%     45.80%     48.80%   50.90%          
Proceeds from sale of equity interest in the JV Company | $                   $ 16,924        
Third Party Investors | Corporate Joint Venture                            
Related Party Transaction [Line Items]                            
Proceeds from sale of equity interest in the JV Company   $ 80,000 ¥ 509.0   $ 9,400 ¥ 60.0       $ 16,900 ¥ 108.0      
Facility in Liangjiang New Area of Chongqing (the 'Joint Venture')                            
Related Party Transaction [Line Items]                            
Simple annual interest rate to noncontrolling interest if joint venture is early terminated and liquidated 10.00%                          
Third Party Investors                            
Related Party Transaction [Line Items]                            
Joint venture cumulative percentage ownership after all transactions   42.20% 42.20%                      
Third Party Investors | Third Party Investors | Corporate Joint Venture                            
Related Party Transaction [Line Items]                            
Equity Method Investment, Ownership Percentage   7.82% 7.82%   1.10% 1.10%   2.10%            
Proceeds from sale of equity interest in the JV Company   $ 80,000 ¥ 509.0                      
Third Party Investors | Employee Incentive Plan | Corporate Joint Venture | Employee Incentive Plan                            
Related Party Transaction [Line Items]                            
Equity Method Investment, Ownership Percentage         3.99% 3.99%                
Parent Company | Facility in Liangjiang New Area of Chongqing (the 'Joint Venture')                            
Related Party Transaction [Line Items]                            
Joint venture cumulative percentage ownership after all transactions               51.00%            
Chongqing Funds | Facility in Liangjiang New Area of Chongqing (the 'Joint Venture')                            
Related Party Transaction [Line Items]                            
Joint venture cumulative percentage ownership after all transactions       45.80%       49.00%            
XML 56 R40.htm IDEA: XBRL DOCUMENT v3.22.2.2
The Company and Significant Accounting Policies - Restricted Cash Narrative (Details) - USD ($)
$ in Millions
Jun. 30, 2022
Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Restricted cash $ 0.3 $ 2.4
XML 57 R41.htm IDEA: XBRL DOCUMENT v3.22.2.2
The Company and Significant Accounting Policies - Property and Equipment Useful Lives (Details)
12 Months Ended
Jun. 30, 2022
Minimum | Software Development  
Property, Plant and Equipment [Line Items]  
Finite-lived intangible asset, useful life 3 years
Maximum | Software Development  
Property, Plant and Equipment [Line Items]  
Finite-lived intangible asset, useful life 5 years
Building | Minimum  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment, useful life 20 years
Manufacturing machinery and equipment | Minimum  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment, useful life 8 years
Manufacturing machinery and equipment | Maximum  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment, useful life 10 years
Equipment and tooling | Minimum  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment, useful life 3 years
Equipment and tooling | Maximum  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment, useful life 5 years
Computer equipment and software | Minimum  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment, useful life 3 years
Computer equipment and software | Maximum  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment, useful life 5 years
Office furntiture and equipment  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment, useful life 5 years
Leasehold improvements | Minimum  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment, useful life 2 years
Leasehold improvements | Maximum  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment, useful life 20 years
Vehicles  
Property, Plant and Equipment [Line Items]  
Property, plant and equipment, useful life 5 years
XML 58 R42.htm IDEA: XBRL DOCUMENT v3.22.2.2
The Company and Significant Accounting Policies - Government Grants (Details) - USD ($)
$ in Millions
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Government grants, reduction recorded to interest expense $ 0.9 $ 3.0 $ 6.1
Government grants, reduction recorded to operating expenses 0.2 3.7 4.7
Government grants, reduction recorded to property, plant and equipment $ 1.4 $ 0.1 $ 1.3
XML 59 R43.htm IDEA: XBRL DOCUMENT v3.22.2.2
The Company and Significant Accounting Policies - Government Grants Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Government grants, reduction recorded to interest expense $ 0.9 $ 3.0 $ 6.1
Government grants, reduction recorded to operating expenses 0.2 3.7 4.7
Government grants, reduction recorded to property, plant and equipment $ 1.4 $ 0.1 $ 1.3
XML 60 R44.htm IDEA: XBRL DOCUMENT v3.22.2.2
The Company and Significant Accounting Policies - Long-lived Assets Narrative (Details) - USD ($)
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Impairment of long-lived assets $ 0 $ 0 $ 0
XML 61 R45.htm IDEA: XBRL DOCUMENT v3.22.2.2
The Company and Significant Accounting Policies - Product Warranty Narrative (Details)
12 Months Ended
Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Length of product warranty 1 year
XML 62 R46.htm IDEA: XBRL DOCUMENT v3.22.2.2
The Company and Significant Accounting Policies - Advertising Expense Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Advertising expense $ 0.2 $ 0.4 $ 0.7
XML 63 R47.htm IDEA: XBRL DOCUMENT v3.22.2.2
Equity Method Investment in Equity Investee - Narrative (Details)
$ in Thousands, ¥ in Millions
1 Months Ended 12 Months Ended
Jun. 30, 2022
Jan. 26, 2022
USD ($)
Jan. 26, 2022
CNY (¥)
Dec. 31, 2021
Dec. 24, 2021
USD ($)
Dec. 24, 2021
CNY (¥)
Dec. 02, 2021
director
Dec. 01, 2021
Nov. 30, 2021
director
Dec. 31, 2021
USD ($)
Dec. 31, 2021
CNY (¥)
Jun. 30, 2022
USD ($)
Jun. 30, 2021
USD ($)
Jun. 30, 2020
USD ($)
Schedule of Equity Method Investments [Line Items]                            
Joint venture cumulative percentage ownership after all transactions   42.20% 42.20%                      
Equity Method Investment, Number of Appointments to Board of Directors | director             3   4          
Equity Method Investment, Number of Directors | director             7              
Loss on changes of equity interest in the JV Company, net                       $ (3,140) $ 0 $ 0
Proceeds from sale of equity interest in the JV Company                       26,347 0 0
Equity method investment loss from equity investee                       2,629 $ 0 $ 0
Facility in Liangjiang New Area of Chongqing (the 'Joint Venture') | Chongqing Funds                            
Schedule of Equity Method Investments [Line Items]                            
Joint venture cumulative percentage ownership after all transactions       45.80%       49.00%            
Third Party Investors                            
Schedule of Equity Method Investments [Line Items]                            
Joint venture cumulative percentage ownership after all transactions   42.20% 42.20%                      
Corporate Joint Venture                            
Schedule of Equity Method Investments [Line Items]                            
Joint venture cumulative percentage ownership after all transactions 42.20%     45.80%     48.80%   50.90%          
Proceeds from sale of equity interest in the JV Company                   $ 16,924        
Loss on changes on equity interest of the JV Company, net                       $ (3,140)    
Third Party Investors | Corporate Joint Venture                            
Schedule of Equity Method Investments [Line Items]                            
Proceeds from sale of equity interest in the JV Company   $ 80,000 ¥ 509.0   $ 9,400 ¥ 60.0       $ 16,900 ¥ 108.0      
Third Party Investors | Corporate Joint Venture | Third Party Investors                            
Schedule of Equity Method Investments [Line Items]                            
Equity Method Investment, Ownership Percentage   7.82% 7.82%   1.10% 1.10%   2.10%            
Proceeds from sale of equity interest in the JV Company   $ 80,000 ¥ 509.0                      
Employee Incentive Plan | Corporate Joint Venture | Third Party Investors | Employee Incentive Plan                            
Schedule of Equity Method Investments [Line Items]                            
Equity Method Investment, Ownership Percentage         3.99% 3.99%                
XML 64 R48.htm IDEA: XBRL DOCUMENT v3.22.2.2
Equity Method Investment in Equity Investee - Schedule of Gain on Deconsolidation (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Dec. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Dec. 01, 2021
Schedule of Equity Method Investments [Line Items]          
Cash received for sales of shares in the JV Company   $ 26,347 $ 0 $ 0  
Gain on deconsolidation of the JV Company   399,093 0 0  
Gain on equity interest sold   (3,140) 0 0  
Share-based Payment Arrangement, Expense   (31,324) $ (15,324) $ (10,454)  
Corporate Joint Venture          
Schedule of Equity Method Investments [Line Items]          
Cash received for sales of shares in the JV Company $ 16,924        
Fair value of retained equity method investment 393,124        
Carrying amount of non-controlling interest 143,889        
Cumulative translation adjustment removal 1,793        
Carrying amount of net assets of the JV Company at December 1, 2021         $ (156,637)
Gain on deconsolidation of the JV Company $ 399,093 399,100      
Share-based Payment Arrangement, Expense   (8,116)      
Loss on changes on equity interest of the JV Company, net   (3,140)      
Corporate Joint Venture | 1.1% equity interest sold          
Schedule of Equity Method Investments [Line Items]          
Gain on equity interest sold   475      
Corporate Joint Venture | 7.82% equity interest sold          
Schedule of Equity Method Investments [Line Items]          
Gain on equity interest sold   $ 4,501      
XML 65 R49.htm IDEA: XBRL DOCUMENT v3.22.2.2
Equity Method Investment in Equity Investee - Equity Method Investment, Summarized Financial Information (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2022
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Schedule of Equity Method Investments [Line Items]        
Current assets   $ 549,592 $ 407,322  
Current liabilities   267,722 233,230  
Gross loss   268,556 204,543 $ 102,731
Operating expenses   508,996 452,359 362,178
Net loss   $ 102,038 $ 64,076 $ (13,937)
Facility in Liangjiang New Area of Chongqing (the 'Joint Venture')        
Schedule of Equity Method Investments [Line Items]        
Current assets $ 198,323      
Non-current assets 364,777      
Current liabilities 251,988      
Non-current liabilities 76,207      
Revenue 68,972      
Gross loss 870      
Operating expenses 2,280      
Net loss $ 6,197      
XML 66 R50.htm IDEA: XBRL DOCUMENT v3.22.2.2
Related Party Transactions (Details) - USD ($)
$ in Millions
7 Months Ended
Jun. 30, 2022
Jan. 26, 2022
Dec. 31, 2021
Dec. 02, 2021
Nov. 30, 2021
Jun. 30, 2022
Related Party Transaction [Line Items]            
Joint venture cumulative percentage ownership after all transactions   42.20%        
Payable to related party $ 29.0         $ 29.0
Corporate Joint Venture            
Related Party Transaction [Line Items]            
Joint venture cumulative percentage ownership after all transactions 42.20%   45.80% 48.80% 50.90%  
Transactions with related party           117.6
Revenue from related parties           $ 36.4
XML 67 R51.htm IDEA: XBRL DOCUMENT v3.22.2.2
Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited - Basic and Diluted Income Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Earnings Per Share [Abstract]      
Net income (loss) attributable to AOS $ 453,163 $ 58,116 $ (6,596)
Basic:      
Weighted average number of common shares used to compute basic net income (loss) per share 26,764 25,786 24,840
Effect of potentially dilutive securities:      
Stock options, RSUs and ESPP shares 1,439 1,486 0
Weighted average number of common shares used to compute diluted net income (loss) per share 28,203 27,272 24,840
Net income (loss) per share attributable to common shareholders:      
Basic (in dollars per share) $ 16.93 $ 2.25 $ (0.27)
Diluted (in dollars per share) $ 16.07 $ 2.13 $ (0.27)
XML 68 R52.htm IDEA: XBRL DOCUMENT v3.22.2.2
Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited - Potential Dilutive Shares (Details) - shares
shares in Thousands
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Incremental common shares attributable to dilutive effect of share-based payment arrangements (USD per share) 1,439 1,486 0
Potential dilutive securities (in shares) 298 264 2,862
Employee stock options and RSUs      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potential dilutive securities (in shares) 277 193 2,028
Employee Stock      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potential dilutive securities (in shares) 21 71 834
XML 69 R53.htm IDEA: XBRL DOCUMENT v3.22.2.2
Concentration of Credit Risk and Significant Customers - Schedule of Concentration Risk (Details)
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Minimum      
Concentration Risk [Line Items]      
Terms of credit sales, (in days) 30 days    
Maximum      
Concentration Risk [Line Items]      
Terms of credit sales, (in days) 60 days    
Customer A | Revenue Benchmark | Customer Concentration Risk      
Concentration Risk [Line Items]      
Concentration risk, percentage 24.60% 28.70% 29.30%
Customer A | Accounts Receivable | Customer Concentration Risk      
Concentration Risk [Line Items]      
Concentration risk, percentage 24.60% 12.40%  
Customer B | Revenue Benchmark | Customer Concentration Risk      
Concentration Risk [Line Items]      
Concentration risk, percentage 39.70% 35.40% 35.50%
Customer B | Accounts Receivable | Customer Concentration Risk      
Concentration Risk [Line Items]      
Concentration risk, percentage 36.40% 22.10%  
Customer C | Accounts Receivable | Customer Concentration Risk      
Concentration Risk [Line Items]      
Concentration risk, percentage   21.90%  
Customer D | Accounts Receivable | Customer Concentration Risk      
Concentration Risk [Line Items]      
Concentration risk, percentage 12.00%    
XML 70 R54.htm IDEA: XBRL DOCUMENT v3.22.2.2
Balance Sheet Components - Accounts receivable (Details) - USD ($)
$ in Thousands
Jun. 30, 2022
Jun. 30, 2021
Balance Sheet Related Disclosures [Abstract]    
Accounts receivable $ 84,442 $ 48,234
Less: Allowance for price adjustments (18,731) (12,415)
Less: Allowance for doubtful accounts (30) (30)
Accounts receivable, net $ 65,681 $ 35,789
XML 71 R55.htm IDEA: XBRL DOCUMENT v3.22.2.2
Balance Sheet Components - Inventories (Details) - USD ($)
$ in Thousands
Jun. 30, 2022
Jun. 30, 2021
Balance Sheet Related Disclosures [Abstract]    
Raw materials $ 67,960 $ 68,900
Work in-process 80,720 68,824
Finished goods 9,360 16,569
Inventories $ 158,040 $ 154,293
XML 72 R56.htm IDEA: XBRL DOCUMENT v3.22.2.2
Balance Sheet Components - Other Current Assets (Details) - USD ($)
$ in Thousands
Jun. 30, 2022
Jun. 30, 2021
Balance Sheet Related Disclosures [Abstract]    
VAT receivable $ 737 $ 1,539
Other prepaid expenses 3,954 1,465
Prepaid insurance 2,590 2,615
Prepaid maintenance 826 1,670
Prepayments to supplier 257 2,540
Prepaid income tax 2,086 2,221
Interest receivable 25 2,207
Customs deposit 0 270
Other receivables 745 68
Total other current assets $ 11,220 $ 14,595
XML 73 R57.htm IDEA: XBRL DOCUMENT v3.22.2.2
Balance Sheet Components - Property, plant, and equipment (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Property, Plant and Equipment [Line Items]      
Property, plant, and equipment excluding equipment and construction In progress, gross $ 422,026 $ 748,052  
Less accumulated depreciation (233,340) (348,749)  
Property, plant and equipment excluding equipment and construction in progress, net 188,686 399,303  
Equipment and construction in progress 129,980 37,674  
Property, plant and equipment, net 318,666 436,977  
Depreciation expense 39,900 49,300 $ 43,900
Finance lease liabilities 802 16,724  
Accumulated depreciation 136 96,470  
Land      
Property, Plant and Equipment [Line Items]      
Property, plant, and equipment excluding equipment and construction In progress, gross 4,877 4,877  
Building      
Property, Plant and Equipment [Line Items]      
Property, plant, and equipment excluding equipment and construction In progress, gross 16,691 71,454  
Manufacturing machinery and equipment      
Property, Plant and Equipment [Line Items]      
Property, plant, and equipment excluding equipment and construction In progress, gross 287,574 515,320  
Equipment and tooling      
Property, Plant and Equipment [Line Items]      
Property, plant, and equipment excluding equipment and construction In progress, gross 28,052 27,017  
Computer equipment and software      
Property, Plant and Equipment [Line Items]      
Property, plant, and equipment excluding equipment and construction In progress, gross 46,758 41,518  
Office furniture and equipment      
Property, Plant and Equipment [Line Items]      
Property, plant, and equipment excluding equipment and construction In progress, gross 2,820 3,814  
Leasehold improvements      
Property, Plant and Equipment [Line Items]      
Property, plant, and equipment excluding equipment and construction In progress, gross 35,254 74,733  
Land use rights      
Property, Plant and Equipment [Line Items]      
Property, plant, and equipment excluding equipment and construction In progress, gross 0 9,319  
Computer software development      
Property, Plant and Equipment [Line Items]      
Finance lease liabilities 300 300 1,000
Accumulated depreciation 400 500 $ 500
Unamortized capitalized software development costs $ 800 $ 1,200  
XML 74 R58.htm IDEA: XBRL DOCUMENT v3.22.2.2
Balance Sheet Components - Goodwill (Details) - USD ($)
$ in Thousands
Jun. 30, 2022
Jun. 30, 2021
Balance Sheet Related Disclosures [Abstract]    
Goodwill $ 269 $ 269
XML 75 R59.htm IDEA: XBRL DOCUMENT v3.22.2.2
Balance Sheet Components - Other long term assets (Details) - USD ($)
$ in Thousands
Jun. 30, 2022
Jun. 30, 2021
Balance Sheet Related Disclosures [Abstract]    
Prepayments for property and equipment $ 6,890 $ 14,882
Investments in privately held companies 100 100
Customs deposit 1,708 1,120
Deposit with supplier 6,396 0
Other long-term deposits 18 927
Office leases deposits 1,012 1,100
Other 1,553 740
Other long-term assets $ 17,677 $ 18,869
XML 76 R60.htm IDEA: XBRL DOCUMENT v3.22.2.2
Balance Sheet Components - Future amortization expense of intangible assets (Details)
$ in Thousands
Jun. 30, 2022
USD ($)
Balance Sheet Related Disclosures [Abstract]  
2023 $ 3,286
2024 3,249
2025 3,246
Intangible assets, net $ 9,781
XML 77 R61.htm IDEA: XBRL DOCUMENT v3.22.2.2
Balance Sheet Components - Intangible assets (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Acquired Finite-Lived Intangible Assets [Line Items]      
Intangible assets, gross $ 19,455 $ 19,455  
Less accumulated amortization (9,674) (6,314)  
Intangible assets, net (excluding goodwill) 9,781 13,141  
Goodwill 269 269  
Intangible assets, net 10,050 13,410  
Amortization expense 3,400 3,400 $ 100
Patents and exclusive technology rights      
Acquired Finite-Lived Intangible Assets [Line Items]      
Intangible assets, gross $ 18,037 18,037  
Finite-lived intangible asset, useful life 5 years    
Trade name      
Acquired Finite-Lived Intangible Assets [Line Items]      
Intangible assets, gross $ 268 268  
Finite-lived intangible asset, useful life 10 years    
Customer relationships      
Acquired Finite-Lived Intangible Assets [Line Items]      
Intangible assets, gross $ 1,150 $ 1,150  
XML 78 R62.htm IDEA: XBRL DOCUMENT v3.22.2.2
Balance Sheet Components - Accrued liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2019
Balance Sheet Related Disclosures [Abstract]        
Accrued compensation and benefits $ 34,681 $ 32,756    
Warranty accrual 2,650 2,795 $ 709 $ 623
Stock rotation accrual 4,798 3,917 $ 3,358 $ 1,921
Accrued professional fees 2,659 3,017    
Accrued inventory 2,491 1,138    
Accrued facilities related expenses 2,421 2,536    
Accrued property, plant and equipment 20,485 8,688    
Other accrued expenses 5,159 6,793    
Customer deposit 40,578 7,139    
ESPP payable 971 715    
Accrued liabilities $ 116,893 $ 69,494    
XML 79 R63.htm IDEA: XBRL DOCUMENT v3.22.2.2
Balance Sheet Components - Product Warranty Accrual (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]      
Beginning balance $ 2,795 $ 709 $ 623
Addition 1,127 2,443 895
Utilization (1,272) (357) (809)
Ending balance $ 2,650 $ 2,795 $ 709
XML 80 R64.htm IDEA: XBRL DOCUMENT v3.22.2.2
Balance Sheet Components - Stock Rotation Accrual (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Stock Rotation Accrual Increae (Decrease) [Roll Forward]      
Beginning balance $ 3,917 $ 3,358 $ 1,921
Addition 5,817 4,742 9,441
Utilization (4,936) (4,183) (8,004)
Ending balance $ 4,798 $ 3,917 $ 3,358
XML 81 R65.htm IDEA: XBRL DOCUMENT v3.22.2.2
Balance Sheet Components - Impairment of long-lived assets, intangible assets, and goodwill (Details) - USD ($)
$ in Thousands
Jun. 30, 2022
Jun. 30, 2021
Balance Sheet Related Disclosures [Abstract]    
Goodwill $ 269 $ 269
XML 82 R66.htm IDEA: XBRL DOCUMENT v3.22.2.2
Balance Sheet Components - Other long-term liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2022
Jun. 30, 2021
Concentration Risk [Line Items]    
Deferred payroll taxes $ 0 $ 1,219
Customer deposits 70,301 42,000
Computer software liabilities 8,302 0
Other 0 904
Other long-term liabilities 78,603 44,123
Customer A    
Concentration Risk [Line Items]    
Customer deposits 34,500 21,000
Customer B    
Concentration Risk [Line Items]    
Customer deposits 21,900 $ 21,000
Other Customers    
Concentration Risk [Line Items]    
Customer deposits $ 13,900  
XML 83 R67.htm IDEA: XBRL DOCUMENT v3.22.2.2
Debt - Short-term borrowing (Details)
$ in Thousands, ¥ in Millions
1 Months Ended 3 Months Ended
Oct. 31, 2019
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2021
CNY (¥)
Jun. 30, 2022
USD ($)
Sep. 30, 2021
CNY (¥)
Jun. 30, 2021
USD ($)
Oct. 31, 2019
CNY (¥)
Nov. 16, 2018
USD ($)
Nov. 16, 2018
CNY (¥)
Short-term Debt [Line Items]                  
Short-term debt | $       $ 25,563   $ 58,030      
Bank Of Communications Limited                  
Short-term Debt [Line Items]                  
Short-term debt | $       1,600          
Maximum borrowing capacity $ 8,500       ¥ 140.0   ¥ 60.0    
Bank Of Communications Limited | Credit Facility, 3 Point 85 Percent, Due November 18, 2022                  
Short-term Debt [Line Items]                  
Proceeds from short-term debt   $ 1,600 ¥ 11.0            
Stated interest rate   3.85% 3.85%            
Industrial And Commercial Bank of China | Foreign Line of Credit                  
Short-term Debt [Line Items]                  
Short-term debt       $ 500       $ 10,300 ¥ 72.0
Interest rate   370.00% 370.00%            
Proceeds from short-term debt   $ 800 ¥ 5.0            
Industrial And Commercial Bank of China | Foreign Line of Credit | Line of Credit Facility, Trade Borrowings                  
Short-term Debt [Line Items]                  
Maximum borrowing capacity | ¥                 27.0
Industrial And Commercial Bank of China | Foreign Line of Credit | Line of Credit Facility, Working Capital Borrowings                  
Short-term Debt [Line Items]                  
Maximum borrowing capacity | ¥                 ¥ 45.0
Base Rate | China | Bank Of Communications Limited                  
Short-term Debt [Line Items]                  
Basis spread on variable rate 4.99%                
Basis spread multiple 1.05           1.05    
XML 84 R68.htm IDEA: XBRL DOCUMENT v3.22.2.2
Debt - Accounts Receivable Factoring Agreement (Details) - Secured Debt - Accounts Receivable Factoring Agreement August Ninth Two Thousand Nineteen - USD ($)
Aug. 09, 2019
Jun. 30, 2022
Aug. 11, 2021
Debt Instrument [Line Items]      
Accounts Receivable Factoring Agreement, maximum borrowing capacity, percent of net accounts receivable 70.00%    
Accounts Receivable Factoring Agreement, maximum borrowing capacity $ 30,000,000    
Basis spread on variable rate 1.75%    
Accounts Receivable Factoring Agreement, borrowed amount outstanding   $ 0  
Accounts Receivable Factoring Agreement, remaining borrowing capacity   $ 8,000,000  
Accounts Receivable Factoring Agreement, reduction of maximum borrowing capacity     $ 8,000,000
XML 85 R69.htm IDEA: XBRL DOCUMENT v3.22.2.2
Debt - Debt Financing (Details) - Jireh Semiconductor Incorporated - Sales-Lease Back Transaction with Jireh Semiconductor Incorporated
€ in Millions
12 Months Ended
Jun. 30, 2022
USD ($)
Sep. 30, 2021
EUR (€)
Sep. 30, 2021
USD ($)
Apr. 30, 2021
EUR (€)
Sale Leaseback Transaction [Line Items]        
Historical cost   € 12.0 $ 12,800,000  
Down payment amount received | €       € 6.0
Down payment percent       50.00%
Delivery payment received $ 4,800,000      
Delivery payment percent 40.00%      
Purchase price financing amount, percent 10.00%      
Lease term (in years) 5 years      
Lease term, buyout option amount $ 1      
Implied interest rate, percent 4.75%      
Debt receivable amount $ 5,000,000      
Manufacturing machinery and equipment        
Sale Leaseback Transaction [Line Items]        
Debt instrument, collateral amount $ 12,800,000      
XML 86 R70.htm IDEA: XBRL DOCUMENT v3.22.2.2
Debt - Credit Facilities and Long-term Debt Narrative (Details) - USD ($)
$ in Thousands
Feb. 16, 2022
Aug. 18, 2021
May 01, 2018
Aug. 15, 2017
Jun. 30, 2022
Jun. 30, 2021
Jul. 31, 2018
Jan. 12, 2018
Line of Credit Facility [Line Items]                
Long-term debt         $ 42,486      
Restricted cash         300 $ 2,400    
Secured Debt                
Line of Credit Facility [Line Items]                
Maximum borrowing capacity     $ 17,800          
Amount outstanding         14,200      
Debt term     5 years          
Stated interest rate     5.04%          
Secured Debt | Jireh                
Line of Credit Facility [Line Items]                
Maximum borrowing capacity   $ 45,000            
Amount outstanding         45,000      
Proceeds from lines of credit $ 45,000              
Debt term   5 years 6 months            
Variable Interest Rate Term Loan Maturing August 2022 | Secured Debt | Term Loan                
Line of Credit Facility [Line Items]                
Maximum borrowing capacity       $ 30,000        
Amount outstanding         $ 1,900   $ 16,700 $ 13,200
Debt term       5 years        
Variable Interest Rate Term Loan Maturing August 2022 | Minimum | LIBOR | Secured Debt | Term Loan                
Line of Credit Facility [Line Items]                
Basis spread on variable rate       1.75%        
Variable Interest Rate Term Loan Maturing August 2022 | Maximum | LIBOR | Secured Debt | Term Loan                
Line of Credit Facility [Line Items]                
Basis spread on variable rate       2.25%        
XML 87 R71.htm IDEA: XBRL DOCUMENT v3.22.2.2
Debt - Maturities of Short-tem and Long-term Debt (Details) - USD ($)
$ in Thousands
Jun. 30, 2022
Jun. 30, 2021
Debt Disclosure [Abstract]    
2023 $ 25,638  
2024 9,952  
2025 9,999  
2026 10,047  
2027 12,348  
Thereafter 234  
Total principal of debt 68,218  
Less: debt issuance costs (169)  
Total debt, less debt issuance costs 68,049  
Short-term Debt    
Principal amount 25,638  
Less: debt issuance costs (75)  
Total debt, less debt issuance costs 25,563 $ 58,030
Long-term Debt    
Principal amount 42,580  
Less: debt issuance costs (94)  
Total principal of debt, less debt issuance costs 42,486  
Total    
Principal amount 68,218  
Less: debt issuance costs (169)  
Total debt, less debt issuance costs $ 68,049  
XML 88 R72.htm IDEA: XBRL DOCUMENT v3.22.2.2
Leases - Narrative (Details)
¥ in Millions
May 09, 2018
CNY (¥)
Lease Financing | YinHai Leasing Company and China Import/Export Bank | YinHai Leasing Company and China Import/Export Bank  
Debt Instrument [Line Items]  
Maximum borrowing capacity ¥ 400.0
XML 89 R73.htm IDEA: XBRL DOCUMENT v3.22.2.2
Leases - Schedule of Lease Cost (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Operating leases:    
Fixed rent expense $ 6,262 $ 6,760
Variable rent expense 946 815
Finance lease:    
Amortization of equipment 908 2,200
Interest 976 2,168
Short-term leases:    
Short-term lease expenses 205 221
Total lease expenses $ 9,297 $ 12,164
XML 90 R74.htm IDEA: XBRL DOCUMENT v3.22.2.2
Leases - Schedule of Lease Supplemental Balance Sheet Information (Details) - USD ($)
$ in Thousands
Jun. 30, 2022
Jun. 30, 2021
Operating Lease Right Of Use Asset [Abstract]    
ROU assets associated with operating leases $ 23,674 $ 34,660
Finance Lease:    
Property, plant and equipment, gross 4,831 114,404
Accumulated depreciation (136) (96,470)
Property, plant and equipment, net $ 4,695 $ 17,934
Weighted average remaining lease term (in years)    
Operating leases 7 years 5 months 1 day 8 years 5 months 8 days
Finance lease 5 years 1 year 8 months 19 days
Weighted average discount rate    
Operating leases 4.27% 4.67%
Finance lease 4.76% 5.46%
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Property, plant and equipment, net Property, plant and equipment, net
XML 91 R75.htm IDEA: XBRL DOCUMENT v3.22.2.2
Leases - Schedule of Lease Supplemental Cash Flow Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash paid from amounts included in the measurement of lease liabilities:    
Operating cash flows from operating leases $ 6,480 $ 6,496
Operating cash flows from finance lease 976 2,168
Financing cash flows from finance lease 4,176 16,451
Non-cash investing and financing information:    
Operating lease right-of-use assets obtained in exchange for lease obligations $ 5,852 $ 5,585
XML 92 R76.htm IDEA: XBRL DOCUMENT v3.22.2.2
Leases - Schedule of Lease Maturities - Topic 842 (Details)
$ in Thousands
Jun. 30, 2022
USD ($)
Lessee, Operating Lease, Liability, Payment, Due [Abstract]  
2021 $ 5,206
2022 4,053
2023 3,222
2024 3,176
2025 3,147
Thereafter 10,337
Total minimum lease payments 29,141
Less amount representing interest (4,413)
Total lease liabilities 24,728
Finance Lease, Liability, Payment, Due [Abstract]  
2021 993
2022 1,083
2023 1,083
2024 1,083
2025 1,076
Thereafter 0
Total minimum lease payments 5,318
Less amount representing interest (584)
Total lease liabilities $ 4,734
XML 93 R77.htm IDEA: XBRL DOCUMENT v3.22.2.2
Shareholders' Equity (Details)
$ / shares in Units, $ in Millions
12 Months Ended 140 Months Ended
Jun. 30, 2022
USD ($)
votes
$ / shares
shares
Jun. 30, 2021
$ / shares
shares
Jun. 30, 2022
USD ($)
votes
$ / shares
shares
Common Shares      
Common shares, authorized (in shares) | shares 100,000,000 100,000,000 100,000,000
Common shares, par value (in dollars per share) $ 0.002 $ 0.002 $ 0.002
Number of votes per each common share | votes 1   1
Common stock, dividends declared per share $ 0    
Treasury Shares      
Share repurchase program, authorized amount | $ $ 30.0   $ 30.0
Share repurchase program, remaining authorized amount | $ $ 13.4   $ 13.4
Treasury stock acquired, shares repurchased (in shares) | shares 0 0 6,784,648
Treasury stock acquired less handling fees | $     $ 67.3
Treasury stock acquired, average price per share (in dollars per share)     $ 9.92
Treasury stock retired (in shares) | shares     0
Treasury Stock Reissued      
Treasury Shares      
Treasury stock acquired, average price per share (in dollars per share)     $ 10.06
Treasury stock reissued (in shares) | shares     167,395
Treasury stock reissued average price per share     $ 5.00
XML 94 R78.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-based Compensation - Narrative (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Aug. 31, 2020
Aug. 30, 2020
Dec. 31, 2021
Nov. 30, 2021
Sep. 30, 2018
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2019
Nov. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Allocated share-based compensation expense           $ 31,324,000 $ 15,324,000 $ 10,454,000    
Deferred compensation share-based arrangements, liability, current           0 100,000      
Share-based payment arrangement, expense, non-cash           $ 300,000 $ 3,100,000 $ 600,000    
Grants in period (in shares)           0 0 0    
Weighted Average Remaining Recognition Period (Years)           3 years 2 months 12 days        
Market-based Restricted Stock Units (MSU)                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Risk-free interest rate     1.00%              
Expected term (in years)     3 years 1 month 6 days              
Volatility rate     62.80%              
Dividend yield     0.00%              
Allocated share-based compensation expense           $ 4,500,000        
Granted (in shares)     1,000,000   1,300,000          
Market-based Restricted Stock Units (MSU) | Minimum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Award requisite service period     4 years 1 month 6 days              
Market-based Restricted Stock Units (MSU) | Maximum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Award requisite service period     7 years 1 month 6 days              
Market-based Restricted Stock Units (MSU), Pre-Modification                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Risk-free interest rate   0.13%                
Expected term (in years)   1 year 3 months 18 days                
Volatility rate   66.70%                
Dividend yield   0.00%                
Market-based Restricted Stock Units (MSU), Post-Modification                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Risk-free interest rate 0.14%                  
Expected term (in years) 2 years 3 months 18 days                  
Volatility rate 59.10%                  
Dividend yield 0.00%                  
Allocated share-based compensation expense           $ 1,600,000 $ 1,200,000 $ 600,000    
Employee Stock                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Shares authorized under plan (in shares)       2,500,000           1,430,000
Grant price, percent of fair value of common stock at date of grant           85.00%        
Expected term (in years)           1 year 3 months 18 days 1 year 3 months 18 days 1 year 3 months 18 days    
Dividend yield           0.00% 0.00% 0.00%    
Payroll deduction accumulation period (in months)           6 months        
Performance Based Restricted Stock Units (PRSUs)                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Granted, value           $ 4,000,000        
Allocated share-based compensation expense           $ 4,600,000 $ 2,300,000 $ 1,500,000    
Weighted Average Remaining Recognition Period (Years)           1 year 10 months 6 days 1 year 8 months 26 days 1 year 7 months 6 days 1 year 10 months 17 days  
Granted (in shares)           194,000 165,500 155,000    
2018 Omnibus Incentive Plan | Stock Options | Minimum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Grant price, percent of fair value of common stock at date of grant           100.00%        
2018 Omnibus Incentive Plan | Nonstatutory Stock Options | Minimum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Grant price, percent of fair value of common stock at date of grant           85.00%        
2018 Omnibus Incentive Plan | Employee stock options and RSUs                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Number of shares available for grant (in shares)           537,260        
Stock options exercisable term (in years)           10 years        
2018 Omnibus Incentive Plan | Employee stock options and RSUs | Minimum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Award vesting period (in years)           4 years        
2018 Omnibus Incentive Plan | Employee stock options and RSUs | Maximum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Shares authorized under plan (in shares)       3,065,000           2,065,000
Award vesting period (in years)           5 years        
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized       1,000,000            
2018 Omnibus Incentive Plan | Restricted Stock Units (RSUs) | Minimum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Grant price, percent of fair value of common stock at date of grant           100.00%        
2018 Omnibus Incentive Plan | External Board Members | Restricted Stock Units (RSUs)                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Granted, value           $ 125,000        
Average fair market value per share period           90 days        
2018 Omnibus Incentive Plan | External Board Members | Restricted Stock Units (RSUs) | Maximum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Granted (in shares)           10,000        
XML 95 R79.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-based Compensation - Restricted Stock and Performance-based Restrcited Stock Activity (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2021
Sep. 30, 2018
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2019
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]            
Allocated share-based compensation expense     $ 31,324,000 $ 15,324,000 $ 10,454,000  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]            
Weighted Average Remaining Recognition Period (Years)     3 years 2 months 12 days      
Market-based Restricted Stock Units (MSU)            
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]            
Allocated share-based compensation expense     $ 4,500,000      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]            
Granted (in shares) 1,000,000 1,300,000        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]            
Expected term (in years) 3 years 1 month 6 days          
Dividend yield 0.00%          
Restricted Stock [Member]            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]            
Nonvested (in shares)     1,053,524 932,138 906,341  
Granted (in shares)     597,381 722,873 505,440  
Vested (in shares)     (410,670) (567,087) (455,893)  
Forfeited (in shares)     (70,626) (34,400) (23,750)  
Nonvested (in shares)     1,169,609 1,053,524 932,138 906,341
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]            
Nonvested (in dollars per share)     $ 21.60 $ 11.36 $ 14.09  
Granted (in dollars per share)     45.83 29.85 8.51  
Vested (in dollars per share)     20.54 15.70 13.53  
Forfeited (in dollars per share)     26.79 14.88 13.19  
Nonvested (in dollars per share)     $ 34.03 $ 21.60 $ 11.36 $ 14.09
Weighted Average Remaining Recognition Period (Years)     1 year 8 months 23 days 1 year 8 months 23 days 1 year 7 months 28 days 1 year 7 months 13 days
Aggregate intrinsic value, nonvested     $ 38,994,764 $ 32,016,594 $ 10,141,661 $ 8,465,225
Performance Based Restricted Stock Units (PRSUs)            
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]            
Allocated share-based compensation expense     $ 4,600,000 $ 2,300,000 $ 1,500,000  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]            
Nonvested (in shares)     353,824 342,775 596,724  
Granted (in shares)     194,000 165,500 155,000  
Vested (in shares)     (151,199) (148,211) (110,659)  
Forfeited (in shares)     (7,250) (6,240) (298,290)  
Nonvested (in shares)     389,375 353,824 342,775 596,724
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]            
Nonvested (in dollars per share)     $ 22.69 $ 12.38 $ 13.95  
Granted (in dollars per share)     48.65 36.27 7.36  
Vested (in dollars per share)     19.44 14.24 16.68  
Forfeited (in dollars per share)     40.33 17.23 11.32  
Nonvested (in dollars per share)     $ 36.56 $ 22.69 $ 12.38 $ 13.95
Weighted Average Remaining Recognition Period (Years)     1 year 10 months 6 days 1 year 8 months 26 days 1 year 7 months 6 days 1 year 10 months 17 days
Aggregate intrinsic value, nonvested     $ 12,981,763 $ 10,752,711 $ 3,729,392 $ 5,573,402
XML 96 R80.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-based Compensation - Summary of Stock Option Activities (Details) - USD ($)
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]        
Outstanding (in shares) 487,875 643,978 876,478  
Granted (in shares) 0 0 0  
Exercised (in shares) (98,000) (156,103) (2,500)  
Canceled or forfeited (in shares) 0 0 (230,000)  
Outstanding (in shares) 389,875 487,875 643,978 876,478
Options vested and expected to vest (in shares) 389,875      
Exercisable (in shares) 389,875      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]        
Outstanding (in dollars per share) $ 7.99 $ 8.79 $ 10.98  
Granted (in dollars per share) 0 0 0  
Exercised (in dollars per share) 9.15 11.31 10.50  
Canceled or forfeited (in dollars per share) 0 0 17.11  
Outstanding (in dollars per share) 7.70 $ 7.99 $ 8.79 $ 10.98
Options vested and expected to vest (in dollars per share) 7.70      
Exercisable (in dollars per share) $ 7.70      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]        
Outstanding, Weighted Average Remaining Contractual Term (in years) 1 year 6 months 10 days 2 years 3 months 25 days 2 years 10 months 20 days 3 years 21 days
Options, vested and expected to vest, Weighted Average Remaining Contractual Term (in years) 1 year 6 months 10 days      
Exercisable, Weighted Average Remaining Contractual Term (in years) 1 year 6 months 10 days      
Aggregate Intrinsic Value, Exercised $ 3,936,675 $ 1,272,291 $ 4,726  
Aggregate Intrinsic Value, Outstanding 9,997,364      
Options, vested and expected to vest, outstanding, aggregate intrinsic value 9,997,364      
Exercisable, Intrinsic Value $ 9,997,364      
XML 97 R81.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-based Compensation - Fair Value Weighted Average Assumptions (Details) - Employee Stock
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Volatility rate, minimum 66.40% 63.10% 46.40%
Volatility rate, maximum 69.90% 68.50% 58.30%
Risk-free interest rate, minimum 0.30% 0.10% 0.20%
Risk-free interest rate, maximum 2.10% 0.20% 1.60%
Expected term (in years) 1 year 3 months 18 days 1 year 3 months 18 days 1 year 3 months 18 days
Dividend yield 0.00% 0.00% 0.00%
XML 98 R82.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-based Compensation - Employee Share Purchase Plan (Details) - Employee Stock - USD ($)
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Nov. 30, 2021
Nov. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Duration of offering periods for ESPP (in months) 24 months        
Percent of compensation allowed for purchase of options 15.00%        
Payroll deduction accumulation period (in months) 6 months        
Grant price, percent of fair value of common stock at date of grant 85.00%        
Maximum number of shares authorized for purchase per purchase date (in shares) 300,000        
Shares authorized under plan (in shares)       2,500,000 1,430,000
Weighted-average grant date fair value $ 16.48 $ 11.11 $ 4.33    
Maximum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Maximum number of common shares that may be purchased on any purchase date by a participant (in shares) 875        
Maximum number of common shares that may be purchased per a 24-month offering period by a participant (in shares) 3,500        
Maximum value of common stock that may be purchased in any one calendar year $ 25,000        
XML 99 R83.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-based Compensation - Share-based Compensation Expenses (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2019
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Allocated share-based compensation expense $ 31,324 $ 15,324 $ 10,454  
Unrecognized compensation expense $ 84,300      
Recognition period of share-based compensation expense (in years) 3 years 2 months 12 days      
Cost of goods sold        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Allocated share-based compensation expense $ 5,125 1,756 1,530  
Research and development        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Allocated share-based compensation expense 7,049 5,352 2,895  
Selling, general and administrative        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Allocated share-based compensation expense 19,150 8,216 6,029  
Performance Based Restricted Stock Units (PRSUs)        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Allocated share-based compensation expense $ 4,600 $ 2,300 $ 1,500  
Granted (in shares) 194,000 165,500 155,000  
Recognition period of share-based compensation expense (in years) 1 year 10 months 6 days 1 year 8 months 26 days 1 year 7 months 6 days 1 year 10 months 17 days
XML 100 R84.htm IDEA: XBRL DOCUMENT v3.22.2.2
Employee Benefit Plans (Details)
$ in Millions
12 Months Ended
Jun. 30, 2022
USD ($)
Retirement Benefit Plan Disclosure [Line Items]  
Employer matching contribution, percent of match 50.00%
Employer matching contribution, percent of employees' gross pay 4.00%
Company contributions to retirement plan $ 0.3
Defined Contribution Plan, Employer Matching Contribution, Eligible Compensation Maximum Match, Percent 2.00%
United States  
Retirement Benefit Plan Disclosure [Line Items]  
Mandatory employer contributions according to labor and social security laws and regulations, percent 7.70%
United States | Retirement Plan, 401-K  
Retirement Benefit Plan Disclosure [Line Items]  
Employee maximum salary deferral contribution, percent 100.00%
Taiwan  
Retirement Benefit Plan Disclosure [Line Items]  
Mandatory employer contributions according to labor and social security laws and regulations, percent 6.00%
China | Minimum  
Retirement Benefit Plan Disclosure [Line Items]  
Mandatory employer contributions according to labor and social security laws and regulations, percent 14.00%
China | Maximum  
Retirement Benefit Plan Disclosure [Line Items]  
Mandatory employer contributions according to labor and social security laws and regulations, percent 16.00%
XML 101 R85.htm IDEA: XBRL DOCUMENT v3.22.2.2
Income Taxes - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2020
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2019
Tax Credit Carryforward [Line Items]          
Valuation allowance   $ 5,755 $ 41,474    
Valuation allowance increase   35,700 3,600    
Undistributed earnings of foreign subsidiaries   314,700      
Unrecognized tax benefits   8,609 7,645 $ 7,126 $ 7,150
Unrecognized tax benefit, amount netted against deferred tax assets   6,600      
Unrecognized tax benefits that would reduce effective income tax rate   5,600      
Decrease in unrecognized tax benefits is reasonably possible   10      
Income tax interest and penalties accrued   200 100    
Income tax interest and penalties expense   32 5    
Income tax benefit $ (1,100) 39,258 3,935 $ 348  
Long-term Income Tax Payable          
Tax Credit Carryforward [Line Items]          
Unrecognized tax benefits   2,000      
Federal | Research Tax Credit Carryforward          
Tax Credit Carryforward [Line Items]          
Tax credit carryforward   8,900      
State          
Tax Credit Carryforward [Line Items]          
Tax credit carryforward   7,800      
Tax credit carryforward, subject to expiration   200      
Tax credit carryforward, not subject to expiration   7,600      
Net operating loss carryforwards   900      
Corporate Joint Venture          
Tax Credit Carryforward [Line Items]          
Deferred tax liability   29,600      
State research and development credit carryforward          
Tax Credit Carryforward [Line Items]          
Valuation allowance   5,800 5,800    
Net operating loss, fixed asset and intangible asset | Corporate Joint Venture          
Tax Credit Carryforward [Line Items]          
Valuation allowance   $ 0 $ 35,700    
XML 102 R86.htm IDEA: XBRL DOCUMENT v3.22.2.2
Income Taxes - Income Tax Schedules (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2020
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
U.S. federal taxes:        
Current   $ 645 $ 31 $ (1,673)
Deferred   2,260 1,955 22
Non-U.S. taxes:        
Current   7,749 2,344 1,940
Deferred   28,599 (396) 58
State taxes, net of federal benefit:        
Current   5 1 1
Total provision for income taxes $ (1,100) $ 39,258 $ 3,935 $ 348
Effective income tax rate reconciliation        
United States statutory rate   21.00% 21.00% 21.00%
Stock-based compensation   0.00% 0.10% 0.00%
Foreign taxes, net   (14.30%) (14.40%) (36.10%)
Outside basis difference on equity method investment   1.20% 0.00% 0.00%
Research and development credit   (0.30%) (2.40%) 8.00%
Non-deductible expenses   0.50% 2.40% (1.00%)
U.S. Tax Act deferred tax re-measurement   0.00% 0.00% 6.20%
Foreign Derived Intangible Income Deduction   (0.30%) 0.00% 0.00%
Other   0.10% (0.20%) 0.00%
Effective income tax rate   7.90% 6.50% (1.90%)
Domestic and foreign components of income (loss) before taxes        
U.S. operations   $ 16,684 $ 9,622 $ 3,549
Non-U.S. operations   478,386 50,602 (21,458)
Loss before income taxes   495,070 60,224 (17,909)
Deferred tax assets:        
Accrued compensation   5,742 3,954  
Net operating loss carryforwards   61 22,539  
Depreciation   4,365 7,924  
Tax credits   15,079 15,550  
Operating lease liabilities   5,807 7,292  
Capitalized intangible assets   0 9,982  
Accruals and reserves   643 1,113  
Total deferred tax assets   31,697 68,354  
Valuation allowance   (5,755) (41,474)  
Total deferred tax assets, net of valuation allowance   25,942 26,880  
Deferred tax liabilities:        
Depreciation and amortization   (18,909) (17,193)  
Right of use assets   (5,579) (6,968)  
Investments   (29,619) 0  
Total deferred tax liabilities   (54,107) (24,161)  
Net deferred tax assets/(liabilities)     2,719  
Current and non-current deferred tax assets and liabilities        
Long-term deferred tax assets   592 5,167  
Long-term deferred tax liabilities   (28,757) (2,448)  
Net deferred tax assets/(liabilities)   (28,165)    
Net deferred tax assets/(liabilities)     2,719  
Unrecognized tax benefits rollforward        
Balance at beginning of year   7,645 7,126 7,150
Additions based on tax positions related to the current year   1,121 677 333
Reductions based on tax positions related to prior years   (40) (41) (114)
Reductions due to lapse of applicable statute of limitations   (117) (117) (243)
Balance at end of year   $ 8,609 $ 7,645 $ 7,126
XML 103 R87.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segment and Geographic information Segment Narrative (Details)
12 Months Ended
Jun. 30, 2022
Segment
Segment Reporting [Abstract]  
Number of operating segments 1
XML 104 R88.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segment and Geographic information - Revenue by Geographical Segment (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Segment Reporting Information [Line Items]      
Revenue $ 777,552 $ 656,902 $ 464,909
Hong Kong      
Segment Reporting Information [Line Items]      
Revenue 630,238 537,553 390,478
China      
Segment Reporting Information [Line Items]      
Revenue 120,978 107,325 64,058
South Korea      
Segment Reporting Information [Line Items]      
Revenue 11,802 5,497 3,303
United States      
Segment Reporting Information [Line Items]      
Revenue 12,470 5,492 4,465
Other countries      
Segment Reporting Information [Line Items]      
Revenue $ 2,064 $ 1,035 $ 2,605
XML 105 R89.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segment and Geographic information - Revenue by Product Type (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Segment Reporting Information [Line Items]      
Revenue $ 777,552 $ 656,902 $ 464,909
Power discrete      
Segment Reporting Information [Line Items]      
Revenue 545,135 482,718 391,941
Power IC      
Segment Reporting Information [Line Items]      
Revenue 220,882 161,726 66,360
Packaging and testing services      
Segment Reporting Information [Line Items]      
Revenue $ 11,535 $ 12,458 $ 6,608
XML 106 R90.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segment and Geographic information Location and Net Book Value of Long-Lived Assets (Details) - USD ($)
$ in Thousands
Jun. 30, 2022
Jun. 30, 2021
Revenues from External Customers and Long-Lived Assets [Line Items]    
PPE and land use rights $ 342,340 $ 471,637
China    
Revenues from External Customers and Long-Lived Assets [Line Items]    
PPE and land use rights 105,326 350,387
United States    
Revenues from External Customers and Long-Lived Assets [Line Items]    
PPE and land use rights 232,731 118,756
Other countries    
Revenues from External Customers and Long-Lived Assets [Line Items]    
PPE and land use rights $ 4,283 $ 2,494
XML 107 R91.htm IDEA: XBRL DOCUMENT v3.22.2.2
Restricted Net Assets (Details) - China - Subsidiaries [Member] - USD ($)
$ in Millions
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Restricted Statutory Reserves [Line Items]    
Foreign subsidiaries, restricted statutory reserves $ 92.4 $ 209.9
Foreign subsidiaries, restricted statutory reserves percent of parent consolidated net assets 10.80% 50.40%
Minimum    
Restricted Statutory Reserves [Line Items]    
Foreign subsidiaries, minimum percent of after-tax profit required annually in statutory reserves 10.00%  
Maximum    
Restricted Statutory Reserves [Line Items]    
Foreign subsidiaries, statutory reserves maximum cumulative amount as a percent of registered capital 50.00%  
XML 108 R92.htm IDEA: XBRL DOCUMENT v3.22.2.2
Commitments and Contingencies - Purchase Commitments (Details) - USD ($)
$ in Millions
Jun. 30, 2022
Jun. 30, 2021
Raw materials, wafers, and packaging and testing services purchase commitments [Member]    
Purchase Commitment, Excluding Long-term Committment [Line Items]    
Purchase commitment, amount $ 89.9 $ 81.8
Property and equipment purchase commitments [Member]    
Purchase Commitment, Excluding Long-term Committment [Line Items]    
Purchase commitment, amount $ 63.4 $ 90.0
XML 109 R93.htm IDEA: XBRL DOCUMENT v3.22.2.2
Commitments and Contingencies - Contingencies and Indemnities (Details) - USD ($)
Jun. 30, 2022
Jun. 30, 2021
Indemnification Agreement    
Loss Contingencies [Line Items]    
Indemnification accrual $ 0 $ 0
XML 110 R94.htm IDEA: XBRL DOCUMENT v3.22.2.2
Cybersecutiy Incident (Details)
$ in Millions
3 Months Ended
Mar. 31, 2022
USD ($)
Loss from Cyber Security Incident  
Loss Contingencies [Line Items]  
Loss recorded in the period from cyber security incident $ 1.5
XML 111 R95.htm IDEA: XBRL DOCUMENT v3.22.2.2
Schedule II - Valuation and Qualifying Accounts (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
SEC Schedule, 12-09, Allowance, Credit Loss      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance $ 30 $ 30 $ 30
Additions 0 0 0
Reductions 0 0 0
Balance 30 30 30
Allowance for Price Adjustments      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance 12,415 30,092 24,075
Additions 170,651 178,902 140,413
Reductions (164,335) (196,579) (134,396)
Balance 18,731 12,415 30,092
SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance 41,474 37,827 35,420
Additions 0 3,647 2,407
Reductions (35,719) 0 0
Balance $ 5,755 $ 41,474 $ 37,827
XML 112 aosl-20220630_htm.xml IDEA: XBRL DOCUMENT 0001387467 2021-07-01 2022-06-30 0001387467 2021-12-31 0001387467 2022-07-31 0001387467 2022-06-30 0001387467 2021-06-30 0001387467 2020-07-01 2021-06-30 0001387467 2019-07-01 2020-06-30 0001387467 us-gaap:PreferredStockMember 2019-06-30 0001387467 us-gaap:CommonStockMember 2019-06-30 0001387467 us-gaap:TreasuryStockMember 2019-06-30 0001387467 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001387467 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001387467 us-gaap:RetainedEarningsMember 2019-06-30 0001387467 us-gaap:ParentMember 2019-06-30 0001387467 us-gaap:NoncontrollingInterestMember 2019-06-30 0001387467 2019-06-30 0001387467 us-gaap:CommonStockMember 2019-07-01 2020-06-30 0001387467 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2020-06-30 0001387467 us-gaap:ParentMember 2019-07-01 2020-06-30 0001387467 us-gaap:TreasuryStockMember 2019-07-01 2020-06-30 0001387467 us-gaap:RetainedEarningsMember 2019-07-01 2020-06-30 0001387467 us-gaap:NoncontrollingInterestMember 2019-07-01 2020-06-30 0001387467 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-01 2020-06-30 0001387467 us-gaap:PreferredStockMember 2020-06-30 0001387467 us-gaap:CommonStockMember 2020-06-30 0001387467 us-gaap:TreasuryStockMember 2020-06-30 0001387467 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001387467 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001387467 us-gaap:RetainedEarningsMember 2020-06-30 0001387467 us-gaap:ParentMember 2020-06-30 0001387467 us-gaap:NoncontrollingInterestMember 2020-06-30 0001387467 2020-06-30 0001387467 us-gaap:CommonStockMember 2020-07-01 2021-06-30 0001387467 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2021-06-30 0001387467 us-gaap:ParentMember 2020-07-01 2021-06-30 0001387467 us-gaap:TreasuryStockMember 2020-07-01 2021-06-30 0001387467 us-gaap:RetainedEarningsMember 2020-07-01 2021-06-30 0001387467 us-gaap:NoncontrollingInterestMember 2020-07-01 2021-06-30 0001387467 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2021-06-30 0001387467 us-gaap:PreferredStockMember 2021-06-30 0001387467 us-gaap:CommonStockMember 2021-06-30 0001387467 us-gaap:TreasuryStockMember 2021-06-30 0001387467 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001387467 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001387467 us-gaap:RetainedEarningsMember 2021-06-30 0001387467 us-gaap:ParentMember 2021-06-30 0001387467 us-gaap:NoncontrollingInterestMember 2021-06-30 0001387467 us-gaap:CommonStockMember 2021-07-01 2022-06-30 0001387467 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2022-06-30 0001387467 us-gaap:ParentMember 2021-07-01 2022-06-30 0001387467 us-gaap:TreasuryStockMember 2021-07-01 2022-06-30 0001387467 us-gaap:RetainedEarningsMember 2021-07-01 2022-06-30 0001387467 us-gaap:NoncontrollingInterestMember 2021-07-01 2022-06-30 0001387467 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2022-06-30 0001387467 us-gaap:PreferredStockMember 2022-06-30 0001387467 us-gaap:CommonStockMember 2022-06-30 0001387467 us-gaap:TreasuryStockMember 2022-06-30 0001387467 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001387467 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001387467 us-gaap:RetainedEarningsMember 2022-06-30 0001387467 us-gaap:ParentMember 2022-06-30 0001387467 us-gaap:NoncontrollingInterestMember 2022-06-30 0001387467 srt:ParentCompanyMember aosl:FacilityinLiangjiangNewAreaofChongqingtheJointVentureMember 2021-12-01 2021-12-01 0001387467 aosl:FacilityinLiangjiangNewAreaofChongqingtheJointVentureMember aosl:ChongqingFundsMember 2021-12-01 2021-12-01 0001387467 aosl:FacilityinLiangjiangNewAreaofChongqingtheJointVentureMember 2022-06-30 2022-06-30 0001387467 aosl:ThirdPartyInvestorsMember aosl:ThirdPartyInvestorsMember us-gaap:CorporateJointVentureMember 2021-12-01 0001387467 aosl:ThirdPartyInvestorsMember us-gaap:CorporateJointVentureMember 2021-12-01 2021-12-31 0001387467 us-gaap:CorporateJointVentureMember 2021-11-30 2021-11-30 0001387467 us-gaap:CorporateJointVentureMember 2021-12-02 2021-12-02 0001387467 2021-12-02 0001387467 2021-11-30 0001387467 aosl:ThirdPartyInvestorsMember aosl:ThirdPartyInvestorsMember us-gaap:CorporateJointVentureMember 2021-12-24 0001387467 aosl:ThirdPartyInvestorsMember us-gaap:CorporateJointVentureMember 2021-12-24 2021-12-24 0001387467 aosl:EmployeeIncentivePlanMember aosl:ThirdPartyInvestorsMember aosl:EmployeeIncentivePlanMember us-gaap:CorporateJointVentureMember 2021-12-24 0001387467 us-gaap:CorporateJointVentureMember 2021-12-31 2021-12-31 0001387467 aosl:ThirdPartyInvestorsMember us-gaap:CorporateJointVentureMember 2022-01-26 2022-01-26 0001387467 2022-01-26 2022-01-26 0001387467 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember aosl:HHGraceMember 2021-07-01 2022-06-30 0001387467 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember aosl:HHGraceMember 2020-07-01 2021-06-30 0001387467 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember aosl:HHGraceMember 2019-07-01 2020-06-30 0001387467 srt:MinimumMember us-gaap:BuildingMember 2021-07-01 2022-06-30 0001387467 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2021-07-01 2022-06-30 0001387467 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2021-07-01 2022-06-30 0001387467 srt:MinimumMember us-gaap:EquipmentMember 2021-07-01 2022-06-30 0001387467 srt:MaximumMember us-gaap:EquipmentMember 2021-07-01 2022-06-30 0001387467 srt:MinimumMember us-gaap:ComputerEquipmentMember 2021-07-01 2022-06-30 0001387467 srt:MaximumMember us-gaap:ComputerEquipmentMember 2021-07-01 2022-06-30 0001387467 us-gaap:OfficeEquipmentMember 2021-07-01 2022-06-30 0001387467 srt:MinimumMember us-gaap:LeaseholdImprovementsMember 2021-07-01 2022-06-30 0001387467 srt:MaximumMember us-gaap:LeaseholdImprovementsMember 2021-07-01 2022-06-30 0001387467 us-gaap:VehiclesMember 2021-07-01 2022-06-30 0001387467 srt:MinimumMember us-gaap:SoftwareDevelopmentMember 2021-07-01 2022-06-30 0001387467 srt:MaximumMember us-gaap:SoftwareDevelopmentMember 2021-07-01 2022-06-30 0001387467 us-gaap:CorporateJointVentureMember 2021-07-01 2022-06-30 0001387467 us-gaap:CorporateJointVentureMember 2021-12-01 2021-12-31 0001387467 us-gaap:CorporateJointVentureMember 2021-12-01 0001387467 aosl:FacilityinLiangjiangNewAreaofChongqingtheJointVentureMember aosl:ChongqingFundsMember 2021-12-31 2021-12-31 0001387467 aosl:ThirdPartyInvestorsMember aosl:ThirdPartyInvestorsMember us-gaap:CorporateJointVentureMember 2022-01-26 0001387467 aosl:ThirdPartyInvestorsMember aosl:ThirdPartyInvestorsMember us-gaap:CorporateJointVentureMember 2022-01-26 2022-01-26 0001387467 aosl:ThirdPartyInvestorsMember 2022-01-26 2022-01-26 0001387467 aosl:ThirdPartyInvestorsTransaction1Member us-gaap:CorporateJointVentureMember 2021-07-01 2022-06-30 0001387467 aosl:ThirdPartyInvestorsTransaction2Member us-gaap:CorporateJointVentureMember 2021-07-01 2022-06-30 0001387467 aosl:FacilityinLiangjiangNewAreaofChongqingtheJointVentureMember 2022-03-31 0001387467 aosl:FacilityinLiangjiangNewAreaofChongqingtheJointVentureMember 2022-01-01 2022-03-31 0001387467 us-gaap:CorporateJointVentureMember 2022-06-30 2022-06-30 0001387467 us-gaap:CorporateJointVentureMember 2021-12-02 2022-06-30 0001387467 aosl:StockOptionsAndRestrictedStockUnitsRsusMember 2021-07-01 2022-06-30 0001387467 aosl:StockOptionsAndRestrictedStockUnitsRsusMember 2020-07-01 2021-06-30 0001387467 aosl:StockOptionsAndRestrictedStockUnitsRsusMember 2019-07-01 2020-06-30 0001387467 us-gaap:EmployeeStockMember 2021-07-01 2022-06-30 0001387467 us-gaap:EmployeeStockMember 2020-07-01 2021-06-30 0001387467 us-gaap:EmployeeStockMember 2019-07-01 2020-06-30 0001387467 srt:MinimumMember 2021-07-01 2022-06-30 0001387467 srt:MaximumMember 2021-07-01 2022-06-30 0001387467 aosl:CustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2022-06-30 0001387467 aosl:CustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2021-06-30 0001387467 aosl:CustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2020-06-30 0001387467 aosl:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2022-06-30 0001387467 aosl:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2021-06-30 0001387467 aosl:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2020-06-30 0001387467 aosl:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2022-06-30 0001387467 aosl:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2021-06-30 0001387467 aosl:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2022-06-30 0001387467 aosl:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2021-06-30 0001387467 aosl:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2021-06-30 0001387467 aosl:CustomerDMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2022-06-30 0001387467 us-gaap:LandMember 2022-06-30 0001387467 us-gaap:LandMember 2021-06-30 0001387467 us-gaap:BuildingMember 2022-06-30 0001387467 us-gaap:BuildingMember 2021-06-30 0001387467 us-gaap:MachineryAndEquipmentMember 2022-06-30 0001387467 us-gaap:MachineryAndEquipmentMember 2021-06-30 0001387467 aosl:EquipmentAndToolingMember 2022-06-30 0001387467 aosl:EquipmentAndToolingMember 2021-06-30 0001387467 us-gaap:ComputerEquipmentMember 2022-06-30 0001387467 us-gaap:ComputerEquipmentMember 2021-06-30 0001387467 us-gaap:FurnitureAndFixturesMember 2022-06-30 0001387467 us-gaap:FurnitureAndFixturesMember 2021-06-30 0001387467 us-gaap:LeaseholdImprovementsMember 2022-06-30 0001387467 us-gaap:LeaseholdImprovementsMember 2021-06-30 0001387467 aosl:LandUseRightsMember 2022-06-30 0001387467 aosl:LandUseRightsMember 2021-06-30 0001387467 aosl:ComputerSoftwareDevelopmentMember 2022-06-30 0001387467 aosl:ComputerSoftwareDevelopmentMember 2021-06-30 0001387467 aosl:ComputerSoftwareDevelopmentMember 2020-06-30 0001387467 aosl:PatentsAndPatentedTechnologyMember 2022-06-30 0001387467 aosl:PatentsAndPatentedTechnologyMember 2021-06-30 0001387467 us-gaap:TradeNamesMember 2022-06-30 0001387467 us-gaap:TradeNamesMember 2021-06-30 0001387467 us-gaap:CustomerRelationshipsMember 2022-06-30 0001387467 us-gaap:CustomerRelationshipsMember 2021-06-30 0001387467 aosl:PatentsAndPatentedTechnologyMember 2021-07-01 2022-06-30 0001387467 us-gaap:TradeNamesMember 2021-07-01 2022-06-30 0001387467 aosl:CustomerMember 2022-06-30 0001387467 aosl:CustomerBMember 2022-06-30 0001387467 aosl:OtherCustomersMember 2022-06-30 0001387467 aosl:CustomerMember 2021-06-30 0001387467 aosl:CustomerBMember 2021-06-30 0001387467 country:CN aosl:BankOfCommunicationsLimitedMember us-gaap:BaseRateMember 2019-10-31 0001387467 country:CN aosl:BankOfCommunicationsLimitedMember us-gaap:BaseRateMember 2019-10-01 2019-10-31 0001387467 aosl:BankOfCommunicationsLimitedMember 2019-10-31 0001387467 aosl:BankOfCommunicationsLimitedMember 2021-09-30 0001387467 aosl:CreditFacility3Point85PercentDueNovember182022Member aosl:BankOfCommunicationsLimitedMember 2021-10-01 2021-12-31 0001387467 aosl:CreditFacility3Point85PercentDueNovember182022Member aosl:BankOfCommunicationsLimitedMember 2021-12-31 0001387467 aosl:BankOfCommunicationsLimitedMember 2022-06-30 0001387467 aosl:IndustrialAndCommercialBankofChinaMember us-gaap:ForeignLineOfCreditMember 2018-11-16 0001387467 aosl:LineOfCreditFacilityTradeBorrowingsMember aosl:IndustrialAndCommercialBankofChinaMember us-gaap:ForeignLineOfCreditMember 2018-11-16 0001387467 aosl:LineOfCreditFacilityWorkingCapitalBorrowingsMember aosl:IndustrialAndCommercialBankofChinaMember us-gaap:ForeignLineOfCreditMember 2018-11-16 0001387467 aosl:IndustrialAndCommercialBankofChinaMember us-gaap:ForeignLineOfCreditMember 2021-10-01 2021-12-31 0001387467 aosl:IndustrialAndCommercialBankofChinaMember us-gaap:ForeignLineOfCreditMember 2021-12-31 0001387467 aosl:IndustrialAndCommercialBankofChinaMember us-gaap:ForeignLineOfCreditMember 2022-06-30 0001387467 aosl:AccountsReceivableFactoringAgreementAugustNinthTwoThousandNineteenMember us-gaap:SecuredDebtMember 2019-08-09 0001387467 aosl:AccountsReceivableFactoringAgreementAugustNinthTwoThousandNineteenMember us-gaap:SecuredDebtMember 2019-08-09 2019-08-09 0001387467 aosl:AccountsReceivableFactoringAgreementAugustNinthTwoThousandNineteenMember us-gaap:SecuredDebtMember 2021-08-11 0001387467 aosl:AccountsReceivableFactoringAgreementAugustNinthTwoThousandNineteenMember us-gaap:SecuredDebtMember 2022-06-30 0001387467 aosl:JirehSemiconductorIncorporatedMember aosl:SalesLeaseBackTransactionWithJirehSemiconductorIncorporatedMember 2021-09-30 0001387467 aosl:JirehSemiconductorIncorporatedMember aosl:SalesLeaseBackTransactionWithJirehSemiconductorIncorporatedMember 2021-04-30 0001387467 aosl:JirehSemiconductorIncorporatedMember aosl:SalesLeaseBackTransactionWithJirehSemiconductorIncorporatedMember 2022-06-30 0001387467 aosl:JirehSemiconductorIncorporatedMember aosl:SalesLeaseBackTransactionWithJirehSemiconductorIncorporatedMember 2021-07-01 2022-06-30 0001387467 aosl:JirehSemiconductorIncorporatedMember us-gaap:MachineryAndEquipmentMember aosl:SalesLeaseBackTransactionWithJirehSemiconductorIncorporatedMember 2022-06-30 0001387467 us-gaap:SecuredDebtMember aosl:JirehMember 2021-08-18 0001387467 us-gaap:SecuredDebtMember aosl:JirehMember 2021-08-18 2021-08-18 0001387467 us-gaap:SecuredDebtMember aosl:JirehMember 2022-02-16 2022-02-16 0001387467 us-gaap:SecuredDebtMember aosl:JirehMember 2022-06-30 0001387467 us-gaap:SecuredDebtMember 2018-05-01 0001387467 us-gaap:SecuredDebtMember 2018-05-01 2018-05-01 0001387467 us-gaap:SecuredDebtMember 2022-06-30 0001387467 aosl:TermLoanMember aosl:VariableInterestRateTermLoanMaturingAugust2022Member us-gaap:SecuredDebtMember 2017-08-15 0001387467 aosl:TermLoanMember aosl:VariableInterestRateTermLoanMaturingAugust2022Member us-gaap:SecuredDebtMember 2017-08-15 2017-08-15 0001387467 aosl:TermLoanMember aosl:VariableInterestRateTermLoanMaturingAugust2022Member us-gaap:SecuredDebtMember 2018-01-12 0001387467 aosl:TermLoanMember aosl:VariableInterestRateTermLoanMaturingAugust2022Member us-gaap:SecuredDebtMember 2018-07-31 0001387467 srt:MinimumMember aosl:TermLoanMember aosl:VariableInterestRateTermLoanMaturingAugust2022Member us-gaap:SecuredDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-08-15 2017-08-15 0001387467 srt:MaximumMember aosl:TermLoanMember aosl:VariableInterestRateTermLoanMaturingAugust2022Member us-gaap:SecuredDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-08-15 2017-08-15 0001387467 aosl:TermLoanMember aosl:VariableInterestRateTermLoanMaturingAugust2022Member us-gaap:SecuredDebtMember 2022-06-30 0001387467 aosl:LeaseFinancingMember aosl:YinHaiLeasingCompanyandChinaImportExportBankMember aosl:YinHaiLeasingCompanyandChinaImportExportBankMember 2018-05-09 0001387467 2010-10-22 2022-06-30 0001387467 aosl:TreasuryStockReissuedMember 2010-10-22 2022-06-30 0001387467 srt:MaximumMember aosl:StockOptionsAndRestrictedStockUnitsRsusMember aosl:TwoThousandEighteenPlanMember 2018-11-30 0001387467 srt:MaximumMember aosl:StockOptionsAndRestrictedStockUnitsRsusMember aosl:TwoThousandEighteenPlanMember 2021-11-01 2021-11-30 0001387467 srt:MaximumMember aosl:StockOptionsAndRestrictedStockUnitsRsusMember aosl:TwoThousandEighteenPlanMember 2021-11-30 0001387467 aosl:StockOptionsAndRestrictedStockUnitsRsusMember aosl:TwoThousandEighteenPlanMember 2022-06-30 0001387467 us-gaap:RestrictedStockUnitsRSUMember aosl:TwoThousandEighteenPlanMember aosl:ExternalBoardMembersMember 2021-07-01 2022-06-30 0001387467 srt:MaximumMember us-gaap:RestrictedStockUnitsRSUMember aosl:TwoThousandEighteenPlanMember aosl:ExternalBoardMembersMember 2021-07-01 2022-06-30 0001387467 srt:MinimumMember us-gaap:RestrictedStockUnitsRSUMember aosl:TwoThousandEighteenPlanMember 2021-07-01 2022-06-30 0001387467 srt:MinimumMember us-gaap:EmployeeStockOptionMember aosl:TwoThousandEighteenPlanMember 2021-07-01 2022-06-30 0001387467 srt:MinimumMember aosl:NonstatutoryStockOptionsMember aosl:TwoThousandEighteenPlanMember 2021-07-01 2022-06-30 0001387467 srt:MinimumMember aosl:StockOptionsAndRestrictedStockUnitsRsusMember aosl:TwoThousandEighteenPlanMember 2021-07-01 2022-06-30 0001387467 srt:MaximumMember aosl:StockOptionsAndRestrictedStockUnitsRsusMember aosl:TwoThousandEighteenPlanMember 2021-07-01 2022-06-30 0001387467 aosl:StockOptionsAndRestrictedStockUnitsRsusMember aosl:TwoThousandEighteenPlanMember 2021-07-01 2022-06-30 0001387467 us-gaap:RestrictedStockMember 2019-06-30 0001387467 us-gaap:RestrictedStockMember 2018-07-01 2019-06-30 0001387467 us-gaap:RestrictedStockMember 2019-07-01 2020-06-30 0001387467 us-gaap:RestrictedStockMember 2020-06-30 0001387467 us-gaap:RestrictedStockMember 2020-07-01 2021-06-30 0001387467 us-gaap:RestrictedStockMember 2021-06-30 0001387467 us-gaap:RestrictedStockMember 2021-07-01 2022-06-30 0001387467 us-gaap:RestrictedStockMember 2022-06-30 0001387467 aosl:PerformanceBasedRestrictedStockUnitsPRSUsMemberMember 2021-07-01 2022-06-30 0001387467 aosl:PerformanceBasedRestrictedStockUnitsPRSUsMemberMember 2020-07-01 2021-06-30 0001387467 aosl:PerformanceBasedRestrictedStockUnitsPRSUsMemberMember 2019-07-01 2020-06-30 0001387467 aosl:PerformanceBasedRestrictedStockUnitsPRSUsMemberMember 2019-06-30 0001387467 aosl:PerformanceBasedRestrictedStockUnitsPRSUsMemberMember 2018-07-01 2019-06-30 0001387467 aosl:PerformanceBasedRestrictedStockUnitsPRSUsMemberMember 2020-06-30 0001387467 aosl:PerformanceBasedRestrictedStockUnitsPRSUsMemberMember 2021-06-30 0001387467 aosl:PerformanceBasedRestrictedStockUnitsPRSUsMemberMember 2022-06-30 0001387467 aosl:MarketbasedRestrictedStockUnitsMSUMember 2021-12-01 2021-12-31 0001387467 srt:MinimumMember aosl:MarketbasedRestrictedStockUnitsMSUMember 2021-12-01 2021-12-31 0001387467 srt:MaximumMember aosl:MarketbasedRestrictedStockUnitsMSUMember 2021-12-01 2021-12-31 0001387467 aosl:MarketbasedRestrictedStockUnitsMSUMember 2021-07-01 2022-06-30 0001387467 aosl:MarketbasedRestrictedStockUnitsMSUMember 2018-07-01 2018-09-30 0001387467 aosl:MarketBasedRestrictedStockUnitsMSUPreModificationMember 2020-08-30 2020-08-30 0001387467 aosl:MarketBasedRestrictedStockUnitsMSUPostModificationMember 2020-08-31 2020-08-31 0001387467 aosl:MarketBasedRestrictedStockUnitsMSUPostModificationMember 2021-07-01 2022-06-30 0001387467 aosl:MarketBasedRestrictedStockUnitsMSUPostModificationMember 2020-07-01 2021-06-30 0001387467 aosl:MarketBasedRestrictedStockUnitsMSUPostModificationMember 2019-07-01 2020-06-30 0001387467 2018-07-01 2019-06-30 0001387467 us-gaap:EmployeeStockMember 2018-11-30 0001387467 us-gaap:EmployeeStockMember 2021-11-30 0001387467 us-gaap:EmployeeStockMember 2021-07-01 2022-06-30 0001387467 us-gaap:EmployeeStockMember 2022-06-30 0001387467 srt:MaximumMember us-gaap:EmployeeStockMember 2021-07-01 2022-06-30 0001387467 us-gaap:EmployeeStockMember 2020-07-01 2021-06-30 0001387467 us-gaap:EmployeeStockMember 2019-07-01 2020-06-30 0001387467 us-gaap:CostOfSalesMember 2021-07-01 2022-06-30 0001387467 us-gaap:CostOfSalesMember 2020-07-01 2021-06-30 0001387467 us-gaap:CostOfSalesMember 2019-07-01 2020-06-30 0001387467 us-gaap:ResearchAndDevelopmentExpenseMember 2021-07-01 2022-06-30 0001387467 us-gaap:ResearchAndDevelopmentExpenseMember 2020-07-01 2021-06-30 0001387467 us-gaap:ResearchAndDevelopmentExpenseMember 2019-07-01 2020-06-30 0001387467 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-07-01 2022-06-30 0001387467 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-07-01 2021-06-30 0001387467 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-07-01 2020-06-30 0001387467 aosl:RetirementPlan401KMember country:US 2021-07-01 2022-06-30 0001387467 country:US 2021-07-01 2022-06-30 0001387467 srt:MinimumMember country:CN 2021-07-01 2022-06-30 0001387467 srt:MaximumMember country:CN 2021-07-01 2022-06-30 0001387467 country:TW 2021-07-01 2022-06-30 0001387467 aosl:StateResearchAndDevelopmentCreditCarryforwardMember 2022-06-30 0001387467 aosl:StateResearchAndDevelopmentCreditCarryforwardMember 2021-06-30 0001387467 us-gaap:CorporateJointVentureMember aosl:NetOperatingLossFixedAssetAndIntangibleAssetMember 2021-06-30 0001387467 us-gaap:CorporateJointVentureMember aosl:NetOperatingLossFixedAssetAndIntangibleAssetMember 2022-06-30 0001387467 us-gaap:DomesticCountryMember us-gaap:ResearchMember 2022-06-30 0001387467 us-gaap:StateAndLocalJurisdictionMember 2022-06-30 0001387467 us-gaap:CorporateJointVentureMember 2022-06-30 0001387467 aosl:LongTermIncomeTaxPayableMember 2022-06-30 0001387467 2020-01-01 2020-03-31 0001387467 country:HK 2021-07-01 2022-06-30 0001387467 country:HK 2020-07-01 2021-06-30 0001387467 country:HK 2019-07-01 2020-06-30 0001387467 country:CN 2021-07-01 2022-06-30 0001387467 country:CN 2020-07-01 2021-06-30 0001387467 country:CN 2019-07-01 2020-06-30 0001387467 country:KR 2021-07-01 2022-06-30 0001387467 country:KR 2020-07-01 2021-06-30 0001387467 country:KR 2019-07-01 2020-06-30 0001387467 country:US 2021-07-01 2022-06-30 0001387467 country:US 2020-07-01 2021-06-30 0001387467 country:US 2019-07-01 2020-06-30 0001387467 aosl:OtherCountriesMember 2021-07-01 2022-06-30 0001387467 aosl:OtherCountriesMember 2020-07-01 2021-06-30 0001387467 aosl:OtherCountriesMember 2019-07-01 2020-06-30 0001387467 aosl:PowerDiscreteMember 2021-07-01 2022-06-30 0001387467 aosl:PowerDiscreteMember 2020-07-01 2021-06-30 0001387467 aosl:PowerDiscreteMember 2019-07-01 2020-06-30 0001387467 aosl:PowerIcMember 2021-07-01 2022-06-30 0001387467 aosl:PowerIcMember 2020-07-01 2021-06-30 0001387467 aosl:PowerIcMember 2019-07-01 2020-06-30 0001387467 aosl:PackagingAndTestingServicesMember 2021-07-01 2022-06-30 0001387467 aosl:PackagingAndTestingServicesMember 2020-07-01 2021-06-30 0001387467 aosl:PackagingAndTestingServicesMember 2019-07-01 2020-06-30 0001387467 country:CN 2022-06-30 0001387467 country:CN 2021-06-30 0001387467 country:US 2022-06-30 0001387467 country:US 2021-06-30 0001387467 aosl:OtherCountriesMember 2022-06-30 0001387467 aosl:OtherCountriesMember 2021-06-30 0001387467 srt:SubsidiariesMember srt:MinimumMember country:CN 2021-07-01 2022-06-30 0001387467 srt:SubsidiariesMember srt:MaximumMember country:CN 2021-07-01 2022-06-30 0001387467 srt:SubsidiariesMember country:CN 2022-06-30 0001387467 srt:SubsidiariesMember country:CN 2021-06-30 0001387467 aosl:InventoriesAndServicesMember 2022-06-30 0001387467 aosl:InventoriesAndServicesMember 2021-06-30 0001387467 us-gaap:CapitalAdditionsMember 2022-06-30 0001387467 us-gaap:CapitalAdditionsMember 2021-06-30 0001387467 us-gaap:IndemnificationGuaranteeMember 2022-06-30 0001387467 us-gaap:IndemnificationGuaranteeMember 2021-06-30 0001387467 aosl:LossFromCyberSecurityIncidentMember 2022-01-01 2022-03-31 0001387467 us-gaap:AllowanceForCreditLossMember 2019-06-30 0001387467 aosl:AllowanceForPriceAdjustmentsMember 2019-06-30 0001387467 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-06-30 0001387467 us-gaap:AllowanceForCreditLossMember 2019-07-01 2020-06-30 0001387467 aosl:AllowanceForPriceAdjustmentsMember 2019-07-01 2020-06-30 0001387467 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-07-01 2020-06-30 0001387467 us-gaap:AllowanceForCreditLossMember 2020-06-30 0001387467 aosl:AllowanceForPriceAdjustmentsMember 2020-06-30 0001387467 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2020-06-30 0001387467 us-gaap:AllowanceForCreditLossMember 2020-07-01 2021-06-30 0001387467 aosl:AllowanceForPriceAdjustmentsMember 2020-07-01 2021-06-30 0001387467 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2020-07-01 2021-06-30 0001387467 us-gaap:AllowanceForCreditLossMember 2021-06-30 0001387467 aosl:AllowanceForPriceAdjustmentsMember 2021-06-30 0001387467 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2021-06-30 0001387467 us-gaap:AllowanceForCreditLossMember 2021-07-01 2022-06-30 0001387467 aosl:AllowanceForPriceAdjustmentsMember 2021-07-01 2022-06-30 0001387467 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2021-07-01 2022-06-30 0001387467 us-gaap:AllowanceForCreditLossMember 2022-06-30 0001387467 aosl:AllowanceForPriceAdjustmentsMember 2022-06-30 0001387467 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2022-06-30 iso4217:USD shares iso4217:USD shares pure iso4217:CNY aosl:director iso4217:EUR aosl:votes aosl:Segment 0001387467 2022 FY false P3Y http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet 10-K true 2022-06-30 --06-30 false 001-34717 Alpha and Omega Semiconductor Limited D0 77-0553536 Clarendon House 2 Church Street Hamilton HM 11 BM 408 830-9742 Common Shares, $0.002 par value per share AOSL NASDAQ No No Yes Yes Large Accelerated Filer false false false false 1327000000 27397273 243 BDO USA, LLP San Jose, California 314352000 202412000 299000 233000 65681000 35789000 158040000 154293000 11220000 14595000 549592000 407322000 318666000 436977000 23674000 34660000 10050000 13410000 378378000 0 592000 5167000 0 2168000 17677000 18869000 1298629000 918573000 87377000 80699000 116893000 69494000 28989000 0 4248000 2604000 25563000 58030000 802000 16724000 3850000 5679000 267722000 233230000 42486000 77990000 2158000 1319000 28757000 2448000 3932000 12698000 20878000 30440000 78603000 44123000 444536000 402248000 0.002 0.002 10000000 10000000 0 0 0 0 0 0 0.002 0.002 100000000 100000000 33988000 27371000 32975000 26350000 68000 66000 6617000 6625000 66000000 66064000 288951000 259993000 1080000 2315000 629994000 176895000 854093000 373205000 0 143120000 854093000 516325000 1298629000 918573000 777552000 656902000 464909000 508996000 452359000 362178000 268556000 204543000 102731000 71259000 62953000 51252000 95259000 77514000 64816000 0 0 600000 166518000 140467000 116668000 102038000 64076000 -13937000 999000 2456000 -1229000 -3920000 -6308000 -2743000 399093000 0 0 -3140000 0 0 495070000 60224000 -17909000 39258000 3935000 348000 455812000 56289000 -18257000 -2629000 0 0 453183000 56289000 -18257000 20000 -1827000 -11661000 453163000 58116000 -6596000 16.93 2.25 -0.27 16.07 2.13 -0.27 26764000 25786000 24840000 28203000 27272000 24840000 453183000 56289000 -18257000 1307000 14190000 -4839000 3642000 0 0 450848000 70479000 -23096000 -1080000 4921000 -14066000 451928000 65558000 -9030000 0 0 31163000 62000 6646000 -66240000 234410000 -2693000 125485000 291024000 152265000 443289000 562000 1000 24000 25000 25000 7000 56000 -56000 0 0 181000 1509000 1509000 1509000 400000 1000 3324000 3325000 3325000 9854000 9854000 9854000 -6596000 -6596000 -11661000 -18257000 -2434000 -2434000 -2405000 -4839000 0 0 31944000 64000 6639000 -66184000 246103000 -5127000 118833000 293689000 138199000 431888000 857000 1000 1698000 1699000 1699000 14000 120000 -54000 66000 66000 225000 6924000 6924000 6924000 399000 1000 3326000 3327000 3327000 12190000 12190000 12190000 3600000 3600000 3600000 58116000 58116000 -1827000 56289000 7442000 7442000 6748000 14190000 0 0 32975000 66000 6625000 -66064000 259993000 2315000 176895000 373205000 143120000 516325000 652000 1000 897000 898000 898000 8000 64000 -64000 0 0 183000 8641000 8641000 8641000 544000 1000 5244000 5245000 5245000 31058000 31058000 31058000 400000 400000 400000 453163000 453163000 20000 453183000 558000 558000 749000 1307000 1793000 1793000 143889000 145682000 0 0 33988000 68000 6617000 -66000000 288951000 1080000 629994000 854093000 0 854093000 453183000 56289000 -18257000 399093000 0 0 -3140000 0 0 29973000 0 0 42851000 52685000 45090000 -2629000 0 0 31324000 15324000 10454000 -1592000 -1551000 -85000 -18000 -426000 102000 0 0 600000 30085000 22517000 -11024000 57416000 18765000 22793000 9408000 5843000 -27306000 -48192000 0 0 23755000 -528000 -1777000 -1687000 1660000 -270000 3490000 0 0 76407000 48462000 10955000 218865000 128744000 62315000 26347000 0 0 20734000 0 0 138014000 72700000 62398000 135000 42000 295000 1444000 119000 1254000 -130822000 -72539000 -60849000 8641000 6924000 1509000 6143000 5092000 3350000 64276000 65876000 96232000 35748000 66584000 49394000 4176000 16451000 11028000 21854000 -18991000 37651000 -59000 4895000 -708000 109838000 42109000 38409000 204813000 162704000 124295000 314651000 204813000 162704000 3404000 5641000 2223000 5768000 970000 2258000 62165000 20204000 17370000 64000 120000 56000 314352000 202412000 158536000 299000 233000 2190000 0 2168000 1978000 314651000 204813000 162704000 The Company and Significant Accounting Policies <div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Alpha and Omega Semiconductor Limited and its subsidiaries (the “Company”, “AOS”, “we” or “us”) design, develop and supply a broad range of power semiconductors. The Company's portfolio of products targets high-volume applications, including personal computers, graphic cards, flat panel TVs, home appliances, smart phones, battery packs, quick chargers, home appliances, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment. The Company conducts its operations primarily in the United States of America (“USA”), Hong Kong, China, and South Korea. </span></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Preparation</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The consolidated financial statements include the accounts of the Company, its wholly-owned subsidiaries and a subsidiary in which it had a controlling interest until December 1, 2021. As of December 2, 2021, the Company ceased having control over this subsidiary. Therefore, the Company deconsolidated this subsidiary as of that date.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Subsequently, the Company has accounted for it using the equity method of accounting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">All intercompany account balances and transactions have been eliminated. The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). </span></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Reclassification</span></div><div style="margin-top:13.5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Certain reclassifications of prior period presentation to conform to current period presentation have been made with no changes made to balance sheet, income statement or statement of cash flows subtotals.</span></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Joint Venture</span></div><div style="margin-top:13.5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On March 29, 2016, the Company entered into a joint venture contract (the “JV Agreement”) with two investment funds owned by the Municipality of Chongqing (the “Chongqing Funds”), pursuant to which the Company and the Chongqing Funds formed a joint venture, (the “JV Company”), for the purpose of constructing and operating a power semiconductor packaging, testing and 12-inch wafer fabrication facility in the Liangjiang New Area of Chongqing, China (the “JV Transaction”). As of December 1, 2021, the Company owned 51%, and the Chongqing Funds owned 49%, of the equity interest in the JV Company. The Joint Venture was accounted under the provisions of the consolidation guidance since the Company had controlling financial interest until December 1, 2021. If both parties agree that the termination of the JV Company is the best interest of each party or the JV Company is bankrupt or insolvent where either party may terminate early, after paying the debts of the JV Company, the remaining assets of the JV Company shall be paid to the Chongqing Funds to cover the principal of its total paid-in contributions plus interest at 10% simple annual rate prior to distributing the balance of the JV Company's assets to the Company. The JV Company has reached its targeted production of assembly and testing.</span></div><div style="margin-top:13.5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Effective December 1, 2021, the Company entered into a share transfer agreement (the “STA”) with a third-party investor (the “Investor”), pursuant to which the Company sold to the Investor approximately 2.1% of outstanding equity interest held by the Company in the JV Company for an aggregate purchase price of RMB 108 million or approximately $16.9 million (the “Transaction”). The Transaction was closed on December 2, 2021 (the “Closing Date”). As a result of the Transaction, as of the Closing Date, the Company’s equity interest in the JV Company decreased from 50.9% to 48.8%. Also, the Company’s right to designate directors on the board of JV Company was reduced to three (3) out of seven (7) directors from four (4) directors prior to the Transaction. As a result of the Transaction, AOS no longer had a controlling financial interest in the JV Company under generally accepted accounting principles. Loss of control is deemed to have occurred when, among other things, a parent company owns less than a majority of the outstanding equity interest in the subsidiary, lacks a controlling financial interest in the subsidiary and, is unable to unilaterally control the subsidiary through other means such as having, or the ability to obtain or represent, a majority of the subsidiary’s board of directors. Because of these factors, as of December 2, 2021, the Company ceased having control over the JV Company. Therefore, the Company deconsolidated the financial statements of the JV Company as of that date. Subsequently, the Company has accounted for its investment in the JV Company using the equity method of accounting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%"> </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On December 24, 2021, the Company entered into a share transfer agreement with another third-party investor, pursuant to which the Company sold to this investor 1.1% of outstanding equity interest held by the Company in the JV Company for an aggregate purchase price of RMB 60 million, or approximately $9.4 million. In addition, on December 30, 2021, the JV </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Company adopted an employee equity incentive plan and issued an equity interest equivalent to 3.99% of the JV Company in exchange for cash. As a result, the Company owned 45.8% of the equity interest in the JV Company as of December 31, 2021. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 26, 2022, the JV Company completed a financing transaction pursuant to a corporate financing agreement (the “Financing Agreement”) between the JV Company and certain third-party investors (the “New Investors”).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Under the Financing Agreement, the New Investors purchased newly issued equity interest of the JV Company for a total purchase price of RMB 509 million (or approximately $80 million based on the currency exchange rate as of January 26, 2022) (the “Investment”). Immediately following the closing of the Investment, the percentage of outstanding JV Company equity interest beneficially owned by the Company was further reduced to 42.2%.</span></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Significant Risks and Uncertainties Related to Outbreak of Coronavirus Disease 2019 (“COVID-19”)</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The COVID-19 pandemic has had and continues to have a negative impact on business and economic activities across the globe. As a result of the COVID-19 pandemic and the global economic downturn and changing consumer behaviors due to various restrictions imposed by governments, the Company has experienced shifting market trends, including an increasing demand in the markets for notebooks, PCs and gaming devices and decreasing demand for mobile phone and industrial products, as more consumers are staying at and working from home. While the Company has recently benefited from the increasing demand of consumer electronics and PC related products, there is no guarantee that this trend will continue, and such increasing demand may discontinue or decline as government authorities relax and terminate COVID-19 related restrictions and consumer behaviors change. Furthermore, as the COVID-19 pandemic continues and global economic downturn and high unemployment persists, consumer spending may slow down substantially, in which case the Company may experience a significant decline of customer orders for its products, including those designed for PC-related applications, and such decline will adversely affect its financial conditions and results of operations. The full extent of the future impact of the COVID-19 pandemic on the Company’s operational and financial performance is uncertain and will depend on many factors outside the Company’s control, including, without limitation, the timing, extent, trajectory and duration of the pandemic; the availability, distribution and effectiveness of vaccines; the spread of new variants of COVID-19; the continued or renewed imposition of protective public safety measures and government mandates; the continuing disruption of global supply chain affecting the semiconductor industry; and the impact of the pandemic on the global economy and demand for consumer products.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In April 2022, the operations of our two packaging and testing facilities in Shanghai, China were suspended due to a strict lockdown of the city imposed by the local government in response to surging COVID cases. Our facilities in Shanghai were required to be shut down and production was halted beginning in early April. Transportation suspension in and out of Shanghai also interrupted the shipping of raw materials and finished parts to and from our facilities. We received permission to reopen our facilities partially in early May. We gradually ramped up production at these facilities in May and returned to normal operation in June 2022. The suspension of our Shanghai facilities, and the subsequent partial resumption of production, reduced our ability to complete orders from our customers in a timely manner, which adversely affected our revenue and results of operation for the three months ended June 30, 2022.</span></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is subject to certain risks and uncertainties. The Company believes changes in any of the following areas could have a material adverse effect on the Company's future financial position or results of operations or cash flows: the timing and success of new product development, including market receptiveness, operation of in-house manufacturing facilities, litigation or claims against the Company based on intellectual property, patent, product regulatory or other factors, competition from other products, general economic conditions, the inability to attract and retain qualified employees, lack of control to the JV Company and ultimately to sustain profitable operations, risks associated with doing business in China, and ability to diversify products and develop digital business; the general state of the U.S., China and world economies; the highly cyclical nature of the industries the Company serves; the loss of any of its larger customers; restrictions on the Company’s ability to sell to foreign customers due to trade laws, regulations and requirements; disruptions of the supply chain of components needed for our products; inability to obtain additional financing; inability to meet certain debt covenants; fundamental changes in the technology underlying the Company’s products; successful and timely completion of product design efforts; and new product design introductions by competitors. Additional risks and uncertainties that the Company is unaware of, or that the Company currently believes are not material, may also become important factors that adversely affect its business.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's revenue limited by its ability to utilize wafer production and packaging and testing capacity from its in-house facilities and obtain adequate wafer supplies from third-party foundries. The Company recently entered into a new agreement with the JV Company pursuant to which the JV Company agrees to provide us with a guaranteed supply of a fixed number of wafers until December 2023. Currently the Company's main third-party foundry is Shanghai Hua Hong Grace Electronic Company Limited, or HHGrace, located in Shanghai, China. HHGrace has been manufacturing wafers for the Company since 2002. HHGrace manufactured approximately 10.3%, 11.5% and 12.7% of the wafers used in the Company's products for the fiscal years ended June 30, 2022, 2021 and 2020, respectively. Although the Company believes that its volume </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of production allows the Company to secure favorable pricing and priority in allocation of capacity in its third-party foundries, if the foundries' capacities are constrained due to market demands, HHGrace, together with other foundries from which the Company purchases wafers, may not be willing or able to satisfy all of the Company's manufacturing requirements on a timely basis and/or at favorable prices. The Company is also subject to the risks of service disruptions and raw material shortages by its foundries. Such disruptions, shortages and price increases could harm the Company’s operating results. In addition, manufacturing facilities' capacity affects the Company's gross margin because the Company has certain fixed costs associated with its Oregon Fab and the JV Company, as well as in-house packaging and testing facilities. If the Company fails to utilize its manufacturing facilities' capacity at a desirable level, its financial condition and results of operations will be adversely affected.</span></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses. To the extent there are material differences between these estimates and actual results, the Company's condensed consolidated financial statements will be affected. On an ongoing basis, the Company evaluates the estimates, judgments and assumptions including those related to stock rotation returns, price adjustments, allowance for doubtful accounts, inventory reserves, warranty accrual, income taxes, leases, share-based compensation, recoverability of and useful lives for property, plant and equipment and intangible assets, as well as the economic implications of the COVID-19 pandemic.</span></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Transactions and Translation </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of the Company's principal subsidiaries use U.S. dollars as their functional currency because their transactions are primarily conducted and settled in U.S. dollars. All of their revenues and a significant portion of their operating expenses are denominated in U.S. dollars. The functional currencies for the Company's in-house packaging and testing facilities in China are U.S. dollars, and a majority of their capital expenditures are denominated in U.S. dollars. Foreign currency transactions are translated into the functional currencies using the exchange rates prevailing at the dates of the transactions. Foreign exchange gains and losses, resulting from the settlement of such transactions and from the re-measurement of monetary assets and liabilities denominated in foreign currencies using exchange rates at balance sheet date and non-monetary assets and liabilities using historical exchange rates, are recognized in the consolidated statements of operations. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company's subsidiaries which use the local currency as their functional currency, their results and financial position are translated into U.S. dollars using exchange rates at balance sheet dates for assets and liabilities and using average exchange rates for income and expenses items. The resulting translation differences are presented as a separate component of accumulated other comprehensive income (loss) and noncontrolling interest in the consolidated statements of equity.</span></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents primarily consist of cash on hand and short-term bank deposits with original maturities of three months or less. Cash equivalents are highly liquid investments with stated maturities of three months or less as of the dates of purchase. The carrying amounts reported for cash and cash equivalents are considered to approximate fair values based upon their short maturities. </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents are maintained with reputable major financial institutions. If, due to current economic conditions or other factors, one or more of the financial institutions with which the Company maintains deposits fails, the Company's cash and cash equivalents may be at risk. Deposits with these banks may exceed the amount of insurance provided on such deposits; however, these deposits typically may be redeemed upon demand and, therefore, bear minimal risk.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company maintains restricted cash in connection with cash balances temporarily restricted for regular business operations, including the possibility of a dispute with a vendor. These balances have been excluded from the Company’s cash and cash equivalents balance and are classified as restricted cash in the Company’s consolidated balance sheets. As of June 30, 2022 and 2021, the amount of restricted cash was $0.3 million and $2.4 million, respectively. </span></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable, net</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for doubtful accounts is based on assessment of the collectability of accounts receivable from customers. The Company reviews the allowance by considering factors such as historical collection experience, credit quality, age of the accounts receivable balances and current economic conditions that may affect a customer's ability to pay. The Company writes off a receivable and charges against its recorded allowance when it has exhausted its collection efforts without success. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value, which are the following: </span></div><div style="margin-top:9pt;padding-left:47.25pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">Level 1 - Quoted prices in active markets for identical assets or liabilities. </span></div><div style="margin-top:4.5pt;padding-left:47.25pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">Level 2 - Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. </span></div><div style="margin-top:4.5pt;padding-left:47.25pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-top:13.5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of cash equivalents is based on observable market prices and have been categorized in Level 1 in the fair value hierarchy. Cash equivalents consist primarily of short-term bank deposits. The carrying values of financial instruments such as cash and cash equivalents, accounts receivable and accounts payable approximate their carrying values due to their short-term maturities. The carrying value of the company's debt is considered a reasonable estimate of fair value which is estimated by considering the current rates available to the Company for debt of the same remaining maturities, structure and terms of the debts.</span></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company carries inventories at the lower of cost (determined on a first-in, first-out basis) or net realizable value. Cost includes semiconductor wafer and raw materials, labor, depreciation expenses and other manufacturing expenses and overhead, and packaging and testing fees paid to third parties if subcontractors are used. Valuation of inventories are based on the Company's periodic review of inventory quantities on hand as compared with its sales forecasts, historical usage, aging of inventories, production yield levels and current product selling prices. If actual market conditions are less favorable than those forecasted by management, additional future inventory write-downs may be required that could adversely affect the Company's operating results. Adjustments to inventory once established are not reversed until the related inventory has been sold or scrapped.</span></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Property, plant and equipment are stated at historical cost less accumulated depreciation. Historical cost includes expenditures that are directly attributable to the acquisition of the items and the costs incurred to make the assets ready for their intended use. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation is provided for on a straight-line basis over the estimated useful lives of the related assets as follows:</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.649%"><tr><td style="width:1.0%"/><td style="width:45.013%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.663%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:51.924%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 to 10 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment and tooling</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold and building improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 20 years </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vehicle</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></div></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment and construction in progress represent equipment received but the necessary installation has not been fully performed or building construction and leasehold improvements have been started but not yet completed. Equipment and construction in progress are stated at cost and transferred to respective asset class when fully completed and ready for their intended use.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internal-use software development costs are capitalized to the extent that the costs are directly associated with the development of identifiable and unique software products controlled by the Company that will probably generate economic benefits beyond one year. Costs incurred during the application development stage are required to be capitalized. The application development stage is characterized by software design and configuration activities, coding, testing and installation. Training costs and maintenance are expensed as incurred, while upgrades and enhancements are capitalized if it is probable that such expenditures will result in additional functionality. Costs include employee costs incurred and fees paid to outside consultants for the software development and implementation. Internally developed software is amortized over its estimated useful life of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQxNjU2OTQ3ZDExNDQ0ZWViYWI3OTU4MzI3MTUxYTc4L3NlYzo0MTY1Njk0N2QxMTQ0NGVlYmFiNzk1ODMyNzE1MWE3OF8xMjQvZnJhZzo1ZGE2NWVjOTA2OGU0ZWYzODg0ZTk0YmViOTM5NDBiYi90ZXh0cmVnaW9uOjVkYTY1ZWM5MDY4ZTRlZjM4ODRlOTRiZWI5Mzk0MGJiXzE3Nzgx_1adc946b-3fa7-4e0c-8ba1-1a7f3a134d38">three</span> to five years starting from the date when it is ready for its intended use. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized as selling, general and administrative expenses in the consolidated statements of operations. Costs of maintenance and repairs that do not improve or extend the lives of the respective assets are expensed as incurred.</span></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Government Grants</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company occasionally receives government grants that provide financial assistance for certain eligible expenditures in China. These grants include reimbursements on interest expense on bank borrowings, payroll tax credits, credit for property, plant and equipment in a particular geographical location, employment credits as well as business expansion credits. Government grants are not recognized until there is reasonable assurance that the Company will comply with the conditions attaching to it, and that the grant will be received. The Company records such grants either as a reduction of the related expense, a reduction of the cost of the related asset, or as other income depending upon the nature of the grant. As a result of such grants, during the fiscal year ended June 30, 2022, the Company reduced interest expense by $0.9 million, property, plant and equipment by $1.4 million, and operating expenses by $0.2 million. During the fiscal year ended June 30, 2021, the Company reduced interest expense by $3.0 million, property, plant and equipment by $0.1 million, and operating expenses by $3.7 million. During the fiscal year ended June 30, 2020, the Company reduced interest expenses by $6.1 million, property, plant and equipment by $1.3 million, and operating expenses by $4.7 million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-lived Assets</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews all long-lived assets whenever events or changes in circumstance indicate that these assets may not be recoverable. When evaluating long-lived assets, if the Company concludes that the estimated undiscounted cash flows attributable to the assets are less than their carrying value, the Company recognizes an impairment loss based on the excess of the carrying amount of the assets over their respective fair values, which could adversely affect our results of operations.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no impairment of long-lived assets for fiscal years 2022, 2021 and 2020. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company determines revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract; and (5) recognition of revenue when, or as, a performance obligation is satisfied. The Company recognizes product revenue at a point in time when product is shipped to the customer, as determined by the agreed upon shipping terms, net of estimated stock rotation returns and price adjustments that it expects to provide to certain distributors. The Company presents revenue net of sales taxes and any similar assessments. Our standard payment terms range from 30 to 60 days.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells its products primarily to distributors, who in turn sell the products globally to various end customers. The Company allows stock rotation returns from certain distributors. Stock rotation returns are governed by contract and are limited to a specified percentage of the monetary value of products purchased by distributors during a specified period. The Company records an allowance for stock rotation returns based on historical returns, current expectations, and individual distributor agreements. The Company also provides special pricing to certain distributors, primarily based on volume, to encourage resale of the Company's products. Allowance for price adjustments is recorded against accounts receivable and the provision for stock rotation rights is included in accrued liabilities on the consolidated balance sheets. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">The Company's performance obligations relate to contracts with a duration of less than one year. The Company elected to apply the practical expedient provided in ASC 606, “Revenue from Contracts with Customers”. Therefore, the Company is not required to disclose the aggregate amount of transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">The Company recognizes the incremental direct costs of obtaining a contract, which consist of sales commissions, when control over the products they relate to transfers to the customer. Applying the practical expedient, the Company recognizes commissions as expense when incurred, as the amortization period of the commission asset the Company would have otherwise recognized is less than one year. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Packaging and testing services revenue is recognized at a point in time upon shipment of serviced products to the customer. </span></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets, current operating lease liabilities and long-term operating lease liabilities on the Company's consolidated balance sheets. Finance leases are included in property, plant and equipment, finance lease liabilities and long-term finance leases liabilities on the consolidated balance sheets.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. The Company determined its incremental borrowing rate based on the information available at the lease commencement date. The operating lease ROU assets also include any lease payments made and exclude lease incentives. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. Operating lease expense is generally recognized on a straight-line basis over the lease term. Variable lease payments are expensed as incurred and are not included within the operating lease ROU asset and lease liability calculation. The Company does not record leases on the consolidated balance sheet with a term of one year or less. The Company elected to combine its lease and non-lease components as a single lease component for all asset classes. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Warranty</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides a standard one-year warranty for the products from the date of purchase by the end customers. The Company accrues for estimated warranty costs at the time revenue is recognized. The Company's warranty obligation is affected by product failure rates, labor and material costs for replacing defective parts, related freight costs for failed parts and other quality assurance costs. The Company monitors its product returns for warranty claims and maintains warranty reserves based on historical experiences and anticipated warranty claims known at the time of estimation.</span></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shipping and Handling Costs</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling costs are included in cost of goods sold.</span></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are expensed as incurred. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision for Income Taxes </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Income tax expense or benefit is based on income or loss before taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Deferred tax assets and liabilities are recognized principally for the expected tax consequences of temporary differences between the tax basis of assets and liabilities and their reported amounts.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is subject to income taxes in a number of jurisdictions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Significant judgment is required in determining the worldwide provision for income taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There are many transactions and calculations for which the ultimate tax determination is uncertain during the ordinary course of business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company establishes accruals for certain tax contingencies based on estimates of whether additional taxes may be due.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">While the final tax outcome of these matters may differ from the amounts that were initially recorded, such differences will impact the income tax and deferred tax provisions in the period in which such determination is made.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Significant management judgment is also required in determining whether deferred tax assets will be realized in full or in part.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">When it is more likely than not that all or some portion of specific deferred tax assets such as net operating losses or research and experimentation tax credit carryforwards will not be realized, a valuation allowance must be established for the amount of the deferred tax assets that cannot be realized.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company considers all available positive and negative evidence on a jurisdiction-by-jurisdiction basis when assessing whether it is more likely than not that deferred tax assets are recoverable.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company considers evidence such as our past operating results, the existence of cumulative losses in recent years and our forecast of future taxable income.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Financial Accounting Standards Board (FASB), issued guidance which clarifies the accounting for income taxes by prescribing a minimum probability threshold that a tax position must meet before a financial statement benefit is recognized.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The minimum threshold is defined as a tax position that is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The tax benefit to be recognized is measured as the largest amount of benefit that is greater than fifty percent likely to be realized upon ultimate settlement.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Although the guidance on the accounting for uncertainty in income taxes prescribes the use of a recognition and measurement model, the determination of whether an uncertain tax position has met those thresholds will continue to require significant judgment by management.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the ultimate resolution of tax uncertainties is different from what is currently estimated, a material impact on income tax expense could result.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company's provision for income taxes is subject to volatility and could be adversely impacted by changes in earnings or tax laws and regulations in various jurisdictions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is subject to the continuous examination of our income tax returns by the Internal Revenue Service and other tax authorities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of our provision for income taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To the extent that the final tax outcome of these matters is different from the amounts recorded, such differences will impact the provision for income taxes in the period in which such determination is made.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The provision for income taxes includes the impact of changes to reserves, as well as the related net interest and penalties.</span></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-based Compensation Expense</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains an equity-settled, share-based compensation plan to grant restricted share units and stock options. The Company recognizes expense related to share-based compensation awards that are ultimately expected to vest based on estimated fair values on the date of grant. The fair value of restricted share units is based on the fair value of the Company's common share on the date of grant. For restricted stock awards subject to market conditions, the fair value of each restricted stock award is estimated at the date of grant using the Monte-Carlo pricing model. The fair value of stock options is estimated on the date of grant using the Black-Scholes option valuation model. Share-based compensation expense is recognized on the accelerated attribution basis over the requisite service period of the award, which generally equals the vesting period. The Black-Scholes option valuation model requires the input of subjective assumptions, including the expected term and stock price volatility. In addition, judgment is also required in estimating the number of stock-based awards that are expected to be forfeited. Forfeitures are estimated based on historical experience at the time of grant. Changes in estimated forfeitures are recognized in the period of change and impact the amount of stock compensation expenses to be recognized in future periods, which could be material if actual results differ significantly from estimates.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Employee Share Purchase Plan (the “ESPP”) is accounted for at fair value on the date of grant using the Black-Scholes option valuation model. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising expenditures are expensed as incurred. Advertising expense was $0.2 million, $0.4 million and $0.7 million in the fiscal years ended June 30, 2022, 2021, and 2020, respectively.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Income (Loss) </span></div><div style="margin-top:4.5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. The Company's accumulated other comprehensive income (loss) consists of cumulative foreign currency translation adjustments. </span></div><div style="margin-top:4.5pt;text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:13.5pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recently Issued Accounting Standards not yet adopted</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2021, the FASB issued Accounting Standards Update (ASU) No. 2021-10, “Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance.” This ASU requires business entities to make annual disclosures about transactions with a government they account for by analogizing to a grant or contribution accounting model under ASC 958-605. The ASU is effective for all entities within their scope for financial statements issued for annual periods </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">beginning after December 15, 2021. The adoption will not have any impacts on the Company's consolidated financial position, results of operations or cash flows.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> In August 2020, the FASB issued ASU No. 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity”, which, among other things, provides guidance on how to account for contracts on an entity’s own equity. This ASU simplifies the accounting for certain financial instruments with characteristics of liabilities and equity. Specifically, the ASU eliminated the need for the Company to assess (1) whether a contract on the entity’s own equity permits settlement in unregistered shares, (2) whether counterparty rights rank higher than shareholder’s rights, and (3) whether collateral is required. In addition, the ASU requires incremental disclosure related to contracts on the entity’s own equity and clarifies the treatment of certain financial instruments accounted for under this ASU on earnings per share. For public business entities, the ASU is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. The Company does not expect the adoption of this guidance will have a material impact on its consolidated financial position, results of operations or cash flows.</span></div><div style="margin-top:13.5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Recently Adopted Accounting Standards</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-01, “Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.” The ASU is based on a consensus of the Emerging Issues Task Force and is expected to increase comparability in accounting for these transactions. ASU 2016-01 made targeted improvements to accounting for financial instruments, including providing an entity the ability to measure certain equity securities without a readily determinable fair value at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Among other topics, the amendments clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting. The adoption of ASU 2020-01 on July 1, 2021 had no material impact on the Company's Consolidated Financial Statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In December 2019, the FASB issued ASU No. 2019-12 “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”) by removing certain exceptions to the general principles. The Company adopted ASU 2019-12 as of July 1, 2021. ASU 2019-12 had no material impact on the Company's Consolidated Financial Statements.</span></div> <div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Preparation</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The consolidated financial statements include the accounts of the Company, its wholly-owned subsidiaries and a subsidiary in which it had a controlling interest until December 1, 2021. As of December 2, 2021, the Company ceased having control over this subsidiary. Therefore, the Company deconsolidated this subsidiary as of that date.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Subsequently, the Company has accounted for it using the equity method of accounting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">All intercompany account balances and transactions have been eliminated. The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). </span></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Reclassification</span></div><div style="margin-top:13.5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Certain reclassifications of prior period presentation to conform to current period presentation have been made with no changes made to balance sheet, income statement or statement of cash flows subtotals.</span></div> 0.51 0.49 The Joint Venture was accounted under the provisions of the consolidation guidance since the Company had controlling financial interest until December 1, 2021. 0.10 0.021 108000000 16900000 0.509 0.488 3 7 4 0.011 60000000 9400000 0.0399 0.458 509000000 80000000 0.422 <div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Significant Risks and Uncertainties Related to Outbreak of Coronavirus Disease 2019 (“COVID-19”)</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The COVID-19 pandemic has had and continues to have a negative impact on business and economic activities across the globe. As a result of the COVID-19 pandemic and the global economic downturn and changing consumer behaviors due to various restrictions imposed by governments, the Company has experienced shifting market trends, including an increasing demand in the markets for notebooks, PCs and gaming devices and decreasing demand for mobile phone and industrial products, as more consumers are staying at and working from home. While the Company has recently benefited from the increasing demand of consumer electronics and PC related products, there is no guarantee that this trend will continue, and such increasing demand may discontinue or decline as government authorities relax and terminate COVID-19 related restrictions and consumer behaviors change. Furthermore, as the COVID-19 pandemic continues and global economic downturn and high unemployment persists, consumer spending may slow down substantially, in which case the Company may experience a significant decline of customer orders for its products, including those designed for PC-related applications, and such decline will adversely affect its financial conditions and results of operations. The full extent of the future impact of the COVID-19 pandemic on the Company’s operational and financial performance is uncertain and will depend on many factors outside the Company’s control, including, without limitation, the timing, extent, trajectory and duration of the pandemic; the availability, distribution and effectiveness of vaccines; the spread of new variants of COVID-19; the continued or renewed imposition of protective public safety measures and government mandates; the continuing disruption of global supply chain affecting the semiconductor industry; and the impact of the pandemic on the global economy and demand for consumer products.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In April 2022, the operations of our two packaging and testing facilities in Shanghai, China were suspended due to a strict lockdown of the city imposed by the local government in response to surging COVID cases. Our facilities in Shanghai were required to be shut down and production was halted beginning in early April. Transportation suspension in and out of Shanghai also interrupted the shipping of raw materials and finished parts to and from our facilities. We received permission to reopen our facilities partially in early May. We gradually ramped up production at these facilities in May and returned to normal operation in June 2022. The suspension of our Shanghai facilities, and the subsequent partial resumption of production, reduced our ability to complete orders from our customers in a timely manner, which adversely affected our revenue and results of operation for the three months ended June 30, 2022.</span></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is subject to certain risks and uncertainties. The Company believes changes in any of the following areas could have a material adverse effect on the Company's future financial position or results of operations or cash flows: the timing and success of new product development, including market receptiveness, operation of in-house manufacturing facilities, litigation or claims against the Company based on intellectual property, patent, product regulatory or other factors, competition from other products, general economic conditions, the inability to attract and retain qualified employees, lack of control to the JV Company and ultimately to sustain profitable operations, risks associated with doing business in China, and ability to diversify products and develop digital business; the general state of the U.S., China and world economies; the highly cyclical nature of the industries the Company serves; the loss of any of its larger customers; restrictions on the Company’s ability to sell to foreign customers due to trade laws, regulations and requirements; disruptions of the supply chain of components needed for our products; inability to obtain additional financing; inability to meet certain debt covenants; fundamental changes in the technology underlying the Company’s products; successful and timely completion of product design efforts; and new product design introductions by competitors. Additional risks and uncertainties that the Company is unaware of, or that the Company currently believes are not material, may also become important factors that adversely affect its business.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's revenue limited by its ability to utilize wafer production and packaging and testing capacity from its in-house facilities and obtain adequate wafer supplies from third-party foundries. The Company recently entered into a new agreement with the JV Company pursuant to which the JV Company agrees to provide us with a guaranteed supply of a fixed number of wafers until December 2023. Currently the Company's main third-party foundry is Shanghai Hua Hong Grace Electronic Company Limited, or HHGrace, located in Shanghai, China. HHGrace has been manufacturing wafers for the Company since 2002. HHGrace manufactured approximately 10.3%, 11.5% and 12.7% of the wafers used in the Company's products for the fiscal years ended June 30, 2022, 2021 and 2020, respectively. Although the Company believes that its volume </span></div>of production allows the Company to secure favorable pricing and priority in allocation of capacity in its third-party foundries, if the foundries' capacities are constrained due to market demands, HHGrace, together with other foundries from which the Company purchases wafers, may not be willing or able to satisfy all of the Company's manufacturing requirements on a timely basis and/or at favorable prices. The Company is also subject to the risks of service disruptions and raw material shortages by its foundries. Such disruptions, shortages and price increases could harm the Company’s operating results. In addition, manufacturing facilities' capacity affects the Company's gross margin because the Company has certain fixed costs associated with its Oregon Fab and the JV Company, as well as in-house packaging and testing facilities. If the Company fails to utilize its manufacturing facilities' capacity at a desirable level, its financial condition and results of operations will be adversely affected. 0.103 0.115 0.127 <div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses. To the extent there are material differences between these estimates and actual results, the Company's condensed consolidated financial statements will be affected. On an ongoing basis, the Company evaluates the estimates, judgments and assumptions including those related to stock rotation returns, price adjustments, allowance for doubtful accounts, inventory reserves, warranty accrual, income taxes, leases, share-based compensation, recoverability of and useful lives for property, plant and equipment and intangible assets, as well as the economic implications of the COVID-19 pandemic.</span></div> <div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Transactions and Translation </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of the Company's principal subsidiaries use U.S. dollars as their functional currency because their transactions are primarily conducted and settled in U.S. dollars. All of their revenues and a significant portion of their operating expenses are denominated in U.S. dollars. The functional currencies for the Company's in-house packaging and testing facilities in China are U.S. dollars, and a majority of their capital expenditures are denominated in U.S. dollars. Foreign currency transactions are translated into the functional currencies using the exchange rates prevailing at the dates of the transactions. Foreign exchange gains and losses, resulting from the settlement of such transactions and from the re-measurement of monetary assets and liabilities denominated in foreign currencies using exchange rates at balance sheet date and non-monetary assets and liabilities using historical exchange rates, are recognized in the consolidated statements of operations. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company's subsidiaries which use the local currency as their functional currency, their results and financial position are translated into U.S. dollars using exchange rates at balance sheet dates for assets and liabilities and using average exchange rates for income and expenses items. The resulting translation differences are presented as a separate component of accumulated other comprehensive income (loss) and noncontrolling interest in the consolidated statements of equity.</span></div> <div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents primarily consist of cash on hand and short-term bank deposits with original maturities of three months or less. Cash equivalents are highly liquid investments with stated maturities of three months or less as of the dates of purchase. The carrying amounts reported for cash and cash equivalents are considered to approximate fair values based upon their short maturities. </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents are maintained with reputable major financial institutions. If, due to current economic conditions or other factors, one or more of the financial institutions with which the Company maintains deposits fails, the Company's cash and cash equivalents may be at risk. Deposits with these banks may exceed the amount of insurance provided on such deposits; however, these deposits typically may be redeemed upon demand and, therefore, bear minimal risk.</span></div>The Company maintains restricted cash in connection with cash balances temporarily restricted for regular business operations, including the possibility of a dispute with a vendor. These balances have been excluded from the Company’s cash and cash equivalents balance and are classified as restricted cash in the Company’s consolidated balance sheets. As of June 30, 2022 and 2021, the amount of restricted cash was $0.3 million and $2.4 million, respectively. 300000 2400000 Accounts Receivable, netThe allowance for doubtful accounts is based on assessment of the collectability of accounts receivable from customers. The Company reviews the allowance by considering factors such as historical collection experience, credit quality, age of the accounts receivable balances and current economic conditions that may affect a customer's ability to pay. The Company writes off a receivable and charges against its recorded allowance when it has exhausted its collection efforts without success. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value, which are the following: </span></div><div style="margin-top:9pt;padding-left:47.25pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">Level 1 - Quoted prices in active markets for identical assets or liabilities. </span></div><div style="margin-top:4.5pt;padding-left:47.25pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">Level 2 - Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. </span></div><div style="margin-top:4.5pt;padding-left:47.25pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div> <div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-top:13.5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of cash equivalents is based on observable market prices and have been categorized in Level 1 in the fair value hierarchy. Cash equivalents consist primarily of short-term bank deposits. The carrying values of financial instruments such as cash and cash equivalents, accounts receivable and accounts payable approximate their carrying values due to their short-term maturities. The carrying value of the company's debt is considered a reasonable estimate of fair value which is estimated by considering the current rates available to the Company for debt of the same remaining maturities, structure and terms of the debts.</span></div> <div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company carries inventories at the lower of cost (determined on a first-in, first-out basis) or net realizable value. Cost includes semiconductor wafer and raw materials, labor, depreciation expenses and other manufacturing expenses and overhead, and packaging and testing fees paid to third parties if subcontractors are used. Valuation of inventories are based on the Company's periodic review of inventory quantities on hand as compared with its sales forecasts, historical usage, aging of inventories, production yield levels and current product selling prices. If actual market conditions are less favorable than those forecasted by management, additional future inventory write-downs may be required that could adversely affect the Company's operating results. Adjustments to inventory once established are not reversed until the related inventory has been sold or scrapped.</span></div> <div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Property, plant and equipment are stated at historical cost less accumulated depreciation. Historical cost includes expenditures that are directly attributable to the acquisition of the items and the costs incurred to make the assets ready for their intended use. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation is provided for on a straight-line basis over the estimated useful lives of the related assets as follows:</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.649%"><tr><td style="width:1.0%"/><td style="width:45.013%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.663%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:51.924%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 to 10 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment and tooling</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold and building improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 20 years </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vehicle</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></div></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment and construction in progress represent equipment received but the necessary installation has not been fully performed or building construction and leasehold improvements have been started but not yet completed. Equipment and construction in progress are stated at cost and transferred to respective asset class when fully completed and ready for their intended use.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internal-use software development costs are capitalized to the extent that the costs are directly associated with the development of identifiable and unique software products controlled by the Company that will probably generate economic benefits beyond one year. Costs incurred during the application development stage are required to be capitalized. The application development stage is characterized by software design and configuration activities, coding, testing and installation. Training costs and maintenance are expensed as incurred, while upgrades and enhancements are capitalized if it is probable that such expenditures will result in additional functionality. Costs include employee costs incurred and fees paid to outside consultants for the software development and implementation. Internally developed software is amortized over its estimated useful life of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQxNjU2OTQ3ZDExNDQ0ZWViYWI3OTU4MzI3MTUxYTc4L3NlYzo0MTY1Njk0N2QxMTQ0NGVlYmFiNzk1ODMyNzE1MWE3OF8xMjQvZnJhZzo1ZGE2NWVjOTA2OGU0ZWYzODg0ZTk0YmViOTM5NDBiYi90ZXh0cmVnaW9uOjVkYTY1ZWM5MDY4ZTRlZjM4ODRlOTRiZWI5Mzk0MGJiXzE3Nzgx_1adc946b-3fa7-4e0c-8ba1-1a7f3a134d38">three</span> to five years starting from the date when it is ready for its intended use. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized as selling, general and administrative expenses in the consolidated statements of operations. Costs of maintenance and repairs that do not improve or extend the lives of the respective assets are expensed as incurred.</span></div> <div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation is provided for on a straight-line basis over the estimated useful lives of the related assets as follows:</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.649%"><tr><td style="width:1.0%"/><td style="width:45.013%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.663%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:51.924%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 to 10 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment and tooling</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold and building improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 20 years </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vehicle</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></div></td></tr></table></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, plant and equipment, net</span></div><div style="margin-top:18.5pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.450%"><tr><td style="width:1.0%"/><td style="width:65.015%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.428%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;padding-right:13.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,877 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,877 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,691 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,454 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,574 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515,320 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment and tooling</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,052 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,017 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,758 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,518 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,820 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,814 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,254 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,733 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land use rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,319 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422,026 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748,052 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233,340)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(348,749)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,686 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399,303 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment and construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,980 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,674 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318,666 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436,977 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> P20Y P8Y P10Y P3Y P5Y P3Y P5Y P5Y P2Y P20Y P5Y P5Y Government GrantsThe Company occasionally receives government grants that provide financial assistance for certain eligible expenditures in China. These grants include reimbursements on interest expense on bank borrowings, payroll tax credits, credit for property, plant and equipment in a particular geographical location, employment credits as well as business expansion credits. Government grants are not recognized until there is reasonable assurance that the Company will comply with the conditions attaching to it, and that the grant will be received. The Company records such grants either as a reduction of the related expense, a reduction of the cost of the related asset, or as other income depending upon the nature of the grant. 900000 1400000 200000 3000000 100000 3700000 6100000 1300000 4700000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-lived Assets</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews all long-lived assets whenever events or changes in circumstance indicate that these assets may not be recoverable. When evaluating long-lived assets, if the Company concludes that the estimated undiscounted cash flows attributable to the assets are less than their carrying value, the Company recognizes an impairment loss based on the excess of the carrying amount of the assets over their respective fair values, which could adversely affect our results of operations.</span></div> 0 0 0 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company determines revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract; and (5) recognition of revenue when, or as, a performance obligation is satisfied. The Company recognizes product revenue at a point in time when product is shipped to the customer, as determined by the agreed upon shipping terms, net of estimated stock rotation returns and price adjustments that it expects to provide to certain distributors. The Company presents revenue net of sales taxes and any similar assessments. Our standard payment terms range from 30 to 60 days.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells its products primarily to distributors, who in turn sell the products globally to various end customers. The Company allows stock rotation returns from certain distributors. Stock rotation returns are governed by contract and are limited to a specified percentage of the monetary value of products purchased by distributors during a specified period. The Company records an allowance for stock rotation returns based on historical returns, current expectations, and individual distributor agreements. The Company also provides special pricing to certain distributors, primarily based on volume, to encourage resale of the Company's products. Allowance for price adjustments is recorded against accounts receivable and the provision for stock rotation rights is included in accrued liabilities on the consolidated balance sheets. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">The Company's performance obligations relate to contracts with a duration of less than one year. The Company elected to apply the practical expedient provided in ASC 606, “Revenue from Contracts with Customers”. Therefore, the Company is not required to disclose the aggregate amount of transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period. </span></div>The Company recognizes the incremental direct costs of obtaining a contract, which consist of sales commissions, when control over the products they relate to transfers to the customer. Applying the practical expedient, the Company recognizes commissions as expense when incurred, as the amortization period of the commission asset the Company would have otherwise recognized is less than one year. Packaging and testing services revenue is recognized at a point in time upon shipment of serviced products to the customer. <div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets, current operating lease liabilities and long-term operating lease liabilities on the Company's consolidated balance sheets. Finance leases are included in property, plant and equipment, finance lease liabilities and long-term finance leases liabilities on the consolidated balance sheets.</span></div>Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. The Company determined its incremental borrowing rate based on the information available at the lease commencement date. The operating lease ROU assets also include any lease payments made and exclude lease incentives. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. Operating lease expense is generally recognized on a straight-line basis over the lease term. Variable lease payments are expensed as incurred and are not included within the operating lease ROU asset and lease liability calculation. The Company does not record leases on the consolidated balance sheet with a term of one year or less. The Company elected to combine its lease and non-lease components as a single lease component for all asset classes. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Warranty</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides a standard one-year warranty for the products from the date of purchase by the end customers. The Company accrues for estimated warranty costs at the time revenue is recognized. The Company's warranty obligation is affected by product failure rates, labor and material costs for replacing defective parts, related freight costs for failed parts and other quality assurance costs. The Company monitors its product returns for warranty claims and maintains warranty reserves based on historical experiences and anticipated warranty claims known at the time of estimation.</span></div> P1Y <div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shipping and Handling Costs</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling costs are included in cost of goods sold.</span></div> Research and Development Research and development costs are expensed as incurred. <div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision for Income Taxes </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Income tax expense or benefit is based on income or loss before taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Deferred tax assets and liabilities are recognized principally for the expected tax consequences of temporary differences between the tax basis of assets and liabilities and their reported amounts.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is subject to income taxes in a number of jurisdictions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Significant judgment is required in determining the worldwide provision for income taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There are many transactions and calculations for which the ultimate tax determination is uncertain during the ordinary course of business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company establishes accruals for certain tax contingencies based on estimates of whether additional taxes may be due.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">While the final tax outcome of these matters may differ from the amounts that were initially recorded, such differences will impact the income tax and deferred tax provisions in the period in which such determination is made.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Significant management judgment is also required in determining whether deferred tax assets will be realized in full or in part.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">When it is more likely than not that all or some portion of specific deferred tax assets such as net operating losses or research and experimentation tax credit carryforwards will not be realized, a valuation allowance must be established for the amount of the deferred tax assets that cannot be realized.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company considers all available positive and negative evidence on a jurisdiction-by-jurisdiction basis when assessing whether it is more likely than not that deferred tax assets are recoverable.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company considers evidence such as our past operating results, the existence of cumulative losses in recent years and our forecast of future taxable income.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Financial Accounting Standards Board (FASB), issued guidance which clarifies the accounting for income taxes by prescribing a minimum probability threshold that a tax position must meet before a financial statement benefit is recognized.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The minimum threshold is defined as a tax position that is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The tax benefit to be recognized is measured as the largest amount of benefit that is greater than fifty percent likely to be realized upon ultimate settlement.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Although the guidance on the accounting for uncertainty in income taxes prescribes the use of a recognition and measurement model, the determination of whether an uncertain tax position has met those thresholds will continue to require significant judgment by management.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the ultimate resolution of tax uncertainties is different from what is currently estimated, a material impact on income tax expense could result.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company's provision for income taxes is subject to volatility and could be adversely impacted by changes in earnings or tax laws and regulations in various jurisdictions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is subject to the continuous examination of our income tax returns by the Internal Revenue Service and other tax authorities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of our provision for income taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To the extent that the final tax outcome of these matters is different from the amounts recorded, such differences will impact the provision for income taxes in the period in which such determination is made.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The provision for income taxes includes the impact of changes to reserves, as well as the related net interest and penalties.</span></div> <div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-based Compensation Expense</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains an equity-settled, share-based compensation plan to grant restricted share units and stock options. The Company recognizes expense related to share-based compensation awards that are ultimately expected to vest based on estimated fair values on the date of grant. The fair value of restricted share units is based on the fair value of the Company's common share on the date of grant. For restricted stock awards subject to market conditions, the fair value of each restricted stock award is estimated at the date of grant using the Monte-Carlo pricing model. The fair value of stock options is estimated on the date of grant using the Black-Scholes option valuation model. Share-based compensation expense is recognized on the accelerated attribution basis over the requisite service period of the award, which generally equals the vesting period. The Black-Scholes option valuation model requires the input of subjective assumptions, including the expected term and stock price volatility. In addition, judgment is also required in estimating the number of stock-based awards that are expected to be forfeited. Forfeitures are estimated based on historical experience at the time of grant. Changes in estimated forfeitures are recognized in the period of change and impact the amount of stock compensation expenses to be recognized in future periods, which could be material if actual results differ significantly from estimates.</span></div>The Employee Share Purchase Plan (the “ESPP”) is accounted for at fair value on the date of grant using the Black-Scholes option valuation model. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising expenditures are expensed as incurred. Advertising expense was $0.2 million, $0.4 million and $0.7 million in the fiscal years ended June 30, 2022, 2021, and 2020, respectively.</span></div> 200000 400000 700000 Comprehensive Income (Loss) Comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. The Company's accumulated other comprehensive income (loss) consists of cumulative foreign currency translation adjustments. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:13.5pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recently Issued Accounting Standards not yet adopted</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2021, the FASB issued Accounting Standards Update (ASU) No. 2021-10, “Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance.” This ASU requires business entities to make annual disclosures about transactions with a government they account for by analogizing to a grant or contribution accounting model under ASC 958-605. The ASU is effective for all entities within their scope for financial statements issued for annual periods </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">beginning after December 15, 2021. The adoption will not have any impacts on the Company's consolidated financial position, results of operations or cash flows.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> In August 2020, the FASB issued ASU No. 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity”, which, among other things, provides guidance on how to account for contracts on an entity’s own equity. This ASU simplifies the accounting for certain financial instruments with characteristics of liabilities and equity. Specifically, the ASU eliminated the need for the Company to assess (1) whether a contract on the entity’s own equity permits settlement in unregistered shares, (2) whether counterparty rights rank higher than shareholder’s rights, and (3) whether collateral is required. In addition, the ASU requires incremental disclosure related to contracts on the entity’s own equity and clarifies the treatment of certain financial instruments accounted for under this ASU on earnings per share. For public business entities, the ASU is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. The Company does not expect the adoption of this guidance will have a material impact on its consolidated financial position, results of operations or cash flows.</span></div><div style="margin-top:13.5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Recently Adopted Accounting Standards</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-01, “Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.” The ASU is based on a consensus of the Emerging Issues Task Force and is expected to increase comparability in accounting for these transactions. ASU 2016-01 made targeted improvements to accounting for financial instruments, including providing an entity the ability to measure certain equity securities without a readily determinable fair value at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Among other topics, the amendments clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting. The adoption of ASU 2020-01 on July 1, 2021 had no material impact on the Company's Consolidated Financial Statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In December 2019, the FASB issued ASU No. 2019-12 “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”) by removing certain exceptions to the general principles. The Company adopted ASU 2019-12 as of July 1, 2021. ASU 2019-12 had no material impact on the Company's Consolidated Financial Statements.</span></div> Equity Method Investment in Equity Investee<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On December 1, 2021 (the “Effective Date”), Alpha &amp; Omega Semiconductor (Shanghai) Ltd. (“AOS SH”) and Agape Package Manufacturing (Shanghai) Limited (“APM SH”), each a wholly-owned subsidiary of the Company, entered into a share transfer agreement (“STA”) with a third-party investor to sell a portion of the Company's equity interest in the JV Company which consists of a power semiconductor packaging, testing and 12-inch wafer fabrication facility in Chongqing, China (the “Transaction”). The Transaction closed on December 2, 2021 (the “Closing Date”), which reduced the Company’s equity interest in the JV Company from 50.9% to 48.8%. Also, the Company’s right to designate directors on the board of JV Company was reduced to three (3) out of seven (7) directors, from four (4) directors prior to the Transaction. As a result of the Transaction and other factors, the Company no longer has a controlling financial interest in the JV Company and has determined that the JV Company was deconsolidated from the Company’s Consolidated Financial Statements effective as of the Closing Date. In connection with the deconsolidation and in accordance with ASC 810, the Company recorded a gain on deconsolidation of $399.1 million during the fiscal year ended June 30, 2022 in the Consolidated Statements of Income. The gain on deconsolidation of the JV Company was calculated as follows:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.742%"><tr><td style="width:1.0%"/><td style="width:4.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:65.951%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.305%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.437%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cash received for sales of shares in the JV Company</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">16,924 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair value of retained equity method investment</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">393,124 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Carrying amount of non-controlling interest</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">143,889 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cumulative translation adjustment removal</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1,793 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Carrying amount of net assets of the JV Company at December 1, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(156,637)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Gain on deconsolidation of the JV Company</span></div></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">399,093 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company retained significant influence over the operating and financial policies of the JV Company and measured the fair value of the retained investment based on their share of the fair value of the JV Company, which was calculated using the market approach based on the Transaction. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On December 24, 2021, the Company entered into a share transfer agreement with another third-party investor, pursuant to which the Company sold to this investor 1.1% of outstanding equity interest held by the Company in the JV Company. In addition, on December 30, 2021, the JV Company adopted an employee equity incentive plan and issued an equity interest equivalent to 3.99% of the JV Company in exchange to cash. As a result of these two transactions, the Company owned 45.8% of the equity interest in the JV Company as of December 31, 2021. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 26, 2022, the JV Company completed a financing transaction pursuant to a corporate investment agreement (the “Investment Agreement”) between the JV and certain third-party investors (the “New Investors”). Under the Investment Agreement, the New Investors purchased newly issued equity interest of the JV Company, representing approximately 7.82% of post-transaction outstanding equity interests of the JV Company, for a total purchase price of RMB 509 million (or approximately USD 80 million based on the currency exchange rate as of January 26, 2022) (the “Investment”). Following the closing of the Investment and as of June 30, 2022, the percentage of outstanding JV Company equity interest beneficially owned by the Company was reduced to 42.2%. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The net loss associated with these sales of JV Company equity interest held by the Company were recorded in the fiscal year ended June 30, 2022 as follows:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.426%"><tr><td style="width:1.0%"/><td style="width:72.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.308%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.642%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.972%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Gain on 1.1% equity interest sold</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">475 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Loss on diluted equity interest from issuance of shares under the employee equity incentive plan</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(8,116)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on 7.82% equity interest sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4,501 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Loss on changes on equity interest of the JV Company, net</span></div></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(3,140)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company accounts for its investment in the JV Company as an equity method investment and reports its equity in earnings or loss of the JV Company on a three-month lag due to an inability to timely obtain financial information of the JV Company. During the fiscal year ended June 30, 2022, the Company recorded $2.6 million of its equity in loss of the JV Company, using lag reporting.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Summarized Financial Information</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table presents summarized financial information for the JV Company as of and for the period from December 2, 2021 through March 31, 2022, using lag reporting (in thousands): </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.549%"><tr><td style="width:1.0%"/><td style="width:73.224%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.658%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.872%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.646%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,323 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364,777 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251,988 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,207 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the periods of December 2, 2021 to March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,972 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,280 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,197 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div> 0.509 0.488 3 7 4 399100000 The gain on deconsolidation of the JV Company was calculated as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.742%"><tr><td style="width:1.0%"/><td style="width:4.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:65.951%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.305%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.437%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cash received for sales of shares in the JV Company</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">16,924 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair value of retained equity method investment</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">393,124 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Carrying amount of non-controlling interest</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">143,889 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cumulative translation adjustment removal</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1,793 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Carrying amount of net assets of the JV Company at December 1, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(156,637)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Gain on deconsolidation of the JV Company</span></div></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">399,093 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The net loss associated with these sales of JV Company equity interest held by the Company were recorded in the fiscal year ended June 30, 2022 as follows:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.426%"><tr><td style="width:1.0%"/><td style="width:72.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.308%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.642%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.972%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Gain on 1.1% equity interest sold</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">475 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Loss on diluted equity interest from issuance of shares under the employee equity incentive plan</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(8,116)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on 7.82% equity interest sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4,501 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Loss on changes on equity interest of the JV Company, net</span></div></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(3,140)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div> 16924000 393124000 143889000 1793000 -156637000 399093000 0.011 0.0399 0.458 0.0782 509000000 80000000 0.422 475000 8116000 4501000 -3140000 -2600000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table presents summarized financial information for the JV Company as of and for the period from December 2, 2021 through March 31, 2022, using lag reporting (in thousands): </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.549%"><tr><td style="width:1.0%"/><td style="width:73.224%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.658%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.872%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.646%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,323 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364,777 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251,988 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,207 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the periods of December 2, 2021 to March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,972 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,280 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,197 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div> 198323000 364777000 251988000 76207000 68972000 870000 2280000 6197000 Related Party TransactionsAs of June 30, 2022, the Company owned 42.2% equity interest in the JV Company, which, by definition, is a related party to the Company. The JV Company supplies 12-inch wafers and provides assembly and testing services for 8-inch wafer products to AOS. Due to the right of offset of receivables and payables with the JV Company, as of June 30, 2022, AOS recorded the net amount of $29.0 million as a payable related to equity investee, net, in the Consolidated Balance Sheet. Since the December 2, 2021 deconsolidation of the JV Company and through the fiscal year ended June 30, 2022, the Company purchased finished goods and services of $117.6 million from the JV Company and AOS provided the JV Company with $36.4 million of 8-inch wafers. 0.422 29000000 117600000 36400000 Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is computed using the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed using the weighted-average number of common shares outstanding, plus potential shares of common stock during the period. Potential shares of common stock include dilutive shares attributable to the assumed exercise of share options, ESPP shares and vesting of RSUs using the treasury stock method and contingent issuances of common shares related to convertible preferred shares, if dilutive. Under the treasury stock method, potential common shares outstanding are not included in the computation of diluted net income per share if their effect is anti-dilutive.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of basic and diluted net income (loss) per share attributable to common shareholders:</span></div><div style="margin-top:14pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.304%"><tr><td style="width:1.0%"/><td style="width:54.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.308%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30,  </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to Alpha and Omega Semiconductor Limited</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453,163 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,116 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,596)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares used to compute basic net income per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,764 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,786 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,840 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares used to compute basic net income per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,764 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,786 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,840 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of potentially dilutive securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options, RSUs and ESPP shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,439 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,486 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares used to compute diluted net income per share</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,203 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,272 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,840 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share attributable to Alpha and Omega Semiconductor Limited:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.93 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.27)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.07 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.13 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.27)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:13.5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potential dilutive securities were excluded from the computation of diluted net income (loss) per share as their effect would have been anti-dilutive:</span></div><div style="margin-top:18.5pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.304%"><tr><td style="width:1.0%"/><td style="width:54.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.308%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30,  </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock options and RSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,028 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total potential dilutive securities</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,862 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of basic and diluted net income (loss) per share attributable to common shareholders:</span></div><div style="margin-top:14pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.304%"><tr><td style="width:1.0%"/><td style="width:54.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.308%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30,  </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to Alpha and Omega Semiconductor Limited</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453,163 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,116 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,596)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares used to compute basic net income per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,764 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,786 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,840 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares used to compute basic net income per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,764 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,786 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,840 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of potentially dilutive securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options, RSUs and ESPP shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,439 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,486 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares used to compute diluted net income per share</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,203 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,272 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,840 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share attributable to Alpha and Omega Semiconductor Limited:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.93 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.27)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.07 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.13 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.27)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 453163000 58116000 -6596000 26764000 25786000 24840000 26764000 25786000 24840000 1439000 1486000 0 28203000 27272000 24840000 16.93 2.25 -0.27 16.07 2.13 -0.27 <div style="margin-top:13.5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potential dilutive securities were excluded from the computation of diluted net income (loss) per share as their effect would have been anti-dilutive:</span></div><div style="margin-top:18.5pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.304%"><tr><td style="width:1.0%"/><td style="width:54.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.308%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30,  </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock options and RSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,028 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total potential dilutive securities</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,862 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 277000 193000 2028000 21000 71000 834000 298000 264000 2862000 Concentration of Credit Risk and Significant Customers <div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages its credit risk associated with exposure to distributors and direct customers on outstanding accounts receivable through the application of credit approvals, credit ratings and other monitoring procedures. In some instances, the Company also obtains letters of credit from certain customers. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit sales, which are mainly on credit terms of 30 to 60 days, are only made to customers who meet the Company's credit standards, while sales to new customers or customers with low credit ratings are usually made on an advance payment basis. The Company considers its financial assets to be of good credit quality because its key distributors and direct customers have long-standing business relationships with the Company and the Company has not experienced any significant bad debt write-offs of accounts receivable in the past. The Company closely monitors the aging of accounts receivable from its distributors and direct customers, and regularly reviews their financial positions, where available.</span></div><div><span><br/></span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are individual customers whose revenue or accounts receivable balances were 10% or higher than the respective total consolidated amounts:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.805%"><tr><td style="width:1.0%"/><td style="width:48.428%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.623%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.623%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.626%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 5.5pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">  </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">  </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.247%"><tr><td style="width:1.0%"/><td style="width:65.253%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.895%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.552%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of accounts receivable</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 5.5pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">  </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">  </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer D</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> * Less than 10%</span></div> P30D P60D <div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are individual customers whose revenue or accounts receivable balances were 10% or higher than the respective total consolidated amounts:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.805%"><tr><td style="width:1.0%"/><td style="width:48.428%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.623%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.623%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.626%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 5.5pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">  </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">  </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.247%"><tr><td style="width:1.0%"/><td style="width:65.253%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.895%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.552%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of accounts receivable</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 5.5pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">  </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">  </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer D</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> * Less than 10%</span></div> 0.246 0.287 0.293 0.397 0.354 0.355 0.246 0.124 0.364 0.221 0.219 0.120 Balance Sheet Components <div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts receivable, net</span></div><div style="margin-top:14pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.450%"><tr><td style="width:1.0%"/><td style="width:65.015%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.428%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.37pt;padding-right:12.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,442 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,234 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Allowance for price adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,731)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,415)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,681 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,789 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories </span></div><div style="margin-top:14pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.450%"><tr><td style="width:1.0%"/><td style="width:65.015%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.428%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.37pt;padding-right:12.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,960 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,900 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,720 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,824 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,360 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,569 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158,040 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,293 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4.5pt"><span><br/></span></div><div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other current assets</span></div><div style="margin-top:14pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.450%"><tr><td style="width:1.0%"/><td style="width:65.015%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.428%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.37pt;padding-right:12.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VAT receivable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">737 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,539 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,954 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,590 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,615 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid maintenance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,670 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepayments to supplier</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,540 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,086 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,221 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,207 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customs deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,220 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,595 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, plant and equipment, net</span></div><div style="margin-top:18.5pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.450%"><tr><td style="width:1.0%"/><td style="width:65.015%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.428%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;padding-right:13.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,877 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,877 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,691 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,454 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,574 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515,320 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment and tooling</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,052 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,017 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,758 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,518 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,820 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,814 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,254 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,733 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land use rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,319 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422,026 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748,052 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233,340)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(348,749)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,686 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399,303 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment and construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,980 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,674 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318,666 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436,977 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:13.5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total depreciation expense was $39.9 million, $49.3 million and $43.9 million for fiscal year 2022, 2021 and 2020, respectively.</span></div><div style="margin-top:13.5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalized $0.3 million, $0.3 million and $1.0 million of software development costs during the fiscal year 2022, 2021 and 2020, respectively. Amortization of capitalized software development costs was $0.4 million in fiscal year 2022, $0.5 million in fiscal year 2021 and $0.5 million in fiscal year 2020. Unamortized capitalized software development costs in each of the periods presented at June 30, 2022 and 2021 were $0.8 million and $1.2 million, respectively. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other long-term assets</span></div><div style="margin-top:14pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.450%"><tr><td style="width:1.0%"/><td style="width:65.015%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.428%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;padding-right:13.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,  </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepayments for property and equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,890 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,882 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in privately held companies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customs deposit </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,708 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,120 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposit with supplier</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,396 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term deposits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">927 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office leases deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,553 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,677 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,869 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible assets, net</span></div><div style="margin-top:14pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.450%"><tr><td style="width:1.0%"/><td style="width:65.015%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.428%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;padding-right:13.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and technology rights</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,037 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,037 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,455 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,455 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,674)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,314)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,781 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,141 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,050 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,410 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is amortizing intangible assets of patents and technology rights related to a license agreement with STMicroelectronices International N.V. Amortization expense for intangible assets was $3.4 million, $3.4 million and $0.1 million for the years ended June 30, 2022, 2021 and 2020, respectively. The estimated useful lives for patents and technology rights and trade name were five years and ten years, respectively. Customer relationships are fully amortized.</span></div><div style="margin-top:13.5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated future minimum amortization expense of intangible assets is as follows (in thousands):</span></div><div style="margin-top:18.5pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.304%"><tr><td style="width:1.0%"/><td style="width:82.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.457%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ending June 30,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,286 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,249 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,246 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,781 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Accrued liabilities</span></div><div style="margin-top:13.5pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.426%"><tr><td style="width:1.0%"/><td style="width:64.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.622%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.37pt;padding-right:12.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 7.75pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 7.75pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,681 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,756 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty accrual</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,795 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock rotation accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,798 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,917 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,659 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,017 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,491 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,138 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued facilities related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,421 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,536 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,485 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,688 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,159 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,793 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,578 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,139 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,893 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,494 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:13.5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The activity in the warranty accrual, included in accrued liabilities is as follows: </span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.450%"><tr><td style="width:1.0%"/><td style="width:47.660%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.428%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.428%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.432%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,795 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Addition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,127 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,443 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,272)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(357)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(809)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,795 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    The activity in the stock rotation accrual, included in accrued liabilities is as follows:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.450%"><tr><td style="width:1.0%"/><td style="width:47.660%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.428%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.428%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.432%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,917 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,358 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Addition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,817 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,742 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,441 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,936)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,183)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,004)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,798 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,917 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,358 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other long-term liabilities</span></div><div style="margin-top:13.5pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.035%"><tr><td style="width:1.0%"/><td style="width:65.238%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.320%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.621%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.321%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.37pt;padding-right:12.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></div></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred payroll taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer deposits </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,301 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,302 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,603 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,123 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    Customer deposits are payments received from customers for securing future product shipments. As of June 30, 2022, $34.5 million were from Customer A and $21.9 million were from Customer B, and $13.9 million were from other customers. As of June 30, 2021, $21.0 million were from Customer A and $21.0 million were from Customer B.</span></div> <div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts receivable, net</span></div><div style="margin-top:14pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.450%"><tr><td style="width:1.0%"/><td style="width:65.015%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.428%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.37pt;padding-right:12.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,442 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,234 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Allowance for price adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,731)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,415)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,681 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,789 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 84442000 48234000 18731000 12415000 30000 30000 65681000 35789000 <div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories </span></div><div style="margin-top:14pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.450%"><tr><td style="width:1.0%"/><td style="width:65.015%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.428%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.37pt;padding-right:12.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,960 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,900 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,720 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,824 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,360 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,569 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158,040 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,293 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 67960000 68900000 80720000 68824000 9360000 16569000 158040000 154293000 <div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other current assets</span></div><div style="margin-top:14pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.450%"><tr><td style="width:1.0%"/><td style="width:65.015%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.428%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.37pt;padding-right:12.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VAT receivable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">737 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,539 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,954 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,590 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,615 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid maintenance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,670 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepayments to supplier</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,540 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,086 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,221 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,207 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customs deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,220 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,595 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 737000 1539000 3954000 1465000 2590000 2615000 826000 1670000 257000 2540000 2086000 2221000 25000 2207000 0 270000 745000 68000 11220000 14595000 4877000 4877000 16691000 71454000 287574000 515320000 28052000 27017000 46758000 41518000 2820000 3814000 35254000 74733000 0 9319000 422026000 748052000 233340000 348749000 188686000 399303000 129980000 37674000 318666000 436977000 39900000 49300000 43900000 300000 300000 1000000 400000 500000 500000 800000 1200000 <div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other long-term assets</span></div><div style="margin-top:14pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.450%"><tr><td style="width:1.0%"/><td style="width:65.015%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.428%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;padding-right:13.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,  </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepayments for property and equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,890 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,882 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in privately held companies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customs deposit </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,708 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,120 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposit with supplier</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,396 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term deposits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">927 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office leases deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,553 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,677 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,869 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 6890000 14882000 100000 100000 1708000 1120000 6396000 0 18000 927000 1012000 1100000 1553000 740000 17677000 18869000 <div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible assets, net</span></div><div style="margin-top:14pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.450%"><tr><td style="width:1.0%"/><td style="width:65.015%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.428%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;padding-right:13.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and technology rights</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,037 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,037 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,455 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,455 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,674)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,314)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,781 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,141 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,050 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,410 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 18037000 18037000 268000 268000 1150000 1150000 19455000 19455000 9674000 6314000 9781000 13141000 269000 269000 10050000 13410000 3400000 3400000 100000 P5Y P10Y <div style="margin-top:13.5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated future minimum amortization expense of intangible assets is as follows (in thousands):</span></div><div style="margin-top:18.5pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.304%"><tr><td style="width:1.0%"/><td style="width:82.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.457%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ending June 30,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,286 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,249 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,246 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,781 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 3286000 3249000 3246000 9781000 Accrued liabilities<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.426%"><tr><td style="width:1.0%"/><td style="width:64.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.622%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.37pt;padding-right:12.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 7.75pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 7.75pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,681 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,756 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty accrual</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,795 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock rotation accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,798 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,917 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,659 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,017 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,491 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,138 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued facilities related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,421 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,536 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,485 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,688 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,159 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,793 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,578 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,139 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,893 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,494 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 34681000 32756000 2650000 2795000 4798000 3917000 2659000 3017000 2491000 1138000 2421000 2536000 20485000 8688000 5159000 6793000 40578000 7139000 971000 715000 116893000 69494000 <div style="margin-top:13.5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The activity in the warranty accrual, included in accrued liabilities is as follows: </span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.450%"><tr><td style="width:1.0%"/><td style="width:47.660%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.428%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.428%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.432%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,795 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Addition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,127 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,443 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,272)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(357)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(809)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,795 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2795000 709000 623000 1127000 2443000 895000 1272000 357000 809000 2650000 2795000 709000 The activity in the stock rotation accrual, included in accrued liabilities is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.450%"><tr><td style="width:1.0%"/><td style="width:47.660%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.428%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.428%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.432%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,917 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,358 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Addition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,817 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,742 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,441 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,936)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,183)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,004)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,798 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,917 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,358 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 3917000 3358000 1921000 5817000 4742000 9441000 4936000 4183000 8004000 4798000 3917000 3358000 <div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other long-term liabilities</span></div><div style="margin-top:13.5pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.035%"><tr><td style="width:1.0%"/><td style="width:65.238%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.320%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.621%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.321%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.37pt;padding-right:12.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></div></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred payroll taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer deposits </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,301 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,302 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,603 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,123 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    Customer deposits are payments received from customers for securing future product shipments. As of June 30, 2022, $34.5 million were from Customer A and $21.9 million were from Customer B, and $13.9 million were from other customers. As of June 30, 2021, $21.0 million were from Customer A and $21.0 million were from Customer B.</span></div> 0 1219000 70301000 42000000 8302000 0 0 904000 78603000 44123000 34500000 21900000 13900000 21000000 21000000 Debt<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Short-term bank borrowing</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2019, the Company's subsidiary in China entered into a line of credit facility with Bank of Communications Limited in China. This line of credit matured on February 14, 2021 and was based on the China Base Rate multiplied by 1.05, or 4.99% on October 31, 2019. The purpose of the credit facility is to provide short-term borrowings. The Company could borrow up to approximately RMB 60.0 million or $8.5 million based on the currency exchange rate between the RMB and the U.S. Dollar on October 31, 2019. In September 2021, this line of credit was renewed with maximum borrowings up to RMB 140.0 million with the same terms and a maturity date of September 18, 2022. During the three months ended December 31, 2021, the Company borrowed RMB 11.0 million, or $1.6 million, at an interest rate of 3.85% per annum, with principal due on November 18, 2022. As of June 30, 2022, there was $1.6 million outstanding balance under the loan.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On November 16, 2018, the Company's subsidiary in China entered into a line of credit facility with Industrial and Commercial Bank of China. The purpose of the credit facility was to provide short-term borrowings. The Company could borrow up to approximately RMB 72.0 million or $10.3 million based on currency exchange rate between RMB and U.S. Dollar on November 16, 2018. The RMB 72.0 million consists of RMB 27.0 million for trade borrowings with a maturity date of December 31, 2021, and RMB 45.0 million for working capital borrowings or trade borrowings with a maturity date of September 13, 2022. During the three months ended December 31, 2021, the Company borrowed RMB 5.0 million, or $0.8 million, at an interest rate of 3.7% per annum, with principal due on September 12, 2022. As of June 30, 2022, the total outstanding balance of this loan was $0.5 million.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable Factoring Agreement</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 9, 2019, one of the Company's wholly-owned subsidiaries (the "Borrower") entered into a factoring agreement with the Hongkong and Shanghai Banking Corporation Limited (“HSBC”), whereby the Borrower assigns certain of its accounts receivable with recourse. This factoring agreement allows the Borrower to borrow up to 70% of the net amount of its eligible accounts receivable of the Borrower with a maximum amount of $30.0 million. The interest rate is based on one month London Interbank Offered Rate ("LIBOR") plus 1.75% per annum. The Company is the guarantor for this agreement. The Company is accounting for this transaction as a secured borrowing under the Transfers and Servicing of Financial Assets guidance. In addition, any cash held in the restricted bank account controlled by HSBC has a legal right of offset against the borrowing. This agreement, with certain financial covenants required, has no expiration date. On August 11, 2021, the Borrower signed an agreement with HSBC to decrease the borrowing maximum amount to $8.0 million with certain financial covenants required. Other terms remain the same. The Borrower was in compliance with these covenants as of June 30, 2022. As of June 30, 2022, there was no outstanding balance and the Company had unused credit of approximately $8.0 million. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt financing</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In September 2021, Jireh Semiconductor Incorporated (“Jireh”) entered into a financing arrangement agreement with a company (“Lender”) for the lease and purchase of a machinery equipment manufactured by a supplier. The total purchase price of this machinery equipment was euro 12.0 million, or $12.8 million based on the currency exchange rate between the euro and U.S. Dollar on June 30, 2022. In April 2021, Jireh made a down payment of euro 6.0 million, representing 50% of the total purchase price of the equipment, to the supplier. In June 2022, the equipment was delivered to Jireh after Lender paid 40% of the total purchase price, for euro 4.8 million, to the supplier on behalf of Jireh. Based on the terms of the agreement between Jireh and Lender, after the installation and configuration of the equipment for its intended use, Lender will make the remaining 10% payment for the total purchase price and reimburse Jireh for the down payment made to the supplier. By that time, the title of the equipment will be transferred to Lendor. This agreement has a 5 years term, after which Jireh has the option to purchase the equipment for $1. Jireh is required to make a monthly payment of interest at an implied interest rate of 4.75% per annum to Lessor. Principal payment is required to be paid monthly after the completion of the title transfer. The financing arrangement is secured by this machneray equipment which had the carrying amount of $12.8 million as of June 30, 2022. As of June 30, 2022, the outstanding balance of this debt financing was $5.0 million. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term bank borrowings</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On August 18, 2021, Jireh entered into a term loan agreement with a financial institution (the "Bank") in an amount up to $45.0 million for the purpose of expanding and upgrading the Company’s fabrication facility located in Oregon. The obligation under the loan agreement is secured by substantially all assets of Jireh and guaranteed by the Company. The agreement has a 5.5 years term and matures on February 16, 2027. Jireh is required to make consecutive quarterly payments of principal and interest. The loan accrues interest based on adjusted LIBOR plus the applicable margin based on the outstanding balance of the loan. This agreement contains customary restrictive covenants and includes certain financial covenants that the Company is required to maintain. Jireh drew down $45.0 million on February 16, 2022. As of June 30, 2022, Jireh was in compliance with these covenants and the outstanding balance of this loan was $45.0 million.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On May 1, 2018, Jireh entered into a loan agreement with the Bank that provided a term loan in an amount of $17.8 million. The obligation under the loan agreement is secured by certain real estate assets of Jireh and guaranteed by the Company.  The loan has a five-year term and matures on June 1, 2023. Beginning June 1, 2018, Jireh made consecutive monthly payments of principal and interest to the Bank. The outstanding principal shall accrue interest at a fixed rate of 5.04% per annum on the basis of a 360-day year. The loan agreement contains customary restrictive covenants and includes certain financial covenants that require the Company to maintain, on a consolidated basis, specified financial ratios. In August 2021, Jireh signed an amendment of this loan with the Bank to modify the financial covenants requirement to align with the new term loan agreement entered into on August 18, 2021 discussed above. The amendment was accounted for as a debt modification and no gain or loss was recognized. The Company was in compliance with these covenants as of June 30, 2022. As of June 30, 2022, the outstanding balance of the term loan was $14.2 million.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On August 15, 2017, Jireh entered into a credit agreement with the Bank that provided a term loan in an amount up to $30.0 million for the purpose of purchasing certain equipment for the fabrication facility located in Oregon.  The obligation under the credit agreement is secured by substantially all assets of Jireh and guaranteed by the Company.  The credit agreement has a five-year term and matures on August 15, 2022. In January 2018 and July 2018, Jireh drew down on the loan in the amount of $13.2 million and $16.7 million, respectively.  Beginning in October 2018, Jireh is required to pay to the Bank on each payment date, the outstanding principal amount of the loan in monthly installments.  The loan accrues interest based on an adjusted London Interbank Offered Rate ("LIBOR") as defined in the credit agreement, plus specified applicable margin in the range of 1.75% to 2.25%, based on the outstanding balance of the loan.  The credit agreement contains customary restrictive covenants and includes certain financial covenants that require the Company to maintain, on a consolidated basis, specified financial ratios and fixed charge coverage ratio. In August 2021, Jireh signed an amendment of this loan with the Bank to modify the financial covenants requirement to align with the new term loan agreement entered into on August 18, 2021, discussed above. The amendment was accounted for as a debt modification and no gain or loss was recognized. The Company was in compliance with these covenants as of June 30, 2022. As of June 30, 2022, the outstanding balance of the term loan was $1.9 million.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">At June 30, 2022, maturities of short-term debt and long-term debt were as follows (in thousands):</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.725%"><tr><td style="width:1.0%"/><td style="width:61.869%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.252%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.767%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.612%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ending June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,638 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,952 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,999 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,047 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,348 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total principal of debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,218 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total principal of debt, less debt issuance costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,049 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.116%"><tr><td style="width:1.0%"/><td style="width:41.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.965%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.077%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.968%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term Debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term Debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,638 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,580 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,218 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt, less debt issuance costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,563 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,486 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,049 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1.05 0.0499 60000000 8500000 140000000 11000000 1600000 0.0385 1600000 72000000 10300000 72000000 27000000 45000000 5000000 800000 3.7 500000 0.70 30000000 0.0175 8000000 0 8000000 12000000 12800000 6000000 0.50 0.40 4800000 0.10 5 years 1 0.0475 12800000 5000000 45000000 P5Y6M 45000000 45000000 17800000 P5Y 0.0504 14200000 30000000 P5Y 13200000 16700000 0.0175 0.0225 1900000 <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">At June 30, 2022, maturities of short-term debt and long-term debt were as follows (in thousands):</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.725%"><tr><td style="width:1.0%"/><td style="width:61.869%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.252%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.767%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.612%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ending June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,638 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,952 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,999 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,047 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,348 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total principal of debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,218 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total principal of debt, less debt issuance costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,049 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.116%"><tr><td style="width:1.0%"/><td style="width:41.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.965%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.077%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.968%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term Debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term Debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,638 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,580 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,218 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt, less debt issuance costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,563 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,486 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,049 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 25638000 9952000 9999000 10047000 12348000 234000 68218000 169000 68049000 25638000 42580000 68218000 75000 94000 169000 25563000 42486000 68049000 Leases<div style="margin-bottom:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates contracts for lease accounting at contract inception and assesses lease classification at the lease commencement date. Operating leases are included in operating lease right-of-use ("ROU") assets, operating lease liabilities and operating lease liabilities - long-term on the Company's consolidated balance sheets. Finance leases are included in property, plant and equipment, finance lease liabilities and finance lease liabilities-long-term on the consolidated balance sheets. The Company recognizes a ROU asset and corresponding lease obligation liability at the lease commencement date where the lease obligation liability is measured at the present value of the minimum lease payments. As most of the leases do not provide an implicit rate, the Company uses its incremental borrowing rate at lease commencement. The Company uses an interest rate commensurate with the interest rate to borrow on a collateralized basis over a similar term with an amount equal to the lease payments. Operating leases are primarily related to offices, research and development facilities, sales and marketing facilities, and manufacturing facilities. In addition, long-term supply agreements to lease gas tank equipment and purchase industrial gases are accounted for as operating leases. Lease agreements frequently include renewal provisions and require the Company to pay real estate taxes, insurance and maintenance costs. For operating leases, the amortization of the ROU asset and the accretion of its lease obligation liability result in a single straight-line expense recognized over the lease term. The finance lease is related to the machinery lease financing with a vendor. In addition, the finance lease related to the RMB 400.0 million of lease financing of the JV Company with YinHai Leasing Company and The Export-Import Bank of China was not included in the Company’s Consolidated Balance Sheet at June 30, 2022 due to the deconsolidation of the JV Company on December 2, 2021. The Company does not record leases on the consolidated balance sheet with a term of one year or less.</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company’s operating and finance lease expenses are as follows for the years presented (in thousands):</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.298%"><tr><td style="width:1.0%"/><td style="width:40.450%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.040%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.962%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.885%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.963%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal Year Ended June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal Year Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Fixed rent expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,262 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,760 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Variable rent expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Amortization of equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">908 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,168 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Short-term lease expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">               Total lease expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,297 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,164 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to the Company’s operating and finance leases is as follows (in thousands, except lease term and discount rate):</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.920%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.360%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.251%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     ROU assets associated with operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,674 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,660 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Lease:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Property, plant and equipment, gross</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,831 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,404 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96,470)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">          <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQxNjU2OTQ3ZDExNDQ0ZWViYWI3OTU4MzI3MTUxYTc4L3NlYzo0MTY1Njk0N2QxMTQ0NGVlYmFiNzk1ODMyNzE1MWE3OF8xMzkvZnJhZzo5NjgzYzg2ZWNmZmQ0MjQyODM4OTk3ZDZiY2JhZGViYi90YWJsZTo2OTVjOTlmN2I2MzI0YmZhYjE3NjBkZjc0NTc4NTNjYy90YWJsZXJhbmdlOjY5NWM5OWY3YjYzMjRiZmFiMTc2MGRmNzQ1Nzg1M2NjXzYtMC0xLTEtMTYxMjc_4076728c-f821-4074-9238-96cf7b3ec81d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQxNjU2OTQ3ZDExNDQ0ZWViYWI3OTU4MzI3MTUxYTc4L3NlYzo0MTY1Njk0N2QxMTQ0NGVlYmFiNzk1ODMyNzE1MWE3OF8xMzkvZnJhZzo5NjgzYzg2ZWNmZmQ0MjQyODM4OTk3ZDZiY2JhZGViYi90YWJsZTo2OTVjOTlmN2I2MzI0YmZhYjE3NjBkZjc0NTc4NTNjYy90YWJsZXJhbmdlOjY5NWM5OWY3YjYzMjRiZmFiMTc2MGRmNzQ1Nzg1M2NjXzYtMC0xLTEtMTYxMjc_7f922dcf-b5fa-4508-a2c7-904efd3ac493">Property, plant and equipment, net</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,695 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,934 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.42</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.44</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Finance lease</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.72</span></td><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.67 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Finance lease</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.76 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.46 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to the Company’s operating and finance lease is as follows (in thousands):</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.876%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.461%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.610%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal Year Ended June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal Year Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid from amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Operating cash flows from operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,480 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,496 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Operating cash flows from finance lease</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,168 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Financing cash flows from finance lease</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,176 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,451 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing and financing information:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Operating lease right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,852 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,585 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:4.5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments are as follows as of June 30, 2022 (in thousands):</span></div><div style="padding-left:40.5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:66.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.468%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.564%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,206 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,053 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,222 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,176 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,147 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,076 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,337 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,141 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,318 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less amount representing interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,413)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(584)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,728 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,734 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> Leases<div style="margin-bottom:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates contracts for lease accounting at contract inception and assesses lease classification at the lease commencement date. Operating leases are included in operating lease right-of-use ("ROU") assets, operating lease liabilities and operating lease liabilities - long-term on the Company's consolidated balance sheets. Finance leases are included in property, plant and equipment, finance lease liabilities and finance lease liabilities-long-term on the consolidated balance sheets. The Company recognizes a ROU asset and corresponding lease obligation liability at the lease commencement date where the lease obligation liability is measured at the present value of the minimum lease payments. As most of the leases do not provide an implicit rate, the Company uses its incremental borrowing rate at lease commencement. The Company uses an interest rate commensurate with the interest rate to borrow on a collateralized basis over a similar term with an amount equal to the lease payments. Operating leases are primarily related to offices, research and development facilities, sales and marketing facilities, and manufacturing facilities. In addition, long-term supply agreements to lease gas tank equipment and purchase industrial gases are accounted for as operating leases. Lease agreements frequently include renewal provisions and require the Company to pay real estate taxes, insurance and maintenance costs. For operating leases, the amortization of the ROU asset and the accretion of its lease obligation liability result in a single straight-line expense recognized over the lease term. The finance lease is related to the machinery lease financing with a vendor. In addition, the finance lease related to the RMB 400.0 million of lease financing of the JV Company with YinHai Leasing Company and The Export-Import Bank of China was not included in the Company’s Consolidated Balance Sheet at June 30, 2022 due to the deconsolidation of the JV Company on December 2, 2021. The Company does not record leases on the consolidated balance sheet with a term of one year or less.</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company’s operating and finance lease expenses are as follows for the years presented (in thousands):</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.298%"><tr><td style="width:1.0%"/><td style="width:40.450%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.040%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.962%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.885%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.963%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal Year Ended June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal Year Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Fixed rent expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,262 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,760 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Variable rent expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Amortization of equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">908 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,168 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Short-term lease expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">               Total lease expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,297 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,164 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to the Company’s operating and finance leases is as follows (in thousands, except lease term and discount rate):</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.920%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.360%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.251%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     ROU assets associated with operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,674 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,660 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Lease:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Property, plant and equipment, gross</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,831 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,404 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96,470)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">          <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQxNjU2OTQ3ZDExNDQ0ZWViYWI3OTU4MzI3MTUxYTc4L3NlYzo0MTY1Njk0N2QxMTQ0NGVlYmFiNzk1ODMyNzE1MWE3OF8xMzkvZnJhZzo5NjgzYzg2ZWNmZmQ0MjQyODM4OTk3ZDZiY2JhZGViYi90YWJsZTo2OTVjOTlmN2I2MzI0YmZhYjE3NjBkZjc0NTc4NTNjYy90YWJsZXJhbmdlOjY5NWM5OWY3YjYzMjRiZmFiMTc2MGRmNzQ1Nzg1M2NjXzYtMC0xLTEtMTYxMjc_4076728c-f821-4074-9238-96cf7b3ec81d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQxNjU2OTQ3ZDExNDQ0ZWViYWI3OTU4MzI3MTUxYTc4L3NlYzo0MTY1Njk0N2QxMTQ0NGVlYmFiNzk1ODMyNzE1MWE3OF8xMzkvZnJhZzo5NjgzYzg2ZWNmZmQ0MjQyODM4OTk3ZDZiY2JhZGViYi90YWJsZTo2OTVjOTlmN2I2MzI0YmZhYjE3NjBkZjc0NTc4NTNjYy90YWJsZXJhbmdlOjY5NWM5OWY3YjYzMjRiZmFiMTc2MGRmNzQ1Nzg1M2NjXzYtMC0xLTEtMTYxMjc_7f922dcf-b5fa-4508-a2c7-904efd3ac493">Property, plant and equipment, net</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,695 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,934 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.42</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.44</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Finance lease</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.72</span></td><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.67 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Finance lease</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.76 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.46 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to the Company’s operating and finance lease is as follows (in thousands):</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.876%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.461%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.610%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal Year Ended June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal Year Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid from amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Operating cash flows from operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,480 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,496 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Operating cash flows from finance lease</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,168 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Financing cash flows from finance lease</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,176 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,451 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing and financing information:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Operating lease right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,852 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,585 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:4.5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments are as follows as of June 30, 2022 (in thousands):</span></div><div style="padding-left:40.5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:66.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.468%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.564%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,206 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,053 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,222 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,176 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,147 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,076 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,337 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,141 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,318 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less amount representing interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,413)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(584)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,728 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,734 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 400000000 <div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company’s operating and finance lease expenses are as follows for the years presented (in thousands):</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.298%"><tr><td style="width:1.0%"/><td style="width:40.450%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.040%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.962%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.885%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.963%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal Year Ended June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal Year Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Fixed rent expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,262 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,760 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Variable rent expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Amortization of equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">908 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,168 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Short-term lease expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">               Total lease expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,297 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,164 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to the Company’s operating and finance leases is as follows (in thousands, except lease term and discount rate):</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.920%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.360%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.251%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     ROU assets associated with operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,674 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,660 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Lease:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Property, plant and equipment, gross</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,831 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,404 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96,470)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">          <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQxNjU2OTQ3ZDExNDQ0ZWViYWI3OTU4MzI3MTUxYTc4L3NlYzo0MTY1Njk0N2QxMTQ0NGVlYmFiNzk1ODMyNzE1MWE3OF8xMzkvZnJhZzo5NjgzYzg2ZWNmZmQ0MjQyODM4OTk3ZDZiY2JhZGViYi90YWJsZTo2OTVjOTlmN2I2MzI0YmZhYjE3NjBkZjc0NTc4NTNjYy90YWJsZXJhbmdlOjY5NWM5OWY3YjYzMjRiZmFiMTc2MGRmNzQ1Nzg1M2NjXzYtMC0xLTEtMTYxMjc_4076728c-f821-4074-9238-96cf7b3ec81d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQxNjU2OTQ3ZDExNDQ0ZWViYWI3OTU4MzI3MTUxYTc4L3NlYzo0MTY1Njk0N2QxMTQ0NGVlYmFiNzk1ODMyNzE1MWE3OF8xMzkvZnJhZzo5NjgzYzg2ZWNmZmQ0MjQyODM4OTk3ZDZiY2JhZGViYi90YWJsZTo2OTVjOTlmN2I2MzI0YmZhYjE3NjBkZjc0NTc4NTNjYy90YWJsZXJhbmdlOjY5NWM5OWY3YjYzMjRiZmFiMTc2MGRmNzQ1Nzg1M2NjXzYtMC0xLTEtMTYxMjc_7f922dcf-b5fa-4508-a2c7-904efd3ac493">Property, plant and equipment, net</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,695 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,934 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.42</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.44</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Finance lease</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.72</span></td><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.67 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Finance lease</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.76 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.46 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to the Company’s operating and finance lease is as follows (in thousands):</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.876%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.461%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.610%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal Year Ended June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal Year Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid from amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Operating cash flows from operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,480 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,496 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Operating cash flows from finance lease</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,168 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Financing cash flows from finance lease</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,176 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,451 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing and financing information:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Operating lease right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,852 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,585 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 6262000 6760000 946000 815000 908000 2200000 976000 2168000 205000 221000 9297000 12164000 23674000 34660000 4831000 114404000 136000 96470000 4695000 17934000 P7Y5M1D P8Y5M8D P5Y P1Y8M19D 0.0427 0.0467 0.0476 0.0546 6480000 6496000 976000 2168000 4176000 16451000 5852000 5585000 <div style="padding-left:4.5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments are as follows as of June 30, 2022 (in thousands):</span></div><div style="padding-left:40.5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:66.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.468%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.564%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,206 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,053 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,222 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,176 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,147 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,076 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,337 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,141 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,318 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less amount representing interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,413)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(584)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,728 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,734 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="padding-left:4.5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments are as follows as of June 30, 2022 (in thousands):</span></div><div style="padding-left:40.5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:66.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.468%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.564%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,206 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,053 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,222 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,176 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,147 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,076 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,337 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,141 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,318 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less amount representing interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,413)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(584)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,728 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,734 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 5206000 993000 4053000 1083000 3222000 1083000 3176000 1083000 3147000 1076000 10337000 0 29141000 5318000 4413000 584000 24728000 4734000 Shareholders' Equity<div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Shares</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Bye-laws, as amended, authorized the Company to issue 100,000,000 common shares with par value of $0.002. Each common share is entitled to one vote. The holders of common shares are also entitled to receive dividends whenever funds are legally available and when and if declared by the board of directors. No dividends had been declared as of June 30, 2022</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2017, the board of directors approved a repurchase program (the “Repurchase Program”) that allowed the Company to repurchase its common shares from the open market pursuant to a pre-established Rule 10b5-1 trading plan or through privately negotiated transactions up to an aggregate of $30.0 million. The amount and timing of any repurchases under the Repurchase Program depend on a number of factors, including but not limited to, the trading price, volume and availability of the Company's common shares. Shares repurchased under this program are accounted for as treasury shares and the total cost of shares repurchased is recorded as a reduction of shareholders' equity. From time to time, treasury shares may be reissued as part of the Company's stock-based compensation programs. Gains on re-issuance of treasury stock are credited to additional paid-in capital; losses are charged to additional paid-in capital to offset the net gains, if any, from previous sales or re-issuance of treasury stock. Any remaining balance of the losses is charged to retained earnings. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal year 2022, 2021 and 2020, the Company did not repurchase any shares pursuant to the repurchase program. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of June 30, 2022, the Company had repurchased an aggregate of 6,784,648 shares for a total cost of $67.3 million, at an average price of $9.92 per share, excluding fees and related expenses, since inception of the program. No repurchased shares have been retired. Of the 6,784,648 repurchased shares, 167,395 shares with a weighted average repurchase price of $10.06 per share, were reissued at an average price of $5.00 per share for option exercises and vested restricted stock units (“RSU”). As of June 30, 2022, $13.4 million remain available under the share repurchase program.</span></div> 100000000 0.002 1 0 30000000 0 0 6784648 67300000 9.92 0 6784648 167395 10.06 5.00 13400000 Share-based Compensation <div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2018 Omnibus Incentive Plan</span></div><div style="margin-top:13.5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The 2009 Share Option/Share Issuance Plan (the “2009 Plan”) was approved in September 2009 at the annual general meeting of shareholders in connection with the Company's IPO. At the annual general meeting of shareholders in November 2018, the 2009 Plan was approved to be terminated and the 2018 Omnibus Incentive Plan (the “2018 Plan”) was effective. No further awards will be made under the 2009 Plan. The 2018 Plan authorized the board of directors to grant incentive share options, non-statutory share options and restricted shares to employees, directors, non-employee directors and consultants of the Company and its subsidiaries for up to 2,065,000 common shares. The 2018 Plan does not include an evergreen authorization Therefore, the Company is not permitted to increase the number of shares reserved in the share pool without obtaining further shareholder approval. Outstanding shares under the 2018 Plan and awards granted under the 2009 Plan that expire, are forfeited or cancelled or terminate prior to the issuance of the shares subject to those awards or are settled in cash will be available for subsequent issuance under the 2018 Plan. At the annual general meeting of shareholders in November 2021, the 2018 Plan was approved to increase by 1,000,000 shares to a total of 3,065,000 shares. As of June 30, 2022, 537,260 shares were available for grant under the 2018 Plan.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning with the 2014 Annual Shareholders Meeting, on the date of each annual shareholders meeting, each individual who commences service as a non-employee Board member by reason of his or her election to the Board at such annual meeting and each individual who is to continue to serve as a non-employee Board member, whether or not that individual is standing for re-election to the Board at that particular annual meeting, will automatically be granted an award in the form of restricted share units covering that number of common shares determined by dividing one hundred twenty-five thousand dollars ($125,000) by the average fair market value per share for the ninety (90)-day period preceding the grant date, up to a maximum of 10,000 shares.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2018 Plan, incentive share options and RSU are to be granted at a price that is not less than 100% and nonstatutory share options are to be granted at not less than 85% of the fair value of the common shares, at the date of grant for employees and consultants. Options and RSUs generally vest over a four-year to five-year period, and are exercisable for a maximum period of ten years after the date of grant. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of RSU, including time-based restricted stock units and performance-based restricted stock units is based on the market price of the Company's share on the date of grant.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Time-based Restricted Stock Units (“TRSU”)</span></div><div><span><br/></span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's TRSU activities:</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"/><td style="width:30.951%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.925%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.242%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.925%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.925%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.929%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Restricted Stock<br/>Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant Date Fair<br/>Value Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Recognition<br/>Period (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906,341 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.09 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.62</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,465,225 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505,440 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.51 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(455,893)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,750)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.19 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932,138 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.36 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.66</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,141,661 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722,873 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.85 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(567,087)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.70 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.88 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,053,524 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.60 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.73</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,016,594 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597,381 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.83 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(410,670)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,626)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.79 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,169,609 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.03 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.73</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,994,764 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Performance-based Restricted Stock Units (“PRSU”)</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March each year since fiscal year 2017, the Company granted PRSU to certain personnel. The number of shares to be ultimately earned under the PRSU is determined based on the level of attainment of predetermined financial goals. The PRSU vests in four equal annual installments from the first anniversary date after the grant date if certain predetermined financial goals were met. The Company recorded $4.6 million, $2.3 million and $1.5 million of expenses for these PRSUs during the years ended June 30, 2022, 2021 and 2020, respectively.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended June 30, 2019, the Company announced an incentive program. Under this program, each participant’s award is denominated in stock and subject to achievement of certain objective goals within certain timelines. In June 2020, the Company believed it was most likely that predetermined goal measures would be met. Therefore, the Company reported such expenses in the other current liabilities line on the condensed consolidated balance sheets as the amount of bonus is to be settled in variable number of RSU’s at the completion of the objective goals. Such non-cash compensation expense was recorded as part of share-based compensation expense in the condensed consolidated statements of operations. As of June 30, 2022 and 2021, the Company recorded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nil and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$0.1 million such expens</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">es in the other current liabilities, respectively. During the fiscal years ended June 30, 2022, 2021 and 2020, the Company recorded $0.3 million, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$3.1 million and $0.6 million of non-cash compensation expense, respectively. As of June 30, 2022, the Company granted RSUs valued at $4.0 million to participants, which were fully vested due to achievement of certain objective measures.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes the Company’s PRSU activities:</span></div><div style="margin-top:14pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"/><td style="width:30.951%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.925%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.242%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.925%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.925%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.929%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Performance-based Restricted Stock<br/>Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant Date Fair<br/>Value Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Recognition<br/>Period (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596,724 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.95 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.88</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,573,402 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.36 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110,659)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.68 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298,290)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342,775 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.38 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.60</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,729,392 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148,211)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.24 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,240)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353,824 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.69 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.74</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,752,711 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.65 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151,199)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,375 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.56 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.85</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,981,763 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Market-based Restricted Stock Units (“MSUs”)</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2021, the Company granted 1.0 million market-based restricted stock units (“MSUs”) to its certain personnel. The number of shares to be earned at the end of performance period is determined based on the Company’s achievement of specified stock prices and revenue thresholds during the performance period from January 1, 2022 to December 31, 2024 as well as the recipients remaining in continuous service with the Company through such period. The MSU vests in four equal annual installments after the end of performance period. The Company estimated the grant date fair values of its MSU with derived service periods of 4.1 to 7.1 years using a Monte-Carlo simulation model with the following assumptions: Risk-free interest rate of 1.0%, expected term of 3.1 years, expected volatility of 62.8% and dividend yield of 0%. The Company recorded approximately $4.5 million expenses for these MSUs during the fiscal year ended June 30, 2022.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the quarter ended September 30, 2018, the Company granted 1.3 million market-based restricted stock units (“MSUs”) to certain personnel. The number of shares to be earned at the end of the performance period is determined based on the Company’s achievement of specified stock prices and revenue thresholds during the performance period from January 1, 2019 to December 31, 2021 as well as the recipients remaining in continuous service with the Company through such period. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The MSUs vest in four equal annual installments after the end of performance period. On August 31, 2020, the Compensation Committee of the Board approved a modification of the terms of MSU to (i) extend the performance period through December 31, 2022 and (ii) change the commencement date for the four-year time-based service period to January 1, 2023. The modified MSUs were valued immediately before and after the modification, using Morte Carlo simulation pricing model. The Morte Carlo simulation pricing model applied the following assumptions for pre-modification conditions: risk-free interest rate of 0.13%, expected term of 1.3 years, expected volatility of 66.7% and dividend yield of 0%; and for post-modification conditions: risk-free interest rate of 0.14%, expected term of 2.3 years, expected volatility of 59.1% and dividend yield of 0%. The fair value of these MSUs was recalculated to reflect the change as of August 31, 2020 and the unrecognized compensation amount was adjusted to reflect the increase in fair value. The Company recorded approximately $1.6 million, $1.2 million and $0.6 million of expense for these MSUs during the years ended June 30, 2022, 2021 and 2020, respectively. </span></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Stock Option</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's stock option activities:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.912%"><tr><td style="width:1.0%"/><td style="width:35.810%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.938%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.859%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.938%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.672%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.938%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.512%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Remaining</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contractual </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic Value</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at June 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876,478 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.98 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.06</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,726 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled or forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(230,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643,978 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.79 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.89</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156,103)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,272,291 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled or forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487,875 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.99 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.32</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,936,675 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled or forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,875 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.70 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.53</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,997,364 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,875 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.70 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.53</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,997,364 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,875 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.70 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.53</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,997,364 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value for options outstanding at June 30, 2022 in the table above is based on the Company’s common stock closing price on June 30, 2022.</span></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The 2018 Employee Share Purchase Plan </span></div><div style="margin-top:13.5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the annual general meeting of shareholders in November 2018, the 2018 Employee Share Purchase Plan (“Purchase Plan” or “ESPP”) Plan was approved, under which 1,430,000 common shares are available for issuance. The Purchase Plan does not include an evergreen authorization, therefore the Company is not permitted to increase the number of shares reserved in the share pool without obtaining further shareholder approval. At the general meeting of shareholders in November 2021, the ESPP Plan was approved to increase from 1,430,000 shares to 2,500,000 shares. The Purchase Plan provided for a series of overlapping offering periods with a duration of 24 months, generally beginning on May 15 and November 15 of each year. The Purchase Plan allows employees to purchase common shares through payroll deductions of up to 15% of their eligible compensation. Such deductions will accumulate over a six-month accumulation period without interest. After such accumulation period, common shares will be purchased at a price equal to 85% of the fair market value per share on either the first day of the offering period or the last date of the accumulation period, whichever is less. The maximum number of shares that may be purchased by a participant on any purchase date may not exceed 875 shares for a total of 3,500 shares per a 24-</span></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">month offering period. In addition, no participant may purchase more than $25,000 worth of common stock in any one calendar year period. No more than 300,000 common shares may be purchased by all participants on any purchase date.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ESPP is compensatory and results in compensation expense. The fair values of common shares to be issued under the ESPP were determined using the Black-Scholes option pricing model with the following assumptions:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.102%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.4% - 69.9%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.1% - 68.5%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.4% - 58.3%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3% - 2.1%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1% - 0.2%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2% - 1.6%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—%</span></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average estimated fair value of employee stock purchase rights granted pursuant to the ESPP during the years ended June 30, 2022, 2021 and 2020 was $16.48, $11.11 and $4.33 per share, respectively. </span></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-based Compensation Expenses</span></div><div style="margin-top:13.5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total share-based compensation expense related to TRSU, PSUs, MSUs, stock options and ESPP described above, recognized in the consolidated statements of operations for the years presented was as follows:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.102%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,125 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,756 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,049 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,352 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,895 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,150 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,216 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,029 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,324 </span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,324 </span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,454 </span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Total unrecognized share-based compensation expense as of June 30, 2022 was $84.3 million including estimated forfeitures, which is expected to be recognized over a weighted-average period of 3.2 years. 2065000 1000000 3065000 537260 125000 P90D 10000 1 1 0.85 P4Y P5Y P10Y <div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's TRSU activities:</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"/><td style="width:30.951%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.925%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.242%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.925%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.925%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.929%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Restricted Stock<br/>Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant Date Fair<br/>Value Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Recognition<br/>Period (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906,341 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.09 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.62</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,465,225 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505,440 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.51 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(455,893)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,750)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.19 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932,138 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.36 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.66</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,141,661 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722,873 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.85 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(567,087)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.70 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.88 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,053,524 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.60 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.73</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,016,594 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597,381 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.83 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(410,670)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,626)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.79 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,169,609 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.03 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.73</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,994,764 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes the Company’s PRSU activities:</span></div><div style="margin-top:14pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"/><td style="width:30.951%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.925%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.242%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.925%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.925%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.929%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Performance-based Restricted Stock<br/>Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant Date Fair<br/>Value Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Recognition<br/>Period (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596,724 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.95 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.88</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,573,402 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.36 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110,659)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.68 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298,290)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342,775 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.38 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.60</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,729,392 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148,211)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.24 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,240)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353,824 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.69 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.74</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,752,711 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.65 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151,199)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,375 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.56 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.85</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,981,763 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 906341 14.09 P1Y7M13D 8465225 505440 8.51 455893 13.53 23750 13.19 932138 11.36 P1Y7M28D 10141661 722873 29.85 567087 15.70 34400 14.88 1053524 21.60 P1Y8M23D 32016594 597381 45.83 410670 20.54 70626 26.79 1169609 34.03 P1Y8M23D 38994764 4600000 2300000 1500000 0 100000 300000 3100000 600000 4000000 596724 13.95 P1Y10M17D 5573402 155000 7.36 110659 16.68 298290 11.32 342775 12.38 P1Y7M6D 3729392 165500 36.27 148211 14.24 6240 17.23 353824 22.69 P1Y8M26D 10752711 194000 48.65 151199 19.44 7250 40.33 389375 36.56 P1Y10M6D 12981763 1000000 P4Y1M6D P7Y1M6D 0.010 P3Y1M6D 0.628 0 4500000 1300000 0.0013 P1Y3M18D 0.667 0 0.0014 P2Y3M18D 0.591 0 1600000 1200000 600000 <div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's stock option activities:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.912%"><tr><td style="width:1.0%"/><td style="width:35.810%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.938%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.859%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.938%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.672%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.938%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.512%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Remaining</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contractual </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic Value</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at June 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876,478 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.98 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.06</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,726 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled or forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(230,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643,978 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.79 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.89</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156,103)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,272,291 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled or forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487,875 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.99 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.32</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,936,675 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled or forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,875 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.70 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.53</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,997,364 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,875 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.70 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.53</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,997,364 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,875 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.70 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.53</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,997,364 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 876478 10.98 P3Y21D 0 0 2500 10.50 4726 230000 17.11 643978 8.79 P2Y10M20D 0 0 156103 11.31 1272291 0 0 487875 7.99 P2Y3M25D 0 0 98000 9.15 3936675 0 0 389875 7.70 P1Y6M10D 9997364 389875 7.70 P1Y6M10D 9997364 389875 7.70 P1Y6M10D 9997364 1430000 1430000 2500000 P24M 0.15 P6M 0.85 875 3500 25000 300000 <div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ESPP is compensatory and results in compensation expense. The fair values of common shares to be issued under the ESPP were determined using the Black-Scholes option pricing model with the following assumptions:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.102%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.4% - 69.9%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.1% - 68.5%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.4% - 58.3%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3% - 2.1%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1% - 0.2%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2% - 1.6%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—%</span></td></tr></table></div> 0.664 0.699 0.631 0.685 0.464 0.583 0.003 0.021 0.001 0.002 0.002 0.016 P1Y3M18D P1Y3M18D P1Y3M18D 0 0 0 16.48 11.11 4.33 <div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-based Compensation Expenses</span></div><div style="margin-top:13.5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total share-based compensation expense related to TRSU, PSUs, MSUs, stock options and ESPP described above, recognized in the consolidated statements of operations for the years presented was as follows:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.102%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,125 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,756 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,049 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,352 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,895 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,150 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,216 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,029 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,324 </span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,324 </span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,454 </span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 5125000 1756000 1530000 7049000 5352000 2895000 19150000 8216000 6029000 31324000 15324000 10454000 84300000 P3Y2M12D Employee Benefit Plans <div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a 401(k) retirement plan for the benefit of qualified employees in the U.S. Employees who participate may elect to make salary deferral contributions to the plan up to 100% of the employees' eligible salary subject to annual Internal Revenue Code maximum limitations. The employer's contribution is discretionary. Effective from April 1, 2022, the Company begins to match 50% of employee contribution up to 4% of eligible compensation for a 2% maximum match. During the fiscal year ended June 30, 2022, the Company made employer match contributions of $0.3 million.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes mandatory contributions for its employees to the respective local governments in terms of retirement, medical insurance and unemployment insurance, where applicable, according to labor and social security laws and regulations of the countries and areas in which the Company operates. The retirement contribution rate is 7.7% in the U.S., 14.0% to 16.0% in China, and 6.0% in Taiwan. The Company has no obligations for the payment of such social benefits beyond the required contributions as set out above.</span></div> 1 0.50 0.04 0.02 300000 0.077 0.140 0.160 0.060 Income Taxes <div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    The provision for income taxes is comprised of:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.304%"><tr><td style="width:1.0%"/><td style="width:54.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.308%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.37pt;padding-right:12.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30, </span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 7.75pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal taxes:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">645 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,673)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,260 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,955 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,749 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,344 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,940 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,599 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(396)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State taxes, net of federal benefit:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,258 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,935 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:13.5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of the federal statutory income tax rate to our effective income tax rate is as follows (in percentage):</span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.304%"><tr><td style="width:1.0%"/><td style="width:54.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.308%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside basis difference on equity method investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Tax Act deferred tax re-measurement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Derived Intangible Income Deduction</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    The domestic and foreign components of income before taxes are:</span></div><div style="margin-top:18.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.304%"><tr><td style="width:1.0%"/><td style="width:54.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.308%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,684 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,622 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,549 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478,386 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,602 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,458)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,070 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,224 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,909)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of our deferred tax assets and liabilities are as follows:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.649%"><tr><td style="width:1.0%"/><td style="width:67.984%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.925%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.663%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.928%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,742 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,954 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,539 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,365 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,924 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,079 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,550 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,807 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,292 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,982 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals and reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,113 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,697 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,354 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,755)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,474)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets, net of valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,942 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,880 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,909)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,193)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,579)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,968)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,619)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,107)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,161)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets/(liabilities)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,165)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,719 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:13.5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The breakdown between deferred tax assets and liabilities is as follows:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.649%"><tr><td style="width:1.0%"/><td style="width:67.984%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.925%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.663%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.928%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,167 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,757)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,448)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets/(liabilities)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,165)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,719 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s valuation allowance related to deferred income taxes as reflected in the consolidated balance sheets was $5.8 million and $41.5 million as of June 30, 2022 and 2021, respectively. The change in valuation allowance for June 30, 2022 and 2021 was a decrease of $35.7 million and an increase of $3.6 million, respectively.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">At June 30, 2022 and 2021, the Company provided a valuation allowance for its state research and development credit carryforward deferred tax assets of $5.8 million for both years, as it generated more state tax credits each year than it can utilize.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company intends to maintain a valuation allowance equal to the state research and development credit carryforwards in excess of the state net deferred tax liabilities on all other state book/tax differences and net operating loss carryforward. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">At June 30, 2021, the Company provided a valuation allowance mainly for the net operating loss, fixed asset and intangible asset related to deferred tax assets of the JV Company totaling $35.7 million. The valuation allowance related to the deferred tax assets of the JV Company was reduced to $0 at June 30, 2022 as a result of the deconsolidation of the JV Company in December 2021.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2022, the Company had federal research and development tax credit carryforwards of approximately $8.9 million. The federal tax credits begin to expire in 2030, if not utilized.  At June 30, 2022, the Company had $0.9 million of state net operating loss carryforwards and had tax credit carryforwards of approximately $7.8 million. Approximately $0.2 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">million of the state tax credits begin to expire in 2023, if not utilized. The remaining $7.6 million of the state tax credits carryforward indefinitely. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has not provided for withholding taxes on the undistributed earnings of its foreign subsidiaries because it intends to reinvest such earnings indefinitely. However, we have recorded a deferred tax liability of $29.6 million at June 30, 2022 related to our investment in the JV Company. As of June 30, 2022, the cumulative amount of undistributed earnings of its foreign entities considered permanently reinvested is $314.7 million. The determination of the unrecognized deferred tax liability on these earnings is not practicable. Should the Company decide to remit this income to its Bermuda parent company in a future period, its provision for income taxes may increase materially in that period. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of unrecognized tax benefits from July 1, 2019 to June 30, 2022 is as follows:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"/><td style="width:58.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.865%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.865%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.868%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,645 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,126 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,150 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,121 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions due to lapse of applicable statute of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(243)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,609 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,645 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,126 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2022, the total unrecognized tax benefits of $8.6 million included $6.6 million of unrecognized tax benefits that have been netted against the related deferred tax assets. The remaining $2.0 million of unrecognized tax benefits was recorded within long-term income tax payable on the Company's consolidated balance sheet as of June 30, 2022. The Company cannot reasonably estimate the timing and amount of potential cash settlements on the unrecognized tax benefits.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total unrecognized tax benefits of $8.6 million at June 30, 2022 included $5.6 million that, if recognized, would reduce the effective income tax rate in future periods. It is reasonably possible that the Company will recognize approximately $0.01 million reduction to its uncertain tax positions during the next twelve months, related to potential expiration of the relevant statute of limitations.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes interest and penalties related to uncertain tax positions in income tax expense. To the extent accrued interest and penalties do not ultimately become payable, amounts accrued will be reduced and reflected as a reduction of the overall income tax provision in the period that such determination is made. The amount of interest and penalties accrued at June 30, 2022 was $0.2 million, of which $32 thousand was recognized in the year ended June 30, 2022. The amount of interest and penalties accrued at June 30, 2021 was $0.1 million, of which $5 thousand was recognized in the year ended June 30, 2021.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files its income tax returns in the United States and in various foreign jurisdictions. The tax years 2001 to 2022 remain open to examination by U.S. federal and state tax authorities. The tax years 2014 to 2022 remain open to examination by foreign tax authorities. </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company's income tax returns are subject to examinations by the Internal Revenue Service and other tax authorities in various jurisdictions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In accordance with the guidance on the accounting for uncertainty in income taxes, the Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of its provision for income taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">These assessments can require considerable estimates and judgments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the Company's estimate of income tax liabilities proves to be less than the ultimate assessment, then a further charge to expense would be required.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If events occur and the payment of these amounts ultimately proves to be unnecessary, the reversal of the liabilities would result in tax benefits being recognized in the period when the Company determines the liabilities are no longer necessary.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">U.S. Tax Cuts and Jobs Act, Enacted December 22, 2017</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On December 22, 2017, the United States enacted tax legislation commonly known as the Tax Cuts and Jobs Act (“the Tax Act”), which significantly changed the existing U.S. tax laws, including, but not limited to, (1) a reduction in the corporate tax rate from 35% to 21%, (2) a move from a worldwide tax system toward a territorial system through a “participation exemption” deduction for certain foreign-source dividends, (3) eliminating the corporate alternative minimum tax (AMT) and changing how existing AMT credits can be realized, (4) bonus depreciation that allows for full expensing of qualified property, </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(5) creating a new limitation on deductible interest expense and (6) changing rules related to uses and limitations of net operating loss carryforwards created in tax years beginning after December 31, 2017.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is not currently subject to the Base Erosion and Anti-Abuse (BEAT) tax, which is a tax imposed on certain entities who make payments to their non U.S. affiliates, where such payments reduce the U.S. tax base.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The BEAT tax is imposed at a rate of 10% on Adjusted Taxable Income, excluding certain payments to foreign related entities. It is an incremental tax over and above the corporate income tax and is recorded as a period cost.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible that this tax could be applicable in future periods, which would cause an increase to the effective tax rate and cash taxes.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. Coronavirus Aid, Relief and Economic Security Act” (“CARES Act”), Enacted March 27, 2020</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the United States enacted the CARES Act, which made the changes to existing U.S. tax laws, including, but not limited to, (1) allowing U.S. federal net operating losses originated in the 2018, 2019 or 2020 tax years to be carried back five years to recover taxes paid based upon taxable income in the prior five years, (2) eliminated the 80% of taxable income limitation on net operating losses for the 2018, 2019 and 2020 tax years (the 80% limitation will be reinstated for tax years after 2020), (3) accelerating the refund of prior year alternative minimum tax credits, (4) modifying the bonus depreciation for qualified improvement property and (5) modifying the limitation on deductible interest expense.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the ability to carryback net operating losses from the June 2018 and June 2019 years to the June 2015 to June 2017 tax years, net operating losses which were previously tax-effected using the current 21% U.S. federal tax rate were revalued to the U.S. tax rates in effect for the June 2015 to June 2017 tax years due to the ability of receiving tax refunds for the taxes paid in these years. Accordingly, we reported a discrete tax benefit of $1.1 million in the third quarter of fiscal year 2020 related to the re-measurement of the net operating losses that could be realized via the new net operating loss carryback provisions. </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">“U.S. Consolidated Appropriations Act, 2021” (“CAA 2021”), Enacted December 27, 2020</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 27, 2020, the United States enacted the Consolidated Appropriations Act, 2021, which made changes to existing U.S. tax laws. There was no material impact of the tax law changes included in the Consolidated Appropriations Act, 2021 to the Company. </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">“The American Rescue Plan Act of, 2021”, Enacted March 11, 2021</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11, 2021, the United States enacted the American Rescue Plan Act of 2021, which made changes to existing U.S. tax laws. There was no material impact of the tax law changes included in the American Rescue Plan Act of 2021 to the Company. </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">“The Chip and Science Act of 2022”, Enacted August 2, 2022</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022 the U.S. enacted the Chip and Science Act of 2022 (the Chips Act).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Chips Act provides incentives to semiconductor chip manufacturers in the United States, including providing a 25% manufacturing investment credits for investments in semiconductor manufacturing property placed in service after December 31, 2022, for which construction begins before January 1, 2027.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property investments qualify for the 25% credit if, among other requirements, the property is integral to the operation of an advanced manufacturing facility, defined as having a primary purpose of manufacturing semiconductors or semiconductor manufacturing equipment. Currently, we are evaluating the impact of the Chips Act to us.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Altera Litigation</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 27, 2015, in Altera Corp. v. Commissioner, the U.S. Tax Court issued an opinion related to the treatment of stock-based compensation expense in an intercompany cost-sharing arrangement. In the July 2015 ruling, the Tax Court concluded that the sharing of the cost of employee stock compensation in a company’s cost-sharing arrangement was invalid under the U.S. Administrative Procedures Act. In June 2019, a panel of the Ninth Circuit of the U.S. Court of Appeals reversed this decision. In July 2019, Altera petitioned U.S. Court of Appeals for the Ninth Circuit to hold an en banc rehearing of the case. The petition was subsequently denied by the Ninth Circuit. Altera appealed the case to the U.S. Supreme Court in February 2020, but the U.S. Supreme Court declined to hear the case in June 2020, leaving intact the U.S. Court of Appeals for the Ninth Circuit’s decision. AOS has not recorded any benefit related to the Altera Corporation Tax Court decision in any period through June 2022. The Company will continue to monitor ongoing developments and potential impact to its financial statements.</span></div> The provision for income taxes is comprised of:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.304%"><tr><td style="width:1.0%"/><td style="width:54.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.308%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.37pt;padding-right:12.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30, </span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 7.75pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal taxes:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">645 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,673)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,260 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,955 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,749 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,344 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,940 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,599 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(396)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State taxes, net of federal benefit:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,258 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,935 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 645000 31000 -1673000 2260000 1955000 22000 7749000 2344000 1940000 28599000 -396000 58000 5000 1000 1000 39258000 3935000 348000 <div style="margin-top:13.5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of the federal statutory income tax rate to our effective income tax rate is as follows (in percentage):</span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.304%"><tr><td style="width:1.0%"/><td style="width:54.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.308%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside basis difference on equity method investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Tax Act deferred tax re-measurement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Derived Intangible Income Deduction</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 0.210 0.210 0.210 -0.000 -0.001 0 -0.143 -0.144 -0.361 0.012 0 0 0.003 0.024 -0.080 0.005 0.024 -0.010 0 0 0.062 0.003 0 0 0.001 -0.002 0 0.079 0.065 -0.019 The domestic and foreign components of income before taxes are:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.304%"><tr><td style="width:1.0%"/><td style="width:54.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.308%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,684 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,622 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,549 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478,386 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,602 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,458)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,070 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,224 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,909)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 16684000 9622000 3549000 478386000 50602000 -21458000 495070000 60224000 -17909000 Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of our deferred tax assets and liabilities are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.649%"><tr><td style="width:1.0%"/><td style="width:67.984%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.925%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.663%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.928%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,742 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,954 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,539 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,365 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,924 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,079 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,550 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,807 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,292 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,982 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals and reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,113 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,697 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,354 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,755)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,474)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets, net of valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,942 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,880 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,909)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,193)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,579)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,968)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,619)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,107)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,161)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets/(liabilities)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,165)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,719 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 5742000 3954000 61000 22539000 4365000 7924000 15079000 15550000 5807000 7292000 0 9982000 643000 1113000 31697000 68354000 5755000 41474000 25942000 26880000 18909000 17193000 5579000 6968000 29619000 0 54107000 24161000 28165000 2719000 <div style="margin-top:13.5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The breakdown between deferred tax assets and liabilities is as follows:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.649%"><tr><td style="width:1.0%"/><td style="width:67.984%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.925%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.663%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.928%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,167 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,757)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,448)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets/(liabilities)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,165)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,719 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 592000 5167000 28757000 2448000 28165000 2719000 5800000 41500000 35700000 3600000 5800000 5800000 35700000 0 8900000 900000 7800000 200000 7600000 29600000 314700000 <div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of unrecognized tax benefits from July 1, 2019 to June 30, 2022 is as follows:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"/><td style="width:58.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.865%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.865%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.868%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,645 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,126 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,150 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,121 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions due to lapse of applicable statute of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(243)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,609 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,645 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,126 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 7645000 7126000 7150000 1121000 677000 333000 40000 41000 114000 117000 117000 243000 8609000 7645000 7126000 8600000 6600000 2000000 8600000 5600000 10000.00 200000 32000 100000 5000 -1100000 Segment and Geographic Information <div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is organized as, and operates in, one operating segment: the design, development and supply of power semiconductor products for computing, consumer electronics, communication and industrial applications. The chief operating decision-maker is the Chief Executive Officer. The financial information presented to the Company's Chief Executive Officer is on a consolidated basis, accompanied by information about revenue by customer and geographic region, for purposes of evaluating financial performance and allocating resources. The Company has one business segment, and there are no segment managers who are held accountable for operations, operating results and plans for products or components below the consolidated unit level. Accordingly, the Company reports as a single operating segment.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells its products primarily to distributors in the Asia Pacific region, who in turn sell these products to end customers. Because the Company's distributors sell their products to end customers which may have a global presence, revenue by geographical location is not necessarily representative of the geographical distribution of sales to end user markets. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The revenue by geographical location in the following tables is based on the country or region in which the products were shipped to:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:14pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.473%"><tr><td style="width:1.0%"/><td style="width:56.252%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30, </span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">630,238 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537,553 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390,478 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,978 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,325 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,058 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,802 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,497 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,303 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,470 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,492 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,465 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,064 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,035 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,605 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777,552 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656,902 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464,909 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-top:14pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the fiscal year ended June 30, 2022, the Company corrected an immaterial error to reduce revenues in Hong Kong by $0.5 million, and to increase the revenues in China by $0.5 million for the fiscal year ended June 30, 2021.</span></div><div style="margin-top:13.5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following is a summary of revenue by product type:</span></div><div style="margin-top:9pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.473%"><tr><td style="width:1.0%"/><td style="width:56.252%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30, </span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Power discrete</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545,135 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482,718 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391,941 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Power IC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,882 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,726 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,360 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Packaging and testing services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,535 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,458 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,608 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777,552 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656,902 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464,909 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-top:13.5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Long-lived assets, net consisting of property, plant and equipment and land use rights, net, as well as operating lease right-of-use assets, net by geographical area are as follows:</span></div><div style="margin-top:14pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.011%"><tr><td style="width:1.0%"/><td style="width:71.491%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.189%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.190%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,326 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,387 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,731 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,756 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,283 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,494 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342,340 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471,637 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1 1 <div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The revenue by geographical location in the following tables is based on the country or region in which the products were shipped to:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:14pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.473%"><tr><td style="width:1.0%"/><td style="width:56.252%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30, </span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">630,238 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537,553 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390,478 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,978 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,325 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,058 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,802 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,497 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,303 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,470 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,492 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,465 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,064 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,035 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,605 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777,552 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656,902 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464,909 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-top:14pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the fiscal year ended June 30, 2022, the Company corrected an immaterial error to reduce revenues in Hong Kong by $0.5 million, and to increase the revenues in China by $0.5 million for the fiscal year ended June 30, 2021.</span></div><div style="margin-top:13.5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following is a summary of revenue by product type:</span></div><div style="margin-top:9pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.473%"><tr><td style="width:1.0%"/><td style="width:56.252%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended June 30, </span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Power discrete</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545,135 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482,718 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391,941 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Power IC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,882 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,726 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,360 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Packaging and testing services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,535 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,458 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,608 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777,552 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656,902 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464,909 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-top:13.5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Long-lived assets, net consisting of property, plant and equipment and land use rights, net, as well as operating lease right-of-use assets, net by geographical area are as follows:</span></div><div style="margin-top:14pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.011%"><tr><td style="width:1.0%"/><td style="width:71.491%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.189%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.190%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,326 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,387 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,731 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,756 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,283 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,494 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342,340 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471,637 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 630238000 537553000 390478000 120978000 107325000 64058000 11802000 5497000 3303000 12470000 5492000 4465000 2064000 1035000 2605000 777552000 656902000 464909000 545135000 482718000 391941000 220882000 161726000 66360000 11535000 12458000 6608000 777552000 656902000 464909000 105326000 350387000 232731000 118756000 4283000 2494000 342340000 471637000 Restricted Net Assets Laws and regulations in China permit payments of dividends by the Company's subsidiaries in China only out of their retained earnings, if any, as determined in accordance with China accounting standards and regulations. Each China subsidiary is also required to set aside at least 10% of its after-tax profit, if any, based on China accounting standards each year to its statutory reserves until the cumulative amount of such reserves reaches 50% of its registered capital. As a result of these China laws and regulations, the Company's China subsidiaries are restricted in their abilities to transfer a portion of their net assets to the Company. As of June 30, 2022 and 2021, such restricted portion amounted to approximately $92.4 million and $209.9 million, or 10.8% and 50.4%, of our total consolidated net assets attributable to the Company, respectively. As the Company's China subsidiaries are not revenue generating operating units, the Company does not expect to repatriate funds in the form of dividends, loans or advances from its China subsidiaries for working capital and other funding purposes. 0.10 0.50 92400000 209900000 0.108 0.504 Commitments and Contingencies<div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase commitments</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022 and 2021, the Company had approximately $89.9 million and $81.8 million, respectively, of outstanding purchase commitments primarily for purchases of semiconductor raw materials, wafers, spare parts, packaging and testing services and others.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022 and 2021, the Company had approximately $63.4 million, and $90.0 million, respectively, of commitments for the purchase of property and equipment.</span></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other commitments</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes 1, 7 and 8 to the Consolidated Financial Statements contained in this annual Report on Form 10-K for descriptions of commitments including Joint Venture, debt and leases.</span></div><div style="margin-top:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies and indemnities</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has in the past, and may from time to time in the future, become involved in legal proceedings arising from the normal course of business activities.  The semiconductor industry is characterized by frequent claims and litigation, including claims regarding patent and other intellectual property rights as well as improper hiring practices. Irrespective of the validity of such claims, the Company could incur significant costs in the defense of such claims and suffer adverse effects on its operations.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As previously disclosed, U.S. Department of Justice (“DOJ”) commenced an investigation into the Company’s compliance with export control regulations relating to its business transactions with Huawei and its affiliates (“Huawei”), which were added to the “Entity List” by the Department of Commerce (“DOC”) in May 2019. The Company is cooperating fully with federal authorities in the investigation. The Company has continued to respond to inquiries and requests from DOJ for documents and information relating to the investigation, and the matter is currently pending at DOJ, and DOJ has not provided the Company with any specific timeline or indication as to when the investigation will be concluded or resolved. In connection with this investigation, DOC previously requested the Company to suspend shipments of its products to Huawei. The Company complied with such request, and the Company has not shipped any product to Huawei after December 31, 2019. The Company continues to work with DOC to resolve this issue and requested DOC to grant permission to reinstate the Company’s shipments to Huawei. As part of this process and in response to DOC’s request, the Company provided certain documents and materials relating to the Company’s supply chain and shipment process to DOC, and DOC is currently reviewing this matter. DOC has not informed the Company of any specific timeline or schedule under which DOC will provide a response to the Company’s request. Given the case is in still ongoing and neither DOJ nor DOC have provided the Company with any clear indication of the timing and schedule for the investigation, the Company cannot estimate the reasonably possible loss or range of loss that may occur. Also, the Company is unable to predict the duration, scope, result or related costs of the investigation, although the Company expects to incur additional professional fees as a result of this matter. In addition, the Company is unable to predict what, if any, further action that may be taken by the government in connection with the investigation, or what, if any, penalties, sanctions or remedial actions may be sought.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is a party to a variety of agreements that it has contracted with various third parties. Pursuant to these agreements, the Company may be obligated to indemnify another party to such an agreement with respect to certain matters. Typically, these obligations arise in the context of contracts entered into by the Company, under which the Company customarily agrees to hold the other party harmless against losses arising from a breach of representations and covenants related to such matters as title to assets sold, certain intellectual property rights, specified environmental matters and certain income taxes. In these circumstances, payment by the Company is customarily conditioned on the other party making a claim pursuant </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">to the procedures specified in the particular contract, which procedures typically allow the Company to challenge the other party's claim. Further, the Company's obligations under these agreements may be limited in time and/or amount, and in some instances, the Company may have recourse against third parties for certain payments made by it under these agreements. The Company has not historically paid or recorded any material indemnifications, and no accrual was made at June 30, 2022 and 2021.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has agreed to indemnify its directors and certain employees as permitted by law and pursuant to its Bye-laws, and has entered into indemnification agreements with its directors and executive officers. The Company has not recorded a liability associated with these indemnification arrangements, as it historically has not incurred any material costs associated with such indemnification obligations. Costs associated with such indemnification obligations may be mitigated by insurance coverage that the Company maintains. However, such insurance may not cover any, or may cover only a portion of, the amounts the Company may be required to pay. In addition, the Company may not be able to maintain such insurance coverage at reasonable cost, if at all, in the future.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Environmental matters</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to various federal, state, local, and foreign laws and regulations governing environmental</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">matters, including the use, handling, discharge, and disposal of hazardous materials. The Company believes that it has been in material compliance with applicable environmental regulations and standards. Complying with current laws and regulations has not had a material adverse effect on the Company’s financial condition and results of operations. However, it is possible that additional environmental issues may arise in the future, which the Company cannot currently predict.</span></div> 89900000 81800000 63400000 90000000 0 0 Cybersecurity Incident In April 2022, the Company became aware of a cybersecurity incident involving unauthorized access to one email account at the Company, which caused the Company to make payments to unauthorized bank accounts. As a result, the Company recorded a loss of $1.5 million due to the incident for the three months ended March 31, 2022. The financial impact of this incident was not material, and there were no changes to previously released financial results or financial statements. Immediately following the discovery, the Company commenced an investigation, contained the incident and implemented additional protective measures and internal control policies and procedures. The Company has also retained a professional cybersecurity investigation firm to conduct a full forensic analysis of the incident, and concluded that there were no evidence of malware, persistence mechanisms or other compromised exchange on-premises accounts within the Company's environment. In addition, there was no evidence to suggest that these accounts were accessed via the user agent that has the capability to synchronize or download email messages to the user’s local host. This incident appears to be isolated and its financial impact identified to date was not material. The Company believes that it had not incurred other damages and losses based on the conclusion of the full investigation. 1500000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:60.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.219%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> Allowance</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">for Doubtful</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">for Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> for Deferred</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax Assets</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,075 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,420 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,413 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,407 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134,396)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,092 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,827 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,902 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,647 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(196,579)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,415 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,474 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,651 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164,335)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,719)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,731 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,755 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 30000 24075000 35420000 0 140413000 2407000 0 134396000 0 30000 30092000 37827000 0 178902000 3647000 0 196579000 0 30000 12415000 41474000 0 170651000 0 0 164335000 35719000 30000 18731000 5755000 EXCEL 113 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 115 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 116 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 328 529 1 false 112 0 false 9 false false R1.htm 0001001 - Document - Cover Sheet http://www.aosmd.com/role/Cover Cover Cover 1 false false R2.htm 0002002 - Document - Audit Information Sheet http://www.aosmd.com/role/AuditInformation Audit Information Cover 2 false false R3.htm 1001003 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS CONSOLIDATED BALANCE SHEETS Statements 3 false false R4.htm 1002004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETSParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 4 false false R5.htm 1003005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS CONSOLIDATED STATEMENTS OF OPERATIONS Statements 5 false false R6.htm 1004006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) Sheet http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) Statements 6 false false R7.htm 1005007 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Sheet http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Statements 7 false false R8.htm 1006008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 8 false false R9.htm 2101101 - Disclosure - The Company and Significant Accounting Policies Sheet http://www.aosmd.com/role/TheCompanyandSignificantAccountingPolicies The Company and Significant Accounting Policies Notes 9 false false R10.htm 2114102 - Disclosure - Equity Method Investment in Equity Investee Sheet http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvestee Equity Method Investment in Equity Investee Notes 10 false false R11.htm 2119103 - Disclosure - Related Party Transactions Sheet http://www.aosmd.com/role/RelatedPartyTransactions Related Party Transactions Notes 11 false false R12.htm 2121104 - Disclosure - Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited Sheet http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimited Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited Notes 12 false false R13.htm 2125105 - Disclosure - Concentration of Credit Risk and Significant Customers Sheet http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomers Concentration of Credit Risk and Significant Customers Notes 13 false false R14.htm 2128106 - Disclosure - Balance Sheet Components Sheet http://www.aosmd.com/role/BalanceSheetComponents Balance Sheet Components Notes 14 false false R15.htm 2143107 - Disclosure - Debt Sheet http://www.aosmd.com/role/Debt Debt Notes 15 false false R16.htm 2150108 - Disclosure - Leases Sheet http://www.aosmd.com/role/Leases Leases Notes 16 false false R17.htm 2157109 - Disclosure - Shareholders' Equity Sheet http://www.aosmd.com/role/ShareholdersEquity Shareholders' Equity Notes 17 false false R18.htm 2159110 - Disclosure - Share-based Compensation Sheet http://www.aosmd.com/role/SharebasedCompensation Share-based Compensation Notes 18 false false R19.htm 2167111 - Disclosure - Employee Benefit Plans Sheet http://www.aosmd.com/role/EmployeeBenefitPlans Employee Benefit Plans Notes 19 false false R20.htm 2169112 - Disclosure - Income Taxes Sheet http://www.aosmd.com/role/IncomeTaxes Income Taxes Notes 20 false false R21.htm 2173113 - Disclosure - Segment and Geographic information Sheet http://www.aosmd.com/role/SegmentandGeographicinformation Segment and Geographic information Notes 21 false false R22.htm 2179114 - Disclosure - Restricted Net Assets Sheet http://www.aosmd.com/role/RestrictedNetAssets Restricted Net Assets Notes 22 false false R23.htm 2181115 - Disclosure - Commitments and Contingencies Sheet http://www.aosmd.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 23 false false R24.htm 2184116 - Disclosure - Cybersecutiy Incident Sheet http://www.aosmd.com/role/CybersecutiyIncident Cybersecutiy Incident Notes 24 false false R25.htm 2186117 - Disclosure - Schedule II - Valuation and Qualifying Accounts Sheet http://www.aosmd.com/role/ScheduleIIValuationandQualifyingAccounts Schedule II - Valuation and Qualifying Accounts Notes 25 false false R26.htm 2202201 - Disclosure - The Company and Significant Accounting Policies (Policies) Sheet http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPolicies The Company and Significant Accounting Policies (Policies) Policies http://www.aosmd.com/role/TheCompanyandSignificantAccountingPolicies 26 false false R27.htm 2303301 - Disclosure - The Company and Significant Accounting Policies (Tables) Sheet http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesTables The Company and Significant Accounting Policies (Tables) Tables http://www.aosmd.com/role/TheCompanyandSignificantAccountingPolicies 27 false false R28.htm 2315302 - Disclosure - Equity Method Investment in Equity Investee (Tables) Sheet http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeTables Equity Method Investment in Equity Investee (Tables) Tables http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvestee 28 false false R29.htm 2322303 - Disclosure - Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited (Tables) Sheet http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedTables Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited (Tables) Tables http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimited 29 false false R30.htm 2326304 - Disclosure - Concentration of Credit Risk and Significant Customers (Tables) Sheet http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomersTables Concentration of Credit Risk and Significant Customers (Tables) Tables http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomers 30 false false R31.htm 2329305 - Disclosure - Balance Sheet Components (Tables) Sheet http://www.aosmd.com/role/BalanceSheetComponentsTables Balance Sheet Components (Tables) Tables http://www.aosmd.com/role/BalanceSheetComponents 31 false false R32.htm 2344306 - Disclosure - Debt (Tables) Sheet http://www.aosmd.com/role/DebtTables Debt (Tables) Tables http://www.aosmd.com/role/Debt 32 false false R33.htm 2351307 - Disclosure - Leases (Tables) Sheet http://www.aosmd.com/role/LeasesTables Leases (Tables) Tables http://www.aosmd.com/role/Leases 33 false false R34.htm 2360308 - Disclosure - Share-based Compensation (Tables) Sheet http://www.aosmd.com/role/SharebasedCompensationTables Share-based Compensation (Tables) Tables http://www.aosmd.com/role/SharebasedCompensation 34 false false R35.htm 2370309 - Disclosure - Income Taxes (Tables) Sheet http://www.aosmd.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.aosmd.com/role/IncomeTaxes 35 false false R36.htm 2374310 - Disclosure - Segment and Geographic information (Tables) Sheet http://www.aosmd.com/role/SegmentandGeographicinformationTables Segment and Geographic information (Tables) Tables http://www.aosmd.com/role/SegmentandGeographicinformation 36 false false R37.htm 2404401 - Disclosure - The Company and Significant Accounting Policies - Basis of Presentation Narrative (Details) Sheet http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesBasisofPresentationNarrativeDetails The Company and Significant Accounting Policies - Basis of Presentation Narrative (Details) Details 37 false false R38.htm 2405402 - Disclosure - The Company and Significant Accounting Policies - Risks and Uncertainties Narrative (Details) Sheet http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesRisksandUncertaintiesNarrativeDetails The Company and Significant Accounting Policies - Risks and Uncertainties Narrative (Details) Details 38 false false R39.htm 2406403 - Disclosure - The Company and Significant Accounting Policies - Joint Venture Narrative (Details) Sheet http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesJointVentureNarrativeDetails The Company and Significant Accounting Policies - Joint Venture Narrative (Details) Details 39 false false R40.htm 2407404 - Disclosure - The Company and Significant Accounting Policies - Restricted Cash Narrative (Details) Sheet http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesRestrictedCashNarrativeDetails The Company and Significant Accounting Policies - Restricted Cash Narrative (Details) Details 40 false false R41.htm 2408405 - Disclosure - The Company and Significant Accounting Policies - Property and Equipment Useful Lives (Details) Sheet http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails The Company and Significant Accounting Policies - Property and Equipment Useful Lives (Details) Details 41 false false R42.htm 2409406 - Disclosure - The Company and Significant Accounting Policies - Government Grants (Details) Sheet http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesGovernmentGrantsDetails The Company and Significant Accounting Policies - Government Grants (Details) Details 42 false false R43.htm 2410407 - Disclosure - The Company and Significant Accounting Policies - Government Grants Narrative (Details) Sheet http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesGovernmentGrantsNarrativeDetails The Company and Significant Accounting Policies - Government Grants Narrative (Details) Details 43 false false R44.htm 2411408 - Disclosure - The Company and Significant Accounting Policies - Long-lived Assets Narrative (Details) Sheet http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesLonglivedAssetsNarrativeDetails The Company and Significant Accounting Policies - Long-lived Assets Narrative (Details) Details 44 false false R45.htm 2412409 - Disclosure - The Company and Significant Accounting Policies - Product Warranty Narrative (Details) Sheet http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesProductWarrantyNarrativeDetails The Company and Significant Accounting Policies - Product Warranty Narrative (Details) Details 45 false false R46.htm 2413410 - Disclosure - The Company and Significant Accounting Policies - Advertising Expense Narrative (Details) Sheet http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesAdvertisingExpenseNarrativeDetails The Company and Significant Accounting Policies - Advertising Expense Narrative (Details) Details 46 false false R47.htm 2416411 - Disclosure - Equity Method Investment in Equity Investee - Narrative (Details) Sheet http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeNarrativeDetails Equity Method Investment in Equity Investee - Narrative (Details) Details 47 false false R48.htm 2417412 - Disclosure - Equity Method Investment in Equity Investee - Schedule of Gain on Deconsolidation (Details) Sheet http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeScheduleofGainonDeconsolidationDetails Equity Method Investment in Equity Investee - Schedule of Gain on Deconsolidation (Details) Details 48 false false R49.htm 2418413 - Disclosure - Equity Method Investment in Equity Investee - Equity Method Investment, Summarized Financial Information (Details) Sheet http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeEquityMethodInvestmentSummarizedFinancialInformationDetails Equity Method Investment in Equity Investee - Equity Method Investment, Summarized Financial Information (Details) Details 49 false false R50.htm 2420414 - Disclosure - Related Party Transactions (Details) Sheet http://www.aosmd.com/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://www.aosmd.com/role/RelatedPartyTransactions 50 false false R51.htm 2423415 - Disclosure - Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited - Basic and Diluted Income Per Share (Details) Sheet http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedBasicandDilutedIncomePerShareDetails Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited - Basic and Diluted Income Per Share (Details) Details http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedTables 51 false false R52.htm 2424416 - Disclosure - Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited - Potential Dilutive Shares (Details) Sheet http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedPotentialDilutiveSharesDetails Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited - Potential Dilutive Shares (Details) Details http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedTables 52 false false R53.htm 2427417 - Disclosure - Concentration of Credit Risk and Significant Customers - Schedule of Concentration Risk (Details) Sheet http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomersScheduleofConcentrationRiskDetails Concentration of Credit Risk and Significant Customers - Schedule of Concentration Risk (Details) Details 53 false false R54.htm 2430418 - Disclosure - Balance Sheet Components - Accounts receivable (Details) Sheet http://www.aosmd.com/role/BalanceSheetComponentsAccountsreceivableDetails Balance Sheet Components - Accounts receivable (Details) Details 54 false false R55.htm 2431419 - Disclosure - Balance Sheet Components - Inventories (Details) Sheet http://www.aosmd.com/role/BalanceSheetComponentsInventoriesDetails Balance Sheet Components - Inventories (Details) Details 55 false false R56.htm 2432420 - Disclosure - Balance Sheet Components - Other Current Assets (Details) Sheet http://www.aosmd.com/role/BalanceSheetComponentsOtherCurrentAssetsDetails Balance Sheet Components - Other Current Assets (Details) Details 56 false false R57.htm 2433421 - Disclosure - Balance Sheet Components - Property, plant, and equipment (Details) Sheet http://www.aosmd.com/role/BalanceSheetComponentsPropertyplantandequipmentDetails Balance Sheet Components - Property, plant, and equipment (Details) Details 57 false false R58.htm 2434422 - Disclosure - Balance Sheet Components - Goodwill (Details) Sheet http://www.aosmd.com/role/BalanceSheetComponentsGoodwillDetails Balance Sheet Components - Goodwill (Details) Details 58 false false R59.htm 2435423 - Disclosure - Balance Sheet Components - Other long term assets (Details) Sheet http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermassetsDetails Balance Sheet Components - Other long term assets (Details) Details 59 false false R60.htm 2436424 - Disclosure - Balance Sheet Components - Future amortization expense of intangible assets (Details) Sheet http://www.aosmd.com/role/BalanceSheetComponentsFutureamortizationexpenseofintangibleassetsDetails Balance Sheet Components - Future amortization expense of intangible assets (Details) Details 60 false false R61.htm 2437425 - Disclosure - Balance Sheet Components - Intangible assets (Details) Sheet http://www.aosmd.com/role/BalanceSheetComponentsIntangibleassetsDetails Balance Sheet Components - Intangible assets (Details) Details 61 false false R62.htm 2438426 - Disclosure - Balance Sheet Components - Accrued liabilities (Details) Sheet http://www.aosmd.com/role/BalanceSheetComponentsAccruedliabilitiesDetails Balance Sheet Components - Accrued liabilities (Details) Details 62 false false R63.htm 2439427 - Disclosure - Balance Sheet Components - Product Warranty Accrual (Details) Sheet http://www.aosmd.com/role/BalanceSheetComponentsProductWarrantyAccrualDetails Balance Sheet Components - Product Warranty Accrual (Details) Details 63 false false R64.htm 2440428 - Disclosure - Balance Sheet Components - Stock Rotation Accrual (Details) Sheet http://www.aosmd.com/role/BalanceSheetComponentsStockRotationAccrualDetails Balance Sheet Components - Stock Rotation Accrual (Details) Details 64 false false R65.htm 2441429 - Disclosure - Balance Sheet Components - Impairment of long-lived assets, intangible assets, and goodwill (Details) Sheet http://www.aosmd.com/role/BalanceSheetComponentsImpairmentoflonglivedassetsintangibleassetsandgoodwillDetails Balance Sheet Components - Impairment of long-lived assets, intangible assets, and goodwill (Details) Details 65 false false R66.htm 2442430 - Disclosure - Balance Sheet Components - Other long-term liabilities (Details) Sheet http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermliabilitiesDetails Balance Sheet Components - Other long-term liabilities (Details) Details 66 false false R67.htm 2445431 - Disclosure - Debt - Short-term borrowing (Details) Sheet http://www.aosmd.com/role/DebtShorttermborrowingDetails Debt - Short-term borrowing (Details) Details 67 false false R68.htm 2446432 - Disclosure - Debt - Accounts Receivable Factoring Agreement (Details) Sheet http://www.aosmd.com/role/DebtAccountsReceivableFactoringAgreementDetails Debt - Accounts Receivable Factoring Agreement (Details) Details 68 false false R69.htm 2447433 - Disclosure - Debt - Debt Financing (Details) Sheet http://www.aosmd.com/role/DebtDebtFinancingDetails Debt - Debt Financing (Details) Details 69 false false R70.htm 2448434 - Disclosure - Debt - Credit Facilities and Long-term Debt Narrative (Details) Sheet http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails Debt - Credit Facilities and Long-term Debt Narrative (Details) Details 70 false false R71.htm 2449435 - Disclosure - Debt - Maturities of Short-tem and Long-term Debt (Details) Sheet http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails Debt - Maturities of Short-tem and Long-term Debt (Details) Details 71 false false R72.htm 2452436 - Disclosure - Leases - Narrative (Details) Sheet http://www.aosmd.com/role/LeasesNarrativeDetails Leases - Narrative (Details) Details 72 false false R73.htm 2453437 - Disclosure - Leases - Schedule of Lease Cost (Details) Sheet http://www.aosmd.com/role/LeasesScheduleofLeaseCostDetails Leases - Schedule of Lease Cost (Details) Details 73 false false R74.htm 2454438 - Disclosure - Leases - Schedule of Lease Supplemental Balance Sheet Information (Details) Sheet http://www.aosmd.com/role/LeasesScheduleofLeaseSupplementalBalanceSheetInformationDetails Leases - Schedule of Lease Supplemental Balance Sheet Information (Details) Details 74 false false R75.htm 2455439 - Disclosure - Leases - Schedule of Lease Supplemental Cash Flow Information (Details) Sheet http://www.aosmd.com/role/LeasesScheduleofLeaseSupplementalCashFlowInformationDetails Leases - Schedule of Lease Supplemental Cash Flow Information (Details) Details 75 false false R76.htm 2456440 - Disclosure - Leases - Schedule of Lease Maturities - Topic 842 (Details) Sheet http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details Leases - Schedule of Lease Maturities - Topic 842 (Details) Details 76 false false R77.htm 2458441 - Disclosure - Shareholders' Equity (Details) Sheet http://www.aosmd.com/role/ShareholdersEquityDetails Shareholders' Equity (Details) Details http://www.aosmd.com/role/ShareholdersEquity 77 false false R78.htm 2461442 - Disclosure - Share-based Compensation - Narrative (Details) Sheet http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails Share-based Compensation - Narrative (Details) Details 78 false false R79.htm 2462443 - Disclosure - Share-based Compensation - Restricted Stock and Performance-based Restrcited Stock Activity (Details) Sheet http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails Share-based Compensation - Restricted Stock and Performance-based Restrcited Stock Activity (Details) Details 79 false false R80.htm 2463444 - Disclosure - Share-based Compensation - Summary of Stock Option Activities (Details) Sheet http://www.aosmd.com/role/SharebasedCompensationSummaryofStockOptionActivitiesDetails Share-based Compensation - Summary of Stock Option Activities (Details) Details 80 false false R81.htm 2464445 - Disclosure - Share-based Compensation - Fair Value Weighted Average Assumptions (Details) Sheet http://www.aosmd.com/role/SharebasedCompensationFairValueWeightedAverageAssumptionsDetails Share-based Compensation - Fair Value Weighted Average Assumptions (Details) Details 81 false false R82.htm 2465446 - Disclosure - Share-based Compensation - Employee Share Purchase Plan (Details) Sheet http://www.aosmd.com/role/SharebasedCompensationEmployeeSharePurchasePlanDetails Share-based Compensation - Employee Share Purchase Plan (Details) Details 82 false false R83.htm 2466447 - Disclosure - Share-based Compensation - Share-based Compensation Expenses (Details) Sheet http://www.aosmd.com/role/SharebasedCompensationSharebasedCompensationExpensesDetails Share-based Compensation - Share-based Compensation Expenses (Details) Details 83 false false R84.htm 2468448 - Disclosure - Employee Benefit Plans (Details) Sheet http://www.aosmd.com/role/EmployeeBenefitPlansDetails Employee Benefit Plans (Details) Details http://www.aosmd.com/role/EmployeeBenefitPlans 84 false false R85.htm 2471449 - Disclosure - Income Taxes - Narrative (Details) Sheet http://www.aosmd.com/role/IncomeTaxesNarrativeDetails Income Taxes - Narrative (Details) Details 85 false false R86.htm 2472450 - Disclosure - Income Taxes - Income Tax Schedules (Details) Sheet http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails Income Taxes - Income Tax Schedules (Details) Details 86 false false R87.htm 2475451 - Disclosure - Segment and Geographic information Segment Narrative (Details) Sheet http://www.aosmd.com/role/SegmentandGeographicinformationSegmentNarrativeDetails Segment and Geographic information Segment Narrative (Details) Details 87 false false R88.htm 2476452 - Disclosure - Segment and Geographic information - Revenue by Geographical Segment (Details) Sheet http://www.aosmd.com/role/SegmentandGeographicinformationRevenuebyGeographicalSegmentDetails Segment and Geographic information - Revenue by Geographical Segment (Details) Details 88 false false R89.htm 2477453 - Disclosure - Segment and Geographic information - Revenue by Product Type (Details) Sheet http://www.aosmd.com/role/SegmentandGeographicinformationRevenuebyProductTypeDetails Segment and Geographic information - Revenue by Product Type (Details) Details 89 false false R90.htm 2478454 - Disclosure - Segment and Geographic information Location and Net Book Value of Long-Lived Assets (Details) Sheet http://www.aosmd.com/role/SegmentandGeographicinformationLocationandNetBookValueofLongLivedAssetsDetails Segment and Geographic information Location and Net Book Value of Long-Lived Assets (Details) Details 90 false false R91.htm 2480455 - Disclosure - Restricted Net Assets (Details) Sheet http://www.aosmd.com/role/RestrictedNetAssetsDetails Restricted Net Assets (Details) Details http://www.aosmd.com/role/RestrictedNetAssets 91 false false R92.htm 2482456 - Disclosure - Commitments and Contingencies - Purchase Commitments (Details) Sheet http://www.aosmd.com/role/CommitmentsandContingenciesPurchaseCommitmentsDetails Commitments and Contingencies - Purchase Commitments (Details) Details 92 false false R93.htm 2483457 - Disclosure - Commitments and Contingencies - Contingencies and Indemnities (Details) Sheet http://www.aosmd.com/role/CommitmentsandContingenciesContingenciesandIndemnitiesDetails Commitments and Contingencies - Contingencies and Indemnities (Details) Details 93 false false R94.htm 2485458 - Disclosure - Cybersecutiy Incident (Details) Sheet http://www.aosmd.com/role/CybersecutiyIncidentDetails Cybersecutiy Incident (Details) Details http://www.aosmd.com/role/CybersecutiyIncident 94 false false R95.htm 2487459 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details) Sheet http://www.aosmd.com/role/ScheduleIIValuationandQualifyingAccountsDetails Schedule II - Valuation and Qualifying Accounts (Details) Details http://www.aosmd.com/role/ScheduleIIValuationandQualifyingAccounts 95 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:FiniteLivedIntangibleAssetUsefulLife - aosl-20220630.htm 4 aosl-20220630.htm aosl-20220630.xsd aosl-20220630_cal.xml aosl-20220630_def.xml aosl-20220630_lab.xml aosl-20220630_pre.xml aoslex211fy2022listofsubsi.htm aoslex231fy2022bdoconsent.htm aoslex311fy202210k.htm aoslex312fy202210k.htm aoslex321fy202210k.htm aoslex322fy202210k.htm ex1054fy2022aoslshareholde.htm ex991fy2022cqreportofindep.htm aosl-20220630_g1.jpg aosl-20220630_g2.jpg http://fasb.org/srt/2022 http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 119 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "aosl-20220630.htm": { "axisCustom": 0, "axisStandard": 38, "contextCount": 328, "dts": { "calculationLink": { "local": [ "aosl-20220630_cal.xml" ] }, "definitionLink": { "local": [ "aosl-20220630_def.xml" ] }, "inline": { "local": [ "aosl-20220630.htm" ] }, "labelLink": { "local": [ "aosl-20220630_lab.xml" ] }, "presentationLink": { "local": [ "aosl-20220630_pre.xml" ] }, "schema": { "local": [ "aosl-20220630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 836, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 3, "http://xbrl.sec.gov/dei/2022": 4, "total": 7 }, "keyCustom": 89, "keyStandard": 440, "memberCustom": 49, "memberStandard": 53, "nsprefix": "aosl", "nsuri": "http://www.aosmd.com/20220630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover", "role": "http://www.aosmd.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2114102 - Disclosure - Equity Method Investment in Equity Investee", "role": "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvestee", "shortName": "Equity Method Investment in Equity Investee", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2119103 - Disclosure - Related Party Transactions", "role": "http://www.aosmd.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2121104 - Disclosure - Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited", "role": "http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimited", "shortName": "Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2125105 - Disclosure - Concentration of Credit Risk and Significant Customers", "role": "http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomers", "shortName": "Concentration of Credit Risk and Significant Customers", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2128106 - Disclosure - Balance Sheet Components", "role": "http://www.aosmd.com/role/BalanceSheetComponents", "shortName": "Balance Sheet Components", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2143107 - Disclosure - Debt", "role": "http://www.aosmd.com/role/Debt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "us-gaap:LesseeFinanceLeasesTextBlock", "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2150108 - Disclosure - Leases", "role": "http://www.aosmd.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "us-gaap:LesseeFinanceLeasesTextBlock", "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2157109 - Disclosure - Shareholders' Equity", "role": "http://www.aosmd.com/role/ShareholdersEquity", "shortName": "Shareholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i6f4d12136fd14dc492e0904b0294cc21_D20190701-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2159110 - Disclosure - Share-based Compensation", "role": "http://www.aosmd.com/role/SharebasedCompensation", "shortName": "Share-based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i6f4d12136fd14dc492e0904b0294cc21_D20190701-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2167111 - Disclosure - Employee Benefit Plans", "role": "http://www.aosmd.com/role/EmployeeBenefitPlans", "shortName": "Employee Benefit Plans", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "dei:AuditorFirmId", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "false", "longName": "0002002 - Document - Audit Information", "role": "http://www.aosmd.com/role/AuditInformation", "shortName": "Audit Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "dei:AuditorFirmId", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2169112 - Disclosure - Income Taxes", "role": "http://www.aosmd.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2173113 - Disclosure - Segment and Geographic information", "role": "http://www.aosmd.com/role/SegmentandGeographicinformation", "shortName": "Segment and Geographic information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestrictedAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2179114 - Disclosure - Restricted Net Assets", "role": "http://www.aosmd.com/role/RestrictedNetAssets", "shortName": "Restricted Net Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestrictedAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2181115 - Disclosure - Commitments and Contingencies", "role": "http://www.aosmd.com/role/CommitmentsandContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyDisclosures", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2184116 - Disclosure - Cybersecutiy Incident", "role": "http://www.aosmd.com/role/CybersecutiyIncident", "shortName": "Cybersecutiy Incident", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyDisclosures", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2186117 - Disclosure - Schedule II - Valuation and Qualifying Accounts", "role": "http://www.aosmd.com/role/ScheduleIIValuationandQualifyingAccounts", "shortName": "Schedule II - Valuation and Qualifying Accounts", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2202201 - Disclosure - The Company and Significant Accounting Policies (Policies)", "role": "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPolicies", "shortName": "The Company and Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2303301 - Disclosure - The Company and Significant Accounting Policies (Tables)", "role": "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesTables", "shortName": "The Company and Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": null }, "R28": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2315302 - Disclosure - Equity Method Investment in Equity Investee (Tables)", "role": "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeTables", "shortName": "Equity Method Investment in Equity Investee (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2322303 - Disclosure - Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited (Tables)", "role": "http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedTables", "shortName": "Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001003 - Statement - CONSOLIDATED BALANCE SHEETS", "role": "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2326304 - Disclosure - Concentration of Credit Risk and Significant Customers (Tables)", "role": "http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomersTables", "shortName": "Concentration of Credit Risk and Significant Customers (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2329305 - Disclosure - Balance Sheet Components (Tables)", "role": "http://www.aosmd.com/role/BalanceSheetComponentsTables", "shortName": "Balance Sheet Components (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2344306 - Disclosure - Debt (Tables)", "role": "http://www.aosmd.com/role/DebtTables", "shortName": "Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2351307 - Disclosure - Leases (Tables)", "role": "http://www.aosmd.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2360308 - Disclosure - Share-based Compensation (Tables)", "role": "http://www.aosmd.com/role/SharebasedCompensationTables", "shortName": "Share-based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2370309 - Disclosure - Income Taxes (Tables)", "role": "http://www.aosmd.com/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2374310 - Disclosure - Segment and Geographic information (Tables)", "role": "http://www.aosmd.com/role/SegmentandGeographicinformationTables", "shortName": "Segment and Geographic information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CapitalExpendituresIncurredButNotYetPaid", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2404401 - Disclosure - The Company and Significant Accounting Policies - Basis of Presentation Narrative (Details)", "role": "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesBasisofPresentationNarrativeDetails", "shortName": "The Company and Significant Accounting Policies - Basis of Presentation Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R38": { "firstAnchor": { "ancestors": [ "span", "div", "aosl:RisksAndUncertaintiesPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i10864d325e484083b99d432b8d531966_D20210701-20220630", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405402 - Disclosure - The Company and Significant Accounting Policies - Risks and Uncertainties Narrative (Details)", "role": "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesRisksandUncertaintiesNarrativeDetails", "shortName": "The Company and Significant Accounting Policies - Risks and Uncertainties Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "aosl:RisksAndUncertaintiesPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i10864d325e484083b99d432b8d531966_D20210701-20220630", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i50ad7debbb114ade8339ff9289a30b2e_D20220126-20220126", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406403 - Disclosure - The Company and Significant Accounting Policies - Joint Venture Narrative (Details)", "role": "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesJointVentureNarrativeDetails", "shortName": "The Company and Significant Accounting Policies - Joint Venture Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "if94c00bc984643b09e62b45bca2a7889_D20220630-20220630", "decimals": "2", "lang": "en-US", "name": "aosl:SimpleAnnualInterestRatetoNoncontrollingInterestifJointVentureisEarlyTerminatedandLiquidated", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "role": "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RestrictedCash", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407404 - Disclosure - The Company and Significant Accounting Policies - Restricted Cash Narrative (Details)", "role": "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesRestrictedCashNarrativeDetails", "shortName": "The Company and Significant Accounting Policies - Restricted Cash Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R41": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3e5c183ff9c84b23b5ffe04c759d3df1_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408405 - Disclosure - The Company and Significant Accounting Policies - Property and Equipment Useful Lives (Details)", "role": "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails", "shortName": "The Company and Significant Accounting Policies - Property and Equipment Useful Lives (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3e5c183ff9c84b23b5ffe04c759d3df1_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "-5", "first": true, "lang": "en-US", "name": "aosl:GovernmentGrantsReductionRecordedToInterestExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409406 - Disclosure - The Company and Significant Accounting Policies - Government Grants (Details)", "role": "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesGovernmentGrantsDetails", "shortName": "The Company and Significant Accounting Policies - Government Grants (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R43": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "-5", "first": true, "lang": "en-US", "name": "aosl:GovernmentGrantsReductionRecordedToInterestExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410407 - Disclosure - The Company and Significant Accounting Policies - Government Grants Narrative (Details)", "role": "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesGovernmentGrantsNarrativeDetails", "shortName": "The Company and Significant Accounting Policies - Government Grants Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R44": { "firstAnchor": { "ancestors": [ "us-gaap:AssetImpairmentCharges", "us-gaap:AssetImpairmentCharges", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:AssetImpairmentCharges", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411408 - Disclosure - The Company and Significant Accounting Policies - Long-lived Assets Narrative (Details)", "role": "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesLonglivedAssetsNarrativeDetails", "shortName": "The Company and Significant Accounting Policies - Long-lived Assets Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:AssetImpairmentCharges", "us-gaap:AssetImpairmentCharges", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:AssetImpairmentCharges", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:StandardProductWarrantyPolicy", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "aosl:LengthOfProductWarranty", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412409 - Disclosure - The Company and Significant Accounting Policies - Product Warranty Narrative (Details)", "role": "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesProductWarrantyNarrativeDetails", "shortName": "The Company and Significant Accounting Policies - Product Warranty Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "us-gaap:StandardProductWarrantyPolicy", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "aosl:LengthOfProductWarranty", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:AdvertisingCostsPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AdvertisingExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413410 - Disclosure - The Company and Significant Accounting Policies - Advertising Expense Narrative (Details)", "role": "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesAdvertisingExpenseNarrativeDetails", "shortName": "The Company and Significant Accounting Policies - Advertising Expense Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "us-gaap:AdvertisingCostsPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AdvertisingExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i50ad7debbb114ade8339ff9289a30b2e_D20220126-20220126", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2416411 - Disclosure - Equity Method Investment in Equity Investee - Narrative (Details)", "role": "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeNarrativeDetails", "shortName": "Equity Method Investment in Equity Investee - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProceedsFromSaleOfEquityMethodInvestments", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2417412 - Disclosure - Equity Method Investment in Equity Investee - Schedule of Gain on Deconsolidation (Details)", "role": "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeScheduleofGainonDeconsolidationDetails", "shortName": "Equity Method Investment in Equity Investee - Schedule of Gain on Deconsolidation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ia4bdfd5f462a4bbbadad24b5b65f7fc2_D20211201-20211231", "decimals": "-3", "lang": "en-US", "name": "aosl:EquityMethodInvestmentFairValueOfEquityRetained", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AssetsCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2418413 - Disclosure - Equity Method Investment in Equity Investee - Equity Method Investment, Summarized Financial Information (Details)", "role": "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeEquityMethodInvestmentSummarizedFinancialInformationDetails", "shortName": "Equity Method Investment in Equity Investee - Equity Method Investment, Summarized Financial Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:EquityMethodInvestmentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i1ee0690a944844f79a148f4afdaf5cca_I20220331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AssetsCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "role": "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ResearchAndDevelopmentExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i50ad7debbb114ade8339ff9289a30b2e_D20220126-20220126", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420414 - Disclosure - Related Party Transactions (Details)", "role": "http://www.aosmd.com/role/RelatedPartyTransactionsDetails", "shortName": "Related Party Transactions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3dafd791cc3542cc863262d78a74cfba_D20211202-20220630", "decimals": "-5", "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2423415 - Disclosure - Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited - Basic and Diluted Income Per Share (Details)", "role": "http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedBasicandDilutedIncomePerShareDetails", "shortName": "Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited - Basic and Diluted Income Per Share (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2424416 - Disclosure - Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited - Potential Dilutive Shares (Details)", "role": "http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedPotentialDilutiveSharesDetails", "shortName": "Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited - Potential Dilutive Shares (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i52ee0f3f243b40179e6cb9056cfbff5a_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "aosl:ConcentrationOfCreditRiskTermsOfSalesOnCredit", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2427417 - Disclosure - Concentration of Credit Risk and Significant Customers - Schedule of Concentration Risk (Details)", "role": "http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomersScheduleofConcentrationRiskDetails", "shortName": "Concentration of Credit Risk and Significant Customers - Schedule of Concentration Risk (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i52ee0f3f243b40179e6cb9056cfbff5a_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "aosl:ConcentrationOfCreditRiskTermsOfSalesOnCredit", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccountsReceivableGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2430418 - Disclosure - Balance Sheet Components - Accounts receivable (Details)", "role": "http://www.aosmd.com/role/BalanceSheetComponentsAccountsreceivableDetails", "shortName": "Balance Sheet Components - Accounts receivable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccountsReceivableGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2431419 - Disclosure - Balance Sheet Components - Inventories (Details)", "role": "http://www.aosmd.com/role/BalanceSheetComponentsInventoriesDetails", "shortName": "Balance Sheet Components - Inventories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "aosl:LocalVATReceivable", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2432420 - Disclosure - Balance Sheet Components - Other Current Assets (Details)", "role": "http://www.aosmd.com/role/BalanceSheetComponentsOtherCurrentAssetsDetails", "shortName": "Balance Sheet Components - Other Current Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "aosl:LocalVATReceivable", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "aosl:PropertyPlantAndEquipmentExcludingEquipmentAndConstructionInProgressGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2433421 - Disclosure - Balance Sheet Components - Property, plant, and equipment (Details)", "role": "http://www.aosmd.com/role/BalanceSheetComponentsPropertyplantandequipmentDetails", "shortName": "Balance Sheet Components - Property, plant, and equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "aosl:PropertyPlantAndEquipmentExcludingEquipmentAndConstructionInProgressGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2434422 - Disclosure - Balance Sheet Components - Goodwill (Details)", "role": "http://www.aosmd.com/role/BalanceSheetComponentsGoodwillDetails", "shortName": "Balance Sheet Components - Goodwill (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R59": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "aosl:PrepaymentForPropertyAndEquipment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2435423 - Disclosure - Balance Sheet Components - Other long term assets (Details)", "role": "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermassetsDetails", "shortName": "Balance Sheet Components - Other long term assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "aosl:PrepaymentForPropertyAndEquipment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)", "role": "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2436424 - Disclosure - Balance Sheet Components - Future amortization expense of intangible assets (Details)", "role": "http://www.aosmd.com/role/BalanceSheetComponentsFutureamortizationexpenseofintangibleassetsDetails", "shortName": "Balance Sheet Components - Future amortization expense of intangible assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2437425 - Disclosure - Balance Sheet Components - Intangible assets (Details)", "role": "http://www.aosmd.com/role/BalanceSheetComponentsIntangibleassetsDetails", "shortName": "Balance Sheet Components - Intangible assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccruedSalariesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2438426 - Disclosure - Balance Sheet Components - Accrued liabilities (Details)", "role": "http://www.aosmd.com/role/BalanceSheetComponentsAccruedliabilitiesDetails", "shortName": "Balance Sheet Components - Accrued liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccruedSalariesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "iab34498f86e546edb572fcaace4f6f83_I20210630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyAccrualClassifiedCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2439427 - Disclosure - Balance Sheet Components - Product Warranty Accrual (Details)", "role": "http://www.aosmd.com/role/BalanceSheetComponentsProductWarrantyAccrualDetails", "shortName": "Balance Sheet Components - Product Warranty Accrual (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:StandardProductWarrantyAccrualWarrantiesIssued", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "iab34498f86e546edb572fcaace4f6f83_I20210630", "decimals": "-3", "first": true, "lang": "en-US", "name": "aosl:StockRotationAccrualCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2440428 - Disclosure - Balance Sheet Components - Stock Rotation Accrual (Details)", "role": "http://www.aosmd.com/role/BalanceSheetComponentsStockRotationAccrualDetails", "shortName": "Balance Sheet Components - Stock Rotation Accrual (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "-3", "lang": "en-US", "name": "aosl:StockRotationAccrualStockIssued", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2441429 - Disclosure - Balance Sheet Components - Impairment of long-lived assets, intangible assets, and goodwill (Details)", "role": "http://www.aosmd.com/role/BalanceSheetComponentsImpairmentoflonglivedassetsintangibleassetsandgoodwillDetails", "shortName": "Balance Sheet Components - Impairment of long-lived assets, intangible assets, and goodwill (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R66": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccruedPayrollTaxesCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2442430 - Disclosure - Balance Sheet Components - Other long-term liabilities (Details)", "role": "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermliabilitiesDetails", "shortName": "Balance Sheet Components - Other long-term liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccruedPayrollTaxesCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ShortTermBorrowings", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2445431 - Disclosure - Debt - Short-term borrowing (Details)", "role": "http://www.aosmd.com/role/DebtShorttermborrowingDetails", "shortName": "Debt - Short-term borrowing (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i96e7666ff2c34c5c8d3ab41861db8cb8_I20220630", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ShortTermBorrowings", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ia1ab0e96a59e4929bbe926ff718aadd8_I20190809", "decimals": "INF", "first": true, "lang": "en-US", "name": "aosl:AccountsReceivableFactoringAgreementMaximumBorrowingCapacityPercentOfNetAccountsReceivable", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2446432 - Disclosure - Debt - Accounts Receivable Factoring Agreement (Details)", "role": "http://www.aosmd.com/role/DebtAccountsReceivableFactoringAgreementDetails", "shortName": "Debt - Accounts Receivable Factoring Agreement (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ia1ab0e96a59e4929bbe926ff718aadd8_I20190809", "decimals": "INF", "first": true, "lang": "en-US", "name": "aosl:AccountsReceivableFactoringAgreementMaximumBorrowingCapacityPercentOfNetAccountsReceivable", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i040f0cfc26234644b4b092a3509eb7ba_I20210930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:SaleLeasebackTransactionHistoricalCost", "reportCount": 1, "unique": true, "unitRef": "eur", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2447433 - Disclosure - Debt - Debt Financing (Details)", "role": "http://www.aosmd.com/role/DebtDebtFinancingDetails", "shortName": "Debt - Debt Financing (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i040f0cfc26234644b4b092a3509eb7ba_I20210930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:SaleLeasebackTransactionHistoricalCost", "reportCount": 1, "unique": true, "unitRef": "eur", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ifc651d3828db486687995bef229ab4f7_I20190630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005007 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY", "role": "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY", "shortName": "CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ifc651d3828db486687995bef229ab4f7_I20190630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebt", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2448434 - Disclosure - Debt - Credit Facilities and Long-term Debt Narrative (Details)", "role": "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails", "shortName": "Debt - Credit Facilities and Long-term Debt Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i58d013e577254829be0d372a83935121_I20180501", "decimals": "-5", "lang": "en-US", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "aosl:LongTermDebtAndShortTermDebtCombinedAmountMaturityYearOne", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2449435 - Disclosure - Debt - Maturities of Short-tem and Long-term Debt (Details)", "role": "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails", "shortName": "Debt - Maturities of Short-tem and Long-term Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "aosl:LongTermDebtAndShortTermDebtCombinedAmountMaturityYearOne", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ie7694699d04c49ac9e60924c4203c8c3_I20180509", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "cny", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2452436 - Disclosure - Leases - Narrative (Details)", "role": "http://www.aosmd.com/role/LeasesNarrativeDetails", "shortName": "Leases - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ie7694699d04c49ac9e60924c4203c8c3_I20180509", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "cny", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2453437 - Disclosure - Leases - Schedule of Lease Cost (Details)", "role": "http://www.aosmd.com/role/LeasesScheduleofLeaseCostDetails", "shortName": "Leases - Schedule of Lease Cost (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2454438 - Disclosure - Leases - Schedule of Lease Supplemental Balance Sheet Information (Details)", "role": "http://www.aosmd.com/role/LeasesScheduleofLeaseSupplementalBalanceSheetInformationDetails", "shortName": "Leases - Schedule of Lease Supplemental Balance Sheet Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2455439 - Disclosure - Leases - Schedule of Lease Supplemental Cash Flow Information (Details)", "role": "http://www.aosmd.com/role/LeasesScheduleofLeaseSupplementalCashFlowInformationDetails", "shortName": "Leases - Schedule of Lease Supplemental Cash Flow Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2456440 - Disclosure - Leases - Schedule of Lease Maturities - Topic 842 (Details)", "role": "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details", "shortName": "Leases - Schedule of Lease Maturities - Topic 842 (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2458441 - Disclosure - Shareholders' Equity (Details)", "role": "http://www.aosmd.com/role/ShareholdersEquityDetails", "shortName": "Shareholders' Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "INF", "lang": "en-US", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2461442 - Disclosure - Share-based Compensation - Narrative (Details)", "role": "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails", "shortName": "Share-based Compensation - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DeferredCompensationShareBasedArrangementsLiabilityCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2462443 - Disclosure - Share-based Compensation - Restricted Stock and Performance-based Restrcited Stock Activity (Details)", "role": "http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails", "shortName": "Share-based Compensation - Restricted Stock and Performance-based Restrcited Stock Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ib01ab911816c45369df58f5405e413e3_D20210701-20220630", "decimals": "INF", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "role": "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DeferredIncomeTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "iab34498f86e546edb572fcaace4f6f83_I20210630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2463444 - Disclosure - Share-based Compensation - Summary of Stock Option Activities (Details)", "role": "http://www.aosmd.com/role/SharebasedCompensationSummaryofStockOptionActivitiesDetails", "shortName": "Share-based Compensation - Summary of Stock Option Activities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "INF", "lang": "en-US", "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i50edea39f7854e17b9abc4c527ae7506_D20210701-20220630", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2464445 - Disclosure - Share-based Compensation - Fair Value Weighted Average Assumptions (Details)", "role": "http://www.aosmd.com/role/SharebasedCompensationFairValueWeightedAverageAssumptionsDetails", "shortName": "Share-based Compensation - Fair Value Weighted Average Assumptions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i50edea39f7854e17b9abc4c527ae7506_D20210701-20220630", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i50edea39f7854e17b9abc4c527ae7506_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "aosl:DurationOfOfferingPeriodsForEmployeeSharePurchasePlan", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2465446 - Disclosure - Share-based Compensation - Employee Share Purchase Plan (Details)", "role": "http://www.aosmd.com/role/SharebasedCompensationEmployeeSharePurchasePlanDetails", "shortName": "Share-based Compensation - Employee Share Purchase Plan (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i50edea39f7854e17b9abc4c527ae7506_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "aosl:DurationOfOfferingPeriodsForEmployeeSharePurchasePlan", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2466447 - Disclosure - Share-based Compensation - Share-based Compensation Expenses (Details)", "role": "http://www.aosmd.com/role/SharebasedCompensationSharebasedCompensationExpensesDetails", "shortName": "Share-based Compensation - Share-based Compensation Expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-5", "lang": "en-US", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2468448 - Disclosure - Employee Benefit Plans (Details)", "role": "http://www.aosmd.com/role/EmployeeBenefitPlansDetails", "shortName": "Employee Benefit Plans (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsValuationAllowance", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2471449 - Disclosure - Income Taxes - Narrative (Details)", "role": "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails", "shortName": "Income Taxes - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2472450 - Disclosure - Income Taxes - Income Tax Schedules (Details)", "role": "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails", "shortName": "Income Taxes - Income Tax Schedules (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2475451 - Disclosure - Segment and Geographic information Segment Narrative (Details)", "role": "http://www.aosmd.com/role/SegmentandGeographicinformationSegmentNarrativeDetails", "shortName": "Segment and Geographic information Segment Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R88": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2476452 - Disclosure - Segment and Geographic information - Revenue by Geographical Segment (Details)", "role": "http://www.aosmd.com/role/SegmentandGeographicinformationRevenuebyGeographicalSegmentDetails", "shortName": "Segment and Geographic information - Revenue by Geographical Segment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ifb98790e1a154be7a79a1297e497d52c_D20210701-20220630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R89": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2477453 - Disclosure - Segment and Geographic information - Revenue by Product Type (Details)", "role": "http://www.aosmd.com/role/SegmentandGeographicinformationRevenuebyProductTypeDetails", "shortName": "Segment and Geographic information - Revenue by Product Type (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i5be8af4d63374632b004c43f91ab4204_D20210701-20220630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101101 - Disclosure - The Company and Significant Accounting Policies", "role": "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPolicies", "shortName": "The Company and Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "ibdb4031902394d1d8ee58ce5b53a52eb_D20210701-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R90": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "aosl:PropertyPlantEquipmentAndLandUseRights", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2478454 - Disclosure - Segment and Geographic information Location and Net Book Value of Long-Lived Assets (Details)", "role": "http://www.aosmd.com/role/SegmentandGeographicinformationLocationandNetBookValueofLongLivedAssetsDetails", "shortName": "Segment and Geographic information Location and Net Book Value of Long-Lived Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3bce5faff87d433291ac57582b7c33e2_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "aosl:PropertyPlantEquipmentAndLandUseRights", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i02180f15ea1e4506ad52a958f72c2db2_I20220630", "decimals": "-5", "first": true, "lang": "en-US", "name": "aosl:ForeignSubsidiariesRestrictedStatutoryReservesAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2480455 - Disclosure - Restricted Net Assets (Details)", "role": "http://www.aosmd.com/role/RestrictedNetAssetsDetails", "shortName": "Restricted Net Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i02180f15ea1e4506ad52a958f72c2db2_I20220630", "decimals": "-5", "first": true, "lang": "en-US", "name": "aosl:ForeignSubsidiariesRestrictedStatutoryReservesAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i1d97a98267794240a311dc97503514fc_I20220630", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2482456 - Disclosure - Commitments and Contingencies - Purchase Commitments (Details)", "role": "http://www.aosmd.com/role/CommitmentsandContingenciesPurchaseCommitmentsDetails", "shortName": "Commitments and Contingencies - Purchase Commitments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i1d97a98267794240a311dc97503514fc_I20220630", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i2775838bd7614a19811d82814bec6577_I20220630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyAccrualAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2483457 - Disclosure - Commitments and Contingencies - Contingencies and Indemnities (Details)", "role": "http://www.aosmd.com/role/CommitmentsandContingenciesContingenciesandIndemnitiesDetails", "shortName": "Commitments and Contingencies - Contingencies and Indemnities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i2775838bd7614a19811d82814bec6577_I20220630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyAccrualAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R94": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i6ec465bde6d64d8d8cf030f1c553949a_D20220101-20220331", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyLossInPeriod", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2485458 - Disclosure - Cybersecutiy Incident (Details)", "role": "http://www.aosmd.com/role/CybersecutiyIncidentDetails", "shortName": "Cybersecutiy Incident (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i6ec465bde6d64d8d8cf030f1c553949a_D20220101-20220331", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyLossInPeriod", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R95": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "iaa7180c9a3844010acddda674236fc2e_I20210630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2487459 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details)", "role": "http://www.aosmd.com/role/ScheduleIIValuationandQualifyingAccountsDetails", "shortName": "Schedule II - Valuation and Qualifying Accounts (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "aosl-20220630.htm", "contextRef": "i3830b9075d4f4de1ba8594ea9bed3a07_I20190630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } } }, "segmentCount": 112, "tag": { "aosl_AccountsReceivableFactoringAgreementAugustNinthTwoThousandNineteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounts Receivable Factoring Agreement August Ninth Two Thousand Nineteen [Member]", "label": "Accounts Receivable Factoring Agreement August Ninth Two Thousand Nineteen [Member]", "terseLabel": "Accounts Receivable Factoring Agreement August Ninth Two Thousand Nineteen" } } }, "localname": "AccountsReceivableFactoringAgreementAugustNinthTwoThousandNineteenMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtAccountsReceivableFactoringAgreementDetails" ], "xbrltype": "domainItemType" }, "aosl_AccountsReceivableFactoringAgreementBorrowedAmountOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accounts Receivable Factoring Agreement, Borrowed Amount Outstanding", "label": "Accounts Receivable Factoring Agreement, Borrowed Amount Outstanding", "terseLabel": "Accounts Receivable Factoring Agreement, borrowed amount outstanding" } } }, "localname": "AccountsReceivableFactoringAgreementBorrowedAmountOutstanding", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtAccountsReceivableFactoringAgreementDetails" ], "xbrltype": "monetaryItemType" }, "aosl_AccountsReceivableFactoringAgreementMaximumBorrowingCapacity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accounts Receivable Factoring Agreement, Maximum Borrowing Capacity", "label": "Accounts Receivable Factoring Agreement, Maximum Borrowing Capacity", "terseLabel": "Accounts Receivable Factoring Agreement, maximum borrowing capacity" } } }, "localname": "AccountsReceivableFactoringAgreementMaximumBorrowingCapacity", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtAccountsReceivableFactoringAgreementDetails" ], "xbrltype": "monetaryItemType" }, "aosl_AccountsReceivableFactoringAgreementMaximumBorrowingCapacityPercentOfNetAccountsReceivable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounts Receivable Factoring Agreement, Maximum Borrowing Capacity, Percent Of Net Accounts Receivable", "label": "Accounts Receivable Factoring Agreement, Maximum Borrowing Capacity, Percent Of Net Accounts Receivable", "terseLabel": "Accounts Receivable Factoring Agreement, maximum borrowing capacity, percent of net accounts receivable" } } }, "localname": "AccountsReceivableFactoringAgreementMaximumBorrowingCapacityPercentOfNetAccountsReceivable", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtAccountsReceivableFactoringAgreementDetails" ], "xbrltype": "percentItemType" }, "aosl_AccountsReceivableFactoringAgreementReductionOfMaximumBorrowingCapacity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accounts Receivable Factoring Agreement, Reduction Of Maximum Borrowing Capacity", "label": "Accounts Receivable Factoring Agreement, Reduction Of Maximum Borrowing Capacity", "terseLabel": "Accounts Receivable Factoring Agreement, reduction of maximum borrowing capacity" } } }, "localname": "AccountsReceivableFactoringAgreementReductionOfMaximumBorrowingCapacity", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtAccountsReceivableFactoringAgreementDetails" ], "xbrltype": "monetaryItemType" }, "aosl_AccountsReceivableFactoringAgreementRemainingBorrowingCapacity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accounts Receivable Factoring Agreement, Remaining Borrowing Capacity", "label": "Accounts Receivable Factoring Agreement, Remaining Borrowing Capacity", "terseLabel": "Accounts Receivable Factoring Agreement, remaining borrowing capacity" } } }, "localname": "AccountsReceivableFactoringAgreementRemainingBorrowingCapacity", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtAccountsReceivableFactoringAgreementDetails" ], "xbrltype": "monetaryItemType" }, "aosl_AccruedCustomerDeposit": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsAccruedliabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued Customer Deposit", "label": "Accrued Customer Deposit", "terseLabel": "Customer deposit" } } }, "localname": "AccruedCustomerDeposit", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsAccruedliabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "aosl_AccruedFacilityExpenses": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsAccruedliabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued Facility Expenses", "label": "Accrued Facility Expenses", "terseLabel": "Accrued facilities related expenses" } } }, "localname": "AccruedFacilityExpenses", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsAccruedliabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "aosl_AccruedInventory": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsAccruedliabilitiesDetails": { "order": 10.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued Inventory", "label": "Accrued Inventory", "terseLabel": "Accrued inventory" } } }, "localname": "AccruedInventory", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsAccruedliabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "aosl_AccruedPropertyPlantandEquipment": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsAccruedliabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued Property, Plant and Equipment", "label": "Accrued Property, Plant and Equipment", "terseLabel": "Accrued property, plant and equipment" } } }, "localname": "AccruedPropertyPlantandEquipment", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsAccruedliabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "aosl_AllowanceForPriceAdjustmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Allowance for Price Adjustments [Member]", "label": "Allowance for Price Adjustments [Member]", "terseLabel": "Allowance for Price Adjustments" } } }, "localname": "AllowanceForPriceAdjustmentsMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "aosl_AllowanceForPriceAdjustmentsReceivableCurrent": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsAccountsreceivableDetails": { "order": 2.0, "parentTag": "us-gaap_AccountsReceivableNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Allowance for Price Adjustments Receivable, Current", "label": "Allowance for Price Adjustments Receivable, Current", "negatedTerseLabel": "Less: Allowance for price adjustments" } } }, "localname": "AllowanceForPriceAdjustmentsReceivableCurrent", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsAccountsreceivableDetails" ], "xbrltype": "monetaryItemType" }, "aosl_AuditInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Audit Information", "label": "Audit Information [Abstract]" } } }, "localname": "AuditInformationAbstract", "nsuri": "http://www.aosmd.com/20220630", "xbrltype": "stringItemType" }, "aosl_BankOfCommunicationsLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bank Of Communications Limited [Member]", "label": "Bank Of Communications Limited [Member]", "terseLabel": "Bank Of Communications Limited" } } }, "localname": "BankOfCommunicationsLimitedMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtShorttermborrowingDetails" ], "xbrltype": "domainItemType" }, "aosl_CashPaidFromAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash Paid From Amounts Included In The Measurement Of Lease Liabilities [Abstract]", "label": "Cash Paid From Amounts Included In The Measurement Of Lease Liabilities [Abstract]", "terseLabel": "Cash paid from amounts included in the measurement of lease liabilities:" } } }, "localname": "CashPaidFromAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseSupplementalCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "aosl_ChongqingFundsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Chongqing Funds [Member]", "label": "Chongqing Funds [Member]", "terseLabel": "Chongqing Funds" } } }, "localname": "ChongqingFundsMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeNarrativeDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesJointVentureNarrativeDetails" ], "xbrltype": "domainItemType" }, "aosl_ComputerSoftwareDevelopmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Computer Software Development", "label": "Computer Software Development [Member]", "terseLabel": "Computer software development" } } }, "localname": "ComputerSoftwareDevelopmentMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsPropertyplantandequipmentDetails" ], "xbrltype": "domainItemType" }, "aosl_ComputerSoftwareLiabilityNoncurrent": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermliabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Computer Software Liability, Noncurrent", "label": "Computer Software Liability, Noncurrent", "terseLabel": "Computer software liabilities" } } }, "localname": "ComputerSoftwareLiabilityNoncurrent", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermliabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "aosl_ConcentrationOfCreditRiskTermsOfSalesOnCredit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Concentration of Credit Risk, Terms of Sales on Credit", "label": "Concentration of Credit Risk, Terms of Sales on Credit", "terseLabel": "Terms of credit sales, (in days)" } } }, "localname": "ConcentrationOfCreditRiskTermsOfSalesOnCredit", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomersScheduleofConcentrationRiskDetails" ], "xbrltype": "durationItemType" }, "aosl_CreditFacility3Point85PercentDueNovember182022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Credit Facility, 3 Point 85 Percent, Due November 18, 2022", "label": "Credit Facility, 3 Point 85 Percent, Due November 18, 2022 [Member]", "terseLabel": "Credit Facility, 3 Point 85 Percent, Due November 18, 2022" } } }, "localname": "CreditFacility3Point85PercentDueNovember182022Member", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtShorttermborrowingDetails" ], "xbrltype": "domainItemType" }, "aosl_Customdepositnoncurrent": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermassetsDetails": { "order": 2.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Custom deposit non current", "label": "Custom deposit non current", "terseLabel": "Customs deposit" } } }, "localname": "Customdepositnoncurrent", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermassetsDetails" ], "xbrltype": "monetaryItemType" }, "aosl_CustomerBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer B [Member]", "label": "Customer B [Member]", "terseLabel": "Customer B" } } }, "localname": "CustomerBMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermliabilitiesDetails", "http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomersScheduleofConcentrationRiskDetails" ], "xbrltype": "domainItemType" }, "aosl_CustomerCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer C [Member]", "label": "Customer C [Member]", "terseLabel": "Customer C" } } }, "localname": "CustomerCMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomersScheduleofConcentrationRiskDetails" ], "xbrltype": "domainItemType" }, "aosl_CustomerDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer D [Member]", "label": "Customer D [Member]", "terseLabel": "Customer D" } } }, "localname": "CustomerDMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomersScheduleofConcentrationRiskDetails" ], "xbrltype": "domainItemType" }, "aosl_CustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer A [Member]", "label": "Customer A [Member]", "terseLabel": "Customer A" } } }, "localname": "CustomerMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermliabilitiesDetails", "http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomersScheduleofConcentrationRiskDetails" ], "xbrltype": "domainItemType" }, "aosl_Customsdeposit": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsOtherCurrentAssetsDetails": { "order": 6.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Customs deposit", "label": "Customs deposit", "terseLabel": "Customs deposit" } } }, "localname": "Customsdeposit", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "aosl_DebtInstrumentBasisSpreadonVariableRateMultiple": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Basis Spread on Variable Rate, Multiple", "label": "Debt Instrument, Basis Spread on Variable Rate, Multiple", "terseLabel": "Basis spread multiple" } } }, "localname": "DebtInstrumentBasisSpreadonVariableRateMultiple", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails", "http://www.aosmd.com/role/DebtShorttermborrowingDetails" ], "xbrltype": "pureItemType" }, "aosl_DebtLongTermAndShortTermCombinedAmountNet": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt, Long-Term And Short-Term, Combined Amount, Net", "label": "Debt, Long-Term And Short-Term, Combined Amount, Net", "totalLabel": "Total debt, less debt issuance costs" } } }, "localname": "DebtLongTermAndShortTermCombinedAmountNet", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "aosl_DeferredTaxAssetsAccrualsandReserves": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 7.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to accruals and reserves.", "label": "Deferred Tax Assets, Accruals and Reserves", "terseLabel": "Accruals and reserves" } } }, "localname": "DeferredTaxAssetsAccrualsandReserves", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "monetaryItemType" }, "aosl_DeferredTaxAssetsAccruedCompensation": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to accrued compensation.", "label": "Deferred Tax Assets, Accrued Compensation", "terseLabel": "Accrued compensation" } } }, "localname": "DeferredTaxAssetsAccruedCompensation", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "monetaryItemType" }, "aosl_DeferredTaxAssetsCapitalizedIntangibleAssets": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 6.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Capitalized Intangible Assets", "label": "Deferred Tax Assets, Capitalized Intangible Assets", "terseLabel": "Capitalized intangible assets" } } }, "localname": "DeferredTaxAssetsCapitalizedIntangibleAssets", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "monetaryItemType" }, "aosl_DeferredTaxAssetsDepreciation": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to fixed assets.", "label": "Deferred Tax Assets, Depreciation", "terseLabel": "Depreciation" } } }, "localname": "DeferredTaxAssetsDepreciation", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "monetaryItemType" }, "aosl_DeferredTaxAssetsNetOfValuationAllowanceByJurisdiction": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Net Of Valuation Allowance, By Jurisdiction", "label": "Deferred Tax Assets, Net Of Valuation Allowance, By Jurisdiction", "terseLabel": "Deferred income tax assets", "verboseLabel": "Long-term deferred tax assets" } } }, "localname": "DeferredTaxAssetsNetOfValuationAllowanceByJurisdiction", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "monetaryItemType" }, "aosl_DeferredTaxAssetsOperatingLeaseLiabilities": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Operating Lease Liabilities", "label": "Deferred Tax Assets, Operating Lease Liabilities", "terseLabel": "Operating lease liabilities" } } }, "localname": "DeferredTaxAssetsOperatingLeaseLiabilities", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "monetaryItemType" }, "aosl_DeferredTaxLiabilitiesDepreciationandAmortization": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to fixed and intangible assets.", "label": "Deferred Tax Liabilities, Depreciation and Amortization", "negatedTerseLabel": "Depreciation and amortization" } } }, "localname": "DeferredTaxLiabilitiesDepreciationandAmortization", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "monetaryItemType" }, "aosl_DeferredTaxLiabilitiesNetOfValuationAllowanceByJurisdiction": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Liabilities, Net Of Valuation Allowance, By Jurisdiction", "label": "Deferred Tax Liabilities, Net Of Valuation Allowance, By Jurisdiction", "negatedTerseLabel": "Long-term deferred tax liabilities", "terseLabel": "Deferred income tax liabilities" } } }, "localname": "DeferredTaxLiabilitiesNetOfValuationAllowanceByJurisdiction", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "monetaryItemType" }, "aosl_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Liabilities, Operating Lease Right-Of-Use Assets", "label": "Deferred Tax Liabilities, Operating Lease Right-Of-Use Assets", "negatedTerseLabel": "Right of use assets" } } }, "localname": "DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "monetaryItemType" }, "aosl_DefinedContributionPlanEmployerMatchingContributionEligibleCompensationMaximumMatchPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Contribution Plan, Employer Matching Contribution, Eligible Compensation Maximum Match, Percent", "label": "Defined Contribution Plan, Employer Matching Contribution, Eligible Compensation Maximum Match, Percent", "terseLabel": "Defined Contribution Plan, Employer Matching Contribution, Eligible Compensation Maximum Match, Percent" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionEligibleCompensationMaximumMatchPercent", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/EmployeeBenefitPlansDetails" ], "xbrltype": "percentItemType" }, "aosl_DepositsWithSupplier": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermassetsDetails": { "order": 5.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deposits With Supplier", "label": "Deposits With Supplier", "terseLabel": "Deposit with supplier" } } }, "localname": "DepositsWithSupplier", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermassetsDetails" ], "xbrltype": "monetaryItemType" }, "aosl_DurationOfOfferingPeriodsForEmployeeSharePurchasePlan": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Duration of Offering Periods For Employee Share Purchase Plan", "label": "Duration of Offering Periods For Employee Share Purchase Plan", "terseLabel": "Duration of offering periods for ESPP (in months)" } } }, "localname": "DurationOfOfferingPeriodsForEmployeeSharePurchasePlan", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationEmployeeSharePurchasePlanDetails" ], "xbrltype": "durationItemType" }, "aosl_EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017DeferredTax": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 7.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act of 2017, Deferred Tax", "label": "Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act of 2017, Deferred Tax", "terseLabel": "U.S. Tax Act deferred tax re-measurement" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017DeferredTax", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "percentItemType" }, "aosl_EmployeeIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee Incentive Plan", "label": "Employee Incentive Plan [Member]", "terseLabel": "Employee Incentive Plan" } } }, "localname": "EmployeeIncentivePlanMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeNarrativeDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesJointVentureNarrativeDetails" ], "xbrltype": "domainItemType" }, "aosl_EmployeeStockPurchasePlanPayableCurrent": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsAccruedliabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Employee Stock Purchase Plan Payable, Current", "label": "Employee Stock Purchase Plan Payable, Current", "terseLabel": "ESPP payable" } } }, "localname": "EmployeeStockPurchasePlanPayableCurrent", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsAccruedliabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "aosl_EquipmentAndToolingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment and Tooling [Member]", "label": "Equipment and Tooling [Member]", "terseLabel": "Equipment and tooling" } } }, "localname": "EquipmentAndToolingMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsPropertyplantandequipmentDetails" ], "xbrltype": "domainItemType" }, "aosl_EquityMethodInvestmentFairValueOfEquityRetained": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity Method Investment, Fair Value of Equity Retained", "label": "Equity Method Investment, Fair Value of Equity Retained", "terseLabel": "Fair value of retained equity method investment" } } }, "localname": "EquityMethodInvestmentFairValueOfEquityRetained", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeScheduleofGainonDeconsolidationDetails" ], "xbrltype": "monetaryItemType" }, "aosl_EquityMethodInvestmentNumberOfAppointmentsToBoardOfDirectors": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity Method Investment, Number of Appointments to Board of Directors", "label": "Equity Method Investment, Number of Appointments to Board of Directors", "terseLabel": "Equity Method Investment, Number of Appointments to Board of Directors" } } }, "localname": "EquityMethodInvestmentNumberOfAppointmentsToBoardOfDirectors", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeNarrativeDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesJointVentureNarrativeDetails" ], "xbrltype": "integerItemType" }, "aosl_EquityMethodInvestmentNumberOfDirectors": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity Method Investment, Number of Directors", "label": "Equity Method Investment, Number of Directors", "terseLabel": "Equity Method Investment, Number of Directors" } } }, "localname": "EquityMethodInvestmentNumberOfDirectors", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeNarrativeDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesJointVentureNarrativeDetails" ], "xbrltype": "integerItemType" }, "aosl_ExternalBoardMembersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "External Board Members [Member]", "label": "External Board Members [Member]", "terseLabel": "External Board Members" } } }, "localname": "ExternalBoardMembersMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "aosl_FacilityinLiangjiangNewAreaofChongqingtheJointVentureMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Facility in Liangjiang New Area of Chongqing (the 'Joint Venture') [Member]", "label": "Facility in Liangjiang New Area of Chongqing (the 'Joint Venture') [Member]", "terseLabel": "Facility in Liangjiang New Area of Chongqing (the 'Joint Venture')" } } }, "localname": "FacilityinLiangjiangNewAreaofChongqingtheJointVentureMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeEquityMethodInvestmentSummarizedFinancialInformationDetails", "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeNarrativeDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesJointVentureNarrativeDetails" ], "xbrltype": "domainItemType" }, "aosl_FinanceLeaseCost1Abstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Finance Lease Cost1 [Abstract]", "label": "Finance Lease Cost1 [Abstract]", "terseLabel": "Finance lease:" } } }, "localname": "FinanceLeaseCost1Abstract", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseCostDetails" ], "xbrltype": "stringItemType" }, "aosl_FinanceLeaseRightOfUseAssetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Finance Lease Right Of Use Asset [Abstract]", "label": "Finance Lease Right Of Use Asset [Abstract]", "terseLabel": "Finance Lease:" } } }, "localname": "FinanceLeaseRightOfUseAssetAbstract", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseSupplementalBalanceSheetInformationDetails" ], "xbrltype": "stringItemType" }, "aosl_ForeignSubsidiariesRestrictedStatutoryReservesAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Foreign Subsidiaries, Restricted Statutory Reserves, Amount", "label": "Foreign Subsidiaries, Restricted Statutory Reserves, Amount", "terseLabel": "Foreign subsidiaries, restricted statutory reserves" } } }, "localname": "ForeignSubsidiariesRestrictedStatutoryReservesAmount", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/RestrictedNetAssetsDetails" ], "xbrltype": "monetaryItemType" }, "aosl_ForeignSubsidiariesRestrictedStatutoryReservesPercentOfParentConsolidatedNetAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Subsidiaries, Restricted Statutory Reserves, Percent of Parent Consolidated Net Assets", "label": "Foreign Subsidiaries, Restricted Statutory Reserves, Percent of Parent Consolidated Net Assets", "terseLabel": "Foreign subsidiaries, restricted statutory reserves percent of parent consolidated net assets" } } }, "localname": "ForeignSubsidiariesRestrictedStatutoryReservesPercentOfParentConsolidatedNetAssets", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/RestrictedNetAssetsDetails" ], "xbrltype": "percentItemType" }, "aosl_GovernmentGrantsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Government Grants, Policy [Policy Text Block]", "label": "Government Grants, Policy [Policy Text Block]", "terseLabel": "Government Grants" } } }, "localname": "GovernmentGrantsPolicyPolicyTextBlock", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "aosl_GovernmentGrantsReductionRecordedToInterestExpense": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Government Grants, Reduction Recorded To Interest Expense", "label": "Government Grants, Reduction Recorded To Interest Expense", "terseLabel": "Government grants, reduction recorded to interest expense" } } }, "localname": "GovernmentGrantsReductionRecordedToInterestExpense", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesGovernmentGrantsDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesGovernmentGrantsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "aosl_GovernmentGrantsReductionRecordedToOperatingExpenses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Government Grants, Reduction Recorded To Operating Expenses", "label": "Government Grants, Reduction Recorded To Operating Expenses", "terseLabel": "Government grants, reduction recorded to operating expenses" } } }, "localname": "GovernmentGrantsReductionRecordedToOperatingExpenses", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesGovernmentGrantsDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesGovernmentGrantsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "aosl_GovernmentGrantsReductionRecordedToPropertyPlantAndEquipment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Government Grants, Reduction Recorded To Property, Plant And Equipment", "label": "Government Grants, Reduction Recorded To Property, Plant And Equipment", "terseLabel": "Government grants, reduction recorded to property, plant and equipment" } } }, "localname": "GovernmentGrantsReductionRecordedToPropertyPlantAndEquipment", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesGovernmentGrantsDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesGovernmentGrantsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "aosl_HHGraceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "HHGrace", "label": "HHGrace [Member]", "terseLabel": "HHGrace" } } }, "localname": "HHGraceMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesRisksandUncertaintiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "aosl_IncreaseDecreaseInIncomeTaxesPayableFromDeconsolidationAndChangesOfEquityInterestInTheJVCompany": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) in Income Taxes Payable from Deconsolidation and Changes of Equity Interest in the JV Company", "label": "Increase (Decrease) in Income Taxes Payable from Deconsolidation and Changes of Equity Interest in the JV Company", "terseLabel": "Income taxes payable on deconsolidation and changes of equity interest in the JV Company" } } }, "localname": "IncreaseDecreaseInIncomeTaxesPayableFromDeconsolidationAndChangesOfEquityInterestInTheJVCompany", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "aosl_IndustrialAndCommercialBankofChinaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Industrial And Commercial Bank of China [Member]", "label": "Industrial And Commercial Bank of China [Member]", "terseLabel": "Industrial And Commercial Bank of China" } } }, "localname": "IndustrialAndCommercialBankofChinaMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtShorttermborrowingDetails" ], "xbrltype": "domainItemType" }, "aosl_InventoriesAndServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Inventories and Services [Member]", "label": "Inventories and Services [Member]", "terseLabel": "Raw materials, wafers, and packaging and testing services purchase commitments [Member]" } } }, "localname": "InventoriesAndServicesMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/CommitmentsandContingenciesPurchaseCommitmentsDetails" ], "xbrltype": "domainItemType" }, "aosl_InvestmentsInPrivatelyHeldCompanies": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermassetsDetails": { "order": 6.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investments in Privately Held Companies", "label": "Investments in Privately Held Companies", "terseLabel": "Investments in privately held companies" } } }, "localname": "InvestmentsInPrivatelyHeldCompanies", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermassetsDetails" ], "xbrltype": "monetaryItemType" }, "aosl_JirehMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Jireh", "label": "Jireh [Member]", "terseLabel": "Jireh" } } }, "localname": "JirehMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "aosl_JirehSemiconductorIncorporatedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Jireh Semiconductor Incorporated", "label": "Jireh Semiconductor Incorporated [Member]", "terseLabel": "Jireh Semiconductor Incorporated" } } }, "localname": "JirehSemiconductorIncorporatedMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtDebtFinancingDetails" ], "xbrltype": "domainItemType" }, "aosl_JointVenturePolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Joint Venture [Policy Text Block]", "label": "Joint Venture [Policy Text Block]", "terseLabel": "Joint Venture" } } }, "localname": "JointVenturePolicyTextBlock", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "aosl_LandUseRightsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Land Use Rights [Member]", "label": "Land Use Rights [Member]", "terseLabel": "Land use rights" } } }, "localname": "LandUseRightsMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsPropertyplantandequipmentDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "aosl_LeaseFinancingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease Financing [Member]", "label": "Lease Financing [Member]", "terseLabel": "Lease Financing" } } }, "localname": "LeaseFinancingMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails", "http://www.aosmd.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "aosl_LengthOfProductWarranty": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Length of Product Warranty", "label": "Length of Product Warranty", "terseLabel": "Length of product warranty" } } }, "localname": "LengthOfProductWarranty", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesProductWarrantyNarrativeDetails" ], "xbrltype": "durationItemType" }, "aosl_LiabilitiesOtherThanLongTermDebtNoncurrentOther": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermliabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Liabilities, Other Than Long-Term Debt, Noncurrent, Other", "label": "Liabilities, Other Than Long-Term Debt, Noncurrent, Other", "terseLabel": "Other" } } }, "localname": "LiabilitiesOtherThanLongTermDebtNoncurrentOther", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermliabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "aosl_LineOfCreditFacilityTradeBorrowingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of Credit Facility, Trade Borrowings", "label": "Line of Credit Facility, Trade Borrowings [Member]", "terseLabel": "Line of Credit Facility, Trade Borrowings" } } }, "localname": "LineOfCreditFacilityTradeBorrowingsMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtShorttermborrowingDetails" ], "xbrltype": "domainItemType" }, "aosl_LineOfCreditFacilityWorkingCapitalBorrowingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of Credit Facility, Working Capital Borrowings", "label": "Line of Credit Facility, Working Capital Borrowings [Member]", "terseLabel": "Line of Credit Facility, Working Capital Borrowings" } } }, "localname": "LineOfCreditFacilityWorkingCapitalBorrowingsMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtShorttermborrowingDetails" ], "xbrltype": "domainItemType" }, "aosl_LocalVATReceivable": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsOtherCurrentAssetsDetails": { "order": 5.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Local VAT (Value Added Tax) Receivable", "label": "Local VAT Receivable", "terseLabel": "VAT receivable" } } }, "localname": "LocalVATReceivable", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "aosl_LongTermDebtAndShortTermDebtCombinedAmountMaturityYearOne": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails": { "order": 2.0, "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long-Term Debt And Short-Term Debt Combined Amount, Maturity, Year One", "label": "Long-Term Debt And Short-Term Debt Combined Amount, Maturity, Year One", "terseLabel": "2023" } } }, "localname": "LongTermDebtAndShortTermDebtCombinedAmountMaturityYearOne", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "aosl_LongTermIncomeTaxPayableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long-term Income Tax Payable [Member]", "label": "Long-term Income Tax Payable [Member]", "terseLabel": "Long-term Income Tax Payable" } } }, "localname": "LongTermIncomeTaxPayableMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "aosl_LossFromCyberSecurityIncidentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss from Cyber Security Incident", "label": "Loss from Cyber Security Incident [Member]", "terseLabel": "Loss from Cyber Security Incident" } } }, "localname": "LossFromCyberSecurityIncidentMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/CybersecutiyIncidentDetails" ], "xbrltype": "domainItemType" }, "aosl_MandatoryEmployerContributionsAccordingToLaborAndSocialSecurityLawsAndRegulations": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mandatory Employer Contributions According to Labor and Social Security Laws and Regulations", "label": "Mandatory Employer Contributions According to Labor and Social Security Laws and Regulations", "terseLabel": "Mandatory employer contributions according to labor and social security laws and regulations, percent" } } }, "localname": "MandatoryEmployerContributionsAccordingToLaborAndSocialSecurityLawsAndRegulations", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/EmployeeBenefitPlansDetails" ], "xbrltype": "percentItemType" }, "aosl_MarketBasedRestrictedStockUnitsMSUPostModificationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Market-based Restricted Stock Units (MSU), Post-Modification", "label": "Market-based Restricted Stock Units (MSU), Post-Modification [Member]", "terseLabel": "Market-based Restricted Stock Units (MSU), Post-Modification" } } }, "localname": "MarketBasedRestrictedStockUnitsMSUPostModificationMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "aosl_MarketBasedRestrictedStockUnitsMSUPreModificationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Market-based Restricted Stock Units (MSU), Pre-Modification", "label": "Market-based Restricted Stock Units (MSU), Pre-Modification [Member]", "terseLabel": "Market-based Restricted Stock Units (MSU), Pre-Modification" } } }, "localname": "MarketBasedRestrictedStockUnitsMSUPreModificationMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "aosl_MarketbasedRestrictedStockUnitsMSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Market-based Restricted Stock Units (MSU) [Member]", "label": "Market-based Restricted Stock Units (MSU) [Member]", "terseLabel": "Market-based Restricted Stock Units (MSU)" } } }, "localname": "MarketbasedRestrictedStockUnitsMSUMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails", "http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails" ], "xbrltype": "domainItemType" }, "aosl_NetOperatingLossFixedAssetAndIntangibleAssetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net Operating Loss, Fixed Asset And Intangible Asset [Member]", "label": "Net Operating Loss, Fixed Asset And Intangible Asset [Member]", "terseLabel": "Net operating loss, fixed asset and intangible asset" } } }, "localname": "NetOperatingLossFixedAssetAndIntangibleAssetMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "aosl_NonstatutoryStockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nonstatutory Stock Options [Member]", "label": "Nonstatutory Stock Options [Member]", "terseLabel": "Nonstatutory Stock Options" } } }, "localname": "NonstatutoryStockOptionsMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "aosl_NumberOfVotesPerEachCommonShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Votes Per Each Common Share", "label": "Number of Votes Per Each Common Share", "terseLabel": "Number of votes per each common share" } } }, "localname": "NumberOfVotesPerEachCommonShare", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/ShareholdersEquityDetails" ], "xbrltype": "integerItemType" }, "aosl_OfficeLeaseDepositAssetsNoncurrent": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermassetsDetails": { "order": 7.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Office Lease Deposit Assets, Noncurrent", "label": "Office Lease Deposit Assets, Noncurrent", "terseLabel": "Office leases deposits" } } }, "localname": "OfficeLeaseDepositAssetsNoncurrent", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermassetsDetails" ], "xbrltype": "monetaryItemType" }, "aosl_OperatingLeaseRightOfUseAssetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating Lease Right Of Use Asset [Abstract]", "label": "Operating Lease Right Of Use Asset [Abstract]", "terseLabel": "Operating Lease Right Of Use Asset [Abstract]" } } }, "localname": "OperatingLeaseRightOfUseAssetAbstract", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseSupplementalBalanceSheetInformationDetails" ], "xbrltype": "stringItemType" }, "aosl_OtherComprehensiveIncomeLossReclassificationAdjustmentRealizedUponSaleOrLiquidation": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other Comprehensive Income (Loss), Reclassification Adjustment, Realized upon Sale or Liquidation", "label": "Other Comprehensive Income (Loss), Reclassification Adjustment, Realized upon Sale or Liquidation", "negatedTerseLabel": "Cumulative translation adjustment removal due to deconsolidation of the JV Company" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentRealizedUponSaleOrLiquidation", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "aosl_OtherCountriesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Countries [Member]", "label": "Other Countries [Member]", "terseLabel": "Other countries" } } }, "localname": "OtherCountriesMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/SegmentandGeographicinformationLocationandNetBookValueofLongLivedAssetsDetails", "http://www.aosmd.com/role/SegmentandGeographicinformationRevenuebyGeographicalSegmentDetails" ], "xbrltype": "domainItemType" }, "aosl_OtherCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Customers", "label": "Other Customers [Member]", "terseLabel": "Other Customers" } } }, "localname": "OtherCustomersMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermliabilitiesDetails" ], "xbrltype": "domainItemType" }, "aosl_PackagingAndTestingServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Packaging and testing services [Member]", "label": "Packaging and testing services [Member]", "terseLabel": "Packaging and testing services" } } }, "localname": "PackagingAndTestingServicesMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/SegmentandGeographicinformationRevenuebyProductTypeDetails" ], "xbrltype": "domainItemType" }, "aosl_PatentsAndPatentedTechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Patents and Patented Technology [Member]", "label": "Patents and Patented Technology [Member]", "terseLabel": "Patents and exclusive technology rights" } } }, "localname": "PatentsAndPatentedTechnologyMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsIntangibleassetsDetails" ], "xbrltype": "domainItemType" }, "aosl_PercentOfAfterTaxProfitRequiredAnnuallyInStatutoryReserves": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percent of After-tax Profit Required Annually in Statutory Reserves", "label": "Percent of After-tax Profit Required Annually in Statutory Reserves", "terseLabel": "Foreign subsidiaries, minimum percent of after-tax profit required annually in statutory reserves" } } }, "localname": "PercentOfAfterTaxProfitRequiredAnnuallyInStatutoryReserves", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/RestrictedNetAssetsDetails" ], "xbrltype": "percentItemType" }, "aosl_PerformanceBasedRestrictedStockUnitsPRSUsMemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance Based Restricted Stock Units (PRSUs) Member [Member]", "label": "Performance Based Restricted Stock Units (PRSUs) Member [Member]", "terseLabel": "Performance Based Restricted Stock Units (PRSUs)" } } }, "localname": "PerformanceBasedRestrictedStockUnitsPRSUsMemberMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails", "http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails", "http://www.aosmd.com/role/SharebasedCompensationSharebasedCompensationExpensesDetails" ], "xbrltype": "domainItemType" }, "aosl_PowerDiscreteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Power Discrete [Member]", "label": "Power Discrete [Member]", "terseLabel": "Power discrete" } } }, "localname": "PowerDiscreteMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/SegmentandGeographicinformationRevenuebyProductTypeDetails" ], "xbrltype": "domainItemType" }, "aosl_PowerIcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Power IC [Member]", "label": "Power IC [Member]", "terseLabel": "Power IC" } } }, "localname": "PowerIcMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/SegmentandGeographicinformationRevenuebyProductTypeDetails" ], "xbrltype": "domainItemType" }, "aosl_PrepaidMaintenanceCurrent": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsOtherCurrentAssetsDetails": { "order": 3.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepaid Maintenance, Current", "label": "Prepaid Maintenance, Current", "terseLabel": "Prepaid maintenance" } } }, "localname": "PrepaidMaintenanceCurrent", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "aosl_PrepaymentForPropertyAndEquipment": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermassetsDetails": { "order": 1.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepayment for Property and Equipment", "label": "Prepayment for Property and Equipment", "terseLabel": "Prepayments for property and equipment" } } }, "localname": "PrepaymentForPropertyAndEquipment", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermassetsDetails" ], "xbrltype": "monetaryItemType" }, "aosl_PrepaymenttoSupplier": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsOtherCurrentAssetsDetails": { "order": 4.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepayment to Supplier", "label": "Prepayment to Supplier", "terseLabel": "Prepayments to supplier" } } }, "localname": "PrepaymenttoSupplier", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "aosl_PrincipalPaymentsOnCapitalLeases": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Principal Payments on Capital Leases", "label": "Principal Payments on Capital Leases", "negatedTerseLabel": "Principal payments on capital leases" } } }, "localname": "PrincipalPaymentsOnCapitalLeases", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "aosl_ProceedsFromGovernmentGrantRelatedToEquipmentInJointVentureCompany": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds From Government Grant Related To Equipment In Joint Venture Company", "label": "Proceeds From Government Grant Related To Equipment In Joint Venture Company", "terseLabel": "Government grant related to equipment" } } }, "localname": "ProceedsFromGovernmentGrantRelatedToEquipmentInJointVentureCompany", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "aosl_PropertyPlantAndEquipmentExcludingEquipmentAndConstructionInProgressGross": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsPropertyplantandequipmentDetails": { "order": 1.0, "parentTag": "aosl_PropertyPlantAndEquipmentExcludingEquipmentAndConstructionInProgressNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Property, Plant, and Equipment Excluding Equipment and Construction In Progress, Gross", "label": "Property, Plant, and Equipment Excluding Equipment and Construction In Progress, Gross", "terseLabel": "Property, plant, and equipment excluding equipment and construction In progress, gross" } } }, "localname": "PropertyPlantAndEquipmentExcludingEquipmentAndConstructionInProgressGross", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsPropertyplantandequipmentDetails" ], "xbrltype": "monetaryItemType" }, "aosl_PropertyPlantAndEquipmentExcludingEquipmentAndConstructionInProgressNet": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsPropertyplantandequipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Property, Plant and Equipment Excluding Equipment and Construction In Progress, Net", "label": "Property, Plant and Equipment Excluding Equipment and Construction In Progress, Net", "totalLabel": "Property, plant and equipment excluding equipment and construction in progress, net" } } }, "localname": "PropertyPlantAndEquipmentExcludingEquipmentAndConstructionInProgressNet", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsPropertyplantandequipmentDetails" ], "xbrltype": "monetaryItemType" }, "aosl_PropertyPlantEquipmentAndLandUseRights": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of property, plant equipment, and land use rights", "label": "PropertyPlantEquipmentAndLandUseRights", "terseLabel": "PPE and land use rights" } } }, "localname": "PropertyPlantEquipmentAndLandUseRights", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/SegmentandGeographicinformationLocationandNetBookValueofLongLivedAssetsDetails" ], "xbrltype": "monetaryItemType" }, "aosl_RestrictedStatutoryReservesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Statutory Reserves [Line Items]", "label": "Restricted Statutory Reserves [Line Items]", "terseLabel": "Restricted Statutory Reserves [Line Items]" } } }, "localname": "RestrictedStatutoryReservesLineItems", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/RestrictedNetAssetsDetails" ], "xbrltype": "stringItemType" }, "aosl_RestrictedStatutoryReservesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Statutory Reserves [Table]", "label": "Restricted Statutory Reserves [Table]", "terseLabel": "Restricted Statutory Reserves [Table]" } } }, "localname": "RestrictedStatutoryReservesTable", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/RestrictedNetAssetsDetails" ], "xbrltype": "stringItemType" }, "aosl_RetirementPlan401KMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Retirement Plan, 401-K [Member]", "label": "Retirement Plan, 401-K [Member]", "terseLabel": "Retirement Plan, 401-K" } } }, "localname": "RetirementPlan401KMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/EmployeeBenefitPlansDetails" ], "xbrltype": "domainItemType" }, "aosl_RisksAndUncertaintiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Risks and Uncertainties [Policy Text Block]", "label": "Risks and Uncertainties [Policy Text Block]", "terseLabel": "Risks and Uncertainties" } } }, "localname": "RisksAndUncertaintiesPolicyTextBlock", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "aosl_SaleLeasebackTransactionDebtReceivableAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sale Leaseback Transaction, Debt Receivable Amount", "label": "Sale Leaseback Transaction, Debt Receivable Amount", "terseLabel": "Debt receivable amount" } } }, "localname": "SaleLeasebackTransactionDebtReceivableAmount", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtDebtFinancingDetails" ], "xbrltype": "monetaryItemType" }, "aosl_SaleLeasebackTransactionDeliveryPaymentAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sale Leaseback Transaction, Delivery Payment, Amount", "label": "Sale Leaseback Transaction, Delivery Payment, Amount", "terseLabel": "Delivery payment received" } } }, "localname": "SaleLeasebackTransactionDeliveryPaymentAmount", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtDebtFinancingDetails" ], "xbrltype": "monetaryItemType" }, "aosl_SaleLeasebackTransactionDeliveryPaymentPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale Leaseback Transaction, Delivery Payment, Percent", "label": "Sale Leaseback Transaction, Delivery Payment, Percent", "terseLabel": "Delivery payment percent" } } }, "localname": "SaleLeasebackTransactionDeliveryPaymentPercent", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtDebtFinancingDetails" ], "xbrltype": "percentItemType" }, "aosl_SaleLeasebackTransactionDownPaymentAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sale Leaseback Transaction, Down Payment Amount", "label": "Sale Leaseback Transaction, Down Payment Amount", "terseLabel": "Down payment amount received" } } }, "localname": "SaleLeasebackTransactionDownPaymentAmount", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtDebtFinancingDetails" ], "xbrltype": "monetaryItemType" }, "aosl_SaleLeasebackTransactionDownPaymentPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale Leaseback Transaction, Down Payment, Percent", "label": "Sale Leaseback Transaction, Down Payment, Percent", "terseLabel": "Down payment percent" } } }, "localname": "SaleLeasebackTransactionDownPaymentPercent", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtDebtFinancingDetails" ], "xbrltype": "percentItemType" }, "aosl_SaleLeasebackTransactionImpliedInterestRatePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale Leaseback Transaction, Implied Interest Rate, Percent", "label": "Sale Leaseback Transaction, Implied Interest Rate, Percent", "terseLabel": "Implied interest rate, percent" } } }, "localname": "SaleLeasebackTransactionImpliedInterestRatePercent", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtDebtFinancingDetails" ], "xbrltype": "percentItemType" }, "aosl_SaleLeasebackTransactionLeaseTermBuyoutOptionAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sale Leaseback Transaction, Lease Term, Buyout Option Amount", "label": "Sale Leaseback Transaction, Lease Term, Buyout Option Amount", "terseLabel": "Lease term, buyout option amount" } } }, "localname": "SaleLeasebackTransactionLeaseTermBuyoutOptionAmount", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtDebtFinancingDetails" ], "xbrltype": "monetaryItemType" }, "aosl_SaleLeasebackTransactionPurchasePriceFinancingPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale Leaseback Transaction, Purchase Price Financing, Percent", "label": "Sale Leaseback Transaction, Purchase Price Financing, Percent", "terseLabel": "Purchase price financing amount, percent" } } }, "localname": "SaleLeasebackTransactionPurchasePriceFinancingPercent", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtDebtFinancingDetails" ], "xbrltype": "percentItemType" }, "aosl_SalesLeaseBackTransactionWithJirehSemiconductorIncorporatedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sales-Lease Back Transaction with Jireh Semiconductor Incorporated", "label": "Sales-Lease Back Transaction with Jireh Semiconductor Incorporated [Member]", "terseLabel": "Sales-Lease Back Transaction with Jireh Semiconductor Incorporated" } } }, "localname": "SalesLeaseBackTransactionWithJirehSemiconductorIncorporatedMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtDebtFinancingDetails" ], "xbrltype": "domainItemType" }, "aosl_ScheduleOfDeferredTaxAssetsAndLiabilitiesCurrentAndNoncurrentTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Deferred Tax Assets and Liabilities, Current and Noncurrent [Table Text Block]", "label": "Schedule of Deferred Tax Assets and Liabilities, Current and Noncurrent [Table Text Block]", "terseLabel": "Schedule of deferred tax assets and liabilities, current and noncurrent" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesCurrentAndNoncurrentTableTextBlock", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "aosl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherthanOptionsAverageFairMarketValuePerSharePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other than Options, Average Fair Market Value Per Share Period", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other than Options, Average Fair Market Value Per Share Period", "terseLabel": "Average fair market value per share period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherthanOptionsAverageFairMarketValuePerSharePeriod", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "aosl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherthanOptionsValueOfGrantsinPeriod": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other than Options, Value Of Grants in Period", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other than Options, Value Of Grants in Period", "terseLabel": "Granted, value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherthanOptionsValueOfGrantsinPeriod", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "aosl_ShareBasedCompensationArrangementByShareBasedPaymentAwardExerciseOfStockOptionsAndReleaseOfRestrictedStockUnitsInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Exercise of Stock Options and Release of Restricted Stock Units in Period", "label": "Share-based Compensation Arrangement By Share-based Payment Award, Exercise of Stock Options and Release of Restricted Stock Units in Period", "terseLabel": "Exercise of common stock options and release of RSUs (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExerciseOfStockOptionsAndReleaseOfRestrictedStockUnitsInPeriod", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "aosl_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesThatMayBePurchasedOnAnyPurchaseDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Common Shares That May be Purchased On Any Purchase Date", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Common Shares That May be Purchased On Any Purchase Date", "terseLabel": "Maximum number of common shares that may be purchased on any purchase date by a participant (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesThatMayBePurchasedOnAnyPurchaseDate", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationEmployeeSharePurchasePlanDetails" ], "xbrltype": "sharesItemType" }, "aosl_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesThatMayBePurchasedPer24MonthOfferingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Common Shares that May Be Purchased Per a 24-Month Offering Period", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Common Shares that May Be Purchased Per a 24-Month Offering Period", "terseLabel": "Maximum number of common shares that may be purchased per a 24-month offering period by a participant (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesThatMayBePurchasedPer24MonthOfferingPeriod", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationEmployeeSharePurchasePlanDetails" ], "xbrltype": "sharesItemType" }, "aosl_ShareBasedCompensationArrangementByShareBasedPaymentAwardPayrollDeductionAccumulationPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Payroll Deduction Accumulation Period", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Payroll Deduction Accumulation Period", "terseLabel": "Payroll deduction accumulation period (in months)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPayrollDeductionAccumulationPeriod", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationEmployeeSharePurchasePlanDetails", "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "aosl_ShareBasedCompensationArrangementByShareBasedPaymentAwardValueOfCommonStockThatMayBePurchasedInAnyOneCalendarYear": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Value of Common Stock That May Be Purchased in Any One Calendar Year", "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Value of Common Stock That May Be Purchased in Any One Calendar Year", "terseLabel": "Maximum value of common stock that may be purchased in any one calendar year" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardValueOfCommonStockThatMayBePurchasedInAnyOneCalendarYear", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationEmployeeSharePurchasePlanDetails" ], "xbrltype": "monetaryItemType" }, "aosl_ShareBasedPaymentArrangementExpenseNonCash": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Share-Based Payment Arrangement, Expense, Non-Cash", "label": "Share-Based Payment Arrangement, Expense, Non-Cash", "terseLabel": "Share-based payment arrangement, expense, non-cash" } } }, "localname": "ShareBasedPaymentArrangementExpenseNonCash", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "aosl_SharebasedCompensationArrangementbySharebasedPaymentAwardMaximumNumberOfSharesAuthorizedForPurchasePerPurchasePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number Of Shares Authorized For Purchase Per Purchase Period", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number Of Shares Authorized For Purchase Per Purchase Period", "terseLabel": "Maximum number of shares authorized for purchase per purchase date (in shares)" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardMaximumNumberOfSharesAuthorizedForPurchasePerPurchasePeriod", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationEmployeeSharePurchasePlanDetails" ], "xbrltype": "sharesItemType" }, "aosl_ShortTermDebtGross": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails": { "order": 2.0, "parentTag": "us-gaap_ShortTermBorrowings", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Short-Term Debt, Gross", "label": "Short-Term Debt, Gross", "terseLabel": "Principal amount" } } }, "localname": "ShortTermDebtGross", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "aosl_ShortTermLeaseCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Short Term Lease Cost [Abstract]", "label": "Short Term Lease Cost [Abstract]", "terseLabel": "Short-term leases:" } } }, "localname": "ShortTermLeaseCostAbstract", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseCostDetails" ], "xbrltype": "stringItemType" }, "aosl_SimpleAnnualInterestRatetoNoncontrollingInterestifJointVentureisEarlyTerminatedandLiquidated": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Simple Annual Interest Rate to Noncontrolling Interest if Joint Venture is Early Terminated and Liquidated", "label": "Simple Annual Interest Rate to Noncontrolling Interest if Joint Venture is Early Terminated and Liquidated", "terseLabel": "Simple annual interest rate to noncontrolling interest if joint venture is early terminated and liquidated" } } }, "localname": "SimpleAnnualInterestRatetoNoncontrollingInterestifJointVentureisEarlyTerminatedandLiquidated", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesJointVentureNarrativeDetails" ], "xbrltype": "percentItemType" }, "aosl_StateResearchAndDevelopmentCreditCarryforwardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "State Research And Development Credit Carryforward [Member]", "label": "State Research And Development Credit Carryforward [Member]", "terseLabel": "State research and development credit carryforward" } } }, "localname": "StateResearchAndDevelopmentCreditCarryforwardMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "aosl_StatutoryReservesCumulativeAmountAsPercentOfRegisteredCapital": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Statutory Reserves, Cumulative Amount as a Percent of Registered Capital", "label": "Statutory Reserves, Cumulative Amount as a Percent of Registered Capital", "terseLabel": "Foreign subsidiaries, statutory reserves maximum cumulative amount as a percent of registered capital" } } }, "localname": "StatutoryReservesCumulativeAmountAsPercentOfRegisteredCapital", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/RestrictedNetAssetsDetails" ], "xbrltype": "percentItemType" }, "aosl_StockIssuedDuringPeriodValueStockOptionsExercisedAndRestrictedStockUnitsReleased": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Value, Stock Options Exercised and Restricted Stock Units Released", "label": "Stock Issued During Period, Value, Stock Options Exercised and Restricted Stock Units Released", "terseLabel": "Exercise of common stock options and release of RSUs" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercisedAndRestrictedStockUnitsReleased", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "aosl_StockOptionsAndRestrictedStockUnitsRsusMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Options and Restricted Stock Units (RSUs) [Member]", "label": "Stock Options and Restricted Stock Units (RSUs) [Member]", "terseLabel": "Employee stock options and RSUs" } } }, "localname": "StockOptionsAndRestrictedStockUnitsRsusMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedPotentialDilutiveSharesDetails", "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "aosl_StockRotationAccrualCurrent": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsAccruedliabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock Rotation Accrual, Current", "label": "Stock Rotation Accrual, Current", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "terseLabel": "Stock rotation accrual" } } }, "localname": "StockRotationAccrualCurrent", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsAccruedliabilitiesDetails", "http://www.aosmd.com/role/BalanceSheetComponentsStockRotationAccrualDetails" ], "xbrltype": "monetaryItemType" }, "aosl_StockRotationAccrualIncreaeDecreaseRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Rotation Accrual Increase (Decrease) [Roll forward]", "label": "Stock Rotation Accrual Increae (Decrease) [Roll Forward]", "terseLabel": "Stock Rotation Accrual Increae (Decrease) [Roll Forward]" } } }, "localname": "StockRotationAccrualIncreaeDecreaseRollForward", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsStockRotationAccrualDetails" ], "xbrltype": "stringItemType" }, "aosl_StockRotationAccrualPayments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Stock Rotation Accrual, Payments", "label": "Stock Rotation Accrual, Payments", "negatedTerseLabel": "Utilization" } } }, "localname": "StockRotationAccrualPayments", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsStockRotationAccrualDetails" ], "xbrltype": "monetaryItemType" }, "aosl_StockRotationAccrualStockIssued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock Rotation Accrual, Stock Issued", "label": "Stock Rotation Accrual, Stock Issued", "terseLabel": "Addition" } } }, "localname": "StockRotationAccrualStockIssued", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsStockRotationAccrualDetails" ], "xbrltype": "monetaryItemType" }, "aosl_StockRotationAccrualTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Rotation Accrual [Table Text Block]", "label": "Stock Rotation Accrual [Table Text Block]", "terseLabel": "Stock Rotation Accrual" } } }, "localname": "StockRotationAccrualTableTextBlock", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "aosl_TermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term Loan [Member]", "label": "Term Loan [Member]", "terseLabel": "Term Loan" } } }, "localname": "TermLoanMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "aosl_ThirdPartyInvestorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Third Party Investors", "label": "Third Party Investors [Member]", "terseLabel": "Third Party Investors" } } }, "localname": "ThirdPartyInvestorsMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeNarrativeDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesJointVentureNarrativeDetails" ], "xbrltype": "domainItemType" }, "aosl_ThirdPartyInvestorsTransaction1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Third Party Investors, Transaction 1", "label": "Third Party Investors, Transaction 1 [Member]", "terseLabel": "1.1% equity interest sold" } } }, "localname": "ThirdPartyInvestorsTransaction1Member", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeScheduleofGainonDeconsolidationDetails" ], "xbrltype": "domainItemType" }, "aosl_ThirdPartyInvestorsTransaction2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Third Party Investors, Transaction 2", "label": "Third Party Investors, Transaction 2 [Member]", "terseLabel": "7.82% equity interest sold" } } }, "localname": "ThirdPartyInvestorsTransaction2Member", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeScheduleofGainonDeconsolidationDetails" ], "xbrltype": "domainItemType" }, "aosl_TreasuryStockReissuedAveragePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Treasury Stock Reissued, Average Price Per Share", "label": "Treasury Stock Reissued, Average Price Per Share", "terseLabel": "Treasury stock reissued average price per share" } } }, "localname": "TreasuryStockReissuedAveragePricePerShare", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/ShareholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "aosl_TreasuryStockReissuedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Treasury Stock Reissued [Member]", "label": "Treasury Stock Reissued [Member]", "terseLabel": "Treasury Stock Reissued" } } }, "localname": "TreasuryStockReissuedMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "aosl_TreasuryStockValueAcquiredCostMethodLessHandlingFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Treasury Stock, Value, Acquired, Cost Method Less Handling Fees", "label": "Treasury Stock, Value, Acquired, Cost Method Less Handling Fees", "terseLabel": "Treasury stock acquired less handling fees" } } }, "localname": "TreasuryStockValueAcquiredCostMethodLessHandlingFees", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/ShareholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "aosl_TwoThousandEighteenPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Thousand Eighteen Plan [Member]", "label": "Two Thousand Eighteen Plan [Member]", "terseLabel": "2018 Omnibus Incentive Plan" } } }, "localname": "TwoThousandEighteenPlanMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "aosl_UnrecognizedTaxBenefitAmountNettedAgainstDeferredTaxAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross amount of unrecognized tax benefits that have been netted against deferred tax assets", "label": "Unrecognized Tax Benefit, Amount Netted Against Deferred Tax Assets", "terseLabel": "Unrecognized tax benefit, amount netted against deferred tax assets" } } }, "localname": "UnrecognizedTaxBenefitAmountNettedAgainstDeferredTaxAssets", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "aosl_VariableInterestRateTermLoanMaturingAugust2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Variable Interest Rate Term Loan Maturing August 2022 [Member]", "label": "Variable Interest Rate Term Loan Maturing August 2022 [Member]", "terseLabel": "Variable Interest Rate Term Loan Maturing August 2022" } } }, "localname": "VariableInterestRateTermLoanMaturingAugust2022Member", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "aosl_WeightedAverageLeaseDiscountRateAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Lease Discount Rate [Abstract]", "label": "Weighted Average Lease Discount Rate [Abstract]", "terseLabel": "Weighted average discount rate" } } }, "localname": "WeightedAverageLeaseDiscountRateAbstract", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseSupplementalBalanceSheetInformationDetails" ], "xbrltype": "stringItemType" }, "aosl_WeightedAverageRemainingLeaseTermAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Remaining Lease Term [Abstract]", "label": "Weighted Average Remaining Lease Term [Abstract]", "terseLabel": "Weighted average remaining lease term (in years)" } } }, "localname": "WeightedAverageRemainingLeaseTermAbstract", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseSupplementalBalanceSheetInformationDetails" ], "xbrltype": "stringItemType" }, "aosl_YinHaiLeasingCompanyandChinaImportExportBankMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "YinHai Leasing Company and China Import/Export Bank [Member]", "label": "YinHai Leasing Company and China Import/Export Bank [Member]", "terseLabel": "YinHai Leasing Company and China Import/Export Bank" } } }, "localname": "YinHaiLeasingCompanyandChinaImportExportBankMember", "nsuri": "http://www.aosmd.com/20220630", "presentation": [ "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails", "http://www.aosmd.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "country_CN": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CHINA", "terseLabel": "China" } } }, "localname": "CN", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails", "http://www.aosmd.com/role/DebtShorttermborrowingDetails", "http://www.aosmd.com/role/EmployeeBenefitPlansDetails", "http://www.aosmd.com/role/RestrictedNetAssetsDetails", "http://www.aosmd.com/role/SegmentandGeographicinformationLocationandNetBookValueofLongLivedAssetsDetails", "http://www.aosmd.com/role/SegmentandGeographicinformationRevenuebyGeographicalSegmentDetails" ], "xbrltype": "domainItemType" }, "country_HK": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "HONG KONG", "terseLabel": "Hong Kong" } } }, "localname": "HK", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.aosmd.com/role/SegmentandGeographicinformationRevenuebyGeographicalSegmentDetails" ], "xbrltype": "domainItemType" }, "country_KR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "KOREA, REPUBLIC OF", "terseLabel": "South Korea" } } }, "localname": "KR", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.aosmd.com/role/SegmentandGeographicinformationRevenuebyGeographicalSegmentDetails" ], "xbrltype": "domainItemType" }, "country_TW": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TAIWAN", "terseLabel": "Taiwan" } } }, "localname": "TW", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.aosmd.com/role/EmployeeBenefitPlansDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.aosmd.com/role/EmployeeBenefitPlansDetails", "http://www.aosmd.com/role/SegmentandGeographicinformationLocationandNetBookValueofLongLivedAssetsDetails", "http://www.aosmd.com/role/SegmentandGeographicinformationRevenuebyGeographicalSegmentDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r814", "r815", "r816" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID", "terseLabel": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/AuditInformation" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r814", "r815", "r816" ], "lang": { "en-us": { "role": { "label": "Auditor Location", "terseLabel": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/AuditInformation" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r814", "r815", "r816" ], "lang": { "en-us": { "role": { "label": "Auditor Name", "terseLabel": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/AuditInformation" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r814", "r815", "r816" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r817" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityByLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.", "label": "Entity by Location [Axis]", "terseLabel": "Entity by Location [Axis]" } } }, "localname": "EntityByLocationAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/RestrictedNetAssetsDetails" ], "xbrltype": "stringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r812" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails", "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeEquityMethodInvestmentSummarizedFinancialInformationDetails", "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeNarrativeDetails", "http://www.aosmd.com/role/LeasesNarrativeDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesJointVentureNarrativeDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r812" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r812" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r820" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float", "terseLabel": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r812" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r812" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r812" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r812" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r837" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r814", "r815", "r816" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails", "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeEquityMethodInvestmentSummarizedFinancialInformationDetails", "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeNarrativeDetails", "http://www.aosmd.com/role/LeasesNarrativeDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesJointVentureNarrativeDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A domain representing all geographic locations. Depending on the axis, it may contain members that are specific geographies, or synthetic entity-specific geographical groups.", "label": "Location [Domain]", "terseLabel": "Location [Domain]" } } }, "localname": "LocationDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/RestrictedNetAssetsDetails" ], "xbrltype": "domainItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r811" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r813" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.aosmd.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r159", "r332", "r337", "r343", "r613", "r614", "r622", "r623", "r692", "r806", "r822", "r833", "r834", "r835" ], "lang": { "en-us": { "role": { "documentation": "Information by consolidated entity or group of entities.", "label": "Consolidated Entities [Axis]", "terseLabel": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.aosmd.com/role/RestrictedNetAssetsDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesJointVentureNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r159", "r332", "r337", "r343", "r613", "r614", "r622", "r623", "r692", "r806", "r822", "r833", "r834", "r835" ], "lang": { "en-us": { "role": { "documentation": "Entity or group of entities consolidated into reporting entity.", "label": "Consolidated Entities [Domain]", "terseLabel": "Consolidated Entities [Domain]" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.aosmd.com/role/RestrictedNetAssetsDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesJointVentureNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": { "auth_ref": [ "r819" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.", "label": "Contractual Obligation, Fiscal Year Maturity [Table Text Block]", "terseLabel": "Fiscal Year Maturity Schedule" } } }, "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.aosmd.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r85", "r87", "r157", "r158", "r349", "r386", "r836" ], "lang": { "en-us": { "role": { "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.aosmd.com/role/DebtDebtFinancingDetails" ], "xbrltype": "stringItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of investment including named security. Excludes entity that is consolidated.", "label": "Investment, Name [Domain]", "terseLabel": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeNarrativeDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesJointVentureNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r247", "r414", "r418", "r778" ], "lang": { "en-us": { "role": { "documentation": "Information by name or description of a single external customer or a group of external customers.", "label": "Customer [Axis]", "terseLabel": "Major Customers [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermliabilitiesDetails", "http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomersScheduleofConcentrationRiskDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r311", "r313", "r314", "r315", "r348", "r385", "r491", "r498", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r775", "r779", "r807", "r808" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomersScheduleofConcentrationRiskDetails", "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails", "http://www.aosmd.com/role/EmployeeBenefitPlansDetails", "http://www.aosmd.com/role/RestrictedNetAssetsDetails", "http://www.aosmd.com/role/SharebasedCompensationEmployeeSharePurchasePlanDetails", "http://www.aosmd.com/role/SharebasedCompensationFairValueWeightedAverageAssumptionsDetails", "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails", "http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails", "http://www.aosmd.com/role/ShareholdersEquityDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r311", "r313", "r314", "r315", "r348", "r385", "r491", "r498", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r775", "r779", "r807", "r808" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomersScheduleofConcentrationRiskDetails", "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails", "http://www.aosmd.com/role/EmployeeBenefitPlansDetails", "http://www.aosmd.com/role/RestrictedNetAssetsDetails", "http://www.aosmd.com/role/SharebasedCompensationEmployeeSharePurchasePlanDetails", "http://www.aosmd.com/role/SharebasedCompensationFairValueWeightedAverageAssumptionsDetails", "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails", "http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails", "http://www.aosmd.com/role/ShareholdersEquityDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r247", "r414", "r418", "r778" ], "lang": { "en-us": { "role": { "documentation": "Single external customer or group of external customers.", "label": "Customer [Domain]", "terseLabel": "Name of Major Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermliabilitiesDetails", "http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomersScheduleofConcentrationRiskDetails" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.", "label": "Ownership [Axis]", "terseLabel": "Ownership [Axis]" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeNarrativeDetails", "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeScheduleofGainonDeconsolidationDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesJointVentureNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.", "label": "Ownership [Domain]", "terseLabel": "Ownership [Domain]" } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeNarrativeDetails", "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeScheduleofGainonDeconsolidationDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesJointVentureNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ParentCompanyMember": { "auth_ref": [ "r159" ], "lang": { "en-us": { "role": { "documentation": "The registrant that controls, directly or indirectly, another entity (or entities). The usual condition for control is ownership of a majority (over 50 percent) of the outstanding voting stock. The power to control may also exist with a lesser percentage of ownership, for example, by contract, lease, agreement with other stockholders or by court decree.", "label": "Parent Company [Member]", "terseLabel": "Parent Company" } } }, "localname": "ParentCompanyMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesJointVentureNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r243", "r313", "r314", "r414", "r416", "r706", "r774", "r776" ], "lang": { "en-us": { "role": { "documentation": "Information by product and service, or group of similar products and similar services.", "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.aosmd.com/role/SegmentandGeographicinformationRevenuebyProductTypeDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r243", "r313", "r314", "r414", "r416", "r706", "r774", "r776" ], "lang": { "en-us": { "role": { "documentation": "Product or service, or a group of similar products or similar services.", "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.aosmd.com/role/SegmentandGeographicinformationRevenuebyProductTypeDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r303", "r311", "r313", "r314", "r315", "r348", "r385", "r442", "r491", "r498", "r533", "r534", "r535", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r775", "r779", "r807", "r808" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomersScheduleofConcentrationRiskDetails", "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails", "http://www.aosmd.com/role/EmployeeBenefitPlansDetails", "http://www.aosmd.com/role/RestrictedNetAssetsDetails", "http://www.aosmd.com/role/SharebasedCompensationEmployeeSharePurchasePlanDetails", "http://www.aosmd.com/role/SharebasedCompensationFairValueWeightedAverageAssumptionsDetails", "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails", "http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails", "http://www.aosmd.com/role/ShareholdersEquityDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r303", "r311", "r313", "r314", "r315", "r348", "r385", "r442", "r491", "r498", "r533", "r534", "r535", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r775", "r779", "r807", "r808" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomersScheduleofConcentrationRiskDetails", "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails", "http://www.aosmd.com/role/EmployeeBenefitPlansDetails", "http://www.aosmd.com/role/RestrictedNetAssetsDetails", "http://www.aosmd.com/role/SharebasedCompensationEmployeeSharePurchasePlanDetails", "http://www.aosmd.com/role/SharebasedCompensationFairValueWeightedAverageAssumptionsDetails", "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails", "http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails", "http://www.aosmd.com/role/ShareholdersEquityDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r86", "r87", "r157", "r158", "r349", "r386" ], "lang": { "en-us": { "role": { "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.aosmd.com/role/DebtDebtFinancingDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r176", "r181", "r309", "r496" ], "lang": { "en-us": { "role": { "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r261" ], "lang": { "en-us": { "role": { "documentation": "Information by name of investment including named security. Excludes entity that is consolidated.", "label": "Investment, Name [Axis]", "terseLabel": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeNarrativeDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesJointVentureNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": { "auth_ref": [ "r166", "r832" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]", "terseLabel": "Valuation and Qualifying Accounts" } } }, "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.aosmd.com/role/ScheduleIIValuationandQualifyingAccounts" ], "xbrltype": "textBlockItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r244", "r245", "r414", "r417", "r777", "r797", "r798", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r821", "r824", "r825", "r826", "r827", "r828", "r829", "r830", "r831" ], "lang": { "en-us": { "role": { "documentation": "Geographical area.", "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails", "http://www.aosmd.com/role/DebtShorttermborrowingDetails", "http://www.aosmd.com/role/SegmentandGeographicinformationLocationandNetBookValueofLongLivedAssetsDetails", "http://www.aosmd.com/role/SegmentandGeographicinformationRevenuebyGeographicalSegmentDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r244", "r245", "r414", "r417", "r777", "r790", "r797", "r798", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r821", "r823" ], "lang": { "en-us": { "role": { "documentation": "Information by geographical components.", "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails", "http://www.aosmd.com/role/DebtShorttermborrowingDetails", "http://www.aosmd.com/role/SegmentandGeographicinformationLocationandNetBookValueofLongLivedAssetsDetails", "http://www.aosmd.com/role/SegmentandGeographicinformationRevenuebyGeographicalSegmentDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r176", "r181", "r309", "r496", "r696" ], "lang": { "en-us": { "role": { "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "stringItemType" }, "srt_SubsidiariesMember": { "auth_ref": [ "r467", "r686", "r687", "r689" ], "lang": { "en-us": { "role": { "documentation": "Entity owned or controlled by another entity.", "label": "Subsidiaries [Member]", "terseLabel": "Subsidiaries [Member]" } } }, "localname": "SubsidiariesMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.aosmd.com/role/RestrictedNetAssetsDetails" ], "xbrltype": "domainItemType" }, "srt_ValuationAndQualifyingAccountsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]", "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]" } } }, "localname": "ValuationAndQualifyingAccountsAbstract", "nsuri": "http://fasb.org/srt/2022", "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]", "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]" } } }, "localname": "ValuationAndQualifyingAccountsDisclosureLineItems", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.aosmd.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsDisclosureTable": { "auth_ref": [ "r160", "r161", "r162", "r164", "r165", "r832" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]", "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]" } } }, "localname": "ValuationAndQualifyingAccountsDisclosureTable", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.aosmd.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r71", "r695" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableGross": { "auth_ref": [ "r52", "r249" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsAccountsreceivableDetails": { "order": 1.0, "parentTag": "us-gaap_AccountsReceivableNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.", "label": "Accounts Receivable, before Allowance for Credit Loss", "terseLabel": "Accounts receivable" } } }, "localname": "AccountsReceivableGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsAccountsreceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r793" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]", "terseLabel": "Accounts Receivable" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomersScheduleofConcentrationRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNet": { "auth_ref": [ "r750", "r792" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsAccountsreceivableDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.", "label": "Accounts Receivable, after Allowance for Credit Loss", "totalLabel": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsAccountsreceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r249", "r250" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r42", "r726", "r752" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "terseLabel": "Income taxes payable" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesNoncurrent": { "auth_ref": [ "r45", "r726", "r752" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.", "label": "Accrued Income Taxes, Noncurrent", "terseLabel": "Income taxes payable - long-term" } } }, "localname": "AccruedIncomeTaxesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r75" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsAccruedliabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued liabilities", "totalLabel": "Accrued liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsAccruedliabilitiesDetails", "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent": { "auth_ref": [ "r733", "r763" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermliabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs.", "label": "Accrued Payroll Taxes", "terseLabel": "Deferred payroll taxes" } } }, "localname": "AccruedPayrollTaxesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermliabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r75" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsAccruedliabilitiesDetails": { "order": 8.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Professional Fees, Current", "terseLabel": "Accrued professional fees" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsAccruedliabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedSalariesCurrent": { "auth_ref": [ "r27", "r75" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsAccruedliabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Salaries, Current", "terseLabel": "Accrued compensation and benefits" } } }, "localname": "AccruedSalariesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsAccruedliabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r34", "r295" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsPropertyplantandequipmentDetails": { "order": 2.0, "parentTag": "aosl_PropertyPlantAndEquipmentExcludingEquipmentAndConstructionInProgressNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedTerseLabel": "Less accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsPropertyplantandequipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r56", "r92", "r93", "r94", "r757", "r784", "r785" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive income" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r91", "r94", "r101", "r102", "r103", "r168", "r169", "r170", "r620", "r683", "r780", "r781" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Income (loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Acquired Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsIntangibleassetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r54", "r695" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r168", "r169", "r170", "r545", "r546", "r547", "r631" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation", "negatedTerseLabel": "Withholding tax on restricted stock units" } } }, "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement.", "label": "APIC, Share-Based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition", "terseLabel": "Restricted stock units settlement in connection with service" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r501", "r550", "r551" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Share-based compensation expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income (loss) to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r554" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising Cost [Policy Text Block]", "terseLabel": "Advertising" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdvertisingExpense": { "auth_ref": [ "r555" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.", "label": "Advertising Expense", "terseLabel": "Advertising expense" } } }, "localname": "AdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesAdvertisingExpenseNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r538" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-Based Payment Arrangement, Expense", "negatedTerseLabel": "Share-based Payment Arrangement, Expense", "terseLabel": "Allocated share-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeScheduleofGainonDeconsolidationDetails", "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails", "http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails", "http://www.aosmd.com/role/SharebasedCompensationSharebasedCompensationExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForCreditLossMember": { "auth_ref": [ "r160", "r161", "r162", "r164", "r165" ], "lang": { "en-us": { "role": { "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]", "terseLabel": "SEC Schedule, 12-09, Allowance, Credit Loss" } } }, "localname": "AllowanceForCreditLossMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r60", "r255", "r267" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsAccountsreceivableDetails": { "order": 3.0, "parentTag": "us-gaap_AccountsReceivableNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "negatedTerseLabel": "Less: Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsAccountsreceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r135", "r281", "r287" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsIntangibleassetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r194" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Potential dilutive securities (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedPotentialDilutiveSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r194" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedPotentialDilutiveSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedPotentialDilutiveSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r194" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedPotentialDilutiveSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r135", "r291" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Asset Impairment Charges", "verboseLabel": "Impairment of long-lived assets" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesLonglivedAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r38", "r151", "r226", "r232", "r239", "r264", "r332", "r333", "r334", "r336", "r337", "r338", "r339", "r340", "r341", "r343", "r344", "r613", "r622", "r640", "r693", "r695", "r724", "r751" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r25", "r70", "r151", "r264", "r332", "r333", "r334", "r336", "r337", "r338", "r339", "r340", "r341", "r343", "r344", "r613", "r622", "r640", "r693", "r695" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "terseLabel": "Current assets", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeEquityMethodInvestmentSummarizedFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [ "r151", "r264", "r332", "r333", "r334", "r336", "r337", "r338", "r339", "r340", "r341", "r343", "r344", "r613", "r622", "r640", "r693" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.", "label": "Assets, Noncurrent", "terseLabel": "Non-current assets" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeEquityMethodInvestmentSummarizedFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r505", "r506", "r507", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r525", "r526", "r528", "r529", "r532", "r533", "r534", "r535", "r536" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationEmployeeSharePurchasePlanDetails", "http://www.aosmd.com/role/SharebasedCompensationFairValueWeightedAverageAssumptionsDetails", "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails", "http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails", "http://www.aosmd.com/role/SharebasedCompensationSharebasedCompensationExpensesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r628", "r629" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BalanceSheetRelatedDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Balance Sheet Related Disclosures [Abstract]", "terseLabel": "Balance Sheet Related Disclosures [Abstract]" } } }, "localname": "BalanceSheetRelatedDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_BaseRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum rate investor will accept.", "label": "Base Rate [Member]", "terseLabel": "Base Rate" } } }, "localname": "BaseRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails", "http://www.aosmd.com/role/DebtShorttermborrowingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Preparation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]", "terseLabel": "Building" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsPropertyplantandequipmentDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CapitalAdditionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contractual obligation to increase property, plant and equipment either through construction or future purchases.", "label": "Capital Addition Purchase Commitments [Member]", "terseLabel": "Property and equipment purchase commitments [Member]" } } }, "localname": "CapitalAdditionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CommitmentsandContingenciesPurchaseCommitmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "auth_ref": [ "r140", "r141", "r142" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.", "label": "Capital Expenditures Incurred but Not yet Paid", "terseLabel": "Property and equipment purchased but not yet paid" } } }, "localname": "CapitalExpendituresIncurredButNotYetPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesBasisofPresentationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedComputerSoftwareNet": { "auth_ref": [ "r809" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.", "label": "Capitalized Computer Software, Net", "terseLabel": "Unamortized capitalized software development costs" } } }, "localname": "CapitalizedComputerSoftwareNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsPropertyplantandequipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r21", "r32", "r137" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 10.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r138", "r722" ], "lang": { "en-us": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents, Restricted Cash" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r130", "r137", "r143" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents and restricted cash at end of year", "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of year", "totalLabel": "Total cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]", "terseLabel": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r130", "r643" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase in cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashDivestedFromDeconsolidation": { "auth_ref": [ "r123" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reduction in cash due to no longer including the former subsidiary's cash in the consolidated entity's cash.", "label": "Cash Divested from Deconsolidation", "negatedTerseLabel": "Deconsolidation of cash and cash equivalents of the JV Company" } } }, "localname": "CashDivestedFromDeconsolidation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "Supplemental disclosures of non-cash investing and financing information:", "verboseLabel": "Non-cash investing and financing information:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.aosmd.com/role/LeasesScheduleofLeaseSupplementalCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r49", "r50", "r51", "r148", "r151", "r184", "r188", "r189", "r191", "r193", "r202", "r203", "r204", "r264", "r332", "r337", "r338", "r339", "r343", "r344", "r383", "r384", "r388", "r392", "r399", "r640", "r818" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]", "terseLabel": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ShareholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r80", "r734", "r762" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Note 15)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r305", "r306", "r307", "r319", "r794" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CommitmentsandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Declared", "terseLabel": "Common stock, dividends declared per share" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ShareholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r168", "r169", "r631" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Shares" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY", "http://www.aosmd.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract]", "terseLabel": "Common shares, par value $0.002 per share:", "verboseLabel": "Common Shares" } } }, "localname": "CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.aosmd.com/role/ShareholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common shares, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.aosmd.com/role/ShareholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common shares, authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.aosmd.com/role/ShareholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "periodEndLabel": "Balance (in shares)", "periodStartLabel": "Balance (in shares)", "terseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r51", "r399" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r51", "r695" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Authorized: 100,000 shares; issued and outstanding: 33,988 shares and 27,371 shares, respectively at June 30, 2022 and 32,975 shares and 26,350 shares, respectively at June 30, 2021" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": { "auth_ref": [ "r419", "r420", "r499", "r553" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.", "label": "Compensation and Employee Benefit Plans [Text Block]", "terseLabel": "Employee Benefit Plans" } } }, "localname": "CompensationAndEmployeeBenefitPlansTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EmployeeBenefitPlans" ], "xbrltype": "textBlockItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]", "terseLabel": "Retirement Benefits [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Components of Deferred Tax Assets [Abstract]", "terseLabel": "Deferred tax assets:" } } }, "localname": "ComponentsOfDeferredTaxAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Components of Deferred Tax Assets and Liabilities [Abstract]", "terseLabel": "Components of deferred tax assets and liabilities" } } }, "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Components of Deferred Tax Liabilities [Abstract]", "terseLabel": "Deferred tax liabilities:" } } }, "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r96", "r98", "r99", "r110", "r740", "r770" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive income (loss) attributable to Alpha and Omega Semiconductor Limited" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r96", "r98", "r109", "r611", "r612", "r626", "r739", "r769" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "terseLabel": "Less: Noncontrolling interest" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r96", "r98", "r108", "r610", "r626", "r738", "r768" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Comprehensive income (loss)" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for comprehensive income.", "label": "Comprehensive Income, Policy [Policy Text Block]", "terseLabel": "Comprehensive Income (loss)" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]", "terseLabel": "Computer equipment and software" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsPropertyplantandequipmentDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r211", "r212", "r247", "r637", "r638", "r793" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomersScheduleofConcentrationRiskDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesRisksandUncertaintiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r211", "r212", "r247", "r637", "r638", "r787", "r793" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomersScheduleofConcentrationRiskDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesRisksandUncertaintiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r211", "r212", "r247", "r637", "r638", "r787", "r793" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomersScheduleofConcentrationRiskDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesRisksandUncertaintiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r217" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "Concentration Risk Disclosure [Text Block]", "terseLabel": "Concentration of Credit Risk and Significant Customers" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomers" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]", "terseLabel": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermliabilitiesDetails", "http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomersScheduleofConcentrationRiskDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesRisksandUncertaintiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r211", "r212", "r247", "r637", "r638" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Percent of wafers manufactured", "verboseLabel": "Concentration risk, percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomersScheduleofConcentrationRiskDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesRisksandUncertaintiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r209", "r211", "r212", "r213", "r637", "r639", "r793" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]", "terseLabel": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermliabilitiesDetails", "http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomersScheduleofConcentrationRiskDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesRisksandUncertaintiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r211", "r212", "r247", "r637", "r638", "r793" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomersScheduleofConcentrationRiskDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesRisksandUncertaintiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConstructionInProgressGross": { "auth_ref": [ "r294" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsPropertyplantandequipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in Progress, Gross", "terseLabel": "Equipment and construction in progress" } } }, "localname": "ConstructionInProgressGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsPropertyplantandequipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "auth_ref": [ "r411", "r412", "r415" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermliabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Contract with Customer, Liability, Noncurrent", "terseLabel": "Customer deposits" } } }, "localname": "ContractWithCustomerLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermliabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CorporateJointVentureMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Corporation owned and operated by a small group of ventures to accomplish a mutually beneficial venture or project.", "label": "Corporate Joint Venture [Member]", "terseLabel": "Corporate Joint Venture" } } }, "localname": "CorporateJointVentureMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeNarrativeDetails", "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeScheduleofGainonDeconsolidationDetails", "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails", "http://www.aosmd.com/role/RelatedPartyTransactionsDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesJointVentureNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsProductLineMember": { "auth_ref": [ "r211" ], "lang": { "en-us": { "role": { "documentation": "Cost of product sold and service rendered from specified product or service, when it serves as benchmark in concentration of risk calculation.", "label": "Cost of Goods and Service, Product and Service Benchmark [Member]", "terseLabel": "Cost of Goods and Service, Product and Service Benchmark" } } }, "localname": "CostOfGoodsProductLineMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesRisksandUncertaintiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r117", "r151", "r264", "r332", "r333", "r334", "r337", "r338", "r339", "r340", "r341", "r343", "r344", "r640" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "verboseLabel": "Operating expenses" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeEquityMethodInvestmentSummarizedFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of goods sold" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationSharebasedCompensationExpensesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails", "http://www.aosmd.com/role/DebtShorttermborrowingDetails", "http://www.aosmd.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails", "http://www.aosmd.com/role/DebtShorttermborrowingDetails", "http://www.aosmd.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease": { "auth_ref": [ "r647" ], "lang": { "en-us": { "role": { "documentation": "The increase (decrease) in cumulative translation adjustment before transfers included in determining net income.", "label": "Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease)", "terseLabel": "Cumulative translation adjustment removal" } } }, "localname": "CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeScheduleofGainonDeconsolidationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r152", "r586", "r594" ], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Current Federal Tax Expense (Benefit)", "terseLabel": "Current" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r152", "r586" ], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 3.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Foreign Tax Expense (Benefit)", "terseLabel": "Current" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r152", "r586", "r594" ], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 5.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Current State and Local Tax Expense (Benefit)", "terseLabel": "Current" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r210", "r247" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomersScheduleofConcentrationRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r607" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer relationships" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsIntangibleassetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt, Current [Abstract]", "terseLabel": "Short-term Debt" } } }, "localname": "DebtCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r147", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r362", "r369", "r370", "r372", "r379" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Debt" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/Debt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r41", "r42", "r43", "r150", "r159", "r345", "r346", "r347", "r348", "r349", "r350", "r352", "r358", "r359", "r360", "r361", "r363", "r364", "r365", "r366", "r367", "r368", "r375", "r376", "r377", "r378", "r655", "r725", "r728", "r749" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtAccountsReceivableFactoringAgreementDetails", "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails", "http://www.aosmd.com/role/DebtShorttermborrowingDetails", "http://www.aosmd.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Basis spread on variable rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtAccountsReceivableFactoringAgreementDetails", "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails", "http://www.aosmd.com/role/DebtShorttermborrowingDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r43", "r373", "r728", "r749" ], "calculation": { "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-Term Debt, Gross", "verboseLabel": "Principal amount" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentCollateralAmount": { "auth_ref": [ "r745" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets pledged to secure a debt instrument.", "label": "Debt Instrument, Collateral Amount", "terseLabel": "Debt instrument, collateral amount" } } }, "localname": "DebtInstrumentCollateralAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtDebtFinancingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r77", "r346" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Stated interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails", "http://www.aosmd.com/role/DebtShorttermborrowingDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtAccountsReceivableFactoringAgreementDetails", "http://www.aosmd.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r78", "r150", "r159", "r345", "r346", "r347", "r348", "r349", "r350", "r352", "r358", "r359", "r360", "r361", "r363", "r364", "r365", "r366", "r367", "r368", "r375", "r376", "r377", "r378", "r655" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtAccountsReceivableFactoringAgreementDetails", "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails", "http://www.aosmd.com/role/DebtShorttermborrowingDetails", "http://www.aosmd.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r78", "r150", "r159", "r345", "r346", "r347", "r348", "r349", "r350", "r352", "r358", "r359", "r360", "r361", "r363", "r364", "r365", "r366", "r367", "r368", "r371", "r375", "r376", "r377", "r378", "r400", "r403", "r404", "r405", "r652", "r653", "r655", "r656", "r746" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtAccountsReceivableFactoringAgreementDetails", "http://www.aosmd.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Debt term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails", "http://www.aosmd.com/role/DebtShorttermborrowingDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtLongtermAndShorttermCombinedAmount": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails": { "order": 1.0, "parentTag": "aosl_DebtLongTermAndShortTermCombinedAmountNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt.", "label": "Debt, Long-Term and Short-Term, Combined Amount", "terseLabel": "Principal amount", "totalLabel": "Total principal of debt" } } }, "localname": "DebtLongtermAndShorttermCombinedAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtLongtermAndShorttermCombinedAmountAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt, Long-Term and Short-Term, Combined Amount [Abstract]", "terseLabel": "Total" } } }, "localname": "DebtLongtermAndShorttermCombinedAmountAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeconsolidationGainOrLossAmount": { "auth_ref": [ "r621" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from deconsolidation of subsidiary and derecognition of group of assets constituting transfer of business or nonprofit activity, excluding conveyance of oil and gas mineral rights and transfer of good or service in contract with customer.", "label": "Deconsolidation, Gain (Loss), Amount", "negatedTerseLabel": "Gain on deconsolidation of the JV Company", "terseLabel": "Gain on deconsolidation of the JV Company" } } }, "localname": "DeconsolidationGainOrLossAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeScheduleofGainonDeconsolidationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": { "auth_ref": [ "r566" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.", "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible", "terseLabel": "Decrease in unrecognized tax benefits is reasonably possible" } } }, "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationShareBasedArrangementsLiabilityCurrent": { "auth_ref": [ "r75" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for stock option plans and other equity-based compensation arrangements payable within one year (or the operating cycle, if longer).", "label": "Deferred Compensation Share-Based Arrangements, Liability, Current", "terseLabel": "Deferred compensation share-based arrangements, liability, current" } } }, "localname": "DeferredCompensationShareBasedArrangementsLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r152", "r587", "r594" ], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred Federal Income Tax Expense (Benefit)", "terseLabel": "Deferred" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsCurrentGross": { "auth_ref": [ "r654" ], "calculation": { "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails": { "order": 1.0, "parentTag": "us-gaap_ShortTermBorrowings", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs classified as current. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Gross, Current", "negatedTerseLabel": "Less: debt issuance costs" } } }, "localname": "DeferredFinanceCostsCurrentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsGross": { "auth_ref": [ "r654" ], "calculation": { "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails": { "order": 2.0, "parentTag": "aosl_DebtLongTermAndShortTermCombinedAmountNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Gross", "negatedLabel": "Less: debt issuance costs", "negatedTerseLabel": "Less: debt issuance costs" } } }, "localname": "DeferredFinanceCostsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNoncurrentGross": { "auth_ref": [ "r654" ], "calculation": { "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Cost, Gross, Noncurrent", "negatedTerseLabel": "Less: debt issuance costs" } } }, "localname": "DeferredFinanceCostsNoncurrentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r152", "r587", "r594" ], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 4.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Foreign Income Tax Expense (Benefit)", "terseLabel": "Deferred" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r135", "r152", "r587", "r594", "r595", "r596" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "terseLabel": "Deferred income tax on deconsolidation and changes of equity interest in the JV Company" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r47", "r48", "r576", "r727", "r748" ], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails_1": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Tax Liabilities, Gross", "negatedTotalLabel": "Total deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetDomain": { "auth_ref": [ "r578" ], "lang": { "en-us": { "role": { "documentation": "Identification of the deferred tax asset for which a valuation reserve exists.", "label": "Deferred Tax Asset [Domain]", "terseLabel": "Deferred Tax Asset [Domain]" } } }, "localname": "DeferredTaxAssetDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r577" ], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "totalLabel": "Total deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "auth_ref": [ "r579" ], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.", "label": "Deferred Tax Assets, Net", "totalLabel": "Net deferred tax assets/(liabilities)" } } }, "localname": "DeferredTaxAssetsLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r579" ], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails_1": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "totalLabel": "Total deferred tax assets, net of valuation allowance" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net [Abstract]", "terseLabel": "Current and non-current deferred tax assets and liabilities" } } }, "localname": "DeferredTaxAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r584", "r585" ], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "terseLabel": "Net operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration", "terseLabel": "Tax credit carryforward, not subject to expiration" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration", "terseLabel": "Tax credit carryforward, subject to expiration" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": { "auth_ref": [ "r582", "r584", "r585" ], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.", "label": "Deferred Tax Assets, Tax Credit Carryforwards", "terseLabel": "Tax credits" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r578" ], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedTerseLabel": "Valuation allowance", "terseLabel": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails", "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r561", "r579" ], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities, Net", "negatedTotalLabel": "Net deferred tax assets/(liabilities)" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from reserves and accruals.", "label": "Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals", "negatedTerseLabel": "Investments" } } }, "localname": "DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome": { "auth_ref": [ "r584", "r585" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from tax deferred revenue or income classified as other.", "label": "Deferred Tax Liabilities, Tax Deferred Income", "terseLabel": "Deferred tax liability" } } }, "localname": "DeferredTaxLiabilitiesTaxDeferredIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]", "terseLabel": "Retirement Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EmployeeBenefitPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.", "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount", "terseLabel": "Company contributions to retirement plan" } } }, "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EmployeeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.", "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay", "terseLabel": "Employer matching contribution, percent of employees' gross pay" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EmployeeBenefitPlansDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage employer matches of the employee's percentage contribution matched.", "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match", "terseLabel": "Employer matching contribution, percent of match" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EmployeeBenefitPlansDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.", "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent", "terseLabel": "Employee maximum salary deferral contribution, percent" } } }, "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EmployeeBenefitPlansDetails" ], "xbrltype": "percentItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r135", "r293" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsPropertyplantandequipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAmortizationAndAccretionNet": { "auth_ref": [ "r135" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Depreciation, Amortization and Accretion, Net", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAmortizationAndAccretionNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r504", "r505", "r539", "r540", "r542", "r553" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-Based Payment Arrangement [Text Block]", "terseLabel": "Share-based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Discontinued Operations and Disposal Groups [Abstract]" } } }, "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": { "auth_ref": [ "r19", "r302" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]", "terseLabel": "Equity Method Investment in Equity Investee" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvestee" ], "xbrltype": "textBlockItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Tax Authority [Member]", "terseLabel": "Federal" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DomesticPlanMember": { "auth_ref": [ "r486", "r487", "r497" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Domestic Plan [Member]", "terseLabel": "Domestic Plan" } } }, "localname": "DomesticPlanMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EmployeeBenefitPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DueToAffiliateCurrent": { "auth_ref": [ "r39", "r156", "r687", "r788" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due to Affiliate, Current", "terseLabel": "Payable related to equity investee, net" } } }, "localname": "DueToAffiliateCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r156", "r335", "r337", "r338", "r342", "r343", "r344", "r687", "r732", "r764" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties.", "label": "Due to Related Parties", "terseLabel": "Payable to related party" } } }, "localname": "DueToRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Net income (loss) per common share attributable to Alpha and Omega Semiconductor Limited" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r111", "r173", "r174", "r175", "r176", "r177", "r182", "r184", "r191", "r192", "r193", "r197", "r198", "r632", "r633", "r741", "r771" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedBasicandDilutedIncomePerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r111", "r173", "r174", "r175", "r176", "r177", "r184", "r191", "r192", "r193", "r197", "r198", "r632", "r633", "r741", "r771" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedBasicandDilutedIncomePerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareReconciliationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share Reconciliation [Abstract]", "terseLabel": "Net income (loss) per share attributable to common shareholders:" } } }, "localname": "EarningsPerShareReconciliationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedBasicandDilutedIncomePerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r194", "r195", "r196", "r199" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Net Income (Loss) Per Common Share Attributable to Alpha and Omega Semiconductor Limited" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimited" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r643" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r563" ], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "totalLabel": "Effective income tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]", "terseLabel": "Effective income tax rate reconciliation" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r154", "r563", "r598" ], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 4.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "United States statutory rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r563", "r598" ], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 8.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.", "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent", "terseLabel": "Foreign taxes, net" } } }, "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": { "auth_ref": [ "r563", "r598" ], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 2.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent", "terseLabel": "Non-deductible expenses" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "auth_ref": [ "r563", "r598" ], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 9.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent", "terseLabel": "Other" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": { "auth_ref": [ "r552", "r563" ], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 1.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.", "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent", "negatedTerseLabel": "Stock-based compensation" } } }, "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign": { "auth_ref": [ "r563", "r598" ], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 5.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit.", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent", "negatedTerseLabel": "Foreign Derived Intangible Income Deduction" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsForeign", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsInvestment": { "auth_ref": [ "r563", "r598" ], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 6.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to investment tax credit.", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Investment, Percent", "terseLabel": "Outside basis difference on equity method investment" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsInvestment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": { "auth_ref": [ "r563", "r598" ], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 3.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent", "negatedTerseLabel": "Research and development credit" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "terseLabel": "Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationSharebasedCompensationExpensesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r541" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationSharebasedCompensationExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r541" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Weighted Average Remaining Recognition Period (Years)", "verboseLabel": "Recognition period of share-based compensation expense (in years)" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails", "http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails", "http://www.aosmd.com/role/SharebasedCompensationSharebasedCompensationExpensesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.", "label": "Employee Stock [Member]", "terseLabel": "Employee Stock" } } }, "localname": "EmployeeStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedPotentialDilutiveSharesDetails", "http://www.aosmd.com/role/SharebasedCompensationEmployeeSharePurchasePlanDetails", "http://www.aosmd.com/role/SharebasedCompensationFairValueWeightedAverageAssumptionsDetails", "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-Based Payment Arrangement, Option [Member]", "terseLabel": "Stock Options" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationFairValueWeightedAverageAssumptionsDetails", "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services.", "label": "Equipment [Member]", "terseLabel": "Equipment and tooling" } } }, "localname": "EquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r101", "r102", "r103", "r168", "r169", "r170", "r172", "r178", "r180", "r201", "r266", "r399", "r406", "r545", "r546", "r547", "r590", "r591", "r631", "r645", "r646", "r647", "r648", "r649", "r650", "r683", "r780", "r781", "r782" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": { "auth_ref": [ "r259" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.", "label": "Equity Method Investment, Other than Temporary Impairment", "terseLabel": "Impairment of privately-held investment" } } }, "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r261" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Equity Method Investment, Ownership Percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeNarrativeDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesJointVentureNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": { "auth_ref": [ "r112", "r113", "r135" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 5.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.", "label": "Equity Method Investment, Realized Gain (Loss) on Disposal", "negatedTerseLabel": "Loss on changes of equity interest in the JV Company, net", "terseLabel": "Loss on changes of equity interest in the JV Company, net", "verboseLabel": "Gain on equity interest sold" } } }, "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeNarrativeDetails", "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeScheduleofGainonDeconsolidationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets": { "auth_ref": [ "r262" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This item represents the entity's ownership percentage in the investee multiplied by the investee's total equity.", "label": "Equity Method Investment, Underlying Equity in Net Assets", "terseLabel": "Carrying amount of net assets of the JV Company at December 1, 2021" } } }, "localname": "EquityMethodInvestmentUnderlyingEquityInNetAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeScheduleofGainonDeconsolidationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r33", "r227", "r260" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 12.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Equity method investment" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentsTextBlock": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.", "label": "Equity Method Investments [Table Text Block]", "terseLabel": "Summarized financial information of joint venture" } } }, "localname": "EquityMethodInvestmentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r634", "r635" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Federal Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "U.S. federal taxes:" } } }, "localname": "FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinanceLeaseInterestExpense": { "auth_ref": [ "r664", "r669", "r679" ], "calculation": { "http://www.aosmd.com/role/LeasesScheduleofLeaseCostDetails": { "order": 4.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense on finance lease liability.", "label": "Finance Lease, Interest Expense", "terseLabel": "Interest" } } }, "localname": "FinanceLeaseInterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseInterestPaymentOnLiability": { "auth_ref": [ "r666", "r673" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest paid on finance lease liability.", "label": "Finance Lease, Interest Payment on Liability", "terseLabel": "Operating cash flows from finance lease" } } }, "localname": "FinanceLeaseInterestPaymentOnLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, to be Paid [Abstract]", "terseLabel": "Finance Lease, Liability, Payment, Due [Abstract]" } } }, "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details" ], "xbrltype": "stringItemType" }, "us-gaap_FinanceLeaseLiability": { "auth_ref": [ "r662", "r678" ], "calculation": { "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details_1": { "order": 2.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.", "label": "Finance Lease, Liability", "terseLabel": "Total lease liabilities" } } }, "localname": "FinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityCurrent": { "auth_ref": [ "r662" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.", "label": "Finance Lease, Liability, Current", "terseLabel": "Finance lease liabilities" } } }, "localname": "FinanceLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsPropertyplantandequipmentDetails", "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r678" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.", "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]", "terseLabel": "Schedule of Finance Lease Liability Maturities" } } }, "localname": "FinanceLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "auth_ref": [ "r662" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.", "label": "Finance Lease, Liability, Noncurrent", "terseLabel": "Finance lease liabilities - long-term" } } }, "localname": "FinanceLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "auth_ref": [ "r678" ], "calculation": { "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.", "label": "Finance Lease, Liability, to be Paid", "totalLabel": "Total minimum lease payments" } } }, "localname": "FinanceLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r678" ], "calculation": { "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details": { "order": 6.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r678" ], "calculation": { "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details": { "order": 1.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year One", "terseLabel": "2021" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r678" ], "calculation": { "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details": { "order": 5.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Five", "terseLabel": "2025" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r678" ], "calculation": { "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details": { "order": 4.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Four", "terseLabel": "2024" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r678" ], "calculation": { "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details": { "order": 3.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Three", "terseLabel": "2023" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r678" ], "calculation": { "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details": { "order": 2.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Two", "terseLabel": "2022" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r678" ], "calculation": { "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details_1": { "order": 1.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.", "label": "Finance Lease, Liability, Undiscounted Excess Amount", "negatedTerseLabel": "Less amount representing interest" } } }, "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeasePrincipalPayments": { "auth_ref": [ "r665", "r673" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for principal payment on finance lease.", "label": "Finance Lease, Principal Payments", "terseLabel": "Financing cash flows from finance lease" } } }, "localname": "FinanceLeasePrincipalPayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAsset": { "auth_ref": [ "r661" ], "calculation": { "http://www.aosmd.com/role/LeasesScheduleofLeaseSupplementalBalanceSheetInformationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization", "totalLabel": "Property, plant and equipment, net" } } }, "localname": "FinanceLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization": { "auth_ref": [ "r664", "r669" ], "calculation": { "http://www.aosmd.com/role/LeasesScheduleofLeaseSupplementalBalanceSheetInformationDetails": { "order": 2.0, "parentTag": "us-gaap_FinanceLeaseRightOfUseAsset", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated amortization of right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, Accumulated Amortization", "negatedTerseLabel": "Accumulated depreciation", "terseLabel": "Accumulated depreciation" } } }, "localname": "FinanceLeaseRightOfUseAssetAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsPropertyplantandequipmentDetails", "http://www.aosmd.com/role/LeasesScheduleofLeaseSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "auth_ref": [ "r664", "r669", "r679" ], "calculation": { "http://www.aosmd.com/role/LeasesScheduleofLeaseCostDetails": { "order": 3.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, Amortization", "terseLabel": "Amortization of equipment" } } }, "localname": "FinanceLeaseRightOfUseAssetAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization": { "auth_ref": [ "r661" ], "calculation": { "http://www.aosmd.com/role/LeasesScheduleofLeaseSupplementalBalanceSheetInformationDetails": { "order": 1.0, "parentTag": "us-gaap_FinanceLeaseRightOfUseAsset", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, before Accumulated Amortization", "terseLabel": "Property, plant and equipment, gross" } } }, "localname": "FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r663" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset.", "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseSupplementalBalanceSheetInformationDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r676", "r679" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for finance lease calculated at point in time.", "label": "Finance Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Finance lease" } } }, "localname": "FinanceLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseSupplementalBalanceSheetInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r675", "r679" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Finance Lease, Weighted Average Remaining Lease Term", "terseLabel": "Finance lease" } } }, "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseSupplementalBalanceSheetInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "terseLabel": "Finite-lived intangible asset, useful life" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsIntangibleassetsDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r36", "r286" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedTerseLabel": "Less accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsIntangibleassetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r288" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsFutureamortizationexpenseofintangibleassetsDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsFutureamortizationexpenseofintangibleassetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r288" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsFutureamortizationexpenseofintangibleassetsDetails": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsFutureamortizationexpenseofintangibleassetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r288" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsFutureamortizationexpenseofintangibleassetsDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsFutureamortizationexpenseofintangibleassetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r282", "r283", "r286", "r289", "r707", "r708" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsIntangibleassetsDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r286", "r708" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Intangible assets, gross" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsIntangibleassetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r282", "r285" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsIntangibleassetsDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r286", "r707" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsFutureamortizationexpenseofintangibleassetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Intangible assets, net" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsFutureamortizationexpenseofintangibleassetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r651" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Foreign Currency Transactions and Translation" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Foreign Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Non-U.S. taxes:" } } }, "localname": "ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ForeignLineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars, outside the reporting entity's home country.", "label": "Foreign Line of Credit [Member]", "terseLabel": "Foreign Line of Credit" } } }, "localname": "ForeignLineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtShorttermborrowingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignPlanMember": { "auth_ref": [ "r486", "r487", "r497" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Foreign Plan [Member]", "terseLabel": "Foreign Plan" } } }, "localname": "ForeignPlanMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EmployeeBenefitPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]", "terseLabel": "Office furniture and equipment" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsPropertyplantandequipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDispositionOfAssets": { "auth_ref": [ "r135", "r292", "r297" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property", "negatedTerseLabel": "(Gain) loss on disposal of property and equipment" } } }, "localname": "GainLossOnDispositionOfAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r35", "r275", "r276", "r277", "r279", "r695", "r723" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsIntangibleassetsDetails": { "order": 2.0, "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsGoodwillDetails", "http://www.aosmd.com/role/BalanceSheetComponentsImpairmentoflonglivedassetsintangibleassetsandgoodwillDetails", "http://www.aosmd.com/role/BalanceSheetComponentsIntangibleassetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r116", "r151", "r226", "r231", "r235", "r238", "r241", "r264", "r332", "r333", "r334", "r337", "r338", "r339", "r340", "r341", "r343", "r344", "r640" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "terseLabel": "Gross loss", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeEquityMethodInvestmentSummarizedFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r290", "r301" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]", "verboseLabel": "Impairment of Long-Lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [ "r153", "r597" ], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic", "terseLabel": "U.S. operations" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r105", "r226", "r231", "r235", "r238", "r241", "r721", "r736", "r743", "r772" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Net income (loss) before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "auth_ref": [ "r153", "r597" ], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign", "terseLabel": "Non-U.S. operations" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r226", "r231", "r235", "r238", "r241" ], "calculation": { "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest", "totalLabel": "Loss before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]", "terseLabel": "Domestic and foreign components of income (loss) before taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r151", "r171", "r226", "r231", "r235", "r238", "r241", "r264", "r332", "r333", "r334", "r337", "r338", "r339", "r340", "r341", "r343", "r344", "r610", "r633", "r640" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Net income (loss) before loss from equity method investment" } } }, "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": { "auth_ref": [ "r3", "r4", "r5", "r6", "r7", "r15", "r18", "r601", "r766" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Loss on changes on equity interest of the JV Company, net", "verboseLabel": "Loss on changes on equity interest of the JV Company, net" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeNarrativeDetails", "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeScheduleofGainonDeconsolidationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r106", "r135", "r224", "r260", "r735", "r765" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income (Loss) from Equity Method Investments", "negatedTerseLabel": "Equity method investment loss from equity investee" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r298", "r304" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationSharebasedCompensationExpensesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r304" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationSharebasedCompensationExpensesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r567" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r154", "r564", "r574", "r581", "r592", "r599", "r602", "r603", "r605" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r155", "r179", "r180", "r225", "r562", "r593", "r600", "r773" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0 }, "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Income tax expense", "totalLabel": "Total provision for income taxes", "verboseLabel": "Income tax benefit" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails", "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Expense (Benefit), Continuing Operations, by Jurisdiction [Abstract]", "terseLabel": "Provision for (benefit from) income taxes" } } }, "localname": "IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r100", "r559", "r560", "r574", "r575", "r580", "r588" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Provision for Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r132", "r139" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Cash paid for income taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r134" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r134" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedTerseLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties": { "auth_ref": [ "r134" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount due to the reporting entity for good and services provided to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management, an entity and its principal owners, management, member of their immediate families, affiliates, or other parties with the ability to exert significant influence.", "label": "Increase (Decrease) in Accounts Receivable, Related Parties", "negatedTerseLabel": "Payable related to equity investee, net" } } }, "localname": "IncreaseDecreaseInAccountsReceivableRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "auth_ref": [ "r134" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.", "label": "Increase (Decrease) in Income Taxes Payable", "terseLabel": "Income taxes payable" } } }, "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r134" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued and other liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": { "auth_ref": [ "r134" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.", "label": "Increase (Decrease) in Deferred Income Taxes", "negatedTerseLabel": "Deferred income taxes, net" } } }, "localname": "IncreaseDecreaseInDeferredIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r134" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedTerseLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r134" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedTerseLabel": "Other current and long-term assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r185", "r186", "r187", "r193", "r503" ], "calculation": { "http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedBasicandDilutedIncomePerShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "terseLabel": "Stock options, RSUs and ESPP shares", "verboseLabel": "Incremental common shares attributable to dilutive effect of share-based payment arrangements (USD per share)" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedBasicandDilutedIncomePerShareDetails", "http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedPotentialDilutiveSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IndemnificationGuaranteeMember": { "auth_ref": [ "r320", "r329" ], "lang": { "en-us": { "role": { "documentation": "An agreement (contract) that contingently requires the guarantor to make payments to the guaranteed party in compensation for that party's or parties' loss or injury attributable to specified events or actions, such as a patent infringement action against an entity that relied on certain representations as to ownership rights made by a software vendor.", "label": "Indemnification Agreement [Member]", "terseLabel": "Indemnification Agreement" } } }, "localname": "IndemnificationGuaranteeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CommitmentsandContingenciesContingenciesandIndemnitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r280", "r284" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsIntangibleassetsDetails": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets, net (excluding goodwill)" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsIntangibleassetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetIncludingGoodwill": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsIntangibleassetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.", "label": "Intangible Assets, Net (Including Goodwill)", "terseLabel": "Intangible assets, net", "totalLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetIncludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsIntangibleassetsDetails", "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r742" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest Income (Expense), Net", "terseLabel": "Interest expenses, net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r128", "r131", "r139" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestReceivableCurrent": { "auth_ref": [ "r53" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsOtherCurrentAssetsDetails": { "order": 8.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.", "label": "Interest Receivable, Current", "terseLabel": "Interest receivable" } } }, "localname": "InterestReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r61", "r270" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsInventoriesDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r22", "r67", "r695" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsInventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories", "totalLabel": "Inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsInventoriesDetails", "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r28", "r65", "r144", "r200", "r268", "r269", "r271", "r704" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "auth_ref": [ "r63", "r270" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsInventoriesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.", "label": "Inventory, Raw Materials, Net of Reserves", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterialsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r62", "r270" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsInventoriesDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work in-process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LandMember": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "Part of earth's surface not covered by water.", "label": "Land [Member]", "terseLabel": "Land" } } }, "localname": "LandMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsPropertyplantandequipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r677", "r679" ], "calculation": { "http://www.aosmd.com/role/LeasesScheduleofLeaseCostDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "totalLabel": "Total lease expenses" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r677" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Schedule of Operating and Finance Lease Expense" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold improvements" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsPropertyplantandequipmentDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]", "terseLabel": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LesseeFinanceLeasesTextBlock": { "auth_ref": [ "r680" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.", "label": "Lessee, Finance Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeFinanceLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r668" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r678" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Schedule of Operating Lease Liability Maturities" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r678" ], "calculation": { "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total minimum lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r678" ], "calculation": { "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details_1": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r678" ], "calculation": { "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details_1": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2021" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r678" ], "calculation": { "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details_1": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r678" ], "calculation": { "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details_1": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r678" ], "calculation": { "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details_1": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r678" ], "calculation": { "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details_1": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r678" ], "calculation": { "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedTerseLabel": "Less amount representing interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r680" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r74", "r151", "r233", "r264", "r332", "r333", "r334", "r337", "r338", "r339", "r340", "r341", "r343", "r344", "r614", "r622", "r623", "r640", "r693", "r694" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r59", "r151", "r264", "r640", "r695", "r731", "r760" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r26", "r76", "r151", "r264", "r332", "r333", "r334", "r337", "r338", "r339", "r340", "r341", "r343", "r344", "r614", "r622", "r623", "r640", "r693", "r694", "r695" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "terseLabel": "Current liabilities", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeEquityMethodInvestmentSummarizedFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r29", "r30", "r31", "r43", "r44", "r151", "r264", "r332", "r333", "r334", "r337", "r338", "r339", "r340", "r341", "r343", "r344", "r614", "r622", "r623", "r640", "r693", "r694" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "terseLabel": "Non-current liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeEquityMethodInvestmentSummarizedFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermliabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregated carrying amounts of obligations as of the balance sheet date, excluding long-term debt, incurred as part of the normal operations that are expected to be paid after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Credits and Other Liabilities.", "label": "Liabilities, Other than Long-Term Debt, Noncurrent", "totalLabel": "Other long-term liabilities" } } }, "localname": "LiabilitiesOtherThanLongtermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermliabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityAxis": { "auth_ref": [ "r72", "r150" ], "lang": { "en-us": { "role": { "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.", "label": "Lender Name [Axis]", "terseLabel": "Lender Name [Axis]" } } }, "localname": "LineOfCreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails", "http://www.aosmd.com/role/DebtShorttermborrowingDetails", "http://www.aosmd.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding": { "auth_ref": [ "r636" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of the amount outstanding under the credit facility.", "label": "Line of Credit Facility, Fair Value of Amount Outstanding", "terseLabel": "Amount outstanding" } } }, "localname": "LineOfCreditFacilityFairValueOfAmountOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityLenderDomain": { "auth_ref": [ "r72", "r150" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.", "label": "Line of Credit Facility, Lender [Domain]", "terseLabel": "Line of Credit Facility, Lender [Domain]" } } }, "localname": "LineOfCreditFacilityLenderDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails", "http://www.aosmd.com/role/DebtShorttermborrowingDetails", "http://www.aosmd.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Line of Credit Facility [Line Items]", "terseLabel": "Line of Credit Facility [Line Items]" } } }, "localname": "LineOfCreditFacilityLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r72" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails", "http://www.aosmd.com/role/DebtShorttermborrowingDetails", "http://www.aosmd.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityTable": { "auth_ref": [ "r72", "r150" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Line of Credit Facility [Table]", "terseLabel": "Line of Credit Facility [Table]" } } }, "localname": "LineOfCreditFacilityTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "London Interbank Offered Rate (LIBOR) [Member]", "terseLabel": "LIBOR" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r43", "r359", "r374", "r375", "r376", "r728", "r754" ], "calculation": { "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Long-Term Debt", "terseLabel": "Long-term debt", "totalLabel": "Total principal of debt, less debt issuance costs" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails", "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": { "auth_ref": [ "r159", "r330", "r364" ], "calculation": { "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails": { "order": 4.0, "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": { "auth_ref": [ "r159", "r330", "r364" ], "calculation": { "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails": { "order": 6.0, "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Five", "terseLabel": "2027" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "auth_ref": [ "r159", "r330", "r364" ], "calculation": { "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails": { "order": 3.0, "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Four", "terseLabel": "2026" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r159", "r330", "r364" ], "calculation": { "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails": { "order": 1.0, "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Three", "terseLabel": "2025" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r159", "r330", "r364" ], "calculation": { "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails": { "order": 5.0, "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Two", "terseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r43" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.", "label": "Long-Term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Excluding Current Maturities [Abstract]", "terseLabel": "Long-term Debt" } } }, "localname": "LongTermDebtNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r78" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtAccountsReceivableFactoringAgreementDetails", "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r78", "r331" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-Term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtAccountsReceivableFactoringAgreementDetails", "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "auth_ref": [ "r308", "r310", "r311", "r312", "r313", "r322", "r323" ], "lang": { "en-us": { "role": { "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.", "label": "Loss Contingency Nature [Axis]", "terseLabel": "Loss Contingency Nature [Axis]" } } }, "localname": "LossContingenciesByNatureOfContingencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CommitmentsandContingenciesContingenciesandIndemnitiesDetails", "http://www.aosmd.com/role/CybersecutiyIncidentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CommitmentsandContingenciesContingenciesandIndemnitiesDetails", "http://www.aosmd.com/role/CybersecutiyIncidentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r308", "r310", "r311", "r312", "r313", "r322", "r323" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CommitmentsandContingenciesContingenciesandIndemnitiesDetails", "http://www.aosmd.com/role/CybersecutiyIncidentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyAccrualAtCarryingValue": { "auth_ref": [ "r308", "r309" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of loss contingency liability.", "label": "Loss Contingency Accrual", "terseLabel": "Indemnification accrual" } } }, "localname": "LossContingencyAccrualAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CommitmentsandContingenciesContingenciesandIndemnitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyDisclosures": { "auth_ref": [ "r308", "r310", "r312", "r314", "r315", "r316", "r317", "r318" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.", "label": "Contingencies Disclosure [Text Block]", "terseLabel": "Cybersecurity Incident" } } }, "localname": "LossContingencyDisclosures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CybersecutiyIncident" ], "xbrltype": "textBlockItemType" }, "us-gaap_LossContingencyLossInPeriod": { "auth_ref": [ "r308" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.", "label": "Loss Contingency, Loss in Period", "terseLabel": "Loss recorded in the period from cyber security incident" } } }, "localname": "LossContingencyLossInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CybersecutiyIncidentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyNatureDomain": { "auth_ref": [ "r308", "r310", "r311", "r312", "r313", "r322", "r323" ], "lang": { "en-us": { "role": { "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.", "label": "Loss Contingency, Nature [Domain]", "terseLabel": "Loss Contingency, Nature [Domain]" } } }, "localname": "LossContingencyNatureDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CommitmentsandContingenciesContingenciesandIndemnitiesDetails", "http://www.aosmd.com/role/CybersecutiyIncidentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]", "terseLabel": "Manufacturing machinery and equipment" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsPropertyplantandequipmentDetails", "http://www.aosmd.com/role/DebtDebtFinancingDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r84", "r151", "r264", "r332", "r337", "r338", "r339", "r343", "r344", "r640", "r730", "r759" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Noncontrolling interest" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestPeriodIncreaseDecrease": { "auth_ref": [ "r609" ], "lang": { "en-us": { "role": { "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.", "label": "Noncontrolling Interest, Period Increase (Decrease)", "terseLabel": "Carrying amount of non-controlling interest" } } }, "localname": "MinorityInterestPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeScheduleofGainonDeconsolidationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]", "terseLabel": "Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]" } } }, "localname": "MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsProductWarrantyAccrualDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MovementInValuationAllowancesAndReservesRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]", "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]" } } }, "localname": "MovementInValuationAllowancesAndReservesRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r130" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r130" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r130", "r133", "r136" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r18", "r95", "r97", "r103", "r107", "r136", "r151", "r171", "r173", "r174", "r175", "r176", "r179", "r180", "r190", "r226", "r231", "r235", "r238", "r241", "r264", "r332", "r333", "r334", "r337", "r338", "r339", "r340", "r341", "r343", "r344", "r633", "r640", "r737", "r767" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income (loss) attributable to AOS", "totalLabel": "Net income (loss) attributable to Alpha and Omega Semiconductor Limited" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY", "http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedBasicandDilutedIncomePerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r95", "r97", "r103", "r179", "r180", "r616", "r625" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "terseLabel": "Net income (loss) attributable to noncontrolling interest" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation": { "auth_ref": [ "r407", "r618" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of the reduction or elimination during the period of a noncontrolling interest resulting from the parent's loss of control and deconsolidation of the entity in which one or more outside parties had a noncontrolling interest.", "label": "Noncontrolling Interest, Decrease from Deconsolidation", "negatedTerseLabel": "Deconsolidation of noncontrolling interest" } } }, "localname": "NoncontrollingInterestDecreaseFromDeconsolidation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r168", "r169", "r170", "r406", "r608" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Noncontrolling Interest" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r219" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of operating segments" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SegmentandGeographicinformationSegmentNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OfficeEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.", "label": "Office Equipment [Member]", "terseLabel": "Office furntiture and equipment" } } }, "localname": "OfficeEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r226", "r231", "r235", "r238", "r241" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "terseLabel": "Net loss", "totalLabel": "Operating income (loss)" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeEquityMethodInvestmentSummarizedFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r670", "r679" ], "calculation": { "http://www.aosmd.com/role/LeasesScheduleofLeaseCostDetails": { "order": 1.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Fixed rent expense" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid [Abstract]", "terseLabel": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]" } } }, "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r662" ], "calculation": { "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Total lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseMaturitiesTopic842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r662" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r662" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liabilities - long-term" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r667", "r673" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Operating cash flows from operating leases" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r661" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "ROU assets associated with operating leases", "verboseLabel": "Operating lease right-of-use assets, net" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.aosmd.com/role/LeasesScheduleofLeaseSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r676", "r679" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Operating leases" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseSupplementalBalanceSheetInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r675", "r679" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Operating leases" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseSupplementalBalanceSheetInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasesIncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Leases, Income Statement [Abstract]", "terseLabel": "Operating leases:" } } }, "localname": "OperatingLeasesIncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r582" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards", "terseLabel": "Net operating loss carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r20", "r167", "r217", "r627" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]", "terseLabel": "The Company and Significant Accounting Policies" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r75" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsAccruedliabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Other accrued expenses" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsAccruedliabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r69", "r695" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsOtherCurrentAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets", "totalLabel": "Total other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherCurrentAssetsDetails", "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsMiscellaneousNoncurrent": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermassetsDetails": { "order": 4.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.", "label": "Other Assets, Miscellaneous, Noncurrent", "terseLabel": "Other" } } }, "localname": "OtherAssetsMiscellaneousNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermassetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r37" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermassetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 9.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other long-term assets", "totalLabel": "Other long-term assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermassetsDetails", "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r610", "r611", "r619" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to noncontrolling interests.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Noncontrolling Interest", "terseLabel": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r610", "r611", "r619" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent", "terseLabel": "Cumulative translation adjustment" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "auth_ref": [ "r90", "r92", "r641", "r642", "r644" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax", "terseLabel": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r89" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "verboseLabel": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r79" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other long-term liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Table Text Block]", "terseLabel": "Schedule of Other Long-Term Liabilities" } } }, "localname": "OtherNoncurrentLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r119" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Interest expenses, net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherPrepaidExpenseCurrent": { "auth_ref": [ "r68", "r274" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsOtherCurrentAssetsDetails": { "order": 7.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Other Prepaid Expense, Current", "terseLabel": "Other prepaid expenses" } } }, "localname": "OtherPrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherReceivablesNetCurrent": { "auth_ref": [], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsOtherCurrentAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.", "label": "Other Receivables, Net, Current", "terseLabel": "Other receivables" } } }, "localname": "OtherReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ParentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.", "label": "Parent [Member]", "terseLabel": "Total AOS Shareholders' Equity" } } }, "localname": "ParentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r126" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-Based Payment Arrangement", "negatedTerseLabel": "Withholding tax on restricted stock units" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r122" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedTerseLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r505", "r506", "r507", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r525", "r526", "r528", "r529", "r532", "r533", "r534", "r535", "r536" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeNarrativeDetails", "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails", "http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesJointVentureNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r505", "r506", "r507", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r525", "r526", "r528", "r529", "r532", "r533", "r534", "r535", "r536" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeNarrativeDetails", "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails", "http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesJointVentureNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]", "terseLabel": "Preferred Shares" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferred Stock, Number of Shares, Par Value and Other Disclosure [Abstract]", "terseLabel": "Preferred shares, par value $0.002 per share:" } } }, "localname": "PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r50", "r383" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r50", "r383" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "periodEndLabel": "Balance (in shares)", "periodStartLabel": "Balance (in shares)", "terseLabel": "Preferred stock, shares outstanding (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r50", "r695" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Authorized: 10,000 shares; issued and outstanding: none at June\u00a030,\u00a02022 and 2021" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidInsurance": { "auth_ref": [ "r23", "r272", "r274" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsOtherCurrentAssetsDetails": { "order": 9.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Insurance", "terseLabel": "Prepaid insurance" } } }, "localname": "PrepaidInsurance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidTaxes": { "auth_ref": [ "r24", "r273", "r274" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsOtherCurrentAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Taxes", "terseLabel": "Prepaid income tax" } } }, "localname": "PrepaidTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfDebt": { "auth_ref": [ "r125" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.", "label": "Proceeds from Issuance of Debt", "terseLabel": "Proceeds from borrowings" } } }, "localname": "ProceedsFromIssuanceOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": { "auth_ref": [ "r124", "r544" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.", "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised", "terseLabel": "Proceeds from exercise of stock options and ESPP" } } }, "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLinesOfCredit": { "auth_ref": [ "r125", "r150" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Proceeds from Lines of Credit", "terseLabel": "Proceeds from lines of credit" } } }, "localname": "ProceedsFromLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails", "http://www.aosmd.com/role/DebtShorttermborrowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfEquityMethodInvestments": { "auth_ref": [ "r120" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.", "label": "Proceeds from Sale of Equity Method Investments", "terseLabel": "Proceeds from sale of equity interest in the JV Company", "verboseLabel": "Cash received for sales of shares in the JV Company" } } }, "localname": "ProceedsFromSaleOfEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeNarrativeDetails", "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeScheduleofGainonDeconsolidationDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesJointVentureNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment": { "auth_ref": [ "r121" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow for the sale of long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.", "label": "Proceeds from Sale of Other Property, Plant, and Equipment", "terseLabel": "Proceeds from sale of property and equipment" } } }, "localname": "ProceedsFromSaleOfOtherPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromShortTermDebt": { "auth_ref": [ "r125" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.", "label": "Proceeds from Short-Term Debt", "terseLabel": "Proceeds from short-term debt" } } }, "localname": "ProceedsFromShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtShorttermborrowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualClassifiedCurrent": { "auth_ref": [ "r75", "r321", "r324" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsAccruedliabilitiesDetails": { "order": 9.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Product Warranty Accrual, Current", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "terseLabel": "Warranty accrual" } } }, "localname": "ProductWarrantyAccrualClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsAccruedliabilitiesDetails", "http://www.aosmd.com/role/BalanceSheetComponentsProductWarrantyAccrualDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r18", "r95", "r97", "r103", "r129", "r151", "r171", "r179", "r180", "r226", "r231", "r235", "r238", "r241", "r264", "r332", "r333", "r334", "r337", "r338", "r339", "r340", "r341", "r343", "r344", "r610", "r615", "r617", "r625", "r626", "r633", "r640", "r743" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "order": 3.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net income (loss)", "totalLabel": "Net income (loss)" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r296" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsPropertyplantandequipmentDetails", "http://www.aosmd.com/role/DebtDebtFinancingDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsPropertyplantandequipmentDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r296", "r695", "r744", "r761" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsPropertyplantandequipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property, plant and equipment, net", "totalLabel": "Property, plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsPropertyplantandequipmentDetails", "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r296", "r795", "r796" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r296" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsTables", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Long-Lived Tangible Asset [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsPropertyplantandequipmentDetails", "http://www.aosmd.com/role/DebtDebtFinancingDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Property, plant and equipment, useful life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis": { "auth_ref": [ "r46", "r729", "r755" ], "lang": { "en-us": { "role": { "documentation": "Information by arrangement, in which the entity has agreed to expend funds to procure goods or services from one or more suppliers.", "label": "Purchase Commitment, Excluding Long-Term Commitment [Axis]", "terseLabel": "Purchase Commitment, Excluding Long-term Commitment [Axis]" } } }, "localname": "PurchaseCommitmentExcludingLongtermCommitmentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CommitmentsandContingenciesPurchaseCommitmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain": { "auth_ref": [ "r46", "r729", "r755" ], "lang": { "en-us": { "role": { "documentation": "This item is intended to be populated, by the entity, with Members identifying each purchase commitment about which information required or determined to be disclosed is being provided. If only one such commitment exists, this item may be used to capture such information; if multiple commitments exist, this item is the dimensional default, which will aggregate such information, as appropriate.", "label": "Purchase Commitment, Excluding Long-Term Commitment [Domain]", "terseLabel": "Purchase Commitment, Excluding Long-term Commitment [Domain]" } } }, "localname": "PurchaseCommitmentExcludingLongtermCommitmentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CommitmentsandContingenciesPurchaseCommitmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Purchase Commitment, Excluding Long-Term Commitment [Line Items]", "terseLabel": "Purchase Commitment, Excluding Long-term Committment [Line Items]" } } }, "localname": "PurchaseCommitmentExcludingLongtermCommitmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CommitmentsandContingenciesPurchaseCommitmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable": { "auth_ref": [ "r46", "r729", "r755" ], "lang": { "en-us": { "role": { "documentation": "Summarization of information required or determined to be disclosed about arrangements in which the entity has agreed to expend funds to procure goods or services from one or more suppliers. Such disclosure may include identification of the goods or services to be purchased, identity of the seller, pricing, effects on pricing for failing to reach minimum quantities required to be purchased (such as penalties), cancellation rights, and termination provisions.", "label": "Purchase Commitment, Excluding Long-Term Commitment [Table]", "terseLabel": "Purchase Commitment, Excluding Long-term Committment [Table]" } } }, "localname": "PurchaseCommitmentExcludingLongtermCommitmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CommitmentsandContingenciesPurchaseCommitmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted": { "auth_ref": [ "r46", "r729", "r755" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum amount to be expended to satisfy the terms of arrangements in which the entity has agreed to expend funds to procure goods or services, excluding long-term purchase commitments or unconditional purchase obligations.", "label": "Purchase Commitment, Remaining Minimum Amount Committed", "terseLabel": "Purchase commitment, amount" } } }, "localname": "PurchaseCommitmentRemainingMinimumAmountCommitted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CommitmentsandContingenciesPurchaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]", "terseLabel": "Unrecognized tax benefits rollforward" } } }, "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r467", "r686", "r687" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeNarrativeDetails", "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeScheduleofGainonDeconsolidationDetails", "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails", "http://www.aosmd.com/role/RelatedPartyTransactionsDetails", "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesJointVentureNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/RelatedPartyTransactionsDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesJointVentureNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Related Party Transaction, Purchases from Related Party", "terseLabel": "Transactions with related party" } } }, "localname": "RelatedPartyTransactionPurchasesFromRelatedParty", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r467", "r686", "r689", "r709", "r710", "r711", "r712", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeNarrativeDetails", "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeScheduleofGainonDeconsolidationDetails", "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails", "http://www.aosmd.com/role/RelatedPartyTransactionsDetails", "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesJointVentureNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r684", "r685", "r687", "r690", "r691" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r127" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.", "label": "Repayments of Debt", "negatedLabel": "Repayments of borrowings" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r556", "r705", "r810" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and Development Expense [Member]", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationSharebasedCompensationExpensesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r556" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development Expense, Policy [Policy Text Block]", "terseLabel": "Research and Development" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchMember": { "auth_ref": [ "r583" ], "lang": { "en-us": { "role": { "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.", "label": "Research Tax Credit Carryforward [Member]", "terseLabel": "Research Tax Credit Carryforward" } } }, "localname": "ResearchMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedAssetsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for assets that are restricted in their use, generally by contractual agreements or regulatory requirements. This would include, but not limited to, a description of the restricted assets and the terms of the restriction.", "label": "Restricted Assets Disclosure [Text Block]", "terseLabel": "Restricted Net Assets" } } }, "localname": "RestrictedAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/RestrictedNetAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [ "r32", "r143", "r722", "r756" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesRestrictedCashNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r32", "r137", "r143" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash and Cash Equivalents, Current", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashNoncurrent": { "auth_ref": [ "r37", "r143", "r791" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 11.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash, Noncurrent", "terseLabel": "Restricted cash - long-term" } } }, "localname": "RestrictedCashNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r194" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Restricted Stock [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted Stock Units (RSUs)" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictionsForConsolidatedAndUnconsolidatedSubsidiariesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restrictions for Consolidated and Unconsolidated Subsidiaries [Abstract]", "terseLabel": "Restrictions for Consolidated and Unconsolidated Subsidiaries [Abstract]" } } }, "localname": "RestrictionsForConsolidatedAndUnconsolidatedSubsidiariesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r55", "r406", "r695", "r758", "r783", "r785" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r168", "r169", "r170", "r172", "r178", "r180", "r266", "r545", "r546", "r547", "r590", "r591", "r631", "r780", "r782" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanNameAxis": { "auth_ref": [ "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r470", "r471", "r472", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r498" ], "lang": { "en-us": { "role": { "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.", "label": "Retirement Plan Name [Axis]", "terseLabel": "Retirement Plan Name [Axis]" } } }, "localname": "RetirementPlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EmployeeBenefitPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanNameDomain": { "auth_ref": [ "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r470", "r471", "r472", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r498" ], "lang": { "en-us": { "role": { "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.", "label": "Retirement Plan Name [Domain]", "terseLabel": "Retirement Plan Name [Domain]" } } }, "localname": "RetirementPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EmployeeBenefitPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanSponsorLocationAxis": { "auth_ref": [ "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r471", "r472", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r486", "r487", "r497" ], "lang": { "en-us": { "role": { "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Axis]", "terseLabel": "Retirement Plan Sponsor Location" } } }, "localname": "RetirementPlanSponsorLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EmployeeBenefitPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanSponsorLocationDomain": { "auth_ref": [ "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r471", "r472", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r486", "r487", "r497" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Domain]", "terseLabel": "Retirement Plan Sponsor Location [Domain]" } } }, "localname": "RetirementPlanSponsorLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EmployeeBenefitPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r222", "r223", "r230", "r236", "r237", "r243", "r244", "r247", "r413", "r414", "r706" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.aosmd.com/role/SegmentandGeographicinformationRevenuebyGeographicalSegmentDetails", "http://www.aosmd.com/role/SegmentandGeographicinformationRevenuebyProductTypeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromRelatedParties": { "auth_ref": [ "r114", "r335", "r337", "r338", "r342", "r343", "r344", "r789" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.", "label": "Revenue from Related Parties", "terseLabel": "Revenue from related parties" } } }, "localname": "RevenueFromRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r145", "r146" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r104", "r151", "r222", "r223", "r230", "r236", "r237", "r243", "r244", "r247", "r264", "r332", "r333", "r334", "r337", "r338", "r339", "r340", "r341", "r343", "r344", "r640", "r743" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Revenue" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeEquityMethodInvestmentSummarizedFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenues from External Customers and Long-Lived Assets [Line Items]", "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]" } } }, "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SegmentandGeographicinformationLocationandNetBookValueofLongLivedAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r674", "r679" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Operating lease right-of-use assets obtained in exchange for lease obligations" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]", "terseLabel": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SaleLeasebackTransactionDescriptionAxis": { "auth_ref": [ "r657", "r682" ], "lang": { "en-us": { "role": { "documentation": "Information pertinent to a sale and leaseback transaction, by transaction.", "label": "Sale Leaseback Transaction, Description [Axis]", "terseLabel": "Sale Leaseback Transaction, Description [Axis]" } } }, "localname": "SaleLeasebackTransactionDescriptionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtDebtFinancingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SaleLeasebackTransactionHistoricalCost": { "auth_ref": [ "r658", "r659", "r660", "r682" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The historical cost of the asset(s) sold in connection with the sale of the property to another party and the lease of the property back to the seller.", "label": "Sale Leaseback Transaction, Historical Cost", "terseLabel": "Historical cost" } } }, "localname": "SaleLeasebackTransactionHistoricalCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtDebtFinancingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleLeasebackTransactionLeaseTerms": { "auth_ref": [ "r657", "r681" ], "lang": { "en-us": { "role": { "documentation": "A description of the terms of the lease(s) related to the assets being leased-back in connection with the transaction involving the sale of property to another party and the lease of the property back to the seller.", "label": "Sale Leaseback Transaction, Lease Terms", "terseLabel": "Lease term (in years)" } } }, "localname": "SaleLeasebackTransactionLeaseTerms", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtDebtFinancingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SaleLeasebackTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Sale Leaseback Transaction [Line Items]", "terseLabel": "Sale Leaseback Transaction [Line Items]" } } }, "localname": "SaleLeasebackTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtDebtFinancingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SaleLeasebackTransactionNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The name of the significant provisions of the transaction involving the sale of property to another party and the lease of the property back to the seller.", "label": "Sale Leaseback Transaction, Name [Domain]", "terseLabel": "Sale Leaseback Transaction, Name [Domain]" } } }, "localname": "SaleLeasebackTransactionNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtDebtFinancingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleLeasebackTransactionTable": { "auth_ref": [ "r657", "r682" ], "lang": { "en-us": { "role": { "documentation": "A summary of the elements of a transaction involving the entity's sale of property to another party and the lease of the property back to the entity.", "label": "Sale Leaseback Transaction [Table]", "terseLabel": "Sale Leaseback Transaction [Table]" } } }, "localname": "SaleLeasebackTransactionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtDebtFinancingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r211", "r247" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]", "terseLabel": "Revenue Benchmark" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomersScheduleofConcentrationRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "auth_ref": [ "r83" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]", "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule of Accrued Liabilities [Table Text Block]", "terseLabel": "Schedule of Accrued Liabilities" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": { "auth_ref": [ "r282" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.", "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]", "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]" } } }, "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsIntangibleassetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r194" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedPotentialDilutiveSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r194" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r588" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Provision for (benefit from) income taxes" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r579" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Components of deferred tax assets and liabilities" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r469", "r470", "r473", "r474", "r485" ], "lang": { "en-us": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "terseLabel": "Schedule of Retirement Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EmployeeBenefitPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": { "auth_ref": [ "r2", "r8", "r9", "r10", "r11", "r12", "r13", "r14", "r16", "r17", "r18", "r299", "r300" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]", "terseLabel": "Schedule of deconsolidation" } } }, "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r193" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r563" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Effective income tax rate reconciliation" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r537", "r549" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationSharebasedCompensationExpensesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r537" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "terseLabel": "Share-based Compensation, Allocation of Recognized Period Costs" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Equity Method Investments [Line Items]", "terseLabel": "Schedule of Equity Method Investments [Line Items]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeEquityMethodInvestmentSummarizedFinancialInformationDetails", "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeNarrativeDetails", "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeScheduleofGainonDeconsolidationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "auth_ref": [ "r18", "r151", "r263", "r264", "r640" ], "lang": { "en-us": { "role": { "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.", "label": "Schedule of Equity Method Investments [Table]", "terseLabel": "Schedule of Equity Method Investments [Table]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeEquityMethodInvestmentSummarizedFinancialInformationDetails", "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeNarrativeDetails", "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeScheduleofGainonDeconsolidationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r282", "r285" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Finite-Lived Intangible Assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsTables", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r152" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]", "terseLabel": "Domestic and foreign components of income (loss)" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r28", "r64", "r65", "r66" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Schedule of Inventory, Current" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": { "auth_ref": [ "r37" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of noncurrent assets.", "label": "Schedule of Other Assets, Noncurrent [Table Text Block]", "terseLabel": "Schedule of Other Assets, Noncurrent" } } }, "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amounts of other current assets.", "label": "Schedule of Other Current Assets [Table Text Block]", "terseLabel": "Schedule of Other Current Assets" } } }, "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "auth_ref": [ "r328" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.", "label": "Schedule of Product Warranty Liability [Table Text Block]", "terseLabel": "Schedule of Product Warranty Liability" } } }, "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r296" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsPropertyplantandequipmentDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r688", "r689" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]", "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/RelatedPartyTransactionsDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesJointVentureNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": { "auth_ref": [ "r115", "r246" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]", "terseLabel": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SegmentandGeographicinformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "auth_ref": [ "r104", "r246" ], "lang": { "en-us": { "role": { "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]", "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SegmentandGeographicinformationLocationandNetBookValueofLongLivedAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r226", "r228", "r234", "r278" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SegmentandGeographicinformationRevenuebyGeographicalSegmentDetails", "http://www.aosmd.com/role/SegmentandGeographicinformationRevenuebyProductTypeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r500", "r502", "r505", "r506", "r507", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r525", "r526", "r528", "r529", "r532", "r533", "r534", "r535", "r536" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationEmployeeSharePurchasePlanDetails", "http://www.aosmd.com/role/SharebasedCompensationFairValueWeightedAverageAssumptionsDetails", "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": { "auth_ref": [ "r543" ], "lang": { "en-us": { "role": { "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table]", "terseLabel": "Share-based Payment Arrangement, Option, Exercise Price Range [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r509", "r524", "r527" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Summary of Stock Option Activities" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": { "auth_ref": [ "r531" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]", "terseLabel": "Employee Stock Purchase Plan, Valuation Assumptions" } } }, "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Restricted Stock Units Activity" } } }, "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShortTermDebtTable": { "auth_ref": [ "r73" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-Term Debt [Table]", "terseLabel": "Schedule of Short-term Debt [Table]" } } }, "localname": "ScheduleOfShortTermDebtTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtShorttermborrowingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r49", "r50", "r51", "r148", "r202", "r203", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r388", "r392", "r397", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]", "terseLabel": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ShareholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": { "auth_ref": [ "r573", "r589" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in unrecognized tax benefits.", "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]", "terseLabel": "Unrecognized tax benefits rollforward" } } }, "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r285" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": { "auth_ref": [ "r209", "r211", "r212", "r213", "r637", "r639" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]", "terseLabel": "Schedules of Concentration of Risk, by Risk Factor" } } }, "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ConcentrationofCreditRiskandSignificantCustomersTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuredDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.", "label": "Secured Debt [Member]", "terseLabel": "Secured Debt" } } }, "localname": "SecuredDebtMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtAccountsReceivableFactoringAgreementDetails", "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SecurityDeposit": { "auth_ref": [ "r37" ], "calculation": { "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermassetsDetails": { "order": 3.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.", "label": "Security Deposit", "terseLabel": "Other long-term deposits" } } }, "localname": "SecurityDeposit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsOtherlongtermassetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r218", "r220", "r221", "r226", "r229", "r235", "r239", "r240", "r241", "r242", "r243", "r246", "r247", "r248" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Segment and Geographic Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SegmentandGeographicinformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SegmentandGeographicinformationRevenuebyGeographicalSegmentDetails", "http://www.aosmd.com/role/SegmentandGeographicinformationRevenuebyProductTypeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r118" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Selling, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationSharebasedCompensationExpensesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r134" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Share-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Noncash Expense [Abstract]", "terseLabel": "Share-based Payment Arrangement, Noncash Expense [Abstract]" } } }, "localname": "ShareBasedCompensationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": { "auth_ref": [ "r505" ], "lang": { "en-us": { "role": { "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period", "terseLabel": "Award requisite service period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r505" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "terseLabel": "Award vesting period (in years)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r523" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedTerseLabel": "Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r523" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails", "http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails", "http://www.aosmd.com/role/SharebasedCompensationSharebasedCompensationExpensesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted-average grant date fair value", "verboseLabel": "Granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationEmployeeSharePurchasePlanDetails", "http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r518", "r519" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Nonvested (in shares)", "periodStartLabel": "Nonvested (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r518", "r519" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Nonvested (in dollars per share)", "periodStartLabel": "Nonvested (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r522" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedTerseLabel": "Vested (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r522" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Vested (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r534" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationFairValueWeightedAverageAssumptionsDetails", "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails", "http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r533" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Volatility rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum", "terseLabel": "Volatility rate, maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationFairValueWeightedAverageAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum", "terseLabel": "Volatility rate, minimum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationFairValueWeightedAverageAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r535" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum", "terseLabel": "Risk-free interest rate, maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationFairValueWeightedAverageAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum", "terseLabel": "Risk-free interest rate, minimum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationFairValueWeightedAverageAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationEmployeeSharePurchasePlanDetails", "http://www.aosmd.com/role/SharebasedCompensationFairValueWeightedAverageAssumptionsDetails", "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": { "auth_ref": [ "r543" ], "lang": { "en-us": { "role": { "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate", "terseLabel": "Percent of compensation allowed for purchase of options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationEmployeeSharePurchasePlanDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r507" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized", "terseLabel": "Shares authorized under plan (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationEmployeeSharePurchasePlanDetails", "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r543" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant", "terseLabel": "Number of shares available for grant (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationSummaryofStockOptionActivitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r512" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "verboseLabel": "Exercisable (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationSummaryofStockOptionActivitiesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r512" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "verboseLabel": "Exercisable (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationSummaryofStockOptionActivitiesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [ "r526" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value", "terseLabel": "Aggregate Intrinsic Value, Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationSummaryofStockOptionActivitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "auth_ref": [ "r513" ], "lang": { "en-us": { "role": { "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period", "negatedTerseLabel": "Canceled or forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationSummaryofStockOptionActivitiesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r513" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price of options that were either forfeited or expired.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "terseLabel": "Canceled or forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationSummaryofStockOptionActivitiesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Grants in period (in shares)", "verboseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails", "http://www.aosmd.com/role/SharebasedCompensationSummaryofStockOptionActivitiesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r543" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Aggregate Intrinsic Value, Outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationSummaryofStockOptionActivitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r510", "r511" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Outstanding (in shares)", "periodStartLabel": "Outstanding (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationSummaryofStockOptionActivitiesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationSummaryofStockOptionActivitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r510", "r511" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Outstanding (in dollars per share)", "periodStartLabel": "Outstanding (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationSummaryofStockOptionActivitiesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationSummaryofStockOptionActivitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "auth_ref": [ "r528" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value", "terseLabel": "Options, vested and expected to vest, outstanding, aggregate intrinsic value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationSummaryofStockOptionActivitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "auth_ref": [ "r528" ], "lang": { "en-us": { "role": { "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number", "terseLabel": "Options vested and expected to vest (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationSummaryofStockOptionActivitiesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r528" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price", "terseLabel": "Options vested and expected to vest (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationSummaryofStockOptionActivitiesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r505", "r506", "r507", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r525", "r526", "r528", "r529", "r532", "r533", "r534", "r535", "r536" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationEmployeeSharePurchasePlanDetails", "http://www.aosmd.com/role/SharebasedCompensationFairValueWeightedAverageAssumptionsDetails", "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails", "http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails", "http://www.aosmd.com/role/SharebasedCompensationSharebasedCompensationExpensesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Exercised (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationSummaryofStockOptionActivitiesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationSummaryofStockOptionActivitiesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r508", "r530", "r531", "r532", "r533", "r536", "r548", "r553" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-Based Payment Arrangement [Policy Text Block]", "verboseLabel": "Share-based Compensation Expense" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]", "terseLabel": "Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by supplier.", "label": "Supplier [Axis]", "terseLabel": "Supplier [Axis]" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesRisksandUncertaintiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Specific identification or general nature of (for example, a construction contractor, a consulting firm) the party from whom the goods or services were or are to be received.", "label": "Supplier [Domain]", "terseLabel": "Supplier [Domain]" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesRisksandUncertaintiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareRepurchaseProgramAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by share repurchase program.", "label": "Share Repurchase Program [Axis]", "terseLabel": "Share Repurchase Program [Axis]" } } }, "localname": "ShareRepurchaseProgramAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ShareholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareRepurchaseProgramDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the share repurchase program.", "label": "Share Repurchase Program [Domain]", "terseLabel": "Share Repurchase Program [Domain]" } } }, "localname": "ShareRepurchaseProgramDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested", "terseLabel": "Aggregate intrinsic value, nonvested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r506" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period", "terseLabel": "Stock options exercisable term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r532" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationFairValueWeightedAverageAssumptionsDetails", "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails", "http://www.aosmd.com/role/SharebasedCompensationRestrictedStockandPerformancebasedRestrcitedStockActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r543" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "terseLabel": "Exercisable, Intrinsic Value" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationSummaryofStockOptionActivitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r543" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Exercisable, Weighted Average Remaining Contractual Term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationSummaryofStockOptionActivitiesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r528" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Outstanding, Weighted Average Remaining Contractual Term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationSummaryofStockOptionActivitiesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r528" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Options, vested and expected to vest, Weighted Average Remaining Contractual Term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationSummaryofStockOptionActivitiesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase price of common stock expressed as a percentage of its fair value.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent", "terseLabel": "Grant price, percent of fair value of common stock at date of grant" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationEmployeeSharePurchasePlanDetails", "http://www.aosmd.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation", "negatedTerseLabel": "Withholding tax on restricted stock units (in shares)" } } }, "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_ShippingAndHandlingCostPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the classification of shipping and handling costs, including whether the costs are included in cost of sales or included in other income statement accounts. If shipping and handling fees are significant and are not included in cost of sales, disclosure includes both the amounts of such costs and the line item on the income statement which includes such costs.", "label": "Shipping and Handling Cost, Policy [Policy Text Block]", "terseLabel": "Shipping and Handling Costs" } } }, "localname": "ShippingAndHandlingCostPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShortTermBorrowings": { "auth_ref": [ "r40", "r695", "r725", "r753" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.", "label": "Short-Term Debt", "terseLabel": "Short-term debt", "totalLabel": "Total debt, less debt issuance costs" } } }, "localname": "ShortTermBorrowings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.aosmd.com/role/DebtMaturitiesofShorttemandLongtermDebtDetails", "http://www.aosmd.com/role/DebtShorttermborrowingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermDebtLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Short-Term Debt [Line Items]", "terseLabel": "Short-term Debt [Line Items]" } } }, "localname": "ShortTermDebtLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtShorttermborrowingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtPercentageBearingFixedInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The portion of the carrying amount of short-term borrowings outstanding as of the balance sheet date which accrues interest at a set, unchanging rate.", "label": "Short-Term Debt, Percentage Bearing Fixed Interest Rate", "terseLabel": "Interest rate" } } }, "localname": "ShortTermDebtPercentageBearingFixedInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtShorttermborrowingDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r73" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-Term Debt, Type [Axis]", "terseLabel": "Short-term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtShorttermborrowingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r71" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.", "label": "Short-Term Debt, Type [Domain]", "terseLabel": "Short-term Debt, Type [Domain]" } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtShorttermborrowingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r671", "r679" ], "calculation": { "http://www.aosmd.com/role/LeasesScheduleofLeaseCostDetails": { "order": 5.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short-Term Lease, Cost", "terseLabel": "Short-term lease expenses" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SoftwareDevelopmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Internally developed software for sale, licensing or long-term internal use.", "label": "Software Development [Member]", "terseLabel": "Software Development" } } }, "localname": "SoftwareDevelopmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StandardProductWarrantyAccrualPayments": { "auth_ref": [ "r325" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.", "label": "Standard Product Warranty Accrual, Decrease for Payments", "negatedTerseLabel": "Utilization" } } }, "localname": "StandardProductWarrantyAccrualPayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsProductWarrantyAccrualDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardProductWarrantyAccrualWarrantiesIssued": { "auth_ref": [ "r326" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.", "label": "Standard Product Warranty Accrual, Increase for Warranties Issued", "terseLabel": "Addition" } } }, "localname": "StandardProductWarrantyAccrualWarrantiesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsProductWarrantyAccrualDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardProductWarrantyPolicy": { "auth_ref": [ "r327" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.", "label": "Standard Product Warranty, Policy [Policy Text Block]", "terseLabel": "Product Warranty" } } }, "localname": "StandardProductWarrantyPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "State and Local Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "State taxes, net of federal benefit:" } } }, "localname": "StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StateAndLocalJurisdictionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.", "label": "State and Local Jurisdiction [Member]", "terseLabel": "State" } } }, "localname": "StateAndLocalJurisdictionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r49", "r50", "r51", "r148", "r151", "r184", "r188", "r189", "r191", "r193", "r202", "r203", "r204", "r264", "r332", "r337", "r338", "r339", "r343", "r344", "r383", "r384", "r388", "r392", "r399", "r640", "r818" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ShareholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r82", "r101", "r102", "r103", "r168", "r169", "r170", "r172", "r178", "r180", "r201", "r266", "r399", "r406", "r545", "r546", "r547", "r590", "r591", "r631", "r645", "r646", "r647", "r648", "r649", "r650", "r683", "r780", "r781", "r782" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "terseLabel": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r168", "r169", "r170", "r201", "r706" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r140", "r141", "r142" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Stock Issued", "terseLabel": "Reissuance of treasury stock" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "auth_ref": [ "r50", "r51", "r399", "r406" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.", "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans", "terseLabel": "Issuance of common shares under Employee Stock Purchase Plan (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture", "terseLabel": "Treasury stock reissued (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ShareholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r50", "r51", "r399", "r406", "r515" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "negatedTerseLabel": "Exercised (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/SharebasedCompensationSummaryofStockOptionActivitiesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued": { "auth_ref": [ "r51", "r399", "r406" ], "lang": { "en-us": { "role": { "documentation": "Number of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.", "label": "Stock Issued During Period, Shares, Treasury Stock Reissued", "terseLabel": "Reissuance of Treasury Stock (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesTreasuryStockReissued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": { "auth_ref": [ "r50", "r51", "r399", "r406" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.", "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan", "terseLabel": "Issuance of common shares under Employee Stock Purchase Plan" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued": { "auth_ref": [ "r50", "r51", "r399", "r406", "r408" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.", "label": "Stock Issued During Period, Value, Treasury Stock Reissued", "terseLabel": "Reissuance of Treasury Stock" } } }, "localname": "StockIssuedDuringPeriodValueTreasuryStockReissued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program, Authorized Amount", "terseLabel": "Share repurchase program, authorized amount" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ShareholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount remaining of a stock repurchase plan authorized.", "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount", "terseLabel": "Share repurchase program, remaining authorized amount" } } }, "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ShareholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r51", "r57", "r58", "r151", "r257", "r264", "r640", "r695" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total Alpha and Omega Semiconductor Limited shareholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r0", "r1", "r102", "r151", "r168", "r169", "r170", "r172", "r178", "r264", "r266", "r406", "r545", "r546", "r547", "r590", "r591", "r608", "r609", "r624", "r631", "r640", "r645", "r646", "r650", "r683", "r781", "r782" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Balance", "totalLabel": "Total equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]", "terseLabel": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r149", "r384", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r398", "r406", "r410", "r630" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Shareholders' Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ShareholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of subsidiary's or equity method investee's stock owned by parent immediately after all stock transactions.", "label": "Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions", "terseLabel": "Joint venture cumulative percentage ownership after all transactions" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/EquityMethodInvestmentinEquityInvesteeNarrativeDetails", "http://www.aosmd.com/role/RelatedPartyTransactionsDetails", "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesJointVentureNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "auth_ref": [ "r88" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.", "label": "Supplemental Balance Sheet Disclosures [Text Block]", "terseLabel": "Balance Sheet Components" } } }, "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosures of cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_SupplierConcentrationRiskMember": { "auth_ref": [ "r210" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.", "label": "Supplier Concentration Risk [Member]", "terseLabel": "Supplier Concentration Risk" } } }, "localname": "SupplierConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesRisksandUncertaintiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TaxCreditCarryforwardAmount": { "auth_ref": [ "r582" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Tax Credit Carryforward, Amount", "terseLabel": "Tax credit carryforward" } } }, "localname": "TaxCreditCarryforwardAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxCreditCarryforwardAxis": { "auth_ref": [ "r583" ], "lang": { "en-us": { "role": { "documentation": "Information by specific tax credit related to an unused tax credit.", "label": "Tax Credit Carryforward [Axis]", "terseLabel": "Tax Credit Carryforward [Axis]" } } }, "localname": "TaxCreditCarryforwardAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Tax Credit Carryforward [Line Items]", "terseLabel": "Tax Credit Carryforward [Line Items]" } } }, "localname": "TaxCreditCarryforwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardNameDomain": { "auth_ref": [ "r583" ], "lang": { "en-us": { "role": { "documentation": "The name of the tax credit carryforward.", "label": "Tax Credit Carryforward, Name [Domain]", "terseLabel": "Tax Credit Carryforward, Name [Domain]" } } }, "localname": "TaxCreditCarryforwardNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TaxCreditCarryforwardTable": { "auth_ref": [ "r583" ], "lang": { "en-us": { "role": { "documentation": "A listing of tax credit carryforwards available to reduce future taxable income including descriptions, amounts, expiration dates, limitations on use and the related deferred tax assets and valuation allowances.", "label": "Tax Credit Carryforward [Table]", "terseLabel": "Tax Credit Carryforward [Table]" } } }, "localname": "TaxCreditCarryforwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "auth_ref": [ "r251", "r252", "r253", "r254", "r256", "r258" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for accounts receivable.", "label": "Accounts Receivable [Policy Text Block]", "terseLabel": "Accounts Receivable" } } }, "localname": "TradeAndOtherAccountsReceivablePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r606" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names [Member]", "terseLabel": "Trade name" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/BalanceSheetComponentsIntangibleassetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockAcquiredAverageCostPerShare": { "auth_ref": [ "r408" ], "lang": { "en-us": { "role": { "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.", "label": "Treasury Stock Acquired, Average Cost Per Share", "terseLabel": "Treasury stock acquired, average price per share (in dollars per share)" } } }, "localname": "TreasuryStockAcquiredAverageCostPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ShareholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r81", "r408" ], "lang": { "en-us": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury Stock" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Treasury Stock, Number of Shares and Restriction Disclosures [Abstract]", "terseLabel": "Treasury Shares" } } }, "localname": "TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ShareholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TreasuryStockShares": { "auth_ref": [ "r81", "r408" ], "lang": { "en-us": { "role": { "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.", "label": "Treasury Stock, Shares", "negatedPeriodEndLabel": "Balance (in shares)", "negatedPeriodStartLabel": "Balance (in shares)", "terseLabel": "Treasury shares (in shares)" } } }, "localname": "TreasuryStockShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockSharesAcquired": { "auth_ref": [ "r51", "r399", "r406" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.", "label": "Treasury Stock, Shares, Acquired", "terseLabel": "Treasury stock acquired, shares repurchased (in shares)" } } }, "localname": "TreasuryStockSharesAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ShareholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockSharesRetired": { "auth_ref": [ "r51", "r399", "r406" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common and preferred stock retired from treasury during the period.", "label": "Treasury Stock, Shares, Retired", "terseLabel": "Treasury stock retired (in shares)" } } }, "localname": "TreasuryStockSharesRetired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ShareholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r81", "r408", "r409" ], "calculation": { "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedTerseLabel": "Treasury shares at cost; 6,617 shares at June 30, 2022 and 6,625 shares at June 30, 2021" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_UndistributedEarningsOfForeignSubsidiaries": { "auth_ref": [ "r557", "r604", "r747", "r786" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.", "label": "Undistributed Earnings of Foreign Subsidiaries", "terseLabel": "Undistributed earnings of foreign subsidiaries" } } }, "localname": "UndistributedEarningsOfForeignSubsidiaries", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r558", "r568" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "periodEndLabel": "Balance at end of year", "periodStartLabel": "Balance at beginning of year", "terseLabel": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails", "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r569" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions", "negatedTerseLabel": "Reductions based on tax positions related to prior years" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r565" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "terseLabel": "Income tax interest and penalties accrued" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": { "auth_ref": [ "r565" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense", "terseLabel": "Income tax interest and penalties expense" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "auth_ref": [ "r570" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.", "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions", "terseLabel": "Additions based on tax positions related to the current year" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": { "auth_ref": [ "r571" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.", "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations", "negatedTerseLabel": "Reductions due to lapse of applicable statute of limitations" } } }, "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesIncomeTaxSchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": { "auth_ref": [ "r572" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.", "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate", "terseLabel": "Unrecognized tax benefits that would reduce effective income tax rate" } } }, "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r205", "r206", "r207", "r208", "r214", "r215", "r216" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceByDeferredTaxAssetAxis": { "auth_ref": [ "r578" ], "lang": { "en-us": { "role": { "documentation": "Information by type of deferred tax consequences attributable to deductible temporary differences.", "label": "Valuation Allowance by Deferred Tax Asset [Axis]", "terseLabel": "Valuation Allowance by Deferred Tax Asset [Axis]" } } }, "localname": "ValuationAllowanceByDeferredTaxAssetAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r579" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "terseLabel": "Valuation allowance increase" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": { "auth_ref": [ "r160", "r161", "r162", "r164", "r165" ], "lang": { "en-us": { "role": { "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward.", "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset" } } }, "localname": "ValuationAllowanceOfDeferredTaxAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationAllowancesAndReservesBalance": { "auth_ref": [ "r160", "r165" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount", "periodEndLabel": "Balance", "periodStartLabel": "Balance" } } }, "localname": "ValuationAllowancesAndReservesBalance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": { "auth_ref": [ "r163" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense", "terseLabel": "Additions" } } }, "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesDeductions": { "auth_ref": [ "r164" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction", "negatedTerseLabel": "Reductions" } } }, "localname": "ValuationAllowancesAndReservesDeductions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesDomain": { "auth_ref": [ "r160", "r161", "r162", "r164", "r165" ], "lang": { "en-us": { "role": { "documentation": "Valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]" } } }, "localname": "ValuationAllowancesAndReservesDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationAllowancesAndReservesTypeAxis": { "auth_ref": [ "r160", "r161", "r162", "r164", "r165" ], "lang": { "en-us": { "role": { "documentation": "Information by valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]" } } }, "localname": "ValuationAllowancesAndReservesTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableLeaseCost": { "auth_ref": [ "r672", "r679" ], "calculation": { "http://www.aosmd.com/role/LeasesScheduleofLeaseCostDetails": { "order": 2.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.", "label": "Variable Lease, Cost", "terseLabel": "Variable rent expense" } } }, "localname": "VariableLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/LeasesScheduleofLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails", "http://www.aosmd.com/role/DebtShorttermborrowingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/DebtCreditFacilitiesandLongtermDebtNarrativeDetails", "http://www.aosmd.com/role/DebtShorttermborrowingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VehiclesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment used primarily for road transportation.", "label": "Vehicles [Member]", "terseLabel": "Vehicles" } } }, "localname": "VehiclesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/TheCompanyandSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract]", "terseLabel": "Effect of potentially dilutive securities:" } } }, "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedBasicandDilutedIncomePerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r183", "r193" ], "calculation": { "http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedBasicandDilutedIncomePerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted (in shares)", "totalLabel": "Weighted average number of common shares used to compute diluted net income (loss) per share" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedBasicandDilutedIncomePerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Weighted average number of common share attributable to Alpha and Omega Semiconductor Limited used to compute net income (loss) per share:", "verboseLabel": "Diluted:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedBasicandDilutedIncomePerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r182", "r193" ], "calculation": { "http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedBasicandDilutedIncomePerShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted average number of common shares used to compute basic net income (loss) per share" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedBasicandDilutedIncomePerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Basic [Abstract]", "terseLabel": "Basic:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.aosmd.com/role/NetIncomeLossPerCommonShareAttributabletoAlphaandOmegaSemiconductorLimitedBasicandDilutedIncomePerShareDetails" ], "xbrltype": "stringItemType" } }, "unitCount": 9 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(7)(c))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(9)(a))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1(e))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column B))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(1)))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(2)))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column D))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column E))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r167": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256" }, "r19": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=2122178" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r199": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759" }, "r20": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r217": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)(1)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)(4)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r248": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org/topic&trid=2134510" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=126903467&loc=d3e32787-111569" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(b)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r271": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742" }, "r302": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r307": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r316": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/subtopic&trid=2127163" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=6397426&loc=d3e17499-108355" }, "r318": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "450", "URI": "https://asc.fasb.org/subtopic&trid=2127197" }, "r319": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907419&loc=d3e10037-110241" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907644&loc=d3e11281-110244" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12524-110249" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(2))", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(3))", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907907&loc=d3e13051-110250" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(10))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r379": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r419": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "710", "URI": "https://asc.fasb.org/topic&trid=2127225" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "712", "URI": "https://asc.fasb.org/topic&trid=2197446" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(10)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(8)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(9)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(8)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(q)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r499": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "https://asc.fasb.org/topic&trid=2235017" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "3B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "740", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126970579&loc=d3e23163-113944" }, "r553": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(b)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126928070&loc=d3e28200-109314" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r605": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r627": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28129-110885" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r651": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "https://asc.fasb.org/topic&trid=2175825" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123416376&loc=d3e50796-112755" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "50", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123386837&loc=d3e51831-112757" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "51", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123386837&loc=d3e51840-112757" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123386837&loc=d3e51843-112757" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r680": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888251" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128295416&loc=SL77919786-209982" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128295416&loc=SL77919786-209982" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r691": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(17))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(3),(4))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(d)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Subparagraph": "(b)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=6479915&loc=d3e66715-112838" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(5))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(19))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r768": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r769": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r770": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r771": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r772": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r773": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r774": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r777": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r778": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r779": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r780": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r781": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r782": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r783": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r784": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r785": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r786": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556" }, "r787": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r788": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r789": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.1(c))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r790": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r791": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580" }, "r792": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942793&loc=d3e3073-115593" }, "r793": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594" }, "r794": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r795": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916" }, "r796": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916" }, "r797": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r798": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r799": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r800": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r801": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r802": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r803": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r804": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r805": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r806": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r807": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r808": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691" }, "r809": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r810": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r811": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r812": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r813": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r814": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r815": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r816": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r817": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r818": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r819": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "303", "Subparagraph": "(5)" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r820": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r821": { "Footnote": "2", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r822": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r823": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29" }, "r824": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column B", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r825": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column C", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r826": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column D", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r827": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column E", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r828": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column F", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r829": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column G", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r830": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column H", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r831": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column I", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r832": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "09" }, "r833": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(i)", "Subsection": "01" }, "r834": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iv)", "Subsection": "01" }, "r835": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iv)", "Subsection": "02" }, "r836": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(m)", "Publisher": "SEC", "Section": "4", "Subparagraph": "(1)(iii)", "Subsection": "08" }, "r837": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r88": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "210", "URI": "https://asc.fasb.org/topic&trid=2122208" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a-c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580" } }, "version": "2.1" } ZIP 120 0001387467-22-000066-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001387467-22-000066-xbrl.zip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

..P-&Q:7$O1+$2$.B*HW!X/^_'3&1^U@Q'__UW\!N6;R MN"Y!?1#?M[/^ICC<1D6B+9'MJMO"?"PX@S]C7XGHF($PG>B(@2D=)*JF"$$G M.J=L6P>FT,)$Y)L++I/E>?QAA4SA($N"EC+-L$(39&IGV-\9'?W\ MKB.<(W M_RNVT./YYW+@MOJUGU^\B4;1>_@_J63K:'L)%%0ZUF3.VP<1G.=(WJ-?.(@0 M$E%Z=7:"[[F.)W4]!S_"Q#G#C$H7"M<^[&L]7%U*LX71)"B%3?.4CE/SHG:D M(MFQ$$RP0Q"!)M28EU6WA7YHOX/0?U]);B%A>::@I/>@15[UZVKDR M&*6^BWJV:TO:"0':H)$P/@R7O\ ZQ^^+9!6=8#_LN^LI+DI94TY>;>KC5TK> MRQ[ S)YY9 [2A&T1+[GEYODL-9FT?;UP;IEM@>N(#?"])(3D4"13#(?!;*2: MLT:E)^0##G 8MC?PVLNM-=^5'7K@* :<^@RV;&67!-^2"I_]DENOP:9TH5UO M\(MQ"6SDQR8Z:@S$%JXC&OU2=JGC;G=X(G,^*8HEA_/6_M^CW/QK+BN1%=QA M[\=Y#NX+=PU"?>R6^1A/R9.@+;@[N;\XE%7%W1-M&)1C(#90>*X,K'E=AZ&")H(X1.H"V1:DC1VBA3_/]!19FQT0M3L0Y'$E,>7U<-,FN [[N"_8Y#O?W]T<_ M/Q.1)CO M)()']Z&3VWNAG;M\#/:4;/XWE5PTU>ED6]Z/!F0IK%&5@L M-\9RFI6VLU327!,D/6XJCR#4/2-R(=I@CATS0BZ/:^E+MZ$?1N6W>;&-V(60 MTH;509VQ88H:DL\E[6G)[-,/3B0N-DQWQV=A\IM56E+RD(^<>T'GQ)L2MN&F M2(-KI"YC/'*#AQ1Q.L*/W296'R)H]-C"GN5N32NO"WO#U5JP6D MZ:K4_!W&0B>YEX[85T3AIL2WHH?#;4F2$W16+O&=M=]I7>9P*])3<\9CP.4& M^:O&OPFO+V$I\%5@XX&T\7U,T2X@GWH9!E$L1?]M$QZ]$/Y M'H9USJS1!=W4OQ2S)W6N0+>=P][^5SS(46_OJP9/5(>T";..8R,7U0&^IV2( MHJGM_7=V>R.Y]P$^Y9/=6Z+)Y!5/=DQ 6!4489LW:SE-08\XC NZD/#\.D]48MU+(,N[;S[ZD!P+@.D0 MGH5 9L(&STB5$-% U:;RWAZC]CHAO-=>VN]G(T#;@CRT.B=K$-[M!;5"BSGU M'E>8ZVOIS80=PRZ.E?\0&'1AV.]Q* "8I%@NU*L;\/[PQA>'#VO.K:' MDI_+L&V8.F1VJ4T&%E+6M:J<@4?-!M_!Y/PW!TGQG>%9F">[N@5BY!'RLT43 M4+9R4KQ"P\V3!!@:2.C2!RAIMZH>+UR"@:2XG4\:>PL MO[46>3 !0;LVSVY'@&\)^NYFR>UO\_,? L)[737\SK#\,?=ASDWV 3UD]R,* M,H9]2[/ 9COYDD0KC(M@J)FJ'4(D8UMO+(PDB)TF.]+V*>!FH(J@Y6,IQLY' M<=F*B77>:H&Q6"8%NHC3A4D[8&S"&?._!8;9SF,'6YMWO*.*:J(3]Q;3[$8*Q/0/!G95> MHR+B?*<3V6\G,M?^*Z!/Y\6RT56*NZFP_SI!T 25KR#O!<+>I9%1,9^G%=HM MCSCCZO8;.7^,Q\/4_D+ZP&L;W]5"F&9](P9MK1(D0EAKJ_0]82[Q_MC3;0Z/ MGU4]MF@##Y$VAU>6T%[S0B)R=DR/NG@7BJCM6$[X:#"2TH1@^KRIJ$VZB,A_ M5SX$SSE]T$.Q+1\O3&L38ZW4"AK>5@.$B:#.H:FA![1,MKHYU% MM43\TG6E+RB-=EK>[T([['6\#+,A7RU&7 Q%HMS>+.'*HA M&IO.-W_3= <'7VS/8 IEN&==M+]^" VD^HCUARA*/0NI#9 ]X#2W:0W!U9U# M_MN%^,B%(&/"7P<_N>P60$]>\B]4<1%B&O:/NU#P2('+(DS9/JK=9@RWZ_JY MUI7,*56]+$61>3(A^ZBQ$E MXIG#'>G)5KN#DJ2((OK2B"&0&^?.4PM#N$SBV^[JNT4_[TVK*VJG>:R5AJYL MZ2]>5QK&XXNYVD+$EFRPRU"F#,Z-)Z@I?F?7;UK&EW-VSK3_!B6$_0)-Z;:! M'QA-XVCWH[8'"N:-L$]M?H3G1E!5>S/6B?8MB+\D#M'A]D;CB',W].>20D%M M434S<2) ,JEYC>2&XRC/0K.QTQ.E-G&OO)NX3 M=OM0-+'Y*L>P+[STA5^X?/2R$[V.+_/X&*NBSX-9\_*6G>CT3#&0GMZ['H8!JEDZCL.[$.:U"C*F]%KOTFH&CBYE1?V6181NV/"N&LYU M\ZRO^I*[*+[&CI-=/,%\!"@GV'>Q_BZ%;)DD*5D\1JWO?(#W_>X7LK608EWWJB\]:BP*_8:@7(1G0^$ MV7IDG\M8(&>YGF"4@7"]5(MJF^=**F:EH2D)5!+T4+)? AH-%UA;JVYJJ]IH M)<;5X7+#K7/P.=?:M3O"=?HWHOG M[=)]KJ4C+]MK2L8UY'Y;=VJPV,S::9:*/;_8IEJ]4W.[9I]SNUF**HI$2Y=G M1C0JF*T3 *)M&STOO,P]9\6]HK.2 J0KQ&(B:%SZ%!*'5VYA@9R^=IMU.LO7#=MW\C%M$N3H3M:,VH& M4:@MT+R'Y5*=MU-5*3$2YNI(8PGIC6H#P M-9?4J;RD*&X^(7X3BSXBG*.)R\E,CBTR(-&C[;1ERWWXMGH7#.A'7%-=3@@= M]@,XWE0K>M. P"'L)\ZMW^@#YWR,@L>UQI9L7ER+_;.!AT=2'M8JIAER #I2 M]1C%X!%3UK*B(Y:J2EU&H^,@%M$E!QO&6%[&V=\$H2#.M:*2/C+6?,A=QR'? M9/S<']Y&7+'RHB/CF*! (VL,:(R9Z0H@4 JBZ#=DVC/XF.P-VYW>-Q _/D*[ MQ4J%V_#@7F*E/GM\??AG[@ MXWCQ.N2[QKX[.5-Y);^!!G9 W" +)B"NIE[]/"(_^+B"T"\AGC0968VFEB-5 M43E F%26?3QC,GV&?JG@E@J9E63D&/;) ^K"0;8SP+2N#H>4B MB<_CTW>O3KJ#0^0P3W"3:#T87@^K7F=+V2I.6NQHQP9,J91(SQ*7H$(*8T)U MO\28"ST%B]%+] R8(XZRXBSO;2+.CV5&"2%3<:,#1P-):U+$6F+E-\J54IN: M).7M>8,6$9DB2P_KY$\/P@3YE6PBGA#@O=O(&>YE3G;(#=PF5V"Z/41U[90G MIOSF<>+G_6 _5#6Q(A2.(]MN$E)5%4O)&FY5RHA# F$3Q7,$_1(>@^=,X!U8 M9KQ M)U:WRN,)J9%XJ=@$%=9@+19_4V>+$(W>"3X!MXI,<% 9)8)@JA$,]6]I_IB5'].ZC7DH+M;F?,] MV[-O-WB'CQ38\+WP'(-M=IW"+?UT2=4(S]JZ6&'BN"::37=^N8I1<$N)?8-M ME-;YI$J?)"&8L2T4XP>C-\S>*M?[B' %$'\Y8C?>'4MV\>BB^&1+C67EJ&Z" M>E6N2/W/_4%O)X+ISD@G_.?>3J^O_Z2?_N=N\(.@=/)C1N9TJE1C2#%&S"&/ M<9'7!*)61M .UQ]UFO)%R']T5'6_Z@:H!BDI*AR=K,JQ;#,%-!P/,. M@L5A>/:Z3C0U,FD: B3GGU.HE=KP4MVPK-">UY)^2XJ!QD@&1P/E6>=8@?^[ MA6Q6Q71Y$Y?&#V0(P4^"!0TX9OFI8^RAP,NU*1%S0ADDBYUQA,0BDF@Z\X1K M<'M3.K?R@N!4*W*3PRDR+C4$2C^U//E21,D47QK&6,1#Z36C@K-K'8,]M=.^%\;I]. MH;7-&]'$#Z8S>P4EF5M'3U@J7KSO1*;A"! DA! \?MX3K::\!!>V2 M2(>3#XR!6/&-&(Z:VE7B#$/\3.OAL$K:KSDG2G8@XIPJKM3;\%2:8,7:K$,U M[ITF_]CV&ZT='KZDE_4M\C&QE^(YH!628QKV5RC(J]36ZQV96)&UMDE _Z-, MKY7F#(\.KJ"XI>&%*FL,0RZ8P(XLFN#7KFZ--R39G#IF"L@&AFUA$EYL//\9!"%EE M^J%](0T/_D1O$7/M*74-&FJ0, MY\D#Y&P6C996'@$AWEU8'6[<49-(25YKN3>^PWC5/( J4:WA@>)46,BF?W[T MFL\[RKGJ*WDHB@^'P1]"\=S=U1GQ'IQQ35D3T:,$\+-5E4Y<"=278&; 7@V->Y[9PT8C+]+M?E>=/+Z]+PCI*!&:4&I/U5'_BO%NQ7V MQ:-N4AWI0@YF8T;RT\*HBEVM)K-BN;Q2/E>\B4#DJJ6LU>OG\ MN(F1OO5OO-87H5&]OGV#\^"VH]A11[%7XJDJJM%6XBEA- GI-.276))M:PN8 M8W^@J!5W0&KE\L(PT(K363HM3%M3KS;?,+95>$_O@ MF4#2D,:B#H)B=_;ZM'D<]Z/4?B@!R;W?>\^!$@)2EK5!N0@RT.Z)F46O/&-.QHFB0O4N=%'6Z+T0F+!%(#B[70B>;@(CF* M7N?SN%[/8=E.A\OS71W1G-H;-2N+UFWF._GZTOD4R^#)VQ,]:L-FV,I5TC.'RH'W()-0DD]_'N"3?YP$N)T(>T/JD>:=K@(#!"SAO^G M9#)'F9G ZT93[4QTP2;J+;%:+U!Q=\U^KYL4_KKVQIL8M/]Z8.U'\E[?!S&T M/IUSK,(NMO%D E9.Z1CF @NK08SHYQ2"9*\7P)*C23FSVOO+XA!"/\RO:H=; MW"!Z)(C.21QN)7Y BX\7QKL6V+=E.2N-X4R8XR>$\R[A-#9WLDN$6%1X2(Q]8W#4EM@# X9* M7PS[PQT8_;&E^&->R+1MQBA4K61?T0]US'QD+TOL*1@PW/*@+2/NTR<__$"_ M>O(U,2*@94,=6W_XX)"#_O]H7>E MIZB3:-#O[7S5B4 ["@GM8"@DM]15369'D'R!3F_-PFX.N#9HA,,4ZQ^QU0_O MAS+G6&;;0?7 S_1C8KZC;+/(E.+$/$V!4!S)_G]4BB%BN!V7,(V]='-'2&L] MZ2..^7K)>@,Q*K#3:VJ5@@3719:05H'O,+6(+ US(N9.Y5/,WB+]BPVL8"D, MJ+$*V[.R7&L[%3^-@9S84V;\ED\ZY"IKY@I'M>0D#K4:P XWI%9MU+#9E)F M\6,+L*)B'4U[^'Z64*F#?U(V1(S]6S21-*W7D4/GQ]O>.,H0"8J_3M?3ZJA,))A@_+(MB M&7% LN75E6*@ 45CP)]4^4_UR@=3U(5AEOQY_A:H)(MG&!!."6&MDS\[G/, M_B.+Y2)$+&6Y!:6)/ 88M\(_T1_XAC[U-RA.V,VL ..@6]SD9H.M'6 D2M-V M)"D'B ):\P1K\GTV_-8;!]"VM7*0!F5FX]CGAV"P1'I!W/E1 <:$*QS5T*&' M(/X%\[%>GXF/> T4(&U:U=81HX'M"*K[$/F=*/!;@(%*1$VI=4EM>PO"?>MG ME%\?4XMWWSCSBWFI+QVB;;#O'Q_,BG[BS;R@.$Z^Y) 1DQS:JL]I5J"C1HV4 MJ4\KZ0"^>P!>"?/&S4*XM?$T:)VQZP3;JD*"2MVQ;363Z^+ 8!W1V=5=,N2K MCD\3-4,.S*6QL=*V5^G8YL^N=LT!L> 5$#N-<7B4(%Y3.Y)I2K3C,(2[U37= M>U?UY^:)\TBC&+B_VDY7/$WH<$[GVJX%S@AV#-3Q6"U$.!V)>S$XNSN*U1/MII+IQWXUDAKP MG38K(BD!"C?*0 %H?QAKUC3,!= ?N0-P-O+?-NZ%CW=<4>NWL4XO_$Y<2C+[ M,-E&=8A"&?CJ_/2PWV='XM71Q8O!WN'H\-MA?[#'9ST,6Z7UM2X/UX^X'Y*7C9F"/1X3-9DS\KRD":=T6,X0SB <8^V"TA$9M.:4Q.)( M;1HOSX0P?1>JNXDK:MARZFMUK[<6$VFGSD)^:U"\);LIC&M2,H:W@F&HMRC! MK+"W!%]Y+/Y^3;8QY45SP0*38!:P(K,LR-D"3D.;J3 M,3@[;,3).]AU\;).S=8A-X;^1HYHWB (DV8*?N0)K);:(<-_$Y=C=? 1SWDA MT3 Y)[FN4<*XB@SO6-.]=4E\_0Y__6;])'X])7%9,9)_;G"NUXSK&S&'Z#IL MBTI^G*R6Y2>,#-U(^\S:[GN"E;0]>;EKB%6@N#3!['DVK*_L;<5\U>Z.6B$( MZNS#GYKW9E(S=H_F%QW/&N97X/(V^MJ\7[RT_'RM M;1Q8G7E^>65>X$>ZRQ M-< E9>4O,0Y9*1HK=A/##MA:8>_[_+2V:$#P!#;$_0@OM>"06DJ._,2,'U(I MI(%I8N09[$2719:@ MA"T62!0QYWYGW(@8-"[(C,'9-36?NXLL1BEIH'RTTFTRP[)+_?02W1167L68 MS@@*V_L#DV 2]\OFP%PL]$PNM.WX+(ZRY8P6V%U2-.]82Y%;K0$W#7W'"0@9 M_*S#M/Z48H>-E<'VGTPHI&#?P_7V]B%*4LL!'Y3UPA:-2$R^]#(-@B$7#(R6 MNF[VH?YV>?=!?YMX_ZC$^ZLVQAWMG/A(O=CV=TZI^D^KFTA-Y5[NTS(PN"YG M9-5K(%G#R.NE651F3GWH.O[1J%:9MCJW-0AM@_-;>*/6N\D;Z*;6-\I98\>4 M2*H<7"PDQ&H$@42;-Z";7*-5UD*$%Y@*: !HIWBV=*N.GQ3P\4]@28//:.;C MS)91<#"-ZL7\_&?[.X%48XT#VN>-;J :6,0(:*/@XS1O8P2F\;Q,VER/65 :I*"BHO]6*!/\L'5WEHV"HOH+W=B M+BD:DM,W7L+''QS/E''SY,_V^K<\B2V4T*'GC031T5-B%NL_DU_3OP;/ONZT MY*/E)YAIIP91>'BB-Y8E741(=J*R6&&Y>9?B.^2 UQAR7\1I8@2M**("B[4^F0&PPD*E*9JJ0^&M:->K -1G=*2&;XZ.HL485(0L-Q^20$@$3/:(])5 /3BF: MB>SN$=$^#:6EQ[?^=!J_K-A>2RVOCY M/E\83\B]2VS7K2JPUI M"4Z5T5SWVX&YV!L*>+!<9+[*<' MW%0@N.- .@Q8.49D"BCK)(WM1QM6#+M&<]@0/1%T8+CK"Q%:A._[!Y;'AIG7 M;H72)RLA@L&0&&]9=OQE"8(PFU[&BI^W<(.#W;;M[4G>WC!\0VTLT2ZP^WL; M?TW*H!/M;/X%2P.OSV#CK]1ZJ6$[DF7TH.M2/D2,%H )-75NFP5+;]A ,Y-B M(T8U+4-=M7>L>\9"A>GE M2[$/TZD@!0S&Z$#Q+VMBM92N6G75D5@ 1SXIHNLV'Q,[B-J6-W.^@ MW_S>6 MQ2V]9,,F,DZ.6\WGZ7+)L:WK]+(HV7#!M(5K&:"NAU24A 42F\E8 PH=#KJ6 M)K]<II+GI"T,C\UQK_C]@II<7&$_],J8 M*Q_\%;,X+8M.Z$7P7';68!2@(C!J?^>"F2\#QVP/^_Q0PTVC8V$M>FLY%A[G ML4,(5&>_1FNVP[ SVAWX(D6&0C&/]G=W^*CV<%TM!L*@LSO<7_NAV 9T\N\/ MUK[F?<+P(D43HV,,F^5-D=L2$3LJ="TL]$?)/!&"( C),8@:'#I!;(3NM<1- M0_EY5?;">C@MBB6(LUB/&J,.>F6=1/M]PQ25^,9:-&C=F057^08,N!585T6G&?^57[IF7N,+QB;"=+&7Q8% M1@[,#2)K+ K44U1,FF676+#RRC+;S5ZFK36@_3L]K\*C5AJ-*WY)+;WIVF06I76ZC154U>R;)]P*R7J0]ZZ M_7W9NF@>71FS:.P V$(P@4J43S4P2;@M+&@#''FP!.+IE'1 G3O/EPV>>=H5 M+$^+')F!C8H_!"AJ^[.RT+9X7C'@H2C MUQ5[E$JL[/S=R.7V=L",.UB4@F68($.R9^)6.,QT:1_J+A23,?.Z(>@X[(]] M4HL6)(H"=>SO<>C5E"\ ;5Q>FQ5QJ&CHVY[@].HF6_@H*FGSO1+N. $E6=B$ MCY]AM8[FBEHK1Z?GY"JDH3=2,#@/F:J0#R@B9$B@A!5/M/"X#T$A4KKA*7G2 MH"FJ%*&?ET3>;.FA'3WSUU*(+T34."Y1]=6]J^D#WXKTKQ) MYN7KOX"@;URGF1=>)6G'QSLVM0R3&;[I,RN8,(U!Z*[N=T;VM[*&JC/_Z8319%MW$V57EK L\,<0I( 4JI8L=L@C% MF48 ,46/7*Q9=& M1X)HB,B^DP=*+ %.A50/"?;!1%$AT4<<&H;W26!"KXIYA3P M$85T; _=EUC.PDB#8UEM0P6 TB*<-)S NW%V7!T;OAS3E@O8E=AD-/[_?0&O M:H]8@8@WT:D2NT7=*5%-S$C'-XJ"]_2R'@)&G% T#=KBBNPY=+$W$KF_XM%9 MZ+4R!JLC?47MU[S'CW&B'S)&3S)=,X91[1C)E ;]#:(1;0+/-M9P2- M4#+93Q\&=,IX$SN'EBIFS>4(X:!K$4>,OC.?,V4CZ9PG4N>.$N2@!U6N^$.Y M_=(&)] C,VQOT [US!PRP5QCB@P3KXC:%6KHAHLCGSIV8C1HEJO@E546^1LZ M%9L'-S!]NKR%)&UI'WS M_+(@S<8A#Y<>=CQ0,ZKPY:TCJB8AS"*F4'8%5OK\=2X.@UOEZ)F MB4OIR:$\);Q9T.U9!HA_IN5I"8R*:UXA3$<>I7:6ZDV53_7Z$,:.IQ(I M9M(H$S_B;?Y+[[SGE=AV&MU[7$64]^9S8U^8=5&]2'2C*W6D=^4<]!N5K82L M :@R#>BY4%%0QGREB\S]3Q3%12 LQISYX$SBO7=U=ZB#T,(+ '9I)4CL]4KK MPC;O W54+$T7;0TZNTHR5N7LP[<'4W(PBI"Q>CXU7)IMVN8:,8TFQ8B+8 M9W)S8?-ROYNR\((_L4OL4G?%]RPG< MF78J6);DH!UAQH&K*>WV0=8%XHN1AFTOJ:5?)C7$9?.IY!WBNVD4TG->Y\0@ M)=$$1Y#2":@T4*J2.=: +;6\.J[TA%6MD\[)92>. <39K@%$/1$1:149$PPU2O)BARQLD&==+*2(F1S M4T6#"%1%YGP_W+/55 JCL".MC[!0$1%@1)I/7=7"HAYGV+ 2E:+-%H#F*>:B M .#.U0PO6Q3@&4H5GMWS@65/+^,0JHE/>P&2=UUD-3*6R2&J+?.8PJ,5.C#\S\ G,X$YT'!/979,03R8BX!RK\]CVT%QK&_L$G MS7S.:W\2+IP'2"QD\751FE"2"67.QHW=*AV*P9';@QM6Z]:HUIB!,'B':C69 M$9B/\O 5TC\(P!D7>T$G%W;KU-$CYUV*%,72-8 U'9T:3>9C]9PU7^/Y-636 MR;^-UF# CV?H9,_2!3S^>:!8[3(0;1]!IYKC\),2THY*VLNS>^@M7=>NG5F8R[5"0O6%ATH8!94J;0.425.GKP.A-X)_/($G_[P%VW7ONPNQ< M#+JDKH:?BE?T 3CHW'< ]6=0?.7)0@O1VG+M]UR)ML[0XC6=T=MH&V+DJ<%S M(&5D1@>V"RAV8>A :<7_R@'N(C!29('RRC\,NA6!NB,T@X*HJ-,<5]QEW*_' MX@Q=BSD1^2#9?$>3DWY!_R=&&^F2$M3[HF#X_0C[&+'L#GU;$'#2O,L!BS[QLII M&"YPDQ0V6958I25F5DB&1Y@ !@Q=:I4\P0>C4!6]#Q-< MX=60BNO013Q/M6V7] M8=@//PBKEBKG*MSI+9L3[3-?!"W/Y<,3@X>'RGEX\[=V*6 67G#,://SCS A MR,DISUWU8#,\YSZ>V86FUTG=N([/>"6$Y/VPT71;GBQ<5._^ JO1B;;0&-PT M7/AB;\_=WRB-R*%#KVA':5<\62:#CD/QM#W$,*U,\'I;4,*?!B4,MZ"$#[ ] M\3$:1!R102P:C)!#S#2LI29QEP-0MAXWXJ.GJ,;M,^(MDE!Q$FQ(,[5-2O!QBS42' = 'T2 81*;CH-G,YPA'PN MD!5FU)P>$O?8L*:< MU.BXS\S[^)H -M%D!KJ>O@516XU+1HU0+'\!CN6*1]KX+M'O#%G :'HQZ!Y3 M,K;M[!UV'<$"B:D'[OKS$GD3[LX7_ M+M)NB1ZK(6X=KI*%6YZDFM1"MO=O#G>_>7Z\WC\^;C[U)3G49TSB2'<$_WO5 M^/B,80*B4ZZ+%)-.J6U'YKG'CO9']AFBS:E(6P"/Y.;?*-@@)/U]O/O,AT=Y M&^H .:NT\G-?(I3'?%(^7#R7+_F> MT!M^/<$!X)]J$W I)E=G-AT$#E+H=S[G-NX<=_R+FO.EC]TAZS@"@7QUO$?E;1J\;J&Y@%] M;*.6@;%2DBE=BR/ZU!H9$0*M.6<\>$$P-G#P@F%(7*3IQF65H)!5LI$(3.MWJ8AU49EO]8]G M,XM6W:4Z#H(N>R=TE?($/T,[6\A!Z'G\MWOS!0:\_&*!#ORSA_Q)]L/CZ M/?+UOUDFZ]\-=WM[H]'&K_N]P<;O;KOM;F_W,]QU#VY+68 /W_8;F@B>#)AN M7,C_>;+SQ(5.**W^[7#Q/AJ$2XC] IHSSI/]J;?_04,8U_1[*1_[&9Z+'6][Z(0CW'0"WN-&# Z 3 MG([$)\OIBS5.##Q42SU$RC-.A/Z>.3Q=V#1_9"K"I?V)HN496-FLQSHM2*R]5C ME=A?3?Y;C2+[.,_^W9U']D(LMJ>V@]L?..'5Z9?;2[X/-9R&%M.>^(8J=9WU#<4'OH3?)3W M+][9'MEM\0EUT%\B&M@C *#MTLP%#U[!IP"L*F8](-99_/:CO21I+2<%$/?RRLA7[+6,;&:1LR; _)) ,FJ%M?>W%NEF>'U>%4 M[N#P\ !G8 @"N+XLS!!N,H?Q]7!('K.9_[IRVX-]O"W>'@L2XI(&"\N"O0.8 M-&]MY;0/QMM=?:-.0M%Q+D2FV$$1&N#_B$1[LK[^XK2[ X7Z/];_P M0.,@+G[W/;K=&VT6<0S>]&7TOS7\SR^Y\G!T+&T^OL=KO!_^02?AA^XLU)O* MZ 'K_3JML'@VO1,#Z^YC4*=K29@OJ4Q15Q'(%94!0]!B+N>7-3AQOZ&!F(BC)/XT[TO8'WSLQ*- 7=C"XYQT;7T7$6 ME[%W^:/ 1ZUM>LJ0M42"OD2Y3K1IOV\*?_#NE\STL#\8;0J(R"_?(-G@F';+ M8$?$BMZZ88V1B9#.-SZ7SR'_9JAMO'%TO&$?30B5Y?F_,II3V.)\?7^O8XLZ MCZ2Z<=GZ'LTG]P_QR2WOQ4VX1EQQ/UWU3Q3+&+]M9Q'3+[%AV[LMO\&(_,HB\?Q/'ZPL5P;,O_8_;[7PP.%;U2!(X:ZZ\/I.\IVL#[C6A/"_XOGB672. M;+M=J2?TOK7;]JVZR*^T$P_[B'"W[ILX+^8&BQ;=@\E;UV+('].XB"Z*P%G] M]%M^'0YV;Y1 (RS=N9>>Y:<(QM[)*47IA\EH"_DTR.Q%64P:RJ*_XRN+C=O^ M)4>U:,1M6_U#W[N7;F@-?/L6FAX^#*W:V&0]ZNN'43[?[_6W.4S!27%39?&5 MX>WFG\Q#K(9C.V%'U K>N?6@/Y-^LW3A_Z4Q+%<0.PI"1?QC#C2)2FKQ*,], MGE>K[#H&G_*#82)O7]Y?\HBCZSC-")'ZRAE#]\G(:#^ M26>K6L"EJDO'!O7\_61&7-!$9DSL"-%3_)WVHGU^K'UHN93(SA%UED5:PQFU M?W?'2L##;[W*W&!YYIBIGCZS!MRX[NT3>'-STXN+:I[T0-?TOF@@ /,C!3.+ M(A]M@3SY*V5^I6DGUXBZ,(033BU9J9>J+5O'-2??8EJ7.?(+$+LQ&S2PKFV\ M6%@91G6PR&.(?6%XQ:*G.$>5F?0NB^NO+>\M9=3%)_NS]LF&]=_.0+66^O M\+P='/U%:J%M#,^"R=D9]0YP,MYBJ=,+KJ?_R$WSY6J^O?0IJ@;'U>TWPO%J M]M0^Q+HNOJ3.I>RTG8PE,=6D3,=8@ U6Z4U'515V"A4*#VS,*R0>7I.=CC<8 MVPVETT[P@37AH$VGV(O<=DCFEBU,[#DQ7C9Z3I0!Q>2J%QTQ7=XRJ%3:\&[: M2M6\C^'3<;QTS"\I&,03U]W.,63"3=!7E'(^KE[E-C$?2<__923$$^GHO)[/ M?4#?1YT&X8;9:VB3P<''*),C/$HWO=?P3J^HW\-JH]OQ^!++?FUK*;?L_ML^WZ_91ZX95 MI(F9$#4:TLPI-S1&(6H*CCX5S^C,.4;:'QF7D N4G1'^$<11V\7[!)M.D^>, M6N*>YL*%PNV1DW1*32:7LFQ192[99\;E0VH8ZKUI$F'))^.BD!IA;+NA]&3; MU?KSJU78G(/N"%R$:59C2VSE F'2/^ZP07\)'?&7H]>88+DN7M-(I M]C,2IGFDF6.2\YJXV#WMN]UZ?W(Q7YH".V$C%WLS5\Q4&L M[-:HERACL7Z?['DEMN'6/!GHCZG"U4"#6 M5MM^2G.4^[A'W-"LBNI%P74#\3C57N(XZ:?/7V/W (\\B3HB:1-X;%2$K%%V M]WJU#U)/\&$ZN^VRW=D%=(3)NC[,C_PB'FM\LI)=I D4C&+:4)[M&D\](]TO MM#4Q>A(89"12+6>YYN:2,A:PW!SDN\59W/H?GT[%>J=HL.?T%&7;YI*6CNM> MMDKR$ZW"B9G29F)2+J2*]V)B39)(#N1+>RMJPBX-'U5K8A\.ZN1I$CWP.E&= ML^-.5''8U42\#KU:XP#8]'.[GG]R/5]-B6:5279A(T$<2UZ:*M[/QYC3R-:=MCF:9Q394% M8=FBKODG'HTWMK^E=51=P1Z1Y_CRG;9;_A-'%815D\S;M$RZ2.6Y:A3&.K)W M#M]IP6FH%!H&%EE5VT7Z=-%6MFJ7-\1(BSV:BQLLD_E@(YMF:Q:R=N^:8&]/ M^&^MV$^]^8(0'#6UQ>.,*L*QN(HAMJ7OVFS:=W&4UU1G". M;-)ZH-D&RJ02KXQFL*AGX;_KU.>I9=YU[3#>(:ICXDZWV\SUOJ.^K][U+CSH MMV3>@#[9[LM/8P>CRJQS-5:X5T-4QC=>PX+UX"FN9SJ5KA4")FI>PTY.%<;M M;>TQH2SAEDK?3?;PI*BL"Z4W\--FV]3+7Q]M/"E>' M.XW3C C>"_3BJH([EKEHU%K*=K-H-/"A?P]@[FXX'9^HUO7S8VRW&]5N5 [6 M1Q*IEP,ZE6KY=&(L:7S%U4=>K>/2Q',/]GYE5JY++^^QE Z&#-&JL33MWGP[ M2#@%*%VIC7W?X/]!-L'.11KQ*VLQ:)-?KF?''B(YU@G&B T:8"G3>MOF]SY#?.SG],;JTO5DI5%S9Y2&\ MQ'617+VNLB(>-AMW 2SK.A%G2+%*J5]@NSZ=8GA3[K]F*$6YEBD1X MV!<.,]IA61Q_(OO#,HE6&WZB=4.PK')X>GM+4RH^ MV85-KU 6/9[P)OO_V7O3Y3BN8UOX53KB'AU+$454[?X[49Z=:K=O -SO2G.>Y\QYR.U2' _5Z06;U#ZL*M9#W:4 M;=L/;3<42X7P9D_;?:@C)8NNQ8A^0"];L>X[]@Z?:4:LGDVK1 M9'4@^B<((O5'<(H'V1YULJR3]YMOK9K7;DVP;*KS3AB-/C5JDTRZ]/KCSVRWFBD*%EBSL1=-LI"K+,W6;(L4O2,@QE(GP M7>7V<)K5N5E][3#-*7<:,C(,+&T[S>P_S^S?*IDB27$)QEU;IVW"[+:59!VJL M%HH>WINWCZ[ H\G6!"X)F> M#/N[7"*8[C^$.1[:-L3>U#TH?,::B89IQ.P7-5R%MAEQ6"[%EZIPY9BG>\\HMM0M??C:QJNF#"9\"YP^4]DAG0^=\:D5:4%09<17E]#9-5>6M MT5;1 OK_!M)=#$O@A^^^/$WJ+YQ4VMM5?DX8R1!9+8/L3A2*]T(*6ZA-U47/ MLJ*.IHT-H=M:MZ53GL=LT5]!/M\6M ^9AUY0Z5=Y-4RXE*EG^]>:Z/"^[?_YXZOYYU/8/G%VTL*7%3AR)JX;6;,5[ MX- ,^G?7F$.YVD.C/T?O'F65SD/LP:V<0QNS'SA*,,UOX),A7T(S-8P/,6O$]3Z(N(;AKR7]FHZE MHM[(J1FBDIPY@R='EEQMMH=2'Q!\C'QE3S:>'X@F\5!<[V/0)0 M,R$"'@ (J-A7.1-[ML6.+ J3<[;"8ZW]@B=3\F[@@+EA?A0KHJ1^TE0=9C69 M(VZRUA]5:-;' 1'9QEE"C2)(6C%']N;#%4@[JACQ4$1H;O].II[V((0:[@P^ M^,U%Y^: ;"$SZA N-BC2#S \.MI;U*!AW^*:YKD/H49^M_C[LBI:D@&(N M-USL7^'0[S:2SDW5@ KE%Z=$7U@+8?KJ,L^4R)-N^J;X*>\4ZH.=R7GZH>Z9 MHXJ3=^06T#=>=&6^^CY?4_N+=#7QZP).6$0URW&.&1Y"BW5$.FY7)6L7Q?<- MCV!CN:Z:CM*6V>JZ:=\2I\-^S]1WG!11+KS,]6YPXI%%V*[R]3I3L*WKHEJJ8>B(4L(9*[\EZ@+N-+^BP@0Y#'WQA%839D]63)A=F2"DN(69 M*)(O;FBY;#'ADHS!E9-=EM>*D*?_$HY'R(HS_@[5]7#S\Z9Y&W[X_2E;PJJ9%F=3'D M;5[W1<%%O)X$4GFX !4(J9,4-@A/)C>B(Q_6.9&V@2J=9:+";Z]FZ1\Z,-. MY9"$'NLG^FJ(]T*<6L-"$6PPZ"R)#55J M)69&H]4Y.](<\(C4UN>WW6LH! ,)V.=M'V&!9&)6_PZSWS/7QCJO*&)K5X<0 M!4*G6!>*.[[BU(OF*5< (:F]";-8=GTDTQ.K&V;N@C0Q>YO?!,=%W4-\26)T M&IT2# '+7/09KG^EK"%^9=ELLI,RU'K^L=SW10@3!^D9VNWU"6<60[K,.C!2 M\VG$#=((HGG1_*6Y#GY+2YM_RP G*8WH1H#)B7(23@B>3TJ^&4%M.C"4F'K= M5=GB2SNT5Z'=(3$Q82.2O"R=XKIEUKF6V2^;#GS:Y7]X)L1F8M9#;)5OZ'>O M=J2KGI*,,G6>&_Y9MF,K+O-I.5TWX _T@N\UC M(8^:C)3:C'1J.S]N1WT;\U:^'HB8(N.%&[R%Q"JB8MP\OV-OI:">D*;KU* M%]K2R- '0MRKM.V%?QZN6=#],&:K;X:6MOH.I89K\^9'#6!-?0$XK3BMJK@X M:J-%6D_.[,6E+-0PCN(/5G&EXO( 5=_ #><;65(IX7QM3D8J M]B.=$]D**L'"PDT@6+<)$I/I*O+)5YAXOR6/>=:]2I8D[.CJ/,>0]_GA2=X_ MN21$ /Q>Z;I:7S:-,[^BFM+S60K#RW#_Z"6'F6C"QB.;ZRD5IXIOL:*5+M4NB29THN3$-3DUA M;>5>.QX/T"Z@]L8^V#WRJIB#CI8T[();\&QWN\NAIY -J[SN#,:6^<4X+_?R'^7KVDF$)ZI1C3? C3 M\@ID5IX]F(A)=R1=[NB#R]I>)2Q^BO["$ *+PEVV6=U KDLGW"X,XNO]P/%&!?*3S'+!(V#1\(1=4U(_97<)5F0J M#M!(UYLH=/4Z'!#_"L?;A>C/T2C\6. ,"^$RMLJN[/!,.-K(.Q=V11L/NG*) MKB3RU?&&W^5R(?'AJ!T\W^W#!8>]'R!$+X0\28>1_ M#E_^ZU 7ZO,0YLH-HY06;/SB7=C&B.8>^Q-ZZ*?N9GS83#C8-V,@'4.U>C,. M-KA1 V?*C:IHK)GLV[@G:PX@ IN&6LIE&^+ 7=B7E]V*S1L&Y..GF1N4I=#1 M:[Y,G"S=B @JI<\_G&"2)-)LF.T\?:,RP1)R:0<01O'KZP-;XLYMS?1>GDE8 M9$@U@6-8QB/RHTNR!D=*_#_7[+Z7T(#/'BHTX,$<@E1](5/-I4_6M%L/26L& MPG+Q#9C06"W)@?'^&B2@U+M>71;A'+ED#R_?%OUAI%R7[DJS>-/MF5!U'_>, MD.)?8?IPB#^YIDUM>[7L)%";1".:]X+^Q891!6L@;RJA>2'6D;"!M>_5SMQU M'OY-=E7BDBC (&E KB/NF(.P<#+REB41W^UHR@Q),7X -CE4!^'L2(5<&,C4 MVIUX>E1*:UD!4E 20_#BOJ;1(?3#S$NA^*87S AHJ[=)Q%SMZ)"R>"T>"Q.D M7MKE"E6_DT9?/DK8H)+_S054[OHE2ZT+CQ[^VKVB83PP&TY4+QEIFPV]/1[G MO.O+?NBE>,MU7*9OY2Q+<) ' B'+#-[S:?Q.#V, 7(!A>5?'LK!=(\,R?RK_ M2$-5L\KA.)\[NX'C.]3]K<05S_;2+(ZH,*=F:%HG$9?%QE Z9N=KLV47.\%B:W_D<_:2T6%G'QII M^3%7RV+:S#BV8M9,8#CE#I_SVR!-2ZFCIF4;LQF-B>4O1DG-I53<%YZRNMC(C@O?+C:CT$Y[58DRF,]*.2!WP6*C<0+K M/81BNL)Y]?Z;=UU\*-=8*>FRE&TSR7E-L\L6DJ8+P<^_*Q]SSO*0N9P5Y\*L M#&0)[5A0XB.'#^3DVI=Y)[UB,E1S6?(8BSG5A&*BW>%TRS24E&(!IX,TARB- M:@YD-@:#94N>.#.;I(5%?1?7C\QD5,F A3?B^Z?ENP,B5HE3-3?3$!=9:@.G MLY8DZ<*RZJ ;[):"S0]XK!?SIQS#TG8\@HBYJP5\2-B2!ZBY]/L]:51@Y^[C M3/FP'DFU2;X-HQW^MJDH8=#UIILT>TT?7IRM)EJRE^%IGUR%B'57W&+R9[N3 MX;EMKD3.VZ[A2(Q5S9L:X9QUS''W\%_$:L9'0+$&H-$ B?+TX3TW2&>K5QV> MHB78X:$LJDV7%!2\#[/2"2#(2]DC@>>:M,,"C)YQ03RF14QIWS@:4MR9./5> M$F%GM]J:7,E-306U2G\'K,(1P)5A6*EU%42R,>"GJ+"RUP(>( E_. M5E_%@N2V_*G82,R:=ZCVTOBPU+H= 7!U@C-YTVADHB.1JD,$1Z(*VR6-+/R" M"B\.P? 6OZBH2#3.UM%O/9W1HM/>+2/ASJA]/IR(.:W!;%0?,;R$)VL2T#W5 M#?(*6.F-EB_F19$E[RJO'#T!)_CHPIM\?5D65ZC#;8/YY@]^QX9PIIS@YNVH M 9O/V*LQY,0]@E/RF:38,*U"B'>"G,0HR3(N/8SQ+$GE@LL6$A2[1\-SB+5" MIN3\4=<3XIL]F$+"J89PJB'. MJ2;.R<\G(:-U\XH":EB8>&\^ZFD$&J3F&J1"K.'1L#ZF(K-> 'TD MC&H$.J):')DDBL(SQ!\A6-OW'+"@4L2^&H'!OSA-SB^;'-D]!Q?GBIHG\4U> M0P94X(:J-N>:2$[#_PN'7]&&^8!J.I>?Q[8/[@O%-)'?96=L6&J**W$$.7))RTER_/PWN) M:?G30\6TG';%K7:%4S'A8I(:IP0E0\&)QM,G0_0+AYR<7R0]J!O1:FDV7^58IC(+#PYNX;LV\S^D\O3-U =.E_.= MRZR.T0CKPSD]11^6%#\&>0W4K?38M]FK44JH59%YJ#WOF]L-%N^EH@8I"97W MJTHWT2[_5^-FTYI"0[R-6IYTX*>"@=7AC(L-82KQ$-+T?.PIV(&N=<=3YK&@ MT@8(4VLJR64Q,2HEU?5;VY&2J*?O-,231 5=KOCYOE1^9O=ZIO""'&K17C&= M@'GR5[3H@U'HN=7/O4*F&3>WI)'=6X/H >FCO)/EYEY,?Z5X8M_S>\5?N1S" M]UU1VP;];/4BJ7O?=5L(OO@0 <: %0O*^,-@!>?D ML^?/O]CEFT)H6N@#$=X<"#V&;F5:>?O+0X?2/XT^B<2W35VN8:_>RF70X0F+ M]L2;-,U%>_H.?DE-90IRZUMLU:)_A\"H!V<7DSRQ= "3HR5 1ZJI-+MKE&G< M$&)0A?+M8&?$A,FEJ+KB.K;UVV$%$*B1/H\3R>G%PV?E1B3B11'^=1.F[\>2 MR+]?M;*GOPJ/CO3T\Z?/GYY1,RR'4UT/K*!U-2BWQLR+W>8,X#Y;U*TS*>U? M$U_!FIJUOP<\1[,(\%=T0]C MJ=:A9@TGRR?.2 '6!%_$4Q0V?V6AYLK M?MKUSEJTI!7+W?/@J..*;O#"\QU-%ZI^9>=>;;\OAFKN;Q6& MSYUJHUBL8EC>0:D'CN$S;JU)_1X/>\HTM6#RS8/D>SCS\ALHJP2-K_OY6F1HPH?7>2M4"D;U\#[/ MZ\V-I +$K3>69 * =D^ N>)F3XQ_:;(C-W@(6!@BV\Y3.$ELO'^3E"#"R.4O M>QYX]FHZGC8]]0F')2!T*]*5VLI*\:[CY_(=89) .#J9UL\C2#OU&M211";B M.D1V3-"2Q9"#[G8U5'4XPLY'\$8K-_*.I\N'E49H)!:*D12GZ7M3[@+V?3'^ M7?D(9N@L\DY&^T.ZRK>QNVYY6@^ M&F\08_67:;=^_M&'5%D''\KB#FW_> MY*TTBNAGPN6>P$BUW!TD[BRXN2^$+VWS4[GC ML.^33\X^_2!;?1)&]@/ HB,]4 M.1"=!Q+K.%+ ?;,?JKP5$%2W"R:" !R[YKRL"KA21PK0)TUD[HBF<'_9 M$',@'.*^X0PLN76N&2A@?$+JAAD:/LA SS%9][G#$/(IS M!"EB *\NL'?#HX5C(+:[@5,-&?/&E9\D,Y>+]Q@C77) MT4_X2*ZQPEL!=-OO/:/(U XI[4/+?!M\-JIH<'K%RA$_\\AZ+V%,GS]4&-/# M<2"XS4@-IL@;VC;"CN%M=/#' UC)MTU5-A(&3YB+G5%,S[7,,4 7M1):@K(P MO)+Y\"[%*N=105N)VR9"8%?@$7E3\PXQSX).1RI'K36)%0L!Q-=^F4.WFV"S M6K8*6R[L CHEBFKUYI]$)^F.\$P/=V.Y)BZ"I@)Y.XTE:"/(T5]3X:ZGNE&S MVPUU? *0)>*AZ&S1I!DWW5,JHF%J4"1T$E[>(TD#S@&.K9P&69HIC0<'<S)"R[$Z5MVG6:/?7(UKQ#[ M4LK^+A1O/_-,$$42L?#/QNHQOZEA>C4SWK.W5]XZH;U8 ),,S/ M+ :-*C(K5=0%&RS2&HJ0@PGW\[2W948T!K)^7[Q3X-\[G;'?%@(8'F%>!I%3 MNZQW8'W_/FTT@UFB7;\6OI58XUN&R)YFZ9?.TI:3AMX=2 35LA%09[Q='>Q' M82) %,B1>IJZ^YLZ;"N=,)4C6>=@RN=S-?;[RJ35%Z<)N<\)8?0Y+70=)PVV3W.:5O( MC&8S7#:Z^92@!L"+TVS\&CY%BA4=5W"XLD7?LZFY+%OK^-")#%^Z://=:0/= MZP9"0DJWBM7<3"X-656$L-&1IY ,!&*8KY2%25 8%B&<)N_^)B_N(P8;=WJ\ M 8[A>"A=Q?AX_]1I3MZ9VXXAF,83(U01 M7UVR2U>%$/H\]NKL*_ Y&6"@^*E8#[ EUIO%,N(JJY,4>:C"I.Q&6N.N;X+T MW9$8\N%*TKX:YM2TD9$T,3*D(*5Y DEA_$OJEIX1V'.]0\N9ZF^>\6??%J0[ MQ;4R!O+5PX[2\W4:7V:*A&-O=7I2V:Q!!*/#9A\J@?X#1G]S=G-!DLJ:GL M-5*9#Q;/JS#;Y AEL%,^L43Z:9[N;YY&M*6) R\S0'6E'M-42)&T*NYW]U*+^+K< M2T-BF,F&!$R8'Z.U):',B8OKX?Q V#*908V0F].!>9_3-R)/H@W+6=I2JE@3 MY@+YIF+I5KOR)_W;4)=]%/*=(I#OX"L4ROR3VLJJ0U6(+';M*XYXM=42!3:S+:KLCP+Y>!_8/VA0Y]U31O ML]5^H%8)[HE$@Z.$(#%_8$H':NCB!S'Z%U,NFV?L\N=;W5\3#N@$=!35/ MQOGC-CF2F%/55V380D'I\2![P>-=H\R?0W.Y<4?P)@$R].]>X1O0S^N=- MT:W;\KR01#4I,!5<>H#8-;&[I=TVAA3JFYOP5H0-8AK#NV&JDOY*D':VDZ:? MV.Q(53&^7YBB)_(,P>63$_AG0L$>#I0.'NN?BX9(*WO0VB+'[%SS;;@&N>]%?TW=V%.> M$98'!3?=,>ZB1[>QDE&) \%L]\C QU&99V#AD6%=:G"\%;4P;F[0!0VP.%#^ M&U[+GLX^F0='D>UO26K7AL@(&^;+@K>J]L][7\-5!PB+0Y!<^VG&4=_"2RY+ M\>K<4N-X;]VK/69APZZJ4/N"?">[>9R(+&93=CD)54L]C&BX%I9GV75#6D4Y M'WKL9-79Z)M,DDYX#*@"FBAT'QYXN^U451/TP12@-DTX,>BK8-:#4>-'S&LK MR^#+47B0V')CP[GJ!G*R>"LE>O+VQ#7W) ;^\5.<6OJM8Q,_4=T;/1XSD=0T M;W1 6C.^"1Q>@1&(*&65--+'AF 38)7P.8UE+ETH-8 MONA*I6UG6G(I8G=]2G*SP,D(MOD#!TA8P*!7B<\]'IAT8=UF[^+20@ L[% V[4_2.IR]L, M)MDF=&C/OPBKB=<5YV$E%)*0-^.QPO+C 2.:!65\V?WX^HF M>,,DRL0_Q41EMSW3E3?=&6+V?-@A5"HC+Q',!PTU'8:Q@Q=MJQX&73A\E>0*2C&Y=#%W_?2&);ACW2TE17 MT@@BWFP9V;671XOX<;"3B^0&1ZEE/.VIS'NV:H>*=Z0_.[R0M>?9#1-=E&* M].S5O=WN+/'A$#0Z!4[D#F+',50TJ[D\4 *:^R:DC6]!2;7]!AZ M7B:JW3.K?IQ/%(_7*&]()0'ACK9PO!V]UZV)0Y,3F,>) MSN%Z?K<*(8I+/D8B'+8+TO_M?-1'3 ]7D60-#@5'G9W6]I='V]'M3-$VC^LH M^1&\F3O11W O'U;/\Z?/_FCJ7B%&Z!BUEBME5N+#FH1=9OIUM&R>/0^O&2Z M'/5JFY^W&EF;E"W6:=B?_RYIC[X9/48GG9WGF"FD,7BG7(NLD1(\KT6Q/1Y= M^-BI]'#,/WI/9O0F=BKR?> ';DF.M3TD&F@"X=5.>]DF8UP\APV>0ER8B2P: MT4UYMGI=UD+5& EH9F J&N)QVW^QF:[8.1;_\74H+FV&B\NH)*4BPCU+-[?F MVX/7E7+5P5"%Y2EJ#-^F"BC/,AG_LB;$T^7<<\W01S(F$J^8MP=1FQP=;NNZ#VR[[FD(G-A- O%L:;C@/EC[$ M_FQG9%._7I?6(_$F$H!_&X[Z*]X67]+2SLC]>/WFQ0\D.(-VM?"D)^B)AYX\ M>VC0D]]F'+"HJ)APF91 X:AK MB ?D+!1Z9"KG?'3EYMR4H#0+YV@X<)1N6.@#6>1NQ!"I8A.CEV-^=4[P*'95 MTT1"7FRGW]GJ&R\L>!V)MRG60J*)%">C>-_4.9EQF,/2)E\*-I\H/L'4:*\^ MH^3*D4FJYVID*R-73")H3F+K+SS,28=ED$W"$3Z2$71PMAB^AOQ)(YRHR+/C M;KHY$.DD5W6V^IJ.V7)R\"'EV"5.J+P',K[QC@LW(G&214;0$!\W?2DTW\TY M(N%M?M7P&QD8)"HGAK'?)4.3I%ZM"6%1BF*>7?3W*51X]ZBP@M['V^)H%E59 M/A"@$T=_D;(-$;%R6<1 ?1R.__#?86M^\54V%X5GQK]<1O]&*Q/2'=07YKO1 MIJ^HC7]@_9HPHV'%P:E$Q8&M[/)VIM7(>6&QC=BZ@_K?@& 3+*([2S/Q9E1B MA*8DO7E"3Q(V0VU;C35A-&$RWF8SY/YZ &?I?S)C9P>-!5:L_2E#U>H) SLB MC=#YO_3I'.=%)' _SKWL;JCV7/5Q-S-MG'! *;5627%ZZ>B/?#',W3=S*Y9A. MEEYF$9.RW3RA2.<0CI :_;4#V*DI#&LAY99S2KV"V37"RU6L367&N1WI5'!D M<1(QS5V(6#*P'EU7S/D:8??-Q6.T>_4@850N:3+' VF==Y>K;=5<AAQCJ5 M>G;;:FC\02ZG]LA T'7@\ZA)6*[4NZ$5T5=Z"\Z^S?L=CSA$,&%%E1$-)_%% M S0"3#>73;5>6EE9&YP*2CDO9X^U%,V8SCED(IAOPM#-0C>A/J(7 M_PVW5TIUG%_^N04=X/!-?.[$'_C B,24(!HH=(*N'>6R"-M^CG'HV(KT*E?2 M?K\N$KQ#? [F&8 G'FJR 1P4)AE5(G" -XF ?I@4Z9FU"!M(#VR.W6^?:3$:B M@2X^\N9V!6D_MB;N[_0+/A?9BYVE$8R1KK##2:E;"C4S+6/I.G?Z:O$[F3VT M>KF"ZO/T.)D'B+O5/7/JS&S&=+GZOC=6MIE8LXG-OA]@_;-;+9C?5 T6@R%; M3P$*XP:+(@Z^E:8X#7F)//=!%II _ASH-.,4R^0.4U9 KPY%G\H"G%ESM$P= MT>%1-:OD9P9QS3D[Y$W@+41\***A^8E[*HO50(4=)1![MOEX(KW^UGYOZ/\1 M0E V<$TN:97L8"@?(3)&I@OR7*;GJ.B66RDJ+H(-75\ Z4I]*&!S150!<0! M3:]_,IQ:X<%?%U9^^8$:'+[A5WR"-YJIB*=TN-X1E_AU[-/?[47/I/3SZ Q MSSZE MPQ*G]UW/*=7!3 N+B&+=7HM]6A&3=N,:.-7F?6W^^7M?F\>:%UIXQN3*PM:0 M9WE%,XU/> J29B>E "X*:)U I=TIBX>'5?"5ER"&\J"Y%G/T?;%22#@ H8&T M=>X?UN_$N2O8=D;;VU$W&FEAB8GM7LE>_$(WE!0GY'X,*/I"ZS(ZB&FR\%"& MD+JS*TQ"5&F7O8U]_X)"-5-_5O9_UMG0'^!I,87VB56^:%1+/K@Y\S>AIC5] M4'*]=0A&0J!49:6@?-MRK!E9.H\LGW\U);XY,7[BCO9>>)L7CDI=QLN8%17T M(UJ;^)):LWUSI2F'32N2HPR:2JF)PUR19]LMCF, M=M*&;*840$G+($=$Z=,?DVQHXUTZ#,#=?&@MQ=,F8!%?Y&L_L MI@"L6U+9JNS;7Q:C.2L8_\!+; M_'446==-NV\XLP5D55B._EW^0#-6HO4G^AMT96PL[NC18F*\I=Q 4[9[YX^T MIMI\9/>%8?B&.QQW:.('#AF.IYU"./.WI9Q=D?J-CSW+F7$M8L,(<+0K6S)8 M_0R!L<5T7NJIV!IEF!=4O27S+^9>A*_EB>1PD)_YW'*<'EZ2W&C -57- -IQ M)M,>%:A'EHW7>W(T8DI*_%IEHVV,IU.P;:JJN2ZC3C5=,!N'>,0-/]4!8M&L M8MYML HU!=?%YC$>*XL!,/-BE*H00N]/OE6Z^\=L[6ES<]QRKM^4W?M'=Y)( MWZAD_JWL-YOG='(N9"",:3[QM%%.H'^X>$K.$TDN3H=;3_/IF$N!S&J;8#HA MLH&"IZ_EU.]=U;(_/]'MW)UN1\G[;EF=.?%8W=]45-RPZ[,$$:FJA?NPE_:] MMCRE&^DT-_H)2<* MJ/\39@MQ6>A;A1V?W+Z,.9GE!Q.NS(5U=PGJ9F**(]'<-)6CI1\J^Z=)Q-6N MV125\ R1LBEC%BC!'7%SD$"VS :!(*5SJZ=#"X*3'%P MK3O#9[.WY4_%9I3)H](@[TKK]X'2../WK6U2[G"$8,3$Q;6AE@I_ DN@-C2! M]=*5J,/X"2&11F#9F "=!R=.FT0-PSR!AV$=7!&77 I IGL,M?8E*,[:G@YP M5VX^'_V.<[I4NC)FE)D.4O3U2'W+XQ8EG^I'SL9V!(#D)+8<:N$5OY*4*\-T MM7&2>FLVAI,KZW0H[X*I6VJ&);1&>RYM'"-_=$3A-,^R'HMI2,?J0J&*:UC) MU(XL(^#SP<>H@%Q9CLK385N1+G*FY)ANA.(,QXY<5SJW49I_IU1E)X7*.G4@^9C>= M%FD)7C'JL3P!>CR@Y^.'!NCY#?+]1T<(A 7ML-=#48K($9/C=X,!3$?T9A7* MH7.@EI47ST6%;--@VS'<@/9XF];WM0UBC'03KRELU1UCQ\-FE>UB1" _'3! M00!M!=6AZ#C48N(;WKON'<2E2VI182>T!\$A98:FL3NCY;3IEC!4[*?F ZJ!G,@S ?=ES+':Q)]M;@+&>H!#'A'U'=IA%Z>E+, M^AVC/)/H9(QH]\N:0$,)4:1X7.3%A+/C0AH.N;"-T[./;$D\;>&Y<5+(_Q=& M$)?D1-O19"I'C'!V2C H"\N 3F!,])[@WOVJVX5')*@-4S]9U=28BX%C(/Q< M>O%P.6H''G>FR:G)M%D-]W7[-NKE1G'9EF[V\$-)$;L. M@^3YG1,:Y(V_!6M 3;N;N/I2<-(R.49=M4?L[2KD/I:Q;9V+*+3<[$ MP4,L'M1M&^.-G&;']?9Q%6*%260L,-L<6[3I" MXGFF6ID81AO&GFI,E)#!27"]IH76;+C(%4F;1UU4"0(EH6B5.3N"7KPN)EWX MX8CO&L_F9$^H3O=>X/$@W^,6<;V8CNJ-P4$"PKASC/]8LRL_SD8N2;G?X)Y( ME%W (C-@;1FF]^A.Z]?%OE?"S&>?P;@6 @5FZ-8JC">Q,$5"$':L7K_YKERW MC2XO(I&ZUEQ4RD/*F06Q"NE [LA_?+)'3YTRI14CKE+'T,68* V[]VT9_DDL MC&(DR&H,?<'T4H4B8(51&2QIPCW-#@5@Y7A0-ITE.POS4SUB<)4SVQW#',.[ ME\<%8W(S>OG\30X7F>R#GNJR-#YCN#!U9[FI"$LKJ,^Z4$\6)S8HU8/MWFZ_ M&'NQC@W96))3'>[1*7)T'+]PV&1B787MY:ZX](3B_!?_9V1AQBQ(T*+CJ$-N M@[Q _:(Q F6!MMM.(AX>1RT870+ &?PUHRM:LK3P4/JPZO=]LEB-H[\J;!'8 MD\$VTVH5NE18"B+"PSFJF6YQ)!:6T-WZ) Q+MXP?.DEOWTIZVT("3L6,PC'@M+4XLG&\>TZ3^,OUT_.KO*Q< M54T](Q=OA,B@'.J0XT(_V,\QEUU#Q_S0=OW Z&D=$Z))<[$-:"N:T(>YO M!I($G+4LN%1>IX [<6XM#?;%LCM_&OM;C7U57$2\Z1Q*XCAFY33*MQKELLXW MQ;^9 V=&XB-F[M&%R\!C9;.I,,H&4&MED"!N!K$<]UU>2;4>MRW)EAHX7M);T'8;8**2,* M"1Z/^KHHKVR^C\_+39: LZ[@QN.4"P6/:V' 3=O_J+USQXUV7!!MBW\5B6A) M_*Y4,P7R$KWI+"F8$GV?+#K3/9'LD( Y.-*)[(MS%07M]2P=?BD \[:T?%Y@NQXR,XGCP"R\_EOMA^I@DPKTA @1JCFT)$_%F*LEM+] M\.ADV2(,-]80R(?"5F[%H/,VSTF#ESZRM:W2\LO)ZO#%H<6)9)J+5BKDC!CK MA5BTQ.WQY-G8?5B-!/LJW/ EGAZ">$*A+MXGRT6@ ES+^83DZ.TV; 0IR4%X M1 SR%\89#[_?FUONI>)A -DE;6%E17+XD"EVS"KO<%R4X2E^R.= IGC3*+XA MN%/8[G'>B& 32!MIG'*<&G]R*L],Y.,[GG_T4)&Q8*)B=]0E(UC(CO6>MS.\ MT&^HK*5%1@.2*^]+V%\UM;:3PSSB:NZZ8<< PDEU4):-.7H;[RI/*%^S! H^ MP78[W/=UP1TH.U6@\"].D8@C5J9UT<#O)9P!-ZXT<\^C72DJ>W\5PE2%W;#F MS"R?=N(BQ:W#ES+(NW&P$B*C[$=:8PFE=3-Y,BT82#JI50[>"G1*&_@R8^YK MDYL_1Z2V)HF:C?+S;C1BA# 'F4J2.0R/#74C4H'@L*/.*X!N$B1,\%K"2DG8 M1LU."!)HC# ARTXPIY' ZR//?U$)=>C#"OE/TNR2AK,16F7!*O0W.NMMB/CZ MZS8LO">;YEH"\DC(HXFU&-M%67;C2:%(4S?YDL568I3Q95@B'R:,5T1DP]^AWY4!F4][/#SMQ)DT;57#PJWRNFXPQ MN0SL@J(]1!C51&"F;UL*W,J=+K>952'NF/O,_YX]L:B;9$,3Z?Z9&C?N\W:,70,*: !?5 M:"RW"UE^!/PSIMXC_DVYFQ3+F3( Q<>KLE F',6GT,I$8PQ;GD3H>]>*3 M*V.%P>U0;4M&\XN9FA()1CV?Q^>^C9MBQV=DXMU&F,TBC"E^66!9U$2IN:]( M*J!X3%*GRT6T@&6%ZQL=1?:=^92/#&7?3K_71)4#)AMR?6F"]0U>A$L0&?AS MJ3^+46K_LVOZ"- M@Q))$BCK2"9(7$UBB'XY)RC5$NNU$:&PVS@Z#+S4DW1QBO^0=(RH_$C$E5X6 M^48@YQ&*_H\:00WDB\,=_YJ'H<]6;_+R6I3TOAXH-VIW^)>4:?06YDABZ,)1 MM&Z+GI.U:-+_M@ZN01'6VAO?D/'BS]GJN_RBSE^2H/GK9,!?:I*7K-^KO\]\ M>I8I7M=+J?S][)_A@S=-.!W/\_0J7X4]'N[ZK:=RI'?[9QF&E>3*PY#$AIR, MOGC+%_[V97S5/W.#PG=D=)X06T$JB;X.3_==$_XSG-OE>O4]?O_ZT/4%R<_Q MYTNO^T/8?'WQUE]0!Z+8T9.G[_NF^"FGUR5D+#MP>*.;7OG1[=D?O<@IK)RW M;BDIL@75Z0Y#A<$E2[B*!C)KSO^/%7W(/>[#)GHR["?]4:AS&A S+*'O'%^V M7T1PQ!(SLKD*\1S<)@C@#G>FW#O1Q?PLNIBTKU]1LQ;.9!&6GBTZ6+-JP2F^ MG#&X&??A""9ZQ]![IAE.9$)5S=.*5M23#5W80Y&P/U8D.)(#4@.+)H0O>>< MPY?#C84%Q3UT!/OC/% LL"&;>UI>][>\/&461ZF8:)U>DM.HZ>B?E!!HUEKT M?;;%.7OEZ<'B0WO26&;:;29 H?MEGOA?%JOD::R;G MKYD$=K44G+1!;U$GF(:%,BTM"KR'XZ)(XG^K?#SV G92?YB*N5I&E%AO/)=& MI%@AQ0.(QW)P>E6T)M05+G8%( _?+YK! _J4RSK M1%\E#_^B[6J[U%^Y(MJVL(1(V%R[<,HDGM?.AA3R.Z+\_(6 KP>569L3#)LK M"R@9JE3$N; HX8\F/T1!XMVQH]XHG_(HVG9>#1+D04& 3IRRW3RA8^@PVG#; M)G@OK6A(+0*[%!D@B2)B37WLAHAJ,D3%L4X0'8SF<(B1\Z*_AEQR)(A:EZX/ M)(YK'$DT)YDH_82"B^&R,;FL))N<@^.2M=9&<8/5^ 9:\8]//&KK>>%4 ^FA MU2[2P!.S EQ+O5PF__+G-UX[.RE;*9O7LZ=G''V2K9\_. M/OT P_(LQ"X?)$RNG4G5)^N*:Z5&6L1FNP _\U^'NOCO__7LCT^_^/@I6(N> MXW^?X0;A'T^QS_=J+7Z?3'%J+T$(.S,QFZ;HE-X(*8 9X0J@(_A;QAVKB\>H MY(S@*V6@7JJ+B_8;.[+C2QPS)(*C:%K/XDN(QO$FR9*EGPI_A8DI:CY_G\!M MRAA :8H1>&5E8Y7F$&D8LZ*$8PX8(OOV9]E" -+26VNRY-K MFHCSO"N=!U(!J8BQE<=GC@7A'Q.SP.AV.AGKAO7F\EJ2]+.T5T8E[G!!R30( M@2RT0@V>9\6J%.VI-.9*IW4$U;S$?97 VXX^' J?8#&R96J8(TMSSEK7N"0+ M)D*SB59$WI3)CJE_QV0W-L VOM2XIY2\KJMOGOA:EK(?YNBD&E0W#$D8C,E# M=T7QEDC8BK;FH,^_7V07'V=6&\\:7^DNY>50M#N&6@HT:42 [_F<:"$RU<>: MR-41\0>C%%7?B7$_(;8@CUI@-%A,\-8:2*V^AD. MCO.#,+3;S[_^,P1X5$,'P#X<&;3=NY2" M&YLU6*"J8G=LY#\G;IB/5TIJGT;63D&]L4W 5KQ;Z1)W**EJ+12]*FO)^<1U M$\GW05UB-&S8"PYV;)>27MZ)/:=]Z_1470'!.K53\E%4F3DS$7F*J3F5/3I% MJYB]3K4W',N_*O@:C'S%L:G@TYU#,L>;KC93-30<5XLST,+^C NR9?:/W(5W M73>"UNZXO:!$R_LNHCGF4Q&)=HCF(S*SA,X]F'CZV:2%B-\!9NNN;R']=U,G M,.RW38.7^BZ$$3TP_.'LLUNF+X]#CEM:\H1*-]*LR?PRR2BW7S-"GW]F33F; MLF"&-KXP?]\Z9C[=(3YUR+J_VZUG9SVZ9'J5@Z.$?!@H*]<1] M[%TGZ@2LO#(6K6P=$: MH/9LC!GF:#-G)__,]<2JVK,&:2>40VK*NF0]XZ3&/9Y7N.WBT(H616 M1:TA1)3%W#Z47(RM%FDM9%1H/@'M$J#='Q\JT.ZT^^ZX M^V(9/DF0B'!/4UT5]?J0^*V_(DWL^S !^3H<5VP TO#@_. *;S?G16;,PF^> MM/[T9Z13?HNE\6(.V\)Y$7836"G*"!$G](>1]4)D+A/^5([R'-%JHOTV:39( MF_H1Y%V7(,FXB=;H=]'*/$;,)+T7JCZ=)DRE,WQ"!C26&W9YL 7DS$-';/U8 MW.7]?QX9DC3%IN-N3(\,I9[KH8[^$^7'%>A"QPIR#+%ETOMH7M$[NELB49)R M7A#5%!5#X?.A02;,H2:O@+F@^+?K65V&B3VG?1?^YN%/Z[N5OKL<#]^/W M?\:=O@^O%B**S!X#]29BVQJH,QRNXQ\_ 0@G_+]G#,()__K3!SHYGA?A'0%N M>+Y,ZTC,B#PJ?D2/?UT &ET7UPS_^>L0GIP$E+C@17"'\++4>Z3BAOQ5>M B M7U\2V?<3>DQ%2PA:JADZU&@KSD,0\R;2R.&;!!0ALJ%NH$2S=#,Z/AJI]L0G M9T#6>=C]5%XR,D&5J@$.PH.T&$.U&O:L7M^E2^9L==26W&0=[MJ;^_D)TWUW M]\>S7I6U,97 !QV5)+!;5VTC.ATM77F&VW=$Q03044)S= $X.%(U4>$KKHM3 MN]RO$>O#)^J%]YIB?=[5%MQSK_4,W?9IJGZEP-"!%HJK,&^NK:8NR!SGS'@% M/R(EG^S%T)=K/NSQGZS"*DQ5Q(Y11YZR;9OO7)F!L26GV;W'V6W60R>E_U*Y M)958O:GC7$YI+4[3Z)61\LC%-BR7U7KO@^48N M>Q ,[D!OWUX$A_P_H@2'0]8J'DW[5D";T&1A4)1CQ!?7*SRDYK#>VR#C@W)%*8<9ZKP&BHD&A.B-E9YCH2^0&8V];8JUQHWZBF@1SM'YXRO MGN0*3BVO]SO?S4Q@GP2QT:1'5F@)P@G0&!SFHN0V=2 51\"2VR; ?LO$\/1_ M?\M4L;0 >0"=FX_5>3@$Z6[23QG^,M37PF+*_""[1G(R$[]9V9FOM?$DM@DA M%R..&,O<=Q&>GY+3U(F"(KG:3 Z/33KM\TUX58] MMW$$C$?6Z[D)S19F-%L1S1J2QF0^B2R0VE7$%RY=2UA97U&M]'83MWH=-0^3 M!9!>^*BC#!.1T/!3$GJWI_8:LD+ AX>?F\Y<%NS'Y&GQ M.\$_Q@8P:UBB(1<1YOATX3$N"B)3VE^JE%41YCIGG+T+CS*3F:^*G^0R\*$] M =]Y01>T+JM-?#;Y]^1)[$42_3,]Y_E)HI$]S]=OPT(?E 8L/,XYXP)]F478 M3U_T?))PI.:^:8 I&F]D!;O8I,:PP5\Q^Q1M,+/I*QX+[%VGSU4K-V#L9!4 MY5V6?8F]:C%EF:Y_%D+I1JV)V>HBF#RJ]._WS!-: 30 DEOU[E;4D=>NM+&,,HOF[C M,[5V"RHB+MK%6(S[]F>:2D=< MRA.;I?XHP+-Z!UV4*N>2L+U_HFK?..'.LCM*Z^V\.#22^& 5;BE@2R?=PCM$49T[//\- MG&GOB([L@;DY/\XFJJ+.I*G3)*I6O8*H!)A4B/39&/HA+/88OE%%,&@FI)1J$<#L:'U#=QW>!Y.+\RCPZ:62-3X5,G!T?++\4I]@R7 MXQJ9Q/6R+!6J%PD?F #.310I?P"^DE&??'V%K)L#)1[F"_:C&,9VW#B:OIWJ+ZA?ZK'B<]XJ25> < M+9Z@-^FJ,'$L_PO:1+8!2'?$?>;)-Q8T&V7)Z(ML;ES!623>:;;;KHAZR@)3 M):56$I*&><4Y."H:4G;HOY[]Z>RSX$V$9Q>/^K^>/3_[)/ZEGX&I*D#UV6T9 MX1[JRL$F7:_;@?P"SG,E%B%O"S$>7CBR_3\[^E*Z^C\\^US_\'E97E-D3('AJ\P6. MP0O04MKJ"!G!&S4!A%,.W'U;.0FF$R&[8,G"\4%[+LQG MR4XTL@GC^XZHK*28X_F5$R?JQH+Q8]C&VIG D]E-4'OC^>2IN,W4:N*HJ,/+ M%RB[N2DWO:HX 9RNB-Q_F:!U^.>NF1W-G=OFH.' F.HCR-*F1"BI^*->H@I)(Z M>%4'ONKRA;PH/7^M2#3BV-+;)S%5<%48T):^*F#,OF<424W8D1+_@$P["FRZ M@;9M@6U+F$W16XUX73XKFIK;Z(GK+UU[\55C;C#9V-XVC/$L5DCG6C54-\+[ MU;V5[1?1)P([8:+^<)Z43$;KX26\6"=;9.9,VE#L$W[9([M%BP? 1%P@%SIQ M>6TK08RR>Z,I!A[LZ1=Q)/"'9U^$.=F"V$QXE#3/%H;B2C?I861QQ]M[?IRE MTAUL-IXU62_1!>-9POYRMC:\>(O40ROFVFT19Z%CY]N,6>@R68RS)W+DH@6$8B_L"!_SOZ2S_)N:"PFOW-F)Y;PD%I(14+<88*+W8US&U M@5E]A-_#<9DIP7JFWFBJI65C.4OUP69>B4%S 4-$CD*,/^HW!P13JP_C^M_E MW5NVEW*;\*./,O)KZ%1JWZJ7LZ$D&+%W0?"%X%S!4)!](O!$[3A*XCE %9HU M3C-W-D1[MBOZ2TG/W/B&HR PH?LUX,XMA^H%=N!<:RDE"JX)H/*G/_V)D_.; MU3_.7I_9"BY^VK.BN%+P6\!VJM3Z2NV?'FJE]G[!O+<=GJ>?/!-DQF;UQ^U(D1QKF^+2LZ$V?N M">^/>];_-;1EMS&@R=!WU%TN@*^P-?Q)^O(RV!S5TA9I;=SN?X*OE3\@,_US MN$U_JW/"3]O<7*DEU,;_79$3"HY@8=&>+XA!C\GG1P@XO;7"X,0@VK5F'D<\ MMRXLTL%\-_E>,_<+A8MVBBH@_P0YOR2'TKHX\4S7!=&(V_Y(\+"T*(+Y)#PB M$[*=>L/NL5<(49Q7%D)2V&CJG7CL; @2$T+_'BCQ<:&4HW&Q(?YW_QT%]6[V M8<59QI-08/ >^V8=0IT5SOP+&P=7N%*MCI8-X?K6DB,EIM!@? M<<1P?J"JM(M+"EI/ZT*315:YN,JE(A7BL;)=#SNJHO*"B@17ZTLBDJ\O1)[* MI:Q0MS1%+T; C94#K1ODM%[NE;-86UF@VT%9Q\M"&@R7'2=)9F%/B]L?T>E' M X NA._F>@LRJB-%DYX77T:E#DX:GGI1[W?JY\V[">$2!)%[19AK'A^H:5!< M9G6X0];#@JR,2:A^RLE91M((41S5WZ"] -5J.G9$ _&DGUU M8'$<\%B9FDPF$GGDLK(P_%BK# MPQD^1B*1U^(0##[>BVC82/9F<.ILA'*))1A9O)2ESI&_D^ZEJ"(DS364U\\I MVS>)I7RF4%ID1'$+B@O%ZM ,?+1R/G_^!01\-KD9+*H*OD"[,CE<_%/&&!NQFHV.C4#$9Z'&UK97_*1HIT_W,J%M MF6&O-S2S]3 _H$WQ,YNQ>-P=Y1D16I>FA;OHD"@ M.?.\^E,\P3[XC@1.5U>!-\',38BI(BQR?E)V#Y6&4*#Q+FJ0+\NS;.9;WZ,* MWR.L+'T[NVJH+W3HK78W5)=A ^) M27M(NF68&0+> #:X%S@,)UQ!P8OYT%8A/N8@K2Z+"B%88P0?UJS 7>XD!Z3< M3RD+OO7VZ9FC$!7:94WDS1\3P[Y9;DB?PWE8GE62H?$+? A*2GH#NI5CEIXK[[W -0G,43_9TYMP;L\^=^9O0US&1IT\!VFM8=15-]<=_;A:H(F?.S5>?J;;XB)O72GI MQNUCR#.7Y4R%5EWB4Z E(QP'?9ZB9"P!.M.0[ !)8GOVI$*L=!13RU'Z@UQ- MAQ0-L"S=:&"_FZ,PQIN@%PL-@YZ9POKN]=7'=8.P#5CX7+!"W.9_,*Q-1X0 MC"*"Y<"1*^L-%K3*PXHDH5>MJ8E:$:]66B2ZT).$,9H.<#% Q)2>8GT0QNDP M0[@[\1A15=B\YG#+X ;48^!AU.@EH&JBJ4F;A WG#)=UW#H Z]8P<+4P&,>+ MZO=@7NB)GX0I B/)S$43%(#\;D3%Q51J/+Y:*[*QIZ6BC3!"61Q=.4^#R]49 M#E/%5[5_&H/P&@HY#W$%:3?/9K/!U-T3&II4A@%H* M;J(52D?8"GP30AC1A.72W>+YEW@6VK\QJ!_"LK18 [[ MPB,LI;M 7.)H]F.1-II]\YUA>+:%+"SU$4%A5!<734]54@%G=@7!.C5?Q5\] M"0PE6)'/'P&4YL'NJH><1-[S(69[BI.DV"EN6ZA4 -(HV"#_^6HD?9$FD*SN-%SPL? M'T\"'93/N/X;YE/J:*=IO+=IQ*'*D80$GYK&M8Q^QD5S/92'\:0"+ M;J(7M)U9$J!F^%EW2Q=3+!1X!\P"&(I-ALX]3IK-FN$:I]:MQY

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

DQH8]) M!+NY921"3!1[*O3 OMY2D)?;-% 3LID(:YC0NS*S!,UIY:Z1HFA4M7IW ]K- M^-HKB#?3;WE)9YG>['L[]**%V@'W^W^"#?/FTONLT2XZ;$++8Z%7Z 30$24. M8(CO>$"/Q41'YBD[+!S#?.7EK'OB=-&%9$:KVKPC"XMX9T:[S'N0W ,JV;7T M:4V>\^!PQ+.,R_<.+2Y_31]RK2#-9!^6F]R^4,@Z>M9K/':FZ.F8QDBL'?AKYF_]96 M7UV"\QA]K!G1B\RM496V7"GD;/#8EI8PV7-B+0Y"FY[;KC9-60'7?,C6:0]6 M%)3SQOD.BDI:*BK;.5_Z/$:!.:65TV9S8XO4 II>/OO]X]MGKS@B5_#-D4LM MJ&FW/#$S:5&$*-"C/7]U)Z&O;W$OFJ?D\3 MY"%9$5A CM0>T\>W3V+3- \#%3JR+FLHC)[RA":^#XA4Y1F#8S@=[<#9# MKT-=MGDNP&S 8S03!,ECL9*9C_+4QOY19[%0VKS"=_-%@,!+W$L02 #72N:- M;Q+)6FFA5[(0XVH*-J>0 S-39]$5U&/$:UX@J1F?& M?)-&CG^D:2HSP]6L]JU]WMS/,MF#C"#(^3=3KLD4Y)JH?%T2!6OG@<%/24@, M(QFML-8D56PM+:R]UU Y262"BHO9.T&?V_C)[V08JN3(I0I&H4,_RW _R4QA M@C+&$JR$$.H2DO&+Z@QN ,WY8^&=E*$AD303GECIUB8]9,P< P.>"]S343Y7 MK@:*P:ZM@)K;NV"IFNM !AS6&FI4J+9O!WC7[1:%Z6*(-[Q=""YD;H^7<$MZ MN&M+J7):Z[.VP6"'M=!@- 25\L=H0=Z!VM+84-C6?R"$.UZI#4]_ME&=%#-5 MG_^LIW%]X'D9BPJ/_?+ARV?=6+6(-J*W*(ZYAH&JEQG5YPT +"U2A*BISKN- MI1O0= 0-B06M=%/39TG &E(E4VU6:YJ\ZC)LL[,-5R#NR0MQPWEJ\6""T'8 M=2NS-.75K<&HH7Y=&A:,2FT[AFFA_5V.%XV4T: =FF 53RM>\"H1C05V9 ?*;<(6,HCO0.^W&I4N"J:?T21& 5(&!%RY9& MM:S.1B9HCS6FBM-3(B&[B4M4AO^S#-EY]OGWGS=-Y7Z2H=;_\Z"!>UP=B[25 M-=<4A&:1Q<5:)F.I'4TH1PJ[70,GO"V\;8@%"4N2"T7D@ZR+22@=U78??,65 M80?^](:2NUR[Q3!M)8(=%L5L9(%@4!$@AMK 43L*8[YN1+J.D@Z:L)YE(DO5 M7W),A27HIKVJ)5JD<@&VFJ'*W8$$K;G"U[+G:YY>FXO1MMM"Y]A:6P-W G<- M/;X$1IJDY QEGF=!JM80=>#]*UOJU&BX0,Z$5;I' Q:)OD+D"G5$4V5VLVUW M;>BUZM4'77&*:6]1B6-2AVJF)'_A+,0.PAS?"+B@T4;7N!R=8UVNQHRK3#?0 M@AE59P+Q2 M-9H ZWFI0@P54Y$$L[:+E46/K/8-[,MEFLZ:8E]U5,R8][_.M6H!\YA$04-^ M:-[--S%$R#=_*UPEC2[8T3"V!(E70Z+>$5ZIOBIR;4GVMSE3JTBYA(5;D.24 M);*L=FS9C-9VRD^X"!7Q?#! ]J$9_&8S M(E52=W^CN7DKK[WJCB&SYOP-=PN\6C0'5/Y*>O,(/\*?X3M E=X>;NYQNI*P M-[D+KJ*%4>/\@')IR'\)LU/(K1 OF:D95HC YJ3)&*9C$:?+PLK8,\5K;'U> M\Q_)9*6:&5"$'S,JD)[9"'23RX![G7.G&O*)OU!/0]KFF22(E MCO8ZIJ,239/A)"-8:MF7IOU?ULA5@SBCDD)QN4"B=Y%$!-5E+9Z2LRHJ&NI* MQ=7LTBJ(%YN;R-+.]O@4]7RFRY++H+3NN14GVR!@&Z#L)C"O[A'\=R8"-OJT MS(X7Y5QWBUR(6&HH->A:^_9A8T_9-9L7%T:\N4GL,I%=WIH$HU#+FPCA3U*7 M?"B7V_ Y8QGNA>IT431$%CVC=C@108^FS6&FH56I")P-F3Z,"-[C9ZE2R M'@R\E$K*(03K362, M._L6PZ9<1QQ7*=BJR4%%?K0X26I+C"JN81$DU)(KQ, M(KS)X]#%)X*N-PE7N2^K = .29"H?X;I#%/J0T1:[7VI@S^MVT]T;,,&? 2?Q.K*N^H M9/0F'9GGT@D#ZESJ0X'GD!!_&C<4TD/)Q3TBFH1V1U0EAHN MA6G*OHO8C:H3WLH>4PX)8R3.B24]6]F5A,NEQ,Q-J*8JAYQB&S&6W,&+ML/. M.\9)]8, MDG]?)LI;1)39JU2]CM%S2BO%B!9#AA6JDAIF3"-1X1_[1>4W5>Q=U@:#N5K. MI;ZP0* UIXK*E?S;Y9=WE__'^RM7C?I"S*6*]@*04!_AE*_( M+3T.EY(_>,WA;;S=^DI-.D!=(BA5)R?Z4PH_$>HZK3CY=SD-#LNB,H8B3Y^B M+2W/?)W&M$!)-SB3U8BLG M_Z.TA)FNF"8 M!$SX)5KH#; !M["/N+!6=,68E @"GAO[<5G$"&-%3"W# M&^PU1P(A-68N"6 MZ9'WGQ4?*\$V["WD%N$QC90D29& D4^F$;)H>,;R)!)?LM(9-V*5G+!0^KXN M-3O6-7DE?A/U*[A%B)/,/MG<=;)2L'T-X8ZMI6H-.] MT,XJXRE?2@8'X_Y?5ZENX9[.M*# +=.7$/JQ?!\#@SVD"O &P^\CT1*2WTQ7 MI84D*))TNE R_71)M)]H0A+J9HD.%HXSP4D7CJ$#;J&?['0S]S$,1L;H/EUR MR@E5YS.EY*D4L*[MQXQ'O''=3MW;74TB+2-%[CNU^3]RAKE/%$L!UUF;6MDW M;IV>TF"QXRNZT/=8"'P32]";W56N/<^9=O(WMV*/N6(3[8M$>"L:E7P)FQ(T M0:,"W"(\J@5I(J=3%<1AZ"2[#*W =3K+PKE;C:=48J$D':1 I?$#:C?(:"4/ M&+R V3%QMTQ/&*"ALN<:->B>9>!Y0,* MO'=W3NW=)ZF:NA=QG-Y( M2&&$I9%!WUV7,!N)'.N99VO%TZMP0@BW/2+$-X')-QH-[S?R$+] MI"U4ARTO8.)7F))J"V%(RT9F5I4 ME(RP/!@7E";%E+CL^MQJ13,L&Z,\:[I@$('[QC+3D@DO++18<8]UGO88.BKS ML\=IAA39,>6'353=C'61XH+:5)V96.*GE)N%7"F8K&51(LN^CBG<.T;G0#BS MYYH.KI31&8P^5;N(.YE2F0_VSF=8%^!&2$&,L9#[=91'HQ(B<0U9JFM8PN_+ M3!UDA$ZTA- &3]":94>V$W7:V MO0Q;;?.[!UO:Y>45ENX_%&*W%!"?86ER(F*U@,O5/;**JI9UHOE00+J04D$Z8RL=D%6]I2)]*W.Z;YG; M$G.3GK&Z6::\3GD(:L(E/3>5O%0BU&!JQ5K*VTUK,"?B->T-&*5PJN(_N#P M8699?5E#(BH6XO?(E@R!*(]E]6 20.FR2PF.6>\;'@T2YAMARL242PH@^D*! M"BOCLYHN1#C7=9I*"T;E%1Q ^+%NSC6*+-["E@8V2ZQ(8BJ0ED=B MVD!_7T>QF!F7%C^!_$HJ;89+(!)MH(3J5YY0A6WL=RQ9K109Q+J@T%V8#W^\@U+-,E _BJ(5CFLV[ I%IA&6EQEM!(S> M[.(QZO)K;C_T))Q^K-:C\)CR!)U0KBBN1O:=B;::4K"AV)^3J0]-3 M3-0D5B6N/)]J*NL3_J17@ /YK(CLV5:>!C RTPS^ >*(H,8\3Q4+(#'\2M/? MYM#;:4%Y-0TU[(:7L62YSME$(C\)G*2-Q.&*/Y99E$^B<6T^CREC52XE;^?O M6\=N)B2? >Y\BV^WE+7J*QY-RT->X=%4E8"L?'^5'+G6G.I?:4'K"KXR'['F M:C4XD2LW3+8=1W?4L)\2OC*DL%_@'7P BS1=NO>L\CP^DH?8U8%3 >P!I> M5[O3@WB0#]<,LT8K[GK,WZ$_'ZB9LXS2##=':;"[T>3/SZ).T.OVAIW^) @Z MG8X0HW#4'W8'[58_Z 9A?_"_K=:S_89V'GOR-D1L,! 8&$+II^]#Y9[4;>!5 MZ=E?L&9D/;GTWQ.R_Z]9YT]EW1145O?:71U:L3W)[M_2VN!0K555ZJC3 VMS MV6D^B![H/KX>J)F9Z?3Q+MNT0!,Q3IGYZ#6=?O@4]"D\F+YX5YF8_OG9?]R] M1'WDV4)O+M5,2A KD?_73^$!*M968Y,2^\30>[0[CD]K7"(R;:?>%^B,K\7\G6+!3N=;D*ZVH4C M;(>^HB86W_J8B5F:*(_,I%R3)VA)IAV#=2IHX]!]:DH=Q$_0Q-$LZFP"M9++ M7!BG.59)7H2EWI,'-:0<'UGCVV1CPY#UH M9]OM1K^_78=^HE7CE0/90 GZ\[/V,W,TD_7XNK7X[@5*2]K62%5 6#8>6G,. M[CH4R 3X36XTK?+EX'<;%QK*^QG5VG'0W 05O=_(#F_%OOQKB=KMES1%TG&W M;L>R;I^4)9*7%TUJD\H]*6B1+54_;GE 450 SF2J4NZI :A):>*4/-MJ_K9X M]"@^N9MB]NB_F_O:$7=;MB0VG7[7^QA^FXMPXGT"2P]N>731KK4G?>_O7RZ] M8: .)LPQJ)1_;G35 M/+J^./1'[]!"RM>3I.25OJ7UPWO2#>UP.GQT0SN0;ISPT$[1_OEY&<6$N1G\ M-/3!$))AIF'@>[^%B8 !P)\_I\GL6YC,R!CZG(83W_L"?_HC@K]Y[]"4C<9@ M[7[!_)&K,/+I.:8-:#6#7K"+D70J5YGCMNF:/3_H#]VM]HQOM9_"\;=PIL*3 M!5)*X3VVS,"7+Q<(L71&Z2D?#3_#8?".CH#(^R"+=2+7 ]R06=6;P^#]=Q0' MIH'(<^__PNGI>Y>9"+V?K3/#.BJ\>QX3IWJ7;OK!<.#NTH>DR/9M=IZP17W" M0SN0;KBAN:&YH1U:A]W0W- .JL-N:(5K-+90ESD@7+F_A M^&A+&8[!@V0X#I[]Y<8Q%4@:(X7JA-EAWGW\E54: M$=V&2;EZ"Q?4PN?>,L$,\FT%_3=(M31?Q!'QF2&?'%*.8N!%E7>79=4D?7', M[*5(2X<\B2J?SBYRQZW\]S*$H9"?/.)R:Z"WJ:+K2V+Z:K[A)^@?P9M7*B'S M1I!:GPCBOL/^RL??)P6F%_X6Y85\1_%FO?OX%E,,?P\IO7#8H.Q".4I,P1RG MAG:52X!1#Z=B0H4+PF5QE4JZ#4F54IJYFR&%-)+P MS.$A22N8"225H0*3-7O:S(\U'Z@]PJQ@'ILHUU1"+(B*DI1HD>'#NBT]3_8< M:8D:2^*;LERKQ-M\3:K7>KI<+)@U79;?5EW7W>/N**%^6Y9\E!G!2<0X)-X< M#7I.+2/OL8HL(>'5)M'/QU=BL@1SCQEY6"]ABR3K590Q M<3\.8(R]_Y"A<*'6O-8$Y-=@[$\D^RP7 :&>6'SJT$ED+;:*O7%9#SGM$S$5 M"5.F9P+SYS/Y7KXDIC99PT"2CA'%&*I6DRN_^>+SX(*\Z;WM;A/MX-E?#H)K MH]/8R!BTZ3]_1RWT)9P*6.EW;.%A);C=&!#W11Q4>)>@SD'VX+:\+BV[L 31 M5>X\+M"MA[A MSL/<8%^@"HP3S^M]?OOT^7GK]Z'#SL*X9:3W7]VH-Z##?6J M4!=U#\=[T&[T<2Y^YU(6>"WZ+&:4QTBEIMXRG>E[N$TA4\]GW/Q$K):.OTFF MX]\E63:>NA_04BBV*O-:3[2=.FF5S-1W#!O_SXY3=F MFUWG3R)30=[)D5?^.];[Q2I'<%+9)+18YX@9SM?H:'UIA!M&3J305 ,29+8@ MU6J18=43$ 6L(I@(L//"^2VNUL.E17X7X?T Y/)3"B^L[B5W>W:_DYPE NNM M8!F9,.-K_2*,)LA8?H5%XFB,9"2N+;GDM-*7-#2($^DL8994-("U*WZZQ(8H MGQE+X'$):1%F"=G_J!V0\$D:L=H:U448['I)LH .4O8B*U2!5Y(5XS57MW=: MWTW6W?VP-TR_5'6'4/'[RPFR6EBK@\';_:ZO"4 O3P1Y.60W M:TKF^>N5A'RL88]"6BI'X'NJ/J>>)ZLDI[FSR(J0)N!2TSVN 0,G"5ACXCJL MJW2S'Z-TQPUJ'0J7[/O#2R#*&9XDY C].RE)>8C@O1XN3KSBGV+HR]'M:5U> M,6CAFGY"-]"'#Q^T*XAK=5F76MLQR:7.[&)HY5F+U*R94LF"9VYLS]P"9^X! MG2$'(TZD/CZ)C&8,Y^&O6;BX.D*#H\S*-Z-1$#=[1J1ZZ,=!_3)>SI=\'2L5 MGP#UAL79Z@X$Y?BM:4&]-;6M&=QQ>(\3F"0BOFL/[:Z!4@69_769R(!QNZD,G1!D>,X'A?1-J[+3 MS^$6I+3X"*S4)*'RC=('PV5:3<4#47ZY=.S'GDZ/J*7]Z_Y0-=TNVS!< !$SQAJ>P)ENP6.M# CBY8=ED4BX_;A;6MZJS+ M;4N=[&GZO,W_ISH>S6=>GHW__"Q,\_@"I;'9:S?_=]9J_+&8/0-3J=CT4\5A MTFPNOM^'BK*++Z)+8,_>HTT.L0-0_+MU^"M5"L,209N.!H[RQ)(8UIRT(--@ M_>&&P;(08&K![S+\B=QGXZB0A:(HN*+"H%SM8:0CI=,H%A/UH]:\7^QBIA/O M_7=9HP\OVQQ6PIM:)OM RLWN&NU4JSC'"&,OLJ(9QY8MXQUCO=!1<]6T3:XQ M:<9@V&YCSZU?=)?,(QT?+@)(AP2=GI,&\34-+0==0)RI+),LCJH#/"JR0^ > MJ^#2 TMG28H"I",FWLO+03"9_/S)_Y9@1:_XRAR: YZEX$ MIN8SV-:XFQPRS7:LMP^M4OI^]D)QE:7+V165G&3O72)F:<$[OH3<62Y(Y.#* M-YOA7; @H^MYN]EH>M"QF- P%%H-Y^E2!CV+:"XM8A1X(^UV19OUK6/Y.$(O M6=(^A2:D'\(.N([@\HE'HJJ95:0U]E:G1M03R6'U2U%NR5: M9,MQR9I%5W3/^;9B>Z689F4&.$<1V/<:[E91O!.(A576:K M4IU0<[=*\T(7V2I_@"[ZZ*A%;<>UJ/#V))U2=E6N/\D;/'3T'6SL MR#YZC^YB;_P\)8C.P5O__'WQSM%?B]%WGT01=X^$&S.(2!4UA1;T%4(E?Z^$"K0 MA0WY+;^'":P3NO/US0%!>4O&89/W) GC51Z1M?J+CM2^54%6>N8SAVCQD8\: M3?F0%?:VE,->'6SI*7TV.WI8_R==PFV!,*H95C\H2@&JB5D(> M?[R$&40KQC/@T3]DF2_VEG*0(:%J$W1'-LT2XM[ W!F.7#"\7P);S!.1RH@0 M<2YN^'Z9\,4D3)(E1>HQ[ IWDH];?1*S"73AV_5VZ+:X@/\=RJ);>'/,)B:S MARJ@_?7R\M-!P&IN-70^7F/)8W%STM!YK@G.I>9$YBO"?^F6G3&DBQ(D(KYN MA]XH2V$?X&K#/HA2#IG=P*\EK'LN1>K.YY2,YA5X5\OO-ILZJ88A_9A/,<)UMJ4D.8GD/U]"2P/E[):2I$..?"Y.,(Y"+*Y?86R0R1:)D$WJGEF7#0 M(8\H\6$=ZZ]"+(487R48@?"^)>E-+"8SZ5 2"854/\\YXXH5=-@+^FJ37'%BULZ/@F,LHK896;(R^)%"FL4R1$M]E M%VP0$8G>Y#JDQ$)"&&8I#$SBO&AN8/^829$9$4;Z:-2HWVAJH;7!8""?XJGJ MM70:!>/'M79>*Z:.GJM:QQ#W)HSS5'9).L3@X6&[1V%G+.DH/ZLFE6L*1BC' MJ*!UA?.:BI"Z&@=F2*18JEQY5FU9D_W HNX88"(WJT>Y*O$UAU]09F82O$5@ MF>\D-1+CAD(#*FBV\E412J[T(:>_S#5(51$U*2%6.5R@._;?>LE+ 71\&MV# MM=I!BPB< %B)\0ITU85RJEJ+8KMFN2X\';?SQ1(!N3Y# Z*Q-PZS"?XSG MY MM"$6= IW!>AQ(F+OZS_@WU>I:AY["']@Z2O2-(9_Y',$*BVNT@1_&A'F=T4# M1K@;- J=RV3^FB83G:<%9;90^BJ+E]Q5K$D94DA?M[I-U^I,;=P8,Y/FRT1+ M(NX&6OMM 0>'@_WZ:(,DY^D$ICY&:"?8M;DZ9# 3<9G1 IC5W2C^G.!ERV'] M1D7K.*<2I]@'4[;&*$;)E2DU,)Z'6/8S)F@9M)E3/V,Z=CCRC?$QJ7?8BB/5 M,X")1@6YN2JI58:UI@2+1 W)NJ6_A".E'3!5#..FV%<&HI(*'8]!0NCCJ/*S M2!18ULULW7+I'NO<*I^1)+AS"C]6@)[6KL781.K-$1S-Z;\4(IR(.;ZM\$[S ME*N=8O =-ZZ*AI@3_$:JQF41X?1:55S+*SD.87NI+#/2]131C+())8^N, B0 M3#+*L?-^H<,+3JL1Z$]%B4K?,FHU0WMBN9 J%:^S6'+7)O* -2'J7FCP0Z*Y M.Z@9U=M\.:(-C8$J2KG+B@1WZ]3.ZP-+.9F$F=*("H>LSLS2YQ=U3*XT>!DV MDFF>=,1RIC2C&8N(3E32QUA]$7MO"X&EC2U-KI;_7V F4$X#16DHW95VQ7@U M1N*1Z#;$^S%;O*R(,$C1$EO)N;_^HYR<3K$D4/ZS?^%\_H(P<5^+ M_&*9+5). ,63H,B68UT!V8"C*TV$(Z6J?D/VZ%^):1J'1\326+I;/>LKF?RZ MW@*/OOR]?+9*Z5<2,5>L(IE#"G(.:%/GGV0_WSVRB]!0_2M -90LV6HAZL7 M.BE1Z;(@-8FK694L2L8987GM=2'CV+,-#+ BJQ&#,S___K,7- =! MKS$T0 (46Y@#RZTQ!D6>4HG43"S0_( ?I-%Y$V88DU=WJS&HY:2S$N.?*-'2.T#ZW5?WB]H=T(K.%'OH/N^C6O?O!DQ'02O M5.C"06@/[7=&*U5V-\7M%4,* M")3WLOT*EY8/;9@9[V7_E6G.Y[Y@^-Y[V;%^P+5C]&!E%AI53=:R)#Q)P9Q* M9IBXSO>L.U3$^B2Q3I*9*6@ZC!'2AZ@$5EL2UH&5W6/4J[^E>2X5/7'2@ :6 MZ,A"7O;2,:4;38BFQ$=X"EZN*+4%=E8R0Q\&F@V4XJ\X(&Y $\9\%T;1YMNX MA1FQ-XO"BV .HAH16"5Y-(E 7GTOQDO)UG-AWD1I]G% 2TD^!B9:$B$TE*=& M#;GREKIY\A#G E:.<2HA.2OH ),'I;)H\'8XHO0K8FB1^\NO&;?YCG9ZKP/G M4)9C^4:.=GMYB51"$=VJY;>4"1W6RA8T2/Y*\D;X\A"J%4#IC2DY3"L2%K&Y M^=9^Q'CGOY3=N&6$#=N)&L5?([VYLBRD.IB+XBJEV3'R>X3W1%M9=NYQHDE" M(;WKULZS.X\O30P$RQ \T8G5:]YR8 TMA)%V#9'E1,F-XQ6BD1FTS'?1BF1W ME&B7;S;VN23=1H%?[7\X25DG)IZ8+^)T)2QC$*.BY&I#X"?=(Q'/RP]7)@G_ MC56B>=;;C>%0VY;6U^ G/10,BH3Y%=NSZJRTC-A.%\ZRK>W3ZJ2TE8UXDB:B MVDJ_PJT:%76K9^52V[/"[E9:8'50H%:Q#!E[L^#+O^BG+O6>&XGB1HCU*4\, M,Q..25F%H+7_KN\#->UQ+TMO> 8_F(@;!-.SI%77?5VD: -*)VS]WNLVM3GH MO5S??8/F'9O/815LK$+O[.'.- ]U&KFZ&U^5KE8H^<]>D3]+Q99)S*3Y+R7; M/,N[9"$R7&_T 56.*6L/5'?)"&S>:20Y9UF;RH2,#?8]3'_KQ8E>IQ7=@!HN MQ>9OT+%W%2WJSRA..>PV7W#HC/DNOYJ%&&)12?*8B+B4Y)2* MKKI,H:6YPN)G* GBM*S?%P89D^./YE!\;>?MYJ6+3.U69#EJ&WO/C1C*]@, MW;H,- @RB4[CX/+[P4?XTC=N/*8^(+1G-EV.NK\.IGO-70 M1>G+U\O/DC;%5^*C*LLQ\8Q.3Y,9$"69R#FRN7X)0;\]71_E82S95%.83=5; M.]**)I>W2 N*&\9VK_3CR,)0A-^$#HYP:G.1RH#8G&,B$\G=LCFC034H]4_) M^5B5*@V.:Q!/(P;X4$:LR+XMVDOT!X&ROP!+>B(NRB28TPBNS!?,\,B7 MC2AG%R'\^/O'+[^\_^I;(?,/;PV00*,%N.$)P#M;S?K_?Z.E33Y/\K^4QA5XP:'1>4.BYT#08^HN28$*_=2A4.)M =?T. M@FQA#)Q:_?;C/SZ\NPB&WB=&=.*+A M&@M;8AWTV!=J[(:] QT=Y&@"(4OQIPG8HTA0 M+]-P2;I*"L9XA(2U#8H+4_ M0*'DDVB\AHTA"X*!$#CA<$$$84NB4*$.I%GR/30P)X1G7$^%FM):P=<0R9QZQ,J!=)KR MFZ%ZFTXCPK>HQ483*ZMR!,.ZYZLS.ZH"7+5RSW9M!S@D'"JD< M GI^)FR9*:$R17%0O>4[_*%"O65 94V0N?36\WV80 YMYCGY CG62R9 MR2R\DIJC^B%B9X,#29G4*7/WX4:,IO;:V?4.L%O?*5 D2>TL,5%=7EOK&DDQ MCN,J*7HFD-E NE&4D:G5J\W83=<%^VX+4YK[4V3TD9H[J2/EB[)TJ#VM@D_:'3M,Z92BU2 M2?,P+9G67#G*R\1VEXPQGC$!8TU9;(':4-;Q;[9(B1" X;0@[40XJ\#JLKRFOCY(?32PX>3B;6O+H)9Z^F4JLT_DX10B MA';":1VPSQ:JAS6;IKP=OK,;!=#BE8B;3 M& ]DZ:PRQL1,[WVZW,"P(@,BNHXR>FA.S)X>F$/?2AH:%%;&/E*M6L9$HT!) M!6E.GJGHW[P2\LBA55]0S@_F3,&HLY0[%')FC8>ZB1:>D?IAAB 71E^7[G@9 MA@G#>%HK-6#G;]$G"=JU)X1P=O0]FA;O%R29@.,H1;OP1M#!1LXH[?,@;$8R M2TEMLE'/MF%N6;3Z3%;FCOU-8[@J*5;77+L>"9J6TM;E])"2K8@'39IP+@'? M;>-P1:/5U5<,\+,$");G!OT0A[#[KU3)("YU 3,;&]%[2,[,0]+XBJ=)\E-K M+YQUEY-G?'&3;@#LEE'$RF$KL9N,/9$E@T"$I6XAKND(ISX=?\/[G49#4J1& MWJ3DG9'@Z+;NKI@XJ-M(B'$OL0Z1CI#ZKG&?-%TBMG %ESOJAB46"L<&FHLN ML)IWDM*>4-?1K*$K>X>/&2#'(TVIP+?K$1R[ PW0$R<2@>A3M (F?TO0R/ MM?#&JM]#!Q2>E4@]A7 .-H02:?2FI9$RX!KU1(2,6M6*1<1Q57Z#FHPD29L< MVN_ABAN2YR""R,,YYETM%_8$,>/;&I8FI[X+5)<"U?VS#U23[K/#GA9(3\57 M/'*)Y&:?&3]H7>"%CUA9PP3CEJ$U!- M^);ZK#;/YG2/V:\TFTA,QG29\L1C&.\%7OZE!;796203>/14HBMQTUPRGE7= M]FMH[>>$#Y(0481.H)M(YMTC?-2RU7RZRN,I9NQ?20!'Q'.^'!/=MOX@;"KK M_\G2W.YL._ -APRL*Z'E-E01?J% _NQ>-O?#-Y6[R2:C^HU*L)"6->\\>%I, M>!]$UCE1R(2"Q7(4PU1+#\><:-[*.7ELCT@G!J^"EO]0WI$1)J][6K9T[9QR M:>2^T2=:60+LA;>\YWSKD#-L7%SZ$FIYRRYC7+<9V?T(&34(9Y@]O!W(31XK M\[UVV39*HKEFR_9#F=6-TL6F8KHA1E 67/0X(EL$SG75OC,+J.6Y6!T!?0)Y M+G^1&XPUH9H0:Y\>'4:Y@B'9[-96SDO"AA#B?"+R,6QQW(K(S>Q7YX+P)>K, M!.M?P2N^B54=*R6)K@()O3[$B=R1:^6KWN.^T2W&QX#U;-XJ/[PI(;)/@K;7 MWL]B'&(VIXWNL%)/*:?;J";#7%!):"?;PJZ:J+W94NF5]*V>$ZN0"M=15+>F MLO%QE^W%H!_[^Y)<54>R^7U*>LGH8D4F(6>.VJG[TFS2ZT2A,7?NTG!&9(*0FIE)BTO L MW#U#7TL#6P\5A93:GA=JR73L(U%^*\9)22> T>LRP(^I+3IZA&3+0D(6RAP$ MY,B_06NE3@ST2:I+C2:H?] B&:=9IJH@DZ6.N94J;F/CH*I3IDYE5<-3'[D5 M2)-V\-X(.>)X53=-MJ!IU%!I]&81+6_L7>:A63L*;V#@SL3A9#"K/GA4NE(H MR^#F2M 1QO[8&[)4-\;%['Y:QS2]O$QDDQ8?\%KO:0=JL9Y61!E72*Z*BD9; MJV()L"\/BI7,6Y>V*D@84;W@2>!7;WN8&45V.=4ZUO+BVP%(ZY!2-J%%O2*^ MB_&R$'IZM23)'\A?7X#V8IHJ!6):V0)DT#T8(TT$O:&2RV0Q.3&3/LWR(:@6 ME-@T;,J,*BV'4DDVZX$]-3J>-F6&_@BOP?A)CD[GIB2]/0D4D9V'%%C6M"RI MA!3+Q9'5[57V@ []*H25!?1BGQZ34LAB(_+A4ITQB:=%:H)4U27#=V#XIHX\ MU:.FN9,YOL32,$WA'J]7RS *?#)0*[E@)!\8C=)+@$C#@TPLV]'6^+U,.9$J MPB6-2K1O9_LU,%'=5V!&MH.N$C#PX*H@.GZ_5'1@MPV:P1#IN1J=+03@MA?[[$, M+JV[S1I$;B*^AZB%4.=M$:=[A%94VA3%1DQTB-17FD'7+3LD].^6$ETYOQT92_56/-;K2;:ES1 M9>>,MJX;Y70"5G#1G T_"G3+6+$Q=R687I\JS!.#MB'J3%SE\3*F]670U;JR M]'F>L=D%&7D%HO7IVRJS _U7*]LV5[.FO/62)TFK$D9%T95$N>-DD'E='6_@ M9D(J1CM]@.R+48HX9:S>))*9TJ;K5HD!EI-M#8==C >>T#Y [(LLMX:0#E3@ M9-(O$4$9*0P5&A:DLTC?2%:E]>Z.U"XH)(>5AN!+ #JX#<-(5$25N M\Y:R5H]9] R\A[;6!=;?&8=%::;D:8.R.25:+Y81N1W4>3(!)9EZH/O&WS M MCU)8K/'*PX/W!U]L:\,,-5*;WWJIK=)=Z7N;E>W%*=Z4YV)JBFR8Z%79BI*2 M:(Y3GK=K>3"!.*#W6E/;L>.;P/W*=%'W&=L8T5@.W&AC&=Z1^YS]VFO[7":I MV$1H53XY?84J[HS;B;^E KI2]9V'^%+I,8 M*F:JDKGJ[8:FEB0Z,\L;@O*REGYM85_K,I8V)2;9+A>X ]GD=7))C8"KU"UM'&)8")1=>)UFVO#*M8T'LXZ<)S;G M!S&U;L@]TG)?9A4@E:<<63@7FW-G<\USH-23=?RM/;N>U<8,$VND%*06:Q/P M<[877>S>CMT/#BUV?U#U/N\FPZA+[U8[U08$J#W%9^TT7I)!4[/#2J>F97EI M31$:UX6=;&4H]BHL( GZ5I"$R++'9<"03((ZBX2-"7E/,X7?59TQQH$J56@8 M8Q3JH%YU&F-7YW^:[U5>TUFQ"JU-QM,WH@F2G'?28E;GMCJARNXXJ4OU1:@\ M0,)W5Y1>>8'J+$6!@>M$\OUFRJQAFPI7/7 M!PEB5FGPS'6+;*9QI.K%[;NH=G89VS4<3X@$Y7BW()"BCO%$/ MO&6&;>^9;J1\&_NP/=(IQYH^G KKF(@.F5\.?T@K[=C M8K[&UDKA^ER(;Y1R.)WFDMA6A82F\A.,VZ_IFZ30ICZI?%MUE0'MR.7VC$EE M#-KU\5!V$+YNDXXKF+N!6[%]*C]78W[+BGMK[;,UFI<\\!3N(0.*42AU U3N M)&O:#3"_3+Y?,BZ+N1PDK5D5WK7!7='D9AS\)LK.6@EK:NJI7 M4_S6!C_]"6BL=R9KF5&_=!80&@-OH15'F92MD#)9]Q<@LQ26G76-VVALD2U* M%#.)$KH/+"*W**.J'.-05@41EHJ68U5X>P*_Z#S7:V0C*A^$K"LM]A_I55@6 M,4);^$T2./)RU8 W*AU '2?T29T+JZNV1P5Y9RFA"4%#6-;"0#Z(G5(Z($LS MA.]O.-"U%QX&@;@:OD^ WB[*3= %[YLHPX8F?RR9H$S6H\()KJX#KC MS/!8!>,8'G7EP;REZVR+*#=:D:K_67'R]DG5X/7RBU[K@*)LM+" MK"W1L"I.6'^NQFX31>E0 _#;%OIE98=6$5#J&5]WF"F/=)]"3LC?]3D M-H6PAE%=DSQ;$DCG7*2VMA^!M5)S1U-)\/5T2SNY*SG=.BRR@' M>VZQ@ L5KZI^@S-\RU$/!GDI.-662T%W#W.7I*^4PVA+K(PW5ZE)M(-#+8Z*8_+DFJN(C ^O0>=+D3JR+5AI5=^W M@F/V*"NW.A/)DDK$W*82IDK.J, 13C1%=XAL@$$!4;+V$DH:3L=-1)%1-G04 M.HD?-L5A>'W(.V)N38:)#%5DQ!&YVAC,W5C"@P=O?V+FJ,E6+_V MGUE\CVY)_VG.-KT%#1!;YV+C-J<;8FV9.UDA3F(^^!FD-,F$8A%2K&1POORW M]FNA2BB3V-N* &/EQ =1 D^7&[<\-K60;*T!1"4_KACO!+F9,+B$M!@E/)L<_U@>R2QIQ-4'MX,)/8M1E MPGCF6GPG?M)\3[)^Z0 !/,ZU"(V=%A4UM9 2"UFP*MV1*5^;*)]'41Q?I-,+ M@]O!=R,F>3%0?.9;4NPM=G7"384(3="OVDI>L35#1&_'\1I5K^JB94<:RVRD MJ!G9YJJ#=,DK;JYCBFQV&,(NL!?TIW0U!00C'=W&_F@)D35=7'&6.,$U*-QX M<.E?,%5SJ9^1/C5+)1R,05 &ARC*%Q<9Z#;N%Q4.DK)J7X,:DIIUO>U,09MX M014M)WMCL,P6$DJ[,5^93O=PA"C2RO.MMHE_.BP5/%9ELS6/U V!ND$0$_Y\C<2LMP1R,(VE\YMB;)5. MDQ)5 FKZ7&J62\OI&U6Q_A'MRE#6N$JVL>7 -$$V/H%UQ041W=-AQ,@8^XUR M(*9$:5="RF]*!7%X!1NO,#P"O$+)!KTCI?QP3=>W,@PV2^&R3SM^^T$6QT.-VX>2 =*0RHDI?RH\.N>:8-?+&"U"/:WTNNV[6J\N MJK+F*C31.IW'0M$KNYYY$=#JU_%K/47E*+,\2R/.EC^*I\'INT M%I^AS/A,M3D7T8K8U'O-,LH])AOK("]9.T8$/V\L/:^6]E&B?L.MSDC# ME+.O$WIC:?*U_60.;CYT0D[K&*7)DHX=2>)+5']W';K6GBF?E[9_AWA:B]5" M:/Y/_9[O384L/R^0=%EP7$=[$W1*QVBE/?OJYIIF%MMGC,Z;G,I<9H6519BG MT^)&A=/E%;%(4[QU3+#@XSC2CY91_]J<('M 9F1;FYK!TA29*A_D:]#V5O+K)C)F*9#" >TF@?,&6A^ "8K#D MS&"J:SCRU8O59X$13)F#FR8;77,YUZ@Q!ZV5JYOHKRLOQ56HH@]WR24=X!6M M:N.W3D%Y?=GEB#IK/;;+8?XH*LW26O.4*\-P?C(6U(5)&:_4']9TF>Z7XMK! M$'Q-&,\N.+!)8=VBGWQ&LF.UY[&P(Z M,C-?LL*"M,+8PN]J7FK(^8Z+@>^?G!MAP54B/FX93>_3M4@XX3K&"BKP[#U1&L2=<8SB_%WL*P0):.9]F!BXLBDZX+Q ME,9@/\&4AN2-9L"8)M>QTHDM\#S[Q#"_\CNU* LM*'@=0D8$55@K$X0SOB=> MG?&2<#R"\SWP3,F6&##%H\E4 [37Q^!OX4RA8A0Z&B%!3''T31"B%P:#'C$, M6N=7NM0V)1NGLR32YOA$7-A_@O4R%)ZXF,KY?\XZB7%5I:DS\XI\/T(6AY6; M@E)MC86 -3ZX*!JJJ2*710ME<__&#&J<:6G J2-\HJ)/,184S6U^./MI%8BK M7_V4Z1^(LVC"T<9<%$5LEV['YLABDQ5BSGE#RI5&]RO>0;%*SK*@,P3-5@ST MP3F22I]6;JDVC77A5=(1;2K2&,F4<:Y.I\J\JI?'ZGXH08=,):?C[ZW!V2KZ'.L8I#TK9_UEG.;Y M*TGY(!/6,0EEC2LR-]EX&^V,XS-<37UFJJ486@$>Y-JXX10R62^G))EAGB. M-YI*9\Z&$XGI!O!*:+ADZMHI4]BP#O/-B6>E.):2V716B0[U(T<77Z,J*TUY MTA9VV#90]IN:R>1R=0"+A5M(L\GSK8@\.SES+ZG,)2(, M6"BN=8&%A1=76(#49J:7B$)SK65U1YL#CRJ%.U6[2:5,Z$L8$9J!26 ^0"C( M&=/2HHVBJ/L,<$ :M'8)-6EYCI%955,W9MGJ BXL-YI7V& "+1Y] E_6;_&' M*VQW 'XL6GLJ:/451OMV*:?IUW24>Y=8'_Q]PAD@[\18$']DBVJ1!_UC]W1] M3-;'Q#+T]X0PE[(JKI 3P(X"S/5$[VJ42Z>$0M+BB[53J%&+Z@GXFP5>9/NW ME*"F5!0)IDK6IS4RQX]5=P(V'1D=!BOJ>R^#5Y0OIP'4;5X9$:F'T-K(^-K$@E-D%2D7HG0J$$_-/T=&FB_*G&) ME#^,=(Q9PLYD=('-EW-J]>7E[U]?\195I5Z14%F/'W[6&QE9UTHFULO.*XXK ME/WS?*6AVC,M!J:4J[%@JH#AE MZ+J&E.#YR:>8/L2H3Y(H#G82$\B;6FRT7$;7,5=D<5D<>WJ"]!E$F MXHKP N1Z#>AZKG*8@N8+7)1+@LC#CU_EW8]C=1@.5C%2M6YV9S%Y'M$HNBZ+ M7-.&]Z%065!XX\ 7E+_M6O+_4[V6RFE7<8M11@J[U#2@#1UA&!%5GX QY:1" MK!K;:,1J;@GCLD5&0+[AZMQE";^DASDQRI0>UTBV&CN?;>/\BN-\.SJ##LJ. M?9MF:1)RM=_+"(R#SPA]G=((WZML["_$SP)7!&.,:3OM[>7G]U_*5IHR@IEM ML]4GMLWF\1O Y?'<:OVB2E438R@[)U+@E<6:_I#!JE)MZ=6IF! (8?WX(R\+ MI0I9]*API WH8!OB+1.'8QV&DE(53DT\T4=(C8?ID.97W)64NDA1[D483:3; MCN^Z:TXXF8N#]J1NATUG9?G*.1N@.EISV);-AMH1*LY!:UPHP96!O53?L%HD M@Y=)M!/*.>;D&_,2&P38TBNVUC7]D#+7X9ZSY,1Z'B2EC6ZRW*55SE;X/)U$ MTY7.\ERWR;$KQKBRL/O:T&)3J5MM:VM3ZX@]V;0O*[2SY-6PRFZBZ4<27"\V M*JPC.=J# 5]&Y;^&1N3MA[KX!_6/OA$5O_XC*E\.#YY,7",I#5^V6>9N:C/..OMO5=BR'$%/L4^?X M0K]$ZC)=5]3L_T@E^5%K9QR'NARCQ0(S1K0_PN34AB8QW0[PPB0_#QH!Z(@X MMGP/G("L>'*?^LUY*9V=,"*V* %:2R^K59$E]^4 M+-1'O;?Q GPY%QA"3N!:DX_AA/N$91++Y6P)5YP6E[<_ MMHSU+M=$5H. $1@;OW3(WC(E?-?%)TB]O]K;5NSN=2MVE7];382A/<(29PE> MS[G(2BF]?XPS6V93D7NRI#KM'!+#+E3.\+82UE1 #I>H^T)SD2AN$B)"WEPG M2E_X)=DG/4ZY*?4Q"XS2XB=4@2.LLR3CFQ3MP* '%:7Y%3Z#7#C\5G_/DK)7 M4?FDYMA>%_:_K(R/"=:.E]*+II3]A$$P0C&529C9[:5:S,GU,LLX^9%X?W1U M-&3 0HJKZY#*0]56/UQA.M4T2M@9CF5V*:[&>6,KY"U"__XZQ4"9C\U+LUNE M3&=H8>4!%07R51$0F9*IG!65\L%ZCU%X[@DC9G>\=Y9AZHKINO\P]1Z-X_I\ M-$,[(2E%3SO$:[@YB5;&YM_<3()+D;K-7!)*)5K.*;Q/H V+/L;__(^@UWS3 M;JKCB(Q6Y9=O"^:[H0M88RY%[C3,#^<469A32DZZUHQNZEWL$0:R2Y&^ M'541T^YH'8!,S1>P4G&XR,5K]3_>3*(<3N+5ZRBA^::7WDB+4BH.W"G7(J., M=ZD4Z(/\L]Q$PTZC-1S@/BHR^/^)^K#<8@W:8C\5D_7?VOU&NS/<^'.S$6S\ M[;9F!XUVMW^O5F__K=OONKX^>%^#1K=Y+'T]IGE]M+[VMNO/3Z0-6". SD'] M]>=G[6?FY)[@9>-U:_'="]3%E55,+*9K:H,QH'6P'+D9U(^/ MRM+HLHD+?/YU3UI\\F\9=4K^\=$MM<%=5@A-SO]@0.>]/C(]."T?Y094[4W] M4E5<2.E,G-K6!F]K'FMKFTT_MJ4R=V_!NPQ_?U)8W_)9VQ\9I#+J[[^[@T&?I M)<4ATB4T,-_^#LW&K! MF?)E&\[D^[Z9%73 M.*D[)JGK=7O^L.FDSDG=4XZMT^N U V/7NIT&ZW=#(I:"3R\98+_;#3WLDC[ M&.V+;6YZ3D*^FBXUVF3K?EM[N[FIUNF9YXF=J]EA_T!VZ9#GN9 M>MU&=R]KM/^#W0G(5@(R:.Q'USH!.0X!Z??/5D >*"S%Z]QJM+H'?DWX*Q6Q M9*K3>UT.Y/BWCED>R19H]09^M[OKS6'7R3@B-^G)+7"SXW<[;;? I[K 0;/E M]]N!6^!37>!V9^=[SA.L[OY-&"=:/RY:0>, %8<3K1,0K5;+B=:YQF0^KM58 M?_TCWHD'@S??V_WA.NDZ>1:=/ ^T\H;ZZO>-&Q\O.*(?^*V=XY$.!O?4<8R6 M/^S>TX/C5NG),!BXEXX?R'SBJS1L[&>)]G_Q!&,DF6%&#:DPB!=CYP4N'W7M<$QP>[LG1+'XWZ+A5 M.NQ5ZG7\0>"0V@>^2D&KL>N%^U2084Y MK0#]P,0=P)R) +2=MC2$PXB?)@O MPBA3M:\6670=%B)>P4/QQ*)S/[-X E;&"%IOG!/4+9-;IA^_*C3WXVIR2W04 M.VG_![V3$28LZ:]P5+'KU\G$-4X6M:A+%5X%:A(G\DC'!J>.&@U_.[ MP3U]*@>3QO* /H^36^!.T^_T^FZ!3W:!@Y[?Z[D=?+(+W KN2[AQVBD=3K0> M0K3N&;EVHN5$ZW;1ZNZ,V#H+T3HW!A"3E!8EXW0NO)=QFM]2T^ ,ND5(G'^T#-Z(]%O-O^ ML-7<7L#KU_E8(&3'N$ ]O]T$6Z"G/\&[3[T\^S_!G6QL M=WUO//GAYV3C2&2CV>B=GVR<0PS@KV&4>&GB3<0X32@>&A81_#N=>L65\'[] MA_/F<@!SZ/G8R MXF3D$,=[?M&"W[#@,=P1QE=A,H-FX:X@_K6,BI47J3@"7"K*UX^A9V,.!DYQ/&>-VG"WT113CWP1F*: M9D+]L0B_WY/&[JYUM+VFWVK=$WCK5O:05_9E MT/>'S0?,4G6K>@"KVFOOS%7WV.NZ?^O%"=6/\B3<,S7'R923J8WNY\8.8.G3 MEZ=S",U\T)/VT8$O MT;T9:(_^-'?RL5U*]WX* COY.!;YV/7>>2KR<0[)'1MC+/@/;YJE_OB^#@=_J.O+J M4US;[N#!PS$GX>UTHO7#$^HDRTG6HX5F''GU^45GWF^X;*W?Q_@W(-/R M>ZU=[7#G.@H^?&;)TZH M#BT*XV3JW&7J8>,OQR]/YQ!\60?#A4611:-E$8YBX16IEZ3P?($"O]<+W H=[ HU7=Z,DX_;=O!.I>Z< M;)R5;+3.L8C2@_*3M8_^KG 9+ZY"+TPFWL>YF(7>%S&/X/(P68Z+-/-^B^91 M(2;WO&'RT*N7S!^X@!_<_#[?Q\P<]FZC,%;OQ\)8/S(]>_:9[S9"T!_>)%WB M7E0K\V,0X5/;(3\T08>]4;H#/PAVS6I^\$ERV^6@A,)MEUN*YG:'.Q3O.[6= M;G1)%)^XSRU>V5?>AV0<+R?09GX59N)B M%.8"]\,<"16Y/*XB5PQS;YK&<7J3O]9CO6UD'>B#7,@+-*)?!P/K+QGW8U"6 M_K' 0#3_)4HF\*_7K9:<(?9'*<%C\8&9BL-%+EZK__%F$N6+.%R]CA(:+[WT M1G9+2B.6"ZB(#GV0?WYS$TV*J]?#3J,U'+QXIAV!\L/\:]# ^:ON!OZMW6^T M.\.-/S<;P<;?;FMVT&AW^_=J]?;?NOVNZ^N#]S5H=)O'TM=CFM='ZVMON_[< M$1HX)I!0O<%I!O7CH[(.AM)!T&OTNVM'@?SCVF'PT+,SJ$Q.OW9R_D>$F?<> M3J")]^LR$5Z[Z9;^#BF-G!3^UA3VWSZJ3V5J7,;WFWXXYO:YBX E3NG,>CNOKN#0Y^EEU2( M.UU"$Y-;8!'S3%R+9"E>/0;NZ:#MW+=I7N $S-)TDN,Z[HQ<.H.( M\1'%?+M^T+IGTMP!16Z=S!V3S 5^OWM/5(Z3.2=S]Y2Y;ON>-7$/2.9V";0> M8:BTV>CO98GV'_!T\O$X!'A./IQ\G(-\G$-6_F>1BS ;7U$JS00NX'&ZN'?] MF>/-*>O[S8XC/C[P1>KZ[>ZN<%FW2$^\2"U_,'2510]\D9J-_2B[_9_I3CZV MDX_]5)YU\G$L\G&N94W/(1SU11 !E^_-1"*R,*:[03B91TF4%UE81-?WJXMR MO'?@8.@'7>?I//!5&OBM^R8FNT5ZJD7J^7BV/F$G'TX^'C-FL#4@0K[GB$:>;H(.6P[;@=]N=>YW+3\>MA&W7=QV>9@C MJNNVB]LN;KMLNUV:?J=[[MME%Z_^V5&R=!K!$8K'_F\,3C:?PI]UC*K+R>9Y MR.8],4UG+IOWH[/ZRW^-LI_^LI$K2GZOTY)L(&D>(=_4ZTS$%/>41$S<'_M% MN0I-\THX@@E?%IM?>716D2T9M[JM\G38_WF5J=XLPIFX&&4B_'813J&SK\/X M)ESESWXJ3SO,>64.J\/?O [[Y"2C%E]'!:S'N#1G:PFK+8;-4JKJ-IQCPS7* ML:#1VA^_&NN:]?_\>B4DE5J$M;=R+_3RY1S&L;)2<[W1REMD*;+L>\5J(;8G M73M(/C40RD:3!7-70K5@T&AV6P].^M1O=%OWHY*Z@Z"JO?F;]^]KKW]?(K+- MK<)QV#ND>;V]KYWFX,%;#4 H@X>?6% [S7;G2&3K$>>@\Z"D:MOP-!P5%4,- MR=C6-%SW(*_8R)5R5)/V]BI,9F*70*#C.OKA(3M"'L=U]&13NPVYV9VSUSM! MZIXGV=$G.G'!@YX8I\D,]> $6O M3^F-R+Q)E(\S4:QE[OPP^O3@QGO*C$O=3M];1O?H-5+BA*MP4? MTV+HM'>NR7 J>_ L JXPB'"&:11(G%B(O,#_#8U=1V.1GQMU(A:).?Z Y:FO M4LOO=(\_P'?BJ]3S>TVW2 >^2"^'K?8:P,KY>1]D:ON-SE-/[?Y-)K?MMBL. M,C@4AN;3G.#!X&Q)81VIXZ%$?\^-=JO?[_O=^Q8].AG>+;=?W'[9\H;4[?G# MIMLO;K^X_;(5LKO7@?URSV)@;K^X_7)F^R5H-?W>SO?,@]POCHNO9GD'CBAR MGZ%UIXB=(MZV(EO@#X>[5ADYA,WJ%/$V=NGN%60.86WWKXCOQXKZ"'VF%NL( M-==&$2#=WR]1#O/I(9N,=YWC?P?>&KGD5A2NM;R23[PPQ+3Y-87!:^;,FS#W MGO?[_4;/@V_%49IXTS3SICSN%;*NX>!]#SH:)>-,A+E YLWGT%BCK][Q/7@' MK907\& ..F2^"#,Q\8K4>][K]AK#VQH/&IZ'-)^Z>>S3(HM *F#TW@1Z">U4 MO]]K-3JZU0AF,8QACN"718E70/&"YEPMM-)(=]AHW=+(A[?Z]6H?D;RA_"%L MO_J:;+!^0%X+.0%+38:P@\.9\'(N=8HOC45U1N,P+TISJ!O,KZ)I05V3GY]' MWWT/7BRB,(Z1,76:BP+94N'CC>"%-Q'FV\LD*K"%Q1Q$5(W7?D")#$[/K5 B M6N0"B5LK4G3G2&HG2O5A O\+I'\"77NWS/"#ZU)Z [,U'HL8IK' ;] 0KD6< MTJBPZPGLHD*,KQ+8;K.5MXC# KH[AT6ZBL977HA4L_#F,L=/1TE!,RF\#HBP MF$3+.8WX"O:3=YW&R-SA_?[QRR_OOVI)\;T"U)DHY/K)L10D/)-E7F2P%A[\ M]9N00@DS,H?)'X?(SRQ_B;#.+?X(6PR:C2TY-FVJ:1ZG2;Z<@^#)5FD/WH ( MX7\''0]&M*FSM:W-%\M"K6U=YU X/H"PPIE4T.:_$6:F)EYOZ*G4&)IM_2W\ M@M7Z8A'+=J''Y>_PE\NC:JPKWCMUZP:=? "G"ZEB<[H$\G1IGN#I;4^C64^8NS5YS?/[P<1+<[SA1?=#'R59DX8?%\_XVS>DPFZ7I),>[ MPH1F#FX>.8XXG4;%5J,:'"&_^;#Y\+S.T&K_?NS>=W!0MX9'T]=!Z^&)K8]I M7@-HMO\HM.F=MIN#[F"[9K=D&ST*AK\[",H=%?OMD^*HV(]G>%L+P(GQ;SO6 M>,<:?WQ3ZUCC'6O\8;#&'\7@MK?C3F=!'<&]HR]W!/=.0AS!_;T1$.M.6D=R M?\R$F=WFP!\.=Z6@.;Q$=R=UQR1UG6[+;W?WPTSLI.YALV1*<1CE#C3)L^L'@0&JUG*9&:77.MFS&.9#<\]+R M?W[2SAQT:TC\WIFQW_>Z.Q^@I\*1^D#)E*EE#S1D;_L \CZX-U\8IMW$.MX*_UB6:W.,4.S4'2=T0#_N ;O4& M?O=02ML\(D6+D[I#&ENKV?&[G7M2:3BI)N#9,R/9K'.C59>&SYM,B.]11HA'1\TUR8NODWTJ6NCP%-YX^-K M X!>S.PNU0YH)(I"9"5JOPF3K58_(4H,0-1!^.(_A2>^+P2\FBZS\O>@]3'( M0I3PEZ8Q?& 9%M0Q:GQ9+#-BNPUA%O-E3$)Q#=UCDE!\#ALMD=OF8AY!J_B' M% G_IM!YI,++PAOX+@P%V5:1P) 854%4E],0/DLCBL,1,9*"]!%[GDA$!D\+ M:"^%5NF/G]Y*_E'L._.=/B03:05RT6DU^D@@LDAS^M3K3,0P^&MAF/.0*3KL_[S28)0%[)"+$4CPMXMP"IU] M'<8WX2I_]E.9U#!*+BIS6!W^YG4X8/5_"R_LR:O_NU7TNOH?-@VA-ZE_A*?7 MJ/]VKV4Q?]^;-I9(:7=6_WBJU:O_6_7YVBA:K5L>QP%\!&WYZS^\M_A.LM+: M=^)%\+TLG"\VZ7;^'#-BLRK&EY+2=$NM/0X7X3@J5MZRB.+HWR7^YB*+1LN" M.UO<#/= TSH<-EJ]X7U86L'VZ+?ZC\ F&MR3G/(.)LUVS_7U$?HZ?!PJT>;P M?G2J=S3;&SP*2^LCK-=CSL%VN_8\V;V.:EB.I=6QM#J65L?2^LA3ZUA:'4OK M2>[H$YTXQ])Z2@OJ6%H=!Z=C:742XEA:[XWEV.3%=5RMQ\S[U _\EB/-=$+W MI&/KM?QA=]=,%"=T3NA^B#,3-=VNN2!.Z)S0_2!$Z*<)IP[:C?WL MZ9.!4SN%V\'FO!N1">]Y/VBT M=P3_#\P;C/V'4[0&_-EKWYY6< ?T/RP8UTA@/&@OA!8; ]V@#7(4\T6@7S)3)OE";+W O'XVP9QKX%(KT2X60,6Y6! MZV&2P._>'-:CT _YV*^@T:_M5WX%DW$QHK9*75/=D?VHX#WS(AU_\\*;,)OD MWBP+DT),Z#L6ZK;TPD0L,C&.2FWG/G=Z\UO(*R;R'/X,HYH*? ,6KXC"&&8H MG4YS42",EEHP\SX1I18H10#^NTB+U0(QKB*9@2P*PKNJ859R#503D]+#X;B( MKJ,B$CGG-]A)#.(ZC"F' 8<4)=@/@6.'S^RF]Z" MHS]-[7FGCEO7GH&E+1@[#R9#C?KLWJ&8[X#.UZC/CM77QU.?]*&-&N<^^L(H MY'I]0=\$:?DA'2P'4]*]F- D+#U:_P6I)E9&-BK]ETV#2H7FX.])@>E/^F%H M73Y!RJE84:[4;>E/APO6_R)@?C %3&5YT=Q-YE$2D<(#+;<;;G]0CR':!TI_ MT&W?$Z4_&#P*FKS5>10D]<-#GEU?$:5_OS?O0J@_0@(((M2#]MG/08>S6[_O=X..$SHG=$^9,=+Q!\&! *F= MT)V)T 5]O]_9#]W_^6!M]V.^[!]KZS3*.6J4EM\;[@==?B8:)1@V]F,F[%^C M./3^(>%/=\'122CJL+LSD#_HKT-1ZVB<^WT+^O@@2/Z!*1^P&Q0U-\,N@U%K M4/O^)LA^";A: F):4%/5$_KX,H&*'J6@CY*)(@=\>S1C#JUCD._=C@X_&U.CIV.B+M.A=8&2;Y7;D(FK.2$VEU5?T($ULGTPR>$E111WZH^ M,4$578MX8VX$?N3MQW]\>'<1#*'GH%?GT?@X"Q5\ '489317,#!8GFN8R7@% M#\4J::W$>+5A9%(9@<;$#7B@N1 =*BERKUR(SL-CP >-H/M_W&:[3W*>AW7''1;V^6#G">&[JB&Y7(A7"[$P^="'-=R_BAH M^J& ^IM1^D"J[**["Y*(02#D>9BOD'E=^ MC?%5F,T$87.1?]PB,$><;[,$R/?"J@\D+\*LN%@N&/6;K!J>=YGCFPI#P.D7 MB ID(#'T[BJ\QBXBVI((FS?[5607 M6%S0#TPX7_?<3Y1R1F.A?>RSC-\U>^ MEXC"VQ',Z+!\1X./.Z:^.BR?P_(Y+)_#\CDLG\/R[1C(/ Z&6,=K?)C8/C>U M#N9WJ#OZ1"?.P?Q.:4$=TL_AN!S2STG(82/]#CI"MLDWZ_!\QQP;' X=>[&3 MN*<<6\OO=!V/K).Y)T5 !'ZK-=P[!L+)V_G(6Z?;W[N\G2;FYF5WV&@_]=SN M'V[C%,D9*I*VWQLX_O/'5"8MK$I^?MKD=O#>&J;JS<' ^39"Q!1SW@2Y^IX' M%DMGE*SQ^%:Y-Q$=&(=Y47K04&O6$,M.TPRZE7CC99:)9+SRQ/?O7 61@E\]N]?WNV USN"U3 ,C[@:;4. ZI$'<0V+ M&=2M2!6O62$\E:L2ED@3=U^7V=?C*8P[@OFS[P];^V5<<8.!3M7>6OY[8$KW_ZH!DN_\>1(Z?WCH9PR.4-E L9YM]?= M^^%UFHHD:#MJQ#*Z#O@X&15CU>U1P?E8]Y5&8?/-&:9:E-R @>-'(0W_[U']Y;IG?$[[T3 M8S$?"88XUO6VBI/LW=+;[3"2Z_C(%A=2,5)\S,86] MZDVS=,XUIZ^P/'6IP+7LE)F$QI%5H29Y_&L(0^=BW'O ME]Y-5%S1/SX056F:^=YBF>7+D,7EYBH:7^'+,,]:J-6CA,U-OX- (^.IUVH$ M+W!FTV61%S#UR(A:G65B186]M,QK)AR)6V'6PMDL$S-H$WL"*Y8+K@2OT+]! MF@ZA_#;H*)3&W] MZ4L5>KD.X+9>]U&-R3^_A5900M[!NOG$UWOWCC2'!VFY;K,Q?(%"V1DT!B_. M>)4NXSSE.233"Z=D(G*PNG 33:(,M$*:D0+$"1VE838A8F,SL[BN=+2HHRL3 MPGO9?H6;&1_-!>P%[V7_E6G.YT68XF=?=JP?Y!$ME86U_&>\0O\47I)Z<0JG M3\:LT2'II"P%106[8!J!IAE'8"K<(OYPO,/;,Y&(+(Q!UX5@D"_0](+_ 79Z M@0W!W$,[BUB^7813Z.SK,+X)5_FSG\HV(1B$E3FL#I\' M^9?_&F7P:LV'-UJ8>S(G>3O,!30!H@1F()P1L'E 4GVTNR@Y:Q3%N % "M,1 M&EA^S;8P8DC57?IO*IRF09GJ:YIR&?J#>@#3]JK9"@O MR,-%G M43:Y@'.([.(M+VA1KI_U@B>ZD_6:MUS)AL;+TX#+HX?^0[X.5._KDY3MF<03 M\T6S*,^7\N'*B/#?UV$L71[MQG#XHL8[ #_I[%,8 M^#C,K\Y8<*V;&Z_+6V/VP"QWNG#%4I-X]TVMHIK:T@]QQO,+BN'7,%FB,=;J M<2V9-?E'2S,6M .4,8C*UKI_VUL?7_Y%/W6I-(FX =TF=5!U0ZPK&]*CL&H%6/?U*K3;U'XK M[^6Z$AT8#3L*I?\%O[&>29^AFN8-6)6X5V>\UK_ +8N%?@@M!ZL9FX8*,_N>[J<(@!HPTU MO40IW51JP%*)+V]&KOVI][P]')I:65LY^WU2<"%&::P7I]Y]7/\GO#;_%,I. MKZN35GN0&P-+VOK6"SCGF5BD65%VX7JPX D%L. CZDY3:3I%'PIY&B_FT.\K M+PYGI:B8=;LL8 YP4]$EL^0H@5',-XA$P_M%WE/O$$-YJ\'O\V#HCFN+YO.6 M%?N##^$]R0RV?H!/*$4;WCN B%V+D?/$0%.$WU5D=:NP8^=0B$X&W?:]B$Y: MC: _? SRD-;CD(>T7%\?A>3CXU3#Y0D)\3D'.H''>+<]:E31YAVF1[Z+>Z!Y*$[7)UST7H_&'[0"JA M.)D[%YGK."WG).Y)):[KMUOMPQ"ZTZ0E& S[C?Z9TA(XE7*.*L7O#O8C\&>B M40*_V6Z>K4ZYC>KD8$!C]=EYOS!FC_!YUSDS;-34R#H:^.4&)!S!,"U\8BZ9 M3Y()#QFQP\_;PT9;PP_QI^=MPW+@8]K&@ID?XA71F*Q]I$)DTC7-42X?';LO MMJ%@J9*>P.>^$@O)VB<9QFOU>RK!F!M1F-!(O&0@\/-VVRH1.(&/9J(HMV_Q MSECI*CK%$+[=:S1+F$WNHR9(R<-8;( #A]X?*?S;NP:!66:"IAQ?4=^LHI$) MMXP4+5;># ..+4*6\BMU>7-J++>EUGGE#*HR?AKGAU'HE(/PO&GQZU _.*U, MSZ>U;%$AYOD=JVED[J[%#$J+V;2DH+26LJ_PV???\7$%&]_80>_E7M954?!4 MIP^[](HS!H0F7\'.4@Z&/4=YK<27=GFOT7Y!?^DW@A=KFQK716'8)4S;7A]\ MKZ8+=B[0 E16.LEEDA?TQ7 1&=(@*;P:!HTYI[12:?I-S33*0F?8M5;AY?/A ML+PH-:\MXB7OD"=?PE=WZYZ*F@LWC;O7;+2VWP26Z%36;AY]IP$JF#S\^1K6 M(H4IFHETEH6+JVCL_;',HGP24>Y77EI,3OLI^--J#O)PKI:94A^P9"H^L(Y$ M/S(+() 60/.H+0#)IK:5!1 HW="4%H"E>\D :-I'>$E7G&^*U]V&SVX,;E7V M-K^6OLU*U"NEZ=FT;C7:Q'R?/HUA2)W,S>J7#L\M]- KV!T-J['FAL;LIE3* MRO.@;R3KG-,#C0&RT?BX\Z!72MF6&]R]?*#;DO5RV.B],,?2&JGA&2]$C:%3 M,^5TY%G[W#X;2[ITD[7S2.>QO?38Q\TK^^-98='DS\^B3M#K]H:=_B0(.IV. M$*-PU!]V!^U6/^@&87_POYWALUT/R[,D ^H=&AG08\]#?:[>;Q'8W!.TNE%\ MWX8+-->\SR)/E]D8/G.ZJ;$?EYFB3X,1)T)2XL2E"1G+": $Y5+FGTC+C#Y#CR6+Q)"4' M78#[#GULEJ4WU,0($U=%3O?VU)L0E>*-D/FQHNXKM4T:U:AXPI!*-I=4'+!4K8\XY]O==FRA*Z MR,X@D!])B("KNES ":F]-U57W#0<9=&8K^/3<,Q)W7$ZIK'"QS]F8H;40.3C M2$=P%O"S2\W.41DF;+E04<7X8J$G[TE2NT0L9%T=\B>\>#'XVQ)YHHBFU D M(.'D#Q O^-^_@3#!OXG$FFBD/X+9A/WXC+I$R=1O'W[^^%DOO?;)P"4&+N64 M6,TYTF66$9L!8Q3&K%VF>FVHIS!T,XF2<#WF11:Q':>Y=>6 R5>8:WX: M(\#FP>(J+$H^JK6I9@VLEV*2P1:>I#=)19IKUJ\%+UVRP)3I*;@EM.&1(0KI M>2(:NZ)-SJM#N76RH,>TF'2CM_MTP@KP ^QOT'#,LAX,_1H-81-5PC0C<7E8 MU7;8,/'BP=^BPJ@16@C49O@C-#M?)E+5Y-YOT3R2*H;:5%)::8OW]:0L%QW? M>&%PN4J[@7OX,YYIM+?F<,.(0#18MP2-9I>B*ATF'C,3P#18P5!N;$N=TA6B M,C0V+!99>AU-A)=?@=UP0;%")_=\;7QK>.Z1?R#8,&F3A"S+6:LY]7VZ*\H(P74XB;I"?%==W M'L((EO.2Q4&C(SKPCCT@S6=.OE">_7",W*5&G4#F?$"W$PSS;Z!TJEVO56!H;G'%!OOSM2JJ?-SNZ#,^.+WST9XDTO(X M58^@?#Z "8<'FSR\40>)C,XNK9:T\KESS]^$C[/I^ZW*I@_LF)S>]7?L>+7; M*SM];9YE#]<^C(901+:*Y#P#PZEB98(9*>Q]+BW:M_R24M?M!]!7W2KZJ+9&&RA+OI;:(O_Q]Z7-[6-=7E_%5>FYWV2*HG6OJ1G M4D4"R4-/@'0@G2'_=&FY B5>&,L.@4__GG/NO=*5+(,!&VS03#V=!&SI+F?Y MG5U9N76CN!!-ZA8#,4:E.U:,8?S'1#!-K;4<"ZZRCVGPQ"E'SC/6G.P_7B)X MI*UQ^5!IG%4V=ME?$#,'@(X3G 0SYOWJSNG)<"93["PL3:B('!, 8,:"=>R/EA% MPI 1-BNZ%WO\KF')>=ISKE^(1I1 .W(:9SVS)#RWF)U%_:PTDF&5;]4;X=!) MO"^::2Y:&=9\B9I8\(321T!R]/O35(99?CH=U_JT52=0-9Z><+$YQ>': M8NL7L 5N1O,H/YIY>"TFG(:\2 M"M,39(H0D/FD/WOO?*5QU=197"??QZR%+-P,(DR!QRW/D$?N^$K/1%;1Z)S. M#K&!W-[L(?YF7NN'B+ARJGP///5"J!2A80;=9Q,V4!)YP24_B M#B\*@EJ5KI6M4QMB9:ZZO$Y1DI^S6CNI3+&D\5Z%2LWRZV[H2Q6?\>S0\_3$2 M#LLC5#)G44X8';_P3NAN) #I-Y *]]]';]_)5VHX,63,A M1+@@]COGIL')@ MB1:1(F\/F2%A^4]RK]&",& M"R$2A4<7PZLDSE7IVOA*7JA9EN7'U<[:)(U+:2*M <4H/A82B?L3CMCX9YZ( M#L+O2W?E-O<\GT[S% 5!,UN3[+6H..,]]T7H6?I%\;UX2K(_JQP-PZ4;$B') M,#!'V2E&H)#7J#MQEA5X]9CI5G 7:;G^&;4C3(3K'*U2<&OTNB%VR3_/!6N@ M+03/5*(:-<.F)";D!MZ;O\&)M V:3R628VK+;5(?1B*"IG=GD;7C&BG2Q&$, MAPVE7TA01T7Z"_IW;Z48A-L%SJ]-0TBGF:10/.KI<(H\)'P""-X;+"T$:+@9WF0S)2 MJE]4)T=FAAH2;(#R:P*"TCK!4Y6GH\B6ZDO%&85!*6981_BPDU^P7XGJ 8PZ M*JJ7(P*C(B^X^\#V##V%^Z?<)34@N>I0GQ#E-2FIA/DTWC^\2O8F]0G+UGJ8 M"YMG:,54#R?]50CW %==JG] T5>PIU0:1XJWJT[1L(Y1FF>7(M]LKB*28W=) MU%4/&0)KML7O:UPUFDD=H-3$:8%*(HKA53)T72[Y8F:@$U$OF2&T8!F&QZL MS<3[[8L.[3SLDHQ.AR =TA;0M705>5U8N3H>'KQPJGS7)QPM58"52V+#GR-P M!4BXI\@5R1XJP&]+]A N!_*A"[:M.QZ("^Z=Y3&SIU7D>\+*!95<^!B6)2N0" MS6@^LSB=YC5IW#*L1/MLPHHTI\A]#(OE5B1LW-JRW/_4;I_0TD(L&Z3K: E< MVP/SCD_YZL81]ZWGHPW7A=IS5H;*B/.GJPL;<3=4A=Q9T)P=RNWDGZ3HQDQQ M_V/>_J#F0?Q<_?H3_W7I>2)&E#ZW*87AE8=A;JN53'VI#66:?86*'HW]G# 6;!-&$N?L ^P)N M1XBAI)J0<$2PTPGPT*37%[[3R4C$2N0V>8CJYZ@_Q3!*]#/*^W*^#TW8:AZO M=)!4RD=\I\^X"PTC=&-B^R/^C6I3:;FIO"C) .=MSHB#"3JAIB#%&V_ED:1D MQ&>Y%;,OR NE[IJ/3L0XL(ACT!?.1GU81/$O4<5:)0LT:^R55#->97:!%= I MG:="@GAQ8B7-,8"S5%\3-#S>4)0 6_S/N1HFJO9Y M,*IM0"R3QGS'&*HXQ;FDPO.1.I3-QH$Q MJ\;PU!W2V-XQDZ-*YYP+6.%&]2T^F(MOEOW"7*)"' Y6!Z#Q7CF,^7SQZ1"] M_=*A_OGHBQ1JS[B,;#[U(]RNVB((UW E7"IYR&^CA;%+&1 "\J*ENG]GIM"_2<,NL.J#P04X&(T,$ MR(-]F&4QR7E=2P;8C\^PQXXZ0B<-07'%.8>!\JOETD3.6*4<28MG:!Q6]RCX M0I;H"26@"281X>$2K/-\,"F'*&!V+@"]]-!II5%3\+0SN&4PM)5/H/BM3>&> MQM\!K%3R^F<.=\EY>EPA42';:.G]R^;PUW243+F'$+\H2HFH8K7\A3!Y90@) MXTG5!6BD9N7-UZ*L@P@'52K'K28:R%.OZ$ ]?C#!)WTFK00:%-]^X/*\:_>% MXA5IAXMTIG,H!ZJ%X!4M^U]%[XA\N-LIK"T'V5<>UGNQLEVYLI='V^]W7_5$ M0@DY0+@U$L-+$TQR^:0BM,J&'%<$J\D-Z[P>BQ,I&X.\+IA"SGAF:%K+RT>V MP!F%4VDJYV/<^G0PY:0$J\ER(AX"86# ,,3UTNJ-B%XJ:T+>DQ*X)/, T*]4 ME>62N2T'H"*AGV 8N>W%B^V+"[W*?8"8."$?^H22S":4>U-N43R=NQ00TU0; M1(Z="D0E6GD(U%92Z'389T4AXZ#TJS,RO>!I\'HE^0JVB[FCN"B9R"E3<*I= MP$%\/B4QY06!*0P%3#'.WK^L=DA94S)0/L/(DF,E#V %-WHCJ*8? MB1A1;<0.MMDGRY^#:$V(.GQS"A^Y;%VJP/QD+8A4L#- 4>0[ +%* M9UCP;&@PE'7>"+XZ+TZ90F@J&F'S.W<1"815"*-V@LB@P)9+CE-]S M:U:9K2I4#HHP^>1Z.Ec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